Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.795832271482781,2.1479578581868024,0.0,0.0,0.0,63/87,14.09%,RPS14;RPS27A;RPL36A;RPS12;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;RPS16;RPS20;RPLP2;RPL35A;RPL30;RPL9;RPL11;RPL13;RPS7;RPL23;RPL17;RPL18;RPS6;RPS23;RPS9;RPS18;RPS8;SEC61B;RPL14;UBA52;RPL8;RPL38;RPS15;RPL21;RPL15;RPS26;RPS3;RPL29;RPS2;RPSA;RPL34;RPL10A;RPS27;RPLP1;RPL39;RPL23A;RPL31;RPS4X;RPS29;RPL27;RPS28;RPL19;RPL18A;RPS21;RPLP0;RPL35;RPS10;RPL7;RPS19;RPS5;RPL4;RPS15A
prerank,cytoplasmic translation (GO:0002181),0.7975938545847265,2.144696738758332,0.0,0.0,0.0,66/91,14.09%,RPS14;RPS27A;RPL36A;RPS12;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;RPS16;RPS20;RPL35A;RPL30;RPL9;RPL11;RPL13;RPS7;RPL23;RPL17;RPL18;RPS6;RPS23;RPS9;RPS18;RPS8;RPL14;UBA52;RPL8;RPL38;RPS15;RPL21;RPL15;RPS26;RPS3;RPL29;EIF3I;RPS2;RPSA;RPL34;RPL10A;RPS27;RPLP1;RPL39;RPL23A;RPL31;RPS4X;RPS29;TMA7;RPL27;RPS28;RPL19;RPL18A;RPS21;RPLP0;DRG2;RPL35;RPS10;RPL7;RPS19;GSPT1;RPS5;ETF1;RPL4;RPS15A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.7721746007761401,2.1055297484826783,0.0,0.0,0.0,73/110,14.85%,RPS14;RPS27A;RPL36A;RPS12;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;RPS16;RPS20;RPLP2;RPL35A;RPL30;RPL9;RPL11;RPL13;RPS7;RPL23;RPL17;RPL18;RPS6;RPS23;RPS9;RPS18;RPS8;RPL14;UBA52;RPL8;PPP2R2A;HELZ2;RPL38;RPS15;RPL21;RPL15;RPS26;RPS3;RPL29;RPS2;RPSA;RPL34;RPL10A;RPS27;RPLP1;RPL39;DCP1A;RPL23A;RPL31;PPP2R1A;RPS4X;RPS29;RPL27;RPS28;RPL19;PABPC1;EIF4A3;RPL18A;RPS21;RPLP0;RPL35;RPS10;RPL7;RPS19;GSPT1;RPS5;ETF1;RPL4;PPP2CA;RPS15A;EIF3E;RBM8A
prerank,cotranslational protein targeting to membrane (GO:0006613),0.7791458249892853,2.104463690767824,0.0,0.0,0.0,62/91,14.09%,RPS14;RPS27A;RPL36A;RPS12;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;RPS16;RPS20;RPLP2;RPL35A;RPL30;RPL9;RPL11;RPL13;RPS7;RPL23;RPL17;RPL18;RPS6;RPS23;RPS9;RPS18;RPS8;RPL14;UBA52;RPL8;RPL38;RPS15;RPL21;RPL15;RPS26;RPS3;RPL29;RPS2;RPSA;RPL34;RPL10A;RPS27;RPLP1;RPL39;RPL23A;RPL31;RPS4X;RPS29;RPL27;RPS28;RPL19;RPL18A;RPS21;RPLP0;RPL35;RPS10;RPL7;RPS19;RPS5;RPL4;RPS15A
prerank,protein targeting to ER (GO:0045047),0.7654108339872221,2.07702433696973,0.0,0.0,0.0,63/99,14.09%,RPS14;RPS27A;RPL36A;RPS12;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;RPS16;RPS20;RPLP2;RPL35A;RPL30;RPL9;RPL11;RPL13;RPS7;RPL23;RPL17;RPL18;RPS6;RPS23;RPS9;RPS18;RPS8;RPL14;UBA52;RPL8;RPL38;RPS15;RPL21;RPL15;RPS26;RPS3;RPL29;RPS2;RPSA;RPL34;RPL10A;RPS27;RPLP1;RPL39;RPL23A;RPL31;RPS4X;RPS29;RPL27;RPS28;RPL19;RPL18A;RPS21;RPLP0;RPL35;RPS10;RPL7;RPS19;EDEM1;RPS5;RPL4;RPS15A
prerank,response to cadmium ion (GO:0046686),0.84185335202314,1.9659364449618275,0.0,0.0004970352312526024,0.003,12/26,6.86%,MMP9;DAXX;NCF1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;MAPK9
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.8109054013287331,1.9583351432362703,0.0,0.0005680402642886884,0.004,10/32,7.50%,S100A9;CAMP;LTF;HRG;CXCL14;RPL30;RNASE3;RNASE6;RPL39;CXCL10
prerank,cellular response to cadmium ion (GO:0071276),0.8452500588417869,1.9523802527469112,0.0,0.0007455528468789036,0.006,12/24,6.86%,MMP9;DAXX;NCF1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;MAPK9
prerank,ceramide catabolic process (GO:0046514),-0.711878973567485,-1.9511291444245358,0.0,0.6627461023484107,0.452,8/14,13.47%,HEXB;NAGA;ASAH1;GM2A;ACER3;ASAH2;NEU1;GLA
prerank,T cell activation (GO:0042110),0.7481759480182234,1.9507075063365735,0.0,0.0006627136416701365,0.006,27/69,11.99%,LCK;CD3E;ITK;CD8B;CD4;CD8A;CD2;CD7;CD3G;PTPN22;RASGRP1;GATA3;CD28;CD74;NCK2;DPP4;LMBR1L;MDK;KIT;MSN;LCP1;CD44;NCK1;JAML;DDOST;ZAP70;FKBP1A
prerank,genitalia development (GO:0048806),-0.7198572402261808,-1.9095963968203384,0.0,0.5737281864273897,0.634,4/12,6.90%,CHD7;PKD1;TIFAB;PTPN11
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.827801663474931,1.9064035771352408,0.0,0.0019881409250104096,0.019,6/23,1.59%,CD226;KLRC2;KLRC1;NCR1;RASGRP1;KLRK1
prerank,peptide biosynthetic process (GO:0043043),0.6962654441673629,1.902492858216662,0.0,0.0018977708829644817,0.02,71/153,14.09%,RPS14;RPS27A;RPL36A;RPS12;MRPS12;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;MRPL51;RPS16;RPS20;RPLP2;RPL35A;RPL30;RPL9;RPL11;MRPL13;RPL13;RPS7;RPL23;MRPL23;RPL17;RPL18;RPS6;RPS23;RPS9;RPS18;RPS8;RPL14;RPL8;RPL38;RPS15;MRPS14;RPL21;RPL15;RPS26;RPS3;RPL29;RPS2;RPSA;RPL34;RPL10A;RPS27;RPLP1;RPL39;RPL23A;RPL31;HBS1L;RPS4X;RPS29;RPL27;RPS28;EEF1A1;RPL19;RPL18A;DMD;RPS21;RPLP0;RPL35;RPS10;RPL7;RPS19;GSPT1;RPS5;MRPL36;RPL4;RPS15A
prerank,regulation of T cell activation (GO:0050863),0.7564541894572482,1.8863360023706894,0.0,0.004059121055229586,0.042,13/42,6.74%,LCK;LAX1;CD4;TBX21;CD2;CCR2;PRKCQ;PTPN22;CCL5;SPINK5;LAPTM5;METTL3;CD47
prerank,antibacterial humoral response (GO:0019731),0.8673929533007011,1.8548615700297213,0.0,0.009864237666397801,0.105,7/16,6.74%,CAMP;LTF;JCHAIN;RNASE3;RNASE6;DMBT1;RPL39
prerank,response to interleukin-4 (GO:0070670),0.925219035925969,1.8516557563946456,0.0,0.009798694558979876,0.111,3/10,1.12%,LEF1;TCF7;GATA3
prerank,superoxide anion generation (GO:0042554),0.8744605560274958,1.8509912288143335,0.0,0.009211719619214897,0.111,4/13,2.81%,CYBA;TAFA4;CYBB;NCF1
prerank,mucosal immune response (GO:0002385),0.8640354943164216,1.847206438591194,0.0,0.009692187009425746,0.121,4/15,6.74%,CAMP;LTF;RNASE3;RPL39
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.8504696527017572,1.8449360249892905,0.0,0.009414432027255174,0.124,4/17,1.59%,CD226;KLRC2;RASGRP1;KLRK1
prerank,retina homeostasis (GO:0001895),0.8021882804965064,1.8402900350097826,0.0,0.010824322813945565,0.143,8/23,6.25%,LTF;ACTG1;POTEF;ACTB;JCHAIN;SLC28A2;B2M;PRDX1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.8541265741963887,1.838645502084189,0.0,0.010725497095450894,0.15,4/16,1.59%,CD226;KLRC2;RASGRP1;KLRK1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.6673404546329207,1.835522286349636,0.0,0.010835368041306732,0.159,77/168,14.43%,RPS14;RPS27A;RPL36A;RPS12;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;RPS16;RPS20;RPLP2;RPL35A;RPL30;RPL9;RPL11;RPL13;RPS7;RPL23;RPL17;EXOSC4;RPL18;RPS6;RPS23;RPS9;RPS18;RPS8;RPL14;UBA52;RPL8;PPP2R2A;HELZ2;RPL38;RPS15;XRN2;RPL21;RPL15;RPS26;ATM;RPS3;RPL29;RPS2;RPSA;RPL34;RPL10A;RPS27;RPLP1;RPL39;DCP1A;RPL23A;RPL31;PPP2R1A;RPS4X;RPS29;RPL27;RPS28;RPL19;PABPC1;EIF4A3;RPL18A;RPS21;RPLP0;RPL35;ERI1;RPS10;RPL7;RPS19;GSPT1;RPS5;ETF1;SAMD4A;RPL4;PPP2CA;RPS15A;EIF3E
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.7575490602864583,1.8328054461146221,0.0,0.011124121842320148,0.168,11/33,5.80%,LCK;CD226;TESPA1;SH2D1A;PTPN22;KCNN4;UBASH3A;CEACAM1;LAPTM5;RPS3;PRKD2
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.3494718301176384,-1.824494704305012,0.0,0.9272270779750279,0.907,52/172,15.77%,INPP5D;PIP4K2A;LPIN2;LPCAT1;PI4KB;LPCAT2;PLD1;PLCG2;DGKZ;DDHD2;RUFY1;PIK3R1;CDS1;INPP4A;PI4KA;FGF2;PLEKHA8;PIK3CA;AGK;LIPH;CDIPT;SACM1L;AGPAT5;PIP5K1A;INPP4B;ACP6;PLD2;PIK3R6;SELENOI;MTMR4;PIK3CG;PITPNM3;PCYT1B;PIK3CB;PIK3CD;MTMR3;ABHD4;PLA2G4A;PLEKHA2;PI4K2B;CRLS1;DGKH;DGKD;LPIN1;PIK3C3;CHKA;INPP5E;RAB5A;PIK3R2;AGPAT4;DGKQ;INPPL1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.8044666739001249,1.8217221874670726,0.0,0.015227352084738818,0.238,8/21,6.99%,LCK;CD226;TESPA1;KCNN4;STAP1;RPS3;PRKD2;FOXP1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.7308562457747982,1.8202490555641302,0.0,0.015127159212035725,0.246,10/41,9.55%,LCK;SKAP1;CD3E;CCL5;ADAM19;MDK;CD47;CD44;ANK3;GCNT2
prerank,response to copper ion (GO:0046688),0.8129194399792462,1.81626319102813,0.0012285012285012285,0.015905127400083277,0.269,11/20,11.01%,DAXX;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;ATP5F1D;PRNP
prerank,cellular defense response (GO:0006968),0.7344608081819871,1.8149956401857819,0.0,0.015865364581583066,0.279,11/40,5.90%,ITK;KLRC2;SPN;CXCR2;NCR1;PRF1;ADORA2A;NCF1;CD5L;ITGB1;LBP
prerank,defense response to bacterium (GO:0042742),0.6749561776553044,1.8122477973119444,0.0,0.016287462193354512,0.293,21/105,6.74%,S100A8;S100A9;CAMP;LCN2;FPR2;LTF;SPN;ADGRB1;RPL30;JCHAIN;PGLYRP2;COLEC12;RNASE3;RNASE6;TLR9;CFP;DMBT1;GBP2;LBP;HMGB2;RPL39
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.8563817603188055,1.8041849871963356,0.0,0.01903460848574781,0.348,6/14,5.80%,LCK;CD226;TESPA1;KCNN4;RPS3;PRKD2
prerank,T cell differentiation (GO:0030217),0.7276013567858374,1.801478468955241,0.0,0.019952414283140183,0.375,13/40,11.18%,LCK;CD4;TCF7;ANXA1;CD8A;PTPN22;GATA3;CD28;LMBR1L;KIT;GLI3;ZFP36L2;ZAP70
prerank,transcription by RNA polymerase III (GO:0006383),-0.5368480192192678,-1.8005271183086171,0.0,0.8837472288690957,0.95,13/27,17.89%,IVNS1ABP;GTF3C2;ICE2;SNAPC1;POLR3GL;BRF1;SNAPC4;GTF3C4;POLR3K;ZC3H8;POLR2K;SNAPC5;GTF3C6
prerank,peptide cross-linking (GO:0018149),0.7782412683970152,1.8001760136473723,0.0,0.019778574374672522,0.384,5/25,4.06%,CD247;ANXA1;CD3G;EVPL;NDNF
prerank,cellular response to interleukin-4 (GO:0071353),0.9100657358653513,1.7996940834848834,0.0,0.01928496697260097,0.387,3/10,1.12%,LEF1;TCF7;GATA3
prerank,cellular response to copper ion (GO:0071280),0.8402588824693067,1.7984755042828444,0.0012787723785166241,0.019111806311390388,0.395,9/16,5.11%,DAXX;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,regulation of lymphocyte activation (GO:0051249),0.8741096550658446,1.7922038308472092,0.0,0.021527838453628344,0.436,4/12,1.52%,LCK;IKZF3;CD4;CCL5
prerank,positive regulation of viral life cycle (GO:1903902),0.7795149666718867,1.7914193120427044,0.001226993865030675,0.02111646649139844,0.439,5/22,2.15%,CD4;TMPRSS2;CD74;TMPRSS4;LGALS1
prerank,granulocyte chemotaxis (GO:0071621),0.682249479519047,1.7748162864280725,0.0,0.029471265476624892,0.55,11/55,10.55%,S100A8;S100A9;ANXA1;CXCR2;CCL5;CCL7;PPIA;TGFB2;CXCL10;BSG;JAML
prerank,water transport (GO:0006833),0.8632999171847549,1.7739937146568567,0.0013869625520110957,0.02908366153158085,0.557,4/12,9.91%,SLC5A1;AQP11;PDPN;AQP4
prerank,positive regulation of T cell proliferation (GO:0042102),0.6891311839088152,1.7713606279062768,0.0,0.02987734001196199,0.575,15/55,11.31%,CD3E;CD24;ANXA1;CCR2;CD6;IL27RA;CD28;CCL5;NCK2;HMGB1;RPS3;SLC7A1;NCK1;IGFBP2;IL6ST
prerank,rRNA metabolic process (GO:0016072),0.6435196277883602,1.7702900242927708,0.0,0.029687780028871655,0.583,60/160,12.65%,RPS14;RPL36A;DEDD2;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;RPS16;RPLP2;RPL35A;RPL30;RPL9;RPL11;RPL13;RPS7;RPL23;RPL17;EXOSC4;RPL18;RPS6;RPS9;RPL14;UBA52;RPL8;BMS1;RPL38;RPS15;XRN2;RPL21;RPL15;RPL29;RPS2;RPL34;RPL10A;RPS27;RPLP1;NOC4L;RPL39;ESF1;RPL23A;RPL31;NVL;RPL27;RPS28;RPL19;RPL18A;MRM2;RPLP0;NOP53;UTP11;MAPT;EXOSC1;NOL8;MPHOSPH10;RPL35;RPL7;RPS19
prerank,regulation of viral entry into host cell (GO:0046596),0.7306123749520997,1.7688760832659967,0.0011441647597254005,0.02974363462811626,0.595,10/30,8.38%,CD4;TMPRSS2;IFITM1;IFITM2;CD74;TMPRSS4;LGALS1;TRIM21;IFITM3;GSN
prerank,positive regulation of stem cell differentiation (GO:2000738),0.810192554435024,1.763233890348576,0.002577319587628866,0.032804325262671755,0.64,7/16,10.56%,TCF15;HOXB4;LTBP3;SOX5;TGFB2;DHX36;NUDT21
prerank,fluid transport (GO:0042044),0.8561525226006833,1.7625854219433392,0.001379310344827586,0.032431548839232306,0.647,4/12,9.91%,AQP11;PDPN;SLC26A6;AQP4
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.8720564498303586,1.762278678511778,0.0014347202295552368,0.031907237284313404,0.652,4/10,3.46%,SKAP1;CD3E;CCL5;DPP4
prerank,cellular zinc ion homeostasis (GO:0006882),0.7548430234906567,1.754808212358825,0.0011737089201877935,0.03732497903263591,0.707,11/26,10.16%,LCK;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SLC30A9;SLC39A6
prerank,positive regulation of T cell activation (GO:0050870),0.6717207995341625,1.754095399400193,0.0,0.03701178629001937,0.713,17/62,11.31%,LCK;CD3E;ANXA1;CCR2;CD6;PRKCQ;GATA3;CD28;CCL5;NCK2;FLOT2;MDK;CD47;SLC7A1;NCK1;ZAP70;IL6ST
prerank,regulation of immune response (GO:0050776),0.6402002327769345,1.7538852704102934,0.0,0.0363739419234859,0.713,46/135,16.67%,CD3E;CD96;CD226;CD247;CD8B;ITGAL;SPN;CD8A;KLRC1;SH2D1A;CD3G;PTPN22;NCR1;SELL;IFITM1;KLRK1;TREML4;C3;ITGA4;SPINK5;COLEC12;B2M;AHR;COL1A2;ITGB1;PDCD1;FOXP1;TGFB2;ITGB7;SLAMF7;APPL1;JAML;HCST;COL1A1;FKBP1A;COL3A1;BCL6;RSAD2;CD300E;TIRAP;SLAMF6;IRF4;TREM2;SAMHD1;RAET1E;ITGB2
prerank,neutrophil migration (GO:1990266),0.6724328606977922,1.7532459650757377,0.0,0.036029531652133094,0.715,11/58,10.55%,S100A8;S100A9;CXCR2;CCL5;CCL7;PECAM1;PPIA;TGFB2;CXCL10;BSG;JAML
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.7400445721753227,1.7508188738590684,0.0,0.03723442188905365,0.736,9/27,7.70%,LCK;SKAP1;CCR2;NR4A3;PRKCQ;MDK;CD47;ETS1;CD44
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.6579734879190685,1.7495890369024663,0.0,0.03749972191535592,0.744,24/73,15.13%,S100A8;S100A9;LCK;DLC1;F2R;LAPTM5;BID;RACK1;ANP32B;ATP2A3;TNFSF10;DAP;JAK2;CASP4;APAF1;ROBO1;MAPT;HIP1;MUL1;NOD1;IFT57;RIPK1;EIF2AK3;BEX3
prerank,innate immune response in mucosa (GO:0002227),0.8854369007877199,1.7487459232699867,0.0,0.037153383536132026,0.747,4/10,6.74%,CAMP;LTF;RNASE3;RPL39
prerank,regulation of mast cell degranulation (GO:0043304),-0.6557647257064941,-1.7438843789897127,0.0,1.0,0.996,10/14,17.47%,GAB2;LYN;CD84;FER;CD300A;FGR;LGALS9;SYK;FES;UNC13D
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.7012739113589749,1.7431140406022443,0.0,0.04112205770404184,0.787,8/37,5.60%,S100A8;S100A9;LCK;BCL2;RPS7;BID;RACK1;RPS3
prerank,translation (GO:0006412),0.6316719343102651,1.7424918587387783,0.0,0.0408165331904637,0.793,80/208,14.09%,RPS14;RPS27A;RPL36A;RPS12;MRPS12;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;MRPL51;RPS16;RPS20;RPLP2;RPL35A;RPL30;RPL9;RPL11;MRPL13;RPL13;RPS7;RPL23;MRPL23;RPL17;RPL18;RPS6;RPS23;RPS9;RPS18;RPS8;LARS2;RPL14;UBA52;RPL8;RPL38;RPS15;MRPS14;RPL21;RPL15;RPS26;RPS3;RPL29;RPS2;RPSA;RPL34;RPL10A;RPS27;RPLP1;RPL39;RPL23A;RPL31;HBS1L;MARS2;RPS4X;RPS29;TMA7;AIMP1;EEF1B2;EEF2;RPL27;RPS28;EEF1A1;RPL19;RPL18A;RPS21;RPLP0;DRG2;GARS1;RPL35;RPS10;RPL7;RPS19;GSPT1;RPS5;ETF1;MRPL36;RPL4;RPS15A
prerank,negative regulation of interleukin-8 production (GO:0032717),0.7816289411165724,1.739482723828427,0.00258732212160414,0.043017911975470335,0.816,4/17,4.05%,TMSB4X;ANXA1;PTPN22;TLR9
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.7282517256566368,1.7360607097155663,0.0011614401858304297,0.045211089304323264,0.832,5/29,2.23%,CD226;KLRC2;RASGRP1;KLRK1;STAP1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6856444321118831,-1.7340381376197136,0.02867383512544803,1.0,0.998,2/12,0.75%,CSF1R;LYN
prerank,neutrophil chemotaxis (GO:0030593),0.6664185685187245,1.7207647586629198,0.0,0.05985054426139828,0.9,10/53,10.55%,S100A8;S100A9;CXCR2;CCL5;CCL7;PPIA;TGFB2;CXCL10;BSG;JAML
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.7502767769210793,1.7143441262522257,0.0012515644555694619,0.06665794712465457,0.929,6/21,5.43%,RPL11;RPS7;RPL23;FBXO5;PTEN;FZR1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.7420345904996286,1.712453137518196,0.003676470588235294,0.0677413835176274,0.935,9/22,5.60%,RPL37;PLA2R1;RPS20;CHD5;RPS7;RPL23;HEXIM1;RPS15;ATM
prerank,cellular response to zinc ion (GO:0071294),0.8100797639319693,1.7088930559289293,0.00261437908496732,0.07141331197604356,0.948,8/15,5.11%,MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,defense response to Gram-negative bacterium (GO:0050829),0.6849871696329141,1.7081618526152715,0.0011261261261261261,0.07113707748348651,0.95,17/42,15.92%,CAMP;LTF;ADGRB1;RPL30;RNASE3;RNASE6;TLR9;DMBT1;LBP;HMGB2;RARRES2;SERPINE1;RPS19;DEFA6;TNFRSF14;TREM2;DROSHA
prerank,zinc ion homeostasis (GO:0055069),0.7267248828495357,1.7042026572627116,0.002331002331002331,0.07476095443875351,0.958,11/28,10.16%,LCK;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SLC30A9;SLC39A6
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.8307172928234929,1.7029400564506265,0.0,0.07529662537179255,0.96,4/12,6.04%,LCK;SKAP1;FUT9;MDK
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4994173737547764,-1.6997413714520138,0.0,1.0,0.999,15/29,24.25%,CYRIB;SSH2;PIK3CA;KANK1;TWF1;SSH3;SHANK1;PRKCD;TJP1;HIP1R;FKBP4;MYADM;SHANK3;CLASP1;PRKN
prerank,rRNA processing (GO:0006364),0.616915382757452,1.699402920194401,0.0,0.07914457665645605,0.968,61/172,12.65%,RPS14;RPL36A;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;RPS16;RPLP2;RPL35A;RPL30;RPL9;RPL11;RPL13;RPS7;RPL23;RPL17;EXOSC4;RPL18;RPS6;RPS9;RPL14;UBA52;RPL8;BMS1;RPL38;RPS15;XRN2;RPL21;RPL15;RPL29;RPS2;RPL34;RPL10A;RPS27;RPLP1;NOC4L;RPL39;ESF1;RPL23A;RPL31;NSA2;NVL;RPL27;RPS28;RPL19;RPL18A;MRM2;RPLP0;NOP53;RIOK2;UTP11;EXOSC1;NOL8;MPHOSPH10;RPL35;ERI1;RPL7;RPS19
prerank,natural killer cell activation (GO:0030101),0.735337123262902,1.6978160860499003,0.006112469437652812,0.08006341282439461,0.971,9/23,9.52%,CD2;NCR1;RASGRP1;KLRK1;PBX1;ELF4;TOX;PRDX1;SLAMF7
prerank,regulation of T cell differentiation (GO:0045580),0.704763728724572,1.6946288880038218,0.0022988505747126436,0.08355001903410682,0.977,9/33,6.28%,TCF7;TBX21;CD2;CCR2;GATA3;CAMK4;SPINK5;MDK;METTL3
prerank,negative regulation of endopeptidase activity (GO:0010951),0.6704155471070641,1.6859449083897409,0.0,0.09607769914593955,0.992,13/47,14.38%,LTF;HRG;SERPINB8;SERPINB9;TIMP4;VTN;SERPING1;TIMP3;TIMP1;SERPINE1;SORL1;GAPDH;PCID2
prerank,ribosome biogenesis (GO:0042254),0.612444242012801,1.6855010080646287,0.0,0.09533757029463981,0.992,68/187,14.13%,RPS14;RPL36A;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;XPO1;RPS16;RPLP2;RPL35A;RPL30;RPL9;RPL11;RPL13;RPS7;RPL23;RPL17;EXOSC4;RPL18;RPS6;RPS9;RPL14;UBA52;MRPL22;RPL8;BMS1;EIF2A;RPL38;RPS15;XRN2;RPL21;RPL15;RPL29;RPS2;RPL34;RPL10A;RPS27;RPLP1;NOC4L;RPL39;ESF1;RPL23A;RPL31;NVL;MALSU1;RPL27;RPS28;RPL19;RPL18A;MRM2;RPLP0;NOP53;RIOK2;UTP11;EXOSC1;NOL8;MPHOSPH10;RPL35;RPL7;RPS19;NPM1;FBL;MRPL36;RPL4;METTL17
prerank,hydrogen peroxide metabolic process (GO:0042743),0.7456880795911108,1.6830112354330904,0.0,0.09827533526243763,0.994,4/19,6.93%,CYBA;PRDX5;PRDX1;GPX1
prerank,fibrinolysis (GO:0042730),0.8189172391062132,1.6787546419256112,0.0,0.10454307697346404,0.997,3/13,11.17%,HRG;PLAU;SERPINE1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.6765425210007243,1.6747131115911231,0.0011248593925759281,0.10982253079796309,0.998,15/40,15.92%,CAMP;PGLYRP2;RNASE3;RNASE6;DMBT1;GBP2;LBP;HMGB2;RPL39;RARRES2;DEFA6;TNFRSF14;TIRAP;PGLYRP1;DROSHA
prerank,positive regulation of interferon-gamma production (GO:0032729),0.6549286864609005,1.674219617288487,0.0,0.10905537721012981,0.998,8/48,4.05%,CD226;IL18R1;CD2;CCR2;PTPN22;RASGRP1;TXK;TLR9
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.813399027052776,1.6740318295663366,0.006925207756232687,0.10789266222755767,0.998,3/12,3.73%,CCR2;PRKCQ;CLEC6A
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.6469103812579191,1.6716135867841322,0.0032085561497326204,0.11096666562879529,0.998,12/55,8.62%,S100A8;S100A9;LCK;DEDD2;BCL2;BID;RACK1;RPS3;TPD52L1;ING5;TNFSF10;CAV1
prerank,cranial nerve development (GO:0021545),-0.6736715690093208,-1.6711451495286807,0.021352313167259787,1.0,0.999,5/11,15.27%,CHD7;TIFAB;SALL1;PAX2;ERBB3
prerank,epidermis development (GO:0008544),0.6475115570448942,1.6709927045190744,0.0010834236186348862,0.11020181141378123,0.998,11/56,9.58%,FOXN1;OVOL1;EVPL;SPINK5;WAS;UGCG;FLOT2;HDAC1;CCN2;FABP5;SCEL
prerank,lymphocyte migration (GO:0072676),0.6837659154678656,1.6691999005015734,0.00936768149882904,0.11216428385267062,0.999,7/32,11.18%,TBX21;GATA3;CCL5;CCL7;MYO1G;MSN;ZAP70
prerank,superoxide metabolic process (GO:0006801),0.6884884485736269,1.6669147342647628,0.0035335689045936395,0.11505344298228047,0.999,7/29,6.25%,CYBA;TAFA4;CYBB;SOD3;ATP7A;NCF1;PRDX1
prerank,organonitrogen compound catabolic process (GO:1901565),-0.43495479817509175,-1.666633659168806,0.01639344262295082,1.0,0.999,18/57,15.14%,NPL;CAPN3;NPEPPS;SGPL1;NAGK;TPP1;PPT1;MTOR;PLA2G15;AMDHD2;GGACT;PNPLA8;TXN2;PLA2G4A;RIDA;CLN8;CLN6;BCKDK
prerank,defense response to fungus (GO:0050832),0.760019230946022,1.6626310399544346,0.00395778364116095,0.12099449534843756,0.999,8/17,10.56%,S100A8;S100A9;LTF;HRG;CLEC6A;CLEC4E;RARRES2;CLEC4D
prerank,T-helper cell differentiation (GO:0042093),0.789506232702334,1.6604832752257623,0.007947019867549669,0.12383467108248171,0.999,5/14,6.99%,LEF1;ATP7A;HMGB1;TMEM98;FOXP1
prerank,negative regulation of DNA binding (GO:0043392),0.6909078330433434,1.6589396816364514,0.0024009603841536613,0.12539675689522892,1.0,8/28,11.35%,LEF1;GZMA;TFAP4;SP100;PER2;JAK2;HEY2;NFKBIA
prerank,regulation of actin filament polymerization (GO:0030833),-0.39519865299717494,-1.65626323888464,0.0,1.0,0.999,27/69,22.64%,NCKAP1L;CYRIB;FCHSD2;PRKCE;SSH2;BIN1;FER;PAK3;KANK1;BAIAP2;COTL1;TWF1;SSH3;BAIAP2L1;HCK;PRKCD;TENM1;GBA2;HIP1R;CDC42EP1;EVL;PYCARD;SNX9;CDC42EP4;MYADM;PTK2B;ARF6
prerank,negative regulation of dephosphorylation (GO:0035305),0.7345918082938399,1.6550600331722487,0.010282776349614395,0.13204354143510694,1.0,7/18,7.84%,CHP1;PPP1R35;SH2D4A;PPP1R15A;ZCCHC9;YWHAB;PTPA
prerank,response to estrogen (GO:0043627),0.6878001307083175,1.6540337563895688,0.0023121387283236996,0.13224960499251937,1.0,7/31,8.62%,CD24;GATA3;SERPINB9;ARID5A;RARA;TRIM24;CAV1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.8066606151211194,1.6517255289506185,0.00554016620498615,0.13559624435387452,1.0,4/12,9.55%,LCK;SKAP1;CD44;GCNT2
prerank,B cell homeostasis (GO:0001782),-0.687080413346028,-1.6467050281833238,0.019169329073482427,1.0,1.0,5/10,8.77%,NCKAP1L;MEF2C;LYN;TNFAIP3;PPP2R3C
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.556063237964341,-1.6453879830097302,0.027777777777777776,1.0,1.0,13/20,26.35%,MBTPS2;TGFB1;ADAM9;SPPL2A;TRAF6;PSEN1;ADAM10;APH1A;SPPL2B;RELA;APH1B;RHBDD1;ADAM17
prerank,regulation of muscle contraction (GO:0006937),0.6974740921633996,1.644346576327196,0.0024390243902439024,0.15097445149297797,1.0,8/26,11.50%,TNNT3;MYL9;ANXA6;DAPK3;CAV1;SRI;KCNA1;ATP1A2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.8003221878094384,1.6422306152143364,0.009628610729023384,0.1541054666379982,1.0,2/12,0.51%,IL18R1;CCR2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.7076406324533919,1.640071557400911,0.0037267080745341614,0.1574146945808547,1.0,8/24,10.20%,TPT1;CD74;BCL2;CLU;ING2;MIF;CD44;CCAR2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6396704590814285,1.6379661499755527,0.001098901098901099,0.16094360090536072,1.0,11/48,7.67%,TMSB4X;ANXA1;ANGPT4;ANGPT1;HDAC9;HDAC7;HMGB1;KDR;PRKD2;RHOJ;ETS1
prerank,ribosomal small subunit biogenesis (GO:0042274),0.6613638686752484,1.6362883418931604,0.004484304932735426,0.16286187744043604,1.0,20/39,19.59%,RPS14;RPS25;RPS24;RPS16;RPS7;RPS6;RPS15;RPSA;RPS27;RPS28;RIOK2;RPS19;NPM1;RPS5;METTL17;RPS17;LSM6;RIOK3;MRPS7;NOB1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.7500457629768508,1.6359206636293164,0.007692307692307693,0.16184636624246507,1.0,4/17,2.96%,FOXN1;CD24;GATA3;CEACAM1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.6472713402135758,1.6353427080818816,0.0043859649122807015,0.16136306577410067,1.0,7/49,5.28%,S100A8;S100A9;LCK;MMP9;BCL2;BID;RACK1
prerank,negative regulation of peptidase activity (GO:0010466),0.6518130608963498,1.6347321500836616,0.0,0.1608908756613309,1.0,13/47,14.28%,HRG;SERPINB8;SERPINB9;SPINK5;TIMP4;VTN;SERPING1;TIMP3;CST7;TIMP1;SERPINE1;CSTB;GAPDH
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5870683422207184,-1.6334254254946583,0.023809523809523808,1.0,1.0,7/15,19.11%,DAGLA;HOMER1;DAGLB;HOMER3;GRIK3;HOMER2;GRM7
prerank,"phototransduction, visible light (GO:0007603)",0.7825648940459051,1.6309907710747253,0.010767160161507403,0.16856272092616664,1.0,3/14,4.27%,ABCA4;PDE6B;SAG
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.6730531164859229,1.6287992269235438,0.004592422502870264,0.17245447124809393,1.0,12/34,14.62%,PTPN22;DNAJB9;SCIMP;TLR9;LAPTM5;SASH3;GPI;SPHK2;EPHB2;CLCF1;SLC7A5;TNFRSF14
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.6004410879312551,1.6281418078736138,0.0,0.1721619588785403,1.0,32/108,15.87%,S100A8;S100A9;LCK;DLC1;SOX7;F2R;HMGB1;LAPTM5;GRAMD4;BID;RACK1;RPS3;ANP32B;MALT1;ATP2A3;TNFSF10;DAP;GSN;JAK2;CASP4;APAF1;ROBO1;MAPT;HIP1;MUL1;NOD1;IFT57;SIRT1;RIPK1;EIF2AK3;BEX3;ARL6IP5
prerank,negative regulation of phosphatase activity (GO:0010923),0.6965454002835463,1.6276663269761054,0.006119951040391677,0.171176748873149,1.0,9/25,12.71%,CHP1;PPP1R35;SH2D4A;PPP1R15A;TGFB2;ZCCHC9;PTPA;FKBP1A;MASTL
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.8067984138627804,1.6263056427602325,0.005657708628005658,0.17293584513473698,1.0,2/11,0.38%,ANXA1;TBX21
prerank,lymphocyte mediated immunity (GO:0002449),0.7924590814349493,1.625808296883087,0.009628610729023384,0.1722521021857137,1.0,4/12,6.34%,KLRC2;CD8A;CD55;MYO1G
prerank,regulation of monocyte differentiation (GO:0045655),0.779668506082558,1.6252157489322148,0.008086253369272238,0.17178383609504835,1.0,5/14,6.99%,CD4;CD74;HOXA7;CDK6;FOXP1
prerank,osteoclast differentiation (GO:0030316),-0.5351574611496323,-1.6231479320670479,0.02702702702702703,1.0,1.0,6/22,6.71%,GAB2;CSF1R;OSTM1;FARP2;TNFRSF11A;ANXA2
prerank,response to interferon-alpha (GO:0035455),0.7511048370145291,1.6228206158584966,0.007633587786259542,0.1762120693535542,1.0,4/16,6.15%,GATA3;IFITM1;IFITM2;IFITM3
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.7053773695364904,1.6206978821681972,0.011166253101736972,0.18004065762060412,1.0,5/22,9.55%,LCK;SKAP1;FLOT2;CD44;GCNT2
prerank,epithelial cell morphogenesis (GO:0003382),0.7417016491243584,1.6146978098295566,0.011349306431273645,0.19545269959689965,1.0,5/17,10.81%,CCDC88C;POF1B;COL18A1;COL22A1;RILPL2
prerank,ncRNA processing (GO:0034470),0.5832513178958317,1.6139741737354696,0.0,0.1952232665446446,1.0,64/200,12.65%,RPS14;RPL36A;THG1L;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;RPS16;RPLP2;RPL35A;RPL30;RPL9;RPL11;RPL13;RPS7;RPL23;RPL17;EXOSC4;RPL18;RPS6;RPS9;RPL14;UBA52;RPL8;BMS1;RPL38;RPS15;XRN2;RPL21;SMAD2;RPL15;RPL29;RPS2;RPL34;RPL10A;RPS27;METTL3;RPLP1;NOC4L;RPL39;ESF1;RPL23A;RPL31;NVL;INTS7;TARBP2;RPL27;RPS28;RPL19;RPL18A;MRM2;RPLP0;NOP53;UTP11;SMAD1;EXOSC1;NOL8;MPHOSPH10;RPL35;RPL7;RPS19
prerank,regulation of glycogen metabolic process (GO:0070873),-0.6380683683849956,-1.6137194919757758,0.036101083032490974,1.0,1.0,8/12,31.22%,RUBCNL;PPP1R3F;KHK;PPP1R3D;PPP1R3C;INPP5K;PPP1R3B;PPP1R3E
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.5381769120863575,-1.6134905044241106,0.024154589371980676,1.0,1.0,7/20,12.57%,NUMB;PID1;ABI3;TGFB1;AP2M1;PICALM;PPP2R5A
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.7191280999202969,1.6134205743879801,0.012048192771084338,0.19476752284054,1.0,3/17,1.52%,SKAP1;CD3E;CCL5
prerank,regulation of DNA binding (GO:0051101),0.6419566884620579,1.61040250510425,0.002232142857142857,0.20135891288505425,1.0,10/44,9.03%,MMP8;LEF1;GZMA;MMP9;TFAP4;SP100;HMGB1;HMGB2;NME1;JAK2
prerank,regulation of T cell proliferation (GO:0042129),0.6159496471805989,1.6098398998691137,0.0,0.20085144483508627,1.0,16/61,17.78%,CD3E;SPN;ANXA1;CD6;CD28;CCL5;NCK2;SLC7A1;NCK1;IL6ST;LGALS3;TNFRSF13C;IL27;CEBPB;GLMN;LILRB1
prerank,detection of visible light (GO:0009584),0.7562936358120793,1.6074725715839193,0.010309278350515464,0.20573360258318504,1.0,2/16,1.88%,ABCA4;PDE6B
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.6239204920681397,-1.6071479110710258,0.03546099290780142,0.9446647557887154,1.0,4/11,6.45%,TNRC6C;AGO4;AGO1;RBM4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.6239204920681397,-1.6071479110710258,0.03546099290780142,0.9446647557887154,1.0,4/11,6.45%,TNRC6C;AGO4;AGO1;RBM4
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.44932170743851585,-1.6062312970680652,0.0,0.9011202112430948,1.0,16/39,17.06%,PIP4K2A;PI4KB;PIK3R1;PI4KA;PIK3CA;ITPKB;EFR3B;PIK3CG;PIK3CB;PIK3CD;TMEM150A;PI4K2B;PIK3C3;PIK3R2;SOCS2;PIP4K2B
prerank,acute inflammatory response (GO:0002526),0.6952376007683212,1.60404005238471,0.004884004884004884,0.21384096347308568,1.0,5/23,5.90%,CD6;HP;HPR;SIGIRR;LBP
prerank,regulation of myoblast fusion (GO:1901739),0.7982144533222402,1.6038932408124802,0.019444444444444445,0.2122053686353659,1.0,3/11,3.74%,RIPOR2;ADGRB1;CD53
prerank,inflammatory response (GO:0006954),0.5858894357565545,1.6034838165575624,0.0,0.21144352104372613,1.0,29/195,7.70%,S100A8;S100A9;CD96;FPR2;ITGAL;ANXA1;CXCR2;CCR2;CYBA;HP;HPR;PRDX5;CCL5;LTB4R;CCL7;CYBB;ADORA2A;F2R;ADGRE5;HDAC9;HMGB1;IL17D;OLR1;PTGIR;HSPG2;TAC4;KIT;CXCL10;CD44
prerank,regulation of coagulation (GO:0050818),0.8000976821431459,1.6030716757039116,0.007122507122507123,0.2106960479349475,1.0,5/11,11.78%,HRG;F2R;PROCR;CAV1;EPHB2
prerank,regulation of interleukin-1 production (GO:0032652),0.7452551000543881,1.6013341587013228,0.0025906735751295338,0.21408747418663496,1.0,5/15,6.99%,ANXA1;F2R;CEACAM1;HMGB1;FOXP1
prerank,negative regulation of T cell activation (GO:0050868),0.6573266256226441,1.5988067182108379,0.008,0.2199749072538138,1.0,6/35,4.20%,LAX1;SPN;RIPOR2;PTPN22;CEACAM1;LAPTM5
prerank,regulation of wound healing (GO:0061041),0.6357305285922135,1.598334659403627,0.005636978579481398,0.2195801332636497,1.0,12/42,11.78%,ANXA1;HRG;ACTG1;F2R;VTN;ITGB1;CADM4;PLAU;INSL3;CAV1;SERPINE1;EPHB2
prerank,negative regulation of cellular component movement (GO:0051271),0.7613148071368977,1.597810756015858,0.010540184453227932,0.2192557960118298,1.0,8/15,12.07%,GATA3;FBLN1;SP100;WAS;ACTN1;PIN1;FRMD5;TGFBR3
prerank,Wnt signaling pathway (GO:0016055),0.5911469384698204,1.5969360485987578,0.0,0.22000301785498072,1.0,22/92,14.48%,CCDC88C;LEF1;TCF7;CD24;RPS27A;SFRP5;WNT6;RARG;DIXDC1;FERMT2;UBA52;TCF7L1;PTEN;NR4A2;CSNK1A1;FZD6;CSNK1G1;CTNNB1;UBB;USP34;ARL6;WNT3
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7483219914133974,1.596806585637503,0.009485094850948509,0.21850911353942534,1.0,3/14,1.85%,CCR2;CCL5;CCL7
prerank,response to molecule of bacterial origin (GO:0002237),0.6066234472961831,1.5952660815767055,0.0010438413361169101,0.22150177146388098,1.0,16/69,13.03%,S100A8;S100A9;CD24;CD6;PTPN22;F2R;TAB2;TLR9;LBP;HMGB2;FOXP1;PELI1;JAK2;SRR;MAPKAPK3;MAPKAPK2
prerank,endoderm development (GO:0007492),0.7612369427191796,1.5948918393155886,0.01455026455026455,0.22077084183953316,1.0,5/13,15.26%,EOMES;SOX7;DUSP5;DUSP2;DUSP4
prerank,regulation of macrophage migration (GO:1905521),-0.665336750736786,-1.5940364669978562,0.03869047619047619,0.930211493653305,1.0,7/10,22.33%,P2RY12;CX3CR1;CD200R1;CD200;CD81;MTUS1;PTK2B
prerank,T cell mediated immunity (GO:0002456),0.7700347423217331,1.5906977077067104,0.006896551724137931,0.2319036727659968,1.0,6/13,16.79%,CD8A;CD55;MYO1G;CTSH;BTN3A3;JAG1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.8001255880426528,1.5903377021848604,0.008683068017366137,0.23083001705207062,1.0,6/11,14.04%,CD74;BCL2;ING2;MIF;CD44;SIRT1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.7676882760076662,1.5899272008691354,0.022068965517241378,0.23005509327567034,1.0,4/12,5.97%,HRG;DCN;CADM4;ATP2B4
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.5743194086947816,1.5898311437302912,0.0,0.22842559822736125,1.0,97/306,13.71%,RPS14;RPS27A;RPL36A;RPS12;MRPS12;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;MRPL51;RPS16;RPS20;RPLP2;RPL35A;RPL30;DUT;RPL9;RPL11;MRPL13;RPL13;RPS7;RPL23;MRPL23;RPL17;RPL18;RPS6;RPS23;RPS9;RPS18;RPS8;RPL14;RAD1;RPL8;RFC4;MCM7;MCM2;TICRR;RPL38;RPS15;NT5M;MRPS14;RPL21;APOE;RPL15;RPS26;ATM;RPS3;RPL29;FUT9;RPS2;RPSA;RPL34;RPL10A;RPS27;RPLP1;NR4A2;BARD1;RPL39;RPL23A;CDK1;RPL31;ING5;HBS1L;CREBL2;MLF1;RPS4X;RPS29;EEF1B2;EEF2;RPL27;RPS28;POLE;EEF1A1;RPL19;EXT2;RPL18A;RPS21;RPLP0;CDK2;CDC7;TAF1B;RFC5;RPL35;RPS10;RPL7;RPS19;BLM;GSPT1;POLR2F;RPS5;RMI2;MRPL36;BRIP1;RPL4
prerank,regulation of oxidative phosphorylation (GO:0002082),0.7276856955058336,1.5883038632814175,0.008905852417302799,0.2310169633662306,1.0,3/16,3.67%,COX7A1;ATP7A;UQCC2
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5945008657567221,1.5883005459182002,0.005128205128205128,0.2291001059253662,1.0,23/91,11.01%,LCK;LCN2;FTL;HEPH;CYBRD1;ATP7A;ATOX1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;ABCB7;FTH1;BMP6;SLC30A9;SLC11A2;ATP6AP1;SLC39A6;PRNP
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.6057887650576727,1.5877056662833826,0.0021208907741251328,0.2290469792945877,1.0,17/63,13.04%,CD3E;ANXA1;CD6;CD28;CCL5;CD74;BCL2;NCK2;TLR9;MIF;SASH3;SLC7A1;NCK1;IL6ST;EPHB2;CLCF1;TNFRSF13C
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.5084506157879075,-1.5863524113868261,0.010416666666666666,0.9332057103682923,1.0,8/20,13.06%,TNRC6C;AGO4;AGO1;CNOT8;TNRC6B;CNOT7;WTIP;MOV10
prerank,positive regulation of biosynthetic process (GO:0009891),0.636816614446757,1.584886922640571,0.003355704697986577,0.23543173724283106,1.0,12/40,10.52%,MMP8;CYBA;CCL5;ADGRB1;SORBS1;F2R;APOE;CREBL2;BMP4;VIM;CD36;SUCO
prerank,response to interleukin-6 (GO:0070741),-0.636896144499324,-1.5833626820728937,0.037383177570093455,0.9094983390711567,1.0,3/10,7.25%,PID1;SELPLG;ST3GAL6
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6750365696076525,1.581800072271282,0.01555023923444976,0.2435472633137752,1.0,7/25,6.16%,CD4;ANXA1;CCR2;CD28;RPS3;PRKD2;MALT1
prerank,canonical Wnt signaling pathway (GO:0060070),0.6020820010709382,1.579071010071279,0.0031512605042016808,0.2502412055411288,1.0,13/68,8.62%,LEF1;TCF7;GATA3;SFRP5;WNT6;RARG;DIXDC1;TCF7L1;PTEN;NR4A2;CSNK1A1;FZD6;CAV1
prerank,positive regulation of DNA binding (GO:0043388),0.6575550010510832,1.5789419089603574,0.012761020881670533,0.24858123613590152,1.0,7/31,8.83%,MMP8;MMP9;GATA3;H1-0;HMGB1;HMGB2;NME1
prerank,positive regulation of inflammatory response (GO:0050729),0.5911812452165748,1.5782596378125469,0.0010235414534288639,0.24891997748017233,1.0,20/86,14.15%,S100A8;S100A9;MMP8;OSMR;CCR2;MAPK13;PDCD4;TLR9;LBP;MDK;CD47;ETS1;NAPEPLD;SERPINE1;IL6ST;NFKBIA;ABCC1;RPS19;GRN;RIPK1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.7341557346425687,1.5780207379579672,0.010243277848911651,0.24783663822285276,1.0,7/18,6.28%,IKZF3;TBX21;CD2;CCR2;SPINK5;TLR9;METTL3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.7802965095485742,1.5755698082212,0.008426966292134831,0.25384521201129,1.0,6/12,14.04%,CD74;BCL2;ING2;MIF;CD44;SIRT1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.6730195706362672,1.571272041159654,0.022085889570552148,0.26671141688191974,1.0,10/25,14.62%,CD226;SCIMP;CD55;LAPTM5;B2M;MALT1;KIT;SPHK2;SLC7A5;TNFRSF14
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.6490032524002456,1.5670978903866672,0.008064516129032258,0.2796014343192524,1.0,3/33,1.89%,LEF1;CD4;CD74
prerank,positive regulation of immune response (GO:0050778),0.602013041204922,1.5663611533700104,0.0031746031746031746,0.2798953359504158,1.0,15/64,14.16%,SKAP1;CD226;FPR2;HRG;CYBA;CCL5;CD74;MYB;SASH3;TGFB2;SPHK2;IL6ST;GRN;SIRT1;RSAD2
prerank,thymus development (GO:0048538),-0.5739940469594355,-1.5654502594530308,0.04797047970479705,0.9792641909260947,1.0,3/13,9.69%,TGFBR1;FOXE1;FGF10
prerank,negative regulation of viral life cycle (GO:1903901),0.7301061768947075,1.5646309965441538,0.01455026455026455,0.28400291880300216,1.0,5/15,8.38%,IFITM1;IFITM2;PPIA;IFITM3;GSN
prerank,regulation of interferon-gamma production (GO:0032649),0.5912717970989381,1.5638716541095399,0.002074688796680498,0.28452090448259876,1.0,12/71,6.74%,CD226;IL18R1;CD2;CCR2;PTPN22;RASGRP1;TXK;HMGB1;TLR9;LAPTM5;RARA;CD47
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.712755030993149,1.5630757746108488,0.011523687580025609,0.28511276183181,1.0,8/17,14.91%,SH2D1A;PTPN22;UBASH3A;CEACAM1;LAPTM5;PRNP;LGALS3;EZR
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.6265720382535898,1.5625995553139083,0.004419889502762431,0.2849374119785289,1.0,12/42,14.71%,SKAP1;CD3E;HRG;CDK6;UTRN;FERMT2;KDR;CDH13;CD36;ROCK1;EFEMP2;S100A10
prerank,carbohydrate transport (GO:0008643),0.763272172547261,1.5615706555484081,0.029005524861878452,0.2863726959594957,1.0,4/11,9.68%,SLC5A1;AQP11;SLC26A6;SLC50A1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.5994276973832766,-1.5612647380861473,0.0390625,0.9629886106716232,1.0,6/13,2.79%,TLR7;IRAK2;PIK3AP1;IRAK1;EPG5;UNC93B1
prerank,T cell receptor signaling pathway (GO:0050852),0.5788213727456328,1.5612432483240306,0.0,0.2854360865257646,1.0,24/138,6.56%,THEMIS;LCK;SKAP1;CD3E;GRAP2;ITK;CD247;CD4;CD3G;PRKCQ;PTPN22;GATA3;CD28;TXK;WAS;PSMC3;TAB2;PSMD8;PRAM1;PRKD2;PSME1;PSMD6;MALT1;PSMB5
prerank,regulation of aerobic respiration (GO:1903715),0.7143278888305822,1.560651514120991,0.027777777777777776,0.28549991819515425,1.0,4/15,10.39%,COX7A1;ATP7A;UQCC2;NOP53
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5898335538972855,1.5587372006910452,0.0020920502092050207,0.2904974258054778,1.0,15/69,9.03%,MMP8;SPN;CD2;CCR2;RASGRP1;CYBA;CLU;HMGB1;TLR9;LBP;FRMD8;MIF;IFNGR1;SPHK2;JAK2
prerank,response to lipid (GO:0033993),0.5801123154924507,1.556543925890448,0.0010245901639344263,0.2964247114157485,1.0,27/105,15.06%,S100A8;S100A9;ANXA1;CD6;PTPN22;TRIM16;RARG;F2R;TAB2;LBP;RARA;HMGB2;FOXP1;PELI1;JAK2;STAT5B;CD36;CTNNB1;SRR;MAPKAPK3;ASXL1;FOXO1;MAPKAPK2;SCD;CTSH;TIRAP;ABCA2
prerank,response to peptide (GO:1901652),0.6341816787263177,1.5547957454970858,0.015855039637599093,0.3007944417218763,1.0,11/33,16.01%,STAT4;ANXA1;MMP9;EIF2B4;STAT5B;PRNP;MMP2;IRS1;MMP12;FYN;AGER
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7882205190045404,1.5546380129553607,0.01818181818181818,0.29929921516864455,1.0,2/10,4.27%,PDE6B;SAG
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.6633132019215832,1.5537363311930257,0.017921146953405017,0.3006333237200181,1.0,8/26,8.62%,LTF;PTPN22;CYBA;TREML4;HMGB1;TLR9;LBP;CAV1
prerank,regulation of interleukin-2 production (GO:0032663),0.6185682263639167,1.5530173045893296,0.013392857142857142,0.3012102534061778,1.0,10/43,6.16%,CD4;ANXA1;TBX21;CCR2;CD28;HDAC7;LAPTM5;RPS3;PRKD2;MALT1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.6555373717688007,1.5528599548096582,0.0199764982373678,0.2997225279328624,1.0,11/29,11.57%,CHP1;SORBS1;APOE;SREBF1;CTDNEP1;NR1H2;CREBL2;MFSD2A;GPLD1;SLC27A1;MID1IP1
prerank,melanocyte differentiation (GO:0030318),-0.5983851179389643,-1.552665646729502,0.05351170568561873,0.9758010159111228,1.0,5/11,12.88%,LRMDA;MEF2C;MITF;MREG;USP13
prerank,regulation of microglial cell activation (GO:1903978),0.7228855867592359,1.552508428358629,0.018276762402088774,0.29906541777451107,1.0,8/15,22.43%,MMP8;STAP1;CST7;GRN;TREM2;PTPRC;LDLR;CX3CL1
prerank,endoderm formation (GO:0001706),0.6331395462752067,1.5491238458597372,0.01245753114382786,0.30949403304405243,1.0,14/35,17.45%,MMP8;EOMES;MMP9;SOX7;ITGA4;VTN;DUSP5;DUSP2;MMP2;COL8A1;DUSP4;ITGB2;LAMB1;MMP15
prerank,lymphocyte differentiation (GO:0030098),0.5924656936209827,1.54907618629738,0.004201680672268907,0.30755062437601904,1.0,17/68,12.31%,LCK;CD4;PTPN22;GATA3;DNAJB9;PBX1;ITGA4;LMBR1L;HDAC9;CD79B;ITGB1;TOX;KIT;CD79A;ZAP70;FLT3;CLCF1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.7727394360688751,1.5489379837758306,0.021398002853067047,0.30594686758096434,1.0,3/11,6.16%,PRKCQ;CLEC6A;MALT1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.7328759509177091,1.5474822611616657,0.02509907529722589,0.3091426595662853,1.0,4/15,10.01%,MAPK13;DAXX;GSTO2;DHX36
prerank,positive regulation of integrin activation (GO:0033625),0.752486162496794,1.5472441238113286,0.024355300859598854,0.30813551038422926,1.0,2/11,3.55%,SKAP1;FERMT2
prerank,inositol lipid-mediated signaling (GO:0048017),-0.4172751178221222,-1.5470129295714787,0.023255813953488372,0.9713600153925195,1.0,16/50,15.53%,GAB2;CSF1R;ADAP2;PI4KB;PIK3R1;PI4KA;PTAFR;PIK3CA;PIK3CG;PLCB4;PIK3CB;PIK3CD;PLCL1;PIK3C3;PIK3R2;PLCB1
prerank,blood circulation (GO:0008015),0.6078208943180604,1.546680072929794,0.006586169045005488,0.3082207028118934,1.0,13/49,12.88%,ELN;F5;ADORA2A;HTR7;OLR1;SERPING1;GPX1;CXCL10;HOXB2;C3AR1;ADCY6;ROCK1;SCPEP1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.7462359807759411,1.5464851158957678,0.013736263736263736,0.30698585152227725,1.0,7/13,12.55%,DNAJB9;PPP1R15A;RACK1;HSPA5;NCK1;PPP1R15B;ABCA7
prerank,regulation of complement activation (GO:0030449),0.6163570845309274,1.546331155359939,0.011111111111111112,0.30548301713025205,1.0,11/40,14.80%,C3;CD55;CLU;CFP;VTN;SERPING1;C1QC;C3AR1;C6;SUSD4;CR1L
prerank,eye photoreceptor cell development (GO:0042462),-0.5647297903083974,-1.5461558796092592,0.07211538461538461,0.9399575356575889,1.0,5/15,11.94%,MYO7A;TOPORS;VEGFA;RPGRIP1L;RORB
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.7476256624073411,1.5449984995357262,0.02857142857142857,0.3081297765875004,1.0,1/12,0.05%,CHAMP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6526722458651165,1.544824656933831,0.016928657799274487,0.30695111653125456,1.0,7/26,9.75%,MMP8;CYBA;ADGRB1;SLC18A2;ABCB7;SPHK2;CD36
prerank,dendritic cell migration (GO:0036336),0.7106126069555936,1.542496502488021,0.023106546854942234,0.3136323967498905,1.0,4/16,3.70%,CXCR2;CCR2;CCL5;HMGB1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.7666004843031503,1.5414303564282676,0.02564102564102564,0.31542862428923063,1.0,5/10,14.04%,ATRX;MYB;DNMT1;JARID2;SIRT1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.7235440396009194,1.5402605324339105,0.02695035460992908,0.3178712234286297,1.0,4/13,7.67%,TESPA1;CAMK4;TOX;BMP4
prerank,negative regulation by host of viral transcription (GO:0043922),0.7470994656313367,1.5396732340501047,0.02789400278940028,0.31810254800166554,1.0,4/12,6.27%,CCL5;TFAP4;PSMC3;HDAC1
prerank,sodium ion export across plasma membrane (GO:0036376),0.7327314513829981,1.539414932473344,0.029931972789115645,0.3171578723447506,1.0,6/13,17.01%,ATP1B3;ATP1A3;ATP1A4;ATP1A1;ATP1A2;ATP1B2
prerank,receptor catabolic process (GO:0032801),-0.47032387091719924,-1.5393124732552463,0.022222222222222223,0.9475887317406124,1.0,10/24,10.04%,LGMN;BECN1;AP2A1;SH3GLB1;MYLIP;UVRAG;SMURF1;CLTA;TGFB1;AP2M1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.5981837745584749,1.5388127884450817,0.0032017075773745998,0.3174459705974183,1.0,20/57,14.13%,RPS25;RPS24;XPO1;RPS16;RPL35A;RPL11;RPS7;RPS6;RPL14;RPL38;RPS15;NVL;MALSU1;RPS28;RIOK2;RPL7;RPS19;NPM1;MRPL36;METTL17
prerank,piRNA metabolic process (GO:0034587),-0.5165180253736968,-1.5377648238422081,0.05555555555555555,0.9242816974602005,1.0,12/19,48.37%,MYBL1;TDRKH;TEX15;EXD1;DDX4;PIWIL2;TDRD12;GPAT2;TDRD9;MOV10L1;PIWIL4;PIWIL1
prerank,erythrocyte development (GO:0048821),-0.6508401959109943,-1.5370080993387811,0.03225806451612903,0.8978974756195471,1.0,5/10,20.04%,NCKAP1L;SH2B3;ABCB10;MED1;LYAR
prerank,substrate-dependent cell migration (GO:0006929),-0.5768442343588717,-1.53569994167096,0.03985507246376811,0.876037211724715,1.0,4/14,5.30%,OPHN1;P2RY12;SHTN1;NRP1
prerank,camera-type eye morphogenesis (GO:0048593),-0.6217306493550335,-1.5355639956540694,0.04697986577181208,0.8494650401509569,1.0,4/10,13.10%,SKI;KDM2B;VEGFA;LRP6
prerank,neuronal action potential (GO:0019228),0.6854474567646096,1.5342083685368257,0.014687882496940025,0.3325135204120937,1.0,9/22,15.16%,SCN4A;KCNMB4;SCN1A;SCN7A;ANK3;CACNA1H;KCNA1;SCN8A;CACNA1I
prerank,epidermal cell differentiation (GO:0009913),0.6128291904220994,1.5327629112393997,0.021181716833890748,0.3359412636794266,1.0,8/41,10.71%,ANXA1;OVOL1;EVPL;SPINK5;UGCG;HDAC1;SCEL;CTNNB1
prerank,cellular response to superoxide (GO:0071451),0.7623236507322808,1.53153669610723,0.029850746268656716,0.33854425151245443,1.0,4/10,15.40%,SOD3;ATP7A;PRDX1;SOD2
prerank,positive regulation of response to wounding (GO:1903036),0.6604972680844559,1.5314776185995804,0.024906600249066,0.3367204098566576,1.0,6/24,8.34%,ANXA1;ACTG1;VTN;ITGB1;MDK;INSL3
prerank,mesoderm development (GO:0007498),0.6891943736118047,1.5312689600427027,0.028186274509803922,0.3354422321769809,1.0,2/18,0.68%,IKZF3;TCF15
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7222985901803128,1.5295990424466122,0.024934383202099737,0.3399780152628664,1.0,4/15,9.92%,CCR2;CD55;HSPH1;GLI3
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6679466770902303,1.5295893178953757,0.022974607013301087,0.3380133676204828,1.0,6/23,6.94%,CCL5;GHR;F2R;CENPJ;IL7R;KIT
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7680723312240278,1.5284101535965307,0.02844950213371266,0.34056269298097436,1.0,3/10,5.76%,HRG;DCN;CADM4
prerank,dendritic cell chemotaxis (GO:0002407),0.7227855985841509,1.5282659448006455,0.023653088042049936,0.339082666710328,1.0,4/14,3.70%,CXCR2;CCR2;CCL5;HMGB1
prerank,regulation of endopeptidase activity (GO:0052548),0.5885674538212958,1.52816261863694,0.01166489925768823,0.33747536306165066,1.0,14/59,16.09%,HRG;SERPINB8;SERPINB9;TIMP4;VTN;SERPING1;PSME1;TIMP3;HDAC1;TIMP1;SERPINE1;PSMB9;GAPDH;PRELID1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.6587763540665416,1.5269285741244112,0.03308823529411765,0.3400467971132689,1.0,10/24,15.76%,RPS27A;UBA52;RFC4;POLB;LIG1;POLE;RFC5;UBB;POLK;PCNA
prerank,leukocyte cell-cell adhesion (GO:0007159),0.661574278909909,1.52562887974108,0.024390243902439025,0.34318854455833425,1.0,11/24,17.95%,ITGAL;CCL5;PECAM1;ITGA4;OLR1;ITGB1;MSN;ROCK1;EZR;ITGB2;TNIP1
prerank,regulation of interleukin-8 production (GO:0032677),0.5743020947812636,1.5240679663767593,0.009473684210526316,0.34716916832531775,1.0,11/69,5.90%,TMSB4X;ANXA1;CD2;PTPN22;CD74;F2R;HMGB1;IL17D;TLR9;PRKD2;LBP
prerank,endothelial cell development (GO:0001885),0.6473745986865125,1.523664678697322,0.02912621359223301,0.3467950363512476,1.0,11/25,22.34%,COL18A1;PECAM1;COL22A1;MSN;MARVELD2;EZR;PPP1R16B;RDX;RAPGEF3;MET;RAP1B
prerank,gas transport (GO:0015669),0.7686318827283787,1.5234977152766325,0.02446043165467626,0.34540859652539607,1.0,1/10,0.83%,NGB
prerank,positive regulation of heart rate (GO:0010460),-0.5253275276947809,-1.523446929034553,0.036734693877551024,0.8853766512221781,1.0,6/17,13.50%,TRPM4;ADRA1A;TPM1;ADRA1B;ADRB1;ATP2A2
prerank,negative regulation of blood coagulation (GO:0030195),0.6259437822662005,1.5233887116613538,0.013437849944008958,0.34389253337160397,1.0,9/38,14.37%,HRG;F8;VTN;APOE;SERPING1;PLAU;TFPI;SERPINE1;F10
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.3588763498609546,-1.5233551745731155,0.0,0.8598809838151261,1.0,28/109,10.66%,INPP5D;PIP4K2A;CSF1R;PI4KB;PLCG2;RUFY1;PIK3R1;CDS1;INPP4A;PI4KA;FGF2;PLEKHA8;PIK3CA;CDIPT;INPP5B;SACM1L;PIP5K1A;INPP4B;PIK3R6;MTMR4;PIK3CG;PITPNM3;PIK3CB;PIK3CD;MTMR3;PLA2G4A;PLEKHA2;PI4K2B
prerank,positive regulation of protein maturation (GO:1903319),-0.6110150665086803,-1.5232258428629184,0.04713804713804714,0.8358716147986077,1.0,7/11,37.56%,ADAM8;SOX4;RHBDD1;NLRC4;TFR2;NKD2;BAG2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.5684535000000885,1.5221060417084005,0.001017293997965412,0.3468195220888969,1.0,23/107,10.16%,LCK;TPT1;CCR2;CSRP3;CCL5;CCL7;SLC24A4;RMDN3;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;ATP2B4;ATP2A3;STIM1;CAV1;SLC30A9;CHERP;SLC39A6
prerank,cAMP-mediated signaling (GO:0019933),0.6540065497670181,1.5217103254064415,0.019441069258809233,0.34645012402410563,1.0,12/24,21.62%,CAP2;PDE7A;AHR;AKAP6;PDE3A;KSR1;EPHA5;ADCY1;PDE7B;SOX9;CAP1;RAPGEF3
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.6880212795946852,1.5205520714264296,0.029150823827629912,0.34880339819726824,1.0,3/18,4.20%,LAX1;PTPN22;LAPTM5
prerank,regulation of cartilage development (GO:0061035),0.6921430361233845,1.5202777571139356,0.032418952618453865,0.34791919995120346,1.0,6/18,10.11%,SCIN;BMP1;MDK;SOX5;BMP4;ZBTB16
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.5609534748271122,1.5189549570436145,0.0,0.35136859998189435,1.0,33/163,10.26%,THEMIS;LCK;SKAP1;LAX1;CD3E;GRAP2;ITK;CD247;CD4;CD3G;PRKCQ;PTPN22;GATA3;CD28;BCL2;TXK;WAS;PSMC3;TAB2;CD79B;PSMD8;PRAM1;PRKD2;PSME1;PSMD6;MALT1;PSMB5;PSMC6;BCAR1;EIF2B4;CD79A;PSMB4;NCK1
prerank,regulation of blood coagulation (GO:0030193),0.6463341408222187,1.5188866954446936,0.017543859649122806,0.3498047516646033,1.0,8/27,11.78%,HRG;F2R;VTN;APOE;CAV1;TFPI;SERPINE1;EPHB2
prerank,secretory granule organization (GO:0033363),0.771501627646716,1.5183351855482043,0.03333333333333333,0.3501116168943331,1.0,3/10,2.59%,BLOC1S3;SRGN;F2R
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.7472518555522604,1.5173587818822534,0.03638814016172507,0.35202921088329475,1.0,10/12,21.07%,CLU;APOE;PFDN5;IAPP;PFDN1;TREM2;PFDN4;CRYAB;LDLR;VBP1
prerank,pyroptosis (GO:0070269),0.696619294464163,1.5172349320269625,0.031081081081081083,0.3507048696409405,1.0,4/15,10.08%,GZMB;GZMA;APIP;CASP4
prerank,regulation of interleukin-4 production (GO:0032673),0.6688491515457569,1.5168426283718892,0.04826732673267327,0.35047857694804513,1.0,5/21,5.91%,LEF1;PRKCQ;GATA3;CD28;RARA
prerank,regulation of immune effector process (GO:0002697),0.6066720891932819,1.5164923454669863,0.017877094972067038,0.35018630366982295,1.0,12/41,15.42%,C3;CD55;CLU;CFP;VTN;SERPING1;C1QC;C3AR1;C6;SUSD4;CR1L;IRF4
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.6245238537975357,1.5161234011006488,0.021814006888633754,0.34948901486781675,1.0,10/33,12.78%,GATA3;ANGPT1;NDNF;SEMA5A;KDR;MDK;CAST;PAK4;SERPINE1;CDH5
prerank,regulation of humoral immune response (GO:0002920),0.6019895528172784,1.515670706206252,0.014460511679644048,0.34944959719364904,1.0,11/44,14.80%,C3;CD55;CLU;CFP;VTN;SERPING1;C1QC;C3AR1;C6;SUSD4;CR1L
prerank,regulation of integrin activation (GO:0033623),0.701716592988683,1.5154214914003608,0.028416779431664412,0.34857184316751516,1.0,3/15,9.35%,SKAP1;FERMT2;JAM3
prerank,tight junction assembly (GO:0120192),0.5966584266580623,1.514471216764411,0.01737242128121607,0.3502681958687381,1.0,9/49,8.88%,POF1B;ACTG1;PECAM1;MICALL2;PATJ;PARD3;ARL2;MPP7;MARVELD2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.6458140325740048,1.5141972880472356,0.026284348864994027,0.3494926286888144,1.0,9/29,15.77%,RPS14;RPS16;RPS8;BMS1;NOL10;TSR2;RPS21;RPS19;HELB
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7578382201288998,1.5141884326820898,0.02442528735632184,0.3477309455815642,1.0,4/10,5.28%,BCL2;DCN;KDR;RACK1
prerank,regulation of adaptive immune response (GO:0002819),0.6851641904955444,1.5126454882051836,0.02911392405063291,0.35187051299839844,1.0,5/18,14.04%,SKAP1;AHR;SASH3;IL6ST;SIRT1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.7591097761741954,1.5125332710104469,0.03070175438596491,0.3504830056559594,1.0,2/10,1.52%,CCR2;CCL5
prerank,regulation of viral genome replication (GO:0045069),0.5832886286357942,1.5104388254695262,0.01368421052631579,0.3568210904604541,1.0,14/56,9.20%,LTF;IFITM1;CD28;CCL5;IFITM2;ISG20;SRPK1;ILF3;PPIA;PPIH;IFITM3;TARBP2;OASL;PABPC1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.6278014734727133,1.5101030578341141,0.02751196172248804,0.35615196866951554,1.0,14/29,19.16%,SCD5;ACSBG1;ACSF3;ELOVL7;FASN;ELOVL1;ACACA;ELOVL6;SCD;HACD1;SLC25A1;ACSL1;HACD2;GCDH
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6492465207417079,1.510018650780563,0.02888086642599278,0.3546296671464193,1.0,8/24,12.78%,GATA3;ANGPT1;NDNF;SEMA5A;KDR;PAK4;SERPINE1;CDH5
prerank,response to interferon-gamma (GO:0034341),0.5735436696438614,1.5088305714964243,0.013569937369519834,0.3571729791150542,1.0,15/67,9.91%,IFITM1;CCL5;IFITM2;CCL7;CD74;SP100;TRIM21;DAPK3;GBP2;IFITM3;CD47;CXCL16;SLC26A6;SYNCRIP;AQP4
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6520770186933488,1.5086513962391872,0.025029797377830752,0.35604454436758204,1.0,11/24,17.98%,DACH1;RTEL1;H1-0;ERCC4;RPS3;SUB1;BLM;ERCC1;MSH6;CDKN1A;DFFA
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.4840975051474069,-1.507519831709025,0.03910614525139665,0.8935809357017327,1.0,7/24,12.57%,NUMB;PID1;ABI3;TGFB1;AP2M1;PICALM;PPP2R5A
prerank,ribosome assembly (GO:0042255),0.5901052471115245,1.506947645444978,0.014207650273224045,0.36091123757418037,1.0,22/47,22.38%,RPS14;RPL11;MRPL22;EIF2A;RPS15;RPSA;RPS27;RPL23A;RPS28;RPLP0;NOP53;RPS19;NPM1;RPS5;PPAN;RPL10;MRPS7;NLE1;RPL3;BRIX1;EFL1;BOP1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.7336121196736918,1.506632558868098,0.05357142857142857,0.36030181371389625,1.0,3/12,1.98%,MMP8;CYBA;ADGRB1
prerank,sarcomere organization (GO:0045214),0.6315541224874077,1.5062804842496482,0.02715466351829988,0.35996018815944564,1.0,2/27,1.00%,TNNT3;CSRP3
prerank,receptor signaling pathway via STAT (GO:0097696),0.6397814736624517,1.5060481327802215,0.029055690072639227,0.3590765882790039,1.0,8/25,12.48%,STAT4;CCR2;IL31RA;GHR;JAK2;STAT5B;CLCF1;CTR9
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.6970076281987849,1.5046346601269727,0.03865979381443299,0.36260040744887917,1.0,7/15,10.81%,C3;SREBF1;CTDNEP1;NR1H2;MFSD2A;GPLD1;SLC27A1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.4723160626374644,-1.5044802001921491,0.05232558139534884,0.8855064487353682,1.0,6/24,10.75%,LPCAT1;ABCA3;PLA2G15;PNPLA8;PLA2G4A;CRLS1
prerank,negative regulation of cell adhesion (GO:0007162),0.5774753099450145,1.5041338375027005,0.005202913631633715,0.3628166020747362,1.0,19/72,11.78%,SPN;RIPOR2;HRG;GTPBP4;FBLN1;ARHGDIB;ANGPT1;SEMA5A;PLXNB1;CDH1;DSCAM;MDK;SIPA1;CDH13;PLXNA2;JAM3;GCNT2;SERPINE1;EPHB2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.4748642001020416,-1.5031353953313795,0.05172413793103448,0.8682428915205153,1.0,11/24,20.54%,ATP5IF1;CPOX;SLC25A38;PPOX;ABCB10;RSAD1;COX10;UROS;FECH;FXN;FLVCR1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5689759412850833,1.501647444702818,0.003134796238244514,0.37058376084033745,1.0,15/73,9.03%,MMP8;SPN;CD2;CCR2;RASGRP1;CYBA;CLU;HMGB1;TLR9;LBP;FRMD8;MIF;IFNGR1;SPHK2;JAK2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5040322595254266,-1.5014486664159274,0.02040816326530612,0.8536062137628898,1.0,7/20,12.57%,NUMB;PID1;ABI3;TGFB1;AP2M1;PICALM;PPP2R5A
prerank,hydrogen peroxide catabolic process (GO:0042744),0.7424073111283749,1.5014171365838243,0.0465444287729196,0.3697232070189001,1.0,3/11,6.93%,PRDX5;PRDX1;GPX1
prerank,amino acid transport (GO:0006865),0.5811399693430694,1.5009560972560154,0.016286644951140065,0.36979892328635566,1.0,17/49,19.74%,SLC6A19;SLC6A14;SLC36A3;SLC7A11;SLC38A11;SLC3A2;PDPN;SLC7A1;SLC1A5;SLC7A5;SLC6A17;SLC25A44;SLC43A2;SLC38A1;SLC6A15;SLC7A6;SLC6A6
prerank,negative regulation of binding (GO:0051100),0.5572276842949839,1.5001196371370809,0.005154639175257732,0.3711727814669198,1.0,21/81,14.95%,LEF1;GZMA;GTPBP4;IFIT2;TFAP4;ACTB;SP100;RACK1;WAPL;CTSZ;PIN1;CAV1;JAK2;NFKBIA;ROCK1;SORL1;DNAJB2;CARD16;RALB;DDX11;CDKN1A
prerank,DNA geometric change (GO:0032392),0.6435242537816865,1.4993713497104457,0.03553921568627451,0.37230505669432024,1.0,9/24,14.10%,ANXA1;RTEL1;HMGB1;HMGB3;HMGB2;DHX36;BLM;DDX1;DDX11
prerank,regulation of lymphocyte proliferation (GO:0050670),0.694450744531795,1.4990616679576492,0.027777777777777776,0.3716708684390955,1.0,3/16,4.64%,IKZF3;PTPN22;AHR
prerank,gliogenesis (GO:0042063),0.687574803692603,1.4989190562739423,0.04868421052631579,0.3704738788332769,1.0,5/15,13.40%,ANXA1;CDK6;METTL3;TGFB2;METTL14
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5773435486376501,1.4987596380323664,0.0041928721174004195,0.3693800160258924,1.0,17/67,11.25%,SKAP1;CD3E;LIMS2;FLNA;DOCK5;CDK6;UTRN;FERMT2;NDNF;ARL2;ECM2;MDK;CDH13;JAK2;CD36;CDC42;ILK
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3810017150546529,-1.4985685942297262,0.012345679012345678,0.8454386517574195,1.0,16/47,16.64%,KIF13A;MACF1;CCDC93;RABEP1;GGA3;EXOC5;GOLGA4;BLZF1;BBS2;GOLPH3;GOPC;LLGL1;ARFGEF2;EXOC4;STEAP2;RAB34
prerank,epithelial cell differentiation (GO:0030855),0.5619361203929251,1.4975869367680843,0.004149377593360996,0.3720434682597244,1.0,17/88,9.19%,ANXA1;IRF6;OVOL1;GATA3;TAGLN2;EHF;DHRS9;SPINK5;TAGLN;DMBT1;KDR;ACADVL;HDAC1;CDK1;BMP4;FSTL1;ALDOC
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6299760585365335,1.4972037685016044,0.02588235294117647,0.3719510713581975,1.0,5/27,6.48%,S100A6;CD74;DDR2;CDK6;MIF
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6033972248014933,1.4963359957963387,0.02727272727272727,0.3736252415969334,1.0,8/37,11.38%,ITGAL;CD6;NECTIN1;AMIGO1;TENM2;GRID2;JAML;ALCAM
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.6087738430904754,1.4963177121156168,0.02502844141069397,0.3719902040736522,1.0,15/35,21.62%,CAP2;PDE7A;AHR;APOE;NUDT4;AKAP6;CD36;PDE3A;KSR1;EPHA5;ADCY1;PDE7B;SOX9;CAP1;RAPGEF3
prerank,protein localization to condensed chromosome (GO:1903083),0.7184998516081198,1.496278975100895,0.035422343324250684,0.37048691273621587,1.0,3/12,8.46%,CHAMP1;CDK1;KNL1
prerank,muscle contraction (GO:0006936),0.5501503177332469,1.4960992687224708,0.002034587995930824,0.3695524111286241,1.0,23/126,11.36%,TNNT3;TPM2;SCN4A;SNTB1;LTB4R;CLCN1;MYL9;SORBS1;ACTA2;FXYD1;EDNRA;MYH11;SLC6A8;UTRN;ALDOA;GJC1;DTNA;VIM;TMOD2;DMD;CACNA1H;MYL12A;ROCK1
prerank,regulation of multicellular organismal development (GO:2000026),0.6334875572580532,1.4950755488973113,0.04039167686658507,0.3718313878428101,1.0,8/25,12.51%,CD24;GATA3;RACGAP1;NIPBL;CDK1;DUSP6;DHX36;CCSAP
prerank,cilium-dependent cell motility (GO:0060285),0.6533689561430112,1.4934791648115362,0.03940886699507389,0.37612253562127734,1.0,4/22,9.27%,DNAH8;CFAP44;CCDC65;DNAH3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.7032662623435004,1.4916189319389532,0.04,0.3818335098756103,1.0,7/15,14.04%,CD74;BCL2;ING2;MIF;CD44;ARMC10;SIRT1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5919679640923984,1.4909928116663183,0.023622047244094488,0.38259836743402753,1.0,6/42,7.51%,CCR2;CCL5;CCL7;GPR75;CXCL10;RBM15
prerank,endodermal cell fate commitment (GO:0001711),0.7615135136681657,1.4905886800411052,0.044096728307254626,0.3824018281821233,1.0,4/10,12.48%,EOMES;PAF1;LEO1;CTR9
prerank,polyol biosynthetic process (GO:0046173),-0.5260594073803458,-1.4897840635940727,0.05982905982905983,0.866082951883499,1.0,9/16,18.76%,FGF2;PPIP5K2;ITPKB;CYP27A1;ACER3;IPPK;CYP2R1;IPMK;ISYNA1
prerank,gene expression (GO:0010467),0.5359312155912116,1.488983214400498,0.0,0.38712940573141297,1.0,103/348,14.85%,RPS14;RPS27A;RPL36A;DEDD2;RPS12;MRPS12;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;MRPL51;M1AP;RPS16;RPS20;RPLP2;RPL35A;RPL30;RPL9;RPL11;AGFG1;MRPL13;RPL13;RPS7;RPL23;MRPL23;RPL17;RPL18;RPS6;RPS23;RPS9;TSPAN17;RPS18;RPS8;RPL14;CLP1;PRPF4;RPL8;RPL38;RPS15;XRN2;MRPS14;RPL21;RPL15;RPS26;RPS3;RPL29;RPS2;RPSA;RPL34;RPL10A;RPS27;RPLP1;NR4A2;RPL39;NUP50;RPL23A;RPL31;HBS1L;ELAVL4;CREBL2;MLF1;RPS4X;RPS29;RPL27;RPS28;RNGTT;EEF1A1;RPL19;EIF4A3;RPL18A;SYNCRIP;RPS21;RPLP0;TAF1B;NUP214;NUP210;TASP1;NUP88;MPHOSPH10;RPL35;TSPAN32;CDC40;RANBP2;SORL1;RPS10;ATXN1;RPL7;RPS19;GSPT1;POLR2F;RPS5;MRPL36;RPL4;SRSF7;HNRNPF;RPS15A;POLDIP3;BAZ2A;XAB2;RBM8A
prerank,regulation of T cell mediated immunity (GO:0002709),0.7558804319704607,1.4887939080863388,0.036818851251840944,0.38607699940939044,1.0,3/10,3.70%,CCR2;WAS;HMGB1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.7420436156765151,1.48715476930611,0.04597701149425287,0.3904190131261746,1.0,2/10,1.31%,GZMA;HP
prerank,T cell activation involved in immune response (GO:0002286),0.7244980315296414,1.4856087710101287,0.04847645429362881,0.39466318695590835,1.0,4/12,7.47%,ITGAL;CD74;MDK;LCP1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6672708692282301,1.4855322975973428,0.037760416666666664,0.3932319940773822,1.0,5/19,11.23%,HRG;DCN;CD63;CADM4;ROBO1
prerank,regulation of nuclear division (GO:0051783),0.6504057271518082,1.4849865129142417,0.0425,0.39367750153306985,1.0,7/20,9.01%,DAPK3;FBXO5;RCC1;PRMT5;CUL9;PIN1;L3MBTL1
prerank,negative regulation of vascular permeability (GO:0043116),0.7387522193743301,1.4849551801534675,0.034916201117318434,0.39210132315712776,1.0,4/12,10.35%,ANGPT1;CEACAM1;FERMT2;PDE3A
prerank,cellular response to osmotic stress (GO:0071470),-0.4700619937520475,-1.4843639423298731,0.07647058823529412,0.8719002257455577,1.0,5/21,11.44%,LRRC8D;CAB39;CAPN3;SCN2A;TRPV4
prerank,regulation of leukocyte activation (GO:0002694),0.7042535647940608,1.4838281423372022,0.04685408299866131,0.3949040089261102,1.0,3/14,6.48%,LCK;CD74;MIF
prerank,regulation of receptor binding (GO:1900120),0.7432433987906888,1.4830222330776213,0.046242774566473986,0.3963350509682298,1.0,4/10,7.77%,MMP9;B2M;ATP2A3;GREM2
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.6745200181898786,1.481130573719699,0.039897039897039896,0.40230073561487006,1.0,5/18,10.93%,CD24;IL27RA;HMGB1;RPS3;IGFBP2
prerank,ribosomal small subunit assembly (GO:0000028),0.6878382120957877,1.4809796176660937,0.03617571059431524,0.4011742598872371,1.0,7/16,13.20%,RPS14;RPS15;RPSA;RPS27;RPS28;RPS19;RPS5
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.7301893078373953,1.480615277285892,0.05352112676056338,0.40098889183766434,1.0,5/12,14.04%,NCOR2;HDAC1;FOXP1;NCOR1;SIRT1
prerank,innate immune response (GO:0045087),0.5368830766550513,1.4804215352906938,0.0,0.4001133611583449,1.0,35/217,8.55%,LCK;CAMP;LCN2;KLRC2;LTF;CYBA;IFITM1;IFITM2;CD74;CYBB;SMPD1;C3;NCF1;JCHAIN;SP100;PGLYRP2;SRPK1;HMGB1;CLEC6A;COLEC12;RNASE3;RNASE6;TLR9;CFP;DMBT1;B2M;TRIM21;CLEC4E;LBP;IFITM3;MALT1;RPL39;CXCL10;RARRES2;CXCL16
prerank,sulfate transport (GO:0008272),0.6908301466593066,1.4803959067705204,0.04583333333333333,0.3985768829538504,1.0,6/14,15.80%,SLC13A4;RACGAP1;SLC26A6;SLC25A10;SLC25A14;SLC25A30
prerank,cell chemotaxis (GO:0060326),0.5742318836672899,1.479522982224955,0.01166489925768823,0.40040500993040223,1.0,16/60,13.10%,LEF1;CXCR2;CCR2;PRKCQ;LPAR1;CXCR3;SEMA5A;HMGB2;KIT;PARVA;NR4A1;BCAR1;EGR3;CXCR4;ABCC1;HOXB9
prerank,regulation of B cell activation (GO:0050864),0.632260671487272,1.4792498331605028,0.045077105575326216,0.399902683673493,1.0,4/25,4.64%,IKZF3;TLR9;LAPTM5;AHR
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.43206987320372314,-1.478817279018518,0.06086956521739131,0.8791222222145085,1.0,9/34,14.21%,SLC8A1;CALM2;ANK2;P2RX4;SMAD7;PIK3CG;ADRA1A;ATP2A2;ZC3H12A
prerank,nucleoside catabolic process (GO:0009164),0.7320762650482141,1.4783413662303542,0.04419889502762431,0.40178372546009544,1.0,3/11,5.78%,UPB1;NT5M;NT5C3A
prerank,negative regulation of viral genome replication (GO:0045071),0.5890089722546453,1.4770505545059047,0.02127659574468085,0.40563349529809317,1.0,9/40,9.20%,LTF;IFITM1;CCL5;IFITM2;ISG20;SRPK1;ILF3;IFITM3;OASL
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.72725865617199,1.4759088456128786,0.046089385474860335,0.40862761507907036,1.0,4/12,7.31%,RASGRP1;IL17D;TLR9;PAEP
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5428203454502853,1.4755161435025421,0.005050505050505051,0.40857503381995297,1.0,20/112,9.03%,MMP8;LTF;SPN;CD2;CCR2;PTPN22;RASGRP1;CYBA;CLU;HMGB1;TLR9;LBP;RARA;FRMD8;MIF;CD47;FOXP1;IFNGR1;SPHK2;JAK2
prerank,muscle filament sliding (GO:0030049),0.596025812819969,1.475333455718798,0.027901785714285716,0.4059919505400273,1.0,7/38,17.53%,TNNT3;TPM2;VIM;DMD;TPM4;MYL1;TNNI1
prerank,actin-myosin filament sliding (GO:0033275),0.596025812819969,1.475333455718798,0.027901785714285716,0.4059919505400273,1.0,7/38,17.53%,TNNT3;TPM2;VIM;DMD;TPM4;MYL1;TNNI1
prerank,histone H3-K36 demethylation (GO:0070544),-0.6130227967070787,-1.4752589971409338,0.0891089108910891,0.8762160231605911,1.0,5/10,7.27%,PHF8;KDM7A;KDM2A;KDM4A;KDM2B
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5346551479321349,-1.4743894576498815,0.09745762711864407,0.8609295986545296,1.0,10/14,26.03%,MEF2C;LRP1;PRKG1;TPM1;AIF1;CORO1B;NDRG4;TRIB1;BMPR1A;IGFBP3
prerank,response to peptide hormone (GO:0043434),0.591050273584847,1.4736088113797574,0.0327313769751693,0.41168036506005545,1.0,13/43,14.82%,STAT4;ANXA1;TRIM16;ZBTB7B;CAV1;EIF2B4;STAT5B;SLC27A1;ROCK1;TGFBR3;IRS1;SIRT1;EPM2AIP1
prerank,regulation of phosphatase activity (GO:0010921),0.632351601189721,1.4732787268365914,0.03730445246690734,0.41132734727222336,1.0,5/24,7.84%,CHP1;PPP1R35;SH2D4A;ZCCHC9;PTPA
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.7282589407497452,1.473137806726022,0.06657420249653259,0.4102789150546779,1.0,4/11,11.31%,STAT4;IL27RA;JAK2;IL6ST
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.7543498164790764,1.4729601817481839,0.04741379310344827,0.40928199129374376,1.0,3/10,5.78%,UPB1;NT5M;NT5C3A
prerank,extracellular matrix assembly (GO:0085029),0.6424752704378127,1.4729282836365643,0.04433497536945813,0.4077802274419973,1.0,10/23,17.67%,ATP7A;MYH11;LTBP3;GPM6B;FBLN5;NTNG1;NTNG2;EFEMP2;LAMB1;EMILIN1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.7372669790309038,1.4727112971823748,0.048104956268221574,0.40702702376718014,1.0,3/10,5.90%,LTF;PTPN22;LBP
prerank,regulation of lipid kinase activity (GO:0043550),-0.5750266102888479,-1.472001819554732,0.08389261744966443,0.8532654720351196,1.0,5/11,15.16%,PIK3R1;WDR81;RBL1;PPP2R5A;PIK3R2
prerank,regulation of macrophage activation (GO:0043030),0.6143140123471258,1.4715520804716988,0.03403755868544601,0.4098987422736306,1.0,5/30,6.48%,MMP8;IL31RA;CD74;LBP;MIF
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7287596950143347,1.4695722018211885,0.06512301013024602,0.416128725944348,1.0,7/11,17.35%,ITM2C;SOAT1;ABCA7;NECAB1;ABCA2;BACE2;AGO2
prerank,regulation of response to oxidative stress (GO:1902882),-0.5726988097385535,-1.4695577088485565,0.06872852233676977,0.8465843564556281,1.0,6/11,32.53%,MCTP1;SELENON;AIFM2;PRKN;STOX1;ALOX5
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.6344249202534349,1.4680934892484105,0.03300733496332518,0.42038777500990465,1.0,5/27,5.97%,RANGRF;FXYD5;FXYD1;UTRN;ATP2B4
prerank,negative regulation of viral entry into host cell (GO:0046597),0.7070585249676764,1.4673695562046072,0.0520694259012016,0.42170848647604975,1.0,4/12,8.38%,IFITM1;IFITM2;IFITM3;GSN
prerank,carboxylic acid catabolic process (GO:0046395),-0.5852160559166211,-1.467074251127659,0.08267716535433071,0.8410392114040972,1.0,7/12,22.14%,NPL;NAGK;AMDHD2;PON3;BCKDK;RENBP;IL4I1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.48441517333127304,-1.4664827502810507,0.06763285024154589,0.8265004235554888,1.0,10/19,23.08%,ROCK2;F11R;NPHP1;RUNX1;TJP1;IKBKB;CBFB;TNF;NPHP4;PRKACA
prerank,amyloid fibril formation (GO:1990000),0.5658480333134835,1.4660803707044672,0.02062975027144408,0.4255577416505454,1.0,14/51,14.15%,LTF;RPS27A;UBA52;B2M;HSPG2;IAPP;CALB1;GSN;CD36;MAPT;FKBP1A;SORL1;UBB;RIPK1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6813476667275915,1.4660130015050132,0.0327455919395466,0.42418624375705816,1.0,6/17,11.17%,FPR2;CCR2;CCL5;HMGB1;CXCL10;SERPINE1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.6197790033939926,1.4658473847245392,0.040380047505938245,0.423178072385708,1.0,8/29,10.71%,LEF1;TCF7;TLE4;TCF7L1;HDAC1;LEO1;PYGO1;CTNNB1
prerank,bicellular tight junction assembly (GO:0070830),0.5803463815887462,1.4655551891489498,0.03278688524590164,0.4227369685854358,1.0,8/46,8.88%,POF1B;PECAM1;MICALL2;PATJ;PARD3;ARL2;MPP7;MARVELD2
prerank,negative regulation of viral process (GO:0048525),0.563130870007069,1.465495896876228,0.025423728813559324,0.42139174064174234,1.0,11/57,6.15%,LTF;IFITM1;CCL5;IFITM2;ISG20;SRPK1;HEXIM1;ILF3;PPIA;TRIM21;IFITM3
prerank,positive regulation of JNK cascade (GO:0046330),0.5560226575240208,1.464698937395366,0.017745302713987474,0.4228250578196195,1.0,11/70,7.36%,MMP8;MAP4K2;RASGRP1;TRAF1;NCF1;MTURN;HMGB1;TLR9;GADD45A;TPD52L1;CCN2
prerank,vitamin D metabolic process (GO:0042359),-0.5460072690201576,-1.4643109225736728,0.07575757575757576,0.820014517505063,1.0,1/13,0.15%,LGMN
prerank,response to zinc ion (GO:0010043),0.6424488751344533,1.4637714449141612,0.04247572815533981,0.42477826737088004,1.0,9/25,9.92%,MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;CRIP1
prerank,cellular protein metabolic process (GO:0044267),0.5292166963086771,1.4637159436406963,0.0,0.423399554820288,1.0,124/396,18.91%,RPS14;RPS27A;RPL36A;RPS12;MRPS12;RPL41;RPS25;RPL37;RPS24;RPL32;RPL27A;RPL28;MRPL51;IGFBP7;RPS16;F5;RPS20;RPLP2;RPL35A;RPL30;LGALS1;RPL9;RPL11;MRPL13;RPL13;ADORA2A;RPS7;NAPSA;RPL23;MRPL23;RPL17;C3;PRKCSH;RPL18;PIGH;RPS6;RPS23;RPS9;RPS18;RPS8;RPL14;UBA52;DMBT1;RPL8;RPL38;RPS15;MRPS14;RPL21;APOE;RPL15;RPS26;ADPRH;RPS3;RPL29;SDC2;RPS2;RPSA;RPL34;RPL10A;RPS27;RPLP1;RPL39;RPL23A;RPL31;HBS1L;UBE2G2;BMP4;UBL5;RPS4X;UBE2L3;RPS29;RPL27;RPS28;FSTL1;EEF1A1;RPL19;RPL18A;TIMP1;ST3GAL1;RPS21;RPLP0;IGFBP2;LOX;MMP2;SLC35A1;LCMT1;RPL35;ANO8;RPS10;RPL7;RPS19;ZDHHC2;GSPT1;RPS5;MRPL36;RPL4;PADI4;RPS15A;RIPK1;CTSH;DENND3;GPC3;ABL2;ATG3;RPS17;MIA3;SPARCL1;DARS1;LAMB1;RPL37A;MFGE8;AGO2;MMP15;SCG3;CSNK1G3;TNIP1;SPPL3;FBXO11;P4HB;RPL22;CDC34;RPL10;OMA1;MRPS7
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.6142677512684928,1.462913653555705,0.05405405405405406,0.4250355978657049,1.0,4/28,4.93%,DEDD2;BCL2;DAXX;BID
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.6887809335084992,1.4595032002827653,0.05053191489361702,0.4371138463101418,1.0,6/14,15.44%,NUDT1;ENTPD5;NUDT15;ENTPD2;ENTPD3;NUDT16
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.6166540436574258,1.4592146651917566,0.041766109785202864,0.4366178375870083,1.0,4/27,3.89%,CCDC88C;RPS27A;MAPK13;UBA52
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.7055072678402027,1.4584462219015037,0.056865464632454926,0.43841441921830104,1.0,2/12,2.23%,MMP8;STAP1
prerank,positive regulation of cell killing (GO:0031343),0.70304478547684,1.4578715668210405,0.052054794520547946,0.43907946142022175,1.0,2/13,1.43%,CYBA;PRF1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.7087896933138531,1.4574223981376304,0.06751054852320675,0.4394046334135186,1.0,5/11,14.96%,ATRX;ASF1B;NASP;UBN1;CABIN1
prerank,regulation of T cell chemotaxis (GO:0010819),0.7260975875530935,1.455994050428284,0.043731778425655975,0.44382343755346426,1.0,3/11,7.50%,CCR2;CCL5;CXCL10
prerank,positive regulation of lymphocyte activation (GO:0051251),0.6219082360593959,1.4554341464332914,0.03588516746411483,0.44455192563400936,1.0,5/28,6.74%,LCK;CCR2;PRKCQ;TLR9;CD47
prerank,natural killer cell mediated immunity (GO:0002228),0.6850302415808742,1.4548243540774055,0.04417670682730924,0.44536517742977755,1.0,5/15,9.52%,KLRC2;GZMB;KLRK1;ARL8B;SLAMF7
prerank,protein localization to kinetochore (GO:0034501),0.6796059578684003,1.4538835731110233,0.04920212765957447,0.44738553865780273,1.0,3/14,8.46%,CHAMP1;CDK1;KNL1
prerank,gastrulation (GO:0007369),0.6794596349915446,1.452523967191916,0.05789473684210526,0.451272232047057,1.0,5/15,7.59%,EOMES;NR4A3;SMAD2;UGDH;MKKS
prerank,transition metal ion transport (GO:0000041),0.593709165612349,1.4521445486944375,0.02968036529680365,0.4512616712819774,1.0,12/35,16.91%,LTF;HEPH;ATP7A;ATOX1;FTH1;SLC30A9;SLC11A2;TRPC5;SLC31A2;TRPC4;IREB2;TRPC1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.6026910719004971,1.452048372197053,0.04834905660377359,0.45003699988601703,1.0,9/30,10.20%,TPT1;CD74;RTEL1;CLU;FBXO5;RPS3;MIF;CD44;CCAR2
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.5893218929501478,-1.4508653128766917,0.09570957095709572,0.8638662583009928,1.0,3/10,10.00%,PLA2G15;PNPLA8;PLA2G4A
prerank,positive regulation of interleukin-12 production (GO:0032735),0.5989043004898545,1.4496117271075992,0.04027617951668585,0.45883603960089,1.0,6/31,6.04%,LTB;SCIMP;HMGB1;TLR9;LAPTM5;MDK
prerank,external encapsulating structure organization (GO:0045229),0.5293471768667259,1.4487202011058418,0.0,0.46086093662058675,1.0,52/205,12.83%,MMP8;ITGAL;MMP9;ELN;COL18A1;COL6A3;ADAMTS14;DDR2;LAMA5;COL9A1;PECAM1;ATP7A;ADAM19;ITGA4;DCN;SPINK5;LUM;SMOC1;NDNF;KDR;VTN;ECM2;COL1A2;BGN;CDH1;ITGB1;HSPG2;FBLN5;COL22A1;COL4A1;CD47;THSD4;ITGA10;COL19A1;CD44;ITGB7;ADAMTSL1;LAMA4;JAM3;BSG;ADAMTSL4;LOX;SERPINE1;MMP2;COL1A1;HRNR;COL5A3;MMP12;COL8A1;ADAMTS2;COL3A1;DAG1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5817510338541577,-1.448425979700932,0.08664259927797834,0.8588902919200513,1.0,4/11,13.12%,CD34;CD200;LGALS9;THBS1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5906106139104698,1.448251657094451,0.04264870931537598,0.46109062686102725,1.0,9/36,5.97%,HRG;ANGPT4;ADGRB1;DCN;SP100;HMGB1;APOE;GADD45A;ATP2B4
prerank,platelet degranulation (GO:0002576),0.5327388303767768,1.4476285897943428,0.00808080808080808,0.4619347432314679,1.0,26/118,13.07%,TMSB4X;CTSW;HRG;TAGLN2;F5;FLNA;SRGN;PECAM1;CLU;F8;CD63;ALDOA;SERPING1;ACTN1;TIMP3;PHACTR2;TGFB2;CLEC3B;TEX264;RARRES2;CD36;TIMP1;SCCPDH;SERPINE1;MANF;TGFB3
prerank,positive regulation of defense response (GO:0031349),0.5431992702351143,1.4471721063200158,0.015368852459016393,0.46215556590154266,1.0,18/89,14.15%,S100A8;S100A9;FPR2;CCR2;MAPK13;CYBA;CCL5;PDCD4;TLR9;MDK;CD47;ETS1;NAPEPLD;SERPINE1;NFKBIA;ABCC1;GRN;RIPK1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6753709165223634,1.4463075407982826,0.06438896189224705,0.46411272978110135,1.0,3/14,2.89%,CCR2;PTPN22;CD55
prerank,negative regulation of cellular catabolic process (GO:0031330),0.5564415767910355,1.4461828195990458,0.025504782146652496,0.4629805246764659,1.0,15/63,12.14%,PTPN22;DAPL1;HP;BCL2;TIMP4;TAB2;APOC1;RGP1;TIMP3;MFSD2A;DAP;GPLD1;TIMP1;ROCK1;SORL1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.7178130519974066,1.4455315029687603,0.06751054852320675,0.46412390534986936,1.0,6/11,10.81%,SREBF1;CTDNEP1;NR1H2;MFSD2A;GPLD1;SLC27A1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6275273880424774,1.4448770084929785,0.04920049200492005,0.4651837001702557,1.0,6/24,10.03%,LCK;F2R;ITPR3;ANXA6;ITPR1;CHERP
prerank,response to axon injury (GO:0048678),-0.4930323003421774,-1.4447470832706375,0.06278026905829596,0.8594223964620592,1.0,5/18,5.79%,P2RY12;RTN4RL1;GAP43;P2RX4;NREP
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.7088392915546021,1.4441607927783082,0.07203389830508475,0.4665755411497705,1.0,4/12,7.43%,ACTG1;LAMA5;ACTB;CELSR1
prerank,myotube cell development (GO:0014904),-0.5961161112357444,-1.4438084741579675,0.08099688473520249,0.8484240203142653,1.0,3/10,16.14%,SKI;SELENON;CAV2
prerank,negative regulation by host of viral process (GO:0044793),0.7280717675192351,1.4428694055522076,0.05293276108726753,0.47062575102707754,1.0,2/10,3.44%,LTF;PSMC3
prerank,alanine transport (GO:0032328),0.7197028987432202,1.4427359222917235,0.0754985754985755,0.4695927586558405,1.0,2/10,1.05%,SLC6A14;SLC36A3
prerank,regulation of water loss via skin (GO:0033561),0.6805588344761759,1.4427312018312852,0.058355437665782495,0.46641853724585197,1.0,5/15,11.79%,TMEM79;UGCG;SFN;FA2H;HRNR
prerank,establishment of skin barrier (GO:0061436),0.6805588344761759,1.4427312018312852,0.058355437665782495,0.46641853724585197,1.0,5/15,11.79%,TMEM79;UGCG;SFN;FA2H;HRNR
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.5465057862011291,-1.4423394652237198,0.10071942446043165,0.8394721592846257,1.0,4/13,5.49%,SLC35A3;UAP1;NAGK;AMDHD2
prerank,neuron projection regeneration (GO:0031102),-0.5996754142478499,-1.4415915228584055,0.08754208754208755,0.8277526810137383,1.0,3/10,5.79%,RTN4RL1;GAP43;NREP
prerank,intestinal lipid absorption (GO:0098856),0.7169147936939355,1.4405439782902214,0.06318681318681318,0.473885183532566,1.0,5/11,19.70%,UGCG;CD36;CEL;SOAT2;LDLR
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5972652093362397,1.4402536215184494,0.05562130177514793,0.4735301664989742,1.0,8/29,12.48%,STAT4;CCR2;IL31RA;GHR;JAK2;STAT5B;CLCF1;CTR9
prerank,actin nucleation (GO:0045010),0.6310483256254718,1.440186186559105,0.05506883604505632,0.4722303282302924,1.0,7/21,14.03%,SCIN;ARPC2;IQGAP2;ARPC1A;ARPC5;ACTR3;ARPC5L
prerank,lymphocyte proliferation (GO:0046651),0.6291581885945282,1.439850009079993,0.0535279805352798,0.4720000003093086,1.0,11/22,19.29%,RASGRP1;BCL2;LMBR1L;ELF4;MSN;CD79A;FLT3;MS4A1;PPP3CB;HELLS;PTPRC
prerank,positive regulation of protein acetylation (GO:1901985),-0.5480529541353365,-1.4395627560666444,0.06666666666666667,0.8227273928820619,1.0,3/12,6.57%,DIP2B;CAMK1;PRKAA2
prerank,positive regulation of secretion (GO:0051047),0.7071415667938217,1.4394465575250048,0.06388888888888888,0.4721203013328231,1.0,2/11,9.09%,SCIN;GPLD1
prerank,regulation of axon extension (GO:0030516),-0.39783821984965817,-1.4390202673866208,0.056910569105691054,0.8110442369443631,1.0,9/37,8.41%,DIP2B;MACF1;ABL1;SHTN1;ZFYVE27;SIN3A;MAG;GOLGA4;OLFM1
prerank,regulation of activated T cell proliferation (GO:0046006),0.5974856342556731,1.4384715597831812,0.052083333333333336,0.4747614257560691,1.0,8/30,16.01%,CD24;IL27RA;HMGB1;RPS3;IGFBP2;PRNP;PRKAR1A;AGER
prerank,heme biosynthetic process (GO:0006783),-0.4677473525252731,-1.4382014027496801,0.06842105263157895,0.8011001944588326,1.0,10/22,20.54%,ATP5IF1;CPOX;SLC25A38;PPOX;ABCB10;COX10;UROS;FECH;FXN;FLVCR1
prerank,regulation of metal ion transport (GO:0010959),0.6642628043385943,1.4359547447028478,0.06683804627249357,0.4837985720708055,1.0,5/16,11.30%,CD4;BCL2;STIM1;SRI;CACNA2D1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6479556169721379,1.4354919344430817,0.06143790849673202,0.48403660788693,1.0,5/18,7.21%,ANXA1;HDAC9;HDAC7;KDR;RHOJ
prerank,positive regulation of isotype switching (GO:0045830),-0.5248333729154397,-1.4348638344498044,0.09623430962343096,0.8006981443046288,1.0,6/15,12.92%,SHLD1;PAXIP1;SHLD2;KMT5B;TGFB1;HMCES
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.7225538665015948,1.4343203994639413,0.07539118065433854,0.48724544161525746,1.0,5/10,21.23%,CD24;LAPTM4B;LILRB1;TYROBP;HSP90AB1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4665227057937616,-1.43410494218478,0.08,0.7908448487879658,1.0,7/20,13.44%,DIP2B;PAXIP1;BRD7;PRKAA2;PPARGC1A;ARRB1;SOX4
prerank,regulation of transmembrane transport (GO:0034762),0.5872165140351262,1.4335136538797273,0.05113636363636364,0.489118637207454,1.0,6/31,5.20%,BCL2;ACTB;KCNJ10;NEDD4;KCNJ15;PIM1
prerank,respiratory system development (GO:0060541),-0.416353702912714,-1.4331713825687815,0.07142857142857142,0.7817741603513272,1.0,10/32,11.28%,CHD7;FGF2;ABCA3;SPEF2;BAG6;CEBPA;NPHP3;BASP1;VEGFA;LOXL3
prerank,positive regulation by host of viral transcription (GO:0043923),0.6698876331201356,1.4331682894109643,0.06044678055190539,0.48891970518165834,1.0,2/15,2.08%,LEF1;TFAP4
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.587053663949571,-1.431354725434371,0.08754208754208755,0.7650459544238326,1.0,4/10,10.04%,AP2A1;MYLIP;CLTA;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.587053663949571,-1.431354725434371,0.08754208754208755,0.7650459544238326,1.0,4/10,10.04%,AP2A1;MYLIP;CLTA;AP2M1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.700085825223049,1.4312832171707857,0.0659025787965616,0.4952420061045538,1.0,4/11,9.08%,GATA3;TGFB2;BMP4;HEY2
prerank,positive regulation of growth (GO:0045927),0.5497494412179075,1.4310287248688565,0.021052631578947368,0.4947427169612223,1.0,11/64,10.83%,S100A8;S100A9;BCL2;EXOSC4;TGFB2;MFSD2A;CXCL16;AKAP6;LGI1;CDC42;ZPR1
prerank,potassium ion import across plasma membrane (GO:1990573),0.572402304614101,1.4296227785236255,0.03389830508474576,0.49914601723467517,1.0,10/41,12.04%,ATP1B3;KCNJ10;KCNJ15;SLC12A7;ATP1A3;ATP1A4;ATP1A1;ATP1A2;SLC12A5;SLC12A4
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6601997506213776,1.427916341062496,0.06838709677419355,0.5048977173702811,1.0,6/17,6.04%,NR4A3;CCL5;DOCK5;S100A11;VTN;MDK
prerank,prostanoid metabolic process (GO:0006692),-0.5317436099984022,-1.4277123657260367,0.10687022900763359,0.7678418650667277,1.0,2/13,0.60%,HPGDS;PTGS1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6289535144246172,1.4276582164431197,0.05721393034825871,0.5044554862533671,1.0,8/21,10.26%,NCK2;PAQR3;RACK1;PTEN;GADD45A;CAV1;DMD;NCK1
prerank,regulation of cell killing (GO:0031341),0.657155081901094,1.4266287667968927,0.06887417218543046,0.5072508235296656,1.0,5/16,16.13%,CYBA;CD55;TGFB2;CR1L;NOXO1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.5155279368556677,-1.4257117585843864,0.08979591836734693,0.7638794361483305,1.0,3/15,4.18%,SKI;ACVR1B;SMAD7
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.39028916495773325,-1.4251206423110852,0.05319148936170213,0.7547207862471379,1.0,14/46,15.49%,LPCAT1;PLD1;DGKZ;DDHD2;LIPH;AGPAT5;ACP6;PLD2;ABHD4;PLA2G4A;DGKH;DGKD;AGPAT4;DGKQ
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5284811647648736,1.4249478082105955,0.0030241935483870967,0.5128033553517635,1.0,30/140,15.99%,FPR2;CD24;CXCR2;CCR2;GPR174;CD52;F2R;EDNRA;LPAR1;CD55;ITPR3;P2RY1;HMGB1;CXCR3;S1PR4;PTGIR;TAC4;IAPP;CAV1;JPH4;C3AR1;CD36;CXCR4;CACNA2D1;P2RX5;NPTN;GRM1;TACR1;DRD2;ABL2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5181198625158169,1.4249320692777425,0.005040322580645161,0.5112348767409755,1.0,32/149,14.15%,S100A8;S100A9;IL18RAP;IL18R1;LTF;RPS27A;PRKCQ;TRAF1;CLU;UBA52;TAB2;TLR9;PPIA;TRIM21;RPS3;PRKD2;FLOT2;MALT1;SLCO3A1;RPS6KA5;CAV1;CD36;NFKBIA;NOD1;CARD16;UBB;ERC1;PSMA6;NPM1;TRIM68;HSPA1A;RIPK1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6213125735391949,1.424774553476648,0.045838359469240045,0.5103412126344793,1.0,8/24,11.27%,FPR2;CCR2;CCL5;HMGB1;CXCL10;GREM1;SERPINE1;NBL1
prerank,regulation of secretion (GO:0051046),0.6766639591857642,1.424316454808252,0.07702888583218707,0.5106208609068402,1.0,3/13,9.09%,SCIN;NRG1;GPLD1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5741754709038498,1.4229005442847074,0.04138702460850112,0.5153185778604513,1.0,10/39,12.78%,GATA3;ANGPT1;ITGA4;PDCD4;NDNF;SEMA5A;KDR;PAK4;SERPINE1;CDH5
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.5237997462060321,1.4223913555524876,0.007070707070707071,0.5159633363367708,1.0,35/142,17.17%,FPR2;CD24;CXCR2;CCR2;CD52;F2R;EDNRA;LPAR1;CD55;ITPR3;P2RY1;HMGB1;CXCR3;S1PR4;PTGIR;ATP2B4;TAC4;IAPP;CALB1;CAV1;CLN3;TRPC5;C3AR1;CD36;CXCR4;ATP1A2;TRPC4;NPTN;TACR1;SLC35G1;DRD2;ATP2B3;ABL2;TRPC1;ATP2B2
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.42267853311347375,-1.4214498618496303,0.06569343065693431,0.757287911385918,1.0,7/30,6.37%,KIF13A;MACF1;SEC16A;GGA3;GOLGA4;BLZF1;BBS2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.6441337871689068,1.421211005019932,0.06459948320413436,0.5193893126279946,1.0,3/17,8.46%,CHAMP1;CDK1;KNL1
prerank,error-prone translesion synthesis (GO:0042276),0.6221273963444737,1.42108274027259,0.078125,0.5182566100916634,1.0,8/21,15.76%,RPS27A;UBA52;RFC4;RFC5;UBB;POLK;REV3L;PCNA
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.5535298065616523,1.4207363101987385,0.03351351351351351,0.5180505021240015,1.0,11/54,7.67%,TMSB4X;HRG;ANGPT4;ANGPT1;HMGB1;KDR;APOE;GADD45A;PRKD2;ATP2B4;ETS1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.6473035057671456,1.4206315008162034,0.07351077313054499,0.516935221259015,1.0,5/18,9.66%,LAX1;FPR2;BCAR1;GPLD1;C3AR1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.7203957298821936,1.420563402821535,0.06973293768545995,0.5156292883820087,1.0,6/10,21.92%,CLU;HSP90AA1;SORL1;NAB2;HSP90AB1;EGR1
prerank,sodium ion transport (GO:0006814),0.5302742911272949,1.4205615427224068,0.01954732510288066,0.514039068111244,1.0,15/85,12.06%,SLC5A1;SLC6A19;SLC6A14;SCN4A;ATP1B3;SLC6A8;SLC24A4;NALCN;SCN1A;SCN7A;NDUFA9;ATP1A4;ATP1A2;HCN3;SCN8A
prerank,peptide hormone secretion (GO:0030072),0.5955812973215725,1.4203802920116801,0.06771463119709795,0.5132348980489835,1.0,3/26,10.58%,ANXA1;PTPRN;SNX19
prerank,extracellular structure organization (GO:0043062),0.5185931649054862,1.4195526260975528,0.0,0.5153873013296216,1.0,51/204,12.83%,MMP8;ITGAL;MMP9;ELN;COL18A1;COL6A3;ADAMTS14;DDR2;LAMA5;COL9A1;PECAM1;ATP7A;ADAM19;ITGA4;DCN;SPINK5;LUM;SMOC1;NDNF;KDR;VTN;ECM2;COL1A2;BGN;CDH1;ITGB1;HSPG2;FBLN5;COL22A1;COL4A1;CD47;THSD4;ITGA10;COL19A1;CD44;ITGB7;ADAMTSL1;LAMA4;JAM3;BSG;ADAMTSL4;LOX;SERPINE1;MMP2;COL1A1;COL5A3;MMP12;COL8A1;ADAMTS2;COL3A1;DAG1
prerank,neutrophil degranulation (GO:0043312),0.5087003209323777,1.419466423333582,0.0,0.5141722741951767,1.0,123/425,18.27%,S100A8;S100A9;CAMP;MMP8;LCN2;FPR2;LTF;TBC1D10C;ATP8B4;ITGAL;CXCR2;PKP1;MMP9;CYBA;FTL;SELL;LRG1;HP;ABCA13;PRDX6;PLAC8;MCEMP1;CYBB;CCT8;PECAM1;C3;IQGAP1;CD55;CEACAM1;DIAPH1;PSMC3;S100A11;ADGRE5;ERP44;HMGB1;CD53;HSPA8;RNASE3;OLR1;CFP;B2M;PPIA;CD63;ALDOA;CCT2;STBD1;RAB3D;GGH;SLCO4C1;PSMD6;PYGB;MIF;PLAU;CD47;CYSTM1;DYNLL1;GPR84;FTH1;CD44;IQGAP2;MAGT1;CTSZ;GPI;STOM;FABP5;GSN;ACP3;PGM2;EEF2;GYG1;ATP11B;EEF1A1;CLEC12A;ALDOC;GLIPR1;PYGL;C3AR1;CD36;NHLRC3;ARPC5;HSP90AA1;CLEC4D;RAB5B;NFASC;APAF1;DDOST;DNAJC5;RAB5C;ROCK1;HRNR;PLEKHO2;KCMF1;LGALS3;CSTB;GCA;GRN;HSPA1A;DEGS1;ITGAX;VAT1;CTSH;SDCBP;PGLYRP1;VCL;AGL;PSMD7;HUWE1;PSMD2;AGPAT2;IGF2R;CDK13;ITGB2;ACTR10;CTSC;TNFAIP6;LILRB3;JUP;RAB9B;AMPD3;PRG2;YPEL5;LAMP2;CPNE1
prerank,regulation of neuroinflammatory response (GO:0150077),0.6327728086491411,1.418633962541088,0.07116104868913857,0.5162478469193696,1.0,2/19,0.95%,MMP8;MMP9
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6736385991286247,1.4181360911498642,0.07452574525745258,0.5168560264501147,1.0,8/14,17.78%,NR4A3;CD74;CAMK4;LAPTM5;KIT;SIRT1;TICAM1;LILRB1
prerank,response to X-ray (GO:0010165),0.6614035913882154,1.418074387699738,0.08176943699731903,0.5155388407127296,1.0,5/14,12.89%,ANXA1;ATM;NIPBL;IKBIP;BLM
prerank,collagen fibril organization (GO:0030199),0.5308149361479578,1.4170011236638813,0.02564102564102564,0.5184890792343056,1.0,25/88,13.83%,P3H1;COL18A1;COL6A3;ADAMTS14;BMP1;DDR2;COL9A1;PLEC;ATP7A;LUM;COL1A2;COL22A1;CRTAP;COL4A1;TGFB2;COL19A1;GREM1;COL25A1;LOX;COL1A1;COL5A3;COL8A1;ADAMTS2;COL3A1;COL4A5
prerank,macromolecule catabolic process (GO:0009057),-0.4414759325599875,-1.416793620262406,0.08333333333333333,0.7633750507808693,1.0,10/26,7.70%,LGMN;CAPN3;BECN1;SH3GLB1;TPP1;PPT1;MTOR;UVRAG;SMURF1;TGFB1
prerank,neutrophil activation involved in immune response (GO:0002283),0.5076041831750797,1.416719937179458,0.0,0.5181509696872674,1.0,123/428,18.27%,S100A8;S100A9;CAMP;MMP8;LCN2;FPR2;LTF;TBC1D10C;ATP8B4;ITGAL;CXCR2;PKP1;MMP9;CYBA;FTL;SELL;LRG1;HP;ABCA13;PRDX6;PLAC8;MCEMP1;CYBB;CCT8;PECAM1;C3;IQGAP1;CD55;CEACAM1;DIAPH1;PSMC3;S100A11;ADGRE5;ERP44;HMGB1;CD53;HSPA8;RNASE3;OLR1;CFP;B2M;PPIA;CD63;ALDOA;CCT2;STBD1;RAB3D;GGH;SLCO4C1;PSMD6;PYGB;MIF;PLAU;CD47;CYSTM1;DYNLL1;GPR84;FTH1;CD44;IQGAP2;MAGT1;CTSZ;GPI;STOM;FABP5;GSN;ACP3;PGM2;EEF2;GYG1;ATP11B;EEF1A1;CLEC12A;ALDOC;GLIPR1;PYGL;C3AR1;CD36;NHLRC3;ARPC5;HSP90AA1;CLEC4D;RAB5B;NFASC;APAF1;DDOST;DNAJC5;RAB5C;ROCK1;HRNR;PLEKHO2;KCMF1;LGALS3;CSTB;GCA;GRN;HSPA1A;DEGS1;ITGAX;VAT1;CTSH;SDCBP;PGLYRP1;VCL;AGL;PSMD7;HUWE1;PSMD2;AGPAT2;IGF2R;CDK13;ITGB2;ACTR10;CTSC;TNFAIP6;LILRB3;JUP;RAB9B;AMPD3;PRG2;YPEL5;LAMP2;CPNE1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.6273787851149485,1.4166497023833087,0.06513872135102533,0.5168627451161851,1.0,3/21,4.20%,LAX1;PTPN22;LAPTM5
prerank,cation transport (GO:0006812),0.5160547839403947,1.4164858630933723,0.0030211480362537764,0.5160479482967335,1.0,27/167,12.06%,SLC5A1;PANX3;SLC6A14;SCN4A;SLC36A3;SLC22A3;KCNN4;CHP1;SLC18A2;KCNJ10;PIEZO2;KCNMB4;KCNJ15;SLC3A2;KCNA4;SCN1A;SCN7A;NDUFA9;SLC7A1;CLN3;SLC11A2;ATP1A4;KCNC4;PANX1;KCNA1;ATP1A2;SCN8A
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.7093405248091579,1.4161181274620314,0.07531380753138076,0.5160832880191691,1.0,3/11,12.58%,NR4A3;RACK1;ATF4
prerank,positive regulation of T cell differentiation (GO:0045582),0.5808083498981952,1.4154542630484712,0.05756207674943566,0.5176199082627475,1.0,7/36,12.94%,LEF1;TESPA1;GATA3;MDK;GLI3;ZAP70;BCL6
prerank,mesoderm formation (GO:0001707),0.6479394475092454,1.4154360040381053,0.07810499359795134,0.5161651705697412,1.0,3/17,5.48%,EOMES;SMAD2;ITGB1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.694307775740436,1.4151581317130035,0.08873239436619719,0.5159373188601197,1.0,3/11,4.64%,KLRC1;CEACAM1;AHR
prerank,regulation of amyloid-beta clearance (GO:1900221),0.6499414667636658,1.4148365587385177,0.08211920529801324,0.5159284521139439,1.0,7/16,15.53%,CLU;APOE;HDAC1;IFNGR1;ROCK1;ABCA7;TREM2
prerank,T cell homeostasis (GO:0043029),-0.5970070048545956,-1.4145191359308915,0.11221122112211221,0.7609524901853091,1.0,3/10,12.31%,NCKAP1L;PPP2R3C;ZC3H8
prerank,negative regulation of JUN kinase activity (GO:0043508),0.701788116178218,1.4142970616176058,0.07771260997067449,0.5167143075767098,1.0,2/10,3.58%,PTPN22;PDCD4
prerank,regulation of programmed cell death (GO:0043067),0.5218912510604471,1.4139085105508187,0.001004016064257028,0.5168113859831471,1.0,55/161,20.96%,IKZF3;CD3E;TPT1;RTKN;LGALS1;DAXX;RARG;CLU;RAF1;HTATIP2;BIRC5;DAPK3;USP42;BID;ACTN1;ATM;RPS3;ANP32B;MALT1;CXCL10;TRIM24;NME1;BCAR1;JAK2;TMEM219;HSP90AA1;NOP53;APAF1;LCMT1;HIP1;FLT3;MAGED1;BCL6;IFT57;SIRT1;NDRG1;BCL2L11;RIPK1;TARDBP;PRELID1;GAS1;STK26;PPP1R13B;DFFA;PHLPP1;FBXO11;FBXO10;OMA1;BNIP3;MECOM;SRA1;SOX9;ANP32A;BIRC3;ACER2
prerank,cellular response to chemokine (GO:1990869),0.5548241411617268,1.4133807561352378,0.0429042904290429,0.5174763517308619,1.0,6/46,7.50%,RIPOR2;CCR2;CCL5;CCL7;GPR75;CXCL10
prerank,maturation of SSU-rRNA (GO:0030490),0.5815544365466,1.4129595773837729,0.05605381165919283,0.5177624723874696,1.0,13/34,19.59%,RPS14;RPS16;RPS8;BMS1;NOL10;RPS28;TSR2;RIOK2;RPS19;HELB;LSM6;RIOK3;NOB1
prerank,skeletal muscle contraction (GO:0003009),0.6441483063360096,1.41270486758213,0.06900878293601004,0.5172905037378761,1.0,1/19,0.27%,TNNT3
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.3492612790035718,-1.4125583030384814,0.0,0.7583372698969141,1.0,38/69,32.26%,POU2F2;INTS3;ICE2;SNAPC1;INTS10;ELL2;CDK9;INTS12;GTF2A1;INTS11;TAF8;NABP2;SNAPC4;POLR2G;ZC3H8;INTS1;TAF13;NCBP2;CCNT2;POLR2K;SNAPC5;GTF2B;POLR2C;GTF2E1;POLR2H;INTS8;GTF2F2;CCNK;ICE1;POLR2J;POLR2L;TAF9;INTS9;PHAX;INTS5;POLR2E;POLR2I;GTF2E2
prerank,inorganic anion transmembrane transport (GO:0098661),0.5334443591765372,1.4123598708821208,0.03965702036441586,0.5172547400495469,1.0,18/63,15.80%,SLC5A1;GABRP;CLCN1;GABRA4;GABRB1;SLC12A7;ANO4;SLC20A1;GABRG1;ANO5;SLC25A10;SLC12A5;SLC12A4;XPR1;GLRB;SLC25A14;SLC37A1;SLC25A30
prerank,regulation of hormone secretion (GO:0046883),0.6420431052267115,1.4121214189223856,0.07733333333333334,0.5167754536833942,1.0,3/15,17.28%,ANXA1;SCG5;SOX11
prerank,neutrophil mediated immunity (GO:0002446),0.5057860223351233,1.4108244268371006,0.0,0.5208412077043889,1.0,123/432,18.27%,S100A8;S100A9;CAMP;MMP8;LCN2;FPR2;LTF;TBC1D10C;ATP8B4;ITGAL;CXCR2;PKP1;MMP9;CYBA;FTL;SELL;LRG1;HP;ABCA13;PRDX6;PLAC8;MCEMP1;CYBB;CCT8;PECAM1;C3;IQGAP1;CD55;CEACAM1;DIAPH1;PSMC3;S100A11;ADGRE5;ERP44;HMGB1;CD53;HSPA8;RNASE3;OLR1;CFP;B2M;PPIA;CD63;ALDOA;CCT2;STBD1;RAB3D;GGH;SLCO4C1;PSMD6;PYGB;MIF;PLAU;CD47;CYSTM1;DYNLL1;GPR84;FTH1;CD44;IQGAP2;MAGT1;CTSZ;GPI;STOM;FABP5;GSN;ACP3;PGM2;EEF2;GYG1;ATP11B;EEF1A1;CLEC12A;ALDOC;GLIPR1;PYGL;C3AR1;CD36;NHLRC3;ARPC5;HSP90AA1;CLEC4D;RAB5B;NFASC;APAF1;DDOST;DNAJC5;RAB5C;ROCK1;HRNR;PLEKHO2;KCMF1;LGALS3;CSTB;GCA;GRN;HSPA1A;DEGS1;ITGAX;VAT1;CTSH;SDCBP;PGLYRP1;VCL;AGL;PSMD7;HUWE1;PSMD2;AGPAT2;IGF2R;CDK13;ITGB2;ACTR10;CTSC;TNFAIP6;LILRB3;JUP;RAB9B;AMPD3;PRG2;YPEL5;LAMP2;CPNE1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5446601112331716,-1.4107829642027976,0.09293680297397769,0.754594067619522,1.0,4/12,14.87%,SNAP29;SNAP25;STX2;STX1B
prerank,regulation of inflammatory response (GO:0050727),0.5118297320657361,1.4104933211655943,0.0020060180541624875,0.5207783320976834,1.0,35/190,14.15%,S100A8;S100A9;MMP8;FPR2;TMSB4X;ANXA1;CCR2;MAPK13;MMP9;GATA3;CCL5;PDCD4;TLR9;APOE;MDK;CD47;FOXP1;NR1D2;ETS1;SMPDL3B;JAK2;CASP4;NAPEPLD;SERPINE1;PTGES;NFKBIA;ABCC1;PSMA6;CDH5;USP18;SHARPIN;BCL6;GRN;AKNA;RIPK1
prerank,positive regulation of transport (GO:0051050),0.5286973170968554,1.410385885628467,0.02368692070030896,0.5197417430527572,1.0,15/85,9.64%,IL2RB;FPR2;ANXA1;SCIN;CYBA;CHP1;ACTB;SMPD1;BID;APOE;CD47;IL2RG;LMAN2;GPLD1;CALY
prerank,negative regulation of locomotion (GO:0040013),0.6943662246888981,1.4089520781892686,0.061224489795918366,0.5243707448017785,1.0,5/12,11.48%,GATA3;FBLN1;WAS;PIN1;FRMD5
prerank,phosphatidic acid metabolic process (GO:0046473),-0.3839886129265296,-1.4086830610668069,0.05747126436781609,0.7517428721970774,1.0,14/48,15.49%,LPCAT1;PLD1;DGKZ;DDHD2;LIPH;AGPAT5;ACP6;PLD2;ABHD4;PLA2G4A;DGKH;DGKD;AGPAT4;DGKQ
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6520348939562647,1.4079857039891315,0.11554921540656206,0.5268885873422945,1.0,3/13,9.08%,TMSB4X;PER2;HEY2
prerank,phospholipid translocation (GO:0045332),0.5947383468333362,1.4077852177446337,0.07200929152148665,0.5262427773489448,1.0,7/28,12.55%,ATP8B4;PLSCR2;ABCA4;MFSD2A;ATP11B;ABCC1;ABCA7
prerank,positive regulation of leukocyte activation (GO:0002696),0.6373542508350141,1.4072810451979167,0.07953063885267275,0.5268206322981773,1.0,4/18,10.56%,CD226;CD2;LBP;CLEC4D
prerank,regulation of cell-matrix adhesion (GO:0001952),0.5422620906487179,1.4066541075723273,0.03632478632478633,0.527978138453756,1.0,13/64,11.36%,SKAP1;CD3E;ACTG1;HOXA7;CDK6;UTRN;GPM6B;DAPK3;PLAU;CDH13;PTPRA;CD36;ROCK1
prerank,mesenchyme development (GO:0060485),-0.49719700158220237,-1.406329166798228,0.10909090909090909,0.7506097475271345,1.0,2/15,1.53%,TGFBR1;BMPR2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.6324615146683321,1.4063156576928495,0.08045977011494253,0.527896345328682,1.0,8/18,18.50%,ACSBG1;ACSF3;ELOVL7;ELOVL1;ELOVL6;HACD1;ACSL1;HACD2
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.6225317674494135,1.4053541846040478,0.07954545454545454,0.5302511856927059,1.0,9/20,13.71%,CLU;BBS10;CCT2;LONP1;MKKS;HSP90AA1;HSPA4;PSMG1;HSPA1A
prerank,regulation of cholesterol esterification (GO:0010872),0.7029764737608712,1.4049593515043783,0.0921595598349381,0.5303645150741252,1.0,4/10,15.06%,STARD4;APOC1;APOE;ABCA2
prerank,negative regulation of complement activation (GO:0045916),0.7138498147055409,1.4037978929642232,0.09219858156028368,0.5339522794091682,1.0,4/10,14.80%,CD55;SERPING1;SUSD4;CR1L
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.4818315821684814,-1.403454635362966,0.048672566371681415,0.7520178651202277,1.0,8/19,24.81%,ABCD2;DAGLB;AKT2;PRKCD;IRS2;MTLN;ANGPTL3;PNPLA2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.6635935033401521,1.4033563597271401,0.08645161290322581,0.5344989147166254,1.0,2/14,11.31%,OSMR;IL6ST
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6904854027464367,1.4029421340435595,0.09192200557103064,0.5347268388727161,1.0,1/11,0.90%,GCK
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.46710460613932325,-1.4027408192307402,0.0860655737704918,0.7446685835352341,1.0,3/17,10.75%,LPCAT1;PLA2G4A;CRLS1
prerank,cardiocyte differentiation (GO:0035051),0.7163137953814805,1.4014109814077174,0.07270233196159122,0.5399597460849452,1.0,3/10,12.85%,NRG1;TGFB2;AKAP13
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.7167165415324751,1.4007842451096912,0.07964601769911504,0.5412754973207703,1.0,4/10,8.49%,FPR2;CD24;KIT;BTLA
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.6158026309548973,1.400694821436369,0.08038976857490865,0.5401756924845271,1.0,8/21,20.64%,LTF;PSMB9;EPHA7;PCID2;BEX3;FYN;USP50;BIRC3
prerank,positive regulation of transmembrane transport (GO:0034764),0.6747383781623685,1.4006267410090865,0.08149171270718232,0.5389641922757903,1.0,9/13,19.25%,NR4A3;C3;SLC26A6;AZIN1;ACSL1;AZIN2;CLIP3;BRAF;C2CD5
prerank,regulation of oxidoreductase activity (GO:0051341),0.6673320687861443,1.400389065288841,0.08038147138964577,0.5385130943969129,1.0,3/13,2.63%,GZMA;HP;ATP7A
prerank,positive regulation of T cell migration (GO:2000406),0.6162727200093205,1.4001373196194635,0.066167290886392,0.5381870249195987,1.0,4/20,7.50%,SPN;CCR2;CCL5;CXCL10
prerank,action potential (GO:0001508),0.5581085141189193,1.3999201605628169,0.04381161007667032,0.5377133550693796,1.0,14/44,16.69%,SCN4A;KCNMB4;SCN1A;SCN7A;ANK3;CLN3;AKAP6;DMD;SRI;CACNA1H;KCNA1;SCN8A;CACNA1I;GNAQ
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6616655293051994,1.399138960322893,0.11564625850340136,0.5395933650588197,1.0,4/13,6.63%,CHP1;SP100;UFM1;BARD1
prerank,entry into host (GO:0044409),0.6750406647813648,1.3989907892489266,0.0797872340425532,0.5387591778935138,1.0,5/13,10.71%,CD4;PPIA;CDH1;CXCR4;CTNNB1
prerank,endodermal cell differentiation (GO:0035987),0.5817878515503258,1.3988737028589235,0.07027649769585254,0.5378109779205665,1.0,13/31,19.03%,MMP8;MMP9;ITGA4;VTN;PAF1;LEO1;MMP2;COL8A1;CTR9;ITGB2;LAMB1;MMP15;CDC73
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.5079252309356939,1.3981169611722688,0.008072653884964682,0.5394927867092774,1.0,29/138,16.47%,LCK;CD3E;CD8B;CD4;CD8A;CD7;CLNK;IL31RA;STAP1;DDR2;LMTK2;NPR2;KDR;POLR1G;KIT;BCAR1;JAK2;ZAP70;IL6ST;EPHB2;FLT3;EPHA7;EPHA5;SHC1;ABI1;FYN;BLK;IGF1R;NEDD9
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5135880602552693,1.3976465283273622,0.0030241935483870967,0.5400240897443369,1.0,25/151,9.75%,FPR2;CD4;PTPN22;RASGRP1;CCL5;CCL7;CD74;GLIPR2;SCIMP;F2R;ANGPT1;MTURN;P2RY1;FERMT2;HMGB1;KDR;APOE;PRKD2;MIF;CCN2;CD44;PRXL2C;ATP6AP1;GCNT2;CD36
prerank,response to cytokine (GO:0034097),0.5110232666428555,1.3973783603470027,0.005060728744939271,0.5396813885405609,1.0,33/141,14.15%,IL18R1;LEF1;ANXA1;OSMR;IFITM1;IFITM2;CD74;BCL2;SMPD1;SIGIRR;SP100;TIMP4;PTPN13;AFF3;TRIM21;IFITM3;TIMP3;PTPN12;PTPN9;CXCL16;JAK2;AKAP6;TIMP1;CXCR4;DDOST;IL6ST;MAPKAPK3;FLT3;COL3A1;MAPKAPK2;PTPN4;KHSRP;RIPK1
prerank,positive regulation of macrophage activation (GO:0043032),0.6253541430291922,1.397259250019196,0.1025974025974026,0.5387808605412928,1.0,3/17,5.90%,MMP8;STAP1;LBP
prerank,defense response to tumor cell (GO:0002357),0.6989637829406044,1.3969160277881674,0.08297567954220315,0.5388047962747128,1.0,4/10,7.21%,PRF1;LAPTM5;RBMS3;DLEC1
prerank,response to reactive oxygen species (GO:0000302),0.5407148877238394,1.3966088236917953,0.04951560818083961,0.5386669022223204,1.0,17/54,16.86%,MMP9;HP;PRDX5;NCF1;APOE;RPS3;PTPRN;MAPK9;GPX1;APTX;MAPT;STK24;SIRT1;FYN;SOD2;APOD;STK26
prerank,cellular response to type I interferon (GO:0071357),0.5657404057616955,1.3954485531776415,0.05580357142857143,0.5407453268943764,1.0,9/41,9.20%,IRF6;IFITM1;IFITM2;IFIT2;SP100;ISG20;GBP2;IFITM3;OASL
prerank,type I interferon signaling pathway (GO:0060337),0.5657404057616955,1.3954485531776415,0.05580357142857143,0.5407453268943764,1.0,9/41,9.20%,IRF6;IFITM1;IFITM2;IFIT2;SP100;ISG20;GBP2;IFITM3;OASL
prerank,regulation of epithelial cell proliferation (GO:0050678),0.5243931136850519,1.395228348596039,0.021671826625386997,0.5404193064376509,1.0,19/85,14.35%,DEAF1;NR4A3;RUNX3;ANGPT1;PEX2;CDK6;B2M;UHRF1;GPX1;TGFB2;BMP4;AQP11;NME1;NR4A1;BMP6;TGFBR3;MAGED1;GRN;FGF7
prerank,copper ion transport (GO:0006825),0.6941298778533975,1.3944420119235916,0.08823529411764706,0.5423769095780047,1.0,5/11,12.31%,ATP7A;ATOX1;STEAP4;SLC11A2;SLC31A2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.607406802743662,1.3942820507739884,0.06998813760379596,0.5416088275963555,1.0,6/24,9.03%,CCL5;GHR;F2R;CENPJ;KIT;JAK2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.556397124927775,-1.39415484906825,0.12110726643598616,0.7672073336131356,1.0,4/11,22.40%,LRRK2;DENND10;MAPK3;SRC
prerank,chloride transmembrane transport (GO:1902476),0.5416736477122411,1.3939189275106054,0.07222222222222222,0.5417579656300346,1.0,11/48,12.04%,SLC5A1;GABRP;CLCN1;GABRA4;GABRB1;SLC12A7;ANO4;GABRG1;ANO5;SLC12A5;SLC12A4
prerank,macrophage migration (GO:1905517),0.6586008660714413,1.3934502506933448,0.09299191374663072,0.5422940623622634,1.0,3/13,1.52%,CCR2;TAFA4;CCL5
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.576996294111797,1.3929387496860792,0.07879490150637311,0.5431855364583597,1.0,7/30,12.85%,GPR174;ARHGEF3;F2R;LPAR1;ROBO1;COL3A1;AKAP13
prerank,cellular response to peptide (GO:1901653),0.5357332188639388,1.3927415998292536,0.04891304347826087,0.542612326468401,1.0,19/56,16.03%,FPR2;PTPN22;RPL23;ITGA4;CAV1;VIM;ATP1A3;CD36;CASP4;PRNP;CACNA2D1;NOD1;ABCC1;CHMP5;DDX11;FYN;TREM2;AGER;IGF1R
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5908863933913926,1.390917216359813,0.06904761904761905,0.5490341534458293,1.0,7/26,10.59%,B3GNT3;LUM;SLC35D2;FMOD;OGN;ST3GAL1;B4GALT3
prerank,regulation of interleukin-13 production (GO:0032656),0.6674618881485945,1.3905952517956055,0.10597826086956522,0.5489638240141437,1.0,4/13,8.58%,LEF1;GATA3;RARA;SPHK2
prerank,regulation of acute inflammatory response (GO:0002673),0.6303518658060047,1.3905089208399075,0.09386733416770963,0.5479254741548069,1.0,3/18,11.34%,OSMR;IL6ST;PTGES
prerank,regulation of phosphate metabolic process (GO:0019220),0.6392315827873132,1.38975790823468,0.10039630118890357,0.5498874981882207,1.0,3/16,6.63%,CD24;MCM7;BARD1
prerank,cellular response to UV (GO:0034644),0.5253272287564712,1.3895806037711862,0.03409090909090909,0.5491562110810244,1.0,28/76,20.46%,MAPK13;MMP9;SMPD1;NEDD4;SDE2;ERCC4;EIF2S1;XPC;METTL3;TIMP1;CRIP1;DHX36;COPS9;MMP2;CARD16;ATF4;NPM1;ERCC1;POLK;SIRT1;CDKN1A;PCNA;USP28;DDB2;YY1;DDB1;STK11;ATR
prerank,negative regulation of secretion (GO:0051048),0.6934401083768275,1.388871843009316,0.09857142857142857,0.550666607154069,1.0,2/10,1.89%,NRG1;CD74
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.6406047203020996,1.3887130802376582,0.08432147562582346,0.5499446951789345,1.0,7/16,17.99%,ATP5PD;ATP5MG;ATP5PF;ATP5MF;ATP5F1D;ATP5MC1;DMAC2L
prerank,regulation of histone modification (GO:0031056),-0.5335959517852038,-1.3884611859996083,0.11610486891385768,0.7793256643875602,1.0,4/13,4.65%,AKAP8L;FLCN;MTHFR;CDK9
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.6685961992914302,1.38623926371143,0.09686221009549795,0.5591849223114738,1.0,7/14,21.58%,PPP2R2C;PPP2R2A;NCK1;PPP1R15B;PPP2CA;PPP2R2B;PPP1CA
prerank,arachidonic acid secretion (GO:0050482),0.693289094359623,1.3859087163394122,0.10914454277286136,0.5577290359379455,1.0,1/10,0.35%,ANXA1
prerank,arachidonate transport (GO:1903963),0.693289094359623,1.3859087163394122,0.10914454277286136,0.5577290359379455,1.0,1/10,0.35%,ANXA1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6409955898473776,1.3858506075360661,0.08854166666666667,0.5565813102737053,1.0,4/15,14.13%,ANXA1;UBE2L3;ZFP36L2;BCL2L11
prerank,negative regulation of DNA replication (GO:0008156),0.6740326306933493,1.385197252735327,0.08819345661450925,0.557942129312612,1.0,3/13,6.57%,GTPBP4;S100A11;WAPL
prerank,cellular response to estrogen stimulus (GO:0071391),0.6532253434780451,1.3836989879862056,0.10638297872340426,0.5631146254730366,1.0,4/14,7.88%,SERPINB9;ARID5A;RARA;TRIM24
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6157198161132962,1.3835656013013928,0.10546378653113088,0.5622617391127115,1.0,7/18,19.25%,NR4A3;C3;APPL1;SLC2A1;CLIP3;BRAF;C2CD5
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6481389686379808,1.3823612232695544,0.08020698576972833,0.5660645803870177,1.0,3/15,4.54%,ITK;TXK;KDR
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.446380547971429,-1.3820499009752727,0.0782122905027933,0.7926092184407,1.0,9/22,35.78%,LGMN;CYP2R1;CBR1;ALDH1A2;RBP1;CYP1A1;LRP2;PIAS4;VKORC1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.6559255903428749,1.3810964673578192,0.10119840213049268,0.5701839062360479,1.0,7/14,15.88%,ELAVL4;BOLL;YBX3;MAPKAPK2;TARDBP;TIRAP;ANGEL2
prerank,epiboly involved in wound healing (GO:0090505),0.6388006445487271,1.3808867862372167,0.09859154929577464,0.5697139290574094,1.0,7/16,15.51%,FLNA;CEACAM1;LCP1;CD44;PDPN;RHOC;CARMIL2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6743650593992352,1.3799943253507487,0.09510086455331412,0.5720529318024045,1.0,5/12,14.04%,SORBS1;ZBTB7B;SORL1;IRS1;SIRT1
prerank,epithelial cell development (GO:0002064),0.6256663121044245,1.3791133254267287,0.09022556390977443,0.5744913270171829,1.0,4/20,10.81%,POF1B;ACTA2;TMEM79;RILPL2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5397960072047997,1.3790524634814352,0.048298572996706916,0.5733449026725873,1.0,13/49,14.89%,CD2;CD74;F2R;HMGB1;IL17D;TLR9;PRKD2;LBP;SERPINE1;NOD1;HSPA1A;RIPK1;TIRAP
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5250507623758948,1.3770191398676859,0.03426791277258567,0.5806525113665896,1.0,11/72,5.19%,RIPOR2;GPR174;DLC1;HEG1;ARHGEF3;ARHGDIB;F2R;ARHGEF18;LPAR1;RAF1;APOE
prerank,eosinophil chemotaxis (GO:0048245),0.6506282398524661,1.3760015849095746,0.11984021304926765,0.582078325684958,1.0,2/14,1.85%,CCL5;CCL7
prerank,eosinophil migration (GO:0072677),0.6506282398524661,1.3760015849095746,0.11984021304926765,0.582078325684958,1.0,2/14,1.85%,CCL5;CCL7
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5451856801249131,1.3752808662221847,0.07513812154696133,0.583716713714729,1.0,15/46,18.79%,STAT4;PDCD4;PPIA;MIF;MSN;LCP1;JAK2;CDC42;CFL1;RPLP0;HNRNPF;SOD2;P4HB;TALDO1;RALA
prerank,negative regulation of translational initiation (GO:0045947),-0.5124756821052864,-1.3750598894846817,0.12648221343873517,0.8094970250112731,1.0,6/13,8.91%,EIF4EBP2;EIF2AK1;PAIP2;RBM4;EIF2AK4;LARP1
prerank,response to muramyl dipeptide (GO:0032495),0.6708451586097057,1.37491553837879,0.1028169014084507,0.5839033789308383,1.0,4/12,12.30%,PTPN22;VIM;NOD1;CHMP5
prerank,positive regulation of endocytosis (GO:0045807),0.5472912987188668,1.374744389966079,0.06870229007633588,0.5832526596591513,1.0,16/45,15.53%,ABCA13;STAP1;SMPD1;C3;CLU;B2M;VTN;APOE;CLN3;CALY;CDC42;SERPINE1;HIP1;VPS28;GPC3;TREM2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5231815285818804,1.374050210726958,0.049893842887473464,0.5848955806953374,1.0,11/68,5.90%,MMP8;MAPK13;CYBA;CD74;SCIMP;F2R;HMGB1;IL17D;TLR9;POU2AF1;LBP
prerank,leukocyte tethering or rolling (GO:0050901),0.6308356603965906,1.3737576448649937,0.10165184243964422,0.5847185193057618,1.0,7/17,11.36%,SPN;SELL;ITGA4;ITGB1;ITGB7;PODXL2;ROCK1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.4848035895218698,-1.3737405404265037,0.12236286919831224,0.8046360738043392,1.0,5/17,8.16%,SLC8A1;CACNA1D;ANK2;TRPM4;HCN2
prerank,macrophage chemotaxis (GO:0048246),0.6860147468424964,1.3733591341076097,0.1016949152542373,0.5850309262616286,1.0,2/10,1.52%,TAFA4;CCL5
prerank,positive regulation of interleukin-4 production (GO:0032753),0.629512775968359,1.3733500772446645,0.12210796915167095,0.5836562262643784,1.0,7/17,16.76%,PRKCQ;GATA3;CD28;RARA;SLC7A5;IRF4;CEBPB
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.4946289567180975,-1.3729526720650247,0.12350597609561753,0.7979609657536102,1.0,10/14,26.70%,OPA1;LRRK2;TXNDC12;TMBIM6;BCL2L1;XBP1;CREB3;PRKN;SYVN1;HERPUD1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6929895230191097,1.370173484509946,0.09852941176470588,0.5961380679880911,1.0,2/10,3.11%,TFAP4;SP100
prerank,secondary palate development (GO:0062009),0.6512267556167111,1.369310722360171,0.11050477489768076,0.5984232496507595,1.0,5/14,13.07%,LEF1;SMAD2;TGFB2;TGFBR3;TGFB3
prerank,second-messenger-mediated signaling (GO:0019932),0.5128323473462651,1.3677665912309087,0.04343329886246122,0.6039919685217175,1.0,14/82,10.31%,FPR2;PPP1R9B;CXCR2;CCR2;MCTP2;CXCR3;NDNF;RCAN3;APOE;RCAN2;PPP2R1A;NUDT4;CD36;CXCR4
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6396473711261388,1.367524945400616,0.09175531914893617,0.6036909061388068,1.0,4/15,5.26%,RPL11;RPS7;RPL23;FBXO5
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5063557777881508,1.3673807434520362,0.016227180527383367,0.6028906868517843,1.0,24/110,16.69%,ADGRB1;ADGRG5;ADGRG7;ADORA2A;LPAR1;ADGRE5;S1PR4;ADGRL4;S1PR2;PTGIR;MC5R;RAMP1;CXCL10;IAPP;TSHR;LGR4;ADGRG2;ADCY6;ADGRL2;CNR2;GNA13;DRD2;ADCY1;GNAQ
prerank,positive regulation of stem cell proliferation (GO:2000648),0.6221085211250684,1.3671091204266188,0.11439588688946016,0.6026599515626494,1.0,8/17,28.10%,FERMT2;LTBP3;SOX11;PTPRC;HNRNPU;PDCD2;GJA1;KAT7
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.5980027507549316,1.3667644860590538,0.09302325581395349,0.6027443536656559,1.0,6/23,9.35%,RIPOR2;CD74;DPP4;MDK;RAC2;JAM3
prerank,macrophage differentiation (GO:0030225),0.6643778552912523,1.3667519025541814,0.10854816824966079,0.6013749399402933,1.0,5/13,9.79%,CD4;MMP9;IL31RA;BMP4;CDC42
prerank,aerobic respiration (GO:0009060),0.6064134659395941,1.3662648613091435,0.09887359198998748,0.6021481949569353,1.0,11/20,20.06%,NDUFS7;SDHB;UQCRB;MTFR2;ATP5F1D;MDH2;SLC25A14;MTFR1;SDHC;UQCRC1;UQCRH
prerank,sodium ion transmembrane transport (GO:0035725),0.5114162305076849,1.3659731491611289,0.042268041237113405,0.6019635886804807,1.0,16/84,12.06%,SLC5A1;SLC6A19;SLC6A14;SCN4A;ATP1B3;SLC6A8;SLC24A4;NALCN;SCN1A;SCN7A;ATP1A3;ATP1A4;ATP1A1;ATP1A2;HCN3;SCN8A
prerank,apical junction assembly (GO:0043297),0.5300111626750422,1.3650838419822282,0.06896551724137931,0.6044182310963999,1.0,11/53,15.29%,POF1B;PECAM1;MICALL2;PATJ;PARD3;ARL2;MPP7;MARVELD2;RHOC;CDH5;VCL
prerank,muscle tissue development (GO:0060537),0.6485549044791671,1.3650417232332042,0.10547945205479452,0.6032234248365504,1.0,6/13,18.60%,CSRP3;BMP4;SRPK3;CSRP2;CSRP1;POGLUT1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6069994573733691,1.364793534608914,0.10331632653061225,0.6028792911537714,1.0,4/20,6.16%,IL18R1;CD55;B2M;MALT1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6772699771796655,1.3645767421256574,0.12375533428165007,0.6024159906563084,1.0,3/10,12.55%,BMP1;APOE;ABCA7
prerank,positive regulation of binding (GO:0051099),0.5117065135377984,1.3645103249567903,0.03319502074688797,0.6013570174820821,1.0,29/84,19.38%,MMP8;MMP9;RPL11;HMGB1;B2M;TRIM21;VTN;APOE;RARA;HMGB2;BMP4;NVL;PIN1;CAV1;NME1;AMFR;DPH3;FKBP1A;HMBOX1;STK4;RALB;DDX11;TIAM1;EDF1;DERL1;SPPL3;HES1;EPB41;MARK3
prerank,regulation of T cell cytokine production (GO:0002724),0.632678608584203,1.3643395190414678,0.11920529801324503,0.6007445219931744,1.0,4/15,6.16%,CCR2;CD55;B2M;MALT1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.648723602813595,1.3631334253836112,0.11612021857923498,0.6045701297301956,1.0,4/14,14.05%,PRKAR1B;ATP2B4;SIRT1;PRKAR1A
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5234269820510428,1.3624902554157516,0.05717367853290183,0.6060815394647764,1.0,14/56,13.03%,S100A8;S100A9;RPS27A;HMGB1;UBA52;TAB2;TLR9;CLEC4E;LBP;CD36;MAPKAPK3;NOD1;UBB;MAPKAPK2
prerank,positive regulation of response to external stimulus (GO:0032103),0.5027255897099336,1.361706077627413,0.027327935222672066,0.608120883606504,1.0,30/128,17.97%,S100A8;S100A9;FPR2;CCR2;MAPK13;HRG;CYBA;CCL5;SCIMP;PDCD4;TLR9;MDK;CD47;ETS1;RARRES2;BMP6;OASL;NAPEPLD;SERPINE1;NFKBIA;ABCC1;GRN;RIPK1;TREM2;USP15;GPSM3;IL33;RIOK3;TNIP1;ACOD1
prerank,focal adhesion assembly (GO:0048041),0.6002506704292526,1.3616239397286756,0.10414052697616061,0.6071273897325855,1.0,7/21,13.27%,DLC1;SORBS1;TRIP6;FERMT2;ACTN1;THSD1;TESK2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.48857054860448984,-1.3614448212161017,0.10588235294117647,0.8333549919748817,1.0,6/14,30.19%,DAGLA;DAGLB;CHAT;NOS1;MOXD1;ACHE
prerank,cellular response to UV-A (GO:0071492),0.6721107566713077,1.3614285246898148,0.11424541607898449,0.6065817962206759,1.0,3/11,11.22%,MMP9;TIMP1;MMP2
prerank,maintenance of blood-brain barrier (GO:0035633),0.5707026921378466,1.3612315464534988,0.09132947976878612,0.606006785737548,1.0,10/30,15.29%,ACTG1;ACTB;PECAM1;GJB6;ITGB1;MFSD2A;JAM3;DMD;CDH5;VCL
prerank,cellular response to hormone stimulus (GO:0032870),0.5185456083271553,1.3607261723543234,0.048625792811839326,0.606740119571226,1.0,20/69,15.91%,NR4A3;GCK;GHR;SERPINB9;ARID5A;RARA;RAMP1;TRIM24;UBE2L3;CAV1;ATP1A3;ATP1A1;STAT5B;CACNA1H;TFPI;ATP1A2;ROBO2;CTSH;NCOA2;WBP2
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.5642522432441615,-1.3604506314122542,0.15614617940199335,0.827330011305608,1.0,5/10,12.43%,SETD3;EHMT1;SETD4;KMT5A;SMYD2
prerank,cellular response to interleukin-6 (GO:0071354),-0.4192541453819614,-1.360431081848407,0.08,0.817645145706934,1.0,8/26,10.31%,IL6R;PID1;FER;SELPLG;PTPN11;ST3GAL6;CEBPA;SPI1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.6238766080472492,1.3597364658486735,0.1248339973439575,0.6098077591325594,1.0,1/16,0.09%,MMP8
prerank,negative regulation of protein metabolic process (GO:0051248),0.5369629716475248,1.3593988642065176,0.07510729613733906,0.60996073003423,1.0,24/48,23.93%,ADGRB1;FLNA;CLU;APOE;PFDN5;FLOT2;IAPP;PIN1;PRNP;AZIN1;ROCK1;PFDN1;AGAP2;TREM2;AZIN2;PFDN4;CRYAB;LDLR;SNX12;VBP1;HSP90AB1;EDNRB;PRKCG;MDM4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5468692646632916,1.3587882080045954,0.08135593220338982,0.6112110016244785,1.0,7/40,5.29%,XPO1;RPL11;RPS7;RPL23;CLU;LAPTM5;PTEN
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6257160207736729,1.3583321370927797,0.12371134020618557,0.6117771105108846,1.0,3/15,3.74%,RIPOR2;ADGRB1;CD53
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5342121726976282,1.357900350458447,0.06775956284153005,0.6122417005780076,1.0,11/49,9.01%,SCIN;NR4A3;PRKCQ;MYL9;MTURN;HDAC1;HMGB2;NFE2;SETD1A;RBM15;L3MBTL1
prerank,positive regulation of DNA recombination (GO:0045911),-0.41385908566308877,-1.3577777577176884,0.08383233532934131,0.8185124972326598,1.0,12/27,16.39%,MMS19;SHLD1;PARP1;PAXIP1;SHLD2;KMT5B;ZCWPW1;ERCC2;WRAP53;HMCES;MRNIP;ARID2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6012427935123219,1.3572547872354104,0.11206896551724138,0.6135389430873828,1.0,4/20,8.38%,PLA2R1;ITGA4;PDCD4;GSN
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.553596127458268,1.3572082960954426,0.07420091324200913,0.6123697938775868,1.0,8/37,9.11%,NUDT1;ENTPD5;ISG20;NUDT15;RNASE3;RNASE6;XRN2;ENTPD2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6502597604315324,1.357040541891122,0.12113055181695828,0.6116504386463486,1.0,5/13,17.48%,CHP1;SOAT1;RAMP1;ABCA2;IL33
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.6500015020185859,1.3569007333139702,0.1111111111111111,0.6108540703519091,1.0,4/14,7.31%,RASGRP1;IL17D;TLR9;PAEP
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4849347058207522,1.356656686468201,0.0,0.6105972182052384,1.0,117/532,15.42%,LCK;GRAP2;IL2RB;LCN2;IL18RAP;IL18R1;TMSB4X;STAT4;CD4;ANXA1;LTB;CXCR2;OSMR;RPS27A;CCR2;PLP2;IRF6;MMP9;GATA3;IL27RA;TRAF1;IFITM1;CCL5;IFITM2;IL31RA;IFIT2;GHR;CCL7;BCL2;TNFRSF11B;LAMA5;IL1R2;CEACAM1;SP100;ISG20;IL20RA;PSMC3;PDCD4;HSPA8;IL7R;UBA52;TAB2;B2M;BIRC5;UGCG;PPIA;TRIM21;PSMD8;GPR75;PIM1;COL1A2;ITGB1;PSME1;GBP2;LBP;PSMD6;IFITM3;MIF;PSMB5;KIT;MSN;LCP1;CXCL10;CD44;GREM2;IFNGR1;IL2RG;RPS6KA5;PELI1;IL3RA;PSMC6;JAK2;OASL;VIM;STAT5B;CD36;TIMP1;CDC42;CFL1;RPLP0;PSMB4;HSP90AA1;APPL1;SLC27A1;MMP2;ILK;IL6ST;NFKBIA;PSMA7;FLT3;NOD1;CLCF1;IRS1;UBB;CTR9;FOXO1;PSMB9;PSMA6;BCL6;TNFRSF13C;TRIM68;TNFSF12;RHOU;HNRNPF;PSMC1;SIRT1;BCL2L11;RIPK1;RSAD2;ITGAX;TNFRSF14;SHC1;CDKN1A;CRKL;FYN;SOD2;IRF4
prerank,regulation of histone acetylation (GO:0035065),-0.39205241021095116,-1.3563716782857294,0.06504065040650407,0.8141788788577339,1.0,9/33,11.77%,CAMK1;FLCN;PAXIP1;BRD7;NOC2L;PPARGC1A;ARRB1;SPI1;TAF7
prerank,cellular response to interleukin-2 (GO:0071352),0.6692212730907907,1.3562499000210486,0.1262002743484225,0.6095223850587593,1.0,4/11,14.64%,IL2RB;IL2RG;STAT5B;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6692212730907907,1.3562499000210486,0.1262002743484225,0.6095223850587593,1.0,4/11,14.64%,IL2RB;IL2RG;STAT5B;SHC1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.6140971820772264,1.355946473793654,0.12041884816753927,0.609530871926108,1.0,7/17,11.50%,BMP4;UBE2L3;ABHD2;ATP1A3;ATP1A1;TFPI;ATP1A2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6544235917806328,1.355685252967639,0.10780141843971631,0.6093034773894153,1.0,5/13,14.04%,SORBS1;ZBTB7B;SORL1;IRS1;SIRT1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5286028587003685,1.3555300524446872,0.06601731601731602,0.6085888508757252,1.0,7/53,8.63%,ANXA1;HTR7;PTGIR;MTNR1A;MC5R;HTR4;TSHR
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.6404343221677083,1.3548964857260273,0.14093959731543623,0.6099840188367203,1.0,4/14,6.16%,ANXA1;MYB;RARA;MALT1
prerank,glial cell development (GO:0021782),0.5764841886700013,1.3546142933066163,0.11124260355029586,0.6099914141154185,1.0,8/25,19.90%,S100A9;CDK6;MDK;EIF2B4;CSPG5;SOX11;SOX10;MXRA8
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6088552633933915,1.3542024817218465,0.12692307692307692,0.6104269918558609,1.0,3/18,1.66%,RIPOR2;DLC1;HEG1
prerank,insulin secretion (GO:0030073),0.6071870689149734,1.3540116092990853,0.1,0.6099123682658854,1.0,3/19,10.58%,ANXA1;PTPRN;SNX19
prerank,mitochondrion localization (GO:0051646),-0.44287869604936614,-1.353966094700619,0.12612612612612611,0.8143759365354782,1.0,9/19,23.32%,MEF2A;LRRK2;TRAK1;MARK1;MFN2;ATCAY;TRAK2;ZBED3;HAP1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.6248467021974091,1.3538825325773225,0.125,0.6091389717911817,1.0,6/16,10.81%,SREBF1;CTDNEP1;NR1H2;MFSD2A;GPLD1;SLC27A1
prerank,aortic valve morphogenesis (GO:0003180),0.5613730168599548,1.3532380453356576,0.10365135453474676,0.6107369239355668,1.0,14/30,22.46%,ELN;GATA3;BMP4;HEY2;ROBO1;ROCK1;ROBO2;JAG1;EMILIN1;SLIT3;SNAI2;SOX9;EFNA1;SMAD6
prerank,anterior/posterior axis specification (GO:0009948),-0.4853622068508669,-1.3530965777744288,0.1067193675889328,0.808636736260929,1.0,1/15,0.18%,SKI
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.6671411119522368,1.3525638564922233,0.12412831241283125,0.6124015481745844,1.0,6/11,20.45%,STAP1;MIF;GREM1;NBL1;RIN3;CCN3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.6138804953124181,1.351508821671434,0.09961190168175937,0.6156516086796636,1.0,6/18,9.03%,RFC4;MCM7;GINS2;GINS3;LIG1;POLE
prerank,cellular response to glucose starvation (GO:0042149),-0.37226942857316514,-1.3510397640555896,0.05263157894736842,0.8076103254445463,1.0,17/41,17.99%,NUAK1;BECN1;SESN1;FOXO3;SH3GLB1;NUAK2;PRKAA2;PRKAG2;MTMR3;PICK1;PIK3C3;ZC3H12A;SESN2;RRP8;ASNS;XBP1;BRSK2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.53831240441617,1.3506382681608962,0.07540983606557378,0.618147946213703,1.0,10/46,10.71%,NR4A3;ELN;CCL5;PTGIR;OGN;CDH13;FOXP1;BMP4;ID2;CTNNB1
prerank,nuclear pore complex assembly (GO:0051292),0.6700340310244051,1.3505544309998858,0.11678832116788321,0.6171434721346436,1.0,9/10,28.43%,AHCTF1;NUP93;NUP205;NDC1;NUP153;TMEM170A;NUP98;TPR;RTN4
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.5985835718453194,1.35053231955228,0.13392857142857142,0.6158835475635649,1.0,2/20,3.66%,GATA3;H1-0
prerank,response to UV-A (GO:0070141),0.6342266878112095,1.3503638014822232,0.12432432432432433,0.6152160694490993,1.0,3/14,11.22%,MMP9;TIMP1;MMP2
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5882503899427777,1.3503111833479653,0.10532837670384139,0.6141345939497747,1.0,3/22,1.56%,TMSB4X;SCIN;TMSB10
prerank,muscle organ development (GO:0007517),0.528255148649191,1.3499574812371526,0.08855291576673865,0.6144272733601646,1.0,14/54,10.26%,ZBTB42;COL6A3;TAGLN;UTRN;CHODL;CHD2;MRAS;CXCL10;POU6F1;TCF12;DMD;SRI;EGR3;CACNA1H
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6083146521816561,1.3497971640437718,0.12849872773536897,0.6137842305181762,1.0,7/17,12.36%,LTF;SCIMP;SIGIRR;CD55;BMP6;CD36;CARD16
prerank,sensory organ development (GO:0007423),0.5313238323693261,1.3493542222687251,0.07667386609071274,0.6143440421569559,1.0,13/51,19.79%,SOX3;GATA3;BLOC1S3;PBX1;SMOC1;TGFB2;HIPK1;MEIS2;GDF3;PBX2;SIPA1L3;ECE1;PBX3
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.6132914347250218,1.3491544803051023,0.11712846347607053,0.6139307111622496,1.0,7/18,11.36%,SPN;SELL;ITGA4;ITGB1;ITGB7;PODXL2;ROCK1
prerank,cell projection assembly (GO:0030031),0.5915696450570165,1.3484458451071093,0.10101010101010101,0.6156214922988615,1.0,10/22,13.85%,SCIN;RHOJ;PARVA;GSN;RAC2;CDC42;NEFH;NCKAP1;CAPG;RHOU
prerank,neutral amino acid transport (GO:0015804),0.5642813268887791,1.3481119274232671,0.10287081339712918,0.6157327319135212,1.0,10/28,19.74%,SLC6A14;SLC36A3;SLC3A2;SLC1A5;SLC7A5;SLC6A17;SLC43A2;SLC38A1;SLC6A15;SLC6A6
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.6435253054012594,1.347982698755864,0.13385826771653545,0.6149294608079338,1.0,4/14,9.76%,LIMS2;FLNA;CD63;TIMP1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.5374259438887908,1.3476193891419657,0.09465478841870824,0.615167790866593,1.0,7/44,3.98%,KCNN4;ATP1B3;FLNA;KCNJ10;KCNMB4;KCNJ15;AMIGO1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.6466790858996899,1.3475554775689444,0.11366711772665765,0.612904084362209,1.0,4/13,9.67%,IL2RB;CD4;IL2RG;STAT5B
prerank,cellular response to interleukin-15 (GO:0071350),0.6466790858996899,1.3475554775689444,0.11366711772665765,0.612904084362209,1.0,4/13,9.67%,IL2RB;CD4;IL2RG;STAT5B
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.43207709929518084,-1.3469447598188466,0.11616161616161616,0.8142512817416545,1.0,8/21,16.58%,PAN3;CNOT8;CNOT7;CNOT9;CNOT4;TNKS1BP1;CNOT11;CNOT3
prerank,calcineurin-mediated signaling (GO:0097720),-0.5449110095367649,-1.3464769314314278,0.14492753623188406,0.7983339603607509,1.0,4/10,13.82%,PPP3R1;NFATC2;NFATC1;NFAT5
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.5449110095367649,-1.3464769314314278,0.14492753623188406,0.7983339603607509,1.0,4/10,13.82%,PPP3R1;NFATC2;NFATC1;NFAT5
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.4923463266060816,-1.3462031550933597,0.12396694214876033,0.7908811027099443,1.0,7/15,34.12%,SAT1;DDC;ASMT;SAT2;MOXD1;SRM;AANAT
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6203627958926965,1.3453905805688942,0.12368421052631579,0.6207928270678513,1.0,4/16,10.20%,TPT1;CLU;RPS3;CCAR2
prerank,organophosphate ester transport (GO:0015748),-0.438358780780056,-1.3453461598441172,0.0935672514619883,0.7857950231816176,1.0,10/24,15.02%,EPG5;PRELID2;ABCA3;SCP2;NPC2;PITPNA;SCARB1;PLTP;PITPNB;MTTP
prerank,regulation of cell junction assembly (GO:1901888),-0.4027671768189087,-1.3452458718575497,0.08928571428571429,0.7778669355704536,1.0,7/27,16.06%,ROCK2;MEF2C;F11R;FLOT1;RUNX1;TJP1;CBFB
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.55099088363171,-1.3446626219381337,0.1111111111111111,0.7719483439996913,1.0,6/10,17.97%,NPL;NAGK;GNE;AMDHD2;ST6GAL1;RENBP
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.6569782224534964,1.3444677195836106,0.1309192200557103,0.6233613721869378,1.0,7/11,30.11%,PELI1;YBX3;RIPK1;SLC25A4;BIRC3;FZD9;NUPR1
prerank,cellular protein-containing complex assembly (GO:0034622),0.48700092758973823,1.3442233767969474,0.01805416248746239,0.6232031534686395,1.0,59/160,23.76%,CD3E;TESPA1;NRG1;COX7A1;CYBA;ANGPT1;NCK2;CLU;FCHO1;FMOD;BBS10;RPL38;CCDC65;CCT2;ARL2;LONP1;SMAD2;POMP;MKKS;TBCA;DMD;CALY;NCK1;HSP90AA1;DLGAP5;SMAD1;MID1IP1;DNAI4;HSPA4;MAPT;HIP1;FKBP1A;PSMG1;PDE4DIP;HSPA1A;ARL6;NSG2;GPX4;TIAM1;AP2S1;AHCTF1;PTGES3;OMA1;DNAAF3;MIS12;HIGD2A;SNCA;RAB5IF;NSG1;VBP1;SRP19;HSP90AB1;DNAJB14;STXBP6;NUP93;EIF4B;CENPF;NUP205;NDC1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.6187413897104982,1.3440624246532504,0.11853720050441362,0.622645061761141,1.0,7/16,13.26%,CHMP6;CHMP7;TMEM50B;SNF8;CHMP5;VPS28;LEPROTL1
prerank,negative regulation of hemostasis (GO:1900047),0.657668245266747,1.343434006468839,0.12631578947368421,0.6240670814601164,1.0,4/12,11.17%,VTN;APOE;TFPI;SERPINE1
prerank,regulation of response to external stimulus (GO:0032101),0.49312819469865055,1.3433786026061632,0.03248730964467005,0.623017645647311,1.0,34/121,18.64%,TMSB4X;ANXA1;CCR2;HRG;PTPN22;PDE6B;F2R;CD55;SAG;EFNB2;FOXP1;NR1D2;CAV1;JAK2;CD36;CASP4;CXCR4;APPL1;PTGES;EPHB2;STK24;PSMA6;USP18;BCL6;GRN;AKNA;TIRAP;TREM2;SAMHD1;CALM1;AREL1;METAP2;RNF135;FNTB
prerank,positive regulation of interferon-beta production (GO:0032728),-0.3714733040960141,-1.3431441091997263,0.05925925925925926,0.7698364298891176,1.0,14/33,17.66%,TLR7;POLR3B;TLR4;PTPN11;TLR2;OAS2;TLR8;TLR3;FLOT1;DHX58;TBK1;IRF3;POLR3D;IRF7
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.48640210398693834,1.343137181156264,0.003006012024048096,0.6227645208909941,1.0,53/214,17.97%,FPR2;CD4;PTPN22;RASGRP1;CCL5;FBLN1;CCL7;CD74;GLIPR2;SCIMP;F2R;ANGPT1;CEACAM1;MTURN;P2RY1;FERMT2;HMGB1;KDR;APOE;PTEN;PRKD2;TIMP3;SPRY1;MIF;LMO3;CCN2;DUSP6;CD44;PRXL2C;PIN1;APIP;ZDHHC17;ATP6AP1;GCNT2;CD36;SPRY3;EPHB2;TGFBR3;ABCA7;EPHA7;SHC1;TIRAP;EZR;CRKL;DUSP4;TREM2;AGER;PDGFD;BRAF;EMILIN1;RANBP9;TNIP1;NTRK3
prerank,regulation of cytokine production (GO:0001817),0.49579673202686053,1.3430979826902576,0.029531568228105907,0.6216315702372869,1.0,30/126,17.48%,ITK;LTF;ANXA1;CCR2;GATA3;CD28;PLA2R1;SRGN;TXK;HDAC9;CLEC6A;TRIM21;MIF;CD47;FOXP1;ASB1;RPS6KA5;LGR4;BCL6;MAPKAPK2;PLD3;NPTN;GAPDH;TREM2;BTN3A3;AGPAT2;S100A13;BATF;GLMN;IL33
prerank,regulation of feeding behavior (GO:0060259),0.6642998753481453,1.3422077239443764,0.13352685050798258,0.6243707282244985,1.0,1/11,0.87%,NR4A3
prerank,positive regulation of cytokine production (GO:0001819),0.48495831031438014,1.3419078484202582,0.005,0.6243131437900213,1.0,71/292,18.17%,MMP8;CD226;ITK;IL18R1;CD4;ANXA1;LTB;CD2;CCR2;MAPK13;CD6;PRKCQ;PTPN22;RASGRP1;GATA3;CYBA;CD28;PLA2R1;CD74;SCIMP;F2R;C3;TXK;HMGB1;CLEC6A;IL17D;TLR9;LAPTM5;POU2AF1;RPS3;PRKD2;LBP;RARA;MDK;ZBTB7B;MALT1;MIF;FOXP1;PAEP;SPHK2;DHX36;APPL1;CTNNB1;SERPINE1;IL6ST;SORL1;NOD1;ATF4;POLR2F;SLC7A5;HSPA1A;RIPK1;GAPDH;TNFRSF14;TIRAP;EIF2AK3;SLAMF6;DRD2;IRF4;TICAM1;AGER;AGPAT2;IL27;S100A13;CEBPB;BATF;GLMN;IL33;LILRB1;MBP;CGAS
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6202050878538672,1.3418392324884219,0.12757731958762886,0.6233435423649921,1.0,3/16,5.78%,UPB1;NT5M;NT5C3A
prerank,protein homotrimerization (GO:0070207),0.6312797387020694,1.3412841344228976,0.14304123711340205,0.6232475504869466,1.0,5/14,10.14%,MLKL;ALOX5AP;STEAP4;MIF;SLC1A5
prerank,protein trimerization (GO:0070206),0.6312797387020694,1.3412841344228976,0.14304123711340205,0.6232475504869466,1.0,5/14,10.14%,MLKL;ALOX5AP;STEAP4;MIF;SLC1A5
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.4260130222715774,-1.3412223750600571,0.11627906976744186,0.7688586597982597,1.0,13/26,20.17%,LGMN;CCDC57;EIF4E;MDM2;USP2;TTL;TAL1;KLHL18;APP;EIF4EBP1;ASNS;SMOC2;CDC25B
prerank,nucleosome assembly (GO:0006334),0.5566046099333815,1.3409525175454402,0.11073059360730593,0.6233777245955441,1.0,11/31,14.96%,DAXX;ATRX;ASF1B;ANP32B;HMGB2;CHAF1B;NASP;UBN1;NPM1;PADI4;CABIN1
prerank,cellular component disassembly (GO:0022411),0.5235394284594235,1.340928575593741,0.08315334773218143,0.6222150757799925,1.0,16/53,17.45%,MMP8;MMP9;SCUBE3;BMP1;LCP1;CD44;GSN;TIMP1;BSG;MMP2;MMP12;CAPG;CAPNS1;CAPNS2;NOXO1;MMP15
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.54236679004363,1.3398177075642401,0.10442678774120318,0.6256266475988714,1.0,7/39,9.63%,RANGRF;FXYD5;FXYD1;NEDD4;UTRN;ANK3;DMD
prerank,neutrophil activation (GO:0042119),0.6618287763801252,1.3395056296737644,0.11972789115646258,0.6256319847629048,1.0,2/12,1.52%,CXCR2;CCL5
prerank,cell-cell junction assembly (GO:0007043),0.51412438276538,1.339394587877987,0.07900432900432901,0.624804539421172,1.0,16/63,12.78%,PKP1;ACTG1;ACTB;PKP4;PATJ;GJB2;GJB6;GJD3;GJC1;CDH20;CDH19;CDH7;JAM3;CTNNB1;RHOC;CDH5
prerank,protein localization to cell junction (GO:1902414),0.5836685926201878,1.3393888973646297,0.1260815822002472,0.6235639003647526,1.0,6/22,9.35%,HEG1;ARHGEF18;NECTIN1;FERMT2;MPP4;JAM3
prerank,microvillus organization (GO:0032528),0.6505829697944153,1.338807572572113,0.12813370473537605,0.6247883473581954,1.0,6/13,16.86%,FXYD5;RAPGEF6;TNIK;EZR;RAP2A;STK26
prerank,plasma membrane repair (GO:0001778),0.6414372061452354,1.337726690768375,0.11924119241192412,0.6284248912947722,1.0,4/13,9.45%,SMPD1;ANXA6;ARL8B;SYT7
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.5633503977472486,1.3373086620934649,0.12396694214876033,0.6289385809323423,1.0,9/27,15.36%,DUT;AK7;TXNRD1;GSR;CMPK1;NME1;AK9;RRM2B;TYMS
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.533835455105839,1.337284401447828,0.10650224215246637,0.6277854389534375,1.0,8/41,9.32%,KCNN4;FLNA;KCNJ10;KCNMB4;KCNJ15;AMIGO1;ANK3;AKAP6
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5207562597860667,1.3368787775915327,0.06796116504854369,0.6282385874270618,1.0,14/57,18.51%,FPR2;FLNA;LPAR1;RGS1;MTNR1A;HTR4;INSL3;GNAI2;ADCY6;DRD2;GABBR1;ADCY1;HTR1F;GNAI1
prerank,proton transmembrane transport (GO:1902600),0.5426008306219129,1.3367783020801907,0.08826945412311266,0.6274552877923603,1.0,11/36,18.42%,SLC36A3;ATP1A3;ATP1A4;ATP1A1;ATP5MF;ATP1A2;SLC25A14;UCP2;ATP6V0E1;DMAC2L;ATP6V1F
prerank,protein K63-linked deubiquitination (GO:0070536),-0.39151397583876024,-1.3363342161337548,0.09941520467836257,0.778181242566456,1.0,10/31,18.02%,USP16;BABAM2;TNFAIP3;ABRAXAS2;CYLD;OTUD4;STAMBPL1;USP13;BABAM1;YOD1
prerank,cellular response to metal ion (GO:0071248),0.4940237534551325,1.3363285266188978,0.024242424242424242,0.6280362574920857,1.0,27/123,11.01%,SLC25A24;MMP9;DAXX;SMPD1;NCF1;IQGAP1;RASGRP2;ALOX5AP;SYT4;B2M;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;CDH1;MAPK9;ANK3;BMP6;GPLD1;SYT7;CACNA1H;KCNA1;PRNP
prerank,positive regulation of ATPase activity (GO:0032781),0.5290775695563,1.3361037426545088,0.09713024282560706,0.6277614377321714,1.0,6/41,7.20%,TNNT3;ATP1B3;DNAJB1;DNAJC9;UHRF1;DYNLL1
prerank,positive regulation of cell death (GO:0010942),0.5221928089317515,1.336012703128651,0.06050955414012739,0.6268987782937148,1.0,22/59,21.92%,HP;HPR;DAXX;RARG;CLU;HTATIP2;EFNB2;EIF2S1;BMP4;CD36;PRNP;MAPT;RIPK1;FYN;ITGB2;BNIP3;TYROBP;SLC6A6;SNCA;GSK3B;ACER2;EGR1
prerank,DNA packaging (GO:0006323),0.6133950300250677,1.33586146553053,0.1310615989515072,0.6262742531884229,1.0,3/16,6.76%,M1AP;H1-0;CHAF1B
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5371367970489893,1.3352864192395622,0.10738255033557047,0.6273490108334084,1.0,15/40,16.79%,LEF1;GLIPR2;FERMT2;SMAD2;MDK;TGFB2;PDPN;GCNT2;CTNNB1;COL1A1;TGFB3;WWTR1;SDCBP;TIAM1;JAG1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.3015513851468143,-1.3349491358760122,0.0,0.7755303192922419,1.0,39/119,15.77%,INPP5D;PIP4K2A;PI4KB;PLCG2;RUFY1;PIK3R1;CDS1;INPP4A;PI4KA;FGF2;PLEKHA8;PIK3CA;ITPKB;CDIPT;SACM1L;PIP5K1A;INPP4B;EFR3B;PGAP2;PIK3R6;MTMR4;PIGM;PIK3CG;PITPNM3;PIK3CB;PIK3CD;PIGB;MTMR3;TMEM150A;PLEKHA2;PI4K2B;DPM2;PIK3C3;INPP5E;RAB5A;PIGF;PIK3R2;DPM1;INPPL1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4699742719805331,-1.3348587687219404,0.10084033613445378,0.76823984924518,1.0,6/16,36.68%,CLDN14;CLDN12;CLDN10;CLDN18;CLDN1;CLDN5
prerank,axonal transport of mitochondrion (GO:0019896),-0.5296317132365804,-1.3347694158483012,0.15112540192926044,0.7611908552043308,1.0,6/11,15.41%,SPAST;OPA1;NEFL;TRAK1;SYBU;TRAK2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.5327270949247437,1.334713049860474,0.08773903262092239,0.6286670557570219,1.0,15/40,19.47%,SLC6A14;SLC36A3;SLC7A11;SLC38A11;SLC16A1;SLC13A3;SLC27A1;SLC25A10;ABCC1;SLC7A5;SLC25A14;SLC25A30;SLC38A1;SLC19A1;SLC7A6
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6253706393123287,1.3338356708070072,0.13570487483530963,0.6312759182070036,1.0,3/15,8.64%,TRIM16;BMP4;SFN
prerank,regulation of histone deacetylation (GO:0031063),0.6339242724415599,1.3337358847875405,0.125,0.6304520110431631,1.0,4/13,8.58%,ING2;ZBTB7B;NIPBL;SPHK2
prerank,intestinal absorption (GO:0050892),0.6364935276904337,1.3333045920116005,0.12980132450331125,0.6311214704357455,1.0,4/13,9.75%,SLC5A1;UGCG;SLC26A6;CD36
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5695269337614225,1.3332527937497696,0.08275862068965517,0.6301003338688873,1.0,7/29,12.84%,FPR2;CCR2;CCL5;HMGB1;CXCL10;SERPINE1;LGALS3
prerank,cellular response to interleukin-12 (GO:0071349),0.5270390118720162,1.3328846311730012,0.09570957095709572,0.6304799504629146,1.0,16/48,18.79%,STAT4;PDCD4;PPIA;MIF;CD47;MSN;LCP1;JAK2;CDC42;CFL1;RPLP0;HNRNPF;SOD2;P4HB;TALDO1;RALA
prerank,inositol phosphate metabolic process (GO:0043647),-0.3585720871813533,-1.3325447245104451,0.049019607843137254,0.7616098193300604,1.0,19/46,19.14%,INPP5D;PLD4;PLCG2;INPP4A;FGF2;PPIP5K2;ITPKB;INPP5B;INPP1;INPP4B;PLCB4;IPPK;PLCB1;INPPL1;IPMK;SYNJ1;ITPK1;ISYNA1;PLCB2
prerank,extracellular matrix disassembly (GO:0022617),0.5183412251116747,1.3323796607144953,0.09120171673819742,0.6313842425689553,1.0,16/53,17.45%,MMP8;MMP9;SCUBE3;BMP1;LCP1;CD44;GSN;TIMP1;BSG;MMP2;MMP12;CAPG;CAPNS1;CAPNS2;NOXO1;MMP15
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.47691493839381305,-1.3321666272439885,0.1422924901185771,0.7554639096275584,1.0,7/15,17.97%,LARGE1;CHST1;NAGK;AMDHD2;CHST7;CHST3;RENBP
prerank,B cell activation (GO:0042113),0.5057222196393316,1.3319186818105937,0.07112970711297072,0.632066042381672,1.0,15/68,12.31%,LAX1;RASGRP1;DNAJB9;BCL2;ITGA4;HDAC9;CD79B;ITGB1;MALT1;KIT;CD79A;ZAP70;EPHB2;FLT3;CLCF1
prerank,regulation of amyloid fibril formation (GO:1905906),0.6291465397998051,1.3316401576311347,0.14398943196829592,0.632114708788937,1.0,10/15,21.07%,CLU;APOE;PFDN5;IAPP;PFDN1;TREM2;PFDN4;CRYAB;LDLR;VBP1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.5747615382809748,1.3315090420907476,0.11722488038277512,0.6314316275493983,1.0,10/25,17.78%,CD2;ITGA4;ITGB1;PARVA;ITGB7;JAM3;CTNNA3;ITGAX;ITGB2;JUP
prerank,regulation of isotype switching (GO:0045191),-0.5049352651149752,-1.3312297233424093,0.1659919028340081,0.751657223954334,1.0,6/14,12.92%,SHLD1;PAXIP1;SHLD2;KMT5B;SLC15A4;HMCES
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.457158387989956,-1.3301847593791574,0.125,0.7480467232012589,1.0,5/16,10.68%,NPNT;FGF2;SALL1;PAX8;PAX2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6653157508519905,1.3298671195368674,0.1246376811594203,0.6372511817807348,1.0,2/11,3.11%,TFAP4;SP100
prerank,modulation by symbiont of host process (GO:0044003),0.6636057313581287,1.3294556279471992,0.14045801526717558,0.637839447827566,1.0,3/10,4.48%,RPS27A;UBA52;B2M
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5661663171932717,1.329398600368777,0.12808460634547592,0.636888279564435,1.0,4/26,3.08%,CBLB;NCF1;NCK2;CHMP6
prerank,cellular response to cytokine stimulus (GO:0071345),0.47616319845207666,1.329239780937135,0.004,0.6363085253000078,1.0,87/416,15.42%,LCK;GRAP2;IL2RB;LCN2;IL18R1;LEF1;STAT4;CD4;TCF7;ANXA1;RIPOR2;OSMR;RPS27A;CCR2;PLP2;MAPK13;MMP9;GATA3;IL27RA;CCL5;IFITM2;IL31RA;GHR;CCL7;BCL2;LAMA5;IL1R2;SIGIRR;IL20RA;HSPA8;NPR2;UBA52;PTPN13;BIRC5;SHMT1;DAPK3;MT1X;PIM1;COL1A2;ITGB1;RPS3;GBP2;LBP;CD47;KIT;UBE2G2;CXCL10;PTPN12;PTPN9;GREM2;IFNGR1;IL2RG;IL3RA;SLC26A6;JAK2;VIM;AKAP6;STAT5B;CD36;TIMP1;SYNCRIP;AQP4;CXCR4;HSP90AA1;ZFP36L2;MMP2;IL6ST;FLT3;YBX3;CLCF1;UBB;FOXO1;BCL6;ZFAND6;PTPN4;RHOU;SIRT1;KHSRP;BCL2L11;RIPK1;GAPDH;ITGAX;SHC1;CDKN1A;CRKL;FYN;IRF4
prerank,response to amyloid-beta (GO:1904645),0.5290714472871011,1.329228217666681,0.08508287292817679,0.635147940299936,1.0,15/44,16.03%,FPR2;MMP9;ITGA4;ATP1A3;CD36;CASP4;PRNP;MMP2;CACNA2D1;ABCC1;MMP12;FYN;TREM2;AGER;IGF1R
prerank,regulation of supramolecular fiber organization (GO:1902903),0.583634845572595,1.3289647474593438,0.1361963190184049,0.6350908212430565,1.0,12/22,18.27%,HSPA8;AEBP1;ARL2;APOE;GPX1;MAPT;PRUNE1;AKAP13;MAP1B;EFEMP2;MAPRE3;MAP2
prerank,cell-matrix adhesion (GO:0007160),0.49450166167258225,1.3289069046457334,0.04708290685772774,0.634114120202889,1.0,19/95,9.51%,CD96;ITGAL;DLC1;SORBS1;ITGA4;TRIP6;FERMT2;CD63;VTN;ECM2;PPFIA2;ITGB1;ACTN1;FBLN5;ZYX;ITGA10;CD44;ITGB7;THSD1
prerank,negative regulation of cell cycle (GO:0045786),0.5020649579792849,1.3288514355478622,0.07450157397691501,0.633122147073726,1.0,18/73,17.78%,GATA3;RUNX3;TFAP4;BRINP2;CDK6;PDCD4;HEXIM1;PTEN;SIPA1;BMP4;BRINP3;NR4A1;BTG2;TAF6;ANGEL2;GAS1;PPP1R13B;LILRB1
prerank,positive regulation of cartilage development (GO:0061036),0.6045875450222216,1.3287659553896032,0.13037974683544304,0.6322193287481337,1.0,7/17,19.83%,BMP1;MDK;SOX5;BMP4;ZBTB16;PKDCC;SOX9
prerank,regulation of postsynapse organization (GO:0099175),-0.3962688041126,-1.328698610924058,0.11333333333333333,0.7463897831399673,1.0,8/28,9.52%,TANC2;ARHGAP22;ABI3;HOMER1;ABHD17B;LRRK2;CDK5;ABHD17C
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.568465104557362,1.3286045331150975,0.11814859926918392,0.6316778150969502,1.0,5/26,10.03%,LCK;F2R;ITPR3;ITPR1;CHERP
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.42642379174181344,-1.3283660029268813,0.10784313725490197,0.7405051897457199,1.0,6/21,15.44%,LPIN2;PPARD;PLA2G15;HOGA1;LPIN1;AGXT
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.667108192221846,1.32815837458977,0.1359773371104816,0.632408351594257,1.0,5/10,11.20%,PAF1;LEO1;DHX36;NUDT21;CPEB3
prerank,regulation of interleukin-12 production (GO:0032655),0.5255969315022595,1.327205426820194,0.08021978021978023,0.6353392926972782,1.0,8/47,6.99%,LTB;SCIMP;HMGB1;TLR9;LAPTM5;MDK;CD47;FOXP1
prerank,response to iron ion (GO:0010039),0.6522424491497565,1.3266998146141125,0.13714285714285715,0.6362709908256562,1.0,4/12,9.25%,BCL2;B2M;BMP6;SLC11A2
prerank,visual system development (GO:0150063),0.5420213225197247,1.3261599316964956,0.09454949944382647,0.6374340602424207,1.0,12/37,21.39%,BLOC1S3;PBX1;C3;SMOC1;TGFB2;HIPK1;MEIS2;GDF3;PBX2;SIPA1L3;PBX3;RBP4
prerank,extracellular matrix organization (GO:0030198),0.48117306984655367,1.3237451537847393,0.002002002002002002,0.6463127294418981,1.0,63/276,12.83%,MMP8;ITGAL;MMP9;ELN;P3H1;COL18A1;COL6A3;SCUBE3;ADAMTS14;BMP1;DDR2;LAMA5;COL9A1;PLEC;PECAM1;ATP7A;ADAM19;ITGA4;DCN;SPINK5;LUM;SMOC1;GPM6B;NDNF;KDR;VTN;ECM2;COL1A2;BGN;CDH1;ITGB1;HSPG2;FBLN5;COL22A1;CRTAP;COL4A1;CD47;THSD4;ITGA10;TGFB2;LCP1;COL19A1;CD44;ITGB7;ADAMTSL1;GSN;GREM1;LAMA4;JAM3;COL25A1;TIMP1;BSG;ADAMTSL4;LOX;SERPINE1;MMP2;COL1A1;COL5A3;MMP12;COL8A1;ADAMTS2;COL3A1;DAG1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6633656590325625,1.322708700822809,0.15942028985507245,0.6495829256173842,1.0,4/10,8.82%,PSMC3;HMGB1;ATF7IP;PSMC6
prerank,camera-type eye development (GO:0043010),-0.4045114655197624,-1.3225806159129607,0.09142857142857143,0.7537380361632138,1.0,9/25,27.53%,SKI;FBN1;VEGFA;PAX2;EFEMP1;NES;CRYBA4;RAB3GAP1;CEP290
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6439079101953632,1.3224169266142,0.12872628726287264,0.6496306529076542,1.0,6/12,19.64%,APOC1;SOAT1;MFSD2A;APOC4;P4HB;SOAT2
prerank,proteolysis (GO:0006508),0.475315219899159,1.3217506922528237,0.006006006006006006,0.6512094053295119,1.0,48/252,14.46%,MMP8;CTSW;CPA4;CPA3;GZMB;GZMA;TMPRSS2;MMP9;ECEL1;CPXM2;PGPEP1L;TMPRSS4;BMP1;CPA6;SRGN;NAPSA;CNDP2;SDE2;ADAM19;DPP4;OLR1;AEBP1;LONP1;CTSE;PSMD6;MALT1;PLAU;CLPP;PSMB5;CPM;PCSK7;CTSZ;CLN3;TMPRSS7;CASP4;ATG4D;LAP3;TASP1;MMP2;TMPRSS5;VHL;MMP12;PSMA6;RSPRY1;DESI1;DESI2;LNPEP;CTSH
prerank,regulation of defense response (GO:0031347),0.4948060509583699,1.321681377229688,0.07924921793534932,0.6502784531129553,1.0,20/76,17.16%,TMSB4X;ANXA1;CCR2;PTPN22;APOE;FOXP1;NR1D2;JAK2;CASP4;APPL1;PTGES;PSMA6;USP18;BCL6;GRN;AKNA;TIRAP;TREM2;SAMHD1;AREL1
prerank,sprouting angiogenesis (GO:0002040),0.5137053967764657,1.3210866502263277,0.09344790547798067,0.651578813772991,1.0,16/51,16.44%,ANGPT1;SEMA5A;EFNB2;KDR;CDH13;BMP4;PARVA;GREM1;NR4A1;GPLD1;EGR3;ROBO1;NAXE;JMJD6;SEMA3E;MIA3
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.5726312431186742,1.320667051512407,0.1295143212951432,0.6521844077662879,1.0,7/22,17.78%,CCR2;SCIMP;LAPTM5;SPHK2;SLC7A5;TNFRSF14;LILRB1
prerank,spermatid development (GO:0007286),0.5524902714349288,1.3206092503148377,0.10194730813287514,0.6511827945361609,1.0,6/32,13.97%,TTC21A;ING2;RFX2;MKKS;SYCP3;TDRD5
prerank,plasma membrane organization (GO:0007009),0.5048155331266684,1.3201733294606037,0.08964781216648879,0.6518774113620098,1.0,19/61,16.00%,PLSCR2;SMPD1;ANXA6;UGCG;BIN3;ARL8B;ANK3;CLN3;SYT7;NSF;CXCR4;CAVIN2;ARV1;FA2H;ABCA7;MICALL1;DEGS1;FNBP1L;SNX33
prerank,gene silencing by miRNA (GO:0035195),-0.3774800231027271,-1.3191228608801029,0.06870229007633588,0.7584810395770171,1.0,10/32,14.59%,TNRC6C;AGO4;AGO1;CNOT8;RBM4;TNRC6B;CNOT7;WTIP;MOV10;PUM2
prerank,cellular potassium ion homeostasis (GO:0030007),0.6311253530174883,1.3185851195505096,0.1453804347826087,0.6576264845413606,1.0,6/13,17.01%,ATP1B3;ATP1A3;ATP1A4;ATP1A1;ATP1A2;ATP1B2
prerank,regulation of telomere capping (GO:1904353),0.5759926276900773,1.3185632243754817,0.11916461916461916,0.6564933377945714,1.0,4/23,9.53%,PRKCQ;RTEL1;ATM;MAP3K4
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5812632749644383,1.3182304913255707,0.12965186074429771,0.6567057321404302,1.0,8/22,14.91%,SH2D1A;PTPN22;UBASH3A;CEACAM1;LAPTM5;PRNP;LGALS3;EZR
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.49401625597628346,1.3179234519687886,0.051387461459403906,0.6567724505541306,1.0,20/93,16.01%,MMP8;MAP4K2;RASGRP1;TRAF1;SCIMP;NCF1;MTURN;HMGB1;TLR9;GADD45A;TPD52L1;TGFB2;CCN2;MAP3K4;TAOK3;RIPK1;SDCBP;TIRAP;ARL6IP5;AGER
prerank,'de novo' posttranslational protein folding (GO:0051084),0.5492537861290254,1.3174063736535966,0.12716763005780346,0.6578146866836467,1.0,14/30,21.86%,DNAJB1;ENTPD5;HSPA8;CCT2;HSPA5;SDF2L1;HSPA1A;GAK;ST13;UGGT1;PTGES3;BAG1;SDF2;DNAJB14
prerank,adenine nucleotide transport (GO:0051503),0.5994057447929647,1.3173458870773824,0.15324675324675324,0.6568576407960403,1.0,2/17,0.43%,SLC25A24;LRRC8C
prerank,phosphate ion transport (GO:0006817),0.6104138523982294,1.3163694407209845,0.1403973509933775,0.6598402612384547,1.0,6/16,15.80%,SLC20A1;SLC25A10;XPR1;SLC25A14;SLC37A1;SLC25A30
prerank,negative regulation of coagulation (GO:0050819),0.6257512651897127,1.3161865565577326,0.1406451612903226,0.6594128179548949,1.0,5/14,11.17%,VTN;APOE;PROCR;TFPI;SERPINE1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6343310160201509,1.315576689723798,0.1522633744855967,0.6608405972642462,1.0,2/12,8.83%,CNDP2;CHAC2
prerank,positive regulation of histone methylation (GO:0031062),0.5747428862111299,1.3154240414563325,0.12014563106796117,0.6603258166966371,1.0,9/24,14.11%,AUTS2;MYB;PAF1;DNMT1;JARID2;CTNNB1;CTR9;SIRT1;WDR5
prerank,potassium ion homeostasis (GO:0055075),0.5751364952170339,1.315159350087574,0.14002478314745972,0.6602655847205791,1.0,8/23,12.04%,ATP1B3;SLC12A7;ATP1A3;ATP1A4;ATP1A1;ATP1A2;SLC12A5;SLC12A4
prerank,positive regulation of potassium ion transport (GO:0043268),0.5312132195468845,1.314700889375315,0.11858608893956671,0.6611887978273482,1.0,6/38,3.98%,KCNN4;FLNA;KCNJ10;KCNMB4;KCNJ15;AMIGO1
prerank,regulated exocytosis (GO:0045055),0.4814528320631332,1.314497441284561,0.023069207622868605,0.6609486103286648,1.0,34/173,13.07%,TMSB4X;CTSW;SCIN;HRG;TAGLN2;F5;FLNA;SRGN;PECAM1;SYNGR2;CLU;F8;RAB11FIP1;SYT4;TMEM79;CD63;ALDOA;SERPING1;ACTN1;TIMP3;PHACTR2;TGFB2;CLEC3B;TEX264;RARRES2;SYT7;CD36;TIMP1;SCCPDH;DNAJC5;SERPINE1;RIMS3;MANF;TGFB3
prerank,regulation of peptidase activity (GO:0052547),0.5944492390254347,1.3139852338861673,0.14687100893997446,0.6619302709252276,1.0,6/19,14.46%,RCN3;HDAC1;CAV1;CST7;CSTB;CTSH
prerank,cellular response to oxidative stress (GO:0034599),0.4804691084287736,1.3131342954173661,0.047764227642276426,0.6642511852546985,1.0,20/118,7.64%,SLC25A24;MMP9;CYBA;PRDX5;PRDX6;PLA2R1;RBM11;CYBB;SOD3;NCF1;PPIA;EIF2S1;LONP1;CHCHD2;RPS3;TXNRD1;PRDX1;MAPK9;GPX1;GSR
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6248635604653341,1.3129376348157746,0.17202797202797201,0.6638578395009261,1.0,1/13,0.19%,TMSB4X
prerank,purine ribonucleotide transport (GO:0015868),0.6000944062959517,1.3128477402151684,0.16010498687664043,0.6630449984909716,1.0,2/16,0.43%,SLC25A24;LRRC8C
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5471484283522046,1.3127460778640283,0.1391509433962264,0.6623316277813681,1.0,10/30,15.51%,NCOR2;RNF14;HDAC1;FOXP1;KDM4C;TRIM68;NCOR1;SIRT1;NCOA2;PKN1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5980593580675531,1.312278225626872,0.13584905660377358,0.6631146012702135,1.0,4/19,8.44%,RIPOR2;CD74;MDK;RAC2
prerank,cellular response to light stimulus (GO:0071482),0.5042925876136396,1.3119940866679587,0.07740585774058577,0.6631287284403224,1.0,19/66,20.46%,MAPK13;PDE6B;SMPD1;NEDD4;SDE2;ERCC4;SAG;EIF2S1;METTL3;DHX36;COPS9;ATF4;NPM1;POLK;PCNA;USP28;YY1;CNGB1;ATR
prerank,regulation of platelet activation (GO:0010543),0.5821331779282634,1.3117769234561951,0.1382316313823163,0.6628707249572944,1.0,4/21,5.19%,HRG;PRKCQ;TXK;APOE
prerank,iron ion homeostasis (GO:0055072),0.5069186318219759,1.311472419977995,0.09169363538295577,0.6629935198420205,1.0,10/58,9.40%,LCN2;FTL;HEPH;CYBRD1;B2M;ABCB7;FTH1;BMP6;SLC11A2;ATP6AP1
prerank,myofibril assembly (GO:0030239),0.5152195073664855,1.310750848346227,0.11517165005537099,0.6649746646828935,1.0,4/42,11.08%,TNNT3;CSRP3;TMOD2;CSRP2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.5734970167906803,1.3107483836319653,0.1344019728729963,0.6637949733594809,1.0,6/21,8.46%,GCK;TKT;HK1;PGLS;GPI;PGM2
prerank,receptor clustering (GO:0043113),0.5611419261704235,1.3103265469156988,0.14011976047904193,0.664321575656853,1.0,12/27,24.89%,ITGAL;FLNA;ITGA4;SAV1;ITGB7;ITGB2;DLG3;LRP4;DLG1;THY1;ITGB1BP1;DLG2
prerank,plasma membrane invagination (GO:0099024),-0.38607053743118336,-1.3102583655634426,0.08270676691729323,0.7829313150080881,1.0,13/29,20.76%,ELMO1;ITGAM;ARHGAP25;VAMP7;ARHGAP12;SH3BP1;SNX18;MSR1;FCGR1A;AIF1;SPIRE1;FCGR2B;SNX9
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4947783193856349,1.3101375034013356,0.06659729448491156,0.6639861928650456,1.0,26/84,15.36%,GZMB;PUS7;MRPL13;CLU;ILF3;SHMT1;DAPK3;APOE;RACK1;RPS3;PIN1;MALSU1;EIF4A3;SYNCRIP;DHX36;PRNP;BTG2;NCL;CPEB3;ROCK1;SORL1;ABCA7;SAMD4A;GAPDH;EIF2AK3;TYMS
prerank,positive regulation of viral genome replication (GO:0045070),0.5519395900030059,1.3100193442580261,0.11384976525821597,0.66330187333615,1.0,7/29,9.20%,CD28;CCL5;SRPK1;PPIA;PPIH;TARBP2;PABPC1
prerank,regulation of cellular localization (GO:0060341),-0.34585058724786355,-1.3099799699455126,0.08433734939759036,0.7769225422585689,1.0,14/46,17.99%,LRP5;LYN;FER;PARP1;LRRK2;STXBP4;TTL;CDK16;DYNC1H1;WWC1;EFNA5;FES;UNC13D;BRSK2
prerank,actin polymerization or depolymerization (GO:0008154),0.516808195035442,1.3099793828224646,0.09913793103448276,0.6623091053393998,1.0,15/50,17.72%,SCIN;MICALL2;DIAPH1;WAS;PSTPIP1;GSN;JAK2;CFL1;DSTN;CAPG;ABI1;TTC17;TWF2;WASF3;ARHGAP6
prerank,regulation of cholesterol transport (GO:0032374),0.5835925431677467,1.309647577009918,0.15822784810126583,0.6625470866543729,1.0,9/20,20.70%,ABCA13;APOC1;NR1H2;ARV1;NAXE;ABCA2;TSPO;TTC39B;ABCB4
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.5391449046061807,1.3094865025462121,0.11824324324324324,0.6620754297652183,1.0,9/35,12.95%,PRKCQ;CCT8;RTEL1;CCT2;ATM;MAP3K4;DHX36;CTNNB1;HMBOX1
prerank,positive regulation of wound healing (GO:0090303),0.5299069679349254,1.3084727032071484,0.1266816143497758,0.6651309741187944,1.0,8/36,11.17%,ANXA1;ACTG1;F2R;FERMT2;VTN;ITGB1;INSL3;SERPINE1
prerank,gland development (GO:0048732),0.5014406537293729,1.3076685878566483,0.09488272921108742,0.6674468122582754,1.0,11/59,14.91%,ANXA1;NRG1;SOX3;PRKCSH;DKK3;MDK;MSN;CAV1;TGFBR3;TGFB3;EZR
prerank,monocyte chemotaxis (GO:0002548),0.5431746308924695,1.3071645007385373,0.12853773584905662,0.6683913914688236,1.0,3/32,1.85%,ANXA1;CCL5;CCL7
prerank,carboxylic acid transport (GO:0046942),0.5078445081086044,1.3071520282840017,0.1256771397616468,0.6672750116128906,1.0,18/55,21.00%,SLC6A14;SLC36A3;SLC16A9;SLC16A1;SLC3A2;SLC13A3;SLC16A4;SLC7A1;CLN3;SLC1A5;SLC25A10;SLC7A5;SLC6A17;SLC38A1;SLC6A15;SLC7A6;SLC6A6;SLC16A2
prerank,snRNA transcription (GO:0009301),-0.31838470048438217,-1.3071212518507844,0.024390243902439025,0.7802721389953807,1.0,21/70,15.12%,POU2F2;INTS3;ICE2;SNAPC1;INTS10;ELL2;CDK9;INTS12;GTF2A1;INTS11;TAF8;NABP2;SNAPC4;POLR2G;ZC3H8;INTS1;TAF13;NCBP2;CCNT2;POLR2K;SNAPC5
prerank,skin development (GO:0043588),0.5030839051857606,1.3069003765496103,0.08280254777070063,0.6672069095547586,1.0,13/65,12.67%,ANXA1;EVPL;ATP7A;TMEM79;UGCG;COL1A2;SFN;SCEL;COL1A1;FA2H;HRNR;COL5A3;COL3A1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.48955463674109045,1.3068427047914266,0.07755946225439504,0.6663077663504834,1.0,7/76,3.33%,FPR2;CXCR2;GPR174;LTB4R;F2R;LPAR1;P2RY1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.621353323624885,1.3066573968838766,0.1503267973856209,0.6659580571506608,1.0,4/15,5.80%,TMSB4X;HRG;SEMA5A;PRKD2
prerank,catecholamine biosynthetic process (GO:0042423),0.6541144776395005,1.306540496195458,0.16923076923076924,0.6653282540845382,1.0,2/11,7.11%,GATA3;TGFB2
prerank,central nervous system neuron development (GO:0021954),0.6096834582945497,1.3063998797365317,0.14246947082767977,0.664783329681037,1.0,6/15,21.23%,ATP7A;PTEN;HSP90AA1;MAPT;MAP2;HSP90AB1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5886882715667601,1.3060231517423333,0.15306122448979592,0.6652240422210651,1.0,4/18,14.13%,ANXA1;UBE2L3;ZFP36L2;BCL2L11
prerank,cellular respiration (GO:0045333),0.519055953788173,1.3054849905727015,0.10579064587973273,0.6663328135785319,1.0,17/41,20.06%,NR4A3;NDUFS7;SDHB;UQCRB;MTFR2;NDUFA5;ETFB;ATP5F1D;COQ10B;MDH2;SDHAF4;SLC25A14;MTFR1;SDHC;UQCRFS1;UQCRC1;UQCRH
prerank,defense response to symbiont (GO:0140546),0.48613000584167254,1.3053956706336163,0.06839378238341969,0.6655730225119978,1.0,16/92,9.20%,PRF1;IFITM1;IFITM2;IFIT2;BCL2;FLNA;MLKL;EXOSC4;ISG20;NDUFAF4;RNASE6;TLR9;NT5C3A;IFITM3;RTP4;OASL
prerank,positive regulation of metabolic process (GO:0009893),0.4860492602339742,1.3049274285275803,0.06332992849846783,0.6663813795613419,1.0,28/103,16.76%,LCN2;CCR2;PLAC8;JCHAIN;PIGA;ZBTB7B;PER2;FABP5;CAV1;TSHR;JAK2;CD36;FASN;CXCR4;HADH;ACACA;ELOVL6;CPT2;EPAS1;SCD;EBF2;ACSL1;FABP4;UCP2;IRF4;IGF1R;PPARGC1B;CEBPB
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.6518277345797183,1.3048119685950692,0.17714285714285713,0.6657522178776911,1.0,4/10,16.35%,RPS27A;UBA52;UBB;CHFR
prerank,icosanoid secretion (GO:0032309),0.6339651038084994,1.3043973758056298,0.1791907514450867,0.6663409473829485,1.0,1/12,0.35%,ANXA1
prerank,positive regulation of histone deacetylation (GO:0031065),0.646114444909577,1.3042707904287207,0.14864864864864866,0.6657259248239265,1.0,4/12,6.30%,ING2;PRKD2;ZBTB7B;NIPBL
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.47543669240128056,1.304096451495373,0.03625377643504532,0.665299924138398,1.0,33/159,13.89%,ITGAL;CD6;SELL;MPZ;EMB;SLITRK2;PECAM1;NECTIN1;CEACAM1;AMIGO1;CDH1;ITGB1;DSCAM;TENM2;UNC5D;CDH13;TGFB2;CDH20;CDH19;CDH7;PCDHB11;GRID2;BSG;KIRREL3;GPC6;JAML;ROBO1;ALCAM;CDH5;ROBO2;NTNG1;PCDHB16;NPTN
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.4679805269601005,-1.3039250233221904,0.1598360655737705,0.7849594904090677,1.0,9/15,21.96%,FGF2;PKM;ITGA5;VEGFA;TJP1;BMPER;KLF4;PDPK1;JMJD8
prerank,regulation of T cell migration (GO:2000404),0.5861543723588951,1.3034594602624505,0.16434892541087232,0.6669330693101899,1.0,3/18,1.52%,SPN;RIPOR2;CCL5
prerank,microvillus assembly (GO:0030033),0.6218738736058014,1.3033382501898318,0.16027397260273973,0.6663286486218022,1.0,6/14,16.86%,FXYD5;RAPGEF6;TNIK;EZR;RAP2A;STK26
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.552593383869096,1.3020365504029283,0.1317365269461078,0.6707676411316583,1.0,6/27,15.34%,GPR174;F2R;LPAR1;C3AR1;GRM1;DRD2
prerank,glutathione biosynthetic process (GO:0006750),0.6343365529884388,1.301702463134248,0.16368638239339753,0.6710498816890399,1.0,2/11,8.83%,CNDP2;CHAC2
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.38279749903210386,-1.3012071479420526,0.12403100775193798,0.7875432942221403,1.0,11/33,13.00%,BTBD9;CX3CR1;PXK;IQSEC2;EIF4EBP2;ABR;GRIK3;LRP8;BDNF;PSMC5;GRIK4
prerank,protein polymerization (GO:0051258),0.5056781090877069,1.30090866250693,0.10899470899470899,0.6733007729066821,1.0,16/56,18.47%,MICALL2;CENPJ;DIAPH1;WAS;PSTPIP1;PIN1;GSN;JAK2;MID1IP1;MAPT;ARL6;TTC17;GPX4;WASF3;ARHGAP6;RNF135
prerank,positive regulation of telomerase activity (GO:0051973),0.540642852940733,1.3004965658618706,0.12344280860702152,0.6737930699891242,1.0,11/33,18.14%,PRKCQ;PARM1;CCT2;NVL;GREM1;MAP3K4;HSP90AA1;CTNNB1;HMBOX1;NAF1;PTGES3
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.6015972735800428,1.3004089266394152,0.15714285714285714,0.6729907406352594,1.0,7/16,26.94%,C3;PRMT5;ACP3;GSK3A;GRP;PDE6H;CHGA
prerank,glucose import (GO:0046323),0.6246601808509149,1.300314128493881,0.16256830601092895,0.6722648763051008,1.0,3/13,13.42%,SLC5A1;SLC27A1;SLC2A1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.593552290663765,1.3002763482773336,0.17938931297709923,0.6712435695276938,1.0,4/17,12.14%,APOC1;MFSD2A;GPLD1;SORL1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5746231531881966,1.2990722401532127,0.13892365456821026,0.675189365200132,1.0,7/21,13.78%,CILP;FAM89B;BMP4;BMP6;JAK2;TGFB3;WWTR1
prerank,granulocyte differentiation (GO:0030851),0.5773531469548401,1.2989884584689257,0.15070242656449553,0.6744601297751757,1.0,6/18,16.83%,LEF1;LBR;RARA;CDK2;CDKN1A;DEK
prerank,ATP transport (GO:0015867),0.6564626162996757,1.2986871121499275,0.16691068814055637,0.6746308314526318,1.0,2/10,6.74%,SLC25A24;CD47
prerank,positive regulation of phospholipid transport (GO:2001140),0.6486278558079654,1.2985758549108437,0.18507890961262555,0.6739299038228848,1.0,6/10,20.70%,APOE;ABCA7;PRELID1;DBI;TMEM30A;ABCB4
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5526897125532583,1.298236319607134,0.14875,0.6731596654469622,1.0,6/23,8.64%,GZMB;BCL2;BID;YWHAB;TFDP2;SFN
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5526897125532583,1.298236319607134,0.14875,0.6731596654469622,1.0,6/23,8.64%,GZMB;BCL2;BID;YWHAB;TFDP2;SFN
prerank,positive regulation of MAPK cascade (GO:0043410),0.46942736022985915,1.298157673797871,0.005,0.6723240921592815,1.0,51/245,16.29%,MMP8;FPR2;CD4;CD24;PTPN22;RASGRP1;CCL5;CCL7;CD74;GLIPR2;SCIMP;F2R;ANGPT1;IQGAP1;LPAR1;MTURN;P2RY1;FERMT2;HMGB1;TLR9;LAPTM5;KDR;APOE;PRKD2;MIF;TPD52L1;KIT;TGFB2;CCN2;CD44;PRXL2C;IAPP;ATP6AP1;GCNT2;CD36;TAOK3;ROBO1;ROCK1;KSR1;FLT3;ABCA7;PIK3R5;SHC1;TIRAP;CRKL;TREM2;ARL6IP5;AGER;IGF1R;PDGFD;MYDGF
prerank,cellular metal ion homeostasis (GO:0006875),0.48272266861781193,1.2979426147658555,0.06109979633401222,0.672080801764773,1.0,23/102,17.17%,TPT1;CCR2;CSRP3;CCL5;CCL7;ATP1B3;SLC24A4;RMDN3;ATP2B4;ATP2A3;STIM1;CAV1;ATP1A3;ATP1A4;ATP1A1;CHERP;ATP1A2;CDH5;NPTN;ATP13A1;ATP2B3;ATP1B2;ATP2B2
prerank,blood vessel endothelial cell migration (GO:0043534),0.5662209396199746,1.2969882035561426,0.14969325153374233,0.675146940887739,1.0,9/22,16.44%,EFNB2;KDR;GREM1;NR4A1;GPLD1;EGR3;ROBO1;CDH5;MIA3
prerank,defense response to virus (GO:0051607),0.48195757243737253,1.2958787917756396,0.06198347107438017,0.6786818585311404,1.0,17/100,9.20%,PRF1;IFITM1;IFITM2;IFIT2;BCL2;FLNA;MLKL;EXOSC4;ISG20;NDUFAF4;RNASE6;TLR9;NT5C3A;IFITM3;CXCL10;RTP4;OASL
prerank,regulation of tissue remodeling (GO:0034103),0.5883932721617802,1.2954612721768275,0.1626733921815889,0.6792754580424203,1.0,5/18,10.52%,DDR2;CEACAM1;MDK;SYT7;SUCO
prerank,inorganic anion transport (GO:0015698),0.49704276341625675,1.295343866042922,0.12203023758099352,0.678671261239857,1.0,13/53,16.96%,CLCN1;SLC13A4;FXYD1;RACGAP1;ANO4;SLC26A6;ANO5;SLC25A10;ANO8;XPR1;SLC25A14;SLC25A30;SLC4A10
prerank,negative regulation of catalytic activity (GO:0043086),0.5656236519235757,1.2952501481388141,0.14846625766871166,0.6779544177506872,1.0,7/24,14.04%,GZMA;HP;PPP1R12A;CLN3;TIMP1;CCAR2;SIRT1
prerank,snRNA metabolic process (GO:0016073),-0.4674636379680722,-1.295169376609001,0.14883720930232558,0.8016406145077747,1.0,7/17,12.91%,ZCCHC8;INTS3;INTS10;INTS12;INTS11;MEPCE;INTS1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5980699361996245,1.2951451559596796,0.16071428571428573,0.677256282142444,1.0,4/17,8.44%,RIPOR2;CD74;MDK;RAC2
prerank,retinal metabolic process (GO:0042574),0.6353335572067506,1.2949727888322653,0.14603616133518776,0.6768428270945126,1.0,1/12,0.93%,ABCA4
prerank,keratinocyte differentiation (GO:0030216),0.5414903469570687,1.2947347528680253,0.15447154471544716,0.6767126525385637,1.0,4/29,9.58%,ANXA1;EVPL;UGCG;SCEL
prerank,regulation of MAPK cascade (GO:0043408),0.47264072494102893,1.29390886756864,0.03815261044176707,0.6791307180700042,1.0,36/157,16.29%,MMP8;CD4;CD24;RASGRP1;CD74;F2R;IQGAP1;LPAR1;CEACAM1;HMGB1;TLR9;LAPTM5;KDR;LBH;KIT;IAPP;APIP;GREM1;CAV1;ZDHHC17;PAK4;SPRY3;TAOK3;ROCK1;KSR1;TGFBR3;FLT3;ABCA7;DAG1;EPHA7;STK4;TNIK;SHC1;PAK1;IGF1R;MYDGF
prerank,urogenital system development (GO:0001655),0.633878568868726,1.2930218262067092,0.18023255813953487,0.6818624924584925,1.0,3/11,11.78%,ANXA1;AMH;EPHB2
prerank,transition metal ion homeostasis (GO:0055076),0.5439939184186281,1.2929127003276701,0.14352392065344224,0.6812317851744885,1.0,5/28,6.96%,FTL;HEPH;CYBRD1;B2M;ABCB7
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5615901201984631,1.2928811991156175,0.1656590084643289,0.680263140785341,1.0,8/22,22.02%,AHNAK;CACNB4;DMD;SRI;CBARP;DRD2;GPR35;STAC2
prerank,activation of phospholipase C activity (GO:0007202),0.5436369639583534,1.2927468212652937,0.1611047180667434,0.6796726453979489,1.0,5/29,4.33%,ITK;EDNRA;LPAR1;TXK;S1PR4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6266956885962419,1.2926814325976614,0.17900403768506057,0.6788226395817402,1.0,6/12,18.07%,CD74;HMGB1;FOXP1;TIRAP;MAP2K5;MBP
prerank,nuclear migration (GO:0007097),-0.5102853763375034,-1.2923228052162103,0.15808823529411764,0.8048765006794462,1.0,5/13,13.64%,CLMN;DYNC1H1;TMEM201;CEP120;SYNE3
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6212555642602373,1.2913900195802457,0.1782312925170068,0.6831503555438119,1.0,4/12,11.78%,PTEN;SPTBN4;HSP90AA1;EPHB2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.5750850237458063,1.2913394008641106,0.14760147601476015,0.6822797793819704,1.0,4/20,10.81%,CNDP2;PTDSS2;CHAC2;SLC27A1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.647131905179695,1.2906063092500557,0.18854748603351956,0.6842914479561475,1.0,2/10,5.91%,RARG;RARA
prerank,neurogenesis (GO:0022008),0.5130953418067619,1.289969729682611,0.13009049773755657,0.6859727527068175,1.0,10/43,13.40%,ANXA1;LPAR1;CDK6;METTL3;TGFB2;CXCR4;BTBD1;MAPT;CIT;METTL14
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.546625906910283,1.2898474307847516,0.1642512077294686,0.6853355479118813,1.0,4/25,10.37%,MMP8;CLU;CD36;HSP90AA1
prerank,chloride transport (GO:0006821),0.4841863729035357,1.2897957947667806,0.10443037974683544,0.68444468256323,1.0,14/74,12.25%,SLC5A1;GABRP;CLCN1;FXYD1;GABRA4;GABRB1;SLC12A7;ANO4;SLC26A6;GABRG1;ANO5;SLC12A5;SLC12A4;ANO8
prerank,cyclooxygenase pathway (GO:0019371),-0.5310002599423118,-1.2896455664620885,0.16433566433566432,0.8072623886413318,1.0,3/10,0.90%,HPGDS;PTGS1;TBXAS1
prerank,supramolecular fiber organization (GO:0097435),0.4651867736722784,1.2893737348777807,0.004,0.6851235747183946,1.0,72/334,14.15%,CCDC88C;LTF;PPP1R9B;RPS27A;POF1B;TPM2;P3H1;COL18A1;COL6A3;ADAMTS14;CHP1;BMP1;FIGNL1;DDR2;COL9A1;PLEC;ATP7A;FAT1;MYH11;CENPJ;LUM;LTBP2;LTBP3;UBA52;MARCKSL1;B2M;ALDOA;COL1A2;ACTN1;HSPG2;FBLN5;COL22A1;CRTAP;HOOK1;MYO1G;COL4A1;BIN3;KIF24;TGFB2;COL19A1;IAPP;WDR73;CLRN1;PIN1;CALB1;GSN;RAC2;GREM1;BCAR1;VIM;TMOD2;COL25A1;CD36;CDC42;RHOC;LOX;MTM1;COL1A1;MAPT;COL5A3;HIP1;FKBP1A;SORL1;UBB;COL8A1;ADAMTS2;COL3A1;TPM4;COL4A5;CLIP4;FIGN;RIPK1
prerank,protein targeting to lysosome (GO:0006622),0.5689808744146949,1.2888729202250957,0.15519399249061328,0.6861348338812767,1.0,9/20,20.39%,NEDD4;CLU;HSPA8;LAPTM5;AP3M1;SORL1;GNPTAB;LAMP2;M6PR
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.6306102266168371,1.2887293101167945,0.1928665785997358,0.6855873355551096,1.0,2/12,2.82%,CD24;IQGAP1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.6554545416613506,1.2885497550954865,0.17893217893217894,0.6852067355112954,1.0,1/10,0.25%,RNF125
prerank,fatty acid biosynthetic process (GO:0006633),0.4955560540195345,1.2884173695849106,0.11397849462365592,0.6846259987072728,1.0,14/63,15.21%,SCD5;ACSBG1;FADS1;ACSF3;ABCD3;ELOVL7;ABHD2;ELOVL1;ACACA;ELOVL6;SCD;HACD1;DEGS1;GPX4
prerank,ribosomal large subunit biogenesis (GO:0042273),0.4997302086284741,1.2883118894219225,0.11147540983606558,0.6839790460493018,1.0,23/54,22.38%,RPL35A;RPL11;RPL14;RPL10A;RPL23A;NSA2;NVL;MALSU1;RPLP0;NOP53;RPL7;NPM1;RRP15;PPAN;WDR12;RPL10;RPL7A;NLE1;NIP7;RPL3;BRIX1;PAK1IP1;BOP1
prerank,positive regulation of locomotion (GO:0040017),-0.39688103358314936,-1.2879374481429156,0.1476510067114094,0.8065040334258745,1.0,4/27,7.70%,CSF1R;P2RY12;AKT2;TGFB1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5903667178126711,1.2879029468554575,0.16775032509752927,0.684634818186176,1.0,2/16,2.96%,KLRC1;CEACAM1
prerank,mitochondrial genome maintenance (GO:0000002),-0.5198689811030542,-1.2872658057045199,0.20915032679738563,0.8023732103286717,1.0,4/11,2.42%,MEF2A;OPA1;AKT3;PARP1
prerank,DNA duplex unwinding (GO:0032508),0.5026326484521719,1.287124856779468,0.12679162072767364,0.6867985488759769,1.0,12/50,14.10%,ANXA1;RPS27A;RTEL1;UBA52;MCM7;MCM2;XPC;GTF2H5;UBB;BLM;DDX1;DDX11
prerank,lipid translocation (GO:0034204),0.5615077760660401,1.286754864281454,0.1684848484848485,0.6872697552293909,1.0,5/21,12.55%,ATP8B4;ABCA4;ATP11B;ABCC1;ABCA7
prerank,regulation of stem cell proliferation (GO:0072091),0.5830039290388591,1.2855153113167492,0.18708827404479578,0.6912187170422267,1.0,7/17,26.95%,FBLN1;HMGB2;SOX11;PTPRC;HNRNPU;YAP1;GJA1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6334420955812325,1.285500076309045,0.19047619047619047,0.6901895608044036,1.0,6/11,20.06%,UQCRB;UQCR11;UQCRQ;UQCRFS1;UQCRC1;UQCRH
prerank,aggrephagy (GO:0035973),0.542134438546839,1.2848031597754892,0.15,0.6919608462346956,1.0,8/27,15.56%,RPS27A;UBA52;DYNLL1;VIM;ATG5;UBQLN1;UBB;PCNT
prerank,sensory perception of smell (GO:0007608),0.6318257190223246,1.284727080633071,0.1972027972027972,0.6912108500837175,1.0,3/11,15.34%,SLC24A4;MKKS;DRD2
prerank,negative regulation of protein modification process (GO:0031400),0.48357063759953794,1.2838751604607097,0.08385093167701864,0.6936798743794969,1.0,30/79,20.56%,P3H1;FBLN1;CHP1;FXYD1;PPP1R15A;PAQR3;PTPN13;PPIA;PTEN;CADM4;ATP2B4;CRTAP;YWHAB;PTPA;DMD;PPP1R15B;PRNP;MAPT;EPHB2;WWTR1;SIRT1;TARDBP;CRKL;PPP1R16B;NIBAN1;NTRK3;DBI;ATG14;PRR5L;GSK3B
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.50218816707588,1.283486142220029,0.10687830687830688,0.6942201093692549,1.0,15/60,12.95%,PRKCQ;CCT8;PARM1;RFC4;CCT2;ATM;PRKD2;POLG2;NVL;GREM1;MAP3K4;HSP90AA1;CTNNB1;RFC5;HMBOX1
prerank,negative regulation of cytokine production (GO:0001818),0.4649955157293667,1.283335910069167,0.04417670682730924,0.693786393828319,1.0,20/163,8.18%,MMP8;TMSB4X;LEF1;RNF125;ANXA1;TBX21;PTPN22;SRGN;SIGIRR;CEACAM1;PDCD4;HDAC9;HDAC7;HMGB1;TLR9;LAPTM5;RARA;ASB1;PIN1;RPS6KA5
prerank,in utero embryonic development (GO:0001701),-0.4005501873202153,-1.282927517286159,0.13333333333333333,0.8111486603696864,1.0,4/25,1.99%,TGFBR1;CHD7;PKD1;FLCN
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5294214867193962,1.2824234322640349,0.13590033975084936,0.6966318236638783,1.0,6/33,5.97%,HRG;ANGPT4;HMGB1;APOE;GADD45A;ATP2B4
prerank,anion transport (GO:0006820),0.5288503513713908,1.2820669095195458,0.15234822451317298,0.6970515277192356,1.0,5/33,9.62%,LRRC8C;SLC22A3;SLC13A4;SLC13A3;VDAC2
prerank,regulation of cell adhesion (GO:0030155),0.471270133193203,1.28172195613504,0.05443548387096774,0.6973412048533781,1.0,29/129,12.86%,SPN;RIPOR2;HRG;CCL5;FBLN1;ARHGDIB;ANGPT1;PKP4;CXCR3;SEMA5A;PPP1R12A;PLXNB1;ATM;PRKD2;DSCAM;MDK;PLAU;CHRD;SIPA1;CDH13;PPP2R1A;RAC2;PLXNA2;CXCR4;ROCK1;FRMD5;EPHB2;ZDHHC2;EPHA7
prerank,primary neural tube formation (GO:0014020),0.5318750363819431,1.2816752969861842,0.16784869976359337,0.6964795210717736,1.0,6/30,9.23%,DEAF1;LMO4;DLC1;TGFB2;CELSR1;MTHFD1
prerank,synaptic membrane adhesion (GO:0099560),0.5984045050173125,1.2816738750006438,0.1784741144414169,0.6954071711062461,1.0,7/14,22.51%,SLITRK2;GPC6;NTNG1;LRRC4;SLITRK1;PTPRD;LRRC4C
prerank,cellular iron ion homeostasis (GO:0006879),0.49865215982232947,1.281578874146896,0.11713665943600868,0.6947472021539094,1.0,9/55,9.40%,LCN2;FTL;HEPH;CYBRD1;ABCB7;FTH1;BMP6;SLC11A2;ATP6AP1
prerank,cochlea morphogenesis (GO:0090103),-0.5074262697192338,-1.2813929169100997,0.16932907348242812,0.8099839692010002,1.0,4/10,22.38%,TIFAB;PAX2;HPN;MYO3B
prerank,outer dynein arm assembly (GO:0036158),0.597672186531274,1.2812590104689927,0.18617021276595744,0.6949924196030187,1.0,1/15,0.40%,DNAH8
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.6085134159336372,1.280829909313011,0.19185282522996058,0.6957739221241345,1.0,4/14,13.15%,RTRAF;CLP1;CSTF2;DDX1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4529376615818447,-1.2808136636048573,0.15611814345991562,0.8051531897331581,1.0,4/16,13.12%,FGF2;HMOX1;VEGFA;THBS1
prerank,mammary gland development (GO:0030879),0.5714867334771117,1.2807814550258017,0.17212121212121212,0.6949028826332365,1.0,6/21,14.48%,NRG1;ZBTB7B;CAV1;JAK2;TGFB3;WNT3
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6347815866913364,1.2802584232307352,0.1753155680224404,0.6960165362234165,1.0,2/11,3.70%,RUNX3;HMGB1
prerank,zinc ion transmembrane transport (GO:0071577),-0.4259422044411114,-1.2801567155816296,0.13917525773195877,0.8009019078578352,1.0,10/22,19.39%,SLC30A4;SLC30A5;SLC39A13;TRPM2;SLC39A8;SLC39A12;SLC39A10;SLC39A3;SLC30A1;SLC39A11
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5838252640365663,1.2800449053708538,0.16404199475065617,0.6958232849279691,1.0,7/17,11.23%,EFNB2;KDR;GREM1;NR4A1;GPLD1;EGR3;ROBO1
prerank,pyruvate metabolic process (GO:0006090),0.5028634009860339,1.2793601438519107,0.13347685683530677,0.6977090001881147,1.0,13/52,14.28%,NR4A3;GCK;SLC16A1;ALDOA;ENO4;HK1;ME2;GPI;ALDOC;BSG;SRR;ME1;GAPDH
prerank,tube closure (GO:0060606),0.5289611168110365,1.2793288574105015,0.1592505854800937,0.6967533018086404,1.0,6/31,9.23%,DEAF1;LMO4;DLC1;TGFB2;CELSR1;MTHFD1
prerank,positive regulation of telomere capping (GO:1904355),0.5831260276390858,1.2791856828848551,0.16881443298969073,0.6962823237710536,1.0,3/17,9.53%,PRKCQ;RTEL1;MAP3K4
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3125023409285819,-1.278893177133043,0.06382978723404255,0.7989396749681946,1.0,30/76,25.88%,BMP2K;WWP2;MAML3;TSPAN14;POFUT1;PRKCI;MMP14;MFNG;ZMIZ1;EPN2;MAML1;ARRB1;NOTCH1;LLGL1;TM2D3;NEPRO;HIF1AN;TSPAN5;STAT3;SNW1;RBPJ;RFNG;LLGL2;SRC;JAG2;EGF;DLK2;NOTCH4;SREBF2;CREBBP
prerank,regulation of DNA replication (GO:0006275),0.5030262567771598,1.2788374060886794,0.12021857923497267,0.6966028687443633,1.0,17/49,21.65%,GTPBP4;S100A11;SMC3;FBXO5;WAPL;PPP2R1A;OBI1;BLM;PPP2CA;PCNA;CCDC88A;ESCO1;STN1;ATR;CTC1;GMNC;BRPF3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.47674608318365475,-1.2785965711638738,0.17898832684824903,0.7935644751697628,1.0,1/13,0.56%,CYRIB
prerank,sister chromatid segregation (GO:0000819),0.5367405457764723,1.2784373296124498,0.16803760282021152,0.6972765900599007,1.0,8/31,20.68%,CHAMP1;SMC4;CDCA8;ESPL1;KIFC1;TOP2B;MIS12;ZW10
prerank,long-term memory (GO:0007616),0.5703571386208698,1.2781670721675433,0.16582278481012658,0.6973427059446435,1.0,5/19,11.20%,CAMK4;APOE;CALB1;PRNP;CPEB3
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5919386674237235,1.2779496059951079,0.17876344086021506,0.6972055631803845,1.0,5/15,12.82%,ENTPD5;AK7;CMPK1;ENTPD2;ENTPD3
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4767539395429718,1.2776686193746334,0.07596253902185224,0.6972867163554394,1.0,21/95,10.59%,B3GNT3;ANGPT1;UST;DCN;LUM;B3GALT6;SLC35D2;FMOD;CEMIP;BGN;HSPG2;SDC2;OGN;UGDH;CHST9;HS3ST3B1;EXT2;GCNT2;ST3GAL1;GPC6;B4GALT3
prerank,regulation of membrane repolarization (GO:0060306),0.6088520437457562,1.277266965275369,0.20136986301369864,0.6979130019478411,1.0,3/13,11.30%,CAV1;AKAP6;CACNA2D1
prerank,regulation of exit from mitosis (GO:0007096),0.5160330171211527,1.2766640695699736,0.16071428571428573,0.6992795456530921,1.0,5/38,6.42%,PPP1R9B;RPS27A;UBA52;BUB1B;MAD2L1BP
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5245624784798307,1.2764842091227726,0.13646788990825687,0.6989535346979211,1.0,9/36,12.27%,CCL5;GHR;F2R;CENPJ;KIT;NLK;CAV1;JAK2;VHL
prerank,regulation of B cell proliferation (GO:0030888),0.5079530274312652,1.2760040541603148,0.14689880304678998,0.6999053117073143,1.0,21/44,22.64%,IKZF3;CD74;BCL2;TLR9;AHR;ATM;MIF;SASH3;EPHB2;CLCF1;TNFRSF13C;CTLA4;TIRAP;BLK;CD320;PTPRC;TYROBP;TNFRSF13B;GPR183;VAV3;TFRC
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.46473512629521363,1.273968443973173,0.05120481927710843,0.7071910370516824,1.0,50/161,20.56%,CCDC88C;SFRP5;PSMC3;LMBR1L;TLE4;BICC1;PSMD8;APOE;DKK3;PFDN5;PSME1;FRMD8;PSMD6;MDK;HDAC1;PSMB5;RBMS3;CSNK1A1;GREM1;FZD6;CAV1;PSMC6;TMEM64;GLI3;AMFR;PSMB4;IGFBP2;TMEM170B;DACT3;PSMA7;LIMD1;ZNRF3;PSMB9;PSMA6;STK4;JADE1;WWTR1;PSMC1;CUL3;PSMD7;PSMD2;GSK3A;PSMD5;MLLT3;SNAI2;SOX9;LRP4;STK11;PSMB6;GSK3B
prerank,regulation of cell motility (GO:2000145),0.4674957246985794,1.2735155560091957,0.07459677419354839,0.7079505947987105,1.0,22/121,11.48%,TMSB4X;NRG1;LMO4;GATA3;TMSB10;FBLN1;FLNA;CEACAM1;DIAPH1;WAS;CDK6;AMOTL1;RAF1;LMNA;DAPK3;PLXNB1;CADM4;PIN1;PLXNA2;SRCIN1;ROCK1;FRMD5
prerank,cristae formation (GO:0042407),0.5363071790858238,1.273484421536304,0.17044100119189512,0.7069966861991459,1.0,8/27,12.57%,ATP5PD;IMMT;CHCHD6;ATP5MG;ATP5PF;ATP5MF;ATP5F1D;ATP5MC1
prerank,regulation of immunoglobulin production (GO:0002637),0.562017407038178,1.2727805777680858,0.1897810218978102,0.7088634251770574,1.0,6/23,12.31%,DNAJB9;TLR9;SASH3;GPI;EPHB2;CLCF1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.3037374342730273,-1.2718347983729348,0.06666666666666667,0.8106644203681854,1.0,21/72,22.13%,HNRNPH1;GRB2;FGF2;SPRED2;FLRT2;GALNT3;PTPN11;FGF10;POLR2G;PTBP1;NCBP2;POLR2K;FLRT3;SPRED1;MAPK3;POLR2C;KIF16B;FGF9;POLR2H;SETX;RAB14
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.4462693166792752,-1.2718218231110365,0.1651376146788991,0.8044200879953536,1.0,6/16,12.64%,SHLD1;SHLD2;KMT5B;PRKDC;PNKP;WRAP53
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.6418518217613284,1.271368802159074,0.1896067415730337,0.7136187064204969,1.0,4/10,12.57%,ATP5PD;ATP5MG;ATP5F1D;ATP5MC1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6478038755835592,1.2708772495425402,0.1825962910128388,0.7146204144211892,1.0,2/10,6.16%,TBX21;MALT1
prerank,metal ion export (GO:0070839),0.5229571778649497,1.270051023728375,0.16511627906976745,0.7168884977040904,1.0,7/31,11.50%,ATP1B3;ATP7A;ATP2B4;ATP1A3;ATP1A4;ATP1A1;ATP1A2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.5106852160151067,1.2699831935796446,0.13835770528683913,0.7160814065899227,1.0,9/40,11.90%,ANGPT1;C3;CLU;B2M;CD63;VTN;GREM1;SERPINE1;HIP1
prerank,protein processing (GO:0016485),0.46978712454165944,1.2697669257767747,0.08401639344262295,0.7159280634089911,1.0,16/102,10.08%,TMPRSS2;ECEL1;CPXM2;HP;HPR;TMPRSS4;SRGN;SDE2;ADAM19;AEBP1;CD5L;KLK1;CPM;PCSK7;CLN3;CASP4
prerank,regulation of macrophage chemotaxis (GO:0010758),0.5620524356077201,1.2695402490551244,0.17945544554455445,0.7158225845218925,1.0,5/21,8.27%,CCL5;STAP1;MDK;MIF;RARRES2
prerank,regulation of mRNA catabolic process (GO:0061013),0.4686204896919141,1.268812300396787,0.08299595141700405,0.717782482604186,1.0,36/121,16.22%,RPS27A;PKP1;XPO1;EXOSC4;PSMC3;YTHDF3;HSPA8;UBA52;PSMD8;PSME1;PSMD6;PSMB5;DCP1A;YWHAB;PSMC6;PABPC1;VIM;PCBP4;DHX36;PSMB4;ZFP36L2;NUP214;EXOSC1;PSMA7;UBB;PSMB9;PSMA6;MAPKAPK2;SAMD4A;HSPA1A;PSMC1;KHSRP;PCID2;ZC3HAV1;PSMD7;PSMD2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6327147274164477,1.268777183212398,0.20114122681883023,0.7168503547133743,1.0,3/10,6.08%,PRKCQ;CD55;ZBTB7B
prerank,cellular response to purine-containing compound (GO:0071415),-0.5152722347707418,-1.2684838784206953,0.20066889632107024,0.809283287018399,1.0,2/10,0.66%,SLC8A1;P2RY6
prerank,positive regulation of phagocytosis (GO:0050766),0.503625946183349,1.268416200196613,0.14891304347826087,0.717291158151122,1.0,8/47,8.86%,IL2RB;FPR2;CYBA;STAP1;C3;CD47;IL2RG;LMAN2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6383777190154127,1.2680541150701845,0.21225071225071226,0.7177012015649801,1.0,4/10,19.83%,SOX5;ZBTB16;PKDCC;SOX9
prerank,mesonephros development (GO:0001823),0.6268191206072022,1.2672084871601499,0.2037037037037037,0.7200511161677123,1.0,3/11,10.11%,GATA3;BMP4;ZBTB16
prerank,regulation of telomerase activity (GO:0051972),0.5075468672717878,1.2671588669117766,0.14332603938730853,0.7191842835618157,1.0,11/45,12.95%,PRKCQ;PARM1;ERCC4;CCT2;ATM;NVL;GREM1;MAP3K4;HSP90AA1;CTNNB1;HMBOX1
prerank,negative regulation of proteolysis (GO:0045861),0.5214371788329982,1.2668222322949876,0.16839677047289503,0.7195721262364372,1.0,14/34,21.56%,TIMP4;TRIM21;TIMP3;CST7;CLN3;TIMP1;PRNP;ROCK1;CSTB;GAS1;DNAJC1;SNX12;TMEM59;EFNA1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.512693507312637,-1.2666109257586666,0.175,0.8097436969046604,1.0,3/10,5.57%,LRP5;PDGFA;TGFBR2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6099162015667741,1.2665887979949892,0.20424403183023873,0.7194815555736124,1.0,2/13,3.08%,CBLB;CHMP6
prerank,amino acid transmembrane transport (GO:0003333),0.5058633773308311,1.2661281076289728,0.14013452914798205,0.7204204065974484,1.0,14/45,21.00%,SLC6A14;SLC36A3;SLC7A11;SLC38A11;SLC3A2;SLC1A6;SLC7A1;SLC7A5;SFXN3;SLC38A1;SLC7A6;SLC6A6;SLC25A22;SLC16A2
prerank,negative regulation of cellular component organization (GO:0051129),0.4779914652673625,1.2659377605888003,0.11455108359133127,0.7202164577192812,1.0,25/74,18.07%,DNAJB1;RTEL1;CLU;HSPA8;RAF1;HSPA5;IAPP;BMP6;CDC42;NOP53;SACS;LCMT1;SORL1;DNAJB2;ABCA7;LGALS3;HSPA1A;CARMIL2;SNX33;TMC8;CRYAB;FAP;LILRB1;RIOK3;EPHA3
prerank,heme catabolic process (GO:0042167),-0.45155093487187015,-1.2654731804043373,0.16236162361623616,0.8015133068447027,1.0,3/14,8.87%,SLCO2B1;HMOX2;HMOX1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.45155093487187015,-1.2654731804043373,0.16236162361623616,0.8015133068447027,1.0,3/14,8.87%,SLCO2B1;HMOX2;HMOX1
prerank,positive regulation of chemotaxis (GO:0050921),0.5101400508100956,1.2653174845593365,0.1418994413407821,0.7216864102908387,1.0,9/43,8.27%,TMSB4X;CCR2;SEMA5A;KDR;PRKD2;DSCAM;MDK;CDH13;RARRES2
prerank,myotube differentiation (GO:0014902),-0.4392107830273301,-1.2652833278845785,0.14814814814814814,0.796100178101375,1.0,6/17,15.93%,SKI;MEF2C;JAM2;MYEF2;ADAMTS5;ADGRB3
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.5146284018583535,-1.2652342736216275,0.20521172638436483,0.7903784694017744,1.0,2/10,4.41%,NCKAP1L;TLR4
prerank,amino acid import across plasma membrane (GO:0089718),0.5481931271077743,1.2649230527361202,0.17759237187127533,0.7222336712562705,1.0,6/24,13.41%,SLC6A14;SLC3A2;SLC1A6;SLC7A1;SLC1A5;SLC7A5
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5148690860157501,1.2645969435384223,0.15706214689265538,0.7225235478308664,1.0,7/36,11.78%,CCR2;NCF1;ITGB1;HDAC1;GREM1;JAK2;EPHB2
prerank,regulation of interleukin-10 production (GO:0032653),0.5042462251385702,1.2643446313542852,0.15222222222222223,0.7225034729285822,1.0,5/44,6.74%,MMP8;CD28;HMGB1;TLR9;CD47
prerank,gonad development (GO:0008406),0.5111307418118579,1.2642123848252373,0.15290178571428573,0.7219806249932299,1.0,6/41,8.73%,GATA3;IRX5;KIT;TGFB2;MKKS;MEA1
prerank,ruffle organization (GO:0031529),-0.44905259304646106,-1.2635363996223021,0.1752136752136752,0.7906809803216088,1.0,7/16,25.69%,CSF1R;PIP5K1A;TPM1;AIF1;CORO1B;ARF6;RAC1
prerank,regulation of cellular component biogenesis (GO:0044087),0.5134498918168198,1.2632425998265122,0.14988814317673377,0.7247916780346173,1.0,11/39,14.91%,FAM110C;HRG;HSPA8;BBS10;APOE;MSN;CD36;HSP90AA1;ROCK1;VPS11;EZR
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4767777830639193,1.2631204742131796,0.11271975180972078,0.7242323472499402,1.0,23/88,15.36%,GZMB;PUS7;MRPL13;RGP1;ILF3;SHMT1;DAPK3;APOE;RACK1;RPS3;MALSU1;CLN3;EIF4A3;SYNCRIP;DHX36;BTG2;NCL;CPEB3;CSTB;SAMD4A;GAPDH;EIF2AK3;TYMS
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5369174785484578,1.2629176524365018,0.17270531400966183,0.7240093633576732,1.0,3/26,6.72%,ANXA1;CCND2;LSM11
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.48369949453080135,1.2628009812863705,0.1178343949044586,0.7234888046567772,1.0,17/67,16.03%,LCK;ITK;GHR;DDR2;TXK;KDR;KIT;JAK2;ZAP70;EPHB2;FLT3;ABI1;FYN;BLK;PKDCC;ABL2;IGF1R
prerank,positive regulation of transferase activity (GO:0051347),0.4637258429060188,1.2626410528220344,0.06256306760847628,0.7231884193678965,1.0,56/142,25.46%,CD4;PRKCQ;LMO4;CD74;DDR2;LMTK2;PARM1;KDR;RFC4;CCT2;RPS2;POLG2;KIT;NVL;PIN1;UBE2L3;DCUN1D5;GREM1;MAP3K4;HSP90AA1;CTNNB1;RFC5;EPHB2;FLT3;SORL1;EPHA7;HMBOX1;EPHA5;EPM2AIP1;DCUN1D2;TREM2;PCNA;IGF1R;GSK3A;NAF1;NTRK3;DBI;EPHA3;PTGES3;BMI1;SERINC5;HSP90AB1;ROR1;MET;ERBB4;DDR1;VAC14;ARRDC3;FGFR1;INSR;FGFR3;AXL;DCUN1D3;FBXW7;SERINC1;PDGFRA
prerank,phosphate ion transmembrane transport (GO:0035435),0.6104534630212325,1.2626231417256428,0.19887165021156558,0.7222123022621628,1.0,6/12,15.80%,SLC20A1;SLC25A10;XPR1;SLC25A14;SLC37A1;SLC25A30
prerank,sulfur amino acid catabolic process (GO:0000098),-0.5193173643984508,-1.2625718428372343,0.15960912052117263,0.7880344715857178,1.0,8/10,37.22%,TXN2;MTRR;ADO;TST;MPST;CBS;GADL1;CTH
prerank,regulation of cell-cell adhesion (GO:0022407),0.5143494994320772,1.262545952267229,0.14253135689851767,0.7214914645728974,1.0,9/39,12.86%,GTPBP4;CEACAM1;DPP4;CDH1;FUT9;FLOT2;CD47;ZDHHC2;EPHA7
prerank,icosanoid biosynthetic process (GO:0046456),0.6343925416052166,1.262542000245209,0.2074074074074074,0.7204676076716217,1.0,2/10,4.15%,FADS1;ALOX5AP
prerank,negative regulation of cation channel activity (GO:2001258),0.5359578278015924,1.2624137202749595,0.16448152562574495,0.7199916479790036,1.0,9/26,19.65%,MMP9;SRI;UBQLN1;EPHB2;FKBP1A;CBARP;DRD2;CALM1;GPR35
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.6050558327137993,1.262185193940195,0.1825503355704698,0.719808421467041,1.0,7/13,21.81%,IL27RA;JAK2;OASL;IL6ST;IL27;CANX;JAK1
prerank,odontogenesis (GO:0042476),0.5202303400704896,1.2616184816539573,0.16840882694541232,0.7210248356677638,1.0,9/35,19.52%,WNT6;COL1A2;HDAC1;TGFB2;BMP4;TGFB3;LAMB1;HDAC2;ANKRD11
prerank,response to lipopolysaccharide (GO:0032496),0.4610324525525432,1.2612228900526465,0.07459677419354839,0.721604008916887,1.0,25/138,13.03%,S100A8;S100A9;CD6;PTPN22;STAP1;F2R;PDCD4;HMGB1;TAB2;LBP;PAF1;HMGB2;FOXP1;CXCL10;TNIP3;PELI1;JAK2;VIM;SRR;SERPINE1;MAPKAPK3;CHMP5;CARD16;CTR9;MAPKAPK2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.6293160226481882,1.261060208058036,0.2058011049723757,0.7212656718307435,1.0,1/10,1.36%,TRIM16
prerank,double-strand break repair via break-induced replication (GO:0000727),0.6163322025015485,1.2610295185956193,0.20675675675675675,0.7203758822649683,1.0,4/12,10.25%,MCM7;MCM2;GINS2;CDC7
prerank,global genome nucleotide-excision repair (GO:0070911),0.5336233393465906,1.2609540531592471,0.18127250900360145,0.7196134219143598,1.0,9/26,14.02%,RPS27A;UBA52;ERCC4;XPC;RNF111;GTF2H5;UBB;ERCC1;USP45
prerank,clathrin-dependent endocytosis (GO:0072583),-0.38636541264070196,-1.2606405850948588,0.12574850299401197,0.7890058271083007,1.0,10/26,12.18%,FCHSD2;FCHO2;AP2A1;SIGLEC1;CLTA;ITSN1;CLTB;SNAP91;AP2M1;PICALM
prerank,chromatin assembly (GO:0031497),0.5118991399776162,1.2604897808160644,0.1635150166852058,0.7205736403851831,1.0,11/38,14.08%,M1AP;DAXX;ATRX;H1-0;ANP32B;PAF1;HMGB2;CHAF1B;NPM1;SIRT1;PADI4
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5282824046439565,1.260457374133156,0.18585131894484413,0.7196716638415881,1.0,9/26,19.25%,NR4A3;SORBS1;C3;CREBL2;APPL1;IRS1;CLIP3;BRAF;C2CD5
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5469698770912973,1.2599231017466856,0.1806060606060606,0.7209030058789697,1.0,9/23,20.15%,RPS27A;UBA52;XPC;COPS6;UBB;COPS3;DDB2;COPS8;DDB1
prerank,sensory perception of chemical stimulus (GO:0007606),0.5865256440173896,1.259904362628529,0.19350649350649352,0.7199777404265356,1.0,4/15,15.34%,SLC24A4;MKKS;CD36;DRD2
prerank,negative regulation of biosynthetic process (GO:0009890),0.5732784752143384,1.2598135356516809,0.1918158567774936,0.7193352944541912,1.0,3/16,6.96%,SLC18A2;CEACAM1;ABCB7
prerank,regulation of axon guidance (GO:1902667),-0.5238830248843938,-1.2594780746648617,0.20666666666666667,0.7872016408049636,1.0,4/10,9.87%,ZSWIM6;NRP1;ZSWIM8;VEGFA
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5767850624412,1.2592335110104291,0.19363395225464192,0.7206842128331757,1.0,8/16,21.16%,SCD5;ACAT1;FASN;ACACA;SCD;SLC25A1;GCDH;DIP2A
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.6238870363331162,1.2590373196519096,0.20985915492957746,0.7204427393203681,1.0,6/11,21.81%,PRKCQ;CCL5;ANK3;BLK;RDX;JAK1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.5994374969574442,1.25880170807895,0.19547872340425532,0.7203295357075797,1.0,3/14,5.78%,UPB1;NT5M;NT5C3A
prerank,positive regulation of neutrophil migration (GO:1902624),0.5759958753098511,1.2585433769803298,0.202275600505689,0.720401464078279,1.0,4/18,8.44%,RIPOR2;CD74;MDK;RAC2
prerank,muscle tissue morphogenesis (GO:0060415),0.5799499628175422,1.2583835182884566,0.1926605504587156,0.7200761211858377,1.0,4/16,14.56%,BMP4;HEY2;TGFBR3;EFEMP2
prerank,ATP synthesis coupled proton transport (GO:0015986),0.5713207866720266,1.2580814964491633,0.1925064599483204,0.7202445389100387,1.0,7/17,17.99%,ATP5PD;ATP5MG;ATP5PF;ATP5MF;ATP5F1D;ATP5MC1;DMAC2L
prerank,glucan catabolic process (GO:0009251),0.5876604136972544,1.2574702564920464,0.2054973821989529,0.7217899619378956,1.0,7/15,16.77%,STBD1;PYGB;PGM2;PYGM;PYGL;AGL;CALM1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4885152212821718,-1.256906857311636,0.19863013698630136,0.7899880614394821,1.0,5/12,15.43%,VEGFA;PAX8;PAX2;SOX8;AGT
prerank,error-free translesion synthesis (GO:0070987),0.5468107692723431,1.256872401681892,0.20660146699266504,0.7232892883832163,1.0,7/22,19.12%,RPS27A;UBA52;RFC4;RFC5;UBB;PCNA;POLDIP2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.6366166107883846,1.256402990119515,0.2086230876216968,0.7242310781894213,1.0,5/10,13.71%,DNAJB1;SACS;SORL1;DNAJB2;HSPA1A
prerank,negative regulation of macroautophagy (GO:0016242),-0.38947330661718227,-1.2560363909113261,0.15757575757575756,0.7871150022208493,1.0,13/26,19.15%,RUBCN;PIK3CA;LRRK2;MTOR;PHF23;CLEC16A;TSC2;CHMP4B;CHMP4A;FEZ1;UBQLN4;LZTS1;USP36
prerank,acylglycerol biosynthetic process (GO:0046463),-0.4001913236599798,-1.2560129089297378,0.14857142857142858,0.7816226695431113,1.0,9/23,25.63%,LPIN2;PLA2G15;PLA2G4A;DGAT1;LPIN1;AGMO;GPAT4;PNPLA2;GPAT3
prerank,myeloid leukocyte differentiation (GO:0002573),0.4846695970101096,1.2554465962993806,0.12367864693446089,0.7272180779852672,1.0,18/65,16.98%,LEF1;CD4;MMP9;IL31RA;CAMK4;MT1G;RARA;KIT;FOXP1;BMP4;CDC42;CDK2;SIRT1;CDKN1A;TREM2;BATF3;DEK;BATF
prerank,negative regulation of cell development (GO:0010721),0.5363593790305352,1.255406328727615,0.1933570581257414,0.7263563341538728,1.0,8/25,20.56%,LTF;B2M;RFLNA;RFLNB;SORL1;GSK3A;LILRB1;GSK3B
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.5324022965199632,1.2550482620975032,0.1751207729468599,0.7268537999894951,1.0,4/25,9.08%,GATA3;H1-0;PER2;HEY2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5275714542387305,1.2548727202452983,0.17894736842105263,0.7265410764617839,1.0,10/26,19.65%,TLR9;THADA;SRI;ATP1A2;UBQLN1;FKBP1A;CBARP;DRD2;CALM1;GPR35
prerank,glycogen catabolic process (GO:0005980),0.5865674116624336,1.254739564032135,0.2094240837696335,0.7261256726040276,1.0,7/15,16.77%,STBD1;PYGB;PGM2;PYGM;PYGL;AGL;CALM1
prerank,regulation of JNK cascade (GO:0046328),0.4680250751900403,1.2543411113398404,0.11819116135662898,0.7267206576315268,1.0,23/101,18.55%,MMP8;MAP4K2;RASGRP1;TRAF1;NCF1;MTURN;HMGB1;TLR9;GADD45A;TPD52L1;CCN2;TAOK3;TGFBR3;NCOR1;RIPK1;SDCBP;TIRAP;RAP2A;AGER;IGF1R;PHLPP1;PER1;FKTN
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5347646370735092,1.2537897116796521,0.19549763033175355,0.7279611040819105,1.0,6/26,14.04%,NCOR2;HDAC1;FOXP1;VPS11;NCOR1;SIRT1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.5268966057405977,1.2535605587559981,0.1923536439665472,0.7279111897497137,1.0,4/26,10.37%,MMP8;CLU;CD36;HSP90AA1
prerank,negative regulation of protein catabolic process (GO:0042177),0.5012703049196574,1.2527420659422879,0.1674057649667406,0.7302573428011301,1.0,10/40,12.87%,ADGRB1;FLNA;TIMP4;RGP1;TIMP3;PIN1;TIMP1;AZIN1;ROCK1;AGAP2
prerank,regulation of secretion by cell (GO:1903530),0.4828467959256705,1.2526226432431908,0.14778856526429343,0.7297162760624414,1.0,7/54,4.97%,ANXA1;MCTP2;P3H1;RHBDF1;KCNMB4;RAB8A;RAB3D
prerank,long-chain fatty acid import into cell (GO:0044539),0.6249480638850262,1.2523551526343217,0.21470588235294116,0.7298079209169926,1.0,5/10,15.45%,CD36;SLC27A1;SLC2A1;ACSL1;RPS6KB1
prerank,negative regulation of protein secretion (GO:0050709),0.5100886503592642,1.2522415631997406,0.1431818181818182,0.7292607566990555,1.0,9/38,15.34%,FAM3D;F2R;RHBDF1;RAB11FIP1;APOE;DPH3;IRS1;RSAD2;DRD2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.4000855880958761,-1.2520274863573426,0.16111111111111112,0.7894488330736216,1.0,9/22,12.75%,PHF8;MTOR;DHX33;UTP15;UBTF;WDR75;NOL11;PIH1D1;IPPK
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.48299557348413286,1.2517622137897728,0.14909478168264112,0.730251262259627,1.0,19/61,16.22%,NCOR2;OAZ3;PSMC3;PSMD8;PSME1;PSMD6;NQO1;PSMB5;CAV1;PSMC6;PSMB4;AZIN1;PSMA7;PSMB9;PSMA6;PSMC1;SIRT1;PSMD7;PSMD2
prerank,regulation of apoptotic process (GO:0042981),0.4498956951272011,1.2513008307204272,0.0,0.7311695063596925,1.0,178/676,20.64%,IKZF3;CD3E;IL2RB;LTF;LEF1;ANXA1;TPT1;RPS27A;SCIN;HRG;GZMA;MMP9;ANGPT4;TFPT;CCND2;PRDX5;CD28;RTKN;IL31RA;IFIT2;CD74;SERPINB9;FIGNL1;TFAP4;ARHGEF3;LGALS1;BCL2;DAXX;FLNA;KALRN;SMPD1;RARG;ANGPT1;ARHGEF18;RPS6;CLU;MELK;HMGB1;UBA52;RAF1;HTATIP2;ING3;BIRC5;KDR;PPIA;DAPK3;USP42;BID;PIM1;RACK1;PAWR;ITGB1;UFM1;ACTN1;ATM;RPS3;ANP32B;GADD45A;ARHGEF19;MALT1;HSPA5;HDAC1;MIF;BARD1;CSRNP3;CDK1;PLEKHG2;ING5;CXCL10;DUSP6;RNF157;BMP4;CD44;TNFSF10;PTPA;TRIM24;GRID2;IAPP;STK17B;WDR73;APIP;BIRC6;GREM1;SPHK2;PDPN;NME1;CLN3;BCAR1;JAK2;FSTL1;GPLD1;EGR3;TMEM219;CFL1;ADAMTSL4;CCAR2;HSP90AA1;NOP53;NAA16;SOS2;CTNNB1;APAF1;UTP11;IL6ST;NFKBIA;LCMT1;ARHGEF12;HIP1;BNIP1;FLT3;VHL;UBB;ERC1;FOXO1;ATF4;MAGED1;AKAP13;BCL6;UBE2Z;TGFB3;NPM1;STK4;ZFAND6;HSPA1A;IFT57;CTLA4;SIRT1;GNA13;NDRG1;BCL2L11;RIPK1;TARDBP;PCID2;CTSH;SHC1;RPS6KB1;HIPK3;ARL6IP5;IGF1R;TIAM1;PRELID1;MYDGF;ERCC5;GAS1;STK26;CRYAB;ARL6IP1;PPP1R13B;AREL1;CLIP3;BRAF;CBX4;LILRB1;HDAC2;DFFA;RYBP;PHLPP1;FBXO11;RBM5;RPL10;MCL1;FBXO10;OMA1;ARHGEF26;BNIP3;KLF11;IP6K2;EEF1E1;SRA1;SOX9;BAG1;HIGD2A;SNCA;ANP32A;DNM1L;GSK3B;YWHAZ;BIRC3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.48248756827771017,1.2512386099059878,0.15309446254071662,0.7304198262627113,1.0,16/52,17.04%,GZMB;BCL2;MICALL2;BID;TOMM7;YWHAB;UBL5;UBE2L3;RAC2;TFDP2;SFN;VPS11;RHOU;HUWE1;GSK3A;PPP1R13B
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5435192910666433,1.2509178332076847,0.19458128078817735,0.7307872968352901,1.0,6/22,14.95%,STAP1;DYNLL1;BMP4;ROCK1;SIRT1;CDKN1A
prerank,tyrosine metabolic process (GO:0006570),-0.4826741996233521,-1.2508930928528903,0.20774647887323944,0.7876184566265096,1.0,8/11,51.75%,GSTZ1;FAH;IL4I1;DCT;HGD;TAT;TH;THAP4
prerank,hematopoietic stem cell differentiation (GO:0060218),0.637005064945094,1.2508066757717915,0.19970193740685543,0.7302574703499471,1.0,4/10,19.38%,HOXB4;LMBR1L;BATF;MLLT3
prerank,regulation of muscle cell differentiation (GO:0051147),-0.36041102845451856,-1.2504758144946793,0.10236220472440945,0.7837764009492614,1.0,9/31,12.68%,MEF2A;MEF2C;CAMK1;ABL1;CDK9;RBM4;MEGF10;CTNNA1;PTBP1
prerank,regulation of phagocytosis (GO:0050764),0.48514334658585967,1.2501123371827438,0.15491452991452992,0.7321661217283049,1.0,8/53,9.45%,IL2RB;FPR2;CYBA;RACK1;CD47;IL2RG;LMAN2;SYT7
prerank,regulation of ATP metabolic process (GO:1903578),0.4874279910675677,1.2500680620019484,0.15276273022751896,0.7313717681147455,1.0,25/54,28.51%,GCK;COX7A1;ATP7A;UQCC2;NUP50;SPHK2;NUP214;NUP210;NUP88;RANBP2;AAAS;SLC25A33;NUP62;PRKAG1;NUP93;NUP205;NDC1;NUP153;SHMT2;AK4;ZBTB7A;OGT;NUP98;TPR;HIF1A
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5579669239909937,1.2499997729888543,0.1860759493670886,0.7306810117690978,1.0,6/20,12.14%,CCL5;S100A11;VTN;PLAU;SERPINE1;SORL1
prerank,negative regulation of programmed cell death (GO:0043069),0.4511482054097915,1.2499673955397224,0.014,0.7298165493807404,1.0,88/355,20.64%,IL2RB;LTF;LEF1;ANXA1;TPT1;RPS27A;MMP9;ANGPT4;CCND2;PRDX5;CD28;IL31RA;CD74;SERPINB9;FIGNL1;BCL2;FLNA;ANGPT1;UBA52;RAF1;HTATIP2;LAPTM5;BIRC5;KDR;BID;PIM1;UFM1;MALT1;HSPA5;HDAC1;MIF;BARD1;CDK1;RNF157;BMP4;CD44;WDR73;APIP;BIRC6;GREM1;PDPN;CLN3;FSTL1;EGR3;CFL1;NAA16;CTNNB1;IL6ST;NFKBIA;BNIP1;VHL;UBB;ERC1;FOXO1;UBE2Z;NPM1;ZFAND6;HSPA1A;SIRT1;RIPK1;PCID2;CTSH;SHC1;GPX4;RPS6KB1;HIPK3;TREM2;IGF1R;PRELID1;MYDGF;ERCC5;CRYAB;ARL6IP1;AREL1;BRAF;CBX4;HDAC2;RPL10;MCL1;BNIP3;MECOM;SOX9;BAG1;HIGD2A;SNCA;GSK3B;YWHAZ;BIRC3
prerank,transport across blood-brain barrier (GO:0150104),0.46612688192319823,1.2494408042037564,0.12939958592132506,0.7309897820435323,1.0,27/83,18.40%,SLC5A1;SLC22A3;SLC28A2;SLC16A1;SLC13A3;ATP2B4;ATP2A3;SLCO3A1;MFSD2A;FABP5;SLCO1C1;SLC7A1;ATP1A4;CD36;SLC1A5;SLC27A1;ATP1A2;ABCC1;SLC7A5;SLC2A1;ABCA2;SLC2A13;AGER;SLC6A17;ATP1B2;SLC38A1;SLC19A1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.6027329049893684,1.2493866798539042,0.20786516853932585,0.7302121036573971,1.0,4/12,14.82%,GCK;SORBS1;IRS1;EPM2AIP1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.4234104454915485,-1.2489741508574905,0.15695067264573992,0.7833421529852583,1.0,7/18,26.35%,IL6R;LYN;SLC8B1;CAMK1D;MTUS1;PTK2B;ADAM17
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5996351518554827,1.2488265363222568,0.2079343365253078,0.7315080705608834,1.0,1/13,0.18%,KLRC2
prerank,cardiac myofibril assembly (GO:0055003),0.5813156014792417,1.2486317707159416,0.20314547837483618,0.7312597256342341,1.0,2/15,4.88%,CSRP3;NEBL
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.34790829080800445,-1.2478800826109981,0.12745098039215685,0.781499663574338,1.0,11/39,10.68%,LRP5;NPNT;PKD1;FGF2;SALL1;NRP1;TGFBR2;FGF10;VEGFA;PAX8;PAX2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.5113168711568981,1.2475498489659889,0.18830409356725147,0.7347938116436921,1.0,5/33,5.29%,ADGRB1;DCN;SP100;APOE;PTEN
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.5946853986068759,1.2475422555626876,0.21052631578947367,0.7338236192519049,1.0,4/13,14.82%,GCK;SORBS1;IRS1;EPM2AIP1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.45533602968011055,1.2474840953314803,0.06820461384152457,0.733080808047849,1.0,34/152,18.51%,FPR2;ADGRB1;ADGRG5;ADGRG7;ADORA2A;LPAR1;ADGRE5;RGS1;S1PR4;ADGRL4;S1PR2;PTGIR;MTNR1A;MC5R;RAMP1;CXCL10;IAPP;INSL3;TSHR;GNAI2;LGR4;ADGRG2;ADCY6;ADGRL2;CNR2;GNA13;GABBR1;ADCY1;GNAQ;ADCYAP1R1;GIPR;HTR1F;VIPR1;GNAI1
prerank,monosaccharide transmembrane transport (GO:0015749),0.5737715077396449,1.2473075157246105,0.20774193548387096,0.732839701111784,1.0,3/16,13.56%,SLC5A1;SLC50A1;SLC2A8
prerank,purine nucleotide catabolic process (GO:0006195),0.6072237458603673,1.2470225937617982,0.21081081081081082,0.733084934930382,1.0,3/13,7.31%,NUDT15;GPX1;GDA
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6094459018149315,1.2468115491626963,0.22207267833109018,0.7329444089214985,1.0,4/12,9.63%,ATP1B3;FXYD1;ANK3;DMD
prerank,magnesium ion transport (GO:0015693),0.6120352093451852,1.246487498055038,0.2188782489740082,0.733303290510282,1.0,5/12,14.60%,NIPAL1;NIPAL2;NIPAL3;MAGT1;TUSC3
prerank,cell-substrate junction assembly (GO:0007044),0.5190314171296481,1.2462554332826745,0.1750291715285881,0.7333023902968541,1.0,7/33,9.51%,DLC1;SORBS1;PLEC;TRIP6;FERMT2;ACTN1;THSD1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5953712194076703,1.246221786643104,0.21592442645074225,0.7324653584533176,1.0,2/13,4.91%,DUT;NT5M
prerank,protein deacetylation (GO:0006476),0.4971967621693472,1.2461350254953785,0.17745535714285715,0.7318611830419987,1.0,14/41,18.76%,FLNA;HDAC9;HDAC7;HDAC11;HDAC1;MORF4L1;MSL3;MIDEAS;SIRT1;BAZ2A;RCOR1;PRDM5;HDAC2;HDAC4
prerank,regulation of cardiac conduction (GO:1903779),0.484802168749392,1.2458507501419391,0.15292841648590022,0.7320144278502708,1.0,16/54,17.17%,ATP1B3;FXYD1;ITPR3;NPR2;ATP2B4;ATP2A3;STIM1;ITPR1;ATP1A3;ATP1A4;ATP1A1;ATP1A2;ATP2B3;TRPC1;ATP1B2;ATP2B2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.57939053871742,1.2454057860595653,0.19573901464713714,0.7328705170686975,1.0,8/15,23.04%,ARPC2;IQGAP2;ARPC1A;ARPC5;ACTR3;ARPC5L;ARPC3;ACTR2
prerank,neural tube closure (GO:0001843),0.5100519105024552,1.2452540233657088,0.17647058823529413,0.7325137579570392,1.0,6/34,9.23%,DEAF1;LMO4;DLC1;TGFB2;CELSR1;MTHFD1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.47406839396917566,1.2451825140818777,0.1323529411764706,0.7318125254462388,1.0,19/74,14.59%,LEF1;GATA3;GLIPR2;FERMT2;SMAD2;PTEN;MDK;SPRY1;TGFB2;GREM1;PDPN;GCNT2;CTNNB1;COL1A1;DAG1;TGFB3;WWTR1;PPP2CA;SDCBP
prerank,positive regulation of macroautophagy (GO:0016239),-0.32270676396618037,-1.2450076495172202,0.08108108108108109,0.7860722823808454,1.0,15/48,13.96%,PIP4K2A;SCOC;VPS13D;MAP3K7;SESN1;SH3GLB1;IRGM;BAG3;UVRAG;GPSM1;PRKAA2;LARP1;TSC2;ADRB2;TBK1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.6153404197070066,1.2446196743931657,0.2085048010973937,0.7331658072613553,1.0,4/12,14.04%,CEACAM1;APOC1;ACADVL;SIRT1
prerank,negative regulation of ATPase activity (GO:0032780),0.5678350236043269,1.244577189153496,0.22597402597402597,0.7323853579747671,1.0,3/16,7.99%,LTF;TLR9;THADA
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5489868233163657,1.2444680305772378,0.21772151898734177,0.7318656653324151,1.0,7/22,16.00%,TIMP4;APOE;TIMP3;GPLD1;TIMP1;ROCK1;SNX33
prerank,negative regulation of bone remodeling (GO:0046851),-0.49829412767430703,-1.2439283352611556,0.19932432432432431,0.7842431081261723,1.0,3/11,4.32%,UBASH3B;TNFAIP3;TMEM119
prerank,negative regulation of growth (GO:0045926),0.461309316918595,1.2435475742324207,0.08163265306122448,0.7345302054048188,1.0,29/121,14.95%,PPP1R9B;HRG;TMPRSS4;RBBP7;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;RACK1;SIPA1;ING5;TGFB2;PPP2R1A;SPHK2;CCAR2;DACT3;MUL1;DNAJB2;BCL6;JADE1;HSPA1A;PPP2CA;SIRT1;SERTAD2;CDKN1A
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.512685258094431,-1.2434684180483266,0.22435897435897437,0.7802154477356725,1.0,4/10,11.22%,PID1;APPL2;GRB10;PRKCB
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.5197626834302425,1.2434246522545018,0.21215733015494637,0.7340588252992649,1.0,6/26,11.00%,HOXA7;CEACAM1;CDK6;RARA;C1QC;TCTA
prerank,glycogen metabolic process (GO:0005977),0.5251934534860612,1.2430203744413963,0.19767441860465115,0.7346991670132875,1.0,10/27,16.77%,STBD1;UGP2;PYGB;PER2;PGM2;PYGM;GYG1;PYGL;AGL;CALM1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4856970880609254,1.2422479634739032,0.1739606126914661,0.7368557100334902,1.0,15/48,20.43%,STAP1;SIGIRR;YTHDF3;TTLL12;METTL3;NR1H2;ROBO1;MUL1;CARD16;USP18;TREM2;SAMHD1;SLIT3;PTPRC;NLRC5
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.53441560338866,1.24210456903644,0.20192307692307693,0.7364561889588921,1.0,9/23,23.91%,CCDC88C;KIF5A;HOOK1;KIF5C;MYO10;CCDC88A;CCDC186;CCDC88B;TUBB
prerank,T cell migration (GO:0072678),0.5837355806786753,1.242006831538357,0.2182061579651941,0.73587531687171,1.0,5/13,11.18%,MYO1G;MSN;CXCL10;CXCL16;ZAP70
prerank,glycogen biosynthetic process (GO:0005978),0.6100825338827499,1.2414450628050877,0.2,0.7362917485961917,1.0,4/12,8.91%,UGP2;PER2;PGM2;GYG1
prerank,glucan biosynthetic process (GO:0009250),0.6100825338827499,1.2414450628050877,0.2,0.7362917485961917,1.0,4/12,8.91%,UGP2;PER2;PGM2;GYG1
prerank,positive regulation of protein deacetylation (GO:0090312),0.5840081692434387,1.2413264204022603,0.20897435897435898,0.7357886351819203,1.0,3/14,6.30%,ING2;ZBTB7B;NIPBL
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3609417813280413,-1.2412128935671642,0.13559322033898305,0.7818024108293903,1.0,8/34,8.63%,P2RY12;PIK3R1;FGF2;RUBCN;WDR81;FGR;TGFB1;WASHC1
prerank,ameboidal-type cell migration (GO:0001667),0.4833322385571907,1.2407667947505083,0.15904139433551198,0.7371622182292834,1.0,13/51,20.45%,PDLIM1;ITGA4;AMOTL1;ANXA6;SEMA5A;ITGB7;GPC3;SEMA3E;PKN1;SOX10;SEMA5B;SEMA3D;CCN3
prerank,fatty acid elongation (GO:0030497),0.5939912918437045,1.2406896476791598,0.23026315789473684,0.7365259622363107,1.0,7/13,26.16%,ELOVL7;ELOVL1;ELOVL6;HACD1;HACD2;HACD4;ELOVL2
prerank,actin filament polymerization (GO:0030041),0.5223128914211502,1.2401619800705064,0.182548794489093,0.737649404996255,1.0,9/29,17.72%,MICALL2;DIAPH1;WAS;PSTPIP1;GSN;JAK2;TTC17;WASF3;ARHGAP6
prerank,positive regulation of cellular component movement (GO:0051272),-0.3947218333551806,-1.2400539657603316,0.15625,0.7802473140010817,1.0,4/24,4.86%,CSF1R;TGFBR1;LYN;AKT2
prerank,response to glucocorticoid (GO:0051384),0.5300562456209149,1.2400108508935124,0.19464720194647203,0.7373459560605327,1.0,6/26,20.71%,ANXA1;UBE2L3;ZFP36L2;BCL2L11;SLIT3;HNRNPU
prerank,negative regulation of developmental process (GO:0051093),0.4685716038626908,1.2398709614258139,0.15916230366492146,0.7369814066263295,1.0,27/69,23.81%,SFRP5;CDK6;IL17D;ANP32B;MIF;BMP4;GRIN3A;PARP3;GREM1;HEY2;SPRY3;ROCK1;MAPT;MUL1;VAT1;DCC;HUWE1;SINHCAF;OMA1;BNIP3;SOX9;RAPGEF3;NFIB;TFRC;FGFR3;THY1;RC3H1
prerank,positive regulation of programmed cell death (GO:0043068),0.44958956068912104,1.2395554068223051,0.029,0.7372255752713632,1.0,61/272,14.15%,RPS27A;SCIN;HRG;GZMA;PRF1;TFPT;IFIT2;TFAP4;ARHGEF3;KALRN;SMPD1;RARG;ARHGEF18;RPS6;CLU;MELK;HMGB1;UBA52;HTATIP2;LAPTM5;ING3;DAPK3;BID;RACK1;PAWR;ITGB1;ATM;GADD45A;ARHGEF19;BARD1;CSRNP3;PLEKHG2;ING5;DUSP6;BMP4;TNFSF10;PTPA;IAPP;STK17B;SPHK2;GPLD1;ADAMTSL4;CCAR2;SOS2;CTNNB1;APAF1;UTP11;ARHGEF12;UBB;FOXO1;ATF4;AKAP13;BCL6;UBE2Z;TGFB3;STK4;CTLA4;SIRT1;GNA13;BCL2L11;RIPK1
prerank,cellular response to chemical stress (GO:0062197),0.459234892273218,1.2386919806200158,0.11806981519507187,0.7397375989727606,1.0,18/96,8.62%,SLC25A24;CYBA;PRDX5;PRDX6;RBM11;CYBB;SOD3;NCF1;PPIA;EIF2S1;LONP1;CHCHD2;ATM;TXNRD1;PRDX1;GPX1;GSR;CAV1
prerank,nuclear pore organization (GO:0006999),0.5732605113849415,1.2384759986181344,0.20081967213114754,0.739646218898204,1.0,10/14,29.69%,AHCTF1;NUP93;NUP205;NDC1;NUP153;TMEM170A;NUP98;TPR;RTN4;NUP35
prerank,modulation by host of symbiont process (GO:0051851),0.5162233050140947,1.2365307062769966,0.1927570093457944,0.7465263945963765,1.0,5/31,10.36%,LEF1;CCL5;TFAP4;HDAC1;NAPEPLD
prerank,regulation of histone methylation (GO:0031060),0.5943112574321056,1.2358250799187906,0.22432432432432434,0.7484377008499883,1.0,4/13,12.48%,TTLL12;PAF1;JARID2;CTR9
prerank,microglial cell activation (GO:0001774),0.5508500207029191,1.235712522755467,0.20460358056265984,0.7479439893427674,1.0,11/21,20.32%,FPR2;CLU;IFNGR1;JAK2;MAPT;GRN;TREM2;AGER;ITGB2;TYROBP;SNCA
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5100933924665029,1.235528170252174,0.2085747392815759,0.7477032589462509,1.0,5/32,7.21%,ANXA1;HDAC9;HDAC7;KDR;RHOJ
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5807248875192231,1.2355025303093092,0.2320730117340287,0.7468416930498024,1.0,7/15,20.43%,YTHDF3;TTLL12;METTL3;MUL1;USP18;SAMHD1;NLRC5
prerank,positive regulation of protein binding (GO:0032092),0.48064652877368624,1.2352539863299408,0.16684491978609625,0.7468298450884294,1.0,21/56,20.56%,MMP9;RPL11;B2M;TRIM21;VTN;APOE;BMP4;NVL;PIN1;CAV1;AMFR;FKBP1A;STK4;RALB;PPP2CA;TIAM1;DERL1;SPPL3;EPB41;MARK3;GSK3B
prerank,regulation of cell development (GO:0060284),0.4990547099694336,1.2351742733731506,0.1928817451205511,0.7461701633633018,1.0,14/36,22.43%,HDAC9;HMGB2;PER2;HEY2;CTNNB1;PRUNE1;FOXO1;RPS19;GRN;WNT3;RHEB;HES1;HES6;CX3CL1
prerank,cellular copper ion homeostasis (GO:0006878),0.5880798557322982,1.2348453850304344,0.21618037135278514,0.7465558156703572,1.0,4/14,12.31%,ATP7A;ATOX1;PRNP;SLC31A2
prerank,regulation of stem cell differentiation (GO:2000736),0.464859149495324,1.2347467765609983,0.13786008230452676,0.746032742964251,1.0,28/89,18.22%,TCF15;GATA3;PUS7;HOXB4;PSMC3;PSMD8;MYB;PSME1;PSMD6;METTL3;PSMB5;SETD1A;PSMC6;TCF12;PSMB4;ZFP36L2;NUDT21;PSMA7;PSMB9;PSMA6;PSMC1;SMYD5;PSMD7;NSUN2;PSMD2;JAG1;PSMD5;HES1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5951474147650835,1.2346912528391232,0.2286096256684492,0.7452662908527222,1.0,7/13,26.16%,ELOVL7;ELOVL1;ELOVL6;HACD1;HACD2;HACD4;ELOVL2
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.5139058165783584,1.2346262788449054,0.1943127962085308,0.7445891683795833,1.0,8/30,14.68%,ACSBG1;PEX2;ABCD3;ELOVL7;ELOVL1;ELOVL6;HACD1;ACSL1
prerank,import into cell (GO:0098657),0.49757399409325076,1.2337241086519912,0.18365061590145576,0.7472817200624209,1.0,15/41,21.00%,LRRC8C;SLC6A14;SLC12A7;SLC1A6;SLC7A1;SLC11A2;SLC27A1;ATP1A2;SLC12A4;SLC7A5;TREM2;SLC38A1;SLC19A1;SLC6A6;SLC16A2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.46393209507181765,1.233538909895576,0.12886597938144329,0.747097634903864,1.0,24/90,16.76%,LCN2;CCR2;PLAC8;ZBTB7B;PER2;FABP5;CAV1;TSHR;JAK2;CD36;CXCR4;HADH;ELOVL6;CPT2;EPAS1;SCD;EBF2;ACSL1;FABP4;UCP2;IRF4;IGF1R;PPARGC1B;CEBPB
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4551579888414017,1.2331650922390813,0.11437246963562753,0.747633078087877,1.0,26/116,19.37%,CD247;CD3G;GPR83;ADORA2A;HTR7;GPR45;PTGIR;PRKAR1B;MC5R;RAMP1;HTR4;GPR84;IAPP;INSL3;TSHR;ADCY6;GPR176;PRKAR1A;FYN;TREM2;ADCY1;ADCYAP1R1;GIPR;VIPR1;SELENOS;PTH1R
prerank,apoptotic nuclear changes (GO:0030262),0.5420440040745315,1.2330644876639383,0.20195838433292534,0.7470571816472574,1.0,4/24,6.36%,DEDD2;H1-0;HMGB1;HMGB2
prerank,histone H4 acetylation (GO:0043967),0.4874139621032716,1.2325769252155614,0.18383167220376523,0.7481701463244869,1.0,15/47,19.21%,LEF1;TRIM16;CHD5;ING3;ING5;MORF4L1;MSL3;JADE1;WDR5;JADE3;RUVBL1;DMAP1;PER1;MSL2;MEAF6
prerank,histone acetylation (GO:0016573),0.47181505231345633,1.2320894122632982,0.15761448349307774,0.7492086635355756,1.0,20/69,19.21%,LEF1;CPA4;TRIM16;CHD5;ING3;TADA1;ING5;MORF4L1;MSL3;DR1;JADE1;WDR5;TAF6;JADE3;RUVBL1;MRGBP;KAT2B;DMAP1;PER1;MEAF6
prerank,artery development (GO:0060840),-0.3831285857628443,-1.2312879963959784,0.16304347826086957,0.8035322293757174,1.0,5/23,9.87%,TGFBR1;BMPR2;SMAD7;NRP1;VEGFA
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5459781262374841,1.2312539243037852,0.21793275217932753,0.7516402733222751,1.0,5/22,9.30%,CHP1;SP100;UFM1;BARD1;LMAN1
prerank,DNA strand elongation (GO:0022616),0.5565622041403594,1.2312175072961131,0.22536945812807882,0.7508315741394451,1.0,4/18,7.53%,RFC4;MCM7;GINS2;GINS3
prerank,regulation of interleukin-6 production (GO:0032675),0.45654070895390436,1.2306381645400926,0.1322314049586777,0.7521920857487588,1.0,13/96,6.74%,MMP8;MAPK13;PTPN22;CYBA;CD74;SCIMP;F2R;HMGB1;IL17D;TLR9;POU2AF1;LBP;CD47
prerank,regulation of protein transport (GO:0051223),0.5222268690139497,1.230435587581496,0.2033898305084746,0.7520611950013434,1.0,5/27,7.47%,P3H1;CHP1;RHBDF1;HSPA8;LCP1
prerank,cellular component assembly (GO:0022607),0.4448581819266642,1.2302803374744915,0.037,0.7517245758056633,1.0,46/253,13.85%,CD3E;IL2RB;CD247;SCIN;CD3G;PKP1;LIMS2;TRAF1;M1AP;CD74;TFAP4;ACTG1;FLNA;ACTB;JCHAIN;WAS;YTHDF3;FERMT2;GPM6B;PARD3;PPIH;CFAP46;PAWR;DCX;CHAF1B;PLS1;RHOJ;LCP1;PPP2R1A;SYCP2;PARVA;GSN;RAC2;ANK3;STAG3;CDC42;SPAG16;NEFH;GPAA1;ILK;NCKAP1;CFAP206;VCPIP1;SLC2A1;CAPG;RHOU
prerank,metanephric mesenchyme development (GO:0072075),-0.5258670630308311,-1.2299172275600365,0.20350877192982456,0.8030323502975131,1.0,5/10,29.68%,BASP1;PAX2;WNT4;PKD2;OSR1
prerank,regulation of actin nucleation (GO:0051125),0.5869994353591341,1.2298552945337256,0.23593964334705075,0.7524651912994856,1.0,2/12,8.38%,SCIN;GSN
prerank,regulation of protein neddylation (GO:2000434),0.6139508840748619,1.2298082789112486,0.2372159090909091,0.7517066164086977,1.0,5/10,15.48%,RPL11;DCUN1D5;COPS9;EPAS1;DCUN1D2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4938049388775058,1.2288751374173805,0.17777777777777778,0.7545380494824238,1.0,9/43,11.22%,NR4A3;MMP9;CCL5;DNMT1;CDH13;FOXP1;BMP4;ID2;MMP2
prerank,UV-damage excision repair (GO:0070914),0.5974386800866476,1.2278153875040894,0.24592391304347827,0.7578954742589837,1.0,6/12,23.32%,XPC;ERCC1;SIRT1;DDB2;DDB1;XPA
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.44364813660201813,1.2278135573109044,0.04804804804804805,0.7569542517965506,1.0,38/234,14.15%,S100A8;S100A9;IL18RAP;IL18R1;LTF;RPS27A;PRKCQ;TRAF1;DDR2;NHLH2;CLU;UBA52;TAB2;TLR9;PPIA;TRIM21;PTEN;RPS3;PRKD2;FLOT2;MALT1;KIT;SLCO3A1;RPS6KA5;CAV1;CD36;CTNNB1;NFKBIA;NOD1;CARD16;UBB;ERC1;PSMA6;NPM1;TRIM68;EPHA5;HSPA1A;RIPK1
prerank,detection of mechanical stimulus (GO:0050982),0.5438912324752865,1.2275614118911622,0.22010178117048346,0.7569685438361018,1.0,3/19,10.71%,CSRP3;PIEZO2;CTNNB1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4706564984562309,1.2275031238539937,0.16631578947368422,0.756243746647515,1.0,25/68,25.49%,ACP5;MMAB;GSTO2;HLCS;MTHFD2;SHMT1;MMUT;MTHFD1;ABCC1;PDZD11;SLC2A1;SLC19A2;ALDH1L2;MCCC1;CYB5A;SLC19A1;CD320;PCCB;MTHFD1L;MTR;MTHFS;PCCA;CYB5R3;SHMT2;BTD
prerank,cellular polysaccharide catabolic process (GO:0044247),0.567893097202433,1.2274621056246144,0.225130890052356,0.7554824238495247,1.0,8/16,19.90%,STBD1;PYGB;PGM2;PYGM;PYGL;AGL;CALM1;AOAH
prerank,adherens junction organization (GO:0034332),0.48957153789315233,1.2274136661113249,0.1737704918032787,0.7547637432513586,1.0,17/48,21.13%,ACTB;NECTIN1;FERMT2;CDH1;CDH13;CDH20;CDH19;CDH7;JAM3;CTNNB1;CDH5;VCL;JUP;AFDN;CDH8;CDH11;CDH12
prerank,calcium ion transmembrane transport (GO:0070588),-0.3006784302139992,-1.2272310057134008,0.10714285714285714,0.8065491260988037,1.0,23/86,13.57%,SLC8A1;CACNA1D;SLC24A3;ATP2C1;PKD1;MCOLN1;P2RX4;MCUR1;ANO6;TRPM4;TRPV2;PARL;SLC8B1;LETM1;MCOLN3;GRIN2A;TRPM7;TRPC7;TRPM2;TRPV4;MAIP1;ATP2A2;CACNA1G
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3312558608474908,-1.2271191323346926,0.0975609756097561,0.8017021851230058,1.0,16/46,23.24%,MAP3K14;F11R;TLR7;TLR4;BCL10;CASP2;TLR8;TLR3;PTGER4;BAD;MAPK8;CNN2;MAPK3;BAK1;FAS;MAP3K2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.4837235990565625,1.227106332799397,0.18181818181818182,0.7550594165128863,1.0,7/51,8.27%,FPR2;CCR2;CCL5;HMGB1;MDK;CXCL10;RARRES2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5614669443315472,1.2268650592077879,0.23468057366362452,0.7551104586739196,1.0,3/17,6.88%,HDAC9;APOC1;NR1H2
prerank,long-chain fatty acid transport (GO:0015909),0.5135238742579592,1.2263926222102879,0.20141342756183744,0.7560840884123745,1.0,12/30,15.45%,APOE;ABCD3;MFSD2A;FABP5;CD36;SLC27A1;MID1IP1;ACACA;CPT2;ACSL1;FABP4;RPS6KB1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.588116735713654,1.2263749963894297,0.24900662251655628,0.7552146219675048,1.0,4/13,12.82%,ENTPD5;NUDT15;ENTPD2;ENTPD3
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.569156836716819,1.2260728888763435,0.22503328894806923,0.7554910970089864,1.0,4/15,15.43%,CD6;IL17D;APPL1;TICAM1
prerank,I-kappaB phosphorylation (GO:0007252),-0.5127249958506357,-1.2260686604702906,0.22372881355932203,0.7999256571803482,1.0,6/10,9.64%,TLR7;MAP3K7;TLR4;TLR2;TLR3;CHUK
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5612997687706217,1.225960835052106,0.2232258064516129,0.754991000468657,1.0,3/17,8.64%,FOXN1;BMP4;SFN
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.46780978883437413,1.2258222965546588,0.14693446088794926,0.7546671998263805,1.0,14/66,12.63%,GATA3;RUNX3;CEACAM1;PEX2;CDK6;B2M;APOE;TGFB2;AQP11;AIMP1;CAV1;ROBO1;TGFBR3;MAGED1
prerank,negative regulation of T cell differentiation (GO:0045581),0.62436399301183,1.2251508715712849,0.23323615160349853,0.7564925128420451,1.0,4/10,14.00%,MDK;BMP4;GLI3;CTLA4
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.60990882553449,1.2249919696236657,0.23504867872044508,0.7561676631689469,1.0,4/11,10.01%,EFNB2;TGFB2;GREM1;DHX36
prerank,male gonad development (GO:0008584),0.5092411276862723,1.2249594149691614,0.1981460023174971,0.7553813374149366,1.0,5/34,8.73%,GATA3;ING2;KIT;TGFB2;MEA1
prerank,digestive tract morphogenesis (GO:0048546),0.5825172781132254,1.2249255856185597,0.24174372523117568,0.7546115576132035,1.0,5/14,25.46%,NIPBL;ID2;SOX11;BBS7;PDGFRA
prerank,morphogenesis of an epithelium (GO:0002009),0.5337117967462812,1.224183294572201,0.220462850182704,0.7568088393496939,1.0,10/25,23.69%,ACTG1;LAMA5;ACTB;LIN7C;DAG1;VCL;SOX10;SOX9;TIMELESS;LAMA3
prerank,protein maturation (GO:0051604),0.4490093268596157,1.2241002350748997,0.1554192229038855,0.7562275595227248,1.0,18/95,12.14%,ECEL1;CPXM2;TMPRSS4;SRGN;SDE2;ADAM19;TSPAN17;NFU1;AEBP1;LIPT2;CPM;PCSK7;CLN3;CIAO1;NAA16;TASP1;TSPAN32;SORL1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5028163041542619,1.2239171983024435,0.20273348519362186,0.7560361027820263,1.0,12/35,21.52%,SELL;CDH13;CDH20;CDH19;CDH7;PCDHB11;CDH5;PCDHB16;CDH8;CDH11;CDH12;PCDHB14
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5688541742232238,1.223738219712533,0.21494102228047182,0.7557990463290182,1.0,4/16,9.22%,PIGC;PIGH;PIGA;PIGG
prerank,regulation of cell migration (GO:0030334),0.4385881861315453,1.22338708721068,0.02,0.756252725901021,1.0,89/382,16.87%,TMSB4X;LEF1;ANXA1;FAM110C;GTPBP4;MMP9;LMO4;DLC1;DACH1;IFITM1;CCL5;TMSB10;CCL7;CD74;ACTG1;FLNA;PECAM1;F2R;FAM89B;CEACAM1;TRIP6;AMOTL1;YTHDF3;FERMT2;FAM83H;LMNA;SEMA5A;CEMIP;KDR;RACK1;PTEN;PLXNB1;CDH1;ITGB1;ATM;MDK;HSPA5;MIF;PLAU;CHRD;IGSF10;CDH13;KIT;CXCL16;CAV1;PDPN;PLXNA2;CLN3;BCAR1;GCNT2;SRCIN1;APPL1;RHOC;SERPINE1;ROBO1;ROCK1;COL1A1;FRMD5;EPHB2;SORL1;STK24;CDH5;DAG1;TCAF1;NTNG1;NTNG2;GRN;FGF7;F10;ITGAX;CTSH;SDCBP;SEMA3E;VCL;DRD2;SOD2;RAP2A;CARMIL2;PAK1;IGF1R;TIAM1;PDGFD;MIA3;NEDD9;MGAT3;JAG1;SINHCAF;STK26;LAMB1
prerank,polyol metabolic process (GO:0019751),-0.3349052658824836,-1.2231720841508318,0.16981132075471697,0.8047891776689365,1.0,18/46,19.14%,INPP5D;PLD4;PLCG2;INPP4A;PPIP5K2;ITPKB;INPP5B;INPP1;INPP4B;PLCB4;IPPK;PLCB1;INPPL1;IPMK;SYNJ1;ITPK1;ISYNA1;PLCB2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.4920744187435156,1.2225610483108351,0.20157657657657657,0.7586281386557969,1.0,14/37,20.15%,RPS27A;UBA52;ERCC4;RFC4;GTF2H5;RFC5;UBB;ERCC1;POLK;PCNA;ERCC5;DDB2;POLD4;DDB1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.4366818825803318,1.221610819933845,0.01,0.7614966258644063,1.0,107/509,16.29%,S100A8;S100A9;LCK;MMP8;LTF;CD4;FAM110C;NRG1;GATA3;RPL37;CD28;CCL5;CD74;RPS20;LGALS1;BCL2;FLNA;CHD5;F2R;ANGPT1;RPL23;NCF1;IQGAP1;LPAR1;NEDD4;DCN;TRIP6;FERMT2;PDCD4;HMGB1;CLEC6A;HEXIM1;TAB2;TMEM9B;TLR9;SMCR8;LAPTM5;SEMA5A;KDR;TRIM21;RPS15;BID;RACK1;PLXNB1;ITGB1;RPS3;PRKD2;MALT1;TMED4;MIF;CDH13;KIT;TGFB2;TNFSF10;IAPP;RAC2;PELI1;SPHK2;CAV1;SLC20A1;ZDHHC17;LAMTOR4;JAK2;OASL;GCNT2;DHX36;CC2D1A;HSP90AA1;RHOC;ILK;ROCK1;HCST;THEM4;HIP1;FKBP1A;KSR1;FLT3;MUL1;NOD1;IRS1;CARD16;P2RX5;AKAP13;SHARPIN;TRIM68;DDX1;PIK3R5;PTP4A3;SIRT1;BCL2L11;RIPK1;GAPDH;FGF7;F10;KITLG;SHC1;TIRAP;EEF1D;FYN;TICAM1;TREM2;RHEB;USP15;AGER;IGF1R;PDGFD;MYDGF
prerank,negative regulation of stem cell differentiation (GO:2000737),0.6055289147445967,1.2214544366305864,0.2493112947658402,0.7611756775699745,1.0,5/12,20.71%,TCF15;ZFP36L2;JAG1;HES1;HNRNPU
prerank,negative regulation of cell motility (GO:2000146),0.4525718940317052,1.220612341533711,0.1326530612244898,0.7637606029503171,1.0,26/108,16.86%,GTPBP4;GATA3;DLC1;DACH1;IFITM1;FBLN1;CD74;WAS;PTEN;CDH1;MIF;CHRD;PIN1;SERPINE1;ROBO1;FRMD5;STK24;DAG1;TCAF1;VCL;DRD2;RAP2A;MIA3;JAG1;SINHCAF;STK26
prerank,cell projection organization (GO:0030030),0.5025883590773186,1.220478185348003,0.22588235294117648,0.7634076039996388,1.0,13/30,17.01%,SCIN;ITGB1;RHOJ;PARVA;GSN;RAC2;CDC42;NEFH;NCKAP1;CAPG;RHOU;CSPG5;ATP1B2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.45241427716625854,1.2204517646343889,0.1290650406504065,0.7625734487520278,1.0,28/110,14.89%,HRG;NRG1;CLU;HSPA8;RAF1;BBS10;BID;APOE;RACK1;RPS3;HSPA5;MPP7;IAPP;GSN;ATF7IP;CD36;CDC42;HSP90AA1;NOP53;RHOC;LCMT1;SORL1;CDH5;LGALS3;RALB;BCL2L11;SAR1B;TIRAP
prerank,activin receptor signaling pathway (GO:0032924),-0.4405562547159052,-1.2204494969508752,0.20072992700729927,0.8085106338827339,1.0,3/15,6.08%,TGFBR1;ACVR1B;SMAD3
prerank,aerobic electron transport chain (GO:0019646),0.46536068868399844,1.2204188081057306,0.1742826780021254,0.7617881305316305,1.0,25/68,22.51%,NDUFA1;NDUFS7;UQCRB;COX4I1;NDUFA10;UQCR11;NDUFA5;NDUFA9;NDUFB10;COX6C;NDUFA4;UQCRQ;NDUFS6;COX8A;NDUFV3;NDUFA8;SDHC;UQCRFS1;UQCRC1;NDUFA2;UQCRH;NDUFB11;AFG1L;COX7B;NDUFS5
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5741190284320625,1.2203185687368476,0.24160206718346253,0.7612793054021313,1.0,4/15,13.15%,RTRAF;CLP1;CSTF2;DDX1
prerank,apoptotic process (GO:0006915),0.44187334592653527,1.2199989221861633,0.07723169508525576,0.761662776747768,1.0,49/203,14.70%,CD2;GZMB;GZMA;CSRNP1;DLC1;PRF1;SFRP5;IFIT2;BCL2;ADORA2A;PDCD4;MELK;PPP1R15A;RAF1;PPIA;AHR;MCM2;DAPK3;BID;PAWR;CYFIP2;GADD45A;PAEP;PPP2R1A;IAPP;DAP;PAK4;JAK2;TRPC5;CASP4;ZBTB16;CXCR4;APAF1;ESPL1;NFKBIA;HIP1;BNIP1;CIT;FOXO1;NCKAP1;STK4;JADE1;TNFSF12;IFT57;PPP2CA;BCL2L11;RIPK1;GAPDH;DCC
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4457806294554483,1.2188334470477418,0.09236947791164658,0.7652488398574212,1.0,51/166,21.94%,MMP8;GCK;CD28;CCL5;CHP1;SORBS1;ATP7A;CLU;STARD4;YTHDF3;SREBF1;CTDNEP1;PRKD2;METTL3;NR1H2;MFSD2A;RPS4X;EEF2;GPLD1;VIM;EIF4A3;CD36;HSP90AA1;APPL1;SLC27A1;CPEB3;MID1IP1;IRS1;NPM1;METTL14;SAMD4A;SIRT1;POLDIP3;EIF3E;EPM2AIP1;RPS6KB1;PCNA;NIBAN1;KLF2;PTH1R;MLXIPL;LDLR;STN1;DDB1;SNCA;ASS1;HSP90AB1;CTC1;BRPF3;EGR1;DYRK2
prerank,positive regulation of myelination (GO:0031643),0.6026364885996034,1.2182538078507474,0.2612481857764877,0.7667114932977795,1.0,8/11,28.66%,PARD3;CST7;ITGAX;EGR2;TENM4;MYRF;NCMAP;DICER1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5017183474444601,1.218251852037221,0.2150170648464164,0.7657958447846368,1.0,12/32,24.22%,F2R;CEMIP;CXCL10;CAV1;AKAP6;P2RX5;TRPC1;SNCA;CX3CL1;P2RX7;THY1;GRIN1
prerank,regulation of protein phosphorylation (GO:0001932),0.4364126380554466,1.2180865417170372,0.046,0.7655546411610377,1.0,60/256,16.76%,CCDC88C;FPR2;CD4;HRG;MMP9;RASGRP1;CCND2;FBLN1;CHP1;CD74;DAXX;PECAM1;ANGPT1;C3;P2RY1;PAQR3;PTPN13;KDR;PPIA;RACK1;PTEN;CADM4;SPTBN4;SLCO3A1;BMP4;PIN1;RARRES2;FAM20A;PPP1R15B;HSP90AA1;NOP53;PDCL3;PRNP;ILK;EPHB2;ATF4;CDH5;EPHA7;NPM1;STK4;RALB;WWTR1;NPTN;TNIK;PPP2CA;SIRT1;RIPK1;TARDBP;FGF7;EIF2AK3;CRKL;FYN;RAP2A;PAK1;TREM2;AGER;MYDGF;NIBAN1;ITGB2;CEBPB
prerank,positive regulation of protein localization to membrane (GO:1905477),0.44830724732394955,1.217897941376974,0.15092402464065707,0.765390207497735,1.0,35/98,22.18%,GZMB;RANGRF;CHP1;SORBS1;BCL2;CEMIP;BID;ITGB1;ATP2B4;PLS1;PTPN9;YWHAB;CNPY4;TFDP2;SFN;ANK3;PRNP;EPHB2;LGALS3;TCAF1;FYN;TREM2;MTCL1;ITGB2;PPP1R13B;CLIP3;EPHA3;C2CD5;YWHAZ;MFF;TCAF2;YWHAG;STAC2;DLG1;DPP10
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6027071035946538,1.2177079800347093,0.25237449118046135,0.7652107091828941,1.0,4/11,10.01%,PAF1;BARD1;LEO1;DHX36
prerank,positive chemotaxis (GO:0050918),0.5598388320688823,1.2174801743064536,0.2138364779874214,0.7652074132875041,1.0,8/17,22.43%,FPR2;ANGPT1;SEMA5A;LGALS3;FGF7;CORO1A;MET;CX3CL1
prerank,regulation of JUN kinase activity (GO:0043506),0.5032899877095466,1.217178119180049,0.2026875699888018,0.7655825363292621,1.0,8/33,15.52%,PTPN22;PDCD4;TLR9;RPS3;MAP3K4;TAOK3;HIPK3;PAK1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5448947304656028,1.217091619694538,0.23618090452261306,0.7649686188325064,1.0,4/18,14.15%,NCOR2;BMP4;NCOR1;RIPK1
prerank,aortic valve development (GO:0003176),0.49816116695784707,1.2170121514523846,0.2048894062863795,0.7644106002360707,1.0,14/34,22.46%,ELN;GATA3;BMP4;HEY2;ROBO1;ROCK1;ROBO2;JAG1;EMILIN1;SLIT3;SNAI2;SOX9;EFNA1;SMAD6
prerank,sulfur compound transport (GO:0072348),0.508871804006545,1.2168579853070414,0.21980676328502416,0.7641281350100203,1.0,8/27,15.80%,SLC13A4;RACGAP1;SLC26A6;SLC27A1;SLC25A10;SLC19A2;SLC25A14;SLC25A30
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5753287045750755,1.216739599568851,0.2403718459495352,0.7636763334227485,1.0,4/15,5.80%,TMSB4X;SEMA5A;KDR;PRKD2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5998461661710155,1.2163228616799178,0.2460881934566145,0.7644142431396044,1.0,2/12,2.63%,SLC22A3;ATP7A
prerank,cardiac muscle tissue development (GO:0048738),0.478404192422325,1.2162004497849135,0.1857451403887689,0.7640361973150342,1.0,7/50,12.85%,NRG1;CSRP3;GJB6;BMP4;HEY2;SMAD1;AKAP13
prerank,positive regulation of cell growth (GO:0030307),0.45539932111749537,1.2161028058137395,0.14067278287461774,0.7635249349921486,1.0,15/96,12.21%,S100A8;S100A9;BCL2;EXOSC4;SYT4;RASAL1;TGFB2;RNF157;MFSD2A;CXCL16;AKAP6;LGI1;CDC42;MAPT;ISLR2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5606112062044305,1.2159810199174654,0.22903629536921152,0.7631088832622254,1.0,7/18,17.60%,NCOR2;RPS26;PTBP3;PTBP2;NCOR1;NUDT16;KAT2B
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5185072957819309,1.2155472221857764,0.22565320665083136,0.7639449108906143,1.0,10/26,21.94%,IQGAP1;PTPN12;EEF1A1;STAT5B;ZFP36L2;ZPR1;SYAP1;SNAI2;SOX9;DUSP3
prerank,regulation of endothelial cell migration (GO:0010594),0.4579448364582984,1.2154573462945084,0.1618556701030928,0.763379296788475,1.0,17/85,9.09%,ANGPT4;GATA3;ADGRB1;ANGPT1;DCN;CEACAM1;SP100;KDR;APOE;PRKD2;FOXP1;RHOJ;ETS1;BMP4;GPI;BCAR1;GPLD1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.597749727666927,1.2150322003463374,0.24793388429752067,0.7640526269820628,1.0,4/11,18.34%,UBQLN1;FYN;STK26;P4HB
prerank,axon development (GO:0061564),0.45705189435416094,1.2143948536046585,0.16546762589928057,0.7657090873745238,1.0,22/78,16.37%,S100A6;SLITRK2;ADGRB1;ACTB;LMTK2;RAB8A;AMIGO1;SEMA5A;PARD3;SPTBN4;ZDHHC17;ANK3;NEFH;ZPR1;MAPT;EPHB2;NTNG1;NTNG2;MAP1B;DCC;DRD2;ATL1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.4700805186356898,-1.2142138446562478,0.25089605734767023,0.8238595254629811,1.0,3/11,5.57%,LRP5;PDGFA;TGFBR2
prerank,apical protein localization (GO:0045176),0.6040730774564913,1.2139047225156971,0.24312590448625182,0.7666841449596546,1.0,3/10,9.35%,ACTB;CELSR1;JAM3
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5874308643314724,1.2137504520664557,0.25102319236016374,0.7664516615788957,1.0,3/12,7.50%,SPN;CCL5;CXCL10
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.3410726607129739,-1.2135057816705244,0.18333333333333332,0.8208645230670619,1.0,9/36,10.94%,KIF13A;MACF1;GGA3;GOLGA4;BLZF1;BBS2;RILPL1;GOLPH3;GORASP2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5770151024808527,1.2134274965704206,0.23687752355316286,0.7667627910964825,1.0,2/13,5.28%,NR4A3;RACK1
prerank,cellular response to amyloid-beta (GO:1904646),0.4952707132688137,1.2132635034550896,0.2180365296803653,0.7665505483696897,1.0,12/35,16.03%,FPR2;ITGA4;ATP1A3;CD36;CASP4;PRNP;CACNA2D1;ABCC1;FYN;TREM2;AGER;IGF1R
prerank,regulation of osteoblast proliferation (GO:0033688),0.5598196822124449,1.2131627042700022,0.24393358876117496,0.7660667407273736,1.0,3/17,8.50%,LTF;PLXNB1;GREM1
prerank,positive regulation of kinase activity (GO:0033674),0.4468304595916324,1.2130762463611389,0.15173116089613034,0.7655143856405882,1.0,35/107,24.48%,CD4;LMO4;CD74;DDR2;DAXX;IQGAP1;LMTK2;TAB2;KDR;KIT;MAPT;EPHB2;FLT3;EPHA7;AGAP2;EPHA5;CDKN1A;TREM2;IGF1R;MAPRE3;NTRK3;EPHA3;CAMKK1;PTPRC;ROR1;MET;ERBB4;DDR1;VAC14;PRKAG1;FGFR1;INSR;FGFR3;RELN;AXL
prerank,regulation of p38MAPK cascade (GO:1900744),0.5008985147177604,1.2130186532513638,0.21058688147295743,0.7648658844526628,1.0,10/35,18.39%,PTPN22;RASGRP1;NCF1;GADD45A;MAP3K4;EZR;TREM2;AGER;PHLPP1;PER1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.48709218560261075,-1.2126680791009952,0.2459016393442623,0.818529043341146,1.0,2/10,1.13%,DNMT3A;PCGF3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.46030203695092714,1.2125926391885935,0.1643979057591623,0.7656115204422516,1.0,23/84,16.22%,RPS27A;PSMC3;UBA52;BUB1B;PSMD8;FBXO5;FBXO31;FZR1;PSME1;PSMD6;PSMB5;CDK1;PSMC6;CDK2;PSMB4;PSMA7;UBB;PSMB9;PSMA6;PSMC1;CUL3;PSMD7;PSMD2
prerank,cellular lipid catabolic process (GO:0044242),-0.3757183322521357,-1.2125079367022116,0.20689655172413793,0.8139998497663972,1.0,5/27,5.87%,LPIN2;PPARD;ABHD12;PLA2G15;ACADL
prerank,thyroid hormone generation (GO:0006590),-0.5002824681438703,-1.2123355499951933,0.26031746031746034,0.8095070650976591,1.0,8/10,50.00%,FOXE1;CPQ;TG;SLC5A5;TPO;CTSK;DUOX1;DIO2
prerank,pre-replicative complex assembly (GO:0036388),0.4685463136518849,1.2121214921398396,0.18494623655913978,0.7665533086752737,1.0,21/64,18.49%,RPS27A;PSMC3;UBA52;MCM7;MCM2;PSMD8;PSME1;PSMD6;PSMB5;PSMC6;PSMB4;PSMA7;UBB;PSMB9;PSMA6;PSMC1;PSMD7;PSMD2;ORC6;PSMD5;MCM6
prerank,neuromuscular junction development (GO:0007528),0.5221718686977983,1.2108994663170742,0.2381516587677725,0.7704913006330312,1.0,5/24,9.06%,F2R;NEDD4;GPHN;ANK3;CACNB4
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5607574100583551,1.2106750832314186,0.23927178153446033,0.77048427262494,1.0,4/16,10.01%,RTEL1;ERCC4;ATM;DHX36
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.47934512754603587,1.2103395288214382,0.21389195148842338,0.7709004904587927,1.0,16/45,20.68%,BRINP2;BUB1B;BMP4;BRINP3;ZFP36L2;CTNNB1;NABP1;BTG2;BCL6;ANGEL2;CHFR;GAS1;PRCC;NME6;WEE1;ZW10
prerank,respiratory tube development (GO:0030323),-0.3571082430936367,-1.2102252585411943,0.17543859649122806,0.811031332758099,1.0,8/28,11.28%,FGF2;PCSK5;ABCA3;BAG6;CEBPA;NPHP3;VEGFA;LOXL3
prerank,myeloid dendritic cell activation (GO:0001773),0.5756435720280537,1.2100861641169616,0.2557142857142857,0.7710761531456364,1.0,4/12,16.98%,CAMK4;HMGB1;BATF3;BATF
prerank,triglyceride biosynthetic process (GO:0019432),-0.3939371996496809,-1.2096733867956007,0.2017167381974249,0.8077946557855671,1.0,6/18,25.63%,LPIN2;DGAT1;LPIN1;AGMO;GPAT4;GPAT3
prerank,organic acid transport (GO:0015849),0.4496678096112125,1.2092884990046024,0.15297741273100615,0.7734167339864858,1.0,26/94,19.74%,SLC6A19;SLC6A14;SLC7A11;CEACAM1;SLC16A1;SLC3A2;SLC13A3;MFSD2A;PDPN;SLCO1C1;SLC26A6;SLC7A1;SLC1A5;SLC27A1;SLC25A10;NCOA2;ACSL1;SLC25A14;SFXN5;SLC25A30;SLC43A2;SLC38A1;SLC6A15;SLC19A1;SLC7A6;SLC6A6
prerank,positive regulation of multicellular organismal process (GO:0051240),0.43571713628578834,1.20908251518866,0.046,0.7732891366044101,1.0,74/308,17.66%,LCN2;ITK;LEF1;CCR2;TRIM16;CD28;PLA2R1;GHR;PLAC8;GLIPR2;BMP1;F2R;TXK;FERMT2;CLEC6A;APOE;FBXO5;SMAD2;LBP;MDK;ZBTB7B;MIF;SOX5;TGFB2;BMP4;PER2;FABP5;CAV1;TSHR;PDPN;JAK2;GCNT2;CD36;CFL1;ZBTB16;CXCR4;CTNNB1;SLC27A1;SERPINE1;ROCK1;COL1A1;HADH;SORL1;ELOVL6;ABCA7;RPS19;CPT2;TGFB3;EPAS1;WWTR1;SCD;EBF2;SIRT1;GAPDH;ITGAX;SDCBP;ACSL1;FABP4;UCP2;IRF4;TREM2;RFX3;IGF1R;TIAM1;AGPAT2;PPARGC1B;S100A13;CEBPB;BATF;GLMN;SOX11;AGO2;IL33;SMURF2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.609829202391649,1.2090573396111293,0.2639257294429708,0.7725006507793334,1.0,5/10,20.96%,HRG;JAM3;SERPINE1;SNAI2;ACER2
prerank,actin filament capping (GO:0051693),0.5473176113748274,1.209012795611014,0.24875,0.7708730126110781,1.0,6/18,20.04%,SCIN;ADD3;GSN;CAPG;TWF2;SVIL
prerank,barbed-end actin filament capping (GO:0051016),0.5473176113748274,1.209012795611014,0.24875,0.7708730126110781,1.0,6/18,20.04%,SCIN;ADD3;GSN;CAPG;TWF2;SVIL
prerank,histone ubiquitination (GO:0016574),0.5420086306793647,1.2086342580902416,0.23671497584541062,0.7714581629823476,1.0,7/21,19.03%,PAF1;UHRF1;LEO1;CTR9;UBE2B;HUWE1;CDC73
prerank,regulation of sodium ion transport (GO:0002028),0.49696855689201697,1.2084945286070192,0.23556058890147225,0.7711050282041954,1.0,15/34,22.79%,RANGRF;NEDD4;ATP2B4;SPTBN4;ANK3;ATP1A1;NKAIN1;DRD2;NKAIN2;PER1;SCN3B;SCN1B;PRSS8;DLG1;P2RX7
prerank,positive regulation of chromatin organization (GO:1905269),0.5915953766182394,1.2081089976066877,0.2465753424657534,0.7718026983572269,1.0,2/12,3.00%,DAXX;ATRX
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.4831239458616265,-1.2078424914286652,0.2356902356902357,0.8084728460194712,1.0,2/11,1.12%,CAB39;BIN1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.44484431136047237,1.2078106163138977,0.14762386248736098,0.7721077521009178,1.0,24/117,18.46%,CD247;CD3G;GPR83;ADORA2A;HTR7;GPR45;PTGIR;PRKAR1B;MC5R;RAMP1;HTR4;GPR84;IAPP;INSL3;TSHR;ADCY6;GPR176;PRKAR1A;FYN;TREM2;ADCY1;ADCYAP1R1;GIPR;VIPR1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.43260821821699547,-1.2077962950257182,0.19215686274509805,0.803783020609186,1.0,5/15,17.27%,ABHD12;GGACT;GGT5;HOGA1;SARDH
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.46060995074832156,1.2075757725585974,0.1902231668437832,0.7721240201235302,1.0,25/69,22.51%,NDUFA1;NDUFS7;UQCRB;COX4I1;NDUFA10;UQCR11;NDUFA5;NDUFA9;NDUFB10;COX6C;NDUFA4;UQCRQ;NDUFS6;COX8A;NDUFV3;NDUFA8;SDHC;UQCRFS1;UQCRC1;NDUFA2;UQCRH;NDUFB11;AFG1L;COX7B;NDUFS5
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.48241565824701405,1.2070391732054566,0.20578420467185762,0.7733458741349416,1.0,12/44,16.92%,LTF;RAF1;CAST;GPX1;CD44;SFN;CST7;CARD16;PCID2;BEX3;MAP2K5;ARL6IP1
prerank,cellular response to interferon-gamma (GO:0071346),0.4540602399696008,1.2069124257822703,0.158004158004158,0.7729891916440472,1.0,16/88,9.91%,IRF6;CCL5;CCL7;SP100;B2M;TRIM21;DAPK3;GBP2;CD47;CD44;IFNGR1;SLC26A6;JAK2;OASL;SYNCRIP;AQP4
prerank,pseudouridine synthesis (GO:0001522),0.5709265978349818,1.2068638084131882,0.262532981530343,0.7723053710268034,1.0,2/13,6.00%,PUS7;TRUB2
prerank,positive regulation of telomere maintenance (GO:0032206),0.5038943238405221,1.2068403998632995,0.22505800464037123,0.7715154283426228,1.0,7/31,13.54%,PRKCQ;RTEL1;ATRX;ATM;MAP3K4;DHX36;ERCC1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.5340093348049686,1.2058069440214874,0.2538265306122449,0.7745473235011083,1.0,3/20,5.29%,TFAP4;HEXIM1;PTEN
prerank,protein-containing complex subunit organization (GO:0043933),0.44374530492529607,1.2055603121494445,0.15885947046843177,0.7745674905490214,1.0,11/109,5.13%,CD3E;IL2RB;CD247;CD3G;TRAF1;CD74;TFAP4;JCHAIN;WAS;PARD3;PPIH
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6179987514651988,1.2055271396031904,0.2591508052708638,0.7738194664053442,1.0,4/10,15.42%,GATA3;RARA;SPHK2;IRF4
prerank,synaptic vesicle recycling (GO:0036465),-0.3427991050410359,-1.2053773828111576,0.13636363636363635,0.8070466498451058,1.0,12/31,19.88%,OPHN1;FCHO2;SYT2;PLD2;CDK5;TBC1D24;AMPH;RAB5A;RAB3A;PACSIN1;SYNJ1;SYT8
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4364742557494622,1.2053171181737183,0.099,0.7737377346007168,1.0,58/186,23.08%,CCDC88C;SFRP5;PSMC3;LMBR1L;TLE4;BICC1;PSMD8;APOE;DKK3;RACK1;PFDN5;PSME1;FRMD8;PSMD6;MDK;HDAC1;PSMB5;RBMS3;CSNK1A1;NLK;GREM1;FZD6;CAV1;PSMC6;TMEM64;GLI3;AMFR;PSMB4;IGFBP2;TMEM170B;DACT3;PSMA7;LIMD1;ZNRF3;PSMB9;PSMA6;STK4;JADE1;WWTR1;PSMC1;CUL3;PSMD7;PSMD2;GSK3A;PSMD5;MLLT3;SNAI2;SOX9;LRP4;STK11;PSMB6;GSK3B;TRABD2B;SOX13;PSMA3;TLE3;IGFBP4;DDIT3
prerank,vascular transport (GO:0010232),0.4501309981853151,1.2047102955040456,0.16873706004140787,0.7752611272883988,1.0,25/81,18.40%,SLC5A1;SLC22A3;SLC28A2;SLC16A1;SLC13A3;ATP2B4;ATP2A3;SLCO3A1;MFSD2A;SLCO1C1;SLC7A1;ATP1A4;SLC1A5;SLC27A1;ATP1A2;ABCC1;SLC7A5;SLC2A1;ABCA2;SLC2A13;AGER;SLC6A17;ATP1B2;SLC38A1;SLC19A1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.47684824173585105,1.204692758518754,0.20662983425414364,0.7744484375483499,1.0,9/44,12.14%,PTPN22;SMPD1;PDCD4;PAQR3;APOE;SPRY1;BMP4;SPRY3;SORL1
prerank,toxin transport (GO:1901998),0.6031459261799306,1.2046679778166813,0.26173541963015645,0.7736825670367856,1.0,4/10,25.57%,SLC22A3;ANTXR1;ANTXR2;RAB29
prerank,response to acidic pH (GO:0010447),-0.45491386797069144,-1.204380594054433,0.2422145328719723,0.8055137683859055,1.0,3/13,2.07%,LGMN;CTSS;RAB11FIP5
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5445186464401182,1.2041023940662718,0.25,0.7749178006656534,1.0,7/19,17.93%,F2R;BMP4;VIM;SUCO;TGFB3;EMILIN1;HDAC2
prerank,Rho protein signal transduction (GO:0007266),0.47034914999454414,1.2039172244990997,0.20604099244875945,0.7747904114188845,1.0,14/53,14.06%,RTKN;ARHGEF3;ARHGDIB;WAS;COL1A2;CDH13;RHOJ;CELSR1;PDPN;CDC42;CFL1;ROCK1;RHOU;GNA13
prerank,response to interleukin-1 (GO:0070555),0.4556501106351632,1.2039090480875163,0.18017057569296374,0.7739438130870708,1.0,7/73,6.74%,ANXA1;MAPK13;CCL5;CCL7;SMPD1;GBP2;CD47
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.43037383727205103,-1.2035337953861331,0.2236842105263158,0.8035835609147314,1.0,5/15,15.79%,BMP2K;PIK3CB;SNAP91;DGKD;HIP1R
prerank,positive regulation of apoptotic process (GO:0043065),0.4363805806494699,1.2035006699154047,0.045,0.7746327662533379,1.0,65/293,14.15%,RPS27A;SCIN;HRG;GZMA;DLC1;TFPT;IFIT2;TFAP4;ARHGEF3;KALRN;SMPD1;RARG;ARHGEF18;RPS6;CLU;MELK;HMGB1;UBA52;ING3;DAPK3;BID;RACK1;PAWR;ITGB1;ATM;RPS3;GADD45A;ARHGEF19;BARD1;TPD52L1;CSRNP3;PLEKHG2;ING5;TGFB2;DUSP6;BMP4;TNFSF10;PTPA;IAPP;STK17B;SPHK2;GPLD1;ADAMTSL4;CCAR2;SOS2;CTNNB1;APAF1;UTP11;PRNP;ARHGEF12;UBB;FOXO1;ATF4;AKAP13;EPHA7;BCL6;UBE2Z;TGFB3;STK4;GRN;CTLA4;SIRT1;GNA13;BCL2L11;RIPK1
prerank,cell junction assembly (GO:0034329),0.45444175706680096,1.203052586848767,0.15583075335397317,0.7755583438315072,1.0,23/100,13.72%,PKP1;LIMS2;ACTG1;FLNA;ACTB;PKP4;FERMT2;PTEN;GJC1;CDH1;DSCAM;CDH20;CDH19;CDH7;PCDHB11;DNM3;SHANK2;CDC42;KIRREL3;ILK;GPM6A;CDH5;PCDHB16
prerank,protein localization to cell-cell junction (GO:0150105),0.5708907018481189,1.2029246989304758,0.2585301837270341,0.7752141223870925,1.0,5/15,12.78%,ACTG1;ACTB;ARHGEF18;MPP7;CDH5
prerank,negative regulation of immune system process (GO:0002683),0.5611963884248963,1.2027027649675737,0.2695883134130146,0.7752522360056023,1.0,5/16,12.67%,HOXA7;SPINK5;IL17D;PDCD1;COL3A1
prerank,regulation of lymphocyte migration (GO:2000401),0.6096401432999368,1.2026901149019595,0.26905829596412556,0.7744221241560306,1.0,2/10,7.16%,SPN;MSN
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.48493737188697983,1.2026524204249418,0.2264367816091954,0.773702963178827,1.0,11/35,20.91%,SCD5;ALOX5AP;ACAT1;BDH1;FASN;ACACA;SCD;SLC25A1;GCDH;GGTA1;AWAT2
prerank,positive regulation of cell motility (GO:2000147),0.4349793184730134,1.2024782622766874,0.071,0.7735224759771765,1.0,46/205,16.87%,LEF1;FAM110C;MMP9;CCL5;CCL7;ACTG1;PECAM1;F2R;FAM89B;TRIP6;FERMT2;FAM83H;SEMA5A;CEMIP;KDR;RACK1;ITGB1;ATM;MDK;HSPA5;PLAU;CDH13;KIT;CXCL16;CAV1;PDPN;BCAR1;GCNT2;RHOC;COL1A1;EPHB2;CDH5;GRN;F10;ITGAX;CTSH;SDCBP;SEMA3E;SOD2;CARMIL2;PAK1;IGF1R;TIAM1;PDGFD;NEDD9;LAMB1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5769286597368237,1.202473661848789,0.252387448840382,0.7726781975328725,1.0,5/13,14.99%,CLU;NR1H2;AQP11;MANF;EIF2AK3
prerank,myeloid cell development (GO:0061515),-0.41507153217518833,-1.201644860081046,0.2018348623853211,0.8045955949317932,1.0,9/18,22.40%,NCKAP1L;SH2B3;ANXA2;TLR2;ABCB10;APP;MED1;LYAR;SRC
prerank,B cell receptor signaling pathway (GO:0050853),0.5035272383966191,1.201532930762272,0.24482758620689654,0.7754126821778602,1.0,9/32,15.46%,LCK;ITK;BCL2;CD79B;BCAR1;CD79A;CTLA4;MS4A1;BLK
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5675252178516746,1.201498321027507,0.27417218543046357,0.7747000567276766,1.0,6/14,14.11%,AUTS2;MYB;DNMT1;CTNNB1;CTR9;WDR5
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5650865773058741,1.2010430355276924,0.26766304347826086,0.7755443291068028,1.0,3/14,14.13%,DNAJB9;HSPA5;BCL2L11
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.45811130314146015,1.1998697178391815,0.20798319327731093,0.7792981665393416,1.0,20/70,16.22%,TCF15;GATA3;PUS7;PSMC3;PSMD8;MYB;PSME1;PSMD6;METTL3;PSMB5;SETD1A;PSMC6;TCF12;PSMB4;PSMA7;PSMB9;PSMA6;PSMC1;PSMD7;PSMD2
prerank,metal ion transport (GO:0030001),0.4507987552082518,1.1997557749573795,0.16821465428276575,0.7788398485772584,1.0,23/86,17.17%,TPT1;CCL5;KCNN4;NIPAL1;CACNG7;SLC3A2;NIPAL2;ATP2A3;RAMP1;NIPAL3;MAGT1;GRIN3A;CAV1;SLC30A9;ITPR1;TRPC5;PANX1;CACNA2D1;TRPC4;TUSC3;FYN;TRPC1;ATP2B2
prerank,positive regulation of double-strand break repair (GO:2000781),-0.336555171716263,-1.1994130516238837,0.08333333333333333,0.806803496171082,1.0,20/39,26.34%,MMS19;SHLD1;PARP1;SLF2;SHLD2;KMT5B;PRKDC;ZCWPW1;PNKP;WRAP53;MRNIP;ARID2;DTX3L;SPIRE1;FMN2;RAD51AP1;SETMAR;SLF1;FANCB;MGMT
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5833610046473492,1.1991221529287603,0.2596026490066225,0.7804986713288369,1.0,7/12,27.89%,TRIM16;ASXL1;KLF2;CYP26B1;EZH2;CALR;CNOT1
prerank,iron ion transport (GO:0006826),0.47331490000939846,1.198694900932591,0.2106430155210643,0.7812236657923248,1.0,14/47,19.74%,LTF;HEPH;ATP6V1G2;LMTK2;ABCB7;FTH1;SLC11A2;ATP6AP1;ATP6V0B;ATP6V0A2;IREB2;ATP6V0E1;ATP6V1F;ATP6V1G1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5915825340578114,1.1986754969008762,0.2783216783216783,0.780430078764939,1.0,2/10,8.85%,CAV1;ANK3
prerank,negative regulation of phosphorylation (GO:0042326),0.4461344797039416,1.1983880109897724,0.17659352142110762,0.7806455135491785,1.0,28/85,20.71%,FBLN1;CHP1;STAP1;NPRL2;PAQR3;PTPN13;PPIA;PTEN;CADM4;DYNLL1;BMP4;PPP1R15B;PRNP;ROCK1;MAPT;EPHB2;WWTR1;NCOR1;SIRT1;TARDBP;CDKN1A;CRKL;NIBAN1;NTRK3;HDAC4;ATG14;PRR5L;HNRNPU
prerank,copper ion homeostasis (GO:0055070),0.5472065508563951,1.1970975320837305,0.23876765083440307,0.7848224746192611,1.0,4/17,12.31%,ATP7A;ATOX1;PRNP;SLC31A2
prerank,cellular calcium ion homeostasis (GO:0006874),0.43775509548655855,1.1969062174743357,0.13723511604439959,0.7847517004588827,1.0,27/133,17.17%,TPT1;CCR2;CSRP3;CCL5;CCL7;BCL2;SLC24A4;ANXA6;RMDN3;ATP2B4;SMDT1;ATP2A3;STIM1;CALB1;CAV1;CLN3;TRPC5;CHERP;CDH5;TRPC4;NPTN;ATP13A1;PDZD8;SLC35G1;ATP2B3;TRPC1;ATP2B2
prerank,pulmonary valve morphogenesis (GO:0003184),0.5403877449876228,1.1965148338772027,0.26098191214470284,0.7853529293214769,1.0,6/17,16.79%,TGFB2;BMP4;HEY2;ROBO1;ROBO2;JAG1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.543040440687761,1.196225691220057,0.2516382699868938,0.7855849840286451,1.0,7/17,21.25%,BCL2;CLU;BID;SFN;SOD2;DNM1L;MFF
prerank,positive regulation of gene expression (GO:0010628),0.4262914023444095,1.1953883727794092,0.031,0.7881349323233784,1.0,105/442,17.97%,CD3E;MMP8;ITK;LEF1;PKP1;PTPN22;CD28;WNT6;PLA2R1;CD74;SERPINB9;ACTG1;STAP1;RPL11;ACTB;RPS7;ACTA2;ANGPT1;RPL23;ADAM19;TXK;CLU;YTHDF3;CLEC6A;TLR9;FUBP1;ATM;RPS3;ZBTB7B;METTL3;POLR1G;AMH;MIF;DNMT1;MAPK9;RBMS3;MSN;ELAVL4;ETS1;BMP4;IFNGR1;RPS4X;GSN;SPHK2;EEF2;ANK3;BMP6;HEY2;VIM;ID2;EIF4A3;CD36;DHX36;MED23;FAM98A;PDCL3;TAF1B;ZPR1;CPEB3;ROBO1;ROCK1;SMAD1;EPHB2;SNF8;SF3B1;ATF4;CDH5;POLR2F;NPM1;METTL14;SAMD4A;TENT4A;HSPA1A;UBR5;RIPK1;GAPDH;POLDIP3;FGF7;EIF3E;ITGAX;CTSH;WNT3;EZR;EIF2AK3;TICAM1;RPS6KB1;TREM2;WBP2;AGPAT2;GSK3A;NIBAN1;S100A13;DEK;BATF;RBM20;GLMN;SOX11;AGO2;IL33;BRAF;KAT2B;EMILIN1;CALCOCO1;LILRB1;NTRK3
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5491962497269254,1.1948527650488612,0.26718547341115434,0.789403370511743,1.0,6/16,17.93%,F2R;BMP4;VIM;SUCO;TGFB3;HDAC2
prerank,negative regulation of innate immune response (GO:0045824),0.490833801813939,1.1947954398887055,0.24022988505747125,0.7887441718480376,1.0,15/34,21.47%,YTHDF3;TRIM21;SERPING1;TTLL12;METTL3;MUL1;RPS19;USP18;GRN;SUSD4;USP15;SAMHD1;ACOD1;NLRC5;NLRC3
prerank,regulation of organelle organization (GO:0033043),0.45314307486239486,1.1946936266670103,0.18724279835390947,0.7882804369339519,1.0,14/80,14.91%,S100A8;S100A9;DIAPH1;PLXNB1;MSN;CLN3;LMAN1;MTM1;MAPT;MUL1;VPS11;PDE4DIP;SAR1B;EZR
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5483684562118872,1.1946604887025043,0.24129032258064517,0.7875455189467029,1.0,2/18,4.13%,CCR2;CACNG7
prerank,regulation of cell death (GO:0010941),0.4453748910129066,1.1946363191531952,0.1728395061728395,0.786787194192864,1.0,18/94,14.70%,SLC25A24;HP;HPR;CCL5;CHP1;CLU;FERMT2;GPR75;CCN2;BMP4;CTSZ;ATG5;CD36;NCK1;UBB;HSPA1A;TMEM109;DCC
prerank,regulation of necroptotic process (GO:0060544),0.5135815669630247,1.1945045092436137,0.23507462686567165,0.7864248959170548,1.0,10/23,20.98%,MLKL;FLOT2;PELI1;HSP90AA1;YBX3;RIPK1;SDCBP;SLC25A4;BIRC3;PDCD6IP
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5915521697699182,1.194165843221687,0.29760225669957685,0.786887078075299,1.0,3/10,22.72%,ATP7A;KYAT1;QDPR
prerank,regulation of protein secretion (GO:0050708),0.4395409358082588,1.1932387925629027,0.15720081135902636,0.7896832879455605,1.0,26/119,15.82%,GCK;P3H1;CCL5;ITPR3;RHBDF1;DPP4;UQCC2;PPIA;APOE;TGFB2;PER2;RAPGEF4;BMP6;ITPR1;SYT7;DPH3;HADH;TGFB3;SLC2A1;APBB3;RSAD2;EZR;DRD2;STXBP5L;TREM2;RFX3
prerank,regulation of B cell differentiation (GO:0045577),0.5488990655044408,1.1930410950506805,0.27963917525773196,0.789602729606844,1.0,4/17,10.44%,IKZF3;TLR9;ID2;ZFP36L2
prerank,determination of heart left/right asymmetry (GO:0061371),0.47770732105437863,1.192775197365655,0.2217343578485181,0.789784114868349,1.0,2/43,0.58%,TBX21;EOMES
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.41435363539497094,-1.1924201682480278,0.22943722943722944,0.8244995394970389,1.0,5/17,13.35%,ADCY9;ADRA1A;ADRA1B;ADRB1;ADRB2
prerank,reverse cholesterol transport (GO:0043691),0.5676322232217161,1.1923346105831722,0.2731034482758621,0.7906350228648868,1.0,2/13,5.19%,CLU;APOE
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.4024269656597992,-1.1920313619857272,0.2300469483568075,0.8210348054266021,1.0,5/19,11.09%,TGFBR1;MEF2C;FGF2;RUNX1;NOTCH1
prerank,neuron development (GO:0048666),0.43811659502138933,1.1919201968073565,0.12474849094567404,0.7913513244739317,1.0,37/141,16.08%,PPP1R9B;RUNX3;FRYL;BLOC1S3;PBX1;ATP7A;NEDD4;MICALL2;HMGB1;GPM6B;UGCG;APOE;DCX;TENM2;UGDH;GPRIN3;TGFB2;CNTNAP2;TBC1D23;ARL3;TMEM108;BICDL1;LGI1;RAB11A;LGI4;BTG2;ROCK1;MAPT;GPM6A;FRY;MANF;EPHA5;MICALL1;MYT1L;BLK;AGER;STMN2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.584522258315238,1.1919131989182468,0.2872777017783858,0.7896688970253156,1.0,5/12,21.94%,CHP1;ATP2B4;PRNP;GSK3B;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.584522258315238,1.1919131989182468,0.2872777017783858,0.7896688970253156,1.0,5/12,21.94%,CHP1;ATP2B4;PRNP;GSK3B;DYRK2
prerank,cellular response to reactive oxygen species (GO:0034614),0.4579595217761417,1.1918527752404056,0.20021299254526093,0.7890520362841774,1.0,7/59,6.86%,ANXA1;MAPK13;MMP9;PRDX5;NCF1;RPS3;MAPK9
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.48468372983195507,1.1918435055033683,0.23103057757644394,0.7882441432281135,1.0,10/38,15.65%,ATRX;RBBP7;CENPH;ASF1B;KNL1;NASP;UBN1;NPM1;CABIN1;RUVBL1
prerank,actin filament organization (GO:0007015),0.4378952586005327,1.1917099679236272,0.12562814070351758,0.7878985309652754,1.0,27/151,12.82%,PPP1R9B;SCIN;POF1B;TPM2;FLNA;FAT1;WAS;MARCKSL1;ALDOA;NEBL;RFLNA;ACTN1;MYO1G;BIN3;PLS1;LCP1;CLRN1;GSN;RAC2;BCAR1;TMOD2;CDC42;RHOC;DSTN;RFLNB;HIP1;TPM4
prerank,apoptotic cell clearance (GO:0043277),0.4884073188793017,1.1916482031493325,0.232,0.7872866486693864,1.0,7/30,15.53%,ANXA1;ADGRB1;HMGB1;RARA;RAC2;XKR4;TREM2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.5111779891632027,1.191487170740867,0.22976190476190475,0.7870724278344011,1.0,12/25,24.01%,DNAJB1;HSPA8;HSPA5;SDF2L1;HSPA1A;GAK;ST13;PTGES3;BAG1;SDF2;DNAJB14;DNAJC7
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.6016522360471133,1.1914204152430081,0.26368876080691644,0.7864595419393035,1.0,2/10,2.96%,KLRC1;CEACAM1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.47193857007958717,1.190997408349774,0.22442244224422442,0.7871541612882611,1.0,10/47,14.95%,MMP8;FPR2;CYBA;ADGRB1;GADD45A;CD36;DCXR;MAPT;RIPK1;CDKN1A
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.49000144411211655,1.1909501596560819,0.23556058890147225,0.7864891169777082,1.0,7/34,13.03%,ANXA1;KDR;MT1G;PRKD2;NR4A1;EGR3;MAPKAPK2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4227520947520608,-1.1908955572527211,0.23580786026200873,0.8203283957057095,1.0,3/16,3.28%,SLC8A1;CALM2;ANK2
prerank,negative regulation of receptor binding (GO:1900121),0.6087017877035145,1.1908893037354382,0.29292929292929293,0.7858884291541819,1.0,2/10,6.66%,B2M;ATP2A3
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4066215559605448,-1.1906222367049275,0.211864406779661,0.8165833406720641,1.0,3/17,2.42%,PID1;FLCN;PARP1
prerank,embryonic digestive tract development (GO:0048566),0.5445993589670621,1.190612009999704,0.2558139534883721,0.7861573756313939,1.0,7/18,17.28%,NIPBL;TGFB2;RARRES2;ID2;GLI3;PKDCC;SOX11
prerank,positive regulation of B cell proliferation (GO:0030890),0.49967124599723794,1.1901790475623217,0.259478672985782,0.7870121839200468,1.0,14/29,22.64%,CD74;BCL2;TLR9;MIF;SASH3;EPHB2;CLCF1;TNFRSF13C;TIRAP;CD320;PTPRC;GPR183;VAV3;TFRC
prerank,platelet aggregation (GO:0070527),0.4897162318061805,1.1896871398095454,0.2224744608399546,0.7880799254887519,1.0,8/33,11.25%,MYL9;ACTG1;FLNA;ACTB;PPIA;ACTN1;MYL12A;ILK
prerank,cell proliferation in forebrain (GO:0021846),-0.48217618185673083,-1.189566513681891,0.2635135135135135,0.8152912547531739,1.0,3/10,13.98%,NUMB;CEP120;NUMBL
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.4000000085305308,-1.18913880996472,0.22380952380952382,0.8122141023558188,1.0,6/19,17.77%,CX3CR1;NLRP3;TNFAIP3;ZC3H12A;GIT1;PYDC1
prerank,cellular response to dsRNA (GO:0071359),0.5561781578720784,1.1890810971945538,0.2657718120805369,0.7896286142554297,1.0,7/15,18.17%,COLEC12;CAV1;MUL1;NPM1;RALB;RIOK3;CGAS
prerank,protein destabilization (GO:0031648),0.49783904675995383,1.1882541001157674,0.2675233644859813,0.7919930180909663,1.0,13/32,21.72%,CCDC88C;PEX2;TRIM21;GSN;PRNP;MUL1;SIRT1;CTSH;CUL3;DERL1;CDC73;SNCA;BTRC
prerank,regulation of biosynthetic process (GO:0009889),0.5830106960665775,1.1879402613736518,0.3032440056417489,0.7923472832029093,1.0,5/11,25.62%,SPHK2;MID1IP1;SLC25A33;SNCA;PIKFYVE
prerank,cholesterol efflux (GO:0033344),0.5258737442245722,1.1877817076677761,0.25818639798488663,0.7921100681782155,1.0,5/20,12.55%,ABCG4;APOC1;APOE;SOAT1;ABCA7
prerank,histone H3-K4 trimethylation (GO:0080182),0.5851451267917496,1.186978983148956,0.2818696883852691,0.7943997773715795,1.0,7/11,27.47%,SETD1A;CTR9;PRDM9;KMT2A;TET2;KMT2D;OGT
prerank,cellular response to inorganic substance (GO:0071241),0.5279624444510433,1.1867361928116493,0.26632522407170295,0.7945168914454459,1.0,10/21,26.21%,ATRX;ADCY10;CDK2;FOXO1;BLM;DDX11;MTR;TIMELESS;GUCY1B1;KCNC2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5062738464229378,1.1866622632309138,0.25853658536585367,0.7939668221218058,1.0,9/24,23.39%,GCK;SORBS1;IRS1;EPM2AIP1;GSK3A;SELENOS;GSK3B;DYRK2;INSR
prerank,receptor internalization (GO:0031623),0.4729855297303552,1.1858729149872955,0.2303370786516854,0.7961502955102131,1.0,9/44,9.75%,CXCR2;NEDD4;CEACAM1;SAG;ITGB1;RAMP1;DNM3;CAV1;CD36
prerank,retinoid metabolic process (GO:0001523),0.45197803857746444,1.1857582957657087,0.21711899791231734,0.7957660417243466,1.0,15/71,21.39%,ABCA4;DHRS9;APOE;HSPG2;SDC2;RARRES2;NAPEPLD;GPC6;RDH12;SCPEP1;GPC3;CYP26B1;AKR1B10;AWAT2;RBP4
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.47782098859817274,-1.1856264816922157,0.2664359861591695,0.8194050563722961,1.0,3/10,6.57%,DIP2B;FLCN;PRKAA2
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5456249253642359,1.1852892060584392,0.2886866059817945,0.7967195996479149,1.0,6/16,14.11%,AUTS2;MYB;DNMT1;CTNNB1;CTR9;WDR5
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.46898307959705215,1.1852309869238837,0.23736263736263735,0.7960760052692315,1.0,11/42,19.13%,RPS27A;UBA52;RFC4;POLE;RFC5;UBB;POLK;SIRT1;PCNA;PARP10;POLD4
prerank,sodium ion import across plasma membrane (GO:0098719),-0.41040143411565005,-1.1851138345350585,0.23214285714285715,0.8166405187399589,1.0,5/17,8.16%,SLC8A1;SLC9A9;SLC9A6;TRPM4;HCN2
prerank,histone H2B ubiquitination (GO:0033523),0.6071636874088163,1.1850512910805606,0.2973352033660589,0.7958777952563317,1.0,6/10,26.52%,PAF1;LEO1;CTR9;CDC73;RNF20;RNF40
prerank,cellular sodium ion homeostasis (GO:0006883),0.5514581216931563,1.184804510011644,0.27873183619550856,0.7959893396806312,1.0,6/15,17.01%,ATP1B3;ATP1A3;ATP1A4;ATP1A1;ATP1A2;ATP1B2
prerank,negative regulation of immune response (GO:0050777),0.4325642784467044,1.1847280932825968,0.13640922768304914,0.7954585360729346,1.0,34/154,18.46%,CD247;CCR2;CD3G;GPR83;ADORA2A;SPINK5;HTR7;GPR45;TRIM21;PTGIR;PRKAR1B;PDCD1;MC5R;RAMP1;HTR4;GPR84;IAPP;INSL3;TSHR;ADCY6;GPR176;MUL1;COL3A1;LGALS3;PRKAR1A;FYN;TREM2;ADCY1;ADCYAP1R1;LILRB1;MAPKBP1;ACOD1;GIPR;VIPR1
prerank,heart looping (GO:0001947),0.4790715710113985,1.1845002654161387,0.23273942093541203,0.7954834366255992,1.0,2/40,0.58%,TBX21;EOMES
prerank,small GTPase mediated signal transduction (GO:0007264),0.442449179994795,1.1844183854503143,0.17820773930753564,0.794969960638521,1.0,29/103,18.99%,GRAP2;CCDC88C;RASGRP1;CHP1;ARHGEF18;RASGRP2;RRAD;BRAP;MRAS;DNMT1;ARL3;RAPGEF6;CDK2;GRAP;ARHGAP32;G3BP2;KSR1;RALB;ARHGAP33;SHC1;CDKN1A;CRKL;RHEB;TIAM1;USP28;CCDC88A;ARHGAP30;RALA;USP50
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.32267259236619583,-1.1843796163280835,0.18248175182481752,0.8143813339595408,1.0,10/35,11.66%,NCKAP1L;LYN;ACVR1B;FOXO3;MAFB;PRKDC;LDB1;TAL1;SPI1;ABCB10
prerank,endocrine system development (GO:0035270),0.5194041165146371,1.1838970369731623,0.2627118644067797,0.7960917233340001,1.0,3/21,6.04%,SOX3;DKK3;MDK
prerank,calcium ion homeostasis (GO:0055074),0.4466523025037038,1.183801043332616,0.19175257731958764,0.7956256259786937,1.0,17/95,15.57%,TPT1;CCR2;CSRP3;CCL5;CCL7;SLC24A4;RMDN3;ATP2B4;ATP2A3;STIM1;CAV1;FAM20A;CHERP;CDH5;NPTN;ATP13A1;ATP2B3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.4725129737306258,1.1836821512879045,0.24242424242424243,0.7952522019938388,1.0,14/39,20.15%,RPS27A;UBA52;ERCC4;RFC4;GTF2H5;RFC5;UBB;ERCC1;POLK;PCNA;ERCC5;DDB2;POLD4;DDB1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5573837538983742,1.1835895863397952,0.28083989501312334,0.7948025325992923,1.0,5/15,10.31%,PIEZO2;KIT;SCN1A;MKKS;KCNA1
prerank,negative regulation of cellular process (GO:0048523),0.42536283574885925,1.1834541135147412,0.027,0.7944681844282444,1.0,121/521,19.52%,PPP1R9B;SPN;RIPOR2;SCIN;HRG;IRF6;GTPBP4;GATA3;P3H1;DLC1;COL18A1;IFITM1;SFRP5;FBLN1;SOX7;IGFBP7;RUNX3;ADGRB1;TFAP4;ARHGDIB;BCL2;CHD5;RARG;F2R;ANGPT1;NCK2;SP100;CLU;CDK6;S100A11;FERMT2;PDCD4;RAF1;ANXA6;RBBP7;LMNA;SEMA5A;FABP7;FBXO5;RACK1;PTEN;PLXNB1;ACTN1;ANP32B;DSCAM;MDK;TMEM98;MIF;SIPA1;CDH13;NR1H2;ING5;TGFB2;CCN2;PPP2R1A;FTH1;ETS1;BMP4;AQP11;SPHK2;MALSU1;PDPN;PLXNA2;NME1;MNT;NR4A1;JAK2;PDS5B;GPLD1;ATG5;CHERP;CCAR2;NCK1;CTNNB1;BTG2;DACT3;EPHB2;TGFBR3;MUL1;DNAJB2;VHL;BLM;BCL6;TGFB3;NPM1;JADE1;HSPA1A;PPP2CA;SIRT1;SERTAD2;TAF6;SMYD5;TMEM109;CDKN1A;EIF2AK3;ABI1;DRD2;SOD2;TREM2;MIA3;SINHCAF;CRYAB;PPP1R13B;GLMN;SOX11;ING1;KAT2B;EMILIN1;DLG3;LILRB1;ORC6;NME6;RBM5;PBRM1;FKTN;CDC73;SLIT3;BNIP3;COPS8;KLF11;IP6K2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5802972698769298,1.1830964931578565,0.286493860845839,0.7949894148224879,1.0,5/12,20.29%,FADS1;ELOVL1;ACSL1;ACOT8;HSD17B4
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.45469086939944925,-1.1829417947051495,0.2640845070422535,0.8145312230802264,1.0,5/11,14.01%,GTF2H2;ARRB2;ARRB1;ADRB2;GRK2
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.4378573097711053,-1.1827264367377257,0.259927797833935,0.8108426966982922,1.0,6/13,17.97%,LARGE1;CHST1;NAGK;CHST7;CHST3;RENBP
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4468813854121999,1.182680215797862,0.2098635886673662,0.7957990619163665,1.0,13/75,12.64%,CCR2;HRG;ANGPT4;ADGRB1;DCN;SPINK5;HSPG2;ATP2B4;TGFB2;CXCL10;CTNNB1;ROCK1;NAXE
prerank,negative regulation of GTPase activity (GO:0034260),-0.3721794498208527,-1.1823662922190885,0.2048780487804878,0.8075723133156834,1.0,7/22,7.18%,LRCH1;F11R;WNK1;RASA4;LRRK2;GPSM1;GMIP
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.46878235940730234,1.18219090226535,0.22333333333333333,0.7968278098593857,1.0,14/47,18.39%,RASGRP1;SCIMP;PPIA;TGFB2;GREM1;TAOK3;TGFBR3;FOXO1;RAP2A;ARL6IP5;AGER;IGF1R;PHLPP1;PER1
prerank,glycine transport (GO:0015816),0.5990092282390433,1.1820874663772136,0.2791023842917251,0.7963757347645471,1.0,1/10,1.05%,SLC36A3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5109377123194301,1.1820322931382932,0.26452410383189123,0.7957642665672129,1.0,7/25,21.25%,MMP9;BID;TNFSF10;BCL2L11;BNIP3;DNM1L;MFF
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4375975607807491,1.182008011996909,0.1835897435897436,0.7950393691755505,1.0,20/98,12.08%,GATA3;CCL5;ANGPT1;STARD4;APOC1;CD63;APOE;CHCHD2;GADD45A;UHRF1;NR1H2;CDK1;LIPT2;GREM1;SLCO1C1;FASN;NSF;DCXR;NFKBIA;ACACA
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.44501344572643253,1.1818591418532012,0.2238648363252376,0.794808367324281,1.0,19/71,17.52%,CTSW;RPS27A;GZMB;GZMA;UBA52;LONP1;MALT1;CLPP;CTSZ;UBB;PSMA6;RSPRY1;CTSH;CHFR;ZER1;FBXL17;FAP;SOCS6;CTSC
prerank,stem cell development (GO:0048864),0.5559131547956109,1.1812250866643776,0.2898172323759791,0.7964587415386878,1.0,5/16,19.53%,NRG1;KBTBD8;SOX11;PTPRC;SNAI2
prerank,regulation of fibroblast proliferation (GO:0048145),0.4674981971170192,1.18083123033154,0.23535791757049893,0.7971342875721918,1.0,8/45,10.71%,S100A6;CD74;DDR2;PEX2;CDK6;MIF;FTH1;CTNNB1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5379604646466737,1.1807372553094833,0.2681992337164751,0.7966898484247329,1.0,2/16,10.93%,CILP;IGFBP2
prerank,regulation of cell growth (GO:0001558),0.42902792711592747,1.1805545904476282,0.10721442885771543,0.7965886505826609,1.0,35/204,14.95%,S100A8;S100A9;PPP1R9B;HRG;PRKCQ;BCL2;EXOSC4;CEACAM1;RASGRP2;RBBP7;RACK1;SIPA1;TGFB2;PPP2R1A;MFSD2A;DCUN1D5;CXCL16;SPHK2;PAK4;BCAR1;AKAP6;LGI1;CDC42;CCAR2;DACT3;MUL1;DNAJB2;BCL6;JADE1;HSPA1A;PPP2CA;SIRT1;SERTAD2;SDCBP;CDKN1A
prerank,telomere capping (GO:0016233),-0.39923215046436583,-1.1802599033058976,0.24423963133640553,0.8096209607012869,1.0,5/16,12.50%,DCLRE1C;PRKDC;TEN1;DCLRE1A;MRE11
prerank,regulation of macrophage cytokine production (GO:0010935),0.5658597838569904,1.1801875044134165,0.28112449799196787,0.7972157568248869,1.0,6/13,17.78%,CD74;LAPTM5;TGFB2;TGFB3;SIRT1;LILRB1
prerank,regulation of cell projection organization (GO:0031344),0.5648496732140745,1.179861619501772,0.27309236947791166,0.7976353683556081,1.0,5/13,15.53%,FAM110C;MFSD2A;NTNG1;NTNG2;TREM2
prerank,zymogen activation (GO:0031638),0.4780817641884762,1.1795331039027221,0.2519422863485017,0.798011072481704,1.0,6/39,6.49%,HP;HPR;CD5L;CYFIP2;KLK1;PLAU
prerank,positive regulation of vacuole organization (GO:0044090),-0.4712316769920156,-1.1794683140612696,0.2711267605633803,0.8078504508439478,1.0,3/10,6.71%,PIP4K2A;SH3GLB1;ANXA2
prerank,keratan sulfate metabolic process (GO:0042339),0.49458858315607607,1.1793330736028413,0.25443786982248523,0.7979468099377001,1.0,7/31,10.59%,B3GNT3;LUM;SLC35D2;FMOD;OGN;ST3GAL1;B4GALT3
prerank,amino sugar biosynthetic process (GO:0046349),-0.45787539885901973,-1.1789486699058658,0.27715355805243447,0.8049547136946291,1.0,3/12,5.49%,UAP1;NAGK;AMDHD2
prerank,positive regulation of vasculogenesis (GO:2001214),0.593442819401184,1.1785118899333646,0.2811594202898551,0.8001336560491097,1.0,2/10,4.54%,CEACAM1;KDR
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5577870515253588,1.178386844459619,0.27900552486187846,0.7997720857742286,1.0,4/14,16.66%,TMSB4X;G3BP2;NFKBIA;KEAP1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.44007953218004114,1.1783419894618563,0.1873706004140787,0.7991030348636937,1.0,20/86,15.53%,HRG;ANGPT4;GHR;CD74;PECAM1;ANGPT1;CLEC6A;VTN;CADM4;MIF;CD44;BMP6;JAK2;PDCL3;PRNP;EPHA7;FGF7;TNFRSF14;FYN;TREM2
prerank,regulation of trophoblast cell migration (GO:1901163),0.5534948055260208,1.1781937897290897,0.2931726907630522,0.7988227889557978,1.0,8/14,26.95%,ARHGDIB;YTHDF3;TIMP1;AGO2;SMURF2;ACVR1C;CALR;GJA1
prerank,positive regulation of cell differentiation (GO:0045597),0.42572064530911097,1.1781863736454044,0.105,0.7980267303095062,1.0,50/237,14.64%,FOXN1;LTF;LEF1;RIPOR2;TCF15;IFITM1;GLIPR2;BRINP2;DDR2;CEACAM1;HOXB4;FERMT2;ADIG;KDR;FBXO5;SMAD2;MDK;SOX5;MAPK9;LMO3;TGFB2;CCN2;CREBL2;BMP4;RARRES2;PDPN;BRINP3;BMP6;ID2;ATP6AP1;GCNT2;TMEM64;CD36;CDC42;DHX36;ZBTB16;SUCO;NUDT21;CTNNB1;NBL1;IL6ST;SYAP1;COL1A1;VHL;CDON;TGFB3;WWTR1;GDF3;SDCBP;KITLG
prerank,negative regulation of secretion by cell (GO:1903531),0.4758174127499274,1.178036603362544,0.26853932584269663,0.79780310323615,1.0,9/38,17.78%,ANXA1;RHBDF1;SYT4;APOE;DPH3;RSAD2;DRD2;PNKD;LILRB1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.5846847978920039,1.1779031858170286,0.2808988764044944,0.7975230132877903,1.0,5/10,22.74%,CBARP;DRD2;CALM1;GPR35;CALM3
prerank,maintenance of protein location in nucleus (GO:0051457),0.5254531774860417,1.1771912352327647,0.2779187817258883,0.7994042533946987,1.0,5/20,8.63%,SP100;ARL2;BARD1;SYNE1;ARL2BP
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.4796917979018541,-1.1767234896435583,0.2714285714285714,0.8078504508439478,1.0,3/11,5.49%,UAP1;NAGK;AMDHD2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4524653225530903,1.1765356680120258,0.23223753976670203,0.8011163139448704,1.0,14/59,13.89%,EMB;PECAM1;NECTIN1;CEACAM1;AMIGO1;CDH1;ITGB1;DSCAM;CDH13;BSG;KIRREL3;ROBO1;ROBO2;NPTN
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4938600669998607,1.1762635208777081,0.2632183908045977,0.8012684189889177,1.0,7/32,12.95%,PRKCQ;CCT8;CCT2;ATM;MAP3K4;CTNNB1;HMBOX1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.4933168191638248,-1.1758819364983435,0.28052805280528054,0.8062580403005478,1.0,3/10,26.54%,BDNF;RAPGEF1;KIDINS220
prerank,regulation of phosphorylation (GO:0042325),0.43144545885895275,1.1755166038117184,0.1918781725888325,0.8033486299606472,1.0,28/120,15.81%,CCDC88C;CD24;GCK;CCL5;STAP1;MCM7;CADM4;DSCAM;MIF;BARD1;NUP50;DYNLL1;BMP4;PIN1;BTBD10;NOP53;NUP214;NUP210;ILK;ROCK1;NUP88;RANBP2;CDH5;PPP2CA;SIRT1;SDCBP;CDKN1A;AAAS
prerank,positive regulation of cell migration (GO:0030335),0.42550210536569366,1.1747810270975068,0.08008008008008008,0.8052789868443359,1.0,68/253,19.83%,LEF1;CCR2;FAM110C;MMP9;CCL5;CCL7;GLIPR2;ACTG1;DDR2;PECAM1;F2R;FAM89B;DOCK5;TRIP6;S100A11;FERMT2;FAM83H;SEMA5A;CEMIP;KDR;VTN;FBXO5;RACK1;ITGB1;ATM;MDK;HSPA5;NIPBL;PLAU;CDH13;KIT;TGFB2;INSL3;CXCL16;CAV1;PDPN;BCAR1;GCNT2;RAB11A;RHOC;COL1A1;EPHB2;CDH5;GRN;F10;ITGAX;CTSH;SDCBP;SEMA3E;CRKL;SOD2;CARMIL2;PAK1;IGF1R;TIAM1;PDGFD;MIA3;NEDD9;LAMB1;AGO2;SMURF2;NTRK3;CEP43;PTPRC;SEMA5B;SNAI2;SEMA3D;SOX9
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.4243764986556705,1.1747772688707039,0.098,0.8044707162323244,1.0,83/248,23.08%,CCDC88C;SFRP5;SOX7;PSMC3;LMBR1L;TLE4;BICC1;SEMA5A;PSMD8;DAPK3;APOE;DKK3;PFDN5;PSME1;FRMD8;PSMD6;MDK;HDAC1;GSKIP;PSMB5;RBMS3;CSNK1A1;PIN1;GREM1;FZD6;CAV1;PSMC6;CSNK1G1;SCEL;TMEM64;GLI3;AMFR;CCAR2;PSMB4;LGR4;CTNNB1;IGFBP2;ILK;COL1A1;TMEM170B;DACT3;PSMA7;LIMD1;ZNRF3;PSMB9;PSMA6;USP34;CCNY;STK4;JADE1;WWTR1;UBR5;PSMC1;UBE2B;GPC3;CUL3;RUVBL1;PSMD7;PSMD2;GSK3A;GNAQ;SMURF2;JUP;CSNK1G3;PSMD5;MLLT3;SNAI2;SOX9;LRP4;STK11;PSMB6;GSK3B;PPP1CA;ATP6AP2;RNF220;BTRC;CTNND2;SOX13;TBL1XR1;PSMA3;TLE3;IGFBP4;DDIT3
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5564890419935196,1.1746961703683712,0.2707774798927614,0.8039840059023821,1.0,5/14,16.49%,UQCC2;TRUB2;RPUSD4;FASTKD3;MRPS27
prerank,central nervous system myelination (GO:0022010),0.5746740921831145,1.17443117225066,0.3155680224403927,0.8042019959816574,1.0,5/11,20.22%,CLU;PTEN;ABCA2;SOX10;TENM4
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.52858714150444,1.1743944534879933,0.2890625,0.8035241759076139,1.0,8/19,12.55%,CLU;APOE;FLOT2;PIN1;PRNP;ROCK1;SORL1;ABCA7
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.45013692466977984,-1.1743853818013468,0.24806201550387597,0.8069075500609573,1.0,4/13,4.92%,ATG10;UBA7;UBA2;ATG7
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5935725421030935,1.1738722527227239,0.2871287128712871,0.8045923819693316,1.0,4/10,13.71%,DNAJB1;NCK1;VHL;HSPA1A
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5218455289194757,1.1737549760624706,0.2950423216444982,0.8042070246741423,1.0,6/20,12.48%,CDK6;PAF1;LEO1;ZBTB16;MEIS2;CTR9
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5548694841574792,1.1737237280530874,0.296448087431694,0.8034991219503306,1.0,5/13,19.04%,TLR9;KDR;JAK2;IL33;SELENOS
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4392639245506533,1.1736739001280774,0.21703011422637591,0.8028909515280056,1.0,9/76,5.60%,MMP8;TMSB4X;PTPN22;TRIP6;PDCD4;HDAC7;TLR9;LAPTM5;RPS3
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.5346662950685419,1.173639573213701,0.29880478087649404,0.8022238820261384,1.0,7/18,18.37%,RPS27A;UBA52;RNF103;AMFR;UBB;UGGT1;OS9
prerank,protein localization to organelle (GO:0033365),0.42921305228103,1.1733383175587349,0.1691842900302115,0.8025882653388952,1.0,43/133,23.32%,TTC21A;CSRP3;TRAM1L1;RPL11;GET1;TSPAN17;SEC61B;FAM83H;PPP1R15A;PAQR3;LMNA;CTDNEP1;GBP2;PAF1;DCP1A;BMP4;COG7;ARL3;RAB11A;PRNP;COL1A1;WDR35;SORL1;ABCA7;DDX1;MICALL1;ARL6;GAK;WDR83OS;SCG3;CYB5A;LAMP2;TMEM30A;ARL1;SYS1;IFT140;MTCH2;TIA1;YBX1;DNAJA1;EHD1;TUB;XPA
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.474658376244303,1.1731275977115054,0.2460136674259681,0.80259789039174,1.0,11/39,20.94%,GTPBP4;FXYD5;CDH1;BMP6;AKNA;MAP2K5;MIA3;JAG1;MBP;ASS1;RDX
prerank,negative regulation of nuclear division (GO:0051784),0.581651952103762,1.1729915094239034,0.30559540889526543,0.8023357502024673,1.0,3/11,18.12%,FBXO5;BMP4;NME6
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.5473185756053716,1.172982176482585,0.30551816958277256,0.8015621302271636,1.0,9/16,23.91%,GZMB;KLRK1;ARL8B;SLAMF7;RAET1E;CORO1A;TUBB4B;LYST;TUBB
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4795651863401522,1.1726967221934308,0.2482837528604119,0.8018678857883885,1.0,9/35,15.99%,RIPOR2;DLC1;HEG1;SPRY1;TGFB2;SPRY3;EPHB2;CUL3;ABL2
prerank,negative regulation of bone mineralization (GO:0030502),0.5559113882904982,1.1725303914499647,0.289875173370319,0.8016670288184758,1.0,4/13,11.56%,SRGN;RFLNA;GREM1;RFLNB
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.4499753773154793,-1.17243162195914,0.27380952380952384,0.8088581199307224,1.0,9/12,27.53%,MYO7A;SDK2;VEGFA;RORB;STAT3;AGTPBP1;NKD1;PROM1;CEP290
prerank,regulation of cation transmembrane transport (GO:1904062),-0.34241207059178935,-1.1716557475282674,0.19594594594594594,0.8072799086292334,1.0,6/29,3.63%,CACNA1D;KCNIP3;KCNIP1;SNTA1;HOMER1;WNK1
prerank,protein monoubiquitination (GO:0006513),0.47136759410483803,1.171614813772171,0.2645739910313901,0.8042995255229298,1.0,13/36,19.03%,KBTBD8;TRIM21;PAF1;UHRF1;LEO1;OBI1;FANCL;CTR9;UBE2B;CUL3;HUWE1;UBE3D;CDC73
prerank,mesenchymal cell development (GO:0014031),0.5359080243264701,1.1713261986785777,0.3083756345177665,0.8045986442107878,1.0,3/18,9.08%,NRG1;KBTBD8;HEY2
prerank,steroid catabolic process (GO:0006706),0.5921635381833783,1.1708689056093222,0.326271186440678,0.8056042363571152,1.0,2/10,21.82%,HSD11B1;SPP1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.5379431369068738,1.1707230987813555,0.2950391644908616,0.8053488638315746,1.0,6/17,17.93%,F2R;BMP4;VIM;SUCO;TGFB3;HDAC2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.47687802562353265,1.1703792959782138,0.2687569988801792,0.8058977803291075,1.0,10/37,15.40%,NR4A3;MMP9;PDCD4;PTEN;DNMT1;MMP2;TGFB3;EFEMP2;CDKN1A;SOD2
prerank,purine-containing compound catabolic process (GO:0072523),0.5722358106602816,1.1702246767328524,0.29649595687331537,0.8057040109606928,1.0,3/13,7.31%,NUDT15;GPX1;GDA
prerank,GPI anchor metabolic process (GO:0006505),0.5016923725426136,1.170178327451896,0.2848699763593381,0.8050793687734565,1.0,6/26,9.57%,PIGC;PIGH;PIGA;GPLD1;PIGG;DPM3
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.5008260055733404,1.1692537102520506,0.2665847665847666,0.8076199978638707,1.0,11/24,21.33%,CHP1;CEMIP;ANK3;PRNP;TCAF1;FYN;MTCL1;ITGB2;C2CD5;MFF;TCAF2
prerank,toll-like receptor signaling pathway (GO:0002224),0.4382631450606296,1.1691288788489682,0.222684703433923,0.8072908417106196,1.0,27/84,21.44%,S100A8;S100A9;RPS27A;SCIMP;HMGB1;COLEC12;UBA52;TAB2;TLR9;LBP;TNIP3;CD36;MAPKAPK3;UBB;MAPKAPK2;RIPK1;TIRAP;TICAM1;ITGB2;TNIP1;S100A1;CD14;BIRC3;UBE2D1;TAB1;TRAF3;TNIP2
prerank,positive regulation of cilium assembly (GO:0045724),-0.40171372029955554,-1.1687111916393966,0.27155172413793105,0.8125663156466287,1.0,8/18,24.15%,CCP110;CROCC;ENTR1;CEP120;ARHGAP35;MARK4;HAP1;KCTD17
prerank,regulation of signal transduction (GO:0009966),0.42110838725237276,1.1686913939669525,0.1358148893360161,0.8081911201889043,1.0,41/190,16.63%,CD3E;CD24;GATA3;IGFBP7;NCK2;CD55;SP100;CLU;RGS3;TCF7L1;HHIP;SEMA5A;RGS8;UGCG;PPIA;CD63;TMEM237;BRAP;GSKIP;PPP2R1A;ZDHHC17;GRK6;TMEM108;CD36;TIMP1;AMFR;NCK1;IGFBP2;ELF1;PRNP;RGS6;ILK;SHARPIN;WWTR1;PPP2CA;SIRT1;FYN;TREM2;RIC8B;GAS1;FBXL17
prerank,translesion synthesis (GO:0019985),0.46265597385502566,1.168281272043493,0.25732899022801303,0.8089211443499985,1.0,11/42,19.13%,RPS27A;UBA52;RFC4;RFC5;UBB;POLK;REV3L;PCNA;PARP10;POLDIP2;POLD4
prerank,sodium ion homeostasis (GO:0055078),0.5063427513613193,1.1678771005536093,0.28378378378378377,0.809703855468633,1.0,6/21,17.01%,ATP1B3;ATP1A3;ATP1A4;ATP1A1;ATP1A2;ATP1B2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5429036141731737,1.1677942393119254,0.28383705650459923,0.809221535957637,1.0,4/15,9.35%,IRX5;NIPBL;MTHFD1;EIF4A3
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.3864058357164476,-1.1677596150096399,0.22167487684729065,0.8113124785803753,1.0,9/20,23.17%,SLC8A1;CALM2;ANK2;ATP2A2;GSTO1;ATP1B1;FKBP1B;PRKACA;CAMK2D
prerank,myelin maintenance (GO:0043217),0.5730528749144629,1.1677364785313953,0.3029411764705882,0.8086488173221441,1.0,5/10,16.50%,CLU;PTEN;CXCR4;DEGS1;PRX
prerank,positive regulation of phospholipase activity (GO:0010518),0.5127247322062011,1.1673886741988837,0.2784503631961259,0.8091203655562601,1.0,10/22,25.46%,CCL5;KIT;GNA13;ABL2;NTRK3;PLAA;ARL1;FGFR1;FGFR3;PDGFRA
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.4747026267687421,1.1666600788267791,0.26914414414414417,0.8110673842243651,1.0,7/41,11.30%,LCK;F2R;ITPR3;ATP2B4;ITPR1;CHERP;CACNA2D1
prerank,negative regulation of protein binding (GO:0032091),0.439867747625476,1.1664221332662843,0.24446786090621708,0.8111340747707986,1.0,17/71,16.51%,IFIT2;ACTB;ITGA4;B2M;RACK1;ATP2A3;CTSZ;PIN1;CAV1;ROCK1;SORL1;DNAJB2;CARD16;RALB;DDX11;CDKN1A;TMC8
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.42812032400083366,1.1662438950893734,0.158953722334004,0.810964835826527,1.0,34/158,15.43%,LTF;CD4;CD74;LGALS1;FLNA;F2R;LPAR1;CLEC6A;TAB2;TMEM9B;TLR9;TRIM21;MALT1;TMED4;TNFSF10;PELI1;SLC20A1;ZDHHC17;DHX36;CC2D1A;RHOC;FKBP1A;MUL1;NOD1;CARD16;AKAP13;SHARPIN;TRIM68;DDX1;RIPK1;GAPDH;TIRAP;EEF1D;TICAM1
prerank,nitrogen compound transport (GO:0071705),0.42717440989911326,1.1660661649142186,0.1875,0.8108496896583876,1.0,17/141,10.14%,HRG;SLC48A1;CD3G;SLC6A19;SLC6A14;SLC22A3;SLC7A11;SLC18A2;SLC6A8;SLC18A1;RCN3;SLC3A2;RAMP1;PDPN;SLC7A1;ATP11B;SLC1A5
prerank,production of siRNA involved in RNA interference (GO:0030422),0.5957806529587529,1.1656287135969552,0.29515418502202645,0.8116565796483435,1.0,4/10,19.49%,TARBP2;DROSHA;AGO2;TSNAX
prerank,mitochondrial gene expression (GO:0140053),0.46339736440518353,1.165118489313889,0.26004464285714285,0.8127340602948833,1.0,6/42,4.94%,MRPS12;MRPL51;MRPL23;LARS2;MRPL12;MRPS14
prerank,negative regulation of reproductive process (GO:2000242),0.5294626765879258,1.1649921040337985,0.2789473684210526,0.8124109075345721,1.0,3/17,9.76%,ARHGDIB;PAEP;TIMP1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.451939816069605,1.1646966339666007,0.24371584699453552,0.8127767402027742,1.0,10/54,9.32%,KCNN4;FLNA;KCNJ10;NEDD4;KCNMB4;KCNJ15;AMIGO1;CD63;CAV1;AKAP6
prerank,response to exogenous dsRNA (GO:0043330),0.5202325122023528,1.1643828141619144,0.28697850821744625,0.8131797911515058,1.0,7/18,18.17%,COLEC12;SLC3A2;CAV1;MUL1;RALB;TICAM1;CGAS
prerank,inorganic cation import across plasma membrane (GO:0098659),0.4404364936678921,1.164170544188775,0.2431578947368421,0.8131846202810173,1.0,14/75,12.04%,SLC5A1;ATP1B3;KCNJ10;KCNJ15;ATP2B4;SLC12A7;ATP1A3;ATP1A4;ATP1A1;SLC39A6;CACNA2D1;ATP1A2;SLC12A5;SLC12A4
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.495515465106689,1.1638744913580132,0.28975265017667845,0.8135175608930167,1.0,12/25,24.98%,GCK;ALDOA;HK1;GPI;ALDOC;GAPDH;PFKP;GAPDHS;PGK1;ADPGK;FOXK1;ENO1
prerank,regulation of mast cell activation (GO:0033003),0.5793023242974635,1.1638025683764517,0.3328611898016997,0.8129867077558909,1.0,1/10,0.13%,CD226
prerank,mitochondrion morphogenesis (GO:0070584),-0.4632962682356514,-1.1633824582509809,0.30714285714285716,0.8213758815041194,1.0,7/11,21.79%,PID1;PNPT1;WASF1;NUBPL;SUPV3L1;SLIRP;MYH14
prerank,diacylglycerol metabolic process (GO:0046339),-0.36205698248050855,-1.1630978105132728,0.22826086956521738,0.8181049720700246,1.0,7/23,15.49%,DGKZ;DAGLA;PLA2G15;DGAT1;DGKH;DGKD;DGKQ
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.5663955635802249,1.162629245813866,0.3,0.8166395426235497,1.0,4/13,11.27%,GREM2;GREM1;FSTL1;NBL1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.5853689043959506,1.1626128079397837,0.30735930735930733,0.8159082564579234,1.0,7/10,25.34%,MTHFD2;SHMT1;MTHFD1;TYMS;MTHFD1L;MTHFS;SHMT2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4806503823946894,1.1625106263370013,0.2830409356725146,0.815490732288134,1.0,12/32,24.14%,DLC1;HOXA7;PTEN;SERPINE1;MMP12;SEMA3E;APOD;JAG1;ARHGAP6;ACER2;CLASP2;ITGB1BP1
prerank,female gamete generation (GO:0007292),0.49451601074238105,1.1624928179920861,0.2946107784431138,0.8147571536349997,1.0,5/29,12.43%,M1AP;DMC1;MDK;METTL3;TOB2
prerank,negative regulation of cyclase activity (GO:0031280),0.5510400004175104,1.1623913709494935,0.29226736566186107,0.8143290112469093,1.0,5/14,22.73%,CCR2;GNAI2;DRD2;PALM;EDNRB
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5142857823849418,1.1622198722046058,0.27649208282582216,0.8141928820154173,1.0,4/21,11.22%,NR4A3;MMP9;DNMT1;MMP2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.42659601947238085,1.1620999813157133,0.21116751269035533,0.8138605142995375,1.0,33/124,18.13%,CCDC88C;LEF1;SFRP5;PDE6B;PSMC3;PSMD8;PSME1;ARHGEF19;PSMD6;PLCB3;PSMB5;CELSR1;NLK;VANGL1;FZD6;PRICKLE2;PSMC6;CDC42;PSMB4;CTNNB1;PSMA7;PSMB9;PSMA6;PSMC1;PSMD7;TIAM1;PSMD2;CALM1;PPP3CB;AGO2;AP2S1;SMURF2;PSMD5
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.4138223729283002,1.161285308860558,0.08508508508508508,0.8161433974859407,1.0,77/348,18.44%,CD3E;MMP8;LEF1;PKP1;PTPN22;CD28;WNT6;CD74;SERPINB9;ACTG1;STAP1;RPL11;RPS7;ACTA2;ANGPT1;RPL23;ADAM19;CLU;TLR9;LAPTM5;CD63;FUBP1;ATM;RPS3;ZBTB7B;AMH;DNMT1;MAPK9;RBMS3;MSN;ETS1;BMP4;IFNGR1;GSN;GREM1;ATF7IP;ANK3;BMP6;HEY2;ID2;CD36;NSF;DHX36;MED23;FAM98A;PDCL3;ZPR1;ROBO1;ROCK1;SMAD1;EPHB2;SNF8;ATF4;CDH5;HSPA1A;UBR5;FGF7;ITGAX;CTSH;WNT3;EZR;EIF2AK3;MAP2K5;TICAM1;TREM2;GSK3A;KLF2;SOX11;AGO2;IL33;BRAF;EMILIN1;CALCOCO1;LILRB1;NTRK3;ECE1;HINFP
prerank,regulation of blood circulation (GO:1903522),0.46693587751210197,1.161260353460118,0.27809965237543455,0.8154463833340205,1.0,8/34,18.90%,FXYD1;KCNMB4;PER2;SRI;CACNA1H;AGER;ECE1;S100A1
prerank,regulation of fibrinolysis (GO:0051917),0.5648072135970977,1.1611784574883253,0.29906542056074764,0.8149524115255108,1.0,3/13,17.28%,HRG;SERPINE1;FAP
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4150023954380872,1.161036966442234,0.068,0.8146676107922722,1.0,78/390,16.47%,LCK;CD3E;CD8B;CD4;CD8A;NRG1;CD7;SH2D2A;NR4A3;MMP9;CLNK;CYBA;IL31RA;GHR;ACTG1;SORBS1;STAP1;DDR2;KALRN;CYBB;ACTB;ANGPT1;NCF1;NCK2;ATP6V1G2;LMTK2;EFNB2;KDR;CYFIP2;SDC2;PRKD2;POLR1G;KIT;ARPC2;ARPC1A;RARRES2;CHN1;BCAR1;JAK2;GPLD1;ATP6AP1;CDC42;ARPC5;NCK1;HSP90AA1;APPL1;ATP6V0B;ZAP70;MMP2;ROCK1;COL1A1;EPHB2;MAPKAPK3;FLT3;IRS1;FOXO1;NCKAP1;EPHA7;GRB14;MAPKAPK2;POLR2F;EPHA5;ACTR3;HNRNPF;FGF7;SDCBP;SHC1;ATP6V0A2;EIF2AK3;ABI1;FYN;BLK;PAK1;IGF1R;TIAM1;PDGFD;GSK3A;NEDD9
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4640717036870436,1.1607173603828174,0.27455357142857145,0.8150409604339082,1.0,9/45,9.20%,IRF6;SP100;B2M;TRIM21;GBP2;CD44;IFNGR1;JAK2;OASL
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.5483450254558643,1.1594660437475341,0.30148048452220727,0.818850699469232,1.0,1/13,0.84%,B3GNT3
prerank,cGMP-mediated signaling (GO:0019934),0.5513891835430234,1.1592470370330759,0.30581867388362655,0.8188605205147181,1.0,3/13,10.35%,APOE;CD36;PDE3A
prerank,regulation of cellular amine metabolic process (GO:0033238),0.45987434614055833,1.1591452569004876,0.2838283828382838,0.8184449752160641,1.0,16/50,16.22%,OAZ3;PSMC3;PSMD8;PSME1;PSMD6;NQO1;PSMB5;PSMC6;PSMB4;AZIN1;PSMA7;PSMB9;PSMA6;PSMC1;PSMD7;PSMD2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.5500540200079481,1.1590135632223044,0.31241473396998637,0.8181486382055446,1.0,6/13,24.11%,ACSF3;ASPA;DDO;ACOT8;MTHFS;GOT2
prerank,hemopoiesis (GO:0030097),0.43518200287909886,1.1588833371297116,0.23681489141675285,0.8178366519398987,1.0,26/87,20.18%,LCK;RUNX3;MELK;KDR;TOX;KIT;TGFB2;BMP4;HIPK1;L3MBTL1;KIRREL3;ZBTB16;ZFP36L2;TGFBR3;FLT3;ATF4;KITLG;TIRAP;RUNX2;CDK13;JAG1;BMI1;LYL1;PTPRC;MECOM;TNFRSF13B
prerank,protein localization to chromatin (GO:0071168),0.5176384382274841,1.1587770475365566,0.2772151898734177,0.8174518761698601,1.0,4/18,7.37%,NIPBL;WAPL;LEMD2;CHMP7
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4993407279056716,1.1587317631307996,0.31946144430844553,0.816838363397979,1.0,8/24,18.52%,PRKAR1B;RNF157;PDE3A;PRKAR1A;UBE2B;CGAS;GNAI1;CDC34
prerank,positive regulation of protein catabolic process (GO:0045732),0.4282977492752393,1.1586643533234482,0.24586776859504134,0.8163011746376592,1.0,27/84,20.94%,OAZ3;NEDD4;APOE;FZR1;BARD1;MSN;ASB5;SEC22B;GPLD1;NSF;HSP90AA1;SORL1;SNF8;FOXO1;VPS11;VPS28;TNFSF12;GPC3;EZR;SNX33;HUWE1;GSK3A;AREL1;SMURF2;DDB1;GSK3B;RDX
prerank,negative regulation of macrophage activation (GO:0043031),0.540206685959902,1.1579906208921007,0.3038461538461538,0.8180525154956669,1.0,6/16,22.43%,IL31RA;CST7;GRN;PTPRC;LDLR;CX3CL1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.5590143932061202,1.1578640095475157,0.29733333333333334,0.8177031836379252,1.0,5/13,22.73%,CCR2;GNAI2;DRD2;PALM;EDNRB
prerank,glycolytic process (GO:0006096),0.4890184799239813,1.1573844165384388,0.28705882352941176,0.8186663499799542,1.0,6/28,9.19%,GCK;ALDOA;ENO4;HK1;GPI;ALDOC
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4279119015996274,1.1572135269889776,0.20626895854398383,0.8185142073361612,1.0,29/112,15.59%,RPS27A;CILP;ARHGEF18;FERMT2;LTBP2;UBA52;PARD3;SMAD2;COL1A2;ITGB1;ZYX;SOX5;TGFB2;CLEC3B;NLK;GCNT2;PDE3A;APPL1;ZFP36L2;SMAD1;FKBP1A;TGFBR3;UBB;COL3A1;CDH5;TGFB3;SIRT1;CRKL;USP15
prerank,calcium-mediated signaling (GO:0019722),0.4334156348282861,1.1571814998900434,0.24871001031991744,0.817841650912282,1.0,9/93,5.68%,FPR2;PPP1R9B;CXCR2;CCR2;MCTP2;CXCR3;RCAN3;KDR;RCAN2
prerank,negative regulation of cell population proliferation (GO:0008285),0.4177477751080522,1.1568632799752896,0.089,0.8182684864197222,1.0,85/351,21.47%,SCIN;HRG;IRF6;GTPBP4;GATA3;P3H1;DLC1;COL18A1;IFITM1;SFRP5;FBLN1;SOX7;IGFBP7;RUNX3;ADGRB1;TFAP4;CHD5;RARG;F2R;NCK2;PEX2;CDK6;S100A11;RAF1;LMNA;B2M;FABP7;PTGIR;PTEN;PLXNB1;OGN;CDH13;ING5;TGFB2;FTH1;ETS1;BMP4;AQP11;PER2;GREM1;PDPN;NME1;MNT;JAK2;PDS5B;GPLD1;CHERP;CTNNB1;BTG2;TGFBR3;DNAJB2;VHL;MAGED1;TGFB3;NPM1;HSPA1A;CDKN1A;ABI1;DRD2;SOD2;PAK1;TREM2;APOD;GLMN;FAP;SOX11;KAT2B;DLG3;HES1;PARP10;RBM5;PBRM1;FKTN;CDC73;COPS8;KLF11;EEF1E1;SOX9;STK11;CCN3;SLC16A2;UTP20;ITGA1;RBP4;NLRC3
prerank,regulation of protein kinase activity (GO:0045859),0.4224042838970536,1.1567708720212477,0.24085365853658536,0.8178128871243747,1.0,14/106,8.64%,CD4;DBNDD1;CHP1;DDR2;DAXX;IQGAP1;CEACAM1;RTRAF;TAB2;SMCR8;PPIA;GSKIP;TARBP2;SFN
prerank,rRNA catabolic process (GO:0016075),0.5294978223124541,1.15658858773953,0.2954248366013072,0.8177234953006135,1.0,2/16,2.84%,DEDD2;EXOSC4
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.4989001081494827,1.155985764738517,0.2920353982300885,0.8191565024428209,1.0,7/22,17.97%,LTF;PTPN22;LBP;APPL1;TIRAP;TREM2;ACOD1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.5018561477556915,1.1557048936069034,0.30619684082624543,0.8194118111195984,1.0,7/23,19.50%,CBLB;CHMP6;CAV1;SRCIN1;SOCS4;PTPRC;MVP
prerank,postreplication repair (GO:0006301),0.45651575246973913,1.1556794741549745,0.2738225629791895,0.8187271643617796,1.0,12/45,20.68%,RPS27A;UBA52;RFC4;NSMCE1;RFC5;UBB;POLK;UBE2B;PCNA;PARP10;POLD4;MSH2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.32157224012280855,-1.1554175024542797,0.24031007751937986,0.8389160247015963,1.0,10/35,18.07%,PTPRM;MEF2C;ATP5IF1;XDH;VASH1;THBS1;SULF1;CAV2;SCG2;SPARC
prerank,response to retinoic acid (GO:0032526),0.45136536040955105,1.155188951652797,0.2508038585209003,0.8197733263779086,1.0,17/59,21.39%,TRIM16;WNT6;BRINP2;RARG;ATM;RARA;BRINP3;ASXL1;CTSH;WNT3;ABL2;TWF2;EPHA3;SOX9;ZNF35;ACER2;RBP4
prerank,regulation of leukocyte migration (GO:0002685),0.5340669267403796,1.1550834648856807,0.30657894736842106,0.8193639880825746,1.0,3/16,8.44%,ANXA1;HOXA7;RAC2
prerank,regulation of cell population proliferation (GO:0042127),0.41366487901518806,1.1545588797952786,0.025,0.8204676490239605,1.0,145/691,18.76%,LEF1;STAT4;PPP1R9B;CXCR2;OSMR;SCIN;HRG;NRG1;IRF6;GTPBP4;NR4A3;ELN;GATA3;P3H1;DLC1;COL18A1;IFITM1;SFRP5;CCND2;SOX7;IGFBP7;IL31RA;ADGRB1;TFAP4;BCL2;CHD5;RARG;F2R;RPL23;NCK2;RPS6;RPS9;CLU;CDK6;S100A11;DPP4;IL7R;RAF1;LMNA;BIRC5;EFNB2;KDR;FABP7;S1PR2;FBXO5;PTEN;CADM4;RARA;HDAC1;UHRF1;HMGB2;CD47;CDH13;KIT;ING5;TGFB2;CXCL10;FTH1;ETS1;BMP4;AQP11;RPS4X;BIRC6;GREM1;TSHR;PDPN;NME1;MNT;GNAI2;BMP6;JAK2;PDS5B;GPLD1;ID2;SHANK2;KDM4C;GCNT2;STAT5B;TIMP1;CHERP;CDK2;CIAO1;CDC7;MEIS2;FAM98A;CTNNB1;BTG2;HP1BP3;COPS9;IL6ST;KSR1;FLT3;DNAJB2;VHL;CLCF1;IRS1;BCL6;MATK;TGFB3;NPM1;HSPA1A;WWTR1;SIRT1;RPS15A;FGF7;ITGAX;CTSH;CAPNS1;SDCBP;KITLG;SHC1;CDKN1A;CRKL;ABI1;CUL3;DRD2;SOD2;PAK1;IGF1R;TIAM1;PDGFD;CDK13;S100A13;JAG1;SINHCAF;RBFOX2;GLMN;SOX11;PIAS1;KAT2B;DLG3;JUP;HDAC2;NTRK3;TSPO;CDC123;HES1;CEP43;RBM5;CCDC88A;VIPR1;PBRM1;FKTN;SLC25A33;HDAC4
prerank,regulation of interferon-beta production (GO:0032648),-0.29505394927852774,-1.1544495673084074,0.20212765957446807,0.8377721786459073,1.0,18/46,20.65%,SIRPA;TLR7;POLR3B;TLR4;PTPN11;TLR2;OAS2;TLR8;TLR3;FLOT1;DHX58;TBK1;PPM1B;IRF3;POLR3D;IRF7;POLR3A;PYCARD
prerank,regulation of protein targeting to membrane (GO:0090313),0.4813643844187792,1.1544253363231558,0.3009478672985782,0.8202131654269831,1.0,11/28,21.33%,CHP1;CEMIP;ANK3;PRNP;TCAF1;FYN;MTCL1;ITGB2;C2CD5;MFF;TCAF2
prerank,receptor-mediated endocytosis (GO:0006898),0.4235830979057721,1.154175572379258,0.20383451059535823,0.8203742164031291,1.0,37/132,20.71%,FPR2;CXCR2;HP;HPR;JCHAIN;NEDD4;FCHO1;LMBR1L;COLEC12;APOE;ITGB1;HSPG2;RAMP1;DNM3;HSPH1;CXCL16;CAV1;TMEM108;CLN3;CD36;HSP90AA1;SORL1;DNAJC6;MICALL1;FNBP1L;GAK;IGF2R;ITGB2;AP2S1;LILRB1;GPR107;CANX;LDLR;VLDLR;SNCA;M6PR;FCER1G
prerank,regulation of adenylate cyclase activity (GO:0045761),0.5025359791144384,1.1539165313271778,0.2871165644171779,0.8205480685888066,1.0,4/22,8.87%,CCR2;CAP2;STIM1;GNAI2
prerank,negative regulation of JNK cascade (GO:0046329),0.4794212001777029,1.1535808508480472,0.2863849765258216,0.8210423520673045,1.0,11/31,23.18%,PTPN22;PDCD4;TAOK3;NCOR1;HIPK3;PER1;FKTN;MECOM;DUSP3;DUSP10;DNAJA1
prerank,nitric oxide mediated signal transduction (GO:0007263),0.5340195919076705,1.1534879362466524,0.3090185676392573,0.8205930212002904,1.0,3/16,9.75%,NDNF;APOE;CD36
prerank,aminoglycan biosynthetic process (GO:0006023),0.45145991703060484,1.153377501154073,0.2720264317180617,0.8202173393077453,1.0,10/49,10.49%,B3GNT3;B3GALT6;SLC35D2;HSPG2;SDC2;UGDH;HS3ST3B1;EXT2;GCNT2;GPC6
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.44640833596231533,1.152900183231621,0.25052854122621565,0.8211488282236006,1.0,13/62,15.01%,GPR174;RASGRP1;ARHGEF3;F2R;LPAR1;AUTS2;MAPRE2;JAK2;ROBO1;COL3A1;AKAP13;SHC1;CRKL
prerank,DNA-dependent DNA replication (GO:0006261),0.4246511682493741,1.1523406267236245,0.20567375886524822,0.822469864108922,1.0,39/128,19.13%,RPS27A;PSMC3;UBA52;RFC4;MCM7;MCM2;PSMD8;GINS2;PSME1;PSMD6;PSMB5;POLG2;POLB;GINS3;NOC3L;PSMC6;POLE;CDK2;PSMB4;CDC7;WDHD1;RFC5;PSMA7;UBB;PSMB9;PSMA6;BLM;POLG;PSMC1;BAZ1A;REV3L;HELB;PSMD7;PSMD2;ORC6;PSMD5;MCM6;CDC34;POLD4
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5762843791677469,1.1523314978993024,0.33285094066570187,0.8217332692330244,1.0,4/10,17.48%,TLR9;KDR;JAK2;IL33
prerank,negative regulation of cell projection organization (GO:0031345),0.45315078073378756,1.1522039119174803,0.2747014115092291,0.8214564965533537,1.0,15/48,17.93%,LPAR1;PAQR3;EFNB2;APOE;PTEN;ITM2C;PTPN9;SPRY3;ADCY6;PRNP;DCC;GAK;FYN;STMN2;HDAC2
prerank,adipose tissue development (GO:0060612),-0.4656609444243019,-1.1520713062787087,0.2755102040816326,0.8413993995031996,1.0,4/11,19.57%,LRP5;SOX8;XBP1;DYRK1B
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4745727324814901,1.152069339478103,0.29161882893226176,0.8211886025461336,1.0,4/33,6.72%,ANXA1;CCND2;PAF1;LSM11
prerank,stress fiber assembly (GO:0043149),0.5426480593542138,1.1517335990978417,0.2923898531375167,0.8209093226858281,1.0,4/15,6.40%,PDLIM1;SORBS1;ITGB1;ZYX
prerank,contractile actin filament bundle assembly (GO:0030038),0.5426480593542138,1.1517335990978417,0.2923898531375167,0.8209093226858281,1.0,4/15,6.40%,PDLIM1;SORBS1;ITGB1;ZYX
prerank,autophagosome assembly (GO:0000045),-0.29012191666567677,-1.1514460155782273,0.136986301369863,0.8392101112135595,1.0,14/52,14.55%,BECN1;STX12;IRGM;ATG7;ULK1;SMURF1;TMEM41B;WIPI1;WDR45B;ATP2A2;MFN2;PIK3C3;GABARAPL1;ULK2
prerank,membrane repolarization (GO:0086009),0.5373135374815158,1.150859841913592,0.3201058201058201,0.8232441320472974,1.0,4/15,17.01%,ATP1B3;ATP1A1;ATP1A2;ATP1B2
prerank,negative regulation of translation (GO:0017148),0.4350852497626835,1.1508044444270364,0.24716786817713698,0.8226840143388162,1.0,24/87,15.36%,GZMB;PUS7;MRPL13;YTHDF3;ILF3;SHMT1;DAPK3;RACK1;RPS3;METTL3;MALSU1;EIF4A3;SYNCRIP;DHX36;BTG2;NCL;CPEB3;ROCK1;METTL14;SAMD4A;GAPDH;EIF3E;EIF2AK3;TYMS
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.5620370466876224,1.1508033423885993,0.33242876526458615,0.8219224257504547,1.0,1/12,0.91%,NCOR2
prerank,regulation of cytoskeleton organization (GO:0051493),0.4304013035232376,1.1503959731040467,0.2396359959555106,0.8226191757276575,1.0,16/108,11.67%,S100A8;S100A9;HRG;DLC1;IQGAP1;DIAPH1;GPM6B;PLXNB1;ARHGEF19;CELSR1;IQGAP2;RAC2;CLN3;RHOC;ROCK1;MAPT
prerank,endochondral bone morphogenesis (GO:0060350),-0.4581853010782728,-1.1503692639180123,0.30633802816901406,0.8384689865667966,1.0,6/11,19.28%,MEF2C;BMPR2;TMEM119;TRPV4;INPPL1;BMPR1B
prerank,regulation of osteoclast differentiation (GO:0045670),-0.32722036804117716,-1.1499926612468687,0.22302158273381295,0.8356566679245481,1.0,11/33,20.24%,UBASH3B;MAFB;MTOR;TLR4;FBN1;TLR3;TMEM178A;TRAF6;CCR1;CCL3;TNF
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5095624765702769,1.1498380326497109,0.299625468164794,0.8239441174926729,1.0,4/20,5.90%,CD6;PTPN22;CCL5;LBP
prerank,negative regulation of potassium ion transport (GO:0043267),-0.4291139492668987,-1.149473831319815,0.27816901408450706,0.8331998233648097,1.0,2/13,1.12%,CAB39;BIN1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4969371240862369,1.1492085136243808,0.3078817733990148,0.8253929347399083,1.0,8/23,18.50%,ACSBG1;ACSF3;ELOVL7;ELOVL1;ELOVL6;HACD1;ACSL1;HACD2
prerank,regulation of response to biotic stimulus (GO:0002831),0.4805001117133814,1.1483004416186993,0.3060747663551402,0.8280588526895185,1.0,12/28,22.43%,PTPN22;CD55;FOXP1;CD36;APPL1;TIRAP;TREM2;SAMHD1;RNF135;BIRC3;TRAF3;CX3CL1
prerank,positive regulation of protein metabolic process (GO:0051247),0.4215427407908637,1.1482402896921378,0.22944162436548224,0.8275167178192979,1.0,30/110,17.87%,RASGRP1;OAZ3;NEDD4;CLU;IL17D;TLR9;APOE;FZR1;UHRF1;BARD1;NR1H2;ASB5;PAEP;SEC22B;NSF;NFKBIA;SORL1;SNF8;FOXO1;VPS28;TNFSF12;GPC3;ABCA2;MAP2K5;HUWE1;GSK3A;KLF2;AREL1;SMURF2;RANBP9
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.45701581713340395,-1.1478597608920467,0.2852112676056338,0.834376359076102,1.0,9/11,38.77%,CD34;RUNX1;ETV6;ARIH2;WNT5A;WNT2B;YJEFN3;YTHDF2;SFRP2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4356764496892566,1.147743401755005,0.26458333333333334,0.8286170436755458,1.0,22/73,16.22%,GATA3;PUS7;PSMC3;PSMD8;MYB;PSME1;PSMD6;METTL3;PSMB5;SETD1A;PSMC6;TCF12;DHX36;PSMB4;PSMA7;PSMB9;PSMA6;METTL14;PSMC1;KITLG;PSMD7;PSMD2
prerank,primary alcohol metabolic process (GO:0034308),0.4989093741590433,1.147501180165088,0.31861575178997614,0.8287231026637545,1.0,8/25,21.39%,DHRS9;NAAA;GDPD1;NAPEPLD;RDH12;GDPD3;GPD2;RBP4
prerank,cholesterol transport (GO:0030301),0.4584839453404992,1.147453806591533,0.2794279427942794,0.8281157684226531,1.0,9/45,12.55%,CLU;STARD4;ABCG4;APOC1;APOE;SOAT1;CAV1;CD36;ABCA7
prerank,histone H2A acetylation (GO:0043968),0.5328813466654376,1.1473612611618422,0.31716906946264745,0.8276984647938748,1.0,7/16,19.21%,ING3;MORF4L1;MSL3;SPHK2;RUVBL1;DMAP1;MEAF6
prerank,regulation of potassium ion transport (GO:0043266),-0.3398187397256568,-1.1471075130757242,0.23404255319148937,0.8327988470563941,1.0,5/31,5.16%,CACNA1D;KCNIP3;KCNIP1;ANK2;KIF5B
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.43029516424136693,1.1467659043270977,0.22910216718266255,0.8291179831135923,1.0,23/87,14.04%,RPS27A;ARHGEF18;FERMT2;LTBP2;UBA52;FMOD;PARD3;SMAD2;COL1A2;ITGB1;ZYX;TGFB2;NLK;GCNT2;APPL1;SMAD1;FKBP1A;TGFBR3;UBB;COL3A1;CDH5;TGFB3;SIRT1
prerank,nucleosome organization (GO:0034728),0.44794983009221856,1.1457723053343454,0.25989304812834224,0.8319280504271344,1.0,14/55,14.08%,DAXX;ATRX;H1-0;ANP32B;SMARCC1;PAF1;SMARCD3;HMGB2;NFE2;CHAF1B;NASP;VPS72;NPM1;PADI4
prerank,positive regulation of phospholipase C activity (GO:0010863),0.46455994730113925,1.1457281552691843,0.27876106194690264,0.8313200026526393,1.0,6/40,6.94%,ITK;EDNRA;LPAR1;TXK;S1PR4;KIT
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5420914537061469,1.1453089269836472,0.33288227334235454,0.8320881425083089,1.0,1/14,0.13%,CD226
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.2622525304428091,-1.1452586151738768,0.1282051282051282,0.8346569964665858,1.0,31/88,16.85%,SCAMP1;VPS13C;DTNBP1;SORCS1;CCDC93;AP1B1;ACBD3;AP2A1;RABEP1;MYO5A;NAPA;VAMP7;EXOC5;CLTA;RP2;CORO7;CLVS1;ARRB1;HGS;AP1S1;GOPC;LLGL1;APP;ARFGEF2;AP1G2;EXOC4;AP1M1;MYO1B;DOP1B;STEAP2;AP4B1
prerank,vasodilation (GO:0042311),-0.41515904601800824,-1.1451596453637791,0.2892857142857143,0.8310301382655786,1.0,3/13,13.35%,KCNMA1;ADRB1;ADRB2
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.5021333686121988,1.1449069109496424,0.31470230862697446,0.8327508091661484,1.0,3/20,16.39%,GCK;NCOR1;GSK3A
prerank,negative regulation of apoptotic process (GO:0043066),0.4118745278747336,1.1445556502680438,0.067,0.8332918770768629,1.0,93/444,17.98%,IL2RB;LTF;LEF1;ANXA1;TPT1;RPS27A;MMP9;ANGPT4;CCND2;PRDX5;CD28;IL31RA;CD74;SERPINB9;FIGNL1;BCL2;FLNA;F2R;ANGPT1;UBA52;RAF1;HTATIP2;NDNF;BIRC5;KDR;BID;APOE;PIM1;ITGB1;UFM1;MDK;MALT1;HSPA5;HDAC1;MIF;NR4A2;BARD1;GPX1;CDK1;RNF157;BMP4;CD44;WDR73;APIP;BIRC6;GREM1;CAV1;SFN;PDPN;CLN3;FSTL1;EGR3;CFL1;NAA16;CTNNB1;IL6ST;NFKBIA;BNIP1;VHL;CLCF1;CARD16;UBB;ERC1;FOXO1;AGAP2;UBE2Z;TGFB3;NPM1;GRN;ZFAND6;HSPA1A;SIRT1;RIPK1;PCID2;CTSH;SHC1;BEX3;MAP2K5;SOD2;RPS6KB1;HIPK3;TREM2;IGF1R;PRELID1;MYDGF;ERCC5;CRYAB;ARL6IP1;AREL1;BRAF;CBX4;HDAC2;DFFA
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5207456807212033,1.1443781394289425,0.3271523178807947,0.8331932332276898,1.0,3/17,6.34%,CD8A;CD55;MYO1G
prerank,"wound healing, spreading of cells (GO:0044319)",0.49949342517778866,1.1442539984466271,0.324455205811138,0.8328671898108169,1.0,8/24,15.51%,FLNA;CEACAM1;LCP1;CD44;PDPN;RHOC;MMP12;CARMIL2
prerank,translational elongation (GO:0006414),0.4276504995298029,1.1442439458566966,0.24668705402650357,0.8321388397809009,1.0,23/101,16.49%,MRPS12;MRPL51;MRPL13;MRPL23;MRPL21;MRPL12;MRPL40;MRPL22;MRPS14;RACK1;MRPL33;EEF1B2;EEF2;MRPL15;MRPL19;EEF1A1;MRPL54;MRPL4;MRPL36;CHCHD1;EEF1D;MRPL17;MRPS27
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4687334181840535,1.1439330253785402,0.2959905660377358,0.8325122045865915,1.0,6/31,8.64%,GZMB;BCL2;BID;YWHAB;TFDP2;SFN
prerank,ribosomal subunit export from nucleus (GO:0000054),0.5529997055340555,1.1434019815695937,0.3297442799461642,0.8336683420676526,1.0,4/13,13.11%,XPO1;RPS15;NUP88;NPM1
prerank,sulfur compound biosynthetic process (GO:0044272),0.4244483567463701,1.1433508520994493,0.23505154639175257,0.833099979472747,1.0,16/104,10.59%,B3GNT3;GSTO2;ANGPT1;CNDP2;UST;DCN;LUM;SLC35D2;FMOD;BGN;OGN;UGDH;CHST9;CHAC2;ST3GAL1;B4GALT3
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.5019746935365941,1.1432652708113986,0.31896551724137934,0.8326386751907885,1.0,10/23,21.97%,RANGRF;SEC61B;LMAN1;TECPR2;DERL1;OS9;PREB;SELENOS;FAF2;TMEM129
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.49205822253348536,1.1432403056555684,0.3142174432497013,0.8319536852383951,1.0,6/26,18.69%,CCR2;C3;IL6ST;ATF4;EIF2AK3;RORA
prerank,negative regulation of viral transcription (GO:0032897),0.5446574044977532,1.1432297759477081,0.3194070080862534,0.8312355699923981,1.0,3/13,6.15%,HEXIM1;TRIM21;IFITM3
prerank,nuclear transport (GO:0051169),0.5277040660637539,1.1428258224301258,0.31216216216216214,0.8319547403785945,1.0,6/16,23.63%,XPO1;NXT2;NPM1;AAAS;ANP32A;NUP205
prerank,response to muscle stretch (GO:0035994),0.5402074749834037,1.1427683051721071,0.32705248990578734,0.8314049613822936,1.0,4/15,10.71%,CSRP3;GSN;DMD;CTNNB1
prerank,regulation of peptide hormone secretion (GO:0090276),0.43395243249848553,1.1424825266960934,0.26785714285714285,0.8316617200275622,1.0,14/67,18.23%,GCK;CCL5;ITPR3;DPP4;UQCC2;PER2;RAPGEF4;ITPR1;SYT7;HADH;SLC2A1;RFX3;PPP3CB;GIPR
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4904216695522097,1.1424408556387757,0.3173076923076923,0.8303090593473388,1.0,11/24,24.98%,GCK;ALDOA;HK1;GPI;ALDOC;GAPDH;PFKP;GAPDHS;PGK1;FOXK1;ENO1
prerank,canonical glycolysis (GO:0061621),0.4904216695522097,1.1424408556387757,0.3173076923076923,0.8303090593473388,1.0,11/24,24.98%,GCK;ALDOA;HK1;GPI;ALDOC;GAPDH;PFKP;GAPDHS;PGK1;FOXK1;ENO1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.47834139697842476,1.1424176635405368,0.3147502903600465,0.82963231617,1.0,6/32,11.57%,SORBS1;C3;CEACAM1;APOE;CREBL2;MID1IP1
prerank,regulation of kinase activity (GO:0043549),0.4266491833818748,1.1422526912954662,0.2577639751552795,0.8294906827043093,1.0,30/89,24.48%,CD4;LMO4;CD74;DDR2;LMTK2;NPRL2;KDR;KIT;EEF1A1;MAPT;EPHB2;FLT3;EPHA7;EPHA5;TREM2;IGF1R;NTRK3;EPHA3;NLRC5;HNRNPU;ROR1;MET;ERBB4;DDR1;VAC14;FGFR1;INSR;FGFR3;RBL2;AXL
prerank,bile acid metabolic process (GO:0008206),-0.3448557140864609,-1.1420737439707476,0.23684210526315788,0.8368821532678402,1.0,8/27,15.57%,OSBPL9;OSBP;SCP2;CYP27A1;CH25H;OSBPL7;OSBPL3;GBA2
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.4026626391722812,-1.1420321078145077,0.27450980392156865,0.8330293141526297,1.0,3/15,4.86%,PRKCE;PPARD;AKT2
prerank,negative regulation of cholesterol transport (GO:0032375),0.5827079908578942,1.1416156954779246,0.32028985507246377,0.831025844921029,1.0,2/10,15.06%,APOC1;ABCA2
prerank,protein heterooligomerization (GO:0051291),-0.390474948857487,-1.1415099830760005,0.2889908256880734,0.8308468880445952,1.0,6/17,13.69%,PKD1;FARSB;TMEM120B;CBR4;FARSA;TMEM120A
prerank,positive regulation of cell population proliferation (GO:0008284),0.4084825781381998,1.141253558418943,0.088,0.8316350424894174,1.0,96/423,18.76%,LTF;LEF1;CXCR2;OSMR;S100A6;NRG1;NR4A3;CCND2;CCL5;IL31RA;CD74;DDR2;BCL2;F2R;RPL23;RPS6;RPS9;CDK6;DPP4;IL7R;BIRC5;EFNB2;KDR;S1PR2;PIM1;FBXO5;PTEN;TOX;RARA;MDK;HDAC1;MIF;CHRD;CD47;CDH13;FOXP1;TGFB2;BMP4;AQP11;RPS4X;GREM1;TSHR;NME1;GNAI2;BMP6;ID2;SHANK2;KDM4C;GCNT2;TIMP1;CDK2;CIAO1;CDC7;MEIS2;FAM98A;COPS9;IL6ST;TGFBR3;FLT3;CLCF1;IRS1;MATK;TGFB3;NPM1;GRN;WWTR1;SIRT1;RPS15A;FGF7;ITGAX;CTSH;CAPNS1;SDCBP;KITLG;SHC1;CDKN1A;CRKL;CUL3;PAK1;IGF1R;TIAM1;PDGFD;CDK13;S100A13;SINHCAF;LAMB1;SOX11;HDAC2;NTRK3;CDC123;HES1;CEP43;BMI1;VIPR1;SLC25A33;HDAC4
prerank,positive regulation of peptidase activity (GO:0010952),0.5156881945836692,1.1411825107162712,0.3286264441591784,0.8311190978079245,1.0,5/20,16.09%,RCN3;PSME1;GRN;CTSH;PRELID1
prerank,proteoglycan metabolic process (GO:0006029),-0.34653952406486993,-1.1411482833496425,0.2756756756756757,0.8281899135830185,1.0,12/26,20.81%,XYLT1;BMPR2;HPSE;HS3ST4;B4GALT7;SULF2;CANT1;SULF1;GAL3ST4;CSGALNACT2;BMPR1B;CHST8
prerank,positive regulation of cellular process (GO:0048522),0.40911668036089166,1.1409054968595664,0.05,0.8313715767982606,1.0,122/565,18.76%,S100A8;S100A9;IL2RB;FPR2;LEF1;CXCR2;OSMR;NRG1;CYBA;HP;HPR;CCND2;CCL5;IL31RA;BCL2;F2R;RPL23;EXOSC4;RPS6;RPS9;DPP4;IL7R;COLEC12;LMNA;BIRC5;EFNB2;KDR;S1PR2;TRIM21;PARD3;FBXO5;PTEN;ATM;PRKD2;LBP;RARA;MDK;HDAC1;CHRD;CD47;TGFB2;CCN2;NSMCE1;ETS1;BMP4;MFSD2A;AQP11;IL2RG;RPS4X;GREM1;CXCL16;CAV1;TSHR;PDPN;CST7;LMAN2;GNAI2;BMP6;AKAP6;SHANK2;KDM4C;GCNT2;LGI1;CD36;TIMP1;CDC42;FASN;DHX36;CDK2;CIAO1;CDC7;MEIS2;FAM98A;COPS9;IL6ST;FRMD5;MAPT;ACACA;FLT3;VHL;CLCF1;IRS1;P2RX5;ABCA7;RPS19;MATK;TGFB3;NPM1;GRN;WWTR1;SIRT1;RPS15A;FGF7;ITGAX;CTSH;CAPNS1;SDCBP;KITLG;SHC1;CRKL;CUL3;PAK1;TREM2;IGF1R;TIAM1;NOXO1;PDGFD;CDK13;S100A13;SINHCAF;MLC1;SOX11;HDAC2;NTRK3;CDC123;HES1;CEP43;P4HB;VIPR1;EGR2;SLC25A33;HDAC4
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5008491223755149,1.1407765543947526,0.29295426452410384,0.8311109078741086,1.0,2/20,2.86%,MMP9;NEDD4
prerank,response to metal ion (GO:0010038),0.43327295932894366,1.1406249657973904,0.28496319663512093,0.8309150720535075,1.0,16/67,16.91%,ANXA11;BCL2;NEDD4;ITPR3;GPHN;MT1X;MT1A;CAV1;SLC11A2;CRIP1;ATP5F1D;MAPT;PPP2CA;NDRG1;CALM1;TRPC1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.45445008410098975,1.1402089521425633,0.29366812227074235,0.8316252372397541,1.0,2/44,0.58%,TBX21;EOMES
prerank,chromatin remodeling (GO:0006338),0.42601778871668156,1.1398330016541862,0.25231719876416064,0.8322404313946403,1.0,31/100,20.95%,SATB1;DAXX;ACTB;ATRX;MYB;SMARCC1;HDAC1;SMARCD3;JARID2;KDM4C;ACTR8;DR1;NPM1;SUV39H2;SIRT1;PADI4;BAZ2A;KDM5B;BAZ1A;PAK1;RUVBL1;GATAD2B;TOP1;KAT2B;HDAC2;MYSM1;PBRM1;HDAC4;SOX9;KDM5C;CECR2
prerank,negative regulation of T cell proliferation (GO:0042130),0.47976460061641635,1.1397308542161788,0.3048065650644783,0.831845295368481,1.0,7/28,17.78%,SPN;PRNP;PRKAR1A;TNFRSF14;CEBPB;GLMN;LILRB1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.46938402234632676,1.1391945051001808,0.30994152046783624,0.8330853829720254,1.0,8/34,14.04%,GATA3;RUNX1T1;FERMT2;ZFP36L2;ASXL1;FOXO1;WWTR1;SIRT1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.46290366690162016,1.1390892346458157,0.3026166097838453,0.8327168963947024,1.0,13/38,22.51%,NDUFA1;NDUFS7;NDUFA10;NDUFA5;NDUFA9;NDUFB10;NDUFA4;NDUFS6;NDUFV3;NDUFA8;NDUFA2;NDUFB11;NDUFS5
prerank,activation of adenylate cyclase activity (GO:0007190),0.46420179126596045,1.1385689559995753,0.3108866442199775,0.8339059718504752,1.0,6/35,10.41%,CAP2;EDNRA;RAF1;TSHR;LGR4;ADCY6
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5483455496617365,1.1384884322402549,0.3397790055248619,0.8334858858964328,1.0,1/12,0.84%,B3GNT3
prerank,establishment of endothelial barrier (GO:0061028),0.47407065346849614,1.1383425577116406,0.3120567375886525,0.8332520507446866,1.0,11/29,24.31%,PECAM1;MSN;MARVELD2;RAPGEF6;EZR;PPP1R16B;AFDN;RDX;RAPGEF3;RAP1B;TJP2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3869806784326785,-1.138117671865948,0.25675675675675674,0.8337907580750782,1.0,2/17,3.28%,SNTA1;ANK2
prerank,fatty acid transport (GO:0015908),0.5198378121220044,1.138095279642815,0.32679738562091504,0.8333981708367008,1.0,7/17,14.90%,APOE;MFSD2A;FABP5;CD36;SLC27A1;ACSL1;FABP4
prerank,positive regulation of protein modification process (GO:0031401),0.41105949951010123,1.1379834249484626,0.19019019019019018,0.8330531970994709,1.0,46/203,18.14%,FPR2;CD4;MMP9;RASGRP1;DLC1;CCND2;CHP1;CD74;DAXX;SMPD1;PECAM1;ANGPT1;C3;P2RY1;KDR;PPIA;RACK1;SLCO3A1;RAMP1;BMP4;PTPA;PIN1;RARRES2;FAM20A;HSP90AA1;ILK;CDH5;STK4;RALB;NPTN;TNIK;SIRT1;RIPK1;FGF7;CRKL;PPP1R16B;RAP2A;PAK1;TREM2;AGER;MYDGF;NIBAN1;CALM1;CLIP3;NTRK3;SPPL3
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4541208758285251,1.1379068504614815,0.30176211453744495,0.832607925868696,1.0,10/43,11.31%,LTF;IFITM1;DDR2;FERMT2;FBXO5;BMP4;BMP6;ATP6AP1;SUCO;IL6ST
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4393788255756681,1.1377522248126208,0.2804232804232804,0.8324163865727414,1.0,16/62,14.11%,NR4A3;PRKCQ;MYL9;CDK6;PAF1;HDAC1;NFE2;SETD1A;LEO1;RBM15;L3MBTL1;ZBTB16;MEIS2;CTR9;LGALS3;WDR5
prerank,homotypic cell-cell adhesion (GO:0034109),0.4551974062666719,1.1377064975701507,0.30760749724366043,0.8318584862427,1.0,11/39,17.82%,MYL9;ACTG1;FLNA;ACTB;PPIA;ACTN1;MYL12A;ILK;VCL;MEGF11;CSRP1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5208799412318016,1.136986001260712,0.3294270833333333,0.8337037666667763,1.0,4/17,15.47%,PLAAT3;MBOAT7;PLBD1;PLA2G12A
prerank,response to steroid hormone (GO:0048545),0.4721540482328877,1.1366118836563484,0.29940828402366865,0.8342967894726135,1.0,11/31,15.91%,TGFB2;UBE2L3;CAV1;ABHD2;ATP1A3;ATP1A1;TFPI;ATP1A2;TGFB3;ABCA2;WBP2
prerank,cholesterol homeostasis (GO:0042632),0.4371353912168053,1.1365839326508624,0.2860215053763441,0.8336470540095843,1.0,15/64,19.70%,CD24;HDAC9;ABCG4;APOE;SOAT1;NR1H2;GRAMD1B;CAV1;SIRT1;CYP7B1;ABCA2;RORA;TTC39B;SOAT2;LDLR
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.45420360081996025,-1.1364992396934213,0.29411764705882354,0.835068937371579,1.0,4/11,7.70%,TGFBR1;SMAD7;TGFBR2;TGFB1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4523146057260149,1.136471150471878,0.32919954904171367,0.8333172060384529,1.0,11/40,21.55%,MMP9;CLU;BID;GPX1;TNFSF10;BCL2L11;PRELID1;BNIP3;DNM1L;MFF;GHITM
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.3777915793272985,-1.1363986352291482,0.2803738317757009,0.8315008082880002,1.0,4/20,3.11%,ROCK2;NCKAP1L;FMNL1;FHOD1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.4416137917108107,-1.1362829913375017,0.3102189781021898,0.8279704818295222,1.0,4/13,9.52%,LGMN;TBC1D10A;ASPH;GRIN2A
prerank,mitochondrial transport (GO:0006839),0.43926523240266985,1.1361348664941886,0.2889366272824919,0.8338438981168438,1.0,16/53,21.25%,SLC25A24;BCL2;TOMM22;TOMM7;TIMM9;SLC25A16;HSP90AA1;TMEM14C;TIMM17B;TIMM10;TIMM17A;TSPO;SLC25A4;BNIP3;TIMM22;MFF
prerank,apoptotic mitochondrial changes (GO:0008637),0.4626738298017788,1.1360504094044874,0.3074245939675174,0.833399319483685,1.0,13/32,22.22%,IFIT2;BCL2;CLU;BID;SFN;CCAR2;THEM4;SOD2;ATG3;BNIP3;DNM1L;MFF;ERBB4
prerank,negative regulation of angiogenesis (GO:0016525),0.424508097457566,1.1359183059760178,0.26804123711340205,0.8331610143889472,1.0,14/84,12.64%,CCR2;HRG;ANGPT4;ADGRB1;DCN;SPINK5;HSPG2;ATP2B4;TGFB2;CXCL10;CTNNB1;SERPINE1;ROCK1;NAXE
prerank,linoleic acid metabolic process (GO:0043651),0.5086366105815705,1.1359175705764382,0.32588699080157685,0.8324256560355588,1.0,3/17,14.68%,FADS1;ELOVL1;ACSL1
prerank,relaxation of muscle (GO:0090075),-0.42688708700059363,-1.1356875786949268,0.27208480565371024,0.8260471820652235,1.0,3/13,3.46%,SLC8A1;PIK3CA;P2RX4
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4868095742381359,1.135637215453669,0.3198090692124105,0.8326804054409119,1.0,4/25,11.78%,CBLB;CHMP6;CNRIP1;EPHB2
prerank,primary miRNA processing (GO:0031053),0.5626032629738433,1.1354014713554712,0.32540861812778604,0.832797200166596,1.0,5/10,21.28%,SMAD2;METTL3;SMAD1;DROSHA;DGCR8
prerank,negative regulation of kinase activity (GO:0033673),0.4317083838603143,1.135388714213245,0.29567053854276665,0.8321139825752195,1.0,19/62,21.45%,DBNDD1;CHP1;CEACAM1;RTRAF;NPRL2;SMCR8;PPIA;GSKIP;TARBP2;SFN;MAPT;WWTR1;GNAQ;CEP43;PTPRC;SNCA;HNRNPU;TAB1;YWHAG
prerank,positive regulation of rRNA processing (GO:2000234),-0.4524513510292404,-1.1350867919303247,0.2871287128712871,0.8241792927154444,1.0,5/10,11.15%,SIRT7;UTP15;WDR75;BUD23;RIOK1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.40651429363460234,1.1350506544788643,0.095,0.8325851584536997,1.0,138/497,23.60%,LEF1;DEAF1;TBX21;NRG1;GZMB;GTPBP4;NCOR2;GATA3;DEDD2;DACH1;SOX7;SCML4;PUS7;TFAP4;DAXX;MRPL13;HOXA7;RUNX1T1;S100A11;PDCD4;HDAC9;HSPA8;HEXIM1;ARID5A;BIRC5;ILF3;AHR;SHMT1;DAPK3;DKK3;RACK1;SMAD2;MYB;RPS3;KCTD1;PFDN5;LBH;RARA;HDAC1;NIPBL;HMGB2;WAPL;NR1H2;FOXP1;NR1D2;ZHX2;RBM15;BMP4;DAP;PER2;JARID2;RPS6KA5;TFDP2;MALSU1;ATF7IP;L3MBTL1;HEY2;TRIM33;ID2;EIF4A3;PSPC1;SYNCRIP;GLI3;DHX36;MIDEAS;ZBTB16;CCAR2;GATAD2A;CTNNB1;BTG2;NCL;CPEB3;LIMD1;FOXO1;ATXN1;BCL6;HMBOX1;SUV39H2;SAMD4A;NCOR1;SIRT1;GAPDH;SHC1;CIC;RBAK;RCOR1;CDKN1A;EIF2AK3;TYMS;IKZF4;RUNX2;RFX3;PRDM5;GSK3A;NKRF;CRYAB;NFIL3;RBFOX2;SMURF2;CBX4;HDAC2;DBI;DMAP1;DPF2;HES1;PER1;HINFP;HDAC4;SELENOS;MLXIPL;MLX;ZBTB33;MECOM;SOX9;GLIS2;KDM5C;ATR;GSK3B;MECP2;GMNC;ZNF148;TRIM28;BTRC;SOX13;BTAF1;DDX6;PAIP2B;MBD2;YBX1;ZFPM2;ARID4A;GIGYF2;DDIT3;TIMELESS;CRY2;EPRS1;CENPF;ZNF318
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5484841969939463,1.1346152960762468,0.3469675599435825,0.8334232599147438,1.0,1/11,7.99%,RTP4
prerank,negative regulation of telomere maintenance (GO:0032205),0.533687306035829,1.1345274424574123,0.33116883116883117,0.8329909007476888,1.0,4/15,13.54%,RTEL1;ERCC4;ATM;ERCC1
prerank,positive regulation of phosphorylation (GO:0042327),0.4087851228717799,1.1343306900196712,0.184,0.8329778560897013,1.0,56/240,18.14%,FPR2;CD4;MMP9;LMO4;RASGRP1;CCND2;CCL5;CD74;DDR2;DAXX;PECAM1;ANGPT1;ENTPD5;C3;P2RY1;LMTK2;KDR;PPIA;RACK1;DSCAM;MIF;KIT;SLCO3A1;BMP4;PRXL2C;PIN1;RARRES2;FAM20A;BTBD10;HSP90AA1;ILK;EPHB2;FLT3;EPHA7;STK4;EPHA5;RALB;NPTN;TNIK;SIRT1;RIPK1;FGF7;SDCBP;CRKL;RAP2A;PAK1;TREM2;AGER;IGF1R;MYDGF;NIBAN1;GLMN;CLIP3;NTRK3;EPHA3;PTGES3
prerank,negative regulation of inflammatory response (GO:0050728),0.4130230967251791,1.1343147345320697,0.20582329317269077,0.8323027014736173,1.0,38/182,19.37%,FPR2;CD247;CD3G;GATA3;GPR83;ADORA2A;HTR7;GPR45;PTGIR;APOE;PRKAR1B;MDK;MC5R;RAMP1;HTR4;GPR84;IAPP;INSL3;TSHR;SMPDL3B;ADCY6;GPR176;RPS19;CDH5;SHARPIN;GRN;PRKAR1A;FYN;TREM2;ADCY1;ADCYAP1R1;TNFAIP6;ACOD1;GIPR;VIPR1;RORA;SELENOS;PTH1R
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4479827510906358,1.1342932892069388,0.31106243154435925,0.831643527161469,1.0,16/52,18.07%,RANGRF;SORBS1;RACK1;ITGB1;ATP2B4;PLS1;PTPN9;CNPY4;CNST;CLN3;EPHB2;ZDHHC2;LGALS3;TREM2;CLIP3;EPHA3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.46511726051060154,1.1342669735881064,0.30344827586206896,0.8310037700219691,1.0,8/34,11.89%,PTPN22;PTPN13;DUSP5;PTPN12;PTPN9;DUSP6;DUSP2;DUSP16
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.538592379665677,1.1332102392065493,0.34146341463414637,0.8339251896299892,1.0,5/12,22.55%,SPTBN4;EPHB2;PAFAH1B1;SZT2;NFIB
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.4802429774148801,1.1326515363560967,0.3333333333333333,0.8351971661854319,1.0,4/23,15.21%,ACSBG1;FADS1;ELOVL6;GPX4
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5116511709330127,1.1325598949481044,0.308300395256917,0.8347962599626061,1.0,5/18,14.91%,TBX21;HDAC7;LAPTM5;PRNP;EZR
prerank,blood vessel diameter maintenance (GO:0097746),0.4639893668293646,1.1325390100075339,0.3181818181818182,0.8341594518881513,1.0,8/34,18.36%,EDNRA;KCNMB4;PER2;ADCY6;ROCK1;SCPEP1;KLF2;ECE1
prerank,response to interferon-beta (GO:0035456),0.49244278273874775,1.1322622636391297,0.3268529769137303,0.8343914001025285,1.0,4/22,7.43%,IFITM1;IFITM2;IFITM3;UBE2G2
prerank,protein-DNA complex disassembly (GO:0032986),0.5234915927812566,1.1321151326161114,0.34285714285714286,0.8341825774188694,1.0,4/16,6.55%,RPL23;SMARCC1;SMARCD3;NFE2
prerank,sterol homeostasis (GO:0055092),0.4345180535839457,1.1319492195054193,0.286480686695279,0.8340640164512693,1.0,15/65,19.70%,CD24;HDAC9;ABCG4;APOE;SOAT1;NR1H2;GRAMD1B;CAV1;SIRT1;CYP7B1;ABCA2;RORA;TTC39B;SOAT2;LDLR
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5110449166725257,1.1315690820906683,0.352112676056338,0.8346538611319657,1.0,4/18,15.59%,RNF125;OASL;NOP53;USP15
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4351877460403848,1.1313924937789475,0.29914529914529914,0.8345644357841114,1.0,14/55,15.53%,CHP1;DCN;LUM;FMOD;CEMIP;BGN;HSPG2;SDC2;OGN;CD44;GPC6;GPC3;CSPG5;SGSH
prerank,response to unfolded protein (GO:0006986),0.4435899618051131,1.1313391148095613,0.2981501632208923,0.834049258521442,1.0,10/48,13.71%,DNAJB1;DAXX;ERP44;HSPA8;HSPA5;HSPH1;HSP90AA1;HSPA4;DNAJB2;HSPA1A
prerank,dendrite self-avoidance (GO:0070593),0.5165860931862061,1.1312856306805725,0.34002677376171353,0.833519468681823,1.0,4/16,13.89%,EMB;DSCAM;BSG;NPTN
prerank,response to nitric oxide (GO:0071731),0.543339610443536,1.131227757465053,0.3388888888888889,0.8330017848990801,1.0,6/13,26.21%,CDK2;FOXO1;MTR;GUCY1B1;TXN;KCNC2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.44420837238021565,1.1310282075774003,0.30491803278688523,0.8329914911422722,1.0,19/46,24.14%,FBLN1;PTEN;TIMP3;SPRY1;LMO3;DUSP6;PIN1;SPRY3;EPHB2;EZR;DUSP4;EMILIN1;RANBP9;TNIP1;PTPRC;DUSP3;DLG1;DUSP10;ITGB1BP1
prerank,neuron projection morphogenesis (GO:0048812),0.41532657961993585,1.1304830111460786,0.2391523713420787,0.834194376366079,1.0,35/137,15.52%,S100A6;SLITRK2;ADGRB1;ACTB;ATP7A;IQGAP1;LMTK2;RAB8A;PARD3;PTEN;PLXNB1;SDC2;SPTBN4;CNTNAP2;ZDHHC17;ANK3;CDC42;NEFH;TAOK3;CTNNB1;NBL1;ROCK1;ALCAM;GPM6A;EPHB2;DCLK1;UBB;NCKAP1;NTNG1;NTNG2;TNIK;MAP1B;DCC;DRD2;PAK1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4591595028931684,1.1298108715698665,0.3162100456621005,0.8358870686750047,1.0,4/38,2.00%,FPR2;CYBA;CCL5;SCIMP
prerank,inner ear morphogenesis (GO:0042472),-0.3632899380275677,-1.1297130166004208,0.26570048309178745,0.8367312865527976,1.0,8/22,23.67%,CHD7;TIFAB;PAX8;PAX2;HPN;ZIC1;MYO3B;TTC39C
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5594827952887923,1.129395826866686,0.3465909090909091,0.8366299428862398,1.0,5/11,19.69%,CAMK4;STAP1;TICAM1;ITGB2;TYROBP
prerank,regulation of mitotic nuclear division (GO:0007088),0.4338181117576585,1.1290027541713774,0.310752688172043,0.837249848343942,1.0,10/55,11.47%,CD28;DAPK3;FBXO5;RCC1;PRMT5;CUL9;BMP4;PIN1;L3MBTL1;LCMT1
prerank,negative regulation of signal transduction (GO:0009968),0.40487233112874077,1.1289303831322541,0.168,0.8368018368273142,1.0,39/249,12.89%,LTF;HRG;CILP;PRKCQ;GATA3;SFRP5;CCL5;BCL2;SMPD1;SIGIRR;NEDD4;DCN;TLR9;HHIP;PTGIR;DKK3;RACK1;PTEN;BRAP;CADM4;METTL3;SPRY1;NR4A2;CD47;PTPN12;RNF157;YWHAB;NLK;SMPDL3B;SPRY3;GLI3;LGR4;NCK1;APPL1;DACT3;ASXL1;IRS1;CARD16;GRB14
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5530493657585485,1.1287688949430574,0.3441466854724965,0.836636050100013,1.0,3/12,5.41%,UST;DCN;BGN
prerank,protein-containing complex disassembly (GO:0032984),0.44276755305761045,1.1285713539716018,0.31607335490830635,0.836577391817482,1.0,18/54,22.95%,RPL23;HSPA8;CSNK1A1;MAP1LC3A;CAV1;CLN3;CTNNB1;UBQLN1;LIX1;STX17;TECPR1;LAMP2;VIPAS39;VPS16;GSK3B;PPP1CA;GABARAP;MAP1LC3B
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5389026721009166,1.1285684795116973,0.33424657534246577,0.8358672228422309,1.0,7/12,26.89%,COLEC12;CAV1;MUL1;RALB;CGAS;IFIH1;MAVS
prerank,response to ionizing radiation (GO:0010212),0.43279718104622833,1.1284723303528663,0.2890295358649789,0.8354765462450612,1.0,17/70,15.31%,ANXA1;FIGNL1;SMPD1;RAD1;AEN;TICRR;ATM;GADD45A;INTS7;NABP1;FANCD2;IKBIP;COP1;BLM;SIRT1;CDKN1A;EEF1D
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.4416809460668223,1.1283796224612612,0.2905701754385965,0.8343854366413868,1.0,9/51,7.50%,CHMP6;LMNA;PPP2R2A;LBR;RCC1;LEMD2;CDK1;CHMP7;PPP2R1A
prerank,mitotic nuclear membrane organization (GO:0101024),0.4416809460668223,1.1283796224612612,0.2905701754385965,0.8343854366413868,1.0,9/51,7.50%,CHMP6;LMNA;PPP2R2A;LBR;RCC1;LEMD2;CDK1;CHMP7;PPP2R1A
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5125184336309737,1.1283529156834484,0.3237971391417425,0.8337706428121672,1.0,5/18,17.36%,MMP9;CAV1;ATP1A2;CBARP;SLC43A2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.47587022350095515,1.127847556390218,0.31899641577060933,0.8348270072173521,1.0,7/27,17.60%,CPA4;MORF4L1;MSL3;TAF6;RUVBL1;MRGBP;KAT2B
prerank,neuron projection fasciculation (GO:0106030),0.5722706518837424,1.1277258621780006,0.33724340175953077,0.8345314992347328,1.0,3/10,11.78%,AMIGO1;SEMA5A;EPHB2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.4901047015578475,1.1273324591653293,0.3345029239766082,0.8352034013911045,1.0,9/26,22.89%,CEACAM1;APOC1;ACADVL;NR1H2;MID1IP1;MLXIPL;ADIPOR2;PRKAB2;SLC45A3
prerank,regulation of gastrulation (GO:0010470),0.5315017455706648,1.1272557486725712,0.33511348464619495,0.8347570999609301,1.0,6/14,23.27%,RACK1;DAG1;POGLUT1;PHLDB1;TENM4;CLASP2
prerank,regulation of osteoblast differentiation (GO:0045667),0.4242813041245346,1.1268064555556883,0.2787564766839378,0.8356251223327532,1.0,19/82,13.78%,LTF;IFITM1;DDR2;SMOC1;CDK6;FERMT2;HDAC7;FBXO5;CHRD;BMP4;GREM1;BMP6;ATP6AP1;TMEM64;SUCO;IL6ST;LIMD1;ATF4;WWTR1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.5353917119037298,1.126646799756886,0.36209150326797385,0.8354908215943341,1.0,3/14,9.84%,GATA3;SPRY1;SPRY3
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5499443147906041,1.1266003126211983,0.34449093444909346,0.8349371248151268,1.0,8/12,17.87%,APOE;FLOT2;PRNP;ROCK1;FKBP1A;ABCA7;ABCA2;RANBP9
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5613238730191199,1.126473833146285,0.3587257617728532,0.8346852957894999,1.0,2/10,8.62%,CHP1;CAV1
prerank,neural crest cell development (GO:0014032),0.4528028748058068,1.1260547079892174,0.31567328918322296,0.8354068506473541,1.0,10/44,19.79%,NRG1;KBTBD8;ANXA6;SEMA5A;SEMA3E;SOX11;SOX10;SEMA5B;SNAI2;SEMA3D
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5148810851291772,1.1259951408158115,0.37017310252996005,0.8349246758627755,1.0,7/17,12.55%,CLU;APOE;PIN1;PRNP;ROCK1;SORL1;ABCA7
prerank,placenta development (GO:0001890),0.5496950052033597,1.125807229790072,0.34864864864864864,0.8348800692284489,1.0,1/12,2.90%,ADAM19
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.4426800344553279,1.1256156552361922,0.314192849404117,0.8348422776593499,1.0,16/53,16.22%,OAZ3;PSMC3;PSMD8;PSME1;PSMD6;NQO1;PSMB5;PSMC6;PSMB4;AZIN1;PSMA7;PSMB9;PSMA6;PSMC1;PSMD7;PSMD2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.42593880169889464,1.12541736474282,0.2908902691511387,0.8348096004051648,1.0,14/84,9.09%,TMSB4X;ANGPT4;GATA3;ANGPT1;HMGB1;SEMA5A;KDR;PRKD2;FOXP1;ETS1;BMP4;GPI;BCAR1;GPLD1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4075977377377046,1.1253996453354445,0.2454728370221328,0.8341596791873835,1.0,37/175,18.13%,TMSB4X;LTB;GATA3;TRAF1;CCL5;CCL7;TNFRSF11B;PSMC3;PSMD8;RPS3;PSME1;GBP2;PSMD6;PSMB5;PSMC6;JAK2;PSMB4;ZFP36L2;ILK;NFKBIA;PSMA7;YBX3;PSMB9;PSMA6;TNFRSF13C;TNFSF12;ZFAND6;PSMC1;SIRT1;RIPK1;TNFRSF14;PSMD7;PSMD2;GBP3;TXNDC17;ACOD1;PSMD5
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.36550552202725933,-1.1247206466325779,0.2654320987654321,0.8493890264287437,1.0,8/22,17.68%,RASSF2;CALM2;PDGFA;TOM1L1;VEGFA;MRE11;TNKS1BP1;NEK10
prerank,response to UV-B (GO:0010224),0.5348932735764067,1.1243568933543562,0.333810888252149,0.8370417815755893,1.0,5/12,22.12%,CRIP1;CDKN1A;STK11;MSH2;MME
prerank,cardiac conduction system development (GO:0003161),0.48328030136217276,1.124289946627455,0.3288009888751545,0.8365690652558793,1.0,4/24,11.46%,GJB6;BMP4;HEY2;SMAD1
prerank,artery morphogenesis (GO:0048844),-0.3258007268293263,-1.1242468576829197,0.28,0.8470217797340494,1.0,7/30,11.09%,TGFBR1;BMPR2;SMAD7;LRP1;NRP1;VEGFA;NOTCH1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5070597810282265,1.1240162523807224,0.33940182054616386,0.8368773033351308,1.0,8/18,20.94%,APOE;MSN;HSP90AA1;VPS11;EZR;ABCA2;CTSC;RDX
prerank,import into nucleus (GO:0051170),-0.26818619773315633,-1.1239921448576078,0.2222222222222222,0.8440268720202041,1.0,25/73,17.58%,APPL2;IPO8;IPO5;BACH2;HEATR3;GEMIN5;TNPO2;HIKESHI;SNUPN;IPO9;E2F3;SNRPD3;RANBP6;SNRPE;TSC2;NUP85;SEC13;KPNB1;GEMIN7;PTTG1IP;SYK;IPO11;SNRPD1;SMN1;STAT3
prerank,chromatin organization (GO:0006325),0.4142692544678451,1.1238208296963412,0.2606060606060606,0.8368648404086186,1.0,38/132,20.24%,SATB1;DAXX;ATRX;TCF7L1;HDAC11;MYB;SMARCC1;HDAC1;SMARCD3;HMGB2;JARID2;L3MBTL1;KDM4C;HP1BP3;SETD5;DR1;NPM1;SUV39H2;SIRT1;PADI4;DDX11;BAZ2A;KDM5B;BAZ1A;SETD7;PAK1;RUVBL1;PWWP3A;HMGN3;TOP1;KAT2B;HDAC2;MYSM1;PBRM1;HDAC4;MECOM;SOX9;KDM5C
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.47146799662412836,1.123818319529768,0.3256616800920598,0.8361707023088746,1.0,14/32,22.74%,DLC1;SMPD1;PPP1R15A;PPIA;PTPA;PIN1;PPP1R15B;CDH5;PPP1R16B;CALM1;SPPL3;HSP90AB1;ITGA1;CALM3
prerank,sensory perception of sound (GO:0007605),0.41802392019090895,1.123803491591097,0.2836438923395445,0.8355120399373818,1.0,13/88,11.45%,RIPOR2;CEMIP;BIRC5;SPTBN4;NIPBL;KIT;TIMM9;MKKS;CLRN1;MARVELD2;TMIE;GRAP;COL1A1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.4378955164807092,-1.1233234176362146,0.3041958041958042,0.8423509790808411,1.0,1/11,0.12%,MERTK
prerank,positive regulation of mitochondrial fission (GO:0090141),0.5062346605970163,1.1232563089344227,0.3155844155844156,0.8366068586543277,1.0,8/18,21.25%,DCN;KDR;MUL1;RALA;BNIP3;DNM1L;MCU;MFF
prerank,negative regulation of gene expression (GO:0010629),0.4068440612582586,1.1224361805411065,0.1743486973947896,0.8387365108221436,1.0,64/302,15.44%,CD3E;MMP8;GZMB;CILP;NCOR2;PTPN22;CD28;PUS7;MRPL13;SRGN;HDAC9;SMCR8;RBBP7;ILF3;KDR;SHMT1;DAPK3;APOE;RACK1;RPS26;RPS3;FLOT2;ATP2B4;PTBP3;HDAC1;METTL3;MIF;DNMT1;RBMS3;FOXP1;TGFB2;BMP4;ASB1;JARID2;RPS6KA5;MALSU1;HEY2;ID2;EIF4A3;SYNCRIP;DHX36;LGR4;NUDT16L1;ZFP36L2;BTG2;NCL;CPEB3;ROBO1;MAPT;VHL;PTBP2;SLC7A5;SAMD4A;HSPA1A;NPTN;NCOR1;SIRT1;TARDBP;GAPDH;SMYD5;EIF2AK3;CRKL;TYMS;NUDT16
prerank,mesenchymal to epithelial transition (GO:0060231),0.5552800572189853,1.1223930821861448,0.36812411847672777,0.8381691649321594,1.0,2/10,7.67%,GATA3;BMP4
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.44624526157823585,1.1222345364114859,0.3118756936736959,0.8380114073126511,1.0,14/48,18.30%,ACTB;H1-0;POLR1G;SPHK2;TAF1B;ELOF1;SF3B1;POLR2F;SERTAD2;ATAD2B;WBP2;DEK;KAT2B;TBP
prerank,replicative senescence (GO:0090399),0.5394599558477647,1.121995987359077,0.353494623655914,0.838150552123898,1.0,5/12,22.12%,PLA2R1;ATM;SERPINE1;ATR;MME
prerank,lymphocyte chemotaxis (GO:0048247),0.45627737420047687,1.1219223560764866,0.3325608342989571,0.8376850290579245,1.0,4/34,8.55%,CCL5;CCL7;CXCL10;CXCL16
prerank,mitotic DNA replication (GO:1902969),0.5626949865281264,1.1218231982934994,0.374079528718704,0.837320939943495,1.0,5/10,22.14%,MCM2;GINS3;LIG1;MCM6;GINS1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.44324725924390224,1.1217257643628744,0.3210810810810811,0.8369707582752434,1.0,13/47,16.47%,LIMS2;FBLN1;FLNA;DOCK5;FERMT2;MDK;PDPN;CDC42;ILK;S100A10;CRKL;CSPG5;NEDD9
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4855984907685178,1.1216652168279635,0.33807829181494664,0.8364700164893316,1.0,8/24,19.83%,SCIN;MDK;SOX5;GREM1;ZBTB16;PKDCC;SNAI2;SOX9
prerank,regulation of mRNA stability (GO:0043488),0.41023010629680073,1.1216391293838424,0.24497991967871485,0.8358780056401758,1.0,40/145,16.22%,RPS27A;XPO1;EXOSC4;PSMC3;YTHDF3;HSPA8;UBA52;PSMD8;PSME1;PSMD6;METTL3;PSMB5;DCP1A;YWHAB;PSMC6;PABPC1;VIM;PCBP4;DHX36;PSMB4;ZFP36L2;NUP214;ROCK1;EXOSC1;PSMA7;UBB;PSMB9;PSMA6;MAPKAPK2;NPM1;METTL14;SAMD4A;HSPA1A;FASTKD3;PSMC1;KHSRP;PCID2;TENT5A;PSMD7;PSMD2
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5115285734890369,1.1213295477446887,0.336283185840708,0.8361915118021054,1.0,4/19,4.89%,CHP1;CCT8;CENPJ;CCT2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4930200600349465,1.121242461270214,0.35199004975124376,0.8357978770333344,1.0,3/22,6.16%,CD55;B2M;MALT1
prerank,serine family amino acid metabolic process (GO:0009069),0.5216749714021423,1.1210918121162432,0.34196891191709844,0.8356316882064985,1.0,6/16,25.34%,SHMT1;MTHFD1;SRR;SEPHS2;SARS1;SHMT2
prerank,heterocycle biosynthetic process (GO:0018130),0.5338040445375465,1.1206777934060783,0.34794156706507307,0.8363978203354837,1.0,4/14,12.34%,GPHN;MOCOS;PYCR2;NFS1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.420200029032472,1.1202883740377132,0.30952380952380953,0.8370345981951868,1.0,16/75,18.64%,PPP1R9B;CCL5;PDE6B;C3;RGS3;SAG;RNF157;YWHAB;GRK6;RGS6;ROCK1;SYP;RIC8B;CALM1;METAP2;FNTB
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5215916172036037,1.1200668306374155,0.34810951760104303,0.8370758575426615,1.0,1/16,0.37%,RIPOR2
prerank,histone modification (GO:0016570),0.41236969362773357,1.1193973794204495,0.29399796541200407,0.838721585380491,1.0,26/109,18.76%,CPA4;HLCS;USP3;HDAC9;HDAC11;HDAC1;UHRF1;MORF4L1;MSL3;RPS6KA5;MIDEAS;CDK2;SIRT1;PADI4;TAF6;BAZ2A;UBE2B;RCOR1;RUVBL1;HUWE1;ENY2;PRDM5;MRGBP;HDAC2;NSD3;HDAC4
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4513932848850595,1.1193896822770752,0.3246311010215664,0.8380516804045018,1.0,8/37,14.59%,RPL11;RPS7;RPL23;CCAR2;NOP53;PDCL3;EIF3H;SDCBP
prerank,nucleotide catabolic process (GO:0009166),0.5215470878591221,1.1187285940871288,0.3464566929133858,0.8396831661590257,1.0,3/16,7.31%,NUDT15;GPX1;GDA
prerank,negative regulation of histone acetylation (GO:0035067),-0.44788009039355,-1.1184058533305372,0.30711610486891383,0.8542843936708348,1.0,4/11,11.77%,SIN3A;NOC2L;SPI1;TAF7
prerank,dermatan sulfate metabolic process (GO:0030205),0.5403616827682793,1.1183958735686634,0.3603851444291609,0.8401615281734076,1.0,3/13,5.41%,UST;DCN;BGN
prerank,intracellular pH reduction (GO:0051452),-0.3197806307499795,-1.1179161244660032,0.2536231884057971,0.8520380981509733,1.0,14/33,18.30%,ATP6V0A1;SLC11A1;TCIRG1;RAB39A;ATP6V1D;ATP6V1A;RAB20;GPR89B;GPR89A;DMXL1;TMEM9;RAB38;SLAMF8;ATP6V1C1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4435332747896565,1.1176099086932425,0.34219269102990035,0.8422136604207662,1.0,4/43,5.91%,LTF;PTPN22;LBP;RARA
prerank,cellular response to growth factor stimulus (GO:0071363),0.407183558966237,1.117413609937187,0.2679474216380182,0.8421962129344923,1.0,36/151,16.94%,ANXA1;CILP;CCL5;IQGAP1;NDNF;KDR;MT1G;RACK1;PRKD2;SOX5;CLEC3B;PTPN12;BMP4;CD44;NR4A1;BMP6;BCAR1;EEF1A1;STAT5B;EGR3;PDE3A;APPL1;ZFP36L2;CTNNB1;ZPR1;SYAP1;MAPT;MAPKAPK2;SHC1;CRKL;MAP2K5;RPS6KB1;RUNX2;STMN2;GAS1;TWF2
prerank,cellular protein catabolic process (GO:0044257),0.4320190779932157,1.117320619586308,0.2922422954303932,0.8418020161110445,1.0,16/59,17.52%,CTSW;GZMB;GZMA;LONP1;MALT1;CLPP;UBE2G2;CTSZ;PSMA6;RSPRY1;RIPK1;CTSH;DENND3;FAP;AP2S1;CTSC
prerank,acute-phase response (GO:0006953),0.5414343269955453,1.1173132585389407,0.3472972972972973,0.8411320656966587,1.0,4/12,18.09%,SIGIRR;LBP;CEBPB;MBL2
prerank,regulation of centriole replication (GO:0046599),0.5090917833781874,1.1171989461895657,0.35094339622641507,0.8408565866118944,1.0,5/18,17.60%,PLK4;CENPJ;NPM1;MDM1;KAT2B
prerank,regulation of interferon-alpha production (GO:0032647),-0.3520894317403419,-1.117113007830395,0.2623762376237624,0.8507907008380768,1.0,9/23,17.66%,TLR7;TLR4;TLR8;TLR3;HAVCR2;CHUK;TBK1;IRF3;IRF7
prerank,response to hydrogen peroxide (GO:0042542),0.44024847944631834,1.1169039643954604,0.34505494505494505,0.8411801326228969,1.0,11/45,16.86%,ANXA1;MAPK13;HP;RPS3;GPX1;APTX;STK24;SIRT1;RIPK1;FYN;STK26
prerank,membrane depolarization (GO:0051899),0.46338688425774066,1.1164210088603554,0.33519553072625696,0.8421683141845123,1.0,11/32,20.66%,SCN4A;SCN1A;SCN7A;CAV1;CACNB4;CACNA1H;SCN8A;CACNA1I;SCN3B;SCN1B;CACNA1B
prerank,positive regulation of dephosphorylation (GO:0035306),0.47597330016214656,1.1162881902243211,0.3467455621301775,0.8419098298929052,1.0,9/27,18.14%,DLC1;SMPD1;PPIA;PTPA;PIN1;CDH5;PPP1R16B;CALM1;SPPL3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4470145483725446,1.115596703977649,0.3231638418079096,0.843575382501695,1.0,8/38,10.37%,MMP8;CLU;ATP2B4;CD47;CAV1;JAK2;CD36;HSP90AA1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.44953857385744544,-1.1154231356992252,0.2953020134228188,0.8524058773760858,1.0,3/11,5.52%,RREB1;ARHGEF7;KANK1
prerank,protein homotetramerization (GO:0051289),0.4397457358131518,1.11529131293813,0.32491767288693746,0.8439935717602893,1.0,10/49,16.35%,THG1L;UPB1;B2M;SHMT1;ALDOA;APIP;AQP4;ACACA;SOD2;SAMHD1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.5177960830584462,1.1148435452809269,0.3526315789473684,0.8448375710872782,1.0,6/15,15.34%,BAIAP3;CLN3;USP46;ZDHHC12;SYN3;DRD2
prerank,neurotrophin signaling pathway (GO:0038179),-0.35773830557147634,-1.1146613630776887,0.24867724867724866,0.8510188591123103,1.0,9/21,27.58%,GRB2;ZFYVE27;CASP3;BDNF;HAP1;RAPGEF1;DDIT4;KIDINS220;SORT1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5438642773614777,1.114451875499859,0.3620457604306864,0.8454935948941298,1.0,3/12,10.12%,SDE2;FBXO31;CDK2
prerank,negative regulation of MAPK cascade (GO:0043409),0.41650098300181426,1.1139845331121074,0.3,0.8463520802636452,1.0,30/87,23.05%,FBLN1;SMPD1;PAQR3;PPIA;APOE;PTEN;TIMP3;SPRY1;LMO3;DUSP6;BMP4;PIN1;CAV1;SPRY3;EPHB2;SORL1;FOXO1;ABCA7;DAG1;EZR;DUSP4;EMILIN1;RANBP9;TNIP1;PTPRC;DUSP3;STK38;DLG1;P2RX7;DUSP10
prerank,vitamin transport (GO:0051180),0.4627940651724029,1.1139249396506252,0.33826879271070615,0.8458522788064848,1.0,7/29,19.23%,AFM;PDPN;SLC27A1;SLC2A8;SLC19A2;SLC19A1;CD320
prerank,positive regulation of cholesterol transport (GO:0032376),0.47263510670741526,1.1139150192533662,0.3464285714285714,0.8451850423674568,1.0,8/27,15.53%,ABCA13;APOE;NR1H2;CAV1;NFKBIA;ABCA7;SIRT1;TREM2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.44944027004605297,1.1136265533619354,0.34054669703872437,0.8454756077893022,1.0,13/36,23.05%,PTPN22;PPIA;TAOK3;FOXO1;NCOR1;EZR;TREM2;PER1;FKTN;MECOM;DUSP3;DLG1;DUSP10
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.49119215138786115,1.1134118132968591,0.3583227445997459,0.8455011543526819,1.0,9/22,18.37%,RPS27A;UBA52;RNF103;AMFR;UBB;EDEM1;UGGT1;MAN1A2;OS9
prerank,regulation of keratinocyte migration (GO:0051547),0.5444120635639402,1.1132915851245566,0.33994334277620397,0.8452039512119803,1.0,4/12,14.35%,MMP9;PTEN;MAPRE2;FGF7
prerank,DNA recombination (GO:0006310),0.4533380127773957,1.112996226381972,0.3321995464852608,0.8455723766417744,1.0,5/37,4.17%,RTEL1;RAD54L;HMGB1;HMGB3;DMC1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.5400894801737618,1.112501004502414,0.36693548387096775,0.8466153280608761,1.0,6/13,21.23%,RANGRF;ABCA7;RIC3;SNX33;TYROBP;HSP90AB1
prerank,positive regulation of filopodium assembly (GO:0051491),0.4879309315352087,1.1116815644837086,0.34541062801932365,0.8487493317924321,1.0,7/24,14.48%,RIPOR2;PLPPR5;TENM2;CDC42;GPM6A;TGFB3;FNBP1L
prerank,ephrin receptor signaling pathway (GO:0048013),0.4140759485992686,1.1115160539663467,0.31191709844559584,0.848648460276476,1.0,24/82,18.07%,MMP9;ACTG1;KALRN;ACTB;NCK2;EFNB2;SDC2;ARPC2;ARPC1A;CHN1;CDC42;ARPC5;MMP2;ROCK1;EPHB2;EPHA7;EPHA5;ACTR3;SDCBP;FYN;PAK1;TIAM1;AP2S1;EPHA3
prerank,protein-DNA complex assembly (GO:0065004),0.4118604340951993,1.1113243376293602,0.3015228426395939,0.84864788647001,1.0,36/116,20.34%,RPS27A;DAXX;ATRX;PSMC3;UBA52;DMC1;MCM7;MCM2;PSMD8;XPC;ANP32B;PSME1;PSMD6;HMGB2;PSMB5;CHAF1B;PSMC6;GTF2H5;PSMB4;PSMA7;UBB;PSMB9;PSMA6;NPM1;PSMC1;PADI4;PSMD7;PSMD2;ERCC5;ORC6;PSMD5;DDB2;MCM6;SOX9;DDB1;PSMB6
prerank,positive regulation of catabolic process (GO:0009896),0.41981099674049005,1.111229106936056,0.3294736842105263,0.8482955159313693,1.0,19/65,20.56%,OAZ3;NEDD4;FZR1;BARD1;ASB5;SEC22B;NSF;SORL1;SNF8;FOXO1;VPS28;TNFSF12;GPC3;HUWE1;GSK3A;AREL1;SMURF2;DDB1;GSK3B
prerank,regulation of cellular component movement (GO:0051270),0.4385509092107349,1.1110968398858345,0.3333333333333333,0.8480404634759223,1.0,17/49,17.34%,NRG1;DIAPH1;SP100;CDK6;RAF1;DAPK3;ACTN1;CADM4;ETS1;PDPN;ROCK1;TGFBR3;RPS19;ZSWIM4;PKN1;ABL2;ZSWIM5
prerank,hexose biosynthetic process (GO:0019319),0.44194791202541517,1.1102901946142032,0.3487348734873487,0.8500921645367342,1.0,14/42,21.43%,ALDOA;SORD;PER2;GPI;ALDOC;MDH2;SLC25A10;ATF4;GAPDH;SLC25A1;CRTC2;GAPDHS;RBP4;PGK1
prerank,cardiac muscle cell development (GO:0055013),0.49520407056859606,1.11024075974228,0.3702770780856423,0.8495841318396204,1.0,3/20,9.08%,CSRP3;MYH11;HEY2
prerank,vesicle organization (GO:0016050),0.44507108687786334,1.1099997970053392,0.3426028921023359,0.8497356135229159,1.0,14/46,20.90%,PLEKHF1;SRGN;ALS2CL;HOOK1;LAPTM4B;CAV1;VPS11;SAR1B;FNBP1L;SNX33;SNX11;CORO1A;USP50;PLEKHJ1
prerank,bone development (GO:0060348),0.44511119478723665,1.109803014602846,0.3204983012457531,0.8497703262648777,1.0,3/39,2.40%,LTF;P3H1;RPL13
prerank,B cell differentiation (GO:0030183),0.43627571850695623,1.1096642810650392,0.3286334056399132,0.8495921972475117,1.0,15/46,21.46%,DNAJB9;ITGA4;HDAC9;CD79B;ITGB1;KIT;CD79A;FLT3;CLCF1;MS4A1;HDAC4;LYL1;PTPRC;MSH2;KLF6
prerank,ribonucleoprotein complex assembly (GO:0022618),0.4046375288718016,1.109607858069146,0.27062374245472837,0.8491006499147261,1.0,45/132,21.45%,RPS14;RPL11;SRPK1;CLP1;RPL38;RPS15;RPSA;RPS27;RPL23A;PRMT5;SNRPG;TARBP2;RPS28;SRPK3;LUC7L2;RPLP0;HSP90AA1;NOP53;NUDT21;SF3B1;RPS19;DDX1;RPS5;SF3A2;XAB2;SNRPB;PPAN;EIF2D;YTHDC1;ZRSR2;NAF1;PTGES3;RBM5;RPL10;MRPS7;CDC73;GEMIN8;NLE1;RPL3;LSM4;PRMT7;HSP90AB1;BRIX1;POLR2D;PRPF6
prerank,arachidonic acid metabolic process (GO:0019369),-0.31415303847553644,-1.1094437531975827,0.26495726495726496,0.8641952841133907,1.0,8/35,10.00%,HPGDS;PTGS1;TBXAS1;DAGLA;DAGLB;MGLL;PNPLA8;PLA2G4A
prerank,negative regulation of neuron differentiation (GO:0045665),0.4870974677456932,1.109316014903144,0.35555555555555557,0.8494011434215846,1.0,2/22,4.48%,SOX3;B2M
prerank,positive regulation of type I interferon production (GO:0032481),-0.2673356166428178,-1.109218825797753,0.14,0.8612209309196422,1.0,31/73,21.77%,TLR7;IRAK1;POLR3B;POLR3GL;TLR4;LRRFIP1;PRKDC;DHX33;PTPN11;TLR2;OAS2;TLR8;TLR3;FLOT1;DHX58;CHUK;POLR3K;MRE11;TBK1;ZBP1;POLR2K;IRF3;POLR3D;IRF7;PQBP1;POLR1C;POLR3E;POLR3A;STAT6;NFKB2;POLR2H
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.42380858717944797,1.1089489041460678,0.31684210526315787,0.8499230362282817,1.0,25/70,20.71%,CYBA;CYBB;NCF1;PSMC3;B2M;PSMD8;PSME1;PSMD6;PSMB5;SEC22B;PSMC6;CD36;PSMB4;PSMA7;PSMB9;PSMA6;PSMC1;LNPEP;PSMD7;PSMD2;PSMD5;TAP1;TAPBP;PSMB6;FCER1G
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.4488716020324658,1.1087635965598097,0.35091743119266056,0.8499038329417387,1.0,8/39,14.15%,RANGRF;FXYD5;FXYD1;NEDD4;UTRN;SPHK2;TCAF1;RIPK1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.42802576614577614,1.1085303470353405,0.3184238551650692,0.8500182162793399,1.0,9/56,11.00%,ANXA1;CCND2;FBXO5;LSM11;CDK1;RAB11A;CDC7;DLGAP5;ESPL1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.43898763977542815,1.1085241539740698,0.3344298245614035,0.8493525019175198,1.0,17/49,22.46%,CLU;HMGB1;RAF1;HSPA5;IAPP;JAM3;CDC42;NOP53;LCMT1;SORL1;TREM2;TMC8;CRYAB;RIOK3;GSK3B;NLRC3;SMAD6
prerank,tryptophan metabolic process (GO:0006568),0.5375708430474623,1.1084863752669507,0.350210970464135,0.8488036322511109,1.0,1/11,2.63%,ATP7A
prerank,calcium ion import across plasma membrane (GO:0098703),-0.3981168950517211,-1.1081393560943138,0.2816326530612245,0.8607938691461481,1.0,4/14,11.44%,SLC8A1;TRPV2;TRPM2;TRPV4
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.42642321911135755,1.1081029129456905,0.33191940615058324,0.8494395926855771,1.0,23/67,20.34%,CYBA;CYBB;NCF1;PSMC3;B2M;PSMD8;PSME1;PSMD6;PSMB5;SEC22B;PSMC6;CD36;PSMB4;PSMA7;PSMB9;PSMA6;PSMC1;PSMD7;PSMD2;PSMD5;TAP1;TAPBP;PSMB6
prerank,cellular response to alkaloid (GO:0071312),-0.3856394590777759,-1.107974671294433,0.29577464788732394,0.8576069768000019,1.0,4/17,16.60%,SLC8A1;CASP3;TGM2;CASP6
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.46853587426757226,1.1078081427602593,0.34951456310679613,0.8498074813270937,1.0,6/24,12.39%,RHBDF1;NUDT15;APOE;PSME1;GPX1;UBB
prerank,diterpenoid metabolic process (GO:0016101),0.43177119575628103,1.10732032768618,0.325782092772384,0.850772178517966,1.0,8/55,11.66%,ABCA4;APOE;HSPG2;SDC2;RARRES2;NAPEPLD;GPC6;RDH12
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4902591390479427,1.1072564094415425,0.35687263556116017,0.8503297837703548,1.0,6/20,12.07%,PDCD4;SPRY1;TGFB2;BMP4;HEY2;TGFBR3
prerank,protein heterotetramerization (GO:0051290),-0.4068151121318289,-1.1067823755732347,0.2988505747126437,0.8577158541408951,1.0,4/13,12.68%,PKD1;FARSB;CBR4;FARSA
prerank,axonemal dynein complex assembly (GO:0070286),0.46424503492908487,1.1067394588656227,0.3467455621301775,0.8514094222901579,1.0,4/28,14.41%,DNAH8;CCDC65;DNAI4;ODAD1
prerank,positive regulation of blood coagulation (GO:0030194),0.519090485044308,1.106287329314919,0.3444302176696543,0.8522624571185711,1.0,2/17,2.59%,HRG;F2R
prerank,actin cytoskeleton reorganization (GO:0031532),0.4210840610140708,1.106111888110847,0.31803628601921025,0.8521819897164427,1.0,19/63,18.82%,ANXA1;FLNA;MICALL2;AUTS2;S1PR2;KIT;PARVA;GSN;BCAR1;CDC42BPG;TNIK;FGF7;EZR;RAP2A;PAK1;NEDD9;ANTXR1;RALA;MKLN1
prerank,bile acid biosynthetic process (GO:0006699),-0.3462169816258718,-1.1057527411182635,0.29878048780487804,0.8574279898083108,1.0,6/24,9.30%,OSBPL9;OSBP;SCP2;CYP27A1;CH25H;OSBPL7
prerank,androgen metabolic process (GO:0008209),0.49449579132264454,1.1056568390989425,0.3686868686868687,0.8530147992793166,1.0,2/18,7.33%,DHRS9;HSD17B7
prerank,embryonic organ development (GO:0048568),0.4285561641576108,1.1055852431721893,0.34574468085106386,0.852607259757644,1.0,18/61,21.78%,GATA3;PBX1;KDR;KIT;TGFB2;MFSD2A;TBC1D23;RARRES2;HEY2;GLI3;ATF4;KITLG;PKDCC;PBX2;RPL10;PBX3;RBP4;TEAD1
prerank,regulation of focal adhesion assembly (GO:0051893),0.4362775889355363,1.1054791330275304,0.33832976445396146,0.8522954202634964,1.0,15/54,18.07%,HRG;DLC1;ACTG1;FERMT2;GPM6B;KDR;DAPK3;PTEN;PTPRA;ROCK1;S100A10;VCL;APOD;ARHGAP6;EPHA3
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5224233601894588,1.1049631057134632,0.36671177266576455,0.853392079998477,1.0,5/13,19.53%,CD74;MIF;CD44;SIRT1;SNAI2
prerank,regulation of inclusion body assembly (GO:0090083),0.5565771472089369,1.1047998452850365,0.36400541271989173,0.8532398595116273,1.0,4/11,13.71%,DNAJB1;SACS;DNAJB2;HSPA1A
prerank,regulation of cellular protein catabolic process (GO:1903362),0.49036267878791906,1.1044987412792542,0.35917312661498707,0.8536023006400913,1.0,5/18,14.91%,RGP1;MSN;HSP90AA1;VPS11;EZR
prerank,modulation by host of viral genome replication (GO:0044827),-0.42700289982690864,-1.1044384333691488,0.33613445378151263,0.857746903137841,1.0,9/13,33.52%,EIF2AK4;FBXL2;ZC3H12A;YTHDC2;VAPA;PRKN;CCNK;NUCKS1;FMR1
prerank,mitochondrial translational elongation (GO:0070125),0.4165398727966582,1.1040978273014816,0.31384615384615383,0.8543565830216198,1.0,25/88,22.23%,MRPS12;MRPL51;MRPL13;MRPL23;MRPL21;MRPL12;MRPL40;MRPL22;MRPS14;MRPL33;MRPL15;MRPL19;MRPL54;MRPL4;MRPL36;CHCHD1;MRPL17;MRPS27;TUFM;MRPS7;MRPS18A;MRPL41;MRPL27;MRPL24;MRPL30
prerank,positive regulation of cell communication (GO:0010647),0.45496232474864107,1.1040944664026502,0.3563218390804598,0.8536919343032396,1.0,10/28,25.39%,GATA3;ANK3;LGI1;ILK;RIMS3;SOX11;GRIK2;RIMS1;NMU;PTPN23
prerank,regulation of DNA recombination (GO:0000018),0.45785821601869847,1.103984589068506,0.3531390134529148,0.8533696819430685,1.0,4/32,3.82%,FIGNL1;RTEL1;H1-0;IL7R
prerank,positive regulation of behavior (GO:0048520),0.5576976268848544,1.1039059509974014,0.39085545722713866,0.8529660200556547,1.0,1/10,0.87%,NR4A3
prerank,positive regulation of protein polymerization (GO:0032273),-0.2791411278603643,-1.1038499277981833,0.21052631578947367,0.8561575181787705,1.0,23/65,22.80%,NCKAP1L;FCHSD2;PRKCE;BIN1;FER;CLIP1;BAIAP2;NAV3;CDK5RAP2;BAIAP2L1;HCK;TENM1;CDK5R1;FES;TPPP3;CDC42EP1;EVL;PYCARD;SNX9;CDC42EP4;PTK2B;ARF6;CLASP1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.521810932404522,1.1028766286898708,0.3513157894736842,0.855770311025314,1.0,3/14,9.63%,CHP1;ANK3;DMD
prerank,tRNA 5'-end processing (GO:0099116),-0.4089889258908014,-1.1028568187500463,0.34901960784313724,0.8558234239468204,1.0,8/15,22.88%,SSB;RPP14;RPP30;POP1;PRORP;RPP38;TRMT10C;RPP40
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.4187722167321911,-1.1028102842753094,0.3487544483985765,0.8523702187714182,1.0,3/12,11.77%,AP2A1;TGFB1;TAF7
prerank,regulation of protein catabolic process (GO:0042176),0.4108287371062237,1.102669909224765,0.311088295687885,0.8557924299573881,1.0,26/99,17.66%,ADGRB1;OAZ3;FLNA;NEDD4;CHMP6;FZR1;BARD1;ASB5;PIN1;SEC22B;EEF1A1;NSF;AZIN1;SORL1;SNF8;FOXO1;ZDHHC2;AGAP2;VPS28;TNFSF12;GPC3;AZIN2;HUWE1;GSK3A;AREL1;SMURF2
prerank,electron transport chain (GO:0022900),0.5174114269327118,1.102561082533473,0.36103542234332425,0.8554828951558329,1.0,4/15,9.91%,SDHB;NDUFA5;POR;ETFB
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5247143481111555,1.1022763095269281,0.38419618528610355,0.8557768873564948,1.0,4/15,19.52%,WNT6;HDAC1;HDAC2;ANKRD11
prerank,mitochondrion disassembly (GO:0061726),-0.2991045885211938,-1.1012806029798103,0.2857142857142857,0.8536823949783879,1.0,10/34,16.86%,BECN1;FUNDC1;ATG7;ULK1;WIPI1;WDR45B;CISD2;GABARAPL1;ULK2;ATG2B
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5364838152914595,1.1012681065509025,0.3748251748251748,0.8585246004903179,1.0,3/11,15.36%,SLC18A2;ABCB7;FYN
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.457752330845019,1.1011480974100891,0.35447338618346547,0.8582771446645785,1.0,8/35,11.90%,C3;CLU;APOC1;B2M;VTN;SERPINE1;SMAP1;HIP1
prerank,protein secretion (GO:0009306),0.423972738486954,1.1011337105997379,0.3503727369542066,0.8576493710034364,1.0,9/56,10.58%,ANXA1;MON1A;RAB8A;LTBP2;RCN3;RAB3D;PTPRN;TMEM167A;SNX19
prerank,DNA catabolic process (GO:0006308),0.5495539894886383,1.1007162259303749,0.38524590163934425,0.8583649724529392,1.0,2/11,4.89%,ISG20;XRN2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.23991577203718228,-1.1007147217150934,0.14285714285714285,0.8520077966124775,1.0,32/140,10.58%,ARHGAP22;CHN2;OPHN1;ARHGAP24;FGD2;CYRIB;VAV2;ARHGAP39;ARHGAP31;ARAP1;RASGRF1;FLCN;PREX1;ARHGAP25;FAM13B;ARAP2;ARHGEF7;INPP5B;RHOT1;ARHGEF9;ARHGEF11;ARHGAP12;ABR;SH3BP1;RASGRF2;GMIP;ITSN1;FGD3;ARHGAP23;CGNL1;ARHGAP20;RABL3
prerank,regulation of dendritic spine development (GO:0060998),-0.37479014545085637,-1.100357952373408,0.32242990654205606,0.8497151114675389,1.0,9/19,17.88%,TANC2;MEF2C;CAMK1;LLPH;SHANK1;CAMK2B;DLG5;KIF1A;PSEN1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.48464597975416046,1.1002813028128757,0.3645320197044335,0.8590833584417128,1.0,6/23,19.99%,PDE6B;SAG;CALM1;METAP2;FNTB;CNGB1
prerank,regulation of cell aging (GO:0090342),0.5380577507223113,1.1002798160422191,0.3825966850828729,0.8584134489564894,1.0,4/11,6.48%,NEK4;LMNA;ING2;MIF
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.45525408807970286,1.1002300790261887,0.35883014623172105,0.857917949103353,1.0,12/34,18.34%,LIMS2;FLNA;DOCK5;FERMT2;MDK;CDC42;ILK;S100A10;CRKL;CSPG5;NEDD9;P4HB
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4456103625197623,1.1002147376208768,0.37400228050171036,0.8573022844762901,1.0,10/36,20.43%,CD74;TXK;LAPTM5;CASP4;CXCR4;HSPA1A;RIPK1;AGPAT2;CPNE1;NLRC5
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5515861650717256,1.1000852400001615,0.36666666666666664,0.8570665018680758,1.0,4/10,16.44%,CD36;TICAM1;TREM2;MIA3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.47949176562394497,1.0999624409239968,0.38179519595448796,0.8568318678771645,1.0,6/23,15.36%,DIAPH1;PRNP;CACNA2D1;ATP1A2;CBARP;FYN
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4130109048895612,1.0995040689327642,0.34285714285714286,0.8577107734550586,1.0,18/92,9.79%,MMP9;ANGPT4;GATA3;GLIPR2;ANGPT1;DOCK5;KDR;PRKD2;FOXP1;TGFB2;ETS1;BMP4;GPI;INSL3;MAPRE2;BCAR1;GPLD1;RAB11A
prerank,heterochromatin organization (GO:0070828),0.511400438154911,1.0993432289021512,0.3989431968295905,0.8575366734958142,1.0,9/14,31.15%,HP1BP3;SIRT1;SETD7;MECOM;SETDB1;EZH1;POLE3;SMCHD1;SETDB2
prerank,regulation of protein binding (GO:0043393),0.4059298917092566,1.0992084696568774,0.28950050968399593,0.8573255389921745,1.0,34/114,21.58%,IFIT2;RPL11;ACTB;B2M;TRIM21;VTN;RACK1;BMP4;NVL;CTSZ;PIN1;CAV1;AMFR;BTBD1;ROCK1;FKBP1A;SORL1;DNAJB2;CARD16;STK4;RALB;PPP2CA;DDX11;CDKN1A;TIAM1;TMC8;DERL1;SPPL3;HDAC4;EPB41;MARK3;GSK3B;PRMT7;PPP1CA
prerank,chromosome organization (GO:0051276),0.41102508671269766,1.0991875550478405,0.33163265306122447,0.8567310853170738,1.0,26/99,20.68%,RPS27A;SATB1;UBA52;TCF7L1;CENPH;HDAC11;XPC;HDAC1;HMGB2;CDCA8;COPS6;L3MBTL1;UBB;COPS3;SIRT1;PADI4;MSH6;SETD7;PWWP3A;HMGN3;HDAC2;DDB2;TOP2B;COPS8;DDB1;MSH2
prerank,endothelial tube morphogenesis (GO:0061154),0.5506734506961365,1.0990121337505903,0.3757062146892655,0.8566194627618524,1.0,3/10,10.71%,PRKD2;BMP4;CTNNB1
prerank,regulation of glucose import (GO:0046324),-0.34018577798687655,-1.0989203987500442,0.3076923076923077,0.8509496997743231,1.0,8/30,7.00%,PID1;PIK3R1;APPL2;PRKCI;AKT2;PRKAG2;PTPN11;GRB10
prerank,regulation of vasculogenesis (GO:2001212),0.5159357640599039,1.0987914948629058,0.3716216216216216,0.8566824806896064,1.0,3/14,9.08%,CEACAM1;KDR;HEY2
prerank,regulation of protein dephosphorylation (GO:0035304),0.44692483879747574,1.098743241749106,0.35625704622322435,0.8561890928278558,1.0,11/37,18.14%,DLC1;SMPD1;PPP1R15A;PPIA;YWHAB;PTPA;PIN1;CDH5;PPP1R16B;CALM1;SPPL3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4591069963788088,1.0984173288509456,0.36554132712456344,0.8565984143621661,1.0,9/30,16.39%,MICALL2;TOMM7;UBL5;UBE2L3;RAC2;VPS11;RHOU;HUWE1;GSK3A
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4104613310569834,1.098248640820164,0.3229166666666667,0.8564918840901751,1.0,12/85,11.45%,RIPOR2;PIEZO2;CEMIP;BIRC5;SPTBN4;NIPBL;TIMM9;CLRN1;MARVELD2;TMIE;GRAP;COL1A1
prerank,vasoconstriction (GO:0042310),0.54042294636568,1.098026762005248,0.40329218106995884,0.8565432102994399,1.0,2/11,2.74%,ACTA2;EDNRA
prerank,filopodium assembly (GO:0046847),0.506978923686423,1.0978310068227524,0.3723404255319149,0.8565272585113027,1.0,3/16,7.85%,PPP1R9B;S1PR2;DNM3
prerank,negative regulation of protein processing (GO:0010955),0.5358095340899919,1.097805992403106,0.358974358974359,0.8559540963424571,1.0,6/12,21.30%,CTSZ;PRNP;SERPINE1;GAS1;SNX12;TMEM59
prerank,translational termination (GO:0006415),0.4125056868080161,1.0976749368470575,0.32340862422997946,0.8557504547363851,1.0,21/95,17.00%,MRPS12;MRPL51;MRPL13;MRPL23;MRPL21;MRPL12;MRPL40;MRPL22;MRPS14;MRPL33;MRPL15;MRPL19;MRPL54;GSPT1;ETF1;MRPL4;MRPL36;CHCHD1;MRPL17;MRPS27;TRMT112
prerank,histone H4 deacetylation (GO:0070933),0.5557578579042706,1.0975333791326312,0.3726346433770015,0.8555540642290532,1.0,5/10,18.76%,HDAC9;HDAC1;RCOR1;HDAC2;HDAC4
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.5105902140819575,1.0975199270043368,0.3783068783068783,0.8549498777774044,1.0,2/15,5.19%,APOC1;APOE
prerank,autophagy of nucleus (GO:0044804),-0.37902258910692854,-1.097340745847282,0.32751091703056767,0.8525468082563723,1.0,6/16,16.86%,ATG7;ULK1;WIPI1;WDR45B;ULK2;ATG2B
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4090970739678577,1.0968861693039422,0.3525773195876289,0.8563955504701477,1.0,23/86,16.92%,RPS27A;DNAJB1;PSMC3;UBA52;PSMD8;PSME1;PSMD6;PSMB5;PSMC6;PSMB4;PSMA7;LIMD1;VHL;UBB;ATF4;PSMB9;PSMA6;EPAS1;HSPA1A;PSMC1;PSMD7;PSMD2;KLF2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.551032639772136,1.0964265857226885,0.3946629213483146,0.8573031269078627,1.0,4/10,22.74%,SRI;CACNA2D1;CALM1;CALM3
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.43015551783434397,1.0961859283945647,0.35490830636461707,0.8574495357719353,1.0,9/49,12.31%,CCL5;IL31RA;GHR;KIT;ARL2BP;JAK2;IL6ST;FLT3;CLCF1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.46600198797898185,1.0957428005244836,0.3730255164034022,0.8582551058016945,1.0,8/25,20.12%,CHMP6;CHMP7;LAPTM4B;TMEM50B;CHMP5;LEPROTL1;UBXN6;MVB12A
prerank,cell-cell junction organization (GO:0045216),0.41529431712403664,1.0957427516070384,0.3305526590198123,0.8575928719237611,1.0,13/79,8.88%,PKP1;LIMS2;F2R;NECTIN1;PKP4;GJC1;CDH1;CDH13;TGFB2;CDH20;CDH19;CDH7;MARVELD2
prerank,axonal fasciculation (GO:0007413),0.5333311319583665,1.095647425490568,0.38055555555555554,0.8572520304290836,1.0,4/12,18.07%,AMIGO1;SEMA5A;EPHB2;EPHA3
prerank,regulation of translational initiation (GO:0006446),0.4260256161168957,1.095522451243682,0.3456659619450317,0.8569745136346487,1.0,19/63,18.03%,CCL5;NCK2;YTHDF3;EIF1B;BOLL;NCK1;PPP1R15B;EIF1;EIF3H;KLHL25;ATF4;NPM1;DDX1;EIF3E;EIF2AK3;RPS6KB1;CEBPB;AGO2;CDC123
prerank,spliceosomal snRNP assembly (GO:0000387),-0.3028070861123466,-1.0954281943557815,0.28346456692913385,0.854818304141422,1.0,20/38,21.22%,PRPF3;GEMIN5;TGS1;SNUPN;SNRPD3;PRPF19;AAR2;SART3;WDR77;SNRPE;STRAP;CLNS1A;USP4;GEMIN7;SNRPD1;SMN1;SART1;SRSF12;COIL;LSM2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.40512795860905954,1.0951068402142452,0.3313008130081301,0.8577542457565407,1.0,25/100,16.29%,CCL5;F2R;ENTPD5;NCF1;NEDD4;DCN;CEACAM1;PTPN13;KDR;PTEN;PLXNB1;KIT;TGFB2;JAK2;PIK3IP1;NOP53;HCST;FLT3;PIK3R5;SIRT1;PPP1R16B;TREM2;IGF1R;PDGFD;MYDGF
prerank,neurotransmitter transport (GO:0006836),0.41468521339265324,1.094630914892989,0.34164070612668745,0.8586673601377843,1.0,12/73,13.39%,SLC22A3;SLC18A2;SLC28A2;HSPA8;PPFIA2;NAAA;SLC1A6;LIN7C;DNAJC5;ATP1A2;PDZD11;SYN3
prerank,negative regulation of mitochondrion organization (GO:0010823),0.450475219850591,1.0946147826746537,0.3605051664753157,0.8580692451088259,1.0,17/33,27.46%,CLU;GPX1;IAPP;MAPT;MUL1;HSPA1A;VAT1;PRELID1;HUWE1;OMA1;BNIP3;GHITM;TFRC;MPV17L;PSMD10;IGF1;FZD9
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.508938881027642,1.0945107328142165,0.3632911392405063,0.8577369816010252,1.0,7/16,25.88%,CEACAM1;APOC1;ACADVL;NCOR1;SOX9;SIRT4;ERLIN1
prerank,protein stabilization (GO:0050821),0.39846262888557216,1.094440932584158,0.2948846539618857,0.8573380920965361,1.0,35/168,14.95%,GTPBP4;P3H1;CHP1;ATP1B3;RPL11;FLNA;GET1;CCT8;RPS7;RPL23;CLU;CCT2;PTEN;FLOT2;CRTAP;AFM;CREBL2;PARVA;COG7;PIN1;NLK;ATF7IP;HSP90AA1;NOP53;NAA16;PDCL3;HIP1;MUL1;VHL;STK4;GRN;HSPA1A;GAPDH;UBE2B;CDKN1A
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5149208147022405,1.0944085154014915,0.3891102257636122,0.8567843002950055,1.0,2/14,3.58%,ITGA4;PDCD4
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.47777022252267476,1.0942025040499346,0.3717146433041302,0.856786665543873,1.0,3/22,5.29%,TFAP4;HEXIM1;PTEN
prerank,embryonic organ morphogenesis (GO:0048562),0.443067794548609,1.094076746102111,0.37583892617449666,0.8565386066635965,1.0,12/42,22.84%,RARG;HOXB4;HOXC4;NIPBL;ID2;HOXC9;HOXB9;SOX11;HES1;HOXB3;RBP4;FBN2
prerank,potassium ion transport (GO:0006813),0.3984614260605902,1.093926772885717,0.32763819095477387,0.8563875202902049,1.0,15/120,11.64%,KCNN4;CHP1;ATP1B3;KCNJ10;KCNQ5;SLC24A4;KCNMB4;KCNJ15;KCNA4;NALCN;ATP1A4;KCNC4;KCNA1;ATP1A2;HCN3
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.36031059867454807,-1.0936722051173453,0.34,0.8567856269902209,1.0,8/21,13.74%,CYRIB;ARHGAP25;RASAL3;ARHGAP12;SH3BP1;CGNL1;MAPKAP1;MFN2
prerank,histone deacetylation (GO:0016575),0.4348054750946859,1.0933703768810115,0.34146341463414637,0.8575073727440731,1.0,14/43,18.76%,HDAC9;HDAC11;HDAC1;MORF4L1;MSL3;PER2;MIDEAS;SIRT1;BAZ2A;RCOR1;PRDM5;HDAC2;PER1;HDAC4
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4049786779909565,1.0933553532203342,0.3340122199592668,0.8569130398672634,1.0,23/113,14.89%,SKAP1;NRG1;CLU;PSMC3;FERMT2;ERCC4;BID;RACK1;ATM;RPS3;MPP7;LCP1;PSMC6;GTF2H5;CD36;HSP90AA1;RHOC;CDH5;LGALS3;ERCC1;CAPG;BCL2L11;TIRAP
prerank,monocarboxylic acid transport (GO:0015718),0.4274094254859589,1.0933278760305978,0.3373362445414847,0.8563408616764875,1.0,10/51,10.81%,CEACAM1;SLC6A8;SLC16A9;SLC16A1;SLCO3A1;SLC16A4;SLCO1C1;SLC26A6;CD36;SLC27A1
prerank,protein lipidation (GO:0006497),0.42699517622550714,1.0933084457181885,0.3569915254237288,0.8557536330483879,1.0,16/59,16.67%,PIGC;PIGH;PIGA;UGCG;ZDHHC17;GPLD1;PIGG;ATG5;DPM3;ZDHHC23;ZDHHC15;ZDHHC12;ZDHHC2;PIGZ;ZDHHC14;ZDHHC18
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4654038283605628,1.0932385906532558,0.37484737484737485,0.85533323055485,1.0,7/26,17.97%,LTF;SIGIRR;TRIM21;MUL1;CARD16;MAPKBP1;ACOD1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3914307269235373,1.093135034099269,0.207,0.8550391467983744,1.0,92/417,20.24%,LEF1;DEAF1;TBX21;NRG1;NCOR2;GATA3;DEDD2;DACH1;SOX7;SCML4;TFAP4;DAXX;HOXA7;RUNX1T1;PDCD4;HDAC9;HSPA8;HEXIM1;ARID5A;BIRC5;ILF3;AHR;DKK3;SMAD2;MYB;KCTD1;PFDN5;LBH;RARA;HDAC1;NIPBL;HMGB2;NR1H2;FOXP1;NR1D2;ZHX2;RBM15;BMP4;DAP;PER2;JARID2;RPS6KA5;TFDP2;ATF7IP;L3MBTL1;HEY2;TRIM33;ID2;PSPC1;GLI3;MIDEAS;ZBTB16;CCAR2;GATAD2A;CTNNB1;LIMD1;FOXO1;ATXN1;BCL6;HMBOX1;NIF3L1;SUV39H2;NCOR1;SIRT1;SHC1;CIC;RBAK;RCOR1;IKZF4;RUNX2;RFX3;PRDM5;NKRF;CRYAB;NFIL3;RBFOX2;SMURF2;CBX4;HDAC2;DMAP1;DPF2;HES1;PER1;HINFP;HDAC4;MLXIPL;MLX;ZBTB33;MECOM;SOX9;GLIS2;KDM5C
prerank,nuclear membrane reassembly (GO:0031468),0.42230783893064716,1.0931001793477504,0.34162162162162163,0.8545125017519911,1.0,9/54,7.50%,CHMP6;LMNA;PPP2R2A;LBR;RCC1;LEMD2;CDK1;CHMP7;PPP2R1A
prerank,regulation of sensory perception of pain (GO:0051930),0.5310726887314288,1.0929042059018221,0.3764367816091954,0.8544901184684378,1.0,3/11,8.81%,F2R;ACP3;ZFHX2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.46123817305801423,1.0928562578452692,0.36275695284159615,0.8539881075426933,1.0,2/23,3.64%,TMSB4X;HDAC7
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.47470774137372507,1.0925985275108683,0.3646477132262052,0.8541525918104043,1.0,8/21,26.49%,ADCY10;NPR2;ADCY6;ADCY1;GUCY1B1;GUCY1A1;ADCY3;ADCY8
prerank,phospholipid catabolic process (GO:0009395),0.4681565235988308,1.0925363372843349,0.38534278959810875,0.8537013776972809,1.0,6/24,17.87%,PRDX6;SMPD1;GDPD1;PLBD1;GDPD3;GPCPD1
prerank,C-terminal protein amino acid modification (GO:0018410),0.541305511947644,1.0923017803701323,0.401673640167364,0.8538439739573325,1.0,4/11,11.47%,AGBL1;GPLD1;ATG5;LCMT1
prerank,regulation of lipid metabolic process (GO:0019216),0.41104704992804236,1.0920788741701457,0.3405349794238683,0.8539110457940733,1.0,20/88,14.51%,NCOR2;APOC1;HELZ2;SREBF1;SMARCD3;NR1D2;NFYB;MBOAT7;RARRES2;PMVK;CAV1;ID2;FASN;MID1IP1;ACACA;ELOVL6;ABCA7;SCD;NCOR1;NCOA2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4445075867939772,-1.0920347594221944,0.35074626865671643,0.8584650363380232,1.0,6/10,15.35%,SYNGR1;DLG4;CAMK2B;APP;RAB5A;NETO1
prerank,selective autophagy (GO:0061912),0.42191249362377137,1.0915786669432035,0.35494155154091395,0.8548870525097183,1.0,11/56,12.39%,RPS27A;UBA52;STBD1;UFM1;ATM;DYNLL1;TEX264;VIM;ATG5;UBQLN1;UBB
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.48821581681332904,1.091525541719187,0.3860759493670886,0.8544178494663306,1.0,6/21,15.02%,PPP1R15A;YWHAB;PTPA;FKBP1A;MASTL;PPP1R16B
prerank,macroautophagy (GO:0016236),-0.23172713156369915,-1.091415583564127,0.21428571428571427,0.8570101892049564,1.0,30/118,14.42%,PIP4K2A;BECN1;STAM;EPG5;NBR1;FUNDC1;ATG10;TBC1D5;TCIRG1;SNAP29;VAMP7;VPS37A;ATG7;STAM2;UVRAG;ULK1;PRKAA2;PRKAG2;MTMR3;WIPI1;PGAM5;HGS;RUBCNL;VPS41;MFN2;PIK3C3;GABARAPL1;PRKAB1;CHMP4B;CHMP4A
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5285278450718947,1.0914127737177974,0.39207650273224043,0.8541259290871723,1.0,1/13,0.16%,FPR2
prerank,mitochondrial translational termination (GO:0070126),0.41271380549696746,1.0913775240608277,0.33126293995859213,0.8536009482298564,1.0,18/88,16.49%,MRPS12;MRPL51;MRPL13;MRPL23;MRPL21;MRPL12;MRPL40;MRPL22;MRPS14;MRPL33;MRPL15;MRPL19;MRPL54;MRPL4;MRPL36;CHCHD1;MRPL17;MRPS27
prerank,regulation of gene expression (GO:0010468),0.3886430404999595,1.0912608443732812,0.116,0.853330341544647,1.0,224/903,21.16%,CD3E;MMP8;LTF;LEF1;TCF7;TBX21;HRG;SOX3;CILP;DHH;PKP1;PRKCQ;PTPN22;GATA3;MBNL3;ZNF395;AHNAK;CD28;WNT6;SOX7;RUNX3;CD74;TMPRSS4;SERPINB9;ACTG1;STAP1;RPL11;DAXX;MYBL2;RPS7;ACTA2;ANGPT1;RPL23;FADS1;ADAM19;TXK;ATRX;CLU;CDK6;TLR9;TCF7L1;AFF3;SMCR8;ING2;PRRX2;KDR;TRIM21;AHR;RNF14;AFF4;DAPK3;FUBP1;APOE;RACK1;CDH1;MYB;ATM;RPS3;PFDN5;HNRNPAB;FLOT2;ATP2B4;PTBP3;ZBTB7B;HDAC1;AMH;MIF;DNMT1;MAPK9;GPX1;RBMS3;FOXP1;PRMT5;TGFB2;MSN;NR1D2;CREBL2;PPP2R1A;ETS1;BMP4;MSL3;NFYB;MLF1;IFNGR1;PIN1;RPS6KA5;NLK;UBE2L3;GSN;ANK3;BMP6;HEY2;ID2;PSPC1;GCNT2;CD36;PCBP4;CRIP1;DHX36;MED23;CDK2;CCAR2;NUDT21;FAM98A;PDCL3;AFF1;ZNF462;ZPR1;ACTR8;HP1BP3;ROBO1;ROCK1;SMAD1;GTF2IRD1;MAPT;EPHB2;LIMD1;YBX3;SNF8;VHL;ERC1;TOB2;CTR9;ATXN1;ATF4;MAGED1;PTBP2;CDH5;BCL6;TRIM68;PTP4A3;SLC7A5;ARNT2;HSPA1A;PRDM10;WWTR1;MBNL2;UBR5;HNRNPF;PPP2CA;SIRT1;KHSRP;APBB3;TARDBP;FGF7;ITGAX;CTSH;WNT3;NCOA2;BAZ2A;RBAK;CIAO3;EZR;EIF2AK3;CRKL;TICAM1;TREM2;AFF2;RFX3;BTN3A3;ZC3H7B;DMTF1;PRDM5;PPARGC1B;GSK3A;PRX;ZNF507;EDF1;CEBPB;NFIL3;RBM20;GLMN;SOX11;AGO2;IL33;BRAF;YTHDC1;EMILIN1;CALCOCO1;LILRB1;NTRK3;PRDM6;RYBP;CPNE1;PARP10;GPBP1L1;BMI1;PER1;HINFP;ATXN1L;NSD3;RORA;HDAC4;LYL1;AFDN;YY1;NAB2;ZFP37;PTPRC;MLXIPL;MLX;MLLT6;BNC2;SNAI2;ATG14;RFXANK;TYROBP;MBNL1;SOX9;SNX12;HES6;MED26;PCBP1;TAPBP;PCBP3;GSK3B;ZNF35;RIMS1;GRSF1;LMX1B;RDX;TRAF3;MECP2;DIP2A
prerank,regulation of multicellular organism growth (GO:0040014),0.5109000857621322,1.091164204546239,0.3875338753387534,0.8530091650418814,1.0,8/15,26.00%,GHR;MFSD2A;STAT5B;MBD5;PPIB;GDF15;PTCH1;IGF1
prerank,epithelial structure maintenance (GO:0010669),0.5430676194082649,1.0911389529480335,0.3870967741935484,0.8524584954878845,1.0,3/11,24.16%,TLR9;RBP4;CXADR
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.46444088429948566,1.0910155472875525,0.373134328358209,0.852251489797544,1.0,5/24,12.39%,RPS27A;UBA52;TAB2;NOD1;UBB
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.48557490831176264,1.0909921232915263,0.37626262626262624,0.8516902513097263,1.0,3/20,7.81%,CCL5;RNF157;YWHAB
prerank,negative regulation of blood pressure (GO:0045776),-0.4108077298021243,-1.0908986443968784,0.3375,0.8551894581545486,1.0,2/13,2.52%,BMPR2;PRCP
prerank,tetrapyrrole metabolic process (GO:0033013),0.501661079496126,1.0908766492353719,0.3871794871794872,0.8514191088715067,1.0,6/18,21.72%,MMAB;MMUT;ABCC1;CD320;ABCB6;MTR
prerank,regulation of microtubule nucleation (GO:0010968),0.5578542757985017,1.0908660207764942,0.37822349570200575,0.8508063120478995,1.0,4/10,21.10%,RANGRF;HSPA1A;PAK1;MECP2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.42905625814876697,1.0908228736322214,0.3541666666666667,0.8503071265106927,1.0,17/48,23.78%,F2R;DIAPH1;CEMIP;CXCL10;JPH4;AKAP6;DMD;SRI;FKBP1A;CALM1;TRPC1;SNCA;JPH1;JPH3;CX3CL1;CALM3;THY1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.35113793604234833,-1.0908100413825894,0.31016042780748665,0.8520153392777771,1.0,11/21,17.98%,EXTL3;XYLT1;HPSE;HS3ST4;HS3ST5;HS6ST1;XYLT2;SULF2;HS2ST1;SULF1;GLCE
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4859580952284256,1.0903376637897193,0.37,0.8512263403135435,1.0,4/19,9.35%,CCL5;MDK;RARRES2;JAM3
prerank,JNK cascade (GO:0007254),0.4386562417030999,1.0900410911537548,0.34977578475336324,0.8516344726891385,1.0,8/40,15.01%,RPS27A;MAP4K2;UBA52;TAB2;MAPK9;NOD1;UBB;CRKL
prerank,positive regulation of translation (GO:0045727),0.40687823690656677,1.0887987679850892,0.3543388429752066,0.8551023903352543,1.0,27/94,18.03%,CD28;CCL5;RPS9;YTHDF3;UQCC2;TRUB2;METTL3;RPUSD4;RPS4X;EEF2;BOLL;VIM;EIF4A3;DHX36;CPEB3;YBX3;NPM1;METTL14;SAMD4A;FASTKD3;POLDIP3;EIF3E;RPS6KB1;NIBAN1;MRPS27;AGO2;CDC123
prerank,neurotransmitter uptake (GO:0001504),0.5281161314715093,1.0886997633200959,0.40551724137931033,0.8547688982994885,1.0,4/12,17.63%,SLC22A3;SLC1A6;ATP1A2;SLC38A1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.3556568253874355,-1.088673803066565,0.30456852791878175,0.85489307480443,1.0,3/21,3.28%,CACNA1D;SNTA1;ANK2
prerank,melanosome localization (GO:0032400),0.4837286859779552,1.0885964555872063,0.3875776397515528,0.8544344181134957,1.0,5/21,13.80%,BLOC1S3;MLPH;MKKS;RAB11A;ARL6
prerank,sulfur compound catabolic process (GO:0044273),0.4403341862318135,1.0884982551911238,0.36941964285714285,0.854095237230294,1.0,7/38,8.83%,DCN;LUM;FMOD;BGN;ACAT1;OGN;CHAC2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5208090507049485,1.0882472465210962,0.3868808567603748,0.8543148460032316,1.0,3/13,6.04%,ITGA4;HMGB1;MDK
prerank,protein-containing complex assembly (GO:0065003),0.39196845263459457,1.0881906663018912,0.2775551102204409,0.8538738861723066,1.0,73/259,22.90%,CD3E;IL2RB;CD247;LEF1;TCF7;CD3G;TRAF1;F5;CD74;TFAP4;JCHAIN;WAS;F8;FERMT2;TLE4;TCF7L1;PARD3;PPIH;HDAC1;GRIA1;CSNK1A1;LEO1;PPP2R1A;CTSZ;SEC22B;PYGO1;LMAN1;DMD;NSF;CTNNB1;GPAA1;BLM;GOSR2;PDZD11;SLC2A1;PDE4DIP;ANKRD28;CAPG;RIPK1;SAR1B;TSPAN4;CUL3;SEC24D;RUVBL1;ST13;TIAM1;DARS1;TRAPPC4;CTSC;WASF3;RANBP9;CDC123;HES1;PREB;AFDN;CDC73;SOX9;TAPBP;TRAPPC5;DNM1L;GSK3B;ZW10;RIMS1;PPP6R1;MCU;TEAD1;DNAJB14;TBC1D20;SEC24C;CX3CL1;TMED2;P2RX7;TLE3
prerank,ribosomal large subunit assembly (GO:0000027),0.46069858320861645,1.0880493309740948,0.375,0.8536900704873092,1.0,10/24,22.38%,RPL11;RPL23A;RPLP0;NOP53;PPAN;RPL10;NLE1;RPL3;BRIX1;BOP1
prerank,endothelial cell proliferation (GO:0001935),0.4976504154215068,1.0879200856822016,0.38838709677419353,0.8534828251276244,1.0,3/17,7.67%,ANGPT4;SEMA5A;BMP4
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.480385762670985,1.0874870431079344,0.3763975155279503,0.8542218467387521,1.0,5/21,21.58%,CSNK1A1;CAV1;CTNNB1;GSK3B;PPP1CA
prerank,regulation of exocytosis (GO:0017157),0.4314216689802212,1.0873331676427587,0.36205016357688113,0.8541269387486871,1.0,15/46,23.27%,ANXA1;CHMP6;RAB8A;RAB3D;ATP6AP1;NSF;CADPS;CPLX2;STXBP5L;RALA;SNCA;RAB27A;STXBP5;STXBP6;CLASP2
prerank,regulation of mitochondrion organization (GO:0010821),-0.2890329728141694,-1.086917460902979,0.26582278481012656,0.8569278731120832,1.0,14/47,15.92%,CYRIB;PID1;HTRA2;FLCN;LRRK2;RHOT1;SIRT7;PARL;PPARGC1A;GOLPH3;INF2;MYO19;HDAC6;VPS35
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.3658972306939332,-1.0867265082169013,0.30808080808080807,0.8542011869529298,1.0,5/19,14.37%,PPP3R1;NFATC2;NFATC1;NFAT5;HRH1
prerank,B cell proliferation (GO:0042100),0.4935244614538438,1.0866341891404199,0.37466666666666665,0.8557002886395547,1.0,5/17,19.29%,RASGRP1;BCL2;CD79A;MS4A1;PTPRC
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.5142317354091743,1.086521180728937,0.370712401055409,0.855429390065883,1.0,3/15,11.57%,NR4A3;NR1H2;MID1IP1
prerank,regulation of ruffle assembly (GO:1900027),-0.34789069102782,-1.0863265984126116,0.3076923076923077,0.8520045086164664,1.0,5/23,5.52%,P2RY12;ARHGAP24;ABI3;P2RX4;KANK1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5036862959979383,1.0858075338541384,0.39738562091503266,0.857103493322834,1.0,7/15,23.27%,DDR2;DPP4;PDPN;CARMIL2;FAP;DDR1;CLASP2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.3065331397190939,-1.0858071743163524,0.36936936936936937,0.8503315781677795,1.0,5/38,5.44%,CACNA1D;BIN1;ANK2;KCND3;TRPM4
prerank,mitotic metaphase plate congression (GO:0007080),0.4276334397871183,1.0856828935530318,0.3723986856516977,0.8568577661576577,1.0,15/51,23.45%,CHAMP1;CHMP6;CHMP7;CDCA8;KIF22;RAB11A;CHMP5;CUL3;KIFC1;MIS12;ZW10;PIBF1;PDCD6IP;NUP62;MAD1L1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5373903773070758,1.0854929048817883,0.38285714285714284,0.8568482094908745,1.0,2/12,5.43%,PTEN;FZR1
prerank,myoblast fusion (GO:0007520),-0.42076633193162377,-1.084789638584722,0.35507246376811596,0.8502618428155679,1.0,5/12,15.93%,JAM2;PTGFRN;CD81;ADAMTS5;ADGRB3
prerank,hexose transmembrane transport (GO:0008645),0.4822748935791865,1.0845947912296794,0.38471177944862156,0.8592001365919338,1.0,4/21,13.56%,SLC5A1;SLC50A1;SLC2A1;SLC2A8
prerank,liver development (GO:0001889),0.4446379469214632,1.084544871013718,0.38329519450800914,0.8587267757004621,1.0,2/32,2.84%,ANXA1;PRKCSH
prerank,heart process (GO:0003015),0.5145104712590167,1.0842717407609317,0.3622994652406417,0.8589827569318643,1.0,6/14,32.12%,GPX1;FYN;SGCG;SGCZ;PPCS;SOD1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3319113133877427,-1.083801229199258,0.3333333333333333,0.8499876344911724,1.0,9/26,17.99%,LRP5;TRPM4;STXBP4;CDK16;C2CD2L;KLF7;EFNA5;PIM3;BRSK2
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.43995238421025507,-1.0834125102549437,0.33807829181494664,0.8479096141949248,1.0,5/11,17.59%,FGF2;PPIP5K2;ITPKB;IPPK;IPMK
prerank,ion transport (GO:0006811),0.39791465908627177,1.0833529732933291,0.33640081799591004,0.8612970334134343,1.0,18/111,12.04%,PLP2;PANX3;KCNN4;SLC24A4;PIEZO2;GABRB1;SLC12A7;SLC1A6;AQP11;SLC20A1;SLC26A6;ATP11B;ATP1A4;VDAC2;PANX1;SLC25A10;SLC12A5;SLC12A4
prerank,regulation of protein localization to membrane (GO:1905475),0.44743632338979217,1.0833216398523682,0.3700234192037471,0.8607717805378248,1.0,8/28,15.36%,ACTB;GSN;CLN3;APPL1;GPC6;ZDHHC2;GPC3;FYN
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.38214400547598676,-1.0831746303540806,0.3349282296650718,0.8454368568001149,1.0,3/16,1.99%,RREB1;FTO;FLCN
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.47689427846813837,1.0830924338984318,0.39879518072289155,0.8608752913682344,1.0,4/23,9.32%,NRG1;EFNB2;GREM1;AKAP6
prerank,icosanoid metabolic process (GO:0006690),-0.2898717305445523,-1.0829568483114749,0.30701754385964913,0.8427328702815644,1.0,10/40,10.11%,PTGS1;TBXAS1;DAGLA;DAGLB;MGLL;PON3;GGT5;PNPLA8;PLA2G4A;LTC4S
prerank,midbody abscission (GO:0061952),0.49453343694432195,1.0828490026739803,0.3986842105263158,0.8610717519973735,1.0,4/17,12.30%,CHMP6;KIF20A;CHMP7;CHMP5
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.43964487389684803,1.0828423717819384,0.3681257014590348,0.8604591877835767,1.0,7/36,7.10%,TRAF1;BCL2;PPIA;RPS3;NR4A2;TPD52L1;ING5
prerank,membrane lipid catabolic process (GO:0046466),-0.45303677323228275,-1.082700238698961,0.36428571428571427,0.8402871703180592,1.0,3/10,5.48%,SGPL1;PPT1;NAGA
prerank,regulation of protein localization to cell periphery (GO:1904375),0.48719790012902875,1.0824420245554258,0.40357598978288634,0.8610904798096631,1.0,5/18,15.06%,ACTB;CLN3;APPL1;ZDHHC2;ABCA2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.40206275600088087,1.0823542829734434,0.3459958932238193,0.8607516423678531,1.0,22/101,16.77%,LTF;CD24;RASGRP1;CCND2;FERMT2;CEMIP;ATP2B4;TPD52L1;KIT;SLC27A1;ROBO1;SYAP1;FLT3;ETAA1;CCNY;PIK3R5;RALB;PPP2CA;SIRT1;PDGFD;MAPRE3;CALM1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.46430719781373747,1.0823463881518738,0.3793103448275862,0.8601413957075367,1.0,10/24,19.82%,AUTS2;ARPC2;CLRN1;RAC2;CDC42;NCKAP1;ACTR3;CARMIL2;TWF2;CYFIP1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4006219966770026,1.0820630347995328,0.34698055271238487,0.8604647629149205,1.0,24/114,16.22%,TMSB4X;LTB;TRAF1;TNFRSF11B;PSMC3;PSMD8;PSME1;PSMD6;PSMB5;PSMC6;JAK2;PSMB4;ILK;NFKBIA;PSMA7;PSMB9;PSMA6;TNFRSF13C;TNFSF12;PSMC1;RIPK1;TNFRSF14;PSMD7;PSMD2
prerank,Ras protein signal transduction (GO:0007265),0.39632077169663427,1.081889610152976,0.31451612903225806,0.860394990149292,1.0,37/137,19.15%,GRAP2;RASGRP1;RTKN;ARHGEF3;ARHGDIB;WAS;RASGRP2;COL1A2;BRAP;MRAS;DNMT1;CDH13;CELSR1;GPSM2;RAC2;PDPN;RAPGEF6;CFL1;CDK2;GRAP;G3BP2;ROCK1;KSR1;NCKAP1;RALB;GNA13;SHC1;CDKN1A;CRKL;RAP2A;TIAM1;USP28;CDC42EP3;ARHGAP6;RALA;USP50;EPS8L1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5390653618793761,1.0818350365804401,0.41522988505747127,0.8599446119281269,1.0,4/11,15.43%,SCIMP;COLEC12;RIPK1;TICAM1
prerank,regulation of lamellipodium assembly (GO:0010591),0.4421781285893682,1.0816942271330783,0.3933865450399088,0.8597922406755428,1.0,11/34,16.94%,HRG;WAS;AUTS2;ARPC2;CLRN1;RAC2;CDC42;NCKAP1;ACTR3;CARMIL2;TWF2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4472790380094777,1.0816443352834377,0.3603707995365006,0.8593233009916879,1.0,11/30,20.18%,HOXB4;LMBR1L;KDR;KIT;BMP4;MLF1;FLT3;BATF;PTPRC;MLLT3;TNFRSF13B
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4859262910968881,1.081533884409106,0.39080459770114945,0.8590260629462345,1.0,9/20,23.03%,APOE;SREBF1;ACADVL;ARV1;ABCA2;TTC39B;SEC14L2;FMO5;MBTPS1
prerank,regulation of macrophage differentiation (GO:0045649),0.5014044399083246,1.0814005559306474,0.37972972972972974,0.8588208858769089,1.0,3/15,14.15%,C1QC;ID2;RIPK1
prerank,positive regulation of chromosome organization (GO:2001252),0.5053829253362351,1.081346325118695,0.3784135240572172,0.8583892909492769,1.0,4/15,14.10%,RTEL1;ATRX;DHX36;DDX11
prerank,sympathetic nervous system development (GO:0048485),0.49652988946372656,1.0809947668194642,0.3970976253298153,0.858894306698069,1.0,3/15,17.28%,GATA3;CTNNB1;SOX11
prerank,regulation of cell differentiation (GO:0045595),0.39537919783375375,1.0806112255229012,0.32630522088353414,0.8594747730797556,1.0,32/148,16.86%,CD24;SCIN;GATA3;RUNX3;FADS1;SMOC1;CDK6;UQCC2;RAF1;ANP32B;FLOT2;MDK;NR1D2;CCN2;PPP2R1A;GREM1;ZFHX2;HEY2;ID2;ROCK1;VHL;ATF4;DAG1;LGALS3;BCL6;PPP2CA;SMYD5;RUNX2;TIAM1;NSUN2;CEBPB;SINHCAF
prerank,regulation of programmed necrotic cell death (GO:0062098),0.47518466699283457,1.0803726560482871,0.3743718592964824,0.8596316770891563,1.0,8/20,20.98%,MLKL;FLOT2;PELI1;HSP90AA1;RIPK1;SDCBP;BIRC3;PDCD6IP
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.48736329823058255,1.0802204631067198,0.39285714285714285,0.8594391235395582,1.0,5/17,14.04%,CD74;MIF;CD44;ARMC10;SIRT1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.46506921575615073,1.0801724667163661,0.3952912019826518,0.858973173392926,1.0,5/21,18.14%,PRKCQ;ADAM19;DAG1;BACE2;SPPL3
prerank,relaxation of cardiac muscle (GO:0055119),-0.4188635570159949,-1.0800168491916564,0.33064516129032256,0.8451310034111418,1.0,3/13,3.46%,SLC8A1;PIK3CA;P2RX4
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.2720164960662141,-1.0798869132042255,0.24489795918367346,0.8423648764362353,1.0,19/69,17.43%,GAB2;CSF1R;PI4KB;PIK3R1;PI4KA;PTAFR;PIK3CA;PIK3CG;PLCB4;PIK3CB;PIK3CD;PLCL1;PIK3C3;PIK3R2;ERBB3;PLCB1;MYO16;HTR2A;IRS2
prerank,negative regulation of DNA recombination (GO:0045910),0.433368107450468,1.0798282199097415,0.38608305274971944,0.8594780968929553,1.0,14/43,21.40%,DAXX;RTEL1;ATRX;H1-0;PARPBP;PARP3;BLM;POLR2F;RMI2;MSH6;HELB;CGAS;MSH2;POLR2D
prerank,chromatin assembly or disassembly (GO:0006333),0.5334527284660849,1.0797825912766688,0.42090784044016505,0.8590185798304248,1.0,3/11,13.50%,M1AP;CHAF1B;SUV39H2
prerank,cellular response to interleukin-1 (GO:0071347),0.3920615856642348,1.079743399872304,0.33367037411526795,0.8584939890920493,1.0,24/143,12.77%,RPS27A;MAPK13;CCL5;CCL7;IL1R2;PSMC3;UBA52;TAB2;PSMD8;PSME1;GBP2;PSMD6;PSMB5;CD47;RPS6KA5;PELI1;PSMC6;PSMB4;NFKBIA;PSMA7;NOD1;UBB;PSMB9;PSMA6
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.5099907474952347,1.0791641997940378,0.38791946308724834,0.8597807112813716,1.0,3/15,9.58%,STOX2;TGFB2;SCEL
prerank,amino acid import (GO:0043090),0.47819105600418327,1.0790348122773978,0.38367844092570036,0.8596062012573218,1.0,7/21,22.24%,SLC6A14;SLC7A1;SLC7A5;SFXN3;SLC6A6;SLC16A2;SH3BP4
prerank,membrane raft organization (GO:0031579),0.5043815901909534,1.078700300481183,0.3983957219251337,0.8600194479025904,1.0,6/15,14.71%,FLOT2;CLN3;FA2H;ABCA7;NAXE;S100A10
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.46648376655506457,1.0783163454162727,0.391304347826087,0.8605891299591164,1.0,11/25,22.87%,DBR1;PRPF4;PRPF8;MPHOSPH10;SF3B1;SF3A3;KHSRP;SLU7;SRSF4;PRPF6;SNRNP40
prerank,tRNA 5'-leader removal (GO:0001682),-0.40707370625439476,-1.078227382270727,0.3711340206185567,0.8443505550093706,1.0,7/13,22.88%,SSB;RPP14;RPP30;POP1;PRORP;RPP38;RPP40
prerank,mitochondrion transport along microtubule (GO:0047497),-0.4100208665041118,-1.0778287526371013,0.354014598540146,0.8423061067743167,1.0,6/13,9.54%,SPAST;OPA1;NEFL;RHOT1;LRPPRC;SYBU
prerank,C21-steroid hormone metabolic process (GO:0008207),0.47002790063383043,1.077074585977664,0.38636363636363635,0.8638846625209696,1.0,2/20,7.00%,DHRS9;STARD3NL
prerank,establishment of melanosome localization (GO:0032401),0.48780748529146745,1.0766062963685614,0.40428211586901763,0.8646758637352617,1.0,5/19,13.80%,BLOC1S3;MLPH;MKKS;RAB11A;ARL6
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.34051452524324843,-1.0763274493599193,0.3181818181818182,0.8435391692347944,1.0,3/22,3.28%,P2RY6;CALM2;ANK2
prerank,regulation of heart contraction (GO:0008016),0.4022306342471804,1.0763232257045243,0.36580310880829014,0.8649325872303874,1.0,21/90,17.17%,ATP1B3;FXYD1;ITPR3;NPR2;ATP2B4;ATP2A3;TGFB2;STIM1;ITPR1;ATP1A3;ATP1A4;ATP1A1;SRI;CACNA1H;ATP1A2;ATP2B3;GSK3A;CALM1;TRPC1;ATP1B2;ATP2B2
prerank,apoptotic DNA fragmentation (GO:0006309),0.5045906055391138,1.0763232236452038,0.39528795811518325,0.8643076359390359,1.0,3/16,6.36%,H1-0;HMGB1;HMGB2
prerank,GPI anchor biosynthetic process (GO:0006506),0.4504060364615564,1.0761663820402647,0.3988505747126437,0.8641802634654723,1.0,11/30,23.69%,PIGC;PIGH;PIGA;PIGG;DPM3;GPAA1;PIGZ;PIGT;MPPE1;PIGP;PGAP1
prerank,nuclear body organization (GO:0030575),0.5225488549871166,1.0759007047810392,0.405777166437414,0.8643715216054004,1.0,5/12,18.99%,USPL1;ETS1;ZPR1;AFF2;USP50
prerank,positive regulation of cell junction assembly (GO:1901890),0.41940984976749585,1.0757485440596966,0.38131041890440387,0.8642478702649252,1.0,9/56,11.78%,HRG;SLITRK2;FERMT2;KDR;CNTNAP2;GRID2;CAV1;ROCK1;EPHB2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.4817499452274789,1.0755148253500075,0.3843283582089552,0.8643858061157289,1.0,5/20,15.06%,CEACAM1;APOC1;ACADVL;SLC27A1;ABCA2
prerank,organic substance transport (GO:0071702),0.3951160052394403,1.075438953610429,0.35264227642276424,0.864001101715035,1.0,13/121,7.69%,HRG;SLC48A1;CD3G;ABCA4;SLC22A3;ABCA13;SLC18A2;SLC18A1;ABCG4;RCN3;ABCD3;RAMP1;MFSD2A
prerank,oligosaccharide metabolic process (GO:0009311),-0.29045210089975276,-1.0753233128854733,0.2988505747126437,0.8435326725197954,1.0,19/46,24.50%,MANBA;B3GALT5;ST3GAL2;NAGA;ST3GAL6;ST6GALNAC6;ST3GAL3;MAN2C1;NEU1;GLA;ST8SIA3;GAL3ST4;B3GALT2;MAN1B1;ST6GALNAC4;AMY1C;AMY1B;AMY1A;ST8SIA2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.4943125974378523,1.0751637677193557,0.3987341772151899,0.8642634542257842,1.0,5/19,14.71%,HRG;FERMT2;KDR;ROCK1;S100A10
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.447582501008639,1.074817933066873,0.3990554899645809,0.8647112370853687,1.0,5/28,8.82%,CLU;PSMC3;LAPTM5;PTEN;PSMC6
prerank,positive regulation of innate immune response (GO:0045089),0.44982841176140664,1.0747953558646526,0.39176470588235296,0.8641514517568414,1.0,3/30,5.90%,FPR2;CCL5;LBP
prerank,regulation of calcium ion transport (GO:0051924),0.4162810210079768,1.0747206377820844,0.37037037037037035,0.8637901424432252,1.0,9/54,11.32%,CD4;CCL5;BCL2;F2R;STIM1;SRI;CTNNB1;CACNA2D1;SARAF
prerank,DNA replication (GO:0006260),0.4025419718380236,1.07445082211003,0.38289205702647655,0.8640112464122713,1.0,30/105,19.58%,DUT;RAD1;RFC4;MCM7;MCM2;TICRR;NT5M;ATM;BARD1;POLG2;POLB;CDK1;ING5;POLE;CDK2;CDC7;WDHD1;RFC5;BLM;POLG;RMI2;BRIP1;BAZ1A;REV3L;HELB;TOP1;ORC6;MCM6;POLD4;RBBP8
prerank,generation of neurons (GO:0048699),0.3938221533596575,1.0743988682588361,0.3226452905811623,0.8635593434103189,1.0,47/190,23.15%,IRX5;WNT6;RUNX3;OTP;CDK6;AUTS2;LHX4;NDNF;IER2;RACGAP1;ITM2C;DCX;FUT9;HMGB2;NR4A2;TGFB2;CELSR1;PER2;PIN1;HEY2;CTNNB1;PEX13;MAPT;GPM6A;PRUNE1;CIT;NIF3L1;CEP85L;MAP1B;WNT3;MYT1L;RUNX2;PAFAH1B1;ATP2B2;SOX11;HES1;FZD8;HES6;LMX1B;SNPH;ELP3;MET;PTPRD;CX3CL1;WNT9A;FGFR1;SPOCK1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3957004111126078,1.0740461659882956,0.3479591836734694,0.8640985978720833,1.0,23/104,15.07%,RPS27A;CILP;FAM89B;UBA52;ASPN;SMAD2;SPRY1;CHRD;LEMD2;PIN1;GREM1;CAV1;TRIM33;NBL1;SMAD1;FKBP1A;SORL1;UBB;SPART;HSPA1A;SIRT1;GDF3;SNX25
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4840163310490924,1.0740393306517464,0.41357234314980795,0.8635028295520606,1.0,1/18,0.56%,FAM3D
prerank,actin filament network formation (GO:0051639),0.5405900416572486,1.0739979400689657,0.4179523141654979,0.863022395195631,1.0,4/11,15.51%,ACTN1;PLS1;LCP1;CARMIL2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.45668883188702714,1.0738351109977007,0.3877551020408163,0.8628957949268197,1.0,3/25,2.65%,RPL11;RPS7;RPL23
prerank,cellular glucan metabolic process (GO:0006073),0.5262820846670747,1.0737804299547968,0.410427807486631,0.862456243319846,1.0,3/11,9.50%,UGP2;PYGM;PYGL
prerank,negative regulation of catabolic process (GO:0009895),0.4266208790864699,1.0737210687101804,0.38177874186550975,0.8620300909787819,1.0,16/47,27.15%,ADGRB1;FLNA;APOC1;PIN1;AZIN1;AGAP2;NCOR1;AZIN2;HDAC4;SNX12;PRKCG;MDM4;ZDHHC7;BSCL2;SF3B3;PFKFB1
prerank,striated muscle contraction (GO:0006941),0.42227623387401453,1.0734282017140453,0.3751363140676118,0.8623561262232652,1.0,6/53,11.50%,TNNT3;CSRP3;ALDOA;DTNA;DMD;ATP1A2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5173710011214445,1.0734227701884391,0.43586387434554974,0.8617627306335659,1.0,2/12,4.74%,CBLB;PTGIR
prerank,T cell proliferation (GO:0042098),0.5069449455720147,1.0728310863648594,0.4197860962566845,0.8630308763306493,1.0,3/13,7.16%,RASGRP1;LMBR1L;MSN
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4041350108628183,1.07237350031325,0.37923946557040084,0.8639073714111959,1.0,18/80,16.92%,SOX7;F2R;HMGB1;RAF1;GRAMD4;MALT1;GPX1;CD44;TNFSF10;SFN;NOD1;CARD16;EPHA7;SIRT1;BEX3;MAP2K5;ARL6IP5;ARL6IP1
prerank,regulation of vacuole organization (GO:0044088),0.48236863941199265,1.0722346098920046,0.385297845373891,0.8637220893339053,1.0,5/20,11.34%,NPRL2;ENO4;ADPRH;LAPTM4B;MTM1
prerank,stress granule assembly (GO:0034063),0.48177079800217987,1.0719098271836516,0.4104750304506699,0.8641510345459336,1.0,4/20,11.67%,RPS23;YTHDF3;EIF2S1;MAPT
prerank,macrophage activation (GO:0042116),0.43703593438658483,1.0709838062300978,0.3875432525951557,0.8664411345301224,1.0,10/34,16.67%,FPR2;CLU;LBP;FOXP1;IFNGR1;JAK2;MAPT;TREM2;AGER;ITGB2
prerank,purine nucleotide metabolic process (GO:0006163),0.4700000148597968,1.070655981952526,0.39568345323741005,0.8668830624352344,1.0,5/24,9.23%,NUDT15;GPX1;GDA;GART;MTHFD1
prerank,signal peptide processing (GO:0006465),-0.4232731903326986,-1.0703209069912316,0.37261146496815284,0.8554631163143803,1.0,2/11,6.58%,PCSK5;PARL
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.39173871665027893,1.0701307899001706,0.3638211382113821,0.8679426612196419,1.0,21/121,12.31%,ANGPT4;CCL5;IL31RA;GHR;CD74;PECAM1;ANGPT1;CLEC6A;VTN;MIF;KIT;CD44;GREM1;ARL2BP;BMP6;JAK2;SRCIN1;PRNP;IL6ST;FLT3;CLCF1
prerank,regulation of defense response to virus (GO:0050688),-0.38429611537282876,-1.0701263502855787,0.3939393939393939,0.8528624433565096,1.0,4/14,14.52%,PCBP2;TNFAIP3;ZMPSTE24;PPM1B
prerank,positive regulation of chemokine production (GO:0032722),-0.2857521666231213,-1.069834075672887,0.3258426966292135,0.8505450784167863,1.0,11/44,13.11%,CSF1R;IL6R;IL18;TLR7;TLR4;TLR2;TLR3;HMOX1;EIF2AK2;APP;LGALS9
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5442815941830328,1.0697946115122094,0.4188034188034188,0.8683821940482392,1.0,4/10,18.52%,RNF157;PDE3A;UBE2B;CDC34
prerank,regulation of telomere maintenance (GO:0032204),0.45792230392858535,1.0694510029886097,0.3971631205673759,0.8688668653431294,1.0,5/26,13.54%,RTEL1;ATRX;ERCC4;DHX36;ERCC1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.323893134895816,-1.0687247305045378,0.3219178082191781,0.8506880597943376,1.0,5/29,7.70%,P2RY12;DGKZ;FGF2;FGR;TGFB1
prerank,non-motile cilium assembly (GO:1905515),0.4409255920536601,1.0683025221538678,0.3873659117997616,0.8718947705020174,1.0,9/30,20.69%,BBS10;GORAB;CEP89;C2CD3;TMEM216;IFT57;TMEM80;CCDC13;PIBF1
prerank,myoblast differentiation (GO:0045445),0.5118805860687657,1.0680934421310686,0.41238471673254284,0.8719425087032658,1.0,6/14,22.04%,NRG1;EPAS1;JAG1;HINFP;MBNL1;DDX17
prerank,regulation of primary metabolic process (GO:0080090),0.3968768815730942,1.0679111885143902,0.3703329969727548,0.871903066541438,1.0,33/126,16.72%,NCOR2;OAZ3;PSMC3;HELZ2;PSMD8;APOE;SREBF1;PSME1;PSMD6;NQO1;SMARCD3;PSMB5;NR1D2;NFYB;PMVK;PSMC6;ID2;FASN;PSMB4;AZIN1;PSMA7;ACACA;ELOVL6;ABCA7;PSMB9;PSMA6;SCD;NCOR1;PSMC1;NCOA2;PSMD7;PSMD2;EDF1
prerank,melanosome transport (GO:0032402),0.4882139593302305,1.0675032960657513,0.4220532319391635,0.8719162498843729,1.0,5/18,13.80%,BLOC1S3;MLPH;MKKS;RAB11A;ARL6
prerank,pigment granule transport (GO:0051904),0.4882139593302305,1.0675032960657513,0.4220532319391635,0.8719162498843729,1.0,5/18,13.80%,BLOC1S3;MLPH;MKKS;RAB11A;ARL6
prerank,intraciliary retrograde transport (GO:0035721),0.5133073602972711,1.0673254218710089,0.4197183098591549,0.871859383761855,1.0,2/12,12.08%,TTC21A;WDR35
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5208239880344926,1.0672202264549517,0.44647887323943664,0.8715707180686226,1.0,5/12,22.74%,GJD3;CAV1;SRI;CALM1;CALM3
prerank,DNA metabolic process (GO:0006259),0.3856345399313507,1.0668431174363446,0.3063063063063063,0.8721526206262918,1.0,72/270,20.73%,RPS27A;NUDT1;RTEL1;RAD54L;SP100;USP3;NUDT15;HMGB1;HMGB3;UBA52;ERCC4;RAD1;DMC1;RFC4;MCM7;MCM2;TICRR;LONP1;XPC;ATM;GADD45A;UHRF1;HMGB2;BARD1;DNMT1;POLB;CDK1;LIG1;PARP3;NOC3L;POLE;PDS5B;CDK2;CDC7;NOP53;NABP1;BTG2;WDHD1;FANCL;RFC5;UBB;BLM;NPM1;POLG;ERCC1;POLK;RMI2;USP45;MSH6;UBE2B;TYMS;PWWP3A;PCNA;HELB;SAMHD1;ERCC5;TOP1;ORC6;PTGES3;DDB2;HINFP;MCM6;TOP2B;CDC34;HELLS;POLD4;RBBP8;STN1;DDB1;ATR;MSH2;MPG
prerank,positive regulation of cholesterol efflux (GO:0010875),0.4673396404779121,1.0667552357682928,0.40425531914893614,0.8717948987182346,1.0,7/21,15.53%,APOE;NR1H2;CAV1;NFKBIA;ABCA7;SIRT1;TREM2
prerank,anion transmembrane transport (GO:0098656),0.4088998910488146,1.0664087720476751,0.38952879581151834,0.8722996271084086,1.0,19/67,18.40%,LRRC8C;SLC13A4;SLC6A8;SLC3A2;SLC13A3;SLC1A6;SLC7A1;SLC27A1;SLC25A10;SLC35A1;ABCC1;SLC7A5;SLC25A1;SLC25A14;SFXN3;SLC25A30;ARL6IP5;SLC25A4;SLC19A1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.38956131590706233,1.0663355644636978,0.35542168674698793,0.8719122659926537,1.0,54/185,21.79%,PPP1R9B;RPS27A;TFAP4;PLK4;CENPJ;PSMC3;UBA52;BUB1B;PSMD8;FBXO5;FZR1;XPC;PSME1;PSMD6;MAD2L1BP;PSMB5;CDK1;DYNLL1;PPP2R1A;PSMC6;ID2;CDK2;PSMB4;HSP90AA1;APPL1;RIOK2;ZFP36L2;PSMA7;UBB;PSMB9;PSMA6;HAUS5;PSMC1;CUL3;CEP41;PCNT;PSMD7;PSMD2;PAFAH1B1;HAUS4;HAUS2;PSMD5;CEP43;NINL;CEP70;DDB1;HAUS3;PSMB6;ZW10;UBE2D1;YWHAG;CDC14A;BTRC;TUBB4B
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4812334645046929,1.066223267039687,0.4049689440993789,0.8716538962303627,1.0,8/19,22.53%,MTHFD2;SHMT1;GGH;MTHFD1;ALDH1L2;SLC19A1;MTHFD1L;MTHFS
prerank,cellular response to organic substance (GO:0071310),0.3904600959356339,1.0660738334744468,0.38328236493374107,0.8715423836867737,1.0,25/116,15.87%,IL18R1;LEF1;CCL5;GHR;SIGIRR;PTPN13;RACK1;RAMP1;CLEC3B;PTPN12;PTPN9;AKAP6;STAT5B;CACNA1H;CXCR4;CTNNB1;FLT3;ROBO2;PTPN4;KHSRP;NCOA2;SHC1;MAP2K5;RPS6KB1;ARL6IP5
prerank,carnitine metabolic process (GO:0009437),0.5235213998550466,1.0656893413376876,0.4171195652173913,0.8721539245055306,1.0,4/12,12.91%,BBOX1;SHMT1;CPT1C;CPT2
prerank,negative regulation of leukocyte activation (GO:0002695),-0.38284547523252527,-1.0653360663211626,0.3436123348017621,0.8578704576059593,1.0,7/15,14.21%,CD84;CD300A;MILR1;HAVCR2;CD200;CD300LF;ZC3H12A
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.40202664657995324,1.0650181011256719,0.39979231568016615,0.8735636263185805,1.0,15/75,14.05%,HEG1;TFAP4;SMPD1;HEXIM1;PAQR3;APOE;PTEN;PRKAR1B;GADD45A;SPRY1;BMP4;SPRY3;SORL1;SIRT1;PRKAR1A
prerank,regulation of small molecule metabolic process (GO:0062012),0.44649829905549676,1.0648948145742507,0.40476190476190477,0.8733493760439108,1.0,8/28,21.17%,NCOR2;APOE;ACADVL;ARV1;SIRT1;RORA;TTC39B;FMO5
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.39019564289168895,1.0648297083532212,0.36217303822937624,0.872946907018514,1.0,31/128,15.76%,RPS27A;ARHGEF18;FERMT2;PDCD4;LTBP2;UBA52;PARD3;SMAD2;COL1A2;ITGB1;ZYX;AMH;TGFB2;RNF111;BMP4;NLK;BMP6;GCNT2;APPL1;SLC33A1;SMAD1;FKBP1A;TGFBR3;UBB;COL3A1;CDH5;TGFB3;SIRT1;GDF3;USP15;RUNX2
prerank,monocyte differentiation (GO:0030224),0.5410064762350822,1.0643787995712009,0.4098591549295775,0.8737316290543387,1.0,3/10,7.67%,IL31RA;MT1G;BMP4
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.5213240256154343,1.063673065313937,0.41735537190082644,0.8753287110255387,1.0,2/11,10.71%,NR4A2;CTNNB1
prerank,stress-activated MAPK cascade (GO:0051403),0.4085223944611566,1.0634595125313138,0.40468583599574015,0.875386640644833,1.0,6/61,6.86%,RPS27A;MAPK13;MAP4K2;UBA52;TAB2;MAPK9
prerank,regulation of phospholipase activity (GO:0010517),0.532903944032992,1.0634031125459793,0.41963015647226176,0.8749637561051918,1.0,1/10,1.10%,RASGRP1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.47418601319087783,1.063096188739748,0.4146341463414634,0.8752935997530662,1.0,8/18,23.10%,MDK;TMEM98;CXCR4;HES1;OPALIN;TENM4;SLC45A3;IL34
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.4870212865428364,1.0628738153349029,0.39738562091503266,0.8747356262796583,1.0,6/16,24.14%,DLC1;PTEN;APOD;ARHGAP6;CLASP2;ITGB1BP1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.4870212865428364,1.0628738153349029,0.39738562091503266,0.8747356262796583,1.0,6/16,24.14%,DLC1;PTEN;APOD;ARHGAP6;CLASP2;ITGB1BP1
prerank,negative regulation of lyase activity (GO:0051350),0.49660881523022754,1.0628384570423426,0.4157014157014157,0.8742348186010718,1.0,5/16,22.73%,CCR2;GNAI2;DRD2;PALM;EDNRB
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.40344674050639906,1.0627900383235211,0.37487019730010385,0.873775493379123,1.0,19/75,16.37%,S100A6;SLITRK2;ADGRB1;ACTB;LMTK2;RAB8A;PARD3;SDC2;SPTBN4;MFSD2A;ZDHHC17;ANK3;NEFH;NTNG1;NTNG2;MAP1B;DCC;DRD2;ATL1
prerank,regulation of MAP kinase activity (GO:0043405),0.3957014531327036,1.0626300550042465,0.3940936863543788,0.8736221429972514,1.0,16/92,13.24%,CD24;RASGRP1;SMPD1;PAQR3;APOE;SPRY1;TPD52L1;KIT;BMP4;SPRY3;ROBO1;KSR1;FLT3;SORL1;SNF8;PIK3R5
prerank,histone H3 deacetylation (GO:0070932),0.48986650972396684,1.0619082280697505,0.40600522193211486,0.8753011326905552,1.0,7/15,18.76%,HDAC9;HDAC1;PER2;SIRT1;HDAC2;PER1;HDAC4
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.46861429950802863,1.061882824930953,0.41604010025062654,0.8747771780710358,1.0,7/20,20.29%,SCD5;FASN;ACACA;SCD;SLC25A1;GCDH;HSD17B4
prerank,regulation of protein kinase A signaling (GO:0010738),0.4782020587293807,1.061820033117777,0.42379182156133827,0.8743676960836609,1.0,5/20,14.05%,PRKAR1B;MIF;IAPP;AKAP6;PRKAR1A
prerank,protein kinase B signaling (GO:0043491),0.45959793754033057,1.0617720206683976,0.4240506329113924,0.8739250259544371,1.0,4/23,11.69%,CCL5;KDR;PTEN;THEM4
prerank,keratan sulfate catabolic process (GO:0042340),0.52681416616922,1.061737016038808,0.4297635605006954,0.8734347799303955,1.0,3/11,6.06%,LUM;FMOD;OGN
prerank,embryonic limb morphogenesis (GO:0030326),0.43655467555089605,1.0616801271853067,0.40023201856148494,0.8729913042959981,1.0,11/34,19.97%,RARG;AFF3;HDAC1;NIPBL;TGFB2;GLI3;CTNNB1;HDAC2;ECE1;MBNL1;CYP26B1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.47300149207198994,1.0615308778590413,0.4132985658409387,0.8728591749965393,1.0,3/18,8.98%,ADAM19;APOE;CLN3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5396075727130372,1.061279861460671,0.427972027972028,0.8730336246085362,1.0,3/10,6.08%,RUNX3;HMGB1;ZBTB7B
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.4034800903270543,1.0612106295196826,0.40540540540540543,0.8726332220959881,1.0,20/72,20.83%,RPS27A;ISG20;UBA52;RNASE6;ERCC4;RFC4;XRN2;DCP1A;GTF2H5;RFC5;UBB;DDX1;ERCC1;POLK;PCNA;ERCC5;DDB2;POLD4;DDB1;MEI4
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3892854831069649,1.0611235129870802,0.4004085801838611,0.8723102086081646,1.0,24/102,19.25%,NR4A3;GCK;SORBS1;CEACAM1;HDAC9;RAB8A;PRKAR1B;NR4A2;CAV1;TSHR;NR4A1;GPLD1;ADCY6;SYAP1;IRS1;FOXO1;PRKAR1A;RPS6KB1;GSK3A;ADCY1;KAT2B;SLC25A33;SELENOS;C2CD5
prerank,regulation of embryonic development (GO:0045995),0.4368002625453856,1.061068403287516,0.4043778801843318,0.8718608109764874,1.0,12/34,23.39%,RACGAP1;NIPBL;CDK1;CFL1;DHX36;CCSAP;DAG1;POGLUT1;PHLDB1;TRIP12;CLASP2;INSR
prerank,regulation of angiogenesis (GO:0045765),0.3856968110532442,1.0607178791406007,0.36172344689378755,0.872312930542231,1.0,35/192,15.02%,CCR2;HRG;ANGPT4;ADGRB1;DCN;CEACAM1;SPINK5;SP100;HTATIP2;SEMA5A;KDR;ITGB1;HSPG2;PRKD2;ATP2B4;TGFB2;RHOJ;CXCL10;STIM1;ETS1;HIPK1;PAK4;PDCL3;CTNNB1;SERPINE1;ROCK1;NAXE;CDH5;GRN;TNFSF12;SIRT1;ITGAX;CTSH;SEMA3E;PPP1R16B
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.40919136636059766,1.0603635033838565,0.40494092373791624,0.8728096123747748,1.0,12/54,13.71%,GTPBP4;CHP1;ADGRB1;RPL11;TRIM21;RPS3;PER2;CAV1;CTNNB1;COPS9;VPS28;HSPA1A
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.43882495609141586,1.0602179255647544,0.3990719257540603,0.8726556677083199,1.0,12/31,24.82%,PTEN;FZR1;RPS2;PIN1;UBE2L3;DCUN1D5;DCUN1D2;BMI1;BTRC;ARRDC3;DCUN1D3;FBXW7
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.49424652648598993,1.0601786374136848,0.41130091984231276,0.8721628296030276,1.0,10/17,24.58%,PPP1R15A;PPP1R12A;PTPA;PPP1R15B;CALM1;PTPRC;HSP90AB1;ITGA1;CALM3;CD33
prerank,positive regulation of immune effector process (GO:0002699),0.45757442666416426,1.0600974454407273,0.4108433734939759,0.8718182422854409,1.0,6/27,19.29%,CCR2;MYB;LBP;RPS19;LILRB1;PTPRC
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4504703015570022,1.060079762883208,0.4217443249701314,0.8712809126833393,1.0,5/27,7.70%,PLA2R1;CD74;ATM;MIF;CD44
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.39339811526026736,1.060057572977428,0.392675483214649,0.8707606951953794,1.0,23/105,16.22%,KLRC2;PSMC3;CLEC6A;RAF1;TAB2;PSMD8;CLEC4E;PSME1;PSMD6;MALT1;PSMB5;RPS6KA5;PSMC6;PSMB4;CLEC4D;PSMA7;PSMB9;PSMA6;PSMC1;FYN;PAK1;PSMD7;PSMD2
prerank,regulation of lamellipodium organization (GO:1902743),0.5113125151299025,1.060024840111744,0.43064729194187584,0.8702582364156076,1.0,6/14,16.94%,WAS;CD44;PDPN;CDC42;CARMIL2;TWF2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3934083347731719,1.0598106728447008,0.39307535641547864,0.8697510572460522,1.0,23/104,16.22%,KLRC2;PSMC3;CLEC6A;RAF1;TAB2;PSMD8;CLEC4E;PSME1;PSMD6;MALT1;PSMB5;RPS6KA5;PSMC6;PSMB4;CLEC4D;PSMA7;PSMB9;PSMA6;PSMC1;FYN;PAK1;PSMD7;PSMD2
prerank,cellular response to lectin (GO:1990858),0.3934083347731719,1.0598106728447008,0.39307535641547864,0.8697510572460522,1.0,23/104,16.22%,KLRC2;PSMC3;CLEC6A;RAF1;TAB2;PSMD8;CLEC4E;PSME1;PSMD6;MALT1;PSMB5;RPS6KA5;PSMC6;PSMB4;CLEC4D;PSMA7;PSMB9;PSMA6;PSMC1;FYN;PAK1;PSMD7;PSMD2
prerank,protein targeting (GO:0006605),0.38960907951920926,1.0597073724701616,0.40060851926977686,0.8694823390836679,1.0,42/118,24.43%,RPL11;NCF1;TOMM22;LTBP2;PARD3;TOMM7;TIMM9;AQP11;RTP4;AP1S3;AKAP6;PEX16;ZDHHC23;ZDHHC15;ZDHHC12;SORL1;EDEM1;ZDHHC2;ZFAND6;TIMM17B;MICALL1;ARL6;AP4S1;SDCBP;KATNB1;ATG3;ZDHHC14;TIMM10;ZDHHC18;TIMM17A;TSPO;LAMP2;SEC63;TIMM22;MFF;GOLGA7B;GABARAP;SRP14;ZDHHC21;GDAP1;AP4E1;ZDHHC7
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.3540011673489752,-1.0594894772481578,0.34545454545454546,0.8729907712456912,1.0,8/19,17.66%,TLR7;TLR4;TLR8;TLR3;CHUK;TBK1;IRF3;IRF7
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5170018875352969,1.0593892316901548,0.43105756358768405,0.8699218047706628,1.0,1/12,0.91%,NCOR2
prerank,positive regulation of neuron death (GO:1901216),0.42109417565471663,1.0593241222200913,0.39672131147540984,0.8695174424499046,1.0,18/46,23.08%,DAXX;CLU;EFNB2;EIF2S1;TGFB2;CTNNB1;PRNP;MAPT;ATF4;EPHA7;GRN;FYN;ITGB2;TYROBP;SNCA;GSK3B;EGR1;DDIT3
prerank,regulation of superoxide anion generation (GO:0032928),0.505223514312377,1.0592135076160225,0.4262734584450402,0.8692854220360149,1.0,1/14,0.16%,FPR2
prerank,negative regulation of lymphocyte migration (GO:2000402),0.5356863900927766,1.059069088365699,0.42961876832844575,0.8691405723115644,1.0,1/10,0.37%,RIPOR2
prerank,positive regulation of cell aging (GO:0090343),0.5169913358836297,1.0590591616034324,0.42837078651685395,0.8685782207416469,1.0,5/11,19.78%,LMNA;B2M;SIRT1;CGAS;EEF1E1
prerank,embryonic skeletal system development (GO:0048706),0.4400322419423622,1.0588710884492614,0.4048165137614679,0.868572962936458,1.0,12/35,23.38%,DEAF1;HOXB4;HOXC4;HOXC9;COL1A1;HOXB9;SOX11;UCMA;HOXB3;RBP4;WNT9A;KIAA1217
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.38536253021564093,1.0584708656253305,0.34534534534534533,0.8692116911840299,1.0,47/208,18.69%,LTF;CD4;TRAF1;CD74;LGALS1;FLNA;F2R;LPAR1;CLEC6A;TAB2;TMEM9B;TLR9;TRIM21;MALT1;TMED4;TNFSF10;TNIP3;PELI1;SPHK2;SLC20A1;ZDHHC17;DHX36;CC2D1A;RHOC;FKBP1A;MUL1;NOD1;CARD16;AKAP13;SHARPIN;TRIM68;DDX1;ZFAND6;SIRT1;RIPK1;GAPDH;TIRAP;EEF1D;TICAM1;TREM2;S100A13;MAPKBP1;RIOK3;TNIP1;CPNE1;PER1;RORA
prerank,DNA dealkylation (GO:0035510),-0.4380920126537967,-1.058380120575253,0.3649122807017544,0.869950034061456,1.0,2/10,4.63%,FTO;ASCC2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.4380920126537967,-1.058380120575253,0.3649122807017544,0.869950034061456,1.0,2/10,4.63%,FTO;ASCC2
prerank,cGMP biosynthetic process (GO:0006182),0.5265280526304262,1.0580406485389051,0.43120567375886526,0.869952408031878,1.0,3/10,24.73%,NPR2;GUCY1B1;GUCY1A1
prerank,skeletal muscle organ development (GO:0060538),-0.3300430570984797,-1.0578586103724248,0.37012987012987014,0.8683508248511006,1.0,6/26,10.49%,MEF2C;LARGE1;FXR1;ZBTB18;BASP1;CFLAR
prerank,autophagosome organization (GO:1905037),-0.27392000901443,-1.0578228303690003,0.22077922077922077,0.8653090285579016,1.0,14/50,17.22%,BECN1;STX12;IRGM;ATG7;ULK1;TMEM41B;WIPI1;WDR45B;ATP2A2;PIK3C3;GABARAPL1;ULK2;ATG2B;ULK3
prerank,cellular response to hypoxia (GO:0071456),0.38933716111327904,1.0577456109123922,0.39918533604887985,0.8702856978173714,1.0,27/126,14.07%,RPS27A;ANGPT4;PSMC3;UBA52;NDNF;LMNA;PSMD8;PSME1;PSMD6;PSMB5;PSMC6;PSMB4;NOP53;HP1BP3;UBQLN1;PSMA7;LIMD1;VHL;CARD16;UBB;PSMB9;PSMA6;SUV39H2;EPAS1;PSMC1;SIRT1;NDRG1
prerank,epithelium development (GO:0060429),0.3944694477892027,1.0574216991190024,0.3879837067209776,0.8707226043748938,1.0,24/107,19.83%,TAGLN2;EHF;DHRS9;SPINK5;TAGLN;DMBT1;RCN3;KDR;ACADVL;CDK1;MFSD2A;JAK2;ALDOC;MTHFD1;DAG1;LGALS3;WNT3;VCL;PCNA;PPP2R3A;SOX11;SOX10;SNAI2;SOX9
prerank,positive regulation of cation channel activity (GO:2001259),0.4184961507970039,1.0573000114341424,0.4107744107744108,0.8705045326095341,1.0,5/40,11.78%,TMSB4X;CCR2;ANK3;AKAP6;EPHB2
prerank,pentose-phosphate shunt (GO:0006098),0.5213704781891546,1.0572571326333393,0.4225352112676056,0.8700404326192702,1.0,5/11,18.68%,TKT;PGLS;PGM2;RPE;TALDO1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.37827056298464,1.0571875608460004,0.291,0.8696673323861002,1.0,107/476,19.83%,SKAP1;LEF1;CD4;DEAF1;TBX21;EOMES;IRF6;GATA3;TRIM16;RUNX3;IL31RA;CD74;CAMK4;TFAP4;EHF;F2R;ACTA2;NCF1;SP100;NEK4;MRPL12;ING2;ILF3;AHR;RNF14;APOE;SMAD2;CDH1;MYB;ELF4;XPC;LBH;HNRNPAB;RARA;SMARCC1;HDAC1;SMARCD3;HMGB2;NFE2;NR1H2;ING5;NR1D2;RNF111;CREBL2;ETS1;BMP4;RLF;ATF7IP;HEY2;ID2;MED30;GLI3;ZBTB16;PHF5A;NAA16;CTNNB1;ELF1;TASP1;ILK;COL1A1;MED13;VHL;FOXO1;ATF4;BLM;NIF3L1;TGFB3;NPM1;ATMIN;ARNT2;JMJD6;FGF7;PCID2;NPAS3;SHC1;IRF4;RUNX2;RFX3;WBP2;CREB5;ENY2;MAPRE3;EDF1;CEBPB;KLF2;NFIL3;PPP3CB;SOX11;ING1;CALCOCO1;HDAC2;SOX10;RYBP;HES1;HINFP;NSD3;EGR2;RORA;HDAC4;LYL1;RGMB;SEC14L2;MLLT3;MLXIPL;MED24;MECOM;SOX9
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4838849693093682,1.056999976543582,0.42912873862158646,0.8696411463347568,1.0,6/17,15.40%,PDCD4;PTEN;TGFB3;EFEMP2;CDKN1A;SOD2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.47258447412692595,1.0569624317599373,0.40875,0.8691772276082602,1.0,3/21,5.60%,BUB1B;FBXO5;ATM
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.5119700916128296,1.0566783427431783,0.44680851063829785,0.8694549469431524,1.0,6/13,20.71%,ITGB1;CDH13;CD36;ITGB2;LDLR;FCER1G
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.49798897243035134,1.0566492173713133,0.43105756358768405,0.8689534450099454,1.0,6/14,24.77%,CSTF2;NUDT21;CSTF2T;ERN1;TUT1;CPSF2
prerank,triglyceride catabolic process (GO:0019433),0.48034866358122097,1.0563174012092216,0.4292929292929293,0.8693794793658941,1.0,3/19,14.90%,FABP7;FABP5;FABP4
prerank,negative regulation of cell aging (GO:0090344),0.4876156435765497,1.0556945168188039,0.42609853528628494,0.8707197514929375,1.0,4/16,14.04%,CDK6;FBXO5;MIF;SIRT1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.39853429315073663,1.055221626752224,0.3981191222570533,0.8716152112975583,1.0,19/74,16.22%,RPS27A;PSMC3;UBA52;PSMD8;PSME1;PSMD6;PSMB5;PSMC6;PSMB4;PSMA7;LIMD1;VHL;UBB;PSMB9;PSMA6;EPAS1;PSMC1;PSMD7;PSMD2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.48096696976555603,1.0548576343933498,0.43285528031290743,0.8721613367636842,1.0,5/17,17.54%,DOLPP1;MPDU1;DHDDS;DPAGT1;ALG1
prerank,integrin-mediated signaling pathway (GO:0007229),0.4021287500351822,1.0546980734549265,0.40270551508844954,0.8720612167096992,1.0,19/73,16.67%,FBLN1;LAMA5;CEACAM1;TXK;FERMT2;PRAM1;ITGB1;ZYX;CD47;ITGA10;PTPRA;ITGB7;BCAR1;CDC42;ILK;COL3A1;CUL3;NEDD9;ITGB2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4137306214791681,1.0545240728959593,0.3963083604777416,0.8720154901513818,1.0,7/50,14.95%,GTPBP4;CCND2;ACTB;GADD45A;CNPPD1;BLM;CDKN1A
prerank,regulation of translation (GO:0006417),0.3884076144211957,1.0541441249483086,0.3817635270541082,0.8725722921246275,1.0,40/173,15.45%,GZMB;CD28;PUS7;MRPL13;YTHDF3;EIF1B;ILF3;EIF2A;SHMT1;DAPK3;RACK1;RPS3;METTL3;RPS4X;MALSU1;EEF2;EIF2B4;RBM4B;VIM;EIF4A3;SYNCRIP;DHX36;BTG2;EIF1;NCL;CPEB3;EIF3H;KLHL25;GSPT1;NPM1;DDX1;ETF1;METTL14;SAMD4A;GAPDH;POLDIP3;EIF3E;EIF2AK3;TYMS;RPS6KB1
prerank,regulation of monooxygenase activity (GO:0032768),0.4534919753667064,1.0522494686639137,0.41987577639751555,0.8777695700500366,1.0,8/23,27.44%,CAV1;POR;HSP90AA1;CALM1;SNCA;ZDHHC21;IL1A;SPR
prerank,calcium-ion regulated exocytosis (GO:0017156),0.44676580344328165,1.0521538427217456,0.4341801385681293,0.8774406608239367,1.0,5/27,12.01%,SCIN;SYT4;ARL8B;SYT7;RIMS3
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5134565603537417,1.0521092608421463,0.42916666666666664,0.8769825904074647,1.0,4/12,14.10%,WAPL;CTNNB1;ESPL1;DDX11
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.38907504554957145,1.051844126610542,0.4152284263959391,0.8771920770983639,1.0,25/109,17.23%,GRAP2;ITK;MS4A2;NR4A3;PRKCQ;PSMC3;TAB2;PSMD8;PSME1;PSMD6;MALT1;PSMB5;MAPK9;PSMC6;PSMB4;PSMA7;PSMB9;PSMA6;PSMC1;SHC1;PAK1;PSMD7;PSMD2;CALM1;PPP3CB
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.28348868766868635,-1.0517879080341843,0.34,0.8808205844640632,1.0,7/40,5.66%,ABL1;PID1;NDUFS1;ATP5IF1;LRRK2;AKT2;BCO2
prerank,intermediate filament organization (GO:0045109),0.4807641785481679,1.0516786228773853,0.4020618556701031,0.8770903853940218,1.0,3/17,11.34%,PKP1;VIM;MTM1
prerank,cellular response to alcohol (GO:0097306),0.4170788220666374,1.051131370047382,0.3894500561167228,0.8781742474561071,1.0,12/42,18.51%,AHR;CDH1;GRAMD1B;SPHK2;GPLD1;ADCY6;CTNNB1;BLM;ADCY1;MLC1;JUP;GNAI1
prerank,organic cation transport (GO:0015695),0.4657155150523793,1.051091132419308,0.42785445420326224,0.8777055868902859,1.0,1/20,1.23%,SLC22A3
prerank,positive regulation of cell projection organization (GO:0031346),0.388309704267825,1.0508049391415262,0.39613034623217924,0.877973951945806,1.0,31/115,22.43%,S100A9;P3H1;CHODL;AMIGO1;NDNF;PLPPR5;APOE;PLXNB1;TOX;FUT9;MDK;PLXNA2;ROBO1;ROBO2;NPTN;GRIP1;CARMIL2;ABL2;TIAM1;STMN2;TWF2;ATP1B2;NTRK3;EPHA3;SCN1B;PLXND1;TENM3;ROR1;SLITRK1;PTPRD;CX3CL1
prerank,sphingoid metabolic process (GO:0046519),0.5161281715616755,1.0505962381769578,0.44039270687237025,0.8780316991992759,1.0,3/12,8.58%,SPTLC3;NAAA;SPHK2
prerank,response to organophosphorus (GO:0046683),0.48124021602430933,1.0505943606445554,0.42297650130548303,0.8774497064665004,1.0,1/16,1.36%,TRIM16
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.4566369808009821,1.0504640187729477,0.43279901356350187,0.8772565513911906,1.0,5/22,12.39%,RPS27A;UBA52;XPC;GTF2H5;UBB
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4731752331928482,1.050265064673961,0.40823970037453183,0.8772382973458005,1.0,5/18,19.30%,BCL2;THEM4;MUL1;SLC25A4;BNIP3
prerank,positive regulation of neuron projection development (GO:0010976),0.39557596676801465,1.0493617793207857,0.40975103734439833,0.8793960069550466,1.0,22/85,22.43%,S100A9;P3H1;NDNF;PLPPR5;APOE;TOX;FUT9;MDK;DHX36;ZDHHC15;NPTN;ABL2;STMN2;TWF2;ATP1B2;NTRK3;EPHA3;SCN1B;VLDLR;TENM3;ROR1;CX3CL1
prerank,cellular amide metabolic process (GO:0043603),0.3917131058741035,1.0489326052494063,0.3997955010224949,0.880083274034111,1.0,28/102,20.89%,CPXM2;SMPD1;HLCS;MTHFD2;AEBP1;SHMT1;NAAA;PPP2R1A;CPM;DNPEP;PLAAT3;MTHFD1;ST3GAL1;PM20D1;NAPEPLD;THEM4;ATF4;PDZD11;PPP2CA;ALDH1L2;ABCA2;MCCC1;DBI;ACOT6;SLC19A1;ACOT8;PCCB;MTHFD1L
prerank,synapse organization (GO:0050808),0.3863040584788131,1.0487895611682956,0.396969696969697,0.8799127360183905,1.0,39/125,22.51%,SLITRK2;F2R;NEDD4;GPHN;PPFIA2;PTEN;CDH1;DSCAM;C1QC;CAST;PCDHB11;DNM3;PIN1;ANK3;CACNB4;SHANK2;CDC42;KIRREL3;GPC6;MAPT;GPM6A;NTNG1;ELFN1;PCDHB16;PPFIBP2;SEMA3E;DRD2;CYFIP1;PLXND1;LRP4;C1QB;SNCA;PCDHB14;CTNND2;LRRC4;SLITRK1;PTPRD;CX3CL1;LRRC4C
prerank,positive regulation of hydrolase activity (GO:0051345),0.3855037176687406,1.0487216567979105,0.39117352056168503,0.8795430813249999,1.0,22/137,11.18%,RASGRP1;CCL5;CCL7;F2R;PKP4;RASGRP2;FERMT2;RGS1;RCN3;RGS8;RGP1;RACK1;PLXNB1;ITGB1;RPS3;HMGB2;MMUT;PIN1;MAPRE2;RAPGEF6;RHOC;RGS6
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.4999808452502911,1.04871543038645,0.44070080862533695,0.8789720603322236,1.0,3/14,8.27%,CCL5;MDK;RARRES2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.39767509716676763,1.0481556486737016,0.4329140461215933,0.8801187698535187,1.0,18/72,16.29%,CCL5;F2R;NCF1;NEDD4;DCN;KDR;PLXNB1;KIT;TGFB2;JAK2;HCST;FLT3;PIK3R5;SIRT1;TREM2;IGF1R;PDGFD;MYDGF
prerank,gluconeogenesis (GO:0006094),0.4215854198616641,1.047729516555292,0.4311111111111111,0.8808614352719492,1.0,15/39,24.98%,ALDOA;PER2;GPI;ALDOC;MDH2;SLC25A10;ATF4;GAPDH;SLC25A1;CRTC2;GAPDHS;RBP4;PGK1;GOT2;ENO1
prerank,skeletal system development (GO:0001501),0.3819613685082575,1.0473229458020155,0.4068479355488419,0.8814809190515753,1.0,34/148,21.39%,DEAF1;P3H1;BMP1;TNFRSF11B;RPL13;ATP7A;HAPLN2;HHIP;RFLNA;COL1A2;PRDX1;SOX5;CHRD;TGFB2;COL19A1;CD44;BMP6;ZBTB16;COL1A1;RFLNB;AKAP13;GDF3;EIF2AK3;PKDCC;SOX11;PAPSS2;GDF11;PTH1R;ANKRD11;SOX9;UCMA;PPIB;CDH11;RBP4
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3975683781469703,1.047221045893568,0.4261954261954262,0.8812071609767088,1.0,23/73,22.45%,ACTB;RBBP7;POLR1G;DNMT1;GPX1;JARID2;SPHK2;TAF1B;SF3B1;POLR2F;SMYD5;WBP2;DEK;GLMN;KAT2B;TBP;BMI1;HDAC4;POLR1F;PRMT7;MECP2;MTF2;KDM1B
prerank,plasma membrane tubulation (GO:0097320),0.4962990175163457,1.0468904191486217,0.43388429752066116,0.8816659614483123,1.0,5/13,16.00%,BIN3;CAVIN2;MICALL1;FNBP1L;SNX33
prerank,cobalamin metabolic process (GO:0009235),0.4846562092881872,1.0466914025596878,0.4339378238341969,0.8816627148876235,1.0,5/17,21.72%,MMAB;MMUT;ABCC1;CD320;MTR
prerank,central nervous system neuron differentiation (GO:0021953),0.4289593343337575,1.0466752132014467,0.42479908151549944,0.8811238998757118,1.0,7/33,11.67%,CHD5;ATP7A;TOX;NR4A2;GRID2;CTNNB1;MAPT
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3927311175401611,1.0465618877370473,0.4140786749482402,0.8808879696136768,1.0,7/78,5.77%,GTPBP4;CCND2;TFAP4;ACTB;HEXIM1;PTEN;GADD45A
prerank,mRNA metabolic process (GO:0016071),-0.25301522827726197,-1.0463464628875438,0.3333333333333333,0.8941290122599762,1.0,26/90,14.57%,AKAP8L;AGO4;DDX5;METTL16;PCBP2;PRPF3;U2AF2;PNPT1;SON;CPSF3;DIS3L2;DHX15;DCP2;SFPQ;SNRPD3;SSB;PPARGC1A;RIDA;SCAF11;SRSF9;SNRPE;TCERG1;PTBP1;TBRG4;NCBP2;SF3A1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.49206155957265396,1.0462760869124392,0.44925575101488496,0.8811102424637711,1.0,3/15,5.41%,UST;DCN;BGN
prerank,potassium ion transmembrane transport (GO:0071805),0.3789862207406166,1.0462141029481133,0.4244244244244244,0.8807280210673428,1.0,18/135,12.04%,KCNN4;ATP1B3;KCNJ10;KCNQ5;SLC24A4;KCNJ15;KCNA4;SLC12A7;NALCN;ATP1A3;ATP1A4;ATP1A1;KCNC4;KCNA1;ATP1A2;SLC12A5;HCN3;SLC12A4
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.5166656033991125,1.0461662173707809,0.42754662840746055,0.8803029416354006,1.0,6/11,25.39%,MSN;SORL1;VPS11;EZR;RDX;PTPN23
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4994466601728607,1.0460202610240388,0.4450402144772118,0.8801673213595786,1.0,4/14,14.25%,MMP9;SPRY1;CAV1;GDF3
prerank,retinol metabolic process (GO:0042572),0.5015116079764496,1.045638938633021,0.46143790849673205,0.880727401368118,1.0,2/14,11.66%,DHRS9;RDH12
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.34202180431690177,-1.044731077190943,0.39285714285714285,0.8959480704953728,1.0,7/19,7.91%,PRKCE;ITGAM;PIK3AP1;IRAK1;TLR4;NMI;LY96
prerank,coenzyme A metabolic process (GO:0015936),-0.3871178107661227,-1.0439095720237308,0.3782771535580524,0.8954055620359612,1.0,4/14,7.31%,PPCDC;DCAKD;ACOT7;NUDT7
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4144187172034697,1.0436799169265816,0.4310915104740904,0.8859672668656711,1.0,10/47,15.36%,GCK;CEACAM1;APOC1;ACADVL;ATP2B4;CAV1;SLC27A1;KHSRP;ABCA2;FYN
prerank,nucleus organization (GO:0006997),0.4081368192714751,1.0435803363767855,0.4211111111111111,0.8856761542947246,1.0,9/47,12.65%,CHMP6;CTDNEP1;SPAG4;LEMD2;CHMP7;SYNE1;WDR73;CHMP5;RPS19
prerank,cellular response to ionizing radiation (GO:0071479),0.41674503805890856,1.0434221160440216,0.430939226519337,0.8855910498597257,1.0,12/47,16.91%,FIGNL1;RAD1;ATM;GADD45A;NIPBL;INTS7;BLM;SIRT1;TMEM109;CDKN1A;EEF1D;CRYAB
prerank,smoothened signaling pathway (GO:0007224),0.4218058747995261,1.0427064781564062,0.4228110599078341,0.8871650229963666,1.0,13/32,30.79%,DHH;HIPK1;GLI3;DYRK2;TCTN3;IFT27;CC2D2A;PTCH1;SMO;ARL13B;TCTN2;GLI2;PKD2L1
prerank,negative regulation of chemotaxis (GO:0050922),0.4355757794040558,1.0426281490939389,0.4409722222222222,0.8868200695067732,1.0,9/31,21.94%,HRG;SEMA5A;ROBO1;ROBO2;SEMA3E;SEMA5B;SEMA3D;ANGPT2;DUSP3
prerank,actin crosslink formation (GO:0051764),0.5169344902470169,1.0423856475749937,0.45816186556927296,0.8869526711418398,1.0,2/12,7.47%,FLNA;LCP1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4457584992528058,1.0421368353627996,0.43855421686746987,0.8871419212177526,1.0,8/25,23.78%,F2R;CEMIP;CXCL10;AKAP6;TRPC1;SNCA;CX3CL1;THY1
prerank,glycoprotein metabolic process (GO:0009100),-0.2630148608585056,-1.0420270764162718,0.39705882352941174,0.8982289145922849,1.0,11/53,10.44%,MGAT4A;MAN1C1;LARGE1;MANBA;MAN2A2;GCNT1;HPSE;ST3GAL2;ST6GALNAC6;B4GALT7;GOLPH3
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4155665566920407,1.0419638930760946,0.4374295377677565,0.8871083501985465,1.0,9/38,15.34%,SFRP5;RACK1;PTEN;NOP53;THEM4;MUL1;DAG1;SIRT1;DRD2
prerank,negative regulation of response to wounding (GO:1903035),-0.3569778775077609,-1.0418774299858724,0.4,0.8954998709477104,1.0,3/19,2.02%,RTN4RL1;CRK;FGF2
prerank,eye development (GO:0001654),0.40690247527706763,1.0418244031951434,0.4344086021505376,0.8869561087842371,1.0,14/54,23.89%,BLOC1S3;PBX1;SMOC1;NIPBL;TGFB2;HIPK1;MEIS2;GDF3;PBX2;SIPA1L3;PBX3;RBP4;FBN2;COL5A2
prerank,regulation of store-operated calcium entry (GO:2001256),-0.4200281940880112,-1.0417857917450175,0.40202702702702703,0.8926192017594046,1.0,4/10,8.75%,CD84;HOMER1;SLC8B1;HOMER3
prerank,mesonephric tubule development (GO:0072164),-0.37811296731329747,-1.0414946483694154,0.376984126984127,0.8903857057056712,1.0,3/15,5.10%,NPNT;PKD1;SALL1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.488662092558488,1.0414123252495475,0.4479768786127168,0.8875804197657783,1.0,9/13,28.08%,ATM;SESN3;RNF152;SZT2;STK11;ITFG2;CASTOR2;DEPDC5;KPTN
prerank,protein insertion into membrane (GO:0051205),0.4330727992556022,1.0405776261984128,0.433411214953271,0.889374518426978,1.0,8/32,18.19%,TRAM1L1;GET1;SEC61B;RTP4;PRNP;REEP1;WDR83OS;CYB5A
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.38113943398754485,1.0403927425719803,0.448938321536906,0.8893382712754487,1.0,27/122,16.39%,GCK;CD28;SORBS1;YTHDF3;TLR9;KDR;PRKD2;METTL3;TGFB2;HSPH1;RPS4X;EEF2;JAK2;VIM;EIF4A3;CPEB3;IRS1;NPM1;METTL14;SAMD4A;SIRT1;POLDIP3;EIF3E;EPM2AIP1;RPS6KB1;PCNA;NIBAN1
prerank,presynaptic endocytosis (GO:0140238),-0.3223753418678489,-1.0400503445394056,0.4375,0.8919593369832173,1.0,5/24,9.24%,OPHN1;FCHO2;SYT2;CDK5;AMPH
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4305451334537192,1.0396391110745338,0.433849821215733,0.8909317486022432,1.0,10/30,21.08%,RPS27A;UBA52;TNIP3;UBB;RIPK1;TICAM1;CD14;BIRC3;UBE2D1;TRAF3
prerank,Golgi to endosome transport (GO:0006895),-0.36763999875140696,-1.0395036480917497,0.39148936170212767,0.8905209960675,1.0,10/16,28.37%,VPS13C;AP2A1;CORO7;WIPI1;DOP1B;KIF16B;RAB14;AP1AR;SORT1;GBF1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4497257120603572,1.039179761447781,0.4538922155688623,0.8916961581834785,1.0,8/26,20.96%,SPTLC3;NQO1;SPHK2;PM20D1;ABCA2;CYB5B;SPTLC2;ACER2
prerank,positive regulation of vasoconstriction (GO:0045907),0.5056043549032955,1.0391269075182152,0.4629878869448183,0.8912868252784494,1.0,2/13,8.62%,F2R;CAV1
prerank,calcium ion transport (GO:0006816),0.3846928605539074,1.0391150919129708,0.42784552845528456,0.8907481681234588,1.0,28/113,17.17%,TPT1;CCL5;KCNN4;SLC24A4;CACNG7;SLC3A2;ATP2B4;ATP2A3;RAMP1;NALCN;STIM1;GRIN3A;MCOLN2;CAV1;ITPR1;TRPC5;PANX1;CACNA1H;CRACR2B;CACNA2D1;FKBP1A;TRPC4;ORAI2;CACNA1I;FYN;MS4A1;TRPC1;ATP2B2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3837814883023241,-1.039009878870878,0.38247011952191234,0.8890855069431496,1.0,4/14,8.01%,MAP3K7;IRAK1;ZFP91;TLR3
prerank,response to tumor necrosis factor (GO:0034612),0.38674987012106005,1.0389027430047912,0.42901554404145076,0.8908052289374154,1.0,14/91,14.15%,GATA3;CCL5;CCL7;SMPD1;AFF3;RPS3;GBP2;CXCL16;JAK2;ZFP36L2;YBX3;ZFAND6;SIRT1;RIPK1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.39043176210924135,1.038766088287579,0.43268242548818087,0.890631367894699,1.0,23/85,18.13%,PSMC3;PSMD8;PSME1;ARHGEF19;PSMD6;PSMB5;CELSR1;VANGL1;FZD6;PRICKLE2;PSMC6;CDC42;PSMB4;PSMA7;PSMB9;PSMA6;PSMC1;PSMD7;TIAM1;PSMD2;AP2S1;SMURF2;PSMD5
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3933147052544546,1.038747150422196,0.44834710743801653,0.8901097440643166,1.0,22/72,22.16%,RPS27A;UBA52;ERCC4;RFC4;LIG1;COPS6;GTF2H5;RFC5;UBB;POLR2F;ERCC1;COPS3;POLK;XAB2;PCNA;TCEA1;ERCC5;POLD4;COPS8;DDB1;POLR2D;ERCC8
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3689899925622475,1.0383492505996343,0.247,0.8907389426372371,1.0,334/1645,19.83%,SKAP1;IKZF3;FOXN1;BCL11B;LEF1;STAT4;CD4;TCF7;DEAF1;TBX21;SATB1;EOMES;NRG1;SOX3;IRF6;TCF15;OVOL1;NR4A3;NCOR2;PRKCQ;SIX5;CSRNP1;ZKSCAN4;GATA3;DEDD2;ZBTB42;TRIM16;DACH1;ZNF395;IRX5;SOX7;RUNX3;IL31RA;RFX5;FOSB;CD74;SCML4;CAMK4;TFAP4;EHF;UXT;PBX1;DAXX;CHD5;HOXA7;MYBL2;NHLH2;F2R;ACTA2;FADS1;HR;NCF1;ATRX;RUNX1T1;SP100;HOXB4;SPIB;PDCD4;HDAC9;HMGB1;NEK4;HSPA8;HMGB3;MRPL12;HEXIM1;LHX4;ARID5A;HTATIP2;TCF7L1;ZXDB;ING2;BIRC5;PRRX2;ILF3;AHR;CDK17;RNF14;ARID4B;DAPK3;HOXC4;APOE;IKZF2;DKK3;FBXO5;SMAD2;ZBTB39;CDH1;MYB;ELF4;TOX;XPC;KCTD1;SREBF1;PFDN5;LBH;HNRNPAB;CHD2;RARA;SMARCC1;ATP2B4;RFX2;ZBTB7B;TADA1;HDAC1;SMARCD3;NIPBL;HMGB2;MAFK;CREBRF;NFE2;NR4A2;SOX5;CSRNP3;ZFX;NR1H2;KIT;FOXP1;PRMT5;ING5;NR1D2;DACH2;RNF111;CREBL2;TOX4;ZHX2;PPP2R1A;RBM15;ZBTB8A;SLTM;MXD4;ETS1;BMP4;POU6F1;MSL3;NFYB;MLF1;DAP;PER2;JARID2;RPS6KA5;NLK;UBE2L3;RLF;TFDP2;KTI12;ATF7IP;ZFHX2;MNT;TCF12;NR4A1;HOXB2;L3MBTL1;NR6A1;HEY2;TRIM33;ID2;PSPC1;KDM4C;MED30;STAT5B;EGR3;TSHZ2;GLI3;DHX36;MIDEAS;ZNF18;MED23;ZBTB16;CIAO1;CCAR2;HOXC9;PHF5A;KLF13;CC2D1A;ZFP62;MEIS2;GATAD2A;KLF12;NAA16;EBF1;TARBP1;KDM3B;CTNNB1;ACTR8;ELF1;TASP1;HP1BP3;HOXC5;ILK;MED7;ZBTB6;SUB1;COL1A1;SMAD1;ZBTB24;GTF2IRD1;E2F6;PAX5;MED13;LIMD1;FOXP4;RFX1;SETD5;SNF8;VHL;HOXC8;PCGF5;ERC1;CTR9;FOXO1;ATXN1;ZBTB25;ATF4;MAGED1;HIVEP2;BLM;BCL6;HMBOX1;HSF2;NIF3L1;TGFB3;HOXB9;NPM1;ATMIN;PTP4A3;SUV39H2;ARNT2;EPAS1;HLF;BRIP1;WWTR1;JMJD6;NCOR1;PPP2CA;EBF2;SIRT1;PRKAR1A;NCOA7;APBB3;FGF7;PCID2;NPAS3;NCOA2;ZFP41;ZBTB22;BAZ2A;SHC1;KDM5B;CIC;RBAK;RCOR1;CDKN1A;MYT1L;ABCA2;BAZ1A;RFX7;TYMS;SOD2;IRF4;PKN1;RUVBL1;IKZF4;RUNX2;PCNA;RFX3;WBP2;BATF3;CREB5;DMTF1;ZSCAN22;ENY2;PRDM5;PPARGC1B;MAPRE3;JDP2;MRGBP;EDF1;CEBPB;NKRF;DEK;ZBTB2;CRYAB;KLF2;BATF;NFIL3;RBFOX2;PPP3CB;ZNF83;SOX11;PRRX1;PIAS1;ZSCAN18;ING1;SMURF2;PBX2;CBX4;CALCOCO1;HDAC2;SOX10;DMAP1;RYBP;DPF2;HES1;GPBP1L1;PER1;HINFP;HSF5;ATXN1L;NSD3;EGR2;RORA;HDAC4;LYL1;RGMB;YY1;NAB2;THOC1;SEC14L2;ZFP37;MLLT3;MLXIPL;MLX;MLLT6;BNC2;KLF11;SNAI2;MED24;RBBP8;ZBTB33;RFXANK;MECOM;PBX3;SRA1;SOX9
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4075598282002273,1.036987360602488,0.4309031556039173,0.8941877380060246,1.0,6/50,5.60%,MMP8;TRIP6;PDCD4;TLR9;LAPTM5;RPS3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.39161664347001296,1.03677826905541,0.4512448132780083,0.8942300869053814,1.0,21/73,15.52%,CD247;CD3G;NR4A3;ACTG1;ACTB;WAS;CYFIP2;MYO1G;ARPC2;ARPC1A;CDC42;ARPC5;NCK1;HSP90AA1;NCKAP1;ACTR3;ABI1;MYO10;FYN;BLK;PAK1
prerank,regulation of cell cycle phase transition (GO:1901987),0.3897273284455508,1.0366306201845419,0.45435684647302904,0.8940778324841838,1.0,21/91,16.22%,TFAP4;PSMC3;BUB1B;PSMD8;FBXO5;FZR1;XPC;PSME1;PSMD6;ATP2B4;PSMB5;CDK1;PSMC6;PSMB4;PSMA7;PSMB9;PSMA6;PSMC1;CDKN1A;PSMD7;PSMD2
prerank,cytoplasmic microtubule organization (GO:0031122),0.40818532488929105,1.0364591067555038,0.4412081984897519,0.8940071618103015,1.0,17/54,23.35%,CCDC88C;CHP1;FIGNL1;HOOK1;WDR73;RAB11A;MAPT;CLIP4;FIGN;EZR;CLIP3;CCDC88A;CCDC13;DLG1;CCDC88B;LIMK2;SLK
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4734827071423779,1.036391393377924,0.44502617801047123,0.893064904505114,1.0,4/17,12.33%,IL7R;IL2RG;STAT5B;IRS1
prerank,cellular response to interleukin-7 (GO:0098761),0.4734827071423779,1.036391393377924,0.44502617801047123,0.893064904505114,1.0,4/17,12.33%,IL7R;IL2RG;STAT5B;IRS1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.47809205641240904,1.0359918477396381,0.4567243675099867,0.8936764370860103,1.0,4/15,7.58%,CEACAM1;RHBDF1;CDH13;PTPN12
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.35537516467333136,-1.0359122865606358,0.4083333333333333,0.8951781984031094,1.0,6/17,20.10%,FCHSD2;WASF2;WASF1;PICK1;CTNNA2;CORO1B
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.369596667391337,-1.0359108730696656,0.415929203539823,0.8921056224985382,1.0,9/16,25.88%,NAA25;NAA40;NAA35;NAA10;NAA60;NAA30;NAA15;NAA80;CREBBP
prerank,positive regulation of intracellular protein transport (GO:0090316),0.37507690747528716,1.0355748620710532,0.42338709677419356,0.8943496688047555,1.0,45/144,21.69%,GZMB;CHP1;BCL2;FLNA;MICALL2;CEMIP;BID;CDH1;ANP32B;TOMM7;YWHAB;UBL5;UBE2L3;RAC2;TFDP2;SFN;ANK3;ZPR1;PRNP;SORL1;ZDHHC2;VPS11;TCAF1;RHOU;UBR5;SAR1B;FYN;PCNT;MTCL1;HUWE1;GSK3A;ITGB2;PPP1R13B;JUP;DMAP1;TMEM30A;C2CD5;PRR5L;GSK3B;YWHAZ;MFF;TCAF2;YWHAG;RAPGEF3;TRIM28
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.4315184238999039,1.035564638838554,0.4386574074074074,0.8938084126444467,1.0,11/32,21.84%,CDK17;FBXO5;TFDP2;ID2;ZPR1;TYMS;PCNA;HINFP;KLF11;NPAT;BRD4
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.4021824482884085,1.0354896826790638,0.44073275862068967,0.8934608805301392,1.0,12/53,17.27%,XPO1;RHBDF1;PSMC3;NUDT15;APOE;PSME1;GPX1;PSMC6;UBB;DESI1;TREM2;GLMN
prerank,RNA biosynthetic process (GO:0032774),-0.3051884139318344,-1.0353395679034645,0.3779527559055118,0.8908250137327384,1.0,11/31,17.01%,BRF1;POLA2;TAF4;TAF7;PRIM2;TAF13;TAF12;SMARCA5;PRIM1;GTF2B;SMN1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.3736125727352277,-1.035309765937026,0.40234375,0.8878557072601828,1.0,10/14,31.98%,ADK;ADSS1;LHPP;PAICS;ATIC;IMPDH2;RFK;ADSS2;PPAT;IMPDH1
prerank,neuron fate commitment (GO:0048663),-0.37180723760906265,-1.03523389354566,0.3939393939393939,0.885100577499774,1.0,1/14,0.18%,TGFBR1
prerank,negative regulation of autophagy (GO:0010507),0.4016865351142511,1.0351845423104689,0.44168466522678185,0.893787013899966,1.0,6/54,7.91%,PTPN22;DAPL1;BCL2;TAB2;SMCR8;DAP
prerank,positive regulation of interleukin-10 production (GO:0032733),0.43406383912110413,1.0351569984707765,0.44779582366589327,0.8933024329065355,1.0,3/30,4.05%,CD28;HMGB1;TLR9
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.3834315608590168,1.035000211840594,0.4256198347107438,0.8931902911636075,1.0,22/94,16.22%,RPS27A;IL1R2;PSMC3;UBA52;TAB2;PSMD8;PSME1;PSMD6;PSMB5;RPS6KA5;PELI1;PSMC6;PSMB4;NFKBIA;PSMA7;NOD1;UBB;PSMB9;PSMA6;PSMC1;PSMD7;PSMD2
prerank,fatty acid transmembrane transport (GO:1902001),0.4744043912662764,1.034972252725856,0.4402035623409669,0.8926951695739203,1.0,7/19,13.42%,ABCD3;CD36;SLC27A1;MID1IP1;ACACA;CPT2;SLC2A1
prerank,regulation of chemokine production (GO:0032642),-0.28351218342850104,-1.034514236382307,0.39344262295081966,0.8843557377737228,1.0,11/36,13.11%,CSF1R;IL6R;IL18;TLR7;TLR4;TLR2;TLR3;HMOX1;EIF2AK2;APP;LGALS9
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5230401753397411,1.0344980307775493,0.45285714285714285,0.8935320999347752,1.0,2/10,10.25%,ATRX;CDC7
prerank,ether lipid biosynthetic process (GO:0008611),-0.42810742778680155,-1.0343534617644479,0.4142857142857143,0.8818062735634371,1.0,4/10,12.47%,LPCAT2;PEX7;PLA2G4A;AGPS
prerank,pharyngeal system development (GO:0060037),0.4832362085821107,1.0342629683877194,0.4521625163826999,0.8936507590459427,1.0,3/15,7.67%,GATA3;TGFB2;BMP4
prerank,cell-cell junction maintenance (GO:0045217),0.5114303262559107,1.0342438530321334,0.469187675070028,0.8931319584738532,1.0,2/11,3.55%,F2R;FERMT2
prerank,regulation of innate immune response (GO:0045088),0.39718031675332677,1.0342273759838858,0.4405144694533762,0.8926112656411674,1.0,17/57,21.47%,FPR2;PTPN22;CCL5;TRIM21;APPL1;MUL1;USP18;TIRAP;TREM2;SAMHD1;RIOK3;ACOD1;RNF135;RNASEL;BIRC3;HSP90AB1;NLRC3
prerank,neuron projection extension (GO:1990138),0.4321940792797627,1.0342016774050309,0.44642857142857145,0.892102757270509,1.0,13/32,21.23%,IQGAP1;AUTS2;SEMA5A;TMEM108;HSP90AA1;CTNNB1;ALCAM;MAP1B;PPP3CB;CPNE1;SEMA5B;CYFIP1;HSP90AB1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.4353767232688005,1.0340892414119145,0.4499411071849234,0.8918423018167193,1.0,7/29,16.46%,DEDD2;BID;TNFSF10;CAV1;TNFSF12;RIPK1;PPP2R1B
prerank,methylguanosine-cap decapping (GO:0110156),-0.4239518061385276,-1.0339448287755055,0.3879003558718861,0.88001016832514,1.0,4/10,10.99%,DCP2;DCP1B;DCPS;PNRC2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5131462864418115,1.0334600811978505,0.46787709497206703,0.8931039522450601,1.0,2/11,8.38%,MMP9;GSN
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.375275919506299,-1.0334457652850677,0.40711462450592883,0.8786260216299275,1.0,4/15,14.20%,NEK6;CDC23;ANAPC1;PTTG1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.3485434809965768,-1.033072272573349,0.4337899543378995,0.8768839044121736,1.0,7/18,17.58%,IL6R;FER;PTPN11;CEBPA;SPI1;ST18;STAT3
prerank,regulation of cholesterol efflux (GO:0010874),0.42997829514511515,1.033008859545208,0.4334511189634865,0.8938813120051218,1.0,10/30,18.72%,APOE;NR1H2;CAV1;NFKBIA;ABCA7;NAXE;SIRT1;ABCA2;TREM2;TTC39B
prerank,MAPK cascade (GO:0000165),0.3713023226866762,1.0328711047942434,0.4194194194194194,0.893710818565005,1.0,63/295,18.13%,IL2RB;RPS27A;MAPK13;NRG1;PRKCQ;RASGRP1;CCL5;IL31RA;ANGPT1;PSMC3;UBA52;RAF1;PAQR3;KDR;PSMD8;ARL2;RASAL1;BRAP;PSME1;DUSP5;PSMD6;SPTBN4;PSMB5;MRAS;KIT;CDK1;DUSP6;YWHAB;PTPRA;IL2RG;IL3RA;PSMC6;JAK2;PSMB4;ZFP36L2;TAOK3;PSMA7;KSR1;FLT3;IRS1;UBB;ABHD17A;PSMB9;PSMA6;MAPKAPK2;TNIK;PSMC1;FGF7;CTSH;KITLG;SHC1;CUL3;RASA2;FYN;PAK1;PSMD7;PSMD2;CALM1;BRAF;DLG3;RANBP9;MBP;PSMD5
prerank,positive regulation of neuron migration (GO:2001224),0.5074628345713039,1.0328449060235416,0.4603616133518776,0.8932242776826034,1.0,2/11,6.30%,MDK;NIPBL
prerank,regulation of actomyosin structure organization (GO:0110020),0.503162116599595,1.032788290055615,0.46442953020134226,0.8928211997757723,1.0,5/13,12.85%,ACTG1;WAS;CDC42;ROCK1;AKAP13
prerank,positive regulation of protein phosphorylation (GO:0001934),0.37021171645104023,1.0323289698588056,0.407,0.8935508979343789,1.0,64/348,16.42%,FPR2;CD4;MMP9;RASGRP1;ANGPT4;CCND2;GHR;CD74;DDR2;DAXX;PECAM1;ANGPT1;C3;IQGAP1;P2RY1;CLEC6A;RAF1;TAB2;CEMIP;KDR;PPIA;S1PR2;VTN;RACK1;PRKD2;ATP2B4;MIF;SLCO3A1;TGFB2;CREBL2;BMP4;CD44;PIN1;RPS6KA5;RARRES2;CAV1;BMP6;JAK2;FAM20A;HSP90AA1;PRNP;ILK;AGAP2;TGFB3;STK4;RALB;NPTN;TNIK;SIRT1;RIPK1;GDF3;FGF7;SDCBP;TNFRSF14;CDKN1A;CRKL;RAP2A;PAK1;TREM2;AGER;PDGFD;MYDGF;NIBAN1;MAPRE3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.435083119915959,1.032117893083444,0.45066991473812423,0.8936292520411304,1.0,5/26,12.39%,RPS27A;UBA52;TAB2;NOD1;UBB
prerank,regulation of execution phase of apoptosis (GO:1900117),0.5115524926038956,1.0321175963242009,0.4710860366713681,0.8930581482781245,1.0,3/11,17.98%,DLC1;FAP;DFFA
prerank,positive regulation of MAP kinase activity (GO:0043406),0.398107137709601,1.0320822041452828,0.4409282700421941,0.8925824784706422,1.0,13/66,16.18%,CD24;RASGRP1;TLR9;RPS3;TPD52L1;KIT;MAP3K4;TAOK3;ROBO1;FLT3;PIK3R5;PAK1;PDGFD
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3969380479367187,-1.0318657510629723,0.40145985401459855,0.8778885605073775,1.0,4/13,10.39%,ABHD12;MGLL;PLA2G4A;DGAT1
prerank,protein localization to cell surface (GO:0034394),0.43917179064415945,1.0310055673640146,0.43985849056603776,0.8951417134165159,1.0,9/26,17.82%,FLNA;ANGPT1;FBLN5;JAM3;CTNNB1;RIC3;FGF7;VCL;GGA1
prerank,peptidyl-amino acid modification (GO:0018193),0.5086392298434275,1.0309572313848043,0.45375722543352603,0.8947122945596734,1.0,3/10,23.02%,ATP7A;METAP2;FKBP7
prerank,response to calcium ion (GO:0051592),0.38479208499121104,1.030910924604028,0.4427402862985685,0.8942643924378907,1.0,14/102,9.45%,SLC25A24;ANXA11;SMPD1;IQGAP1;NEDD4;ITPR3;RASGRP2;KCNMB4;ALOX5AP;SYT4;STIM1;CAV1;GPLD1;SYT7
prerank,snRNA processing (GO:0016180),-0.37616261913154064,-1.0309059123934725,0.3656387665198238,0.8778470621334409,1.0,6/16,12.91%,INTS3;INTS10;INTS12;INTS11;INTS6L;INTS1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.48452742241544866,1.030865679020372,0.4625668449197861,0.8938259372489642,1.0,1/13,0.73%,GIMAP7
prerank,mammary gland epithelium development (GO:0061180),0.4899554114153664,1.0305083267822301,0.4431057563587684,0.8942674353502447,1.0,4/14,14.48%,IRF6;JAK2;ID2;WNT3
prerank,cellular response to misfolded protein (GO:0071218),-0.34237040228212345,-1.0304658812258989,0.44495412844036697,0.8763067718504949,1.0,9/20,23.00%,RNF185;KLHL15;BAG6;DNAJC18;POMT2;RNF126;STUB1;RNF5;DNAJB12
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.393079520347044,1.0302025914558701,0.4447983014861996,0.8946209941394054,1.0,14/62,19.53%,TPT1;MMP9;BCL2;CLU;PPIA;CCAR2;YBX3;ARMC10;HSPA1A;SIRT1;SOD2;MCL1;SELENOS;SNAI2
prerank,renal water homeostasis (GO:0003091),0.45046310822331104,1.0301569364006264,0.4430693069306931,0.894181883713649,1.0,6/23,16.49%,PRKAR1B;RAB11A;AQP4;ADCY6;PRKAR1A;ADCY1
prerank,regulation of vasoconstriction (GO:0019229),0.4320809436052339,1.0301184011419837,0.459954233409611,0.8937199346197876,1.0,4/27,8.62%,F2R;KCNMB4;PER2;CAV1
prerank,development of primary male sexual characteristics (GO:0046546),0.42658543293136936,1.0297510824322607,0.46366782006920415,0.8942027186277508,1.0,4/34,8.73%,GATA3;KIT;TGFB2;MEA1
prerank,axonogenesis (GO:0007409),0.3724749543617714,1.029747991135798,0.4188376753507014,0.893644083518672,1.0,60/237,20.24%,S100A6;LRTM1;PRKCQ;EMB;SLITRK2;ADGRB1;LAMA5;ACTB;AUTS2;LMTK2;RAB8A;SEMA5A;EFNB2;PARD3;KIF5A;PTEN;DSCAM;SPTBN4;UNC5D;PTPRA;RPS6KA5;ZDHHC17;ANK3;LGI1;BSG;CXCR4;HSP90AA1;NEFH;ROBO1;EPHB2;UNC5C;DOK2;DAG1;EPHA7;ROBO2;EPHA5;NTNG1;NTNG2;NPTN;MAP1B;SHC1;DCC;KIF5C;EZR;SEMA3E;DRD2;FYN;ATL1;DOK4;PPP3CB;RANBP9;EPHA3;DAB1;SLIT3;SLIT1;SEMA5B;SEMA3D;CYFIP1;SCN1B;VLDLR
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.4055701476096726,1.0293812759622814,0.453091684434968,0.8941913116794754,1.0,13/57,14.95%,SDE2;MDC1;TICRR;FBXO31;FZR1;ATM;CDK1;CDK2;NOP53;TAOK3;FANCD2;BLM;CDKN1A
prerank,positive regulation of lipid metabolic process (GO:0045834),0.4460096755274284,1.029335945810005,0.4419753086419753,0.8937488209687499,1.0,3/22,7.40%,SORBS1;APOE;CREBL2
prerank,DNA biosynthetic process (GO:0071897),0.472915913264873,1.0290096156749928,0.468,0.8940872714209939,1.0,6/16,23.53%,PPIA;POLE;SIRT1;TYMS;POLD4;WRN
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3617802887469178,-1.0289331133650568,0.3938053097345133,0.8779255840115106,1.0,5/16,8.46%,ARHGAP24;RASGRF1;SH3BP1;PIK3CG;PIK3CB
prerank,histone H3 acetylation (GO:0043966),0.4148962376503863,1.0287920166550997,0.44819819819819817,0.894163861199699,1.0,11/40,19.21%,LEF1;TRIM16;TADA1;ING5;DR1;JADE1;WDR5;JADE3;KAT2B;PER1;MEAF6
prerank,receptor recycling (GO:0001881),0.5138780800850621,1.028741338890836,0.47155688622754494,0.8937480404139734,1.0,5/10,25.90%,LMTK2;SORL1;PLEKHJ1;NSG1;EHD3
prerank,phagosome maturation (GO:0090382),-0.2878356453815649,-1.0286617840695786,0.41935483870967744,0.8758397881503908,1.0,16/35,22.85%,ATP6V0A1;MCOLN1;TCIRG1;RAB39A;ATP6V1D;ATP6V1A;MREG;RAB20;RAB32;RAB34;RAB38;SLAMF8;ATP6V1C1;ATP6V0E2;RAB14;ATP6V0D2
prerank,protein localization to phagophore assembly site (GO:0034497),-0.40158313502005183,-1.0285178481527621,0.40522875816993464,0.8733941560441181,1.0,3/11,13.74%,WIPI1;WDR45B;MFN2
prerank,embryonic appendage morphogenesis (GO:0035113),-0.38996307279112913,-1.0284789588344645,0.4,0.8706531727851854,1.0,2/12,4.36%,SKI;FBXW4
prerank,positive regulation of signaling (GO:0023056),0.4138227244580716,1.0283724796029547,0.4376391982182628,0.8942500591066678,1.0,13/37,25.57%,GATA3;LGI1;NSF;ILK;RIMS3;SOX11;ECE1;GRIK2;SNCA;RIMS1;NMU;PTPN23;RAB29
prerank,regulation of developmental growth (GO:0048638),0.4226612832061607,1.0282646483329014,0.4528301886792453,0.8940057326975809,1.0,5/29,9.67%,GHR;APOE;NIPBL;MFSD2A;STAT5B
prerank,endothelial cell differentiation (GO:0045446),0.4935792350035481,1.028154314841033,0.47009735744089015,0.8937592017189414,1.0,4/12,16.79%,KDR;FSTL1;EDF1;JAG1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.38735857307738475,1.0276787714879718,0.45595854922279794,0.8945955959072741,1.0,31/87,25.14%,CDK6;PSMC3;PSMD8;FBXO5;PTEN;PSME1;PSMD6;PSMB5;PSMC6;PSMB4;ZFP36L2;PSMA7;PSMB9;PSMA6;JADE1;PSMC1;CDKN1A;PSMD7;PSMD2;GPR132;PSMD5;CDC73;WEE1;PSMB6;DLG1;PSMA3;RBL2;FBXL7;DCUN1D3;PSMB2;PSMD1
prerank,regulation of dendrite extension (GO:1903859),0.467681759068441,1.0275075165893726,0.45979899497487436,0.8945197027850419,1.0,6/18,22.10%,SYT4;RASAL1;RNF157;PLAA;RIMS1;SYT17
prerank,smooth muscle contraction (GO:0006939),0.4763057223558635,1.0273963306540967,0.4642375168690958,0.894272059807616,1.0,3/14,2.91%,ACTA2;EDNRA;MYH11
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3962579993397566,1.0271126032781541,0.47357293868921774,0.8944716220796992,1.0,19/70,17.76%,POF1B;LAMA5;ITGA4;MICALL2;FERMT2;ACTN1;METTL3;PARVA;ITGB7;SRCIN1;RILPL2;ILK;ATF4;NTNG1;NTNG2;LAMB1;ANTXR1;MEGF9;SIPA1L3
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5252420877617887,1.0269369138095643,0.4856361149110807,0.8944366654623549,1.0,1/10,2.21%,NPTX2
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5005290986285732,1.0268914875058166,0.4669421487603306,0.8940186476297597,1.0,6/12,20.95%,UGP2;EXTL2;GALT;FUT8;GFPT2;CSGALNACT1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4389919809297002,1.0268907551356519,0.46642685851318944,0.8934578946805827,1.0,4/25,10.95%,B3GNT3;FUT9;EXT2;NDST3
prerank,negative regulation of hydrolase activity (GO:0051346),0.40206940556621495,1.0267953567448052,0.4530386740331492,0.8931554301191105,1.0,7/49,8.73%,KLRK1;CHP1;PPP1R35;SH2D4A;ARL2;ZCCHC9;CST7
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.4129456716733789,1.0267693081860707,0.474972191323693,0.8926677776266254,1.0,20/41,29.69%,GCK;NUP50;NUP214;NUP210;NUP88;RANBP2;AAAS;NUP62;PRKAG1;NUP93;NUP205;NDC1;NUP153;ZBTB7A;OGT;NUP98;TPR;HIF1A;SCARB2;NUP35
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.5145798949261149,1.0266777710590456,0.45544554455445546,0.8923705602632779,1.0,4/10,25.69%,SEMA5A;CARMIL2;ACTN2;PLEK
prerank,L-amino acid transport (GO:0015807),0.43607672525319713,1.0266107656743324,0.4452296819787986,0.8920125616880037,1.0,6/28,15.87%,SLC36A3;SLC3A2;SLC1A6;SLC7A1;SLC7A5;ARL6IP5
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4414673268858964,1.0263794023082635,0.4490049751243781,0.8920878133624971,1.0,4/23,18.76%,GCK;NCOR1;GSK3A;HDAC4
prerank,negative regulation of cell cycle process (GO:0010948),0.39554719800286475,1.026228549381644,0.46375266524520253,0.8919934489434791,1.0,14/61,19.58%,UXT;RBBP7;FBXO5;WAPL;BMP4;TFDP2;CDC7;APAF1;ESPL1;E2F6;NME6;RYBP;BMI1;RBBP8
prerank,"phagocytosis, engulfment (GO:0006911)",-0.29561867479157444,-1.0254608153152904,0.37777777777777777,0.8766117929667371,1.0,11/36,13.12%,ELMO1;ITGAM;ARHGAP25;VAMP7;ARHGAP12;SH3BP1;MEGF10;MSR1;RHOBTB2;FCGR1A;THBS1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4386394187069047,1.0253665682454798,0.4534313725490196,0.8939153720031374,1.0,4/24,5.80%,NEDD4;VTN;CADM4;PRKD2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4268352487367963,1.0252577137470889,0.4630261660978385,0.8936643661029493,1.0,10/31,20.18%,SPN;ATM;CTLA4;BLK;CEBPB;GLMN;SOX11;LILRB1;TYROBP;TNFRSF13B
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4451449264393773,1.025186015630258,0.45554202192448234,0.893322851895048,1.0,10/23,26.84%,TXK;NR1H2;IFNGR1;JAK2;PIAS1;NLRC5;HSP90AB1;JAK1;CDC37;PPARG
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.3813847122366516,1.0251734278518163,0.4784394250513347,0.8927946383870854,1.0,15/93,10.37%,NCK2;RAF1;PAQR3;RACK1;PTEN;PRKD2;ATP2B4;SPTBN4;MIF;CREBL2;CD44;CAV1;DMD;NCK1;HSP90AA1
prerank,negative regulation of protein polymerization (GO:0032272),-0.3128223491697947,-1.02504575711103,0.4012738853503185,0.8749712172481088,1.0,8/27,15.79%,CYRIB;SSH2;KANK1;TWF1;SSH3;PRKCD;DYRK1A;HIP1R
prerank,cortical cytoskeleton organization (GO:0030865),-0.27536270409792307,-1.0250103852848613,0.3867924528301887,0.8722116560814166,1.0,17/41,22.64%,ROCK2;NCKAP1L;FMNL1;FHOD1;EPB41L3;PPP2R3C;TRPV4;LLGL1;RHOBTB2;RHOB;IKBKB;RHOF;TNF;RHOBTB3;RHOBTB1;LLGL2;ARF6
prerank,calcium ion import (GO:0070509),-0.3104797871195981,-1.0248974325567863,0.4012345679012346,0.8697540214568432,1.0,7/28,13.57%,SLC8A1;CACNA1D;MCUR1;TRPV4;MAIP1;ATP2A2;CACNA1G
prerank,cellular component maintenance (GO:0043954),0.49775126216048304,1.0247518372530426,0.4783821478382148,0.8934059171196151,1.0,5/12,16.03%,PRNP;LNPK;FYN;TREM2;IGF1R
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3906537003710235,1.024379067714105,0.45846477392218715,0.8939319890186873,1.0,18/67,15.36%,SH2D2A;CYBA;CYBB;NCF1;NCK2;KDR;CYFIP2;PRKD2;BCAR1;CDC42;NCK1;HSP90AA1;ROCK1;MAPKAPK3;NCKAP1;MAPKAPK2;ABI1;FYN
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.34445819734958394,-1.0240834876139306,0.4225941422594142,0.8693105634730336,1.0,5/18,13.11%,CD34;SMAD3;CD200;ITGB8;LGALS9
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.43146838964357026,1.0239873147184357,0.46744186046511627,0.8944803633293166,1.0,11/29,27.23%,RTEL1;PPIA;CDK2;HSP90AA1;ANKRD28;PTGES3;GAR1;HSP90AB1;PPP6C;TERF1;TERF2IP
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4380158846233052,1.022896164827757,0.44742990654205606,0.8970378989751663,1.0,5/27,12.87%,FPR2;KIT;FLT3;IRS1;AGAP2
prerank,establishment of protein localization to membrane (GO:0090150),0.3933528353734216,1.0222563566314227,0.47071352502662406,0.8983341639787606,1.0,27/66,26.59%,NCF1;BID;PARD3;AQP11;RTP4;RAB11A;ZDHHC23;ZDHHC15;ZDHHC12;ZDHHC2;REEP1;MICALL1;ARL6;SDCBP;ATG3;ZDHHC14;ZDHHC18;BRAF;AFDN;SEC63;GOLGA7B;ZDHHC21;ZDHHC7;PIKFYVE;VPS37C;RAB3GAP2;MYO1C
prerank,peptidyl-tyrosine modification (GO:0018212),0.39862058384322,1.0220336969952397,0.4560085836909871,0.8983876191774531,1.0,13/56,15.99%,LCK;DDR2;KDR;KIT;JAK2;ZAP70;EPHB2;FLT3;ABI1;FYN;BLK;PKDCC;ABL2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5054010902017395,1.0218605197644857,0.46338028169014084,0.8983178322015279,1.0,8/11,31.15%,DNMT1;ATF7IP;TRIM28;SETDB1;RESF1;TASOR;TPR;SETDB2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.4348451738703757,1.0217508351002114,0.4511002444987775,0.8980662672903043,1.0,9/25,22.56%,HEXIM1;NELFCD;LEO1;CDK13;EAF2;CDC73;HNRNPU;BRD4;WDR43
prerank,phospholipid transport (GO:0015914),0.40018294690853395,1.0215694600204155,0.46524064171123,0.8980091310202802,1.0,13/52,20.70%,ATP8B4;ABCA4;APOC1;APOE;MFSD2A;ATP11B;ABCC1;ABCA7;PRELID1;PRELID3A;TMEM30A;LDLR;ABCB4
prerank,axon extension (GO:0048675),0.4443488307985001,1.0215617339819383,0.4647713226205192,0.8974695492818432,1.0,11/23,21.23%,AUTS2;SEMA5A;HSP90AA1;ALCAM;MAP1B;PPP3CB;SLIT3;SLIT1;SEMA5B;CYFIP1;HSP90AB1
prerank,membrane lipid biosynthetic process (GO:0046467),0.3972998940098208,1.0210526046719148,0.46624472573839665,0.8983877845961945,1.0,20/58,21.91%,SPTSSA;SPTLC3;PRKD2;PPM1L;SPHK2;ELOVL7;CERS4;SCCPDH;ELOVL1;FA2H;ELOVL6;HACD1;DEGS1;SGMS1;HACD2;SPTLC2;ACER2;PRKD3;ST8SIA6;HACD4
prerank,regulation of myelination (GO:0031641),0.43347778744783116,1.0206660655022717,0.46153846153846156,0.8989247760399488,1.0,9/25,20.22%,PARD3;TMEM98;CST7;LGI4;ZPR1;ITGAX;EIF2AK3;EGR2;TENM4
prerank,negative regulation of cell differentiation (GO:0045596),0.36990892518588697,1.020088120381449,0.43987975951903807,0.9000524868327445,1.0,33/181,14.04%,SOX3;GATA3;RUNX1T1;CDK6;FERMT2;PDCD4;HDAC7;PTEN;MYB;ANP32B;PAF1;SPRY1;CHRD;NR1H2;LEO1;IQCB1;BMP4;GREM1;CAV1;ID2;TMEM64;ZBTB16;ZFP36L2;MEIS2;NFKBIA;LIMD1;ASXL1;CTR9;FOXO1;METTL14;WWTR1;PPP2CA;SIRT1
prerank,regulation of chemotaxis (GO:0050920),-0.3057936031775435,-1.0200455263674157,0.417910447761194,0.8784506379740001,1.0,6/30,8.90%,P2RY12;ZSWIM6;CYRIB;P2RX4;TGFB1;ZSWIM8
prerank,regulation of cellular component organization (GO:0051128),0.37398478969916094,1.0198239223820726,0.4702920443101712,0.9002235549482503,1.0,40/135,23.15%,HRG;PRKCQ;SLITRK2;NEDD4;CEACAM1;RASGRP2;HSPA8;BBS10;APOE;SETD1A;CDH13;DCUN1D5;PAK4;BCAR1;CD36;HSP90AA1;RAB5B;RUFY2;RAB5C;ROCK1;HIP1;STON2;SETD5;ABL2;TMC8;AP2S1;ALKBH4;ARFGAP1;MLLT3;STON1;SNX12;STK11;HNRNPU;NRG3;RAP1B;GFAP;TFRC;ERMN;LTBP4;SPOCK1
prerank,vacuolar acidification (GO:0007035),-0.3377225968764829,-1.0196990490520956,0.4362745098039216,0.8767974350690055,1.0,10/21,22.85%,ATP6V0A1;SLC11A1;PPT1;TCIRG1;DMXL1;CLN6;TMEM9;CCDC115;ATP6V0E2;ATP6V0D2
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.2809311233229741,-1.0196445104505425,0.3979591836734694,0.8741686002995596,1.0,16/39,22.77%,BMP2K;MAML3;TSPAN14;PRKCI;ZMIZ1;EPN2;MAML1;NOTCH1;TM2D3;NEPRO;TSPAN5;STAT3;SNW1;RBPJ;SRC;JAG2
prerank,regulation of insulin secretion (GO:0050796),0.37828435020073997,1.0194338849176274,0.4676923076923077,0.9007990605839761,1.0,22/101,21.62%,FAM3D;GCK;CCL5;ITPR3;DPP4;UQCC2;PER2;RAPGEF4;ITPR1;SYT7;HADH;IRS1;EPHA5;SLC2A1;BLK;RFX3;PPP3CB;GIPR;CCN3;MCU;RBP4;RAPGEF3
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.45389605012956874,1.0190048822033866,0.45431789737171463,0.901439714534387,1.0,6/20,11.50%,ATP1B3;ATP6AP1;ATP1A3;ATP1A4;ATP1A1;ATP1A2
prerank,ESCRT complex disassembly (GO:1904896),0.5099817301927033,1.018956510595656,0.4629080118694362,0.9004655418113473,1.0,6/10,29.89%,CHMP7;CHMP5;IST1;VPS4B;CHMP1A;CHMP2A
prerank,ESCRT III complex disassembly (GO:1904903),0.5099817301927033,1.018956510595656,0.4629080118694362,0.9004655418113473,1.0,6/10,29.89%,CHMP7;CHMP5;IST1;VPS4B;CHMP1A;CHMP2A
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.315829591969236,-1.0188286314232258,0.432258064516129,0.8737890389543866,1.0,8/26,13.24%,LARGE1;GCNT1;ALG2;ST3GAL2;GBGT1;GOLPH3;RRM1;GK5
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.41227069453859466,1.0185931419456615,0.4689966178128523,0.9009245856510938,1.0,11/38,16.39%,MICALL2;SREBF1;TOMM7;UBL5;UBE2L3;RAC2;LMAN1;VPS11;RHOU;HUWE1;GSK3A
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3963370392510288,1.018495834083816,0.46466809421841543,0.9006554691537505,1.0,11/57,14.01%,CCL5;IL31RA;GHR;KIT;PPP2R1A;ARL2BP;JAK2;IL6ST;FLT3;CLCF1;PPP2CA
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.42821227309511983,1.0184701660745132,0.45579793340987373,0.9001755983316498,1.0,6/31,13.10%,IRX5;HOXB4;HOXC4;EIF4A3;HOXC9;HOXB9
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.3151515586403264,-1.0184582131898752,0.42011834319526625,0.8720812640032634,1.0,4/24,1.07%,MEF2A;MEF2C;CAMK1;ABL1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.43984000545739116,1.0178204079033943,0.463855421686747,0.9014538803085523,1.0,9/24,22.74%,JPH4;AKAP6;DMD;SRI;FKBP1A;CALM1;JPH1;JPH3;CALM3
prerank,negative regulation of multicellular organismal process (GO:0051241),0.36976808990942645,1.0172643245137016,0.44244244244244246,0.902461537441439,1.0,33/199,14.12%,IL18R1;GATA3;ARHGDIB;SRGN;HOXA7;F2R;RAB11FIP1;HDAC9;IL17D;PTEN;ATP2B4;MDK;SPRY1;NR1H2;PAEP;PROCR;BMP4;IFNGR1;ASB1;PARP3;RPS6KA5;HEY2;LAMA4;TIMP1;LGR4;ROBO1;ROCK1;ATF4;RPS19;GRN;NPTN;PPP2CA;LNPEP
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4445462026169133,1.01679320691568,0.46682750301568154,0.9032358193312234,1.0,4/23,12.58%,NR4A3;ATP2B4;ADCY6;ATF4
prerank,telomere organization (GO:0032200),0.4077808217330625,1.0167772105766848,0.4574585635359116,0.9027249359536952,1.0,14/43,23.53%,RTEL1;SP100;ERCC4;ATM;PARP3;BLM;PCNA;PTGES3;POLD4;STN1;ATR;CTC1;DCLRE1B;WRN
prerank,positive regulation of dendrite extension (GO:1903861),0.4676956296702476,1.0162894187559435,0.47570332480818417,0.9035501003216463,1.0,6/17,22.10%,SYT4;RASAL1;RNF157;PLAA;RIMS1;SYT17
prerank,mitochondrial translation (GO:0032543),0.37898616400699947,1.0159855770282002,0.4729315628192033,0.9038393102102444,1.0,14/104,9.61%,MRPS12;MRPL51;MRPL13;MRPL23;MRPL21;LARS2;MRPL12;MRPL40;MRPL22;MRPS14;MRPL33;MRPL15;MRPL19;MRPL54
prerank,nucleotide-excision repair (GO:0006289),0.37920342635677196,1.0158042798801992,0.46852425180598556,0.9037951784750917,1.0,29/101,20.15%,RPS27A;UBA52;ERCC4;RFC4;XPC;POLB;RNF111;LIG1;COPS6;POLE;SLC30A9;GTF2H5;RFC5;UBB;POLR2F;ERCC1;COPS3;POLK;BRIP1;USP45;SIRT1;XAB2;PCNA;TCEA1;ERCC5;DDB2;POLD4;COPS8;DDB1
prerank,regulation of hydrolase activity (GO:0051336),-0.24138015672260338,-1.0156434130205703,0.43636363636363634,0.8775848270375138,1.0,19/71,17.49%,CHN2;FGD2;VAV2;PLXNA4;CRK;ATP5IF1;ARHGAP12;FGD6;FGD3;PRKG1;PLXNA1;CAMK2A;CDK5RAP3;ADAP1;EFNA5;RALBP1;PLXNC1;TBC1D10B;PLXNB3
prerank,response to ketone (GO:1901654),0.440567842322592,1.0155415345419807,0.4738760631834751,0.90398679579522,1.0,8/24,20.70%,TGFB2;CAV1;ABHD2;TGFBR3;TGFB3;WBP2;SLIT3;ABCB4
prerank,regulation of striated muscle contraction (GO:0006942),0.4291892142537282,1.0153287007577005,0.482311320754717,0.904032942271446,1.0,6/27,17.53%,TNNT3;DMD;SRI;ATP1A2;CALM1;TNNI1
prerank,oxoacid metabolic process (GO:0043436),0.4378427008992397,1.0149573745401261,0.4793388429752066,0.9045053236926652,1.0,5/27,15.85%,BPNT1;MIF;LIPT2;DDO;PPA2
prerank,negative regulation of insulin secretion (GO:0046676),0.46390969392598397,1.0149558257156452,0.48764629388816644,0.9039562380461109,1.0,1/17,0.56%,FAM3D
prerank,glutamate receptor signaling pathway (GO:0007215),-0.2887945777785151,-1.0144066745858522,0.432,0.8784551342846347,1.0,13/37,15.87%,DAGLA;HOMER1;DAGLB;HOMER3;GRIK3;GRIN2A;GRIA4;APP;GRIK4;KCNB1;CDK5R1;PLCB1;HOMER2
prerank,regulation of nervous system development (GO:0051960),0.4072724745349955,1.0142017510809385,0.4760820045558087,0.9055214432550628,1.0,12/37,22.43%,HMGB2;PER2;HEY2;LGI4;CTNNB1;ZPR1;PRUNE1;WNT3;HES1;HES6;TENM4;CX3CL1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4280743903943948,1.014032199536653,0.4835680751173709,0.905426527000278,1.0,6/28,12.58%,BCL2;PPP1R15A;ATP2A3;ITPR1;CASP4;ATF4
prerank,regulation of autophagosome maturation (GO:1901096),-0.38757512139023725,-1.0138359477746686,0.45384615384615384,0.8774110673330606,1.0,7/13,16.12%,RUBCN;IRGM;UVRAG;PHF23;CLEC16A;ADRB2;UBQLN4
prerank,regulation of mitochondrial translation (GO:0070129),0.4513388965784306,1.0138050262081846,0.45859085290482077,0.9055105866013599,1.0,6/21,16.49%,UQCC2;TRUB2;RPUSD4;MALSU1;FASTKD3;MRPS27
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.4842221008848006,1.013766505125874,0.47730398899587345,0.9050655884522388,1.0,6/13,27.45%,IL7R;JAK2;HES1;PTPRC;PIGU;CRLF2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.42139974281988196,1.0134232341227447,0.4916467780429594,0.9054869964188683,1.0,12/32,27.15%,TMSB4X;ENTPD5;PRXL2C;TREM2;MLXIPL;GAPDHS;P2RX7;INSR;ENO1;IGF1;ARNT;PFKFB1
prerank,cellular response to leucine starvation (GO:1990253),-0.418036327394528,-1.0128022968969725,0.44964028776978415,0.8776745157696739,1.0,6/10,24.78%,SESN1;MTOR;EIF2AK4;SESN2;LARS1;IMPACT
prerank,microtubule polymerization or depolymerization (GO:0031109),0.43987370858004265,1.0125581844949765,0.4835965978128797,0.9073944408401586,1.0,6/25,16.08%,CENPJ;KIF24;PIN1;MAPT;KATNB1;STMN2
prerank,cellular response to cAMP (GO:0071320),0.42483896978806834,1.0125239624384184,0.47038327526132406,0.9069406112830605,1.0,7/30,22.34%,AHR;SLC26A6;AKAP6;HCN3;EZR;RAPGEF3;RAP1B
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.35971373203099094,1.0120590263641407,0.408,0.9076967171508248,1.0,342/1667,19.83%,SKAP1;IKZF3;FOXN1;BCL11B;LEF1;STAT4;TCF7;RPS14;DEAF1;TBX21;RPS27A;SATB1;EOMES;SOX3;IRF6;TCF15;OVOL1;NR4A3;NCOR2;SIX5;CSRP3;CSRNP1;ZKSCAN4;GATA3;ZBTB42;DACH1;ZNF395;IRX5;RUNX3;OTP;RFX5;FOSB;PLAC8;DNAJB1;TFAP4;EHF;UXT;PBX1;CHD5;HOXA7;MYBL2;NHLH2;RARG;RPL23;CBX7;HR;NCK2;DCN;TXK;ATRX;SP100;PEX2;WAS;HOXB4;PSMC3;AUTS2;SPIB;RTRAF;HDAC9;H1-0;HMGB1;HMGB3;HEXIM1;UBA52;LHX4;ARID5A;HTATIP2;TLR9;TCF7L1;ZXDB;AEBP1;CDK8;PRRX2;AHR;RNF14;IER2;ARID4B;HELZ2;PPP1R12A;HOXC4;APOE;IKZF2;CHCHD2;SMAD2;PTEN;ZBTB39;MYB;ELF4;TOX;POU2AF1;ATM;KCTD1;SREBF1;GADD45A;PRKD2;CHD2;RARA;SMARCC1;ATP2B4;RFX2;ZBTB7B;TENM2;TADA1;PAF1;HDAC1;SMARCD3;UHRF1;NIPBL;HMGB2;MAFK;CREBRF;NFE2;NR4A2;SOX5;PTPRN;CSRNP3;CDH13;ZFX;NR1H2;KIT;FOXP1;CDK1;NFATC2IP;NR1D2;DACH2;RNF111;TOX4;ZHX2;CXCL10;ZBTB8A;SLTM;MXD4;ETS1;BMP4;POU6F1;NFYB;TNIP3;PER2;PIN1;RPS6KA5;RLF;TFDP2;GREM1;KTI12;CAV1;ZFHX2;MNT;TCF12;NR4A1;HOXB2;BMP6;NR6A1;HEY2;TRIM33;SLC30A9;ID2;GTF2H5;KDM4C;MED30;STAT5B;EGR3;TSHZ2;VPS72;GLI3;DHX36;MIDEAS;ZNF18;MED23;ZBTB16;CIAO1;HOXC9;NCK1;KLF13;CC2D1A;NOP53;ZFP62;MLLT10;MEIS2;GATAD2A;KLF12;EBF1;TARBP1;ZNF462;KDM3B;CTNNB1;ELF1;MOSPD1;SERPINE1;CPEB3;HOXC5;NFKBIA;MED7;ZBTB6;SUB1;SMAD1;ZBTB24;GTF2IRD1;E2F6;PAX5;MED13;ASXL1;FOXP4;RFX1;SNF8;VHL;HOXC8;PCGF5;UBB;MMP12;CTR9;FOXO1;ATXN1;DR1;ZBTB25;ATF4;HIVEP2;BCL6;HMBOX1;HSF2;TGFB3;HOXB9;NPM1;ATMIN;SUV39H2;ACTR3;ARNT2;EPAS1;HLF;BRIP1;PRDM10;PAXBP1;WWTR1;JMJD6;NCOR1;AKNA;EBF2;SIRT1;PRKAR1A;NCOA7;RIPK1;ATAD2B;NPAS3;TAF6;NCOA2;ZFP41;ZBTB22;SDCBP;KDM5B;CIC;RBAK;RCOR1;EZR;CDKN1A;PTOV1;MYT1L;ABCA2;BAZ1A;RFX7;MAP2K5;SOD2;IRF4;PKN1;RUVBL1;IKZF4;RUNX2;RFX3;WBP2;TCEA1;BATF3;CREB5;DMTF1;ZSCAN22;ENY2;MYDGF;GATAD2B;PRDM5;PPARGC1B;JDP2;MRGBP;NRIP1;CDK13;ZNF507;CEBPB;NKRF;JAG1;DEK;ZBTB2;KLF2;BATF;NFIL3;PPP3CB;ZNF83;SOX11;AGO2;PRRX1;PIAS1;ZSCAN18;IL33;KAT2B;SMURF2;PBX2;CBX4;CALCOCO1;LILRB1;JUP;CRTC2;HDAC2;TNIP1;SOX10;PRDM6;DMAP1;EAF2;DPF2;HES1;BMI1;PER1;MYSM1;HINFP;HSF5;RPL10;EGR2;RORA;RGMA;HDAC4;LYL1;CDC73;YY1;ZFP37;MLXIPL;MLX;RNASEL;MLLT6;KLF11;SNAI2;MED24;RBBP8;ZBTB33;RFXANK;MECOM;PBX3;SRA1;SOX9
prerank,positive regulation of nervous system process (GO:0031646),0.4574861090611699,1.0117958729341796,0.480946123521682,0.9078790981412702,1.0,10/18,29.68%,PARD3;CST7;ITGAX;EGR2;TENM4;RIMS1;MYRF;NCMAP;DICER1;UNC13B
prerank,sphingosine biosynthetic process (GO:0046512),0.50586077475183,1.0116383029879061,0.47730398899587345,0.9072115882865632,1.0,5/11,20.96%,SPTLC3;SPHK2;ABCA2;SPTLC2;ACER2
prerank,sphingoid biosynthetic process (GO:0046520),0.50586077475183,1.0116383029879061,0.47730398899587345,0.9072115882865632,1.0,5/11,20.96%,SPTLC3;SPHK2;ABCA2;SPTLC2;ACER2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.4899228226759268,1.011484001161593,0.468232044198895,0.9071023052617718,1.0,6/12,20.71%,METTL3;RBM15;PCGF5;LRIF1;YTHDC1;HNRNPU
prerank,lung development (GO:0030324),-0.29332819637253804,-1.0110355290917858,0.3971631205673759,0.8800364688064667,1.0,9/33,11.28%,PKD1;FGF2;ABCA3;BAG6;CEBPA;NPHP3;FGF10;VEGFA;LOXL3
prerank,skeletal system morphogenesis (GO:0048705),0.40505342910654474,1.0109778660396536,0.4733257661748014,0.9079763416640378,1.0,15/42,23.49%,LTF;HOXB4;HHIP;HOXC4;RFLNA;HOXC9;RFLNB;HOXB9;SOX11;ANKRD11;CYP26B1;HOXB3;FBN2;FGFR1;FGFR3
prerank,Fc receptor signaling pathway (GO:0038093),0.3740020147272366,1.0108801931188105,0.49440488301119023,0.9076993360219563,1.0,25/110,17.23%,GRAP2;ITK;MS4A2;PRKCQ;PSMC3;TAB2;PSMD8;PSME1;PSMD6;MALT1;PSMB5;MAPK9;KIT;PSMC6;PSMB4;PSMA7;PSMB9;PSMA6;PSMC1;SHC1;PAK1;PSMD7;PSMD2;CALM1;PPP3CB
prerank,regulation of establishment of planar polarity (GO:0090175),0.3780861472957126,1.0107694410482122,0.47897435897435897,0.9074691696489495,1.0,23/88,18.13%,PSMC3;PSMD8;PSME1;ARHGEF19;PSMD6;PSMB5;CELSR1;VANGL1;FZD6;PRICKLE2;PSMC6;CDC42;PSMB4;PSMA7;PSMB9;PSMA6;PSMC1;PSMD7;TIAM1;PSMD2;AP2S1;SMURF2;PSMD5
prerank,regulation of mRNA metabolic process (GO:1903311),0.5095700071826537,1.010756373849225,0.4925575101488498,0.9069507790207323,1.0,3/11,9.17%,SRPK1;SLTM;SRPK3
prerank,regulation of sequestering of calcium ion (GO:0051282),0.49227453328108545,1.01066740461364,0.4895977808599168,0.9066405176524412,1.0,2/12,3.96%,DIAPH1;ANXA6
prerank,regulation of proteolysis (GO:0030162),-0.26612278610918366,-1.01061100746136,0.41935483870967744,0.878582388805181,1.0,13/48,15.93%,CAPN3;GSAP;TBC1D10A;PARL;BAG6;ASPH;CDK5;SPOP;CLN8;NEDD8;CLN6;HDAC6;BAD
prerank,sodium-independent organic anion transport (GO:0043252),0.49880590608740305,1.010459551805773,0.47214076246334313,0.9066453110471364,1.0,4/10,8.67%,SLCO4C1;SLCO3A1;SLCO5A1;SLCO1C1
prerank,regulation of ion transmembrane transport (GO:0034765),0.4141015556022655,1.0104215762998037,0.4861751152073733,0.9062096952934191,1.0,4/33,9.32%,KCNJ10;NEDD4;KCNJ15;AKAP6
prerank,neuron projection development (GO:0031175),0.36958687385522127,1.0101482401137476,0.47585513078470826,0.9064218669283755,1.0,39/168,16.08%,PPP1R9B;FRYL;BLOC1S3;ATP7A;NEDD4;MICALL2;HMGB1;GPM6B;APOE;PTEN;PLXNB1;GPRIN3;CNTNAP2;TBC1D23;TMEM108;BICDL1;LGI1;CDC42;RAB11A;NEFH;TAOK3;ZPR1;BTG2;NBL1;ROCK1;MAPT;GPM6A;EPHB2;FRY;DCLK1;UBB;NCKAP1;MANF;MICALL1;TNIK;BLK;PAK1;AGER;STMN2
prerank,stem cell differentiation (GO:0048863),0.4077798221797627,1.0101449430164273,0.4833906071019473,0.9058882288500669,1.0,10/39,19.38%,HOXB4;LMBR1L;KIT;TGFB2;JARID2;GPM6A;FBXL17;BATF;PTPRC;MLLT3
prerank,regulation of protein kinase B signaling (GO:0051896),0.363795538800707,1.0101396298903365,0.48697394789579157,0.9053510268170815,1.0,34/193,16.29%,LCK;FAM110C;NRG1;GATA3;SFRP5;CD28;ANGPT1;FERMT2;SEMA5A;RCN3;RACK1;PTEN;ITGB1;KIT;IAPP;RAC2;GCNT2;HSP90AA1;NOP53;THEM4;HIP1;FLT3;MUL1;IRS1;DAG1;PIK3R5;SIRT1;FGF7;F10;KITLG;DRD2;FYN;IGF1R;MYDGF
prerank,response to histamine (GO:0034776),0.504235162740348,1.0098233091731714,0.4745042492917847,0.9056883428352136,1.0,3/10,15.34%,DIAPH1;GABRB1;DRD2
prerank,protein homooligomerization (GO:0051260),0.3740916674663924,1.0098225125154654,0.4902962206332993,0.9051423004171409,1.0,22/114,16.37%,THG1L;PRF1;UPB1;MLKL;ALOX5AP;STEAP4;B2M;SHMT1;ALDOA;MIF;AQP11;APIP;AQP4;SLC1A5;G3BP2;ACACA;BLM;JMJD6;SOD2;IKZF4;SAMHD1;ATL1
prerank,negative regulation of immune effector process (GO:0002698),0.4917293360772447,1.009755538285075,0.49530201342281877,0.9047740012788238,1.0,7/13,17.78%,CD55;CD47;APPL1;RPS19;LGALS3;GRN;LILRB1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4435941080242405,1.0097075194996958,0.4825511432009627,0.90436955144652,1.0,6/24,14.71%,HRG;FERMT2;KDR;MAPRE2;ROCK1;S100A10
prerank,neural crest cell differentiation (GO:0014033),0.4643470508882027,1.0096788549500066,0.48906048906048905,0.9039086312919764,1.0,2/18,3.92%,NRG1;KBTBD8
prerank,positive regulation of viral process (GO:0048524),0.3914065420433865,1.0096410103216444,0.4656652360515021,0.9034878139046627,1.0,8/60,9.20%,CD28;CCL5;SRPK1;PPIA;PPIH;NELFCD;TARBP2;PABPC1
prerank,lipoxygenase pathway (GO:0019372),0.4691710062415194,1.0092717311109003,0.4808454425363276,0.9039861204476246,1.0,3/14,15.21%,ALOX5AP;GPX1;GPX4
prerank,V(D)J recombination (GO:0033151),0.4994170142883325,1.008818656837642,0.4903047091412742,0.9047238162996647,1.0,3/11,7.72%,HMGB1;HMGB2;LIG1
prerank,positive regulation of cellular component organization (GO:0051130),0.3752885210956503,1.008732184334515,0.49540347293156284,0.9044139196721089,1.0,32/107,21.62%,NRG1;SMPD1;CLU;PPP1R15A;BID;APOE;RACK1;RPS3;MPP7;GPX1;ABCB7;TGFB2;LMAN1;CALY;RHOC;CDH5;LGALS3;TGFB3;BCL2L11;TIRAP;GPC3;TREM2;IGF1R;CLIP3;TMEM30A;BNIP3;LRP4;SNCA;GSK3B;ABCB4;TRABD2B;RAPGEF3
prerank,epithelial to mesenchymal transition (GO:0001837),0.3974938891769697,1.008608049413307,0.4793926247288503,0.9042173718783889,1.0,9/47,13.99%,LEF1;EOMES;HNRNPAB;TGFB2;HEY2;CTNNB1;ROCK1;TGFBR3;AKNA
prerank,regulation of cellular response to heat (GO:1900034),0.379747834734211,1.0079501046333514,0.4937888198757764,0.9055121660137556,1.0,28/77,24.01%,CHORDC1;DNAJB1;HSPA8;ATM;NUP50;HSPH1;CCAR2;HSP90AA1;NUP214;NUP210;MAPT;NUP88;RANBP2;MAPKAPK2;HSPA1A;SIRT1;AAAS;CRYAB;PTGES3;BAG1;ATR;GSK3B;HSP90AB1;NUP62;NUP93;NUP205;NDC1;DNAJC7
prerank,response to thyroid hormone (GO:0097066),-0.3796041453801931,-1.0076159604601977,0.4444444444444444,0.8847546975842087,1.0,8/13,29.87%,CTSS;LMO2;KLF9;HPN;MED1;CTSL;BRD8;GAS2L1
prerank,regulation of protein import into nucleus (GO:0042306),0.41076134235373374,1.0074330162981762,0.4563679245283019,0.9064495694080268,1.0,10/36,18.09%,CHP1;FLNA;CDH1;UFM1;BMP4;ZPR1;UBR5;APOD;JUP;DMAP1
prerank,negative regulation of protein transport (GO:0051224),0.4357173546910773,1.007307307074722,0.47129186602870815,0.9062354465967167,1.0,6/25,15.61%,RHBDF1;APOE;DPH3;RSAD2;DRD2;PKDCC
prerank,neuron differentiation (GO:0030182),0.37066437656475504,1.0072978066492746,0.48746238716148443,0.9057210338828992,1.0,38/165,23.66%,IRX5;WNT6;RUNX3;OTP;PBX1;SPINK5;LHX4;UGCG;IER2;ITM2C;FUT9;TENM2;NR4A2;UGDH;TGFB2;PIN1;ID2;CTNNB1;MANF;NIF3L1;EPHA5;WNT3;MYT1L;RUNX2;ATP2B2;SOX11;PBX2;FZD8;PBX3;TENM4;LMX1B;TENM3;SNPH;MET;PTPRD;WNT9A;SPOCK1;DTNB
prerank,BMP signaling pathway (GO:0030509),0.3881510724891413,1.00701032798643,0.483493077742279,0.905979609265505,1.0,16/62,19.00%,PDCD4;SMAD2;AMH;CHRD;TGFB2;BMP4;BMP6;SLC33A1;SMAD1;TGFBR3;TGFB3;GDF3;USP15;RUNX2;RGMA;RGMB
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.38023197206665543,1.0069424754466112,0.4909090909090909,0.9055999781675187,1.0,11/63,14.15%,DEDD2;TRAF1;SP100;BID;BMP4;TNFSF10;BIRC6;CAV1;LGALS3;TNFSF12;RIPK1
prerank,response to estradiol (GO:0032355),0.421132153855853,1.0066781207293996,0.48936170212765956,0.9057981959382906,1.0,3/31,10.71%,ANXA1;STAT5B;CTNNB1
prerank,regulation of cell cycle (GO:0051726),0.3658457687633935,1.0065663336478206,0.5070140280561122,0.9055577384449044,1.0,64/271,21.60%,PPP1R9B;IRF6;GATA3;RUNX3;FIGNL1;TFAP4;MYBL2;RPL23;IQGAP1;CDK6;PDCD4;PPP1R15A;BIRC5;TRIM21;DAPK3;FBXO5;RACK1;TTLL12;ATM;GADD45A;RARA;METTL3;MIF;BARD1;SIPA1;TGFB2;BMP4;MLF1;PER2;NR4A1;L3MBTL1;ID2;NOP53;DLGAP5;MASTL;SIRT1;RPS15A;TARDBP;TAF6;SDCBP;CDKN1A;CKS2;FBXL17;PPP1R13B;FAP;WDR12;KAT2B;LILRB1;PRCC;LIN52;CDC123;PTPRC;MLXIPL;TXLNG;MECOM;SRA1;SOX9;STK11;BIRC3;HNRNPU;HSP90AB1;RPRD1B;GMNC;CDC14A
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.37137549048036944,-1.0064158223008524,0.4883720930232558,0.8854778575795124,1.0,9/14,23.71%,FOXO3;PNPT1;TFAM;POLRMT;TWNK;FASTKD1;TEFM;TFB2M;MTERF2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.4247326772768976,-1.0061354276335706,0.46579804560260585,0.8836317329063141,1.0,2/10,3.55%,LYN;NBR1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3598789260553381,1.0061234830707908,0.476,0.9062492123688224,1.0,117/572,19.53%,RPS14;DEAF1;TBX21;RPS27A;SATB1;EOMES;SOX3;NR4A3;NCOR2;GATA3;DACH1;RUNX3;OTP;FOSB;DNAJB1;UXT;HOXA7;RARG;RPL23;CBX7;NEDD4;ATRX;SP100;PEX2;HDAC9;H1-0;HMGB1;HEXIM1;UBA52;ARID5A;AEBP1;SMAD2;MYB;KCTD1;GADD45A;RARA;ZBTB7B;TENM2;PAF1;HDAC1;UHRF1;NIPBL;MAFK;NR4A2;NR1H2;FOXP1;NR1D2;ZHX2;MXD4;BMP4;POU6F1;PER2;CAV1;MNT;BMP6;NR6A1;HEY2;TRIM33;ID2;VPS72;GLI3;ZBTB16;CC2D1A;NOP53;MEIS2;GATAD2A;KLF12;MOSPD1;CPEB3;GTF2IRD1;E2F6;FOXP4;VHL;UBB;CTR9;ATXN1;DR1;ATF4;BCL6;HMBOX1;SUV39H2;HSPA1A;NCOR1;SIRT1;SDCBP;EZR;MYT1L;MAP2K5;BATF3;GATAD2B;PRDM5;JDP2;NRIP1;CEBPB;ZBTB2;KLF2;NFIL3;SOX11;IL33;SMURF2;CBX4;HDAC2;SOX10;PRDM6;DMAP1;DPF2;HES1;BMI1;PER1;RPL10;HDAC4;CDC73;YY1;ZFP37;MLX;KLF11;SNAI2
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.45288178121704464,1.0059448598949117,0.49037227214377405,0.9062012884847657,1.0,4/18,17.78%,LTF;TCTA;LILRB3;LILRB1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.3449038071860664,-1.0057484385948834,0.43612334801762115,0.8819780509925522,1.0,2/17,3.28%,SNTA1;ANK2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4735871941682282,1.005475067980417,0.49100968188105115,0.906958654561835,1.0,3/14,12.55%,ADAM19;CLN3;ABCA7
prerank,cardiac muscle cell action potential (GO:0086001),-0.3043085134677847,-1.0050523270737084,0.45384615384615384,0.8812971581730037,1.0,4/30,4.06%,SLC8A1;CACNA1D;ANK2;KCND3
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.33295265250837885,-1.0048641205709352,0.44387755102040816,0.8791241309625624,1.0,5/20,7.32%,B3GALT5;ST3GAL2;ST3GAL6;ST6GALNAC6;ST3GAL3
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.41325842205576135,1.004802583121775,0.47350620067643745,0.9082836652782631,1.0,9/36,19.58%,UXT;RBBP7;TFDP2;CDC7;APAF1;E2F6;RYBP;BMI1;RBBP8
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.30531851200166604,-1.0047377161493352,0.43870967741935485,0.8767850084912951,1.0,11/28,13.79%,PIP4K2A;PID1;APPL2;KANK1;GRB10;PTPRE;PRKCB;TSC2;SLC27A4;PRKCD;PTPN1
prerank,positive regulation of vascular permeability (GO:0043117),0.48646201180792203,1.003783714191174,0.4924137931034483,0.9105264320778953,1.0,3/12,10.35%,ANGPT1;BMP6;PDE3A
prerank,cell junction organization (GO:0034330),0.3828851665262912,1.0036970588076937,0.48851774530271397,0.9102241459572628,1.0,16/71,14.97%,LIMS2;ACTG1;FLNA;ACTB;FERMT2;PPFIA2;TGFB2;PIN1;MARVELD2;CDC42;ILK;MAPT;TGFB3;ELFN1;PPFIBP2;SEMA3E
prerank,regulation of calcium ion import (GO:0090279),0.4376095330151511,1.0036180960988919,0.4861111111111111,0.9099085946111258,1.0,5/21,15.36%,SPHK2;CTNNB1;PRNP;LGALS3;FYN
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.46915297321161703,1.0035489476697619,0.4886515353805073,0.9095496066291741,1.0,6/15,21.97%,SEC61B;DERL1;OS9;SELENOS;FAF2;TMEM129
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.37626096735113623,-1.0035342969022758,0.44881889763779526,0.8775976759575914,1.0,5/14,12.68%,U2AF2;SFSWAP;RBMX;SRSF9;PTBP1
prerank,nuclear membrane organization (GO:0071763),-0.33852856638105794,-1.003228593978388,0.416289592760181,0.8758904988828132,1.0,6/19,16.69%,SPAST;AKAP8L;TOR1AIP1;CHMP4B;EMD;TMEM43
prerank,ceramide biosynthetic process (GO:0046513),0.40164877410414396,1.002974669259814,0.48957189901207465,0.9106371818533691,1.0,9/40,15.68%,SMPD1;SPTSSA;SPTLC3;ST6GALNAC3;CERS4;B4GALNT1;FA2H;DEGS1;SGMS1
prerank,regulation of catabolic process (GO:0009894),0.45661916191935153,1.0029371925915918,0.49625,0.9102054506958275,1.0,6/18,17.28%,CHMP6;ITGB1;RARRES2;SNF8;ZDHHC2;FAP
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3572639225512421,1.0028588598611254,0.476,0.9098865238487442,1.0,161/807,19.67%,LEF1;RPS14;DEAF1;TBX21;RPS27A;SATB1;EOMES;NRG1;SOX3;NR4A3;NCOR2;GATA3;DEDD2;DACH1;PRDX5;SOX7;RUNX3;OTP;FOSB;SCML4;DNAJB1;TFAP4;UXT;DAXX;FLNA;HOXA7;RARG;RPL23;CBX7;RUNX1T1;SP100;PEX2;PDCD4;HDAC9;H1-0;HMGB1;HSPA8;HEXIM1;UBA52;ARID5A;AEBP1;BIRC5;ILF3;AHR;DKK3;SMAD2;MYB;KCTD1;PFDN5;LBH;GADD45A;RARA;ZBTB7B;TENM2;PAF1;HDAC1;UHRF1;NIPBL;HMGB2;MAFK;MAF1;NR4A2;NR1H2;FOXP1;NR1D2;ZHX2;RBM15;MXD4;BMP4;POU6F1;DAP;PER2;JARID2;RPS6KA5;TFDP2;CAV1;ATF7IP;MNT;BMP6;L3MBTL1;NR6A1;HEY2;TRIM33;ID2;PSPC1;VPS72;GLI3;MIDEAS;ZBTB16;CCAR2;NOP53;MEIS2;GATAD2A;KLF12;CTNNB1;MOSPD1;CPEB3;GTF2IRD1;E2F6;LIMD1;FOXP4;VHL;UBB;CTR9;FOXO1;ATXN1;DR1;ATF4;BCL6;HMBOX1;SUV39H2;NCOR1;SIRT1;SDCBP;SHC1;CIC;RBAK;RCOR1;EZR;MYT1L;MAP2K5;IKZF4;RUNX2;RFX3;BATF3;GATAD2B;PRDM5;JDP2;NRIP1;CEBPB;NKRF;ZBTB2;CRYAB;KLF2;NFIL3;RBFOX2;SOX11;IL33;SMURF2;CBX4;HDAC2;SOX10;PRDM6;DMAP1;DPF2;HES1;BMI1;PER1;HINFP;RPL10;HDAC4;CDC73;YY1;NAB2;ZFP37;MLXIPL;MLX;KLF11;SNAI2;ZBTB33;MECOM
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.4022873289044181,-1.0028307515031831,0.4452054794520548,0.8743651864781906,1.0,7/11,34.14%,EPN2;PIK3CB;THBS1;E2F2;CREB3L1;ALOX5;SYNJ2BP
prerank,regulation of fat cell differentiation (GO:0045598),0.38035803933671636,1.0027751451831113,0.49478079331941544,0.9095744731922625,1.0,17/74,14.25%,GATA3;RUNX1T1;FERMT2;ADIG;LMO3;CREBL2;RARRES2;ID2;TMEM64;ZBTB16;ZFP36L2;SYAP1;ASXL1;FOXO1;WWTR1;SIRT1;GDF3
prerank,negative chemotaxis (GO:0050919),0.41403703612786436,1.002638783467098,0.49130938586326767,0.9093855761922615,1.0,8/33,19.79%,LRTM1;ROBO1;UNC5C;EPHA7;SEMA3E;SLIT3;SLIT1;SEMA3D
prerank,regulation of dephosphorylation (GO:0035303),-0.3698528217037182,-1.0026200004849743,0.44308943089430897,0.8723765087530643,1.0,8/15,24.31%,MTMR4;MTMR3;CDK5RAP3;PPP1R16A;SMG6;MTMR2;SRC;MTMR9
prerank,response to organic cyclic compound (GO:0014070),0.3871643250224992,1.0023839438859055,0.4989384288747346,0.9095491052220027,1.0,8/52,15.87%,ANXA1;CCL5;HLCS;STAT5B;CTNNB1;ABCA2;DRD2;ARL6IP5
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.44539884835148535,1.0019999168261164,0.49017199017199015,0.9095072983062366,1.0,2/19,3.00%,DAXX;ATRX
prerank,regulation of DNA recombination at telomere (GO:0072695),0.44539884835148535,1.0019999168261164,0.49017199017199015,0.9095072983062366,1.0,2/19,3.00%,DAXX;ATRX
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.3751961582007735,1.0018139379164235,0.5138461538461538,0.9094572812360785,1.0,29/95,22.54%,PLK4;CENPJ;MKS1;KIF24;CDK1;DYNLL1;PPP2R1A;CEP89;IQCB1;C2CD3;RAB11A;HSP90AA1;TMEM216;SCLT1;HAUS5;CEP41;PCNT;B9D2;PAFAH1B1;HAUS4;HAUS2;CEP43;TMEM67;NINL;CEP70;HAUS3;YWHAG;TUBB4B;TCTN3
prerank,negative regulation of cell migration (GO:0030336),0.3669168875051724,1.0014543238777875,0.49291497975708504,0.9099281951271149,1.0,26/137,17.01%,GTPBP4;DLC1;DACH1;IFITM1;CD74;ARHGDIB;HOXA7;PTEN;CDH1;MIF;CHRD;TIMP1;SERPINE1;ROBO1;STK24;COL3A1;DAG1;TCAF1;VCL;DRD2;RAP2A;MIA3;JAG1;SINHCAF;STK26;ATP1B2
prerank,heart trabecula morphogenesis (GO:0061384),0.4514101113344969,1.001362777831691,0.48816936488169366,0.9096379995886829,1.0,4/18,12.07%,NRG1;TGFB2;FKBP1A;TGFBR3
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.49999516758659746,1.0012863885985601,0.4941860465116279,0.9093058213877887,1.0,7/11,30.49%,NT5C3A;SLC19A2;DCK;CTPS2;DCTD;SLC25A19;TPK1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4151814561312017,1.001096274795334,0.48604651162790696,0.90930421762917,1.0,9/33,16.32%,PDCD4;PTGIR;PTEN;OGN;TGFB3;EFEMP2;CDKN1A;SOD2;APOD
prerank,organic anion transport (GO:0015711),0.3783542213058384,1.000975971922837,0.4953560371517028,0.9090906491750714,1.0,8/76,8.76%,SLC25A24;LRRC8C;SLC22A3;SLCO4C1;SLCO3A1;SLCO5A1;SLCO1C1;SLC26A6
prerank,xenobiotic transport (GO:0042908),0.455523657748189,1.0009340460316167,0.493573264781491,0.908656102310432,1.0,3/17,13.41%,SLC22A3;ABCC1;SLC7A5
prerank,protein localization to centrosome (GO:0071539),-0.3407338869604364,-1.000848410416243,0.4026548672566372,0.8746433351766367,1.0,11/17,35.14%,DCTN2;CEP192;NEDD1;NUDCD3;CCDC14;CEP83;SNX10;STIL;CEP131;SPAG5;HOOK3
prerank,melanosome organization (GO:0032438),-0.2934083516237805,-1.00084643028523,0.47183098591549294,0.8720198690315254,1.0,8/26,16.64%,KIF13A;DTNBP1;HPS1;SNAPIN;BLOC1S5;RAB32;AP1M1;RAB38
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.49181950013522224,1.0008441357797322,0.5112994350282486,0.9083446408855523,1.0,4/11,16.39%,LMNA;ATP2B4;FOXO1;GSK3A
prerank,regulation of glycolytic process (GO:0006110),0.3814032350639199,1.0005257514703083,0.4952481520591341,0.9086607020536742,1.0,29/68,28.51%,GCK;ENTPD5;NUP50;PRXL2C;NUP214;NUP210;NUP88;RANBP2;NCOR1;AAAS;HDAC4;MLXIPL;GAPDHS;NUP62;P2RX7;PRKAG1;NUP93;INSR;NUP205;NDC1;NUP153;IGF1;ZBTB7A;ARNT;PFKFB1;OGT;NUP98;TPR;HIF1A
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.4445606204179044,0.9989987054121499,0.4955640050697085,0.9117306342720071,1.0,5/21,19.53%,BCL2;HSPA1A;MAP2K5;MCL1;SNAI2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.4445606204179044,0.9989987054121499,0.4955640050697085,0.9117306342720071,1.0,5/21,19.53%,BCL2;HSPA1A;MAP2K5;MCL1;SNAI2
prerank,sulfation (GO:0051923),0.49866753447903645,0.9980099430583813,0.5027322404371585,0.9138637789960443,1.0,1/11,2.82%,UST
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3816972251996926,0.9977834766482263,0.49732620320855614,0.913974696857175,1.0,18/66,24.55%,ANXA1;CCND2;CDK6;PTEN;PSME1;LSM11;ID2;APPL1;JADE1;CDKN1A;CDC73;WEE1;RDX;UBE2E2;DLG1;KMT2E;RBL2;DCUN1D3
prerank,cell cycle checkpoint signaling (GO:0000075),0.48520807299385627,0.9977123663854843,0.47802197802197804,0.9136384155768955,1.0,6/12,20.68%,BUB1B;NABP1;CHFR;PRCC;WEE1;ZW10
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.4479038591217589,0.997543376830195,0.5,0.9135717812095278,1.0,3/19,12.70%,APOE;NQO1;RIC3
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.48104633336111335,0.9974429662633232,0.504225352112676,0.9132980054766551,1.0,1/12,0.87%,NR4A3
prerank,membrane protein proteolysis (GO:0033619),0.40090812178849233,0.9973560056214543,0.5016987542468856,0.9130064664615807,1.0,8/37,18.14%,PRKCQ;NAPSA;ADAM19;CLPP;DAG1;CTSH;BACE2;SPPL3
prerank,synaptic vesicle membrane organization (GO:0048499),-0.34763879976821965,-0.9972962049266706,0.42,0.879989749084191,1.0,4/17,5.25%,SYNGR1;SNAP29;SNAP25;STX2
prerank,tRNA wobble base modification (GO:0002097),0.4728138153431626,0.997120521329393,0.48456375838926175,0.9130650889453525,1.0,8/14,26.81%,KTI12;DPH3;TRMT9B;URM1;ELP3;CTU2;CTU1;ALKBH1
prerank,prostaglandin metabolic process (GO:0006693),-0.29800518371861207,-0.9970847041243319,0.40828402366863903,0.8780326027594563,1.0,6/26,10.00%,HPGDS;PTGS1;TBXAS1;DAGLB;PNPLA8;PLA2G4A
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3626177551879247,0.9968687749292447,0.5297679112008072,0.9132192039911897,1.0,40/150,20.32%,DBNDD1;FBLN1;CHP1;NCK2;CEACAM1;RTRAF;PAQR3;PTPN13;SMCR8;PPIA;PARD3;RACK1;PTEN;CADM4;GSKIP;TARBP2;GREM1;CAV1;SFN;DMD;NCK1;PPP1R15B;PRNP;EPHB2;WWTR1;TARDBP;CRKL;SNX25;NIBAN1;GNAQ;CALM1;EMILIN1;NTRK3;CEP43;PTPRC;MLXIPL;MVP;ATG14;PRR5L;SNCA
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4773193557333309,0.9968289522278403,0.5040650406504065,0.9127960301920158,1.0,5/13,24.77%,CSTF2;NUDT21;CSTF2T;TUT1;CPSF2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4799479526207824,0.9967460907195833,0.5069832402234636,0.9119546582903146,1.0,1/12,1.62%,FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4799479526207824,0.9967460907195833,0.5069832402234636,0.9119546582903146,1.0,1/12,1.62%,FBLN1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.40152646135776326,0.9965536938925854,0.4889380530973451,0.9119555916802281,1.0,7/39,7.97%,MON1A;RAB8A;LTBP2;RCN3;RAB3D;AFM;TMEM167A
prerank,prostaglandin biosynthetic process (GO:0001516),-0.33503915901073056,-0.9963467797142447,0.45374449339207046,0.877431685838916,1.0,6/18,10.00%,HPGDS;PTGS1;TBXAS1;DAGLB;PNPLA8;PLA2G4A
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4307002734575662,0.9962463685496799,0.5025125628140703,0.9122911730652457,1.0,2/21,9.48%,TEDC1;TUBD1
prerank,oogenesis (GO:0048477),0.4657473606411448,0.9962387843741759,0.506056527590848,0.9117832605984364,1.0,2/15,6.28%,MDK;METTL3
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.38209651927913735,0.9959222317034669,0.5266015200868621,0.9121156492315561,1.0,21/60,21.69%,LEF1;CDK8;PTEN;CDK1;ATF7IP;HEY2;MED30;DHX36;MED23;CTNNB1;MED7;SUB1;MED13;CDKN1A;RUNX2;CEBPB;MED24;SOX9;MED26;MECP2;TRIM28
prerank,regulation of neuron death (GO:1901214),0.37433604179698127,0.995846571742813,0.5124740124740125,0.9117969224409905,1.0,20/82,16.67%,CCL5;CHP1;DAXX;CLU;EFNB2;EIF2S1;GPR75;GRID2;CTSZ;BTBD10;PM20D1;PRNP;MAPT;SORL1;UBB;DCC;NENF;FYN;INPP5A;ITGB2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3640321339459797,-0.9954530899089442,0.4603174603174603,0.8774786733758152,1.0,7/13,22.14%,LGMN;EIF2AK4;CHRNA7;APP;AKAP5;SHISA7;SHANK3
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.4394008921473825,0.995073982109455,0.48759305210918114,0.9133218000377995,1.0,7/21,21.84%,FBXO5;CDK1;RAB11A;CDC7;NPM1;MECP2;BRD4
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.4139157149158631,0.9947150254520576,0.49942987457240595,0.913762197768865,1.0,8/32,14.95%,TICRR;FZR1;ATM;CDK1;NOP53;TAOK3;BLM;CDKN1A
prerank,regulation of establishment of cell polarity (GO:2000114),0.4566279811873852,0.9946236590177598,0.5074257425742574,0.9134558059707334,1.0,5/16,12.78%,RIPOR2;RACK1;GSN;ROCK1;CDH5
prerank,calcium ion import into cytosol (GO:1902656),-0.35640242609736505,-0.9945002822514568,0.42735042735042733,0.8777628695387005,1.0,4/15,11.44%,SLC8A1;TRPV2;TRPM2;TRPV4
prerank,negative regulation of stress fiber assembly (GO:0051497),0.42587860867663635,0.9939614954537258,0.4867149758454106,0.9146923737981171,1.0,3/24,3.26%,DLC1;ARHGEF18;WAS
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.421969595019249,0.9937406582440008,0.4975062344139651,0.9147414421175003,1.0,9/23,26.88%,HHIP;RACK1;GLI3;GPC3;GLIS2;BTRC;PTCH1;HERC4;RFX4
prerank,regulation of mitotic cell cycle (GO:0007346),0.36134177983600313,0.993603756616088,0.524,0.9145812362252173,1.0,39/171,16.60%,TFAP4;BRINP2;IQGAP1;PSMC3;BUB1B;PSMD8;DAPK3;FBXO5;FZR1;TTLL12;XPC;PSME1;PSMD6;RCC1;PSMB5;PRMT5;CDK1;CUL9;PIN1;PSMC6;BRINP3;L3MBTL1;PSMB4;DLGAP5;MEIS2;BTG2;PSMA7;PSMB9;PSMA6;PSMC1;SIRT1;SDCBP;RPS6KB1;CKS2;ANGEL2;PSMD7;PSMD2;GAS1;CDK13
prerank,actin filament depolymerization (GO:0030042),0.4959413116507082,0.9935908178018321,0.5048275862068966,0.914083313419058,1.0,4/11,16.94%,GSN;CFL1;DSTN;TWF2
prerank,actomyosin structure organization (GO:0031032),0.37077005474247365,0.9935272386161673,0.5041152263374485,0.9137112379624784,1.0,13/75,12.75%,TNNT3;PDLIM1;CSRP3;SORBS1;ITGB1;ZYX;TMOD2;CDC42BPG;CSRP2;ROCK1;FRMD5;CIT;FRMD6
prerank,regulation of sequestering of triglyceride (GO:0010889),0.46116925347985493,0.9933482072608111,0.49538866930171277,0.9136419118229424,1.0,6/15,28.92%,PLIN2;APOC4;TREM2;OSBPL8;PPARG;LPL
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3983194843288332,0.993082276804389,0.5149171270718232,0.9138275264007535,1.0,13/46,17.61%,LAMA5;ITGA4;MICALL2;FERMT2;PARVA;ITGB7;SRCIN1;ILK;NTNG1;NTNG2;LAMB1;ANTXR1;MEGF9
prerank,regulation of myotube differentiation (GO:0010830),-0.303569619177392,-0.9930754593949894,0.47802197802197804,0.8790744978826367,1.0,9/24,17.95%,ATP11A;TMEM119;FBXO22;MMP14;MAML1;NOTCH1;BDNF;BHLHE41;XBP1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.44631822803853904,0.9929765043507179,0.4973821989528796,0.9135738059515587,1.0,8/17,27.82%,COX4I1;COX6C;NDUFA4;COX8A;AFG1L;COX7B;COX15;COX5A
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.38060867647380003,-0.9925892665422849,0.45161290322580644,0.8778328797460195,1.0,6/13,23.18%,PHYH;ADHFE1;OGDH;GPT2;GOT1;DLST
prerank,cGMP metabolic process (GO:0046068),0.47667616808700364,0.9925493834114409,0.5068493150684932,0.9142240275629486,1.0,1/12,3.80%,NPR2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.35263082692226455,0.9924335552573504,0.553,0.9140014540417862,1.0,227/1082,19.67%,SKAP1;BCL11B;LEF1;CD4;DEAF1;TBX21;RPS27A;EOMES;SOX3;IRF6;TCF15;NR4A3;CSRP3;CSRNP1;GATA3;TRIM16;ZNF395;RUNX3;IL31RA;RFX5;PLAC8;CD74;CAMK4;TFAP4;EHF;PBX1;HOXA7;MYBL2;NHLH2;RARG;F2R;ACTA2;NCF1;NCK2;DCN;TXK;ATRX;SP100;WAS;HOXB4;PSMC3;AUTS2;SPIB;RTRAF;H1-0;HMGB1;NEK4;MRPL12;UBA52;LHX4;HTATIP2;TLR9;CDK8;ING2;ILF3;AHR;RNF14;IER2;HELZ2;PPP1R12A;HOXC4;APOE;CHCHD2;SMAD2;CDH1;MYB;ELF4;XPC;POU2AF1;ATM;SREBF1;LBH;PRKD2;HNRNPAB;RARA;SMARCC1;HDAC1;SMARCD3;UHRF1;HMGB2;CREBRF;NFE2;NR4A2;PTPRN;CSRNP3;CDH13;NR1H2;ING5;NFATC2IP;NR1D2;RNF111;CREBL2;CXCL10;ETS1;BMP4;NFYB;TNIP3;PIN1;RPS6KA5;RLF;TFDP2;GREM1;ATF7IP;TCF12;NR4A1;HOXB2;BMP6;HEY2;SLC30A9;ID2;MED30;STAT5B;GLI3;DHX36;ZBTB16;NCK1;PHF5A;MLLT10;MEIS2;NAA16;ZNF462;CTNNB1;ZPR1;ELF1;ELOF1;TASP1;MOSPD1;SERPINE1;ILK;NFKBIA;COL1A1;SMAD1;MED13;ASXL1;VHL;PCGF5;UBB;MMP12;FOXO1;DR1;ATF4;BLM;HSF2;NIF3L1;TGFB3;NPM1;ATMIN;ACTR3;ARNT2;EPAS1;HLF;PRDM10;PAXBP1;WWTR1;JMJD6;AKNA;SIRT1;NCOA7;RIPK1;SERTAD2;ATAD2B;FGF7;PCID2;NPAS3;TAF6;NCOA2;SHC1;EIF2AK3;PTOV1;MAP2K5;IRF4;RUNX2;RFX3;WBP2;TCEA1;CREB5;ENY2;MYDGF;PPARGC1B;MAPRE3;NRIP1;ZNF507;EDF1;CEBPB;NKRF;JAG1;KLF2;NFIL3;PPP3CB;SOX11;AGO2;IL33;ING1;KAT2B;PBX2;CALCOCO1;LILRB1;JUP;CRTC2;HDAC2;TNIP1;SOX10;EAF2;RYBP;DPF2;HES1;PER1;MYSM1;HINFP;NSD3;EGR2;RORA;RGMA;HDAC4;LYL1;RGMB;YY1;THOC1;SEC14L2;MLLT3;MLXIPL;MLX;RNASEL;MLLT6;MED24;RFXANK;MECOM
prerank,wound healing (GO:0042060),0.3781903477821758,0.9919052124404184,0.5186766275346851,0.9149250804675869,1.0,12/62,12.67%,NRG1;EVPL;PLEC;SMPD1;RAF1;ANXA6;TGFB2;ARL8B;SYT7;JAML;MMP12;COL3A1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.48808509739975925,0.991786399837964,0.5049928673323824,0.9147150076082594,1.0,4/11,16.92%,BNIP1;VCPIP1;ATL1;ARL6IP1
prerank,glycosphingolipid metabolic process (GO:0006687),-0.27392160338041127,-0.9917462936405407,0.45132743362831856,0.8778298529552706,1.0,15/42,15.74%,HEXB;LARGE1;CERK;ASAH1;SUMF2;ST6GALNAC6;GM2A;SMPD3;NEU1;GLA;B3GALNT1;ST8SIA3;CLN6;GBA2;GALC
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.43219543748345,0.9915440355917141,0.4828009828009828,0.9148602848596528,1.0,9/22,24.91%,DUSP5;DUSP6;DUSP2;DUSP16;PPP2CA;DUSP4;PPP1CA;DUSP10;PPM1A
prerank,kinetochore organization (GO:0051383),0.4719860033134783,0.9909487293872373,0.5033921302578019,0.9159006893765242,1.0,7/13,32.12%,CENPH;DLGAP5;MIS12;CENPF;CENPE;CENPT;NDC80
prerank,positive regulation of interleukin-17 production (GO:0032740),0.43812212465433625,0.9908114410633447,0.5,0.9157765086529039,1.0,4/22,15.22%,PRKCQ;ZBTB7B;SLC7A5;SLAMF6
prerank,response to UV (GO:0009411),0.37079707840621534,0.9907240886230694,0.518935516888434,0.9154861236172933,1.0,29/95,23.53%,MAPK13;SMPD1;NEDD4;SDE2;ERCC4;EIF2S1;METTL3;GPX1;USP1;MAP3K4;DHX36;CCAR2;COPS9;ATF4;NPM1;POLK;MSH6;UBE2B;PCNA;ERCC5;USP28;DDB2;YY1;ATR;MSH2;ERCC8;SPRTN;XPA;WRN
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4366497894016578,0.9906724668834113,0.5073170731707317,0.9151020553142203,1.0,8/20,15.48%,DAXX;DCUN1D5;HSP90AA1;UBQLN1;DNAJB2;EPAS1;HSPA1A;DCUN1D2
prerank,cAMP biosynthetic process (GO:0006171),0.4979030993844329,0.9904397489070267,0.4949640287769784,0.9152100219353178,1.0,5/10,26.49%,ADCY10;ADCY6;ADCY1;ADCY3;ADCY8
prerank,cell part morphogenesis (GO:0032990),-0.37709398749041656,-0.9893345036416178,0.4409448818897638,0.8821569246888484,1.0,7/13,21.79%,PID1;PNPT1;WASF1;NUBPL;SUPV3L1;SLIRP;MYH14
prerank,phospholipid homeostasis (GO:0055091),0.4888903205908461,0.9893043744857228,0.5014285714285714,0.9176581671549272,1.0,1/11,4.38%,RCN3
prerank,positive regulation of coagulation (GO:0050820),0.506828306758849,0.9891039363062184,0.5254237288135594,0.9171615529880803,1.0,2/10,11.17%,F2R;SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),0.506828306758849,0.9891039363062184,0.5254237288135594,0.9171615529880803,1.0,2/10,11.17%,F2R;SERPINE1
prerank,negative regulation of response to external stimulus (GO:0032102),0.3650071155120657,0.9889285479144744,0.5288169868554095,0.9170983118509706,1.0,24/105,21.94%,FPR2;LTF;GATA3;SIGIRR;TRIM21;APOE;PTEN;GRID2;SMPDL3B;SERPINE1;MUL1;CARD16;CDH5;SHARPIN;DRD2;TNFAIP6;MAPKBP1;ACOD1;RORA;SELENOS;AOAH;CCN3;NLRC3;DUSP3
prerank,mRNA modification (GO:0016556),0.4341973744430408,0.9887271360910644,0.48625,0.9170939878057642,1.0,6/22,16.13%,PUS7;TRUB2;METTL3;METTL14;TRMT6;NSUN2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3729269394104825,0.987748704337731,0.5297741273100616,0.9192045664838261,1.0,24/87,22.51%,NDUFA1;NDUFS7;NDUFAF4;UQCC2;NDUFA10;NDUFAF8;NDUFA5;NDUFA9;NDUFB10;PET100;SDHAF4;FASTKD3;NDUFS6;SMIM20;NDUFV3;NDUFA8;SLC25A33;OMA1;UQCRFS1;NDUFA2;NDUFB11;TTC19;NDUFAF2;NDUFS5
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5056804329990564,0.98773096953135,0.5361890694239291,0.9187333887624164,1.0,4/10,14.99%,EIF2S1;HSPA5;ATF4;EIF2AK3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.4478055705540441,0.9873784769270246,0.49870466321243523,0.9190851553682445,1.0,4/19,9.14%,NANS;UGP2;UGDH;PMM2
prerank,RNA stabilization (GO:0043489),-0.2833032686839295,-0.9871563647022261,0.48854961832061067,0.8858737037981989,1.0,6/33,8.91%,THRAP3;TENT5C;TENT2;SLC11A1;CIRBP;LARP1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.35222778784679615,-0.9869718524802912,0.4493927125506073,0.8838070607792456,1.0,4/16,3.87%,SEC16A;UBAC2;ANK2;LRRK2
prerank,detection of calcium ion (GO:0005513),0.46464114641563975,0.9864992999897857,0.5151915455746368,0.9208729047907591,1.0,4/13,22.74%,KCNMB4;STIM1;CALM1;CALM3
prerank,carbohydrate catabolic process (GO:0016052),0.4009825062155819,0.9864672165034428,0.5134228187919463,0.9204158227463808,1.0,6/38,9.19%,GCK;ALDOA;ENO4;HK1;GPI;ALDOC
prerank,cardiac ventricle development (GO:0003231),0.43729041189129114,0.9862338981943726,0.5170239596469105,0.9205143723543686,1.0,2/20,9.08%,GATA3;HEY2
prerank,regulation of platelet aggregation (GO:0090330),0.45528524835154416,0.9855967849002751,0.5064432989690721,0.9216239500749243,1.0,3/17,8.65%,PRKCQ;CEACAM1;PDPN
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.42456859116924933,0.9855241527442788,0.5279126213592233,0.9212911972992389,1.0,4/24,12.35%,NR4A3;ACADVL;COQ10B;SDHAF4
prerank,Golgi to lysosome transport (GO:0090160),0.48813383934861254,0.9851818536311632,0.49318801089918257,0.9216641660498658,1.0,5/11,25.90%,LAPTM5;CLN3;GAK;AP1G1;EHD3
prerank,negative regulation of lipid metabolic process (GO:0045833),0.4405400935375169,0.9851761142511158,0.5314769975786925,0.9211460214160874,1.0,4/22,16.32%,CEACAM1;APOC1;NCOR1;APOD
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.26460100718163854,-0.9851126138595594,0.46808510638297873,0.8866503598624822,1.0,11/45,13.08%,PIK3R1;DDX5;U2AF2;PNPT1;SIRT7;TGFB1;UTP15;WDR75;BUD23;RIOK1;SUPV3L1
prerank,negative regulation of transposition (GO:0010529),-0.3432603318312427,-0.9849298999027164,0.4507042253521127,0.884641006934994,1.0,7/16,30.07%,SIRT7;MOV10;MYBL1;TEX15;DDX4;PIWIL2;UBR2
prerank,peptidyl-arginine modification (GO:0018195),0.4613313483991085,0.9847936350121637,0.5105820105820106,0.9216293516621856,1.0,4/15,21.97%,PRMT5;PADI4;PRMT7;ART4
prerank,telomere maintenance (GO:0000723),0.3903249963945273,0.9847045628359133,0.5275675675675676,0.9213370729400908,1.0,16/50,23.68%,RTEL1;SP100;ERCC4;ATM;PARP3;BLM;PCNA;PTGES3;POLD4;STN1;SMC6;ATR;CTC1;DCLRE1B;WRN;SMC5
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3604960175742564,0.9846423792933827,0.5346038114343029,0.9209855855236897,1.0,41/170,20.38%,HRG;DHH;TMPRSS4;TXK;CDK6;AFF3;TRIM21;AHR;AFF4;FUBP1;APOE;CDH1;HNRNPAB;FOXP1;PIN1;PCBP4;CRIP1;CDK2;AFF1;ZNF462;YBX3;TOB2;TRIM68;PRDM10;KHSRP;TARDBP;CIAO3;TREM2;AFF2;PRDM5;ZNF507;PRDM6;BMI1;HINFP;MKLN1;PTPRC;RFXANK;LDLR;PCBP1;TAPBP;PCBP3
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4217666045476631,0.9845507282662699,0.48564294631710364,0.9207025082728152,1.0,6/22,11.70%,PSMC3;PSMC6;MED30;DHX36;SUB1;MED13
prerank,central nervous system development (GO:0007417),0.3584033600771266,0.9844430563029873,0.549,0.9204809271840217,1.0,61/250,20.52%,SCIN;EOMES;SOX3;PBX1;ADORA2A;NHLH2;HAPLN2;C3;SPINK5;AMIGO1;MARCKSL1;PTEN;UGP2;UFM1;HSPG2;DCX;NIPBL;COL4A1;NR4A2;SETD1A;RNF103;CELSR1;CNTNAP2;POU6F1;MFSD2A;JARID2;TBC1D23;GSN;ZFHX2;ZBTB16;CXCR4;MEIS2;ZPR1;DCLK1;ADAM23;ATXN1;NCKAP1;EPHA7;ROBO2;ADGRL2;SLC2A1;ARNT2;CAPG;CIC;AFF2;APOD;PHGDH;SLC6A17;SOX11;PBX2;SOX10;MBP;EGR2;SZT2;PBX3;SOX9;MARCKS;GLIS2;PAFAH1B2;ABCB6;NPTX1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.38572936152581344,0.9843565253385607,0.5332618025751072,0.9196407803458723,1.0,8/56,8.69%,NDUFA1;NDUFS7;NDUFAF4;NDUFA10;NDUFAF8;NDUFA5;NDUFA9;NDUFB10
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.38572936152581344,0.9843565253385607,0.5332618025751072,0.9196407803458723,1.0,8/56,8.69%,NDUFA1;NDUFS7;NDUFAF4;NDUFA10;NDUFAF8;NDUFA5;NDUFA9;NDUFB10
prerank,neuron cell-cell adhesion (GO:0007158),-0.3574893762779793,-0.9840892389026579,0.4657039711191336,0.8845442692283693,1.0,9/14,32.73%,NCAM2;CDK5R1;NRXN3;NINJ2;NLGN2;RET;NLGN1;NRXN1;CNTN4
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.41728914903658654,-0.983853322105261,0.4801223241590214,0.8827329060612787,1.0,6/10,23.44%,XYLT1;XYLT2;CSGALNACT2;DSEL;B3GAT2;PXYLP1
prerank,regulation of protein localization to cell surface (GO:2000008),0.40479224187123813,0.9838289756573869,0.5163551401869159,0.9204380009087869,1.0,11/33,23.39%,RANGRF;GPM6B;CTNNB1;ABCA7;RIC3;LEPROTL1;ABCA2;SNX33;TYROBP;HSP90AB1;ACTN2
prerank,autophagy of mitochondrion (GO:0000422),-0.27214481419264513,-0.9837450033398782,0.5,0.880524997634596,1.0,10/38,16.86%,BECN1;FUNDC1;ATG7;ULK1;WIPI1;WDR45B;CISD2;GABARAPL1;ULK2;ATG2B
prerank,regulation of myoblast differentiation (GO:0045661),0.41224536703564435,0.9835320775519217,0.5086705202312138,0.9206584436192745,1.0,3/32,7.67%,RIPOR2;FLOT2;BMP4
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.2793897038797258,-0.9832084833898964,0.4881889763779528,0.8794676061895568,1.0,11/34,14.00%,LYN;CD300A;TNFAIP3;TLR4;MFHAS1;LY96;TLR3;NFKBIL1;OTUD4;CD300LF;GPS2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.35723096245541075,0.9827090552157818,0.5543259557344065,0.9223002695506173,1.0,25/150,16.29%,LCK;FAM110C;NRG1;GATA3;CD28;ANGPT1;FERMT2;SEMA5A;ITGB1;KIT;IAPP;RAC2;GCNT2;HSP90AA1;THEM4;HIP1;FLT3;IRS1;PIK3R5;FGF7;F10;KITLG;FYN;IGF1R;MYDGF
prerank,cellular response to hydrogen peroxide (GO:0070301),0.40124537503011454,0.98264955422734,0.5119726339794755,0.9219323326841214,1.0,3/33,5.60%,ANXA1;MAPK13;RPS3
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.2650637183788289,-0.9826023217323419,0.4830508474576271,0.8785862919423967,1.0,10/39,18.06%,LGMN;GRB2;STAM;ARHGEF7;STAM2;HGS;TGFA;ERRFI1;PTPN3;RNF126
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.44664340267069913,0.9825291038861123,0.5083870967741936,0.9217205248308972,1.0,4/18,10.25%,FBXO5;CDK1;RAB11A;CDC7
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.36395790953999063,0.9822804481520059,0.5506072874493927,0.9218303527004944,1.0,28/124,17.01%,PPP1R9B;FRYL;BLOC1S3;NEDD4;MICALL2;HMGB1;GPM6B;APOE;GPRIN3;CNTNAP2;TBC1D23;TMEM108;BICDL1;LGI1;RAB11A;BTG2;ROCK1;MAPT;GPM6A;FRY;MANF;MICALL1;TTC17;BLK;AGER;STMN2;LAMB1;ATP1B2
prerank,GTP metabolic process (GO:0046039),0.45329279820738266,0.9816875055141476,0.5234986945169713,0.9228445249218955,1.0,1/15,0.73%,GIMAP7
prerank,protein alkylation (GO:0008213),0.42505631126264304,0.9816813750170944,0.5174129353233831,0.9223374367904666,1.0,12/22,27.70%,FAM98A;METTL22;LCMT1;METTL21A;GSPT1;ETF1;SNRPB;ETFBKMT;EEF2KMT;VCPKMT;BHMT;PCMT1
prerank,positive regulation of immune system process (GO:0002684),0.45322336409895614,0.9814421396865115,0.505249343832021,0.9224264645851951,1.0,4/16,16.44%,ANXA1;TGFB2;RSAD2;MIA3
prerank,acidic amino acid transport (GO:0015800),-0.34943717121783424,-0.9808093294831834,0.49767441860465117,0.8811042902198379,1.0,2/17,0.70%,LRRC8D;SLC1A3
prerank,positive regulation of keratinocyte migration (GO:0051549),0.49297686232919485,0.9806639893092356,0.5077138849929874,0.923918454280262,1.0,3/10,14.35%,MMP9;MAPRE2;FGF7
prerank,cardiac muscle cell differentiation (GO:0055007),0.4419025193040332,0.980459760794704,0.527027027027027,0.9239215863097655,1.0,2/21,2.91%,NRG1;MYH11
prerank,regulation of fatty acid oxidation (GO:0046320),0.45638814095097957,0.9802145919274797,0.5135135135135135,0.9240213683423735,1.0,2/16,5.87%,NR4A3;ACADVL
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3491451622706268,-0.9799614557668651,0.4596774193548387,0.8811095908062637,1.0,6/16,17.83%,DDX5;SFPQ;SCNM1;SRSF9;CELF4;PQBP1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.41078399475493443,0.9797603646763445,0.5176184690157959,0.9246703036790859,1.0,9/27,21.05%,RPS27A;UBA52;TAB2;CD36;UBB;TIRAP;TNIP1;CD14;TAB1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4215346724698602,0.9795404566050888,0.5312117503059975,0.924701071099689,1.0,4/23,11.01%,HMGB1;LAPTM5;RARA;PRNP
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.34621661392131275,-0.9794470134923795,0.4375,0.8800508675453775,1.0,4/15,12.33%,GRB2;ZFYVE27;CASP3;BDNF
prerank,tRNA wobble uridine modification (GO:0002098),0.45961018103339674,0.979260562194657,0.5061224489795918,0.9248838315002573,1.0,7/14,26.60%,KTI12;DPH3;TRMT9B;URM1;ELP3;CTU2;CTU1
prerank,positive regulation of mRNA processing (GO:0050685),0.43283436401424946,0.9785518576445954,0.529338327091136,0.9262213689070069,1.0,6/21,11.44%,PRDX6;PAF1;LEO1;DHX36;NCL;RBMXL1
prerank,negative regulation of wound healing (GO:0061045),0.41554679445747555,0.9778518833601838,0.533969010727056,0.9275052853285103,1.0,5/28,11.17%,VTN;APOE;PTEN;TFPI;SERPINE1
prerank,peptidyl-lysine methylation (GO:0018022),-0.2984144335553825,-0.977848339365793,0.4779874213836478,0.8820999299772251,1.0,11/26,20.36%,SETD3;ATPSCKMT;EHMT1;SETD4;SMYD3;KMT5A;SMYD2;EHMT2;EEF1AKMT1;SUV39H1;ANTKMT
prerank,DNA alkylation (GO:0006305),0.4382715958295226,0.9777655467596004,0.5137844611528822,0.926689724657625,1.0,7/19,18.83%,ATRX;DNMT1;ATF7IP;GATAD2A;BAZ2A;DMAP1;HELLS
prerank,DNA methylation or demethylation (GO:0044728),0.4382715958295226,0.9777655467596004,0.5137844611528822,0.926689724657625,1.0,7/19,18.83%,ATRX;DNMT1;ATF7IP;GATAD2A;BAZ2A;DMAP1;HELLS
prerank,epithelial cell-cell adhesion (GO:0090136),0.4820180245379964,0.977678107995782,0.5178826895565093,0.9263858437826992,1.0,6/11,20.45%,SERPINB8;KIT;KIFC3;VCL;JUP;CCN3
prerank,lipid droplet formation (GO:0140042),-0.4034056829058198,-0.9775803044339824,0.47058823529411764,0.8804604401959063,1.0,1/10,1.65%,CDS1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.38735618936906124,0.9775646180569078,0.5214446952595937,0.9261499551955761,1.0,9/41,15.21%,SCD5;FADS1;GPX1;ELOVL1;FAAH;SCD;DEGS1;ACSL1;GPX4
prerank,negative regulation of phagocytosis (GO:0050765),0.4489594748548947,0.9774047360039291,0.5280612244897959,0.9260244115540895,1.0,4/17,10.38%,HMGB1;RACK1;CD47;APPL1
prerank,glucose transmembrane transport (GO:1904659),0.4400551821731455,0.9773038513510284,0.5194805194805194,0.92576162620109,1.0,3/18,13.56%,SLC5A1;SLC2A1;SLC2A8
prerank,positive regulation of translational initiation (GO:0045948),0.4442314955530883,0.9771960403247443,0.5175,0.9255276017488732,1.0,7/18,24.29%,CCL5;YTHDF3;BOLL;RPS6KB1;CDC123;POLR2D;KHDRBS1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.46245464180122614,0.9765283753985644,0.5191780821917809,0.9267029431985602,1.0,4/13,16.66%,FLNA;YWHAB;NFKBIA;KEAP1
prerank,mitochondrion distribution (GO:0048311),-0.3740363030261057,-0.976420058049333,0.4551971326164875,0.881248685172441,1.0,5/12,15.41%,MEF2A;LRRK2;TRAK1;ATCAY;TRAK2
prerank,glycolipid metabolic process (GO:0006664),-0.25670927969016055,-0.9762789620565603,0.4787234042553192,0.8791809176526221,1.0,16/47,15.74%,HEXB;CERK;ST3GAL2;NAGA;ASAH1;SUMF2;ST3GAL6;ST6GALNAC6;GM2A;GBGT1;SMPD3;NEU1;GLA;B3GALNT1;GBA2;GALC
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.36809674707268863,0.9761416336587864,0.5519412381951732,0.9271638893569157,1.0,20/72,21.81%,CD24;TRAF1;CD74;SIGIRR;RACK1;HIPK1;IFNGR1;JAK2;ELF1;USP18;SHARPIN;RIPK1;AGPAT2;CLIP3;PIAS1;PTPRC;RNASEL;BIRC3;HSP90AB1;JAK1
prerank,regulation of cellular component size (GO:0032535),0.40471118906622805,0.9760939494679949,0.5302491103202847,0.9267689946788015,1.0,14/30,26.46%,RARG;PPP1R15A;PTEN;MSN;LAMTOR4;HP1BP3;EZR;RIN3;RDX;PPP1CA;VAV3;ATP13A2;RAP1GAP2;RPTOR
prerank,cellular response to organonitrogen compound (GO:0071417),0.36320504849338703,0.9760648434271241,0.5370558375634518,0.9263272057710197,1.0,15/99,11.64%,MAPK13;ACTB;DIAPH1;P2RY1;AHR;CDH1;GABRB1;TSHR;SLC26A6;LAMTOR4;AKAP6;PDE3A;CTNNB1;CPEB3;HCN3
prerank,protein localization to membrane (GO:0072657),0.35206266157711563,0.9758634548346335,0.570281124497992,0.926328957549671,1.0,44/187,17.78%,ITGAL;ATP1B3;PLEKHF1;FLNA;ITGA4;TSPAN17;P2RY1;FERMT2;RAB8A;BID;RAB3D;PRAM1;CDH1;FLOT2;SPTBN4;SAV1;TTC7B;RAMP1;ITGB7;LIN7C;ARL3;CAV1;ANK3;RAPGEF6;RAB11A;BSG;ZDHHC23;ZDHHC15;ROCK1;TSPAN32;ABHD17A;ZDHHC2;PDZD11;TNIK;KCNIP4;S100A10;EZR;GAK;RAP2A;ANK1;ITGB2;BRAF;DLG3;JUP
prerank,sphingosine metabolic process (GO:0006670),0.4449719599619305,0.9754585322994392,0.5137844611528822,0.9268452653855468,1.0,8/17,25.93%,SPTLC3;NAAA;SPHK2;ABCA2;SPTLC2;ACER2;SGPP1;SGPP2
prerank,regulation of cell communication (GO:0010646),0.39650738643781946,0.9753508070390962,0.522196261682243,0.9266098831707982,1.0,6/35,13.07%,ANXA1;IGFBP7;UGCG;GRK6;SRI;SCG5
prerank,regulation of protein sumoylation (GO:0033233),-0.33541950186747277,-0.9753295917672036,0.4721030042918455,0.8793462835515714,1.0,6/17,15.95%,CAPN3;GNL3L;UBA2;ZMIZ1;GNL3;RWDD3
prerank,cellular response to radiation (GO:0071478),0.399038817103171,0.9748783668353127,0.5328054298642534,0.9272893756042961,1.0,8/40,15.31%,FIGNL1;RAD1;GADD45A;INTS7;BLM;SIRT1;CDKN1A;EEF1D
prerank,presynapse organization (GO:0099172),-0.39905330079546936,-0.9746574031013792,0.5050505050505051,0.878790354552877,1.0,6/10,32.03%,LRRTM3;NLGN2;WNT5A;C5AR1;NLGN1;WNT7A
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.38103372469261143,0.973883049301806,0.5469432314410481,0.9292914998407455,1.0,18/52,22.18%,RANGRF;SORBS1;ITGB1;ATP2B4;PLS1;PTPN9;CNPY4;GPSM2;EPHB2;LGALS3;TREM2;CLIP3;EPHA3;GNAI1;EPB41;STAC2;DLG1;DPP10
prerank,maintenance of protein localization in organelle (GO:0072595),0.43747176937323784,0.9738517671684864,0.5538261997405967,0.9288586631136924,1.0,4/19,8.63%,ARL2;HSPA5;HK1;ARL2BP
prerank,positive regulation of monooxygenase activity (GO:0032770),0.41286615999066256,0.9738197892996565,0.5443499392466585,0.9284141054732901,1.0,3/26,9.62%,ATP7A;APOE;POR
prerank,protein import into peroxisome membrane (GO:0045046),0.42391895092649273,0.9731064113736392,0.5270935960591133,0.9297508325182464,1.0,5/22,11.66%,PXMP2;PEX2;ABCD3;PEX16;PEX13
prerank,cilium organization (GO:0044782),0.350681708756462,0.972834211924903,0.5811623246492986,0.9299013855927868,1.0,40/210,15.82%,ABLIM1;CFAP44;PLK4;FLNA;CENPJ;RAB8A;MKS1;CCDC65;TMEM237;RFX2;KIF24;DYNLL1;CEP89;MKKS;IQCB1;PARVA;GSN;WDR90;ARL3;CFAP410;RAB11A;SPAG16;RILPL2;TMEM216;SCLT1;CEP19;WDR35;BBIP1;HYLS1;ACTR3;ARL6;KIF3B;FNBP1L;TTC17;CEP41;PCNT;PTPDC1;CCDC28B;B9D2;RFX3
prerank,heart development (GO:0007507),0.35542503911847234,0.972778866831988,0.5735735735735735,0.9295234460058348,1.0,28/150,18.36%,PDLIM1;CSRP3;DLC1;HEG1;PDLIM2;HDAC9;TAB2;PTEN;NIPBL;TGFB2;MKKS;BMP4;POU6F1;SMYD4;MTHFD1;ID2;CRIP1;FKBP1A;TGFBR3;COL3A1;AKAP13;GPC3;CDKN1A;RBM20;KAT2B;SGCG;NTRK3;ECE1
prerank,protein localization to cell periphery (GO:1990778),0.3535445881189635,0.9727195104061901,0.563894523326572,0.9291514622005079,1.0,31/133,15.41%,ATP1B3;PLEKHF1;FLNA;TSPAN17;P2RY1;RAB8A;RAB3D;PRAM1;CDH1;FLOT2;SPTBN4;TTC7B;RAMP1;LIN7C;ARL3;CAV1;ANK3;RAPGEF6;RAB11A;BSG;ZDHHC23;ROCK1;TSPAN32;ZDHHC2;PDZD11;TNIK;KCNIP4;S100A10;EZR;GAK;RAP2A
prerank,membrane organization (GO:0061024),0.3487335283297202,0.9721617575265764,0.588,0.9300444695164374,1.0,44/227,16.48%,CD4;RPS27A;CD3G;CHP1;ACTG1;AGFG1;ACTB;CHMP6;SYNGR2;FCHO1;HSPA8;IL7R;UBA52;CTDNEP1;SPAG4;LEMD2;KIF20A;CHMP7;ARPC2;DNM3;RTP4;ARPC1A;ANK3;CLN3;ARPC5;EPS15L1;HIP1;STON2;DNAJC6;CHMP5;UBB;UBXN2A;GCA;FNBP1;REEP1;ACTR3;SLC2A8;SAR1B;FNBP1L;GAK;SYP;AZIN2;HUWE1;IGF2R
prerank,actin filament bundle organization (GO:0061572),0.40658557303486065,0.9719193556865177,0.5320139697322468,0.9301187803759281,1.0,7/33,16.47%,RFLNA;PAWR;PLS1;LCP1;RFLNB;EZR;NEDD9
prerank,substantia nigra development (GO:0021762),0.39130315670786614,0.9717909668065124,0.5278725824800911,0.9299509836843923,1.0,14/37,24.57%,ACTB;RAD1;HSPA5;INA;DYNLL1;CDC42;ATP5PF;CALM1;MBP;S100A1;ZNF148;CALM3;MAOB;RHOA
prerank,hyaluronan catabolic process (GO:0030214),0.43597966145676537,0.9716251034041219,0.5459183673469388,0.9298551674114727,1.0,3/18,7.70%,CHP1;CEMIP;CD44
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.47490560145583993,0.9710777506758796,0.5085959885386819,0.930777262057712,1.0,4/11,23.39%,GPM6B;LEPROTL1;SNX33;ACTN2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.40887279664412507,0.970881288719007,0.5362149532710281,0.9307726672337094,1.0,6/31,12.31%,DNAJB9;TLR9;SASH3;GPI;EPHB2;CLCF1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.40401353680629926,0.9706702578852919,0.5407673860911271,0.9307840664380267,1.0,9/29,21.08%,RPS27A;UBA52;UBB;RIPK1;TICAM1;CD14;BIRC3;UBE2D1;TRAF3
prerank,regulation of defense response to virus by host (GO:0050691),0.40390412908908957,0.9706549948222274,0.5309218203033839,0.9303088874733855,1.0,7/30,18.17%,PTPN22;TARBP2;HSP90AA1;MUL1;RNF216;LILRB1;CGAS
prerank,protein autoprocessing (GO:0016540),0.4440875082793124,0.9704648970703139,0.5282051282051282,0.930277573927163,1.0,2/17,10.08%,TMPRSS2;CASP4
prerank,macrophage activation involved in immune response (GO:0002281),-0.3611394035809322,-0.9700760497596432,0.46564885496183206,0.8894493756457446,1.0,4/13,9.06%,CX3CR1;PLCG2;NMI;IFI35
prerank,protein neddylation (GO:0045116),0.46631046608056037,0.9699435813768608,0.5403225806451613,0.9311044101473517,1.0,6/13,24.55%,RNF7;DCUN1D5;DCUN1D2;UBE2F;UBA3;DCUN1D3
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3654149209662123,0.9699223283196645,0.5501551189245087,0.9306441459725333,1.0,22/80,16.39%,CD28;CLU;YTHDF3;RACK1;METTL3;IFNGR1;RPS4X;SPHK2;EEF2;VIM;EIF4A3;CPEB3;NPM1;METTL14;SAMD4A;POLDIP3;EIF3E;ABCA2;RPS6KB1;SLC2A13;GSK3A;NIBAN1
prerank,pulmonary valve development (GO:0003177),0.43569017637280005,0.969819094371141,0.5419354838709678,0.9303823253236282,1.0,6/18,16.79%,TGFB2;BMP4;HEY2;ROBO1;ROBO2;JAG1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4628898046887746,0.969359200571194,0.5491251682368775,0.9309840803175611,1.0,2/13,5.76%,NEDD4;CADM4
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.43007720951146156,0.9693204423845317,0.5308953341740227,0.9305630902061292,1.0,4/21,6.84%,DCN;BGN;UGDH;CHST9
prerank,DNA conformation change (GO:0071103),0.44709421972921526,0.9692658870924097,0.5272020725388601,0.9302002002486377,1.0,3/17,6.36%,HMGB1;HMGB3;HMGB2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3240763828694844,-0.9687938979891778,0.4797979797979798,0.8906055855311679,1.0,5/18,15.53%,GNA15;RGS10;GRK2;CDK5R1;PLCB1
prerank,smooth muscle tissue development (GO:0048745),0.48467670913711175,0.9687426726042179,0.5233236151603499,0.9310007513289088,1.0,6/10,30.98%,BMP4;EFEMP2;PTCH1;SMO;NF1;PROX1
prerank,positive regulation of cyclase activity (GO:0031281),-0.3516445960303093,-0.9686939558187357,0.5040983606557377,0.8884214526266327,1.0,5/14,22.32%,CACNA1D;MAPK8;AKAP5;MAPK3;ORAI1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.3254702213475685,-0.9675887469987896,0.4666666666666667,0.8889775898058261,1.0,3/21,3.28%,SLC8A1;CALM2;ANK2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3581311985716295,0.9675659154533696,0.5764587525150905,0.9333839137680076,1.0,28/148,14.43%,RPL37;RPS20;RPL11;DAXX;CHD5;RPL23;HEXIM1;RAD1;RBBP7;ING2;RFC4;RPS15;ATM;HDAC1;BARD1;PRMT5;CDK1;ING5;HIPK1;PIN1;L3MBTL1;CDK2;NOP53;RFC5;BLM;RMI2;BRIP1;TAF6
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.4206365292532135,0.9675107760030296,0.5205992509363296,0.9330184249323038,1.0,5/21,15.34%,TOX;MDK;SMARCD3;CTNNB1;DRD2
prerank,negative regulation of transmembrane transport (GO:0034763),-0.38801011179278405,-0.9673250588469778,0.5095541401273885,0.887323029704216,1.0,5/10,17.43%,CTTNBP2NL;AKT2;PRKCB;THBS1;IRS2
prerank,positive regulation of lipid transport (GO:0032370),0.4767898047471379,0.9670148991526939,0.5188679245283019,0.9337591395354262,1.0,5/12,21.82%,APOE;PRELID1;DBI;ABCB4;SPP1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3730088960248695,0.9670060586949206,0.553030303030303,0.9332679456036473,1.0,15/57,21.25%,MMP9;DCN;KDR;BID;TNFSF10;MUL1;BCL2L11;TREM2;GSK3A;RALA;BNIP3;DNM1L;GSK3B;MCU;MFF
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3517355937026599,0.966970518891201,0.5668341708542713,0.9328413023774144,1.0,37/182,18.44%,CD3E;MMP8;CILP;PTPN22;CD28;SMCR8;KDR;APOE;RACK1;FLOT2;ATP2B4;HDAC1;MIF;DNMT1;RBMS3;FOXP1;TGFB2;BMP4;HEY2;ID2;ROBO1;SUB1;MAPT;VHL;SLC7A5;SIRT1;TARDBP;SDCBP;CRKL;ANKRD13A;SOX11;AGO2;EMILIN1;RIN3;CPNE1;PARP10;HINFP
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.47403134530448354,0.9668105483660987,0.5272727272727272,0.9327295347300555,1.0,2/12,5.53%,HEXIM1;NELFCD
prerank,engulfment of apoptotic cell (GO:0043652),0.4498112483613789,0.9662463409976707,0.5259165613147914,0.9336217973053006,1.0,3/15,13.22%,ADGRB1;RAC2;XKR4
prerank,chemical synaptic transmission (GO:0007268),0.3498717244956368,0.966205576805892,0.605,0.9332202415784026,1.0,62/284,21.71%,GABRP;MPZ;CAMK4;NPTX2;SLC18A2;HTR7;KCNMB4;HSPA8;GABRA4;APOE;KIF5A;PTEN;PRKAR1B;NAAA;GABRB1;NQO1;GRIA1;ERC2;HTR4;SLC12A7;PCDHB11;SLC1A6;GRID2;DTNA;LIN7C;CACNB4;GABRG1;KCNC4;KCNA1;DNAJC5;GPR176;SLC12A5;SLC12A4;ERC1;RIC3;PDZD11;GRIA2;SYN3;PCDHB16;PRKAR1A;SDCBP;GLRB;GRM1;DRD2;GRIK5;PAFAH1B1;PDE7B;CALM1;CEL;MBP;HTR1F;CAMKK1;GRIA3;GRIK2;CDH8;SNCA;NPTX1;CACNA1B;RIMS1;NSG1;PCDHB14;SNPH
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.41032714232196393,0.9659312976968062,0.5549065420560748,0.9333983189498966,1.0,8/27,22.39%,AHNAK;CACNB4;JPH4;DMD;FKBP1A;CALM1;JPH1;JPH3
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.3795259816704357,-0.965832039702571,0.5111821086261981,0.8890460147610432,1.0,3/10,10.95%,GPR37;LRRK2;NFE2L2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.37931123648627396,-0.965519628318232,0.4597315436241611,0.8874703876747262,1.0,4/11,14.33%,P3H2;P4HA1;EGLN2;EGLN1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.45258022962430794,0.9653575305398349,0.5260347129506008,0.9343149337810446,1.0,1/14,1.94%,ATP1B3
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.34970037200256265,0.9653337084867099,0.5691220988900101,0.9338645822171086,1.0,16/136,11.35%,TMSB4X;EOMES;SFRP5;CHP1;FLNA;SIGIRR;MTURN;SP100;TLR9;TRIM21;PIM1;DAP;FZD6;ID2;PRNP;NFKBIA
prerank,glycolipid biosynthetic process (GO:0009247),0.39528699458844596,0.9651713272309359,0.5447338618346546,0.9337597061498247,1.0,7/38,11.07%,PIGC;PIGH;PIGA;PIGG;DPM3;ST8SIA5;SCCPDH
prerank,glutamate metabolic process (GO:0006536),-0.3227631081333174,-0.9651691766748823,0.4751131221719457,0.8860179799286543,1.0,6/19,22.27%,DGLUCY;GLS;ALDH18A1;ALDH5A1;FPGS;GOT1
prerank,telomere maintenance via recombination (GO:0000722),0.48287646742818313,0.9647070637593567,0.5540540540540541,0.9344218771857419,1.0,4/11,23.68%,ERCC4;ERCC1;SMC6;SMC5
prerank,sphingolipid catabolic process (GO:0030149),-0.3389452776497849,-0.9645859487743407,0.4732510288065844,0.8852260499263861,1.0,6/15,13.47%,SGPL1;PPT1;ASAH1;ACER3;ASAH2;GLA
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.38663997310713827,-0.9645308939829349,0.46105919003115264,0.8782503490463888,1.0,3/11,3.15%,PPCDC;DCAKD;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),-0.38663997310713827,-0.9645308939829349,0.46105919003115264,0.8782503490463888,1.0,3/11,3.15%,PPCDC;DCAKD;ACOT7
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.38663997310713827,-0.9645308939829349,0.46105919003115264,0.8782503490463888,1.0,3/11,3.15%,PPCDC;DCAKD;ACOT7
prerank,acetyl-CoA metabolic process (GO:0006084),0.44904167523164806,0.9645156926311808,0.5338645418326693,0.9343794165403387,1.0,5/15,21.16%,ACAT1;PMVK;ACACA;HMGCS1;DIP2A
prerank,regulation of smooth muscle contraction (GO:0006940),0.42628475487651807,0.9636690345049871,0.5548549810844893,0.9360177268746669,1.0,3/20,8.62%,F2R;DAPK3;CAV1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.37707056405247086,-0.9629081348832923,0.4774436090225564,0.8803681375295654,1.0,4/12,8.81%,LYN;FNIP1;BTK;NOC2L
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3724107024055054,0.9628808593874482,0.5614973262032086,0.9374622825624234,1.0,15/55,18.13%,PSMC3;PSMD8;PSME1;PSMD6;PSMB5;PSMC6;PSMB4;PSMA7;PSMB9;PSMA6;PSMC1;PSMD7;PSMD2;GPR132;PSMD5
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3887441320461241,0.9628640314641046,0.5407577497129736,0.936986142834936,1.0,9/36,17.35%,LEF1;PDE6B;PLCB3;NLK;FZD6;CTNNB1;CALM1;PPP3CB;AGO2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.311070797477512,-0.9628448013749183,0.5078534031413613,0.8781848129612615,1.0,5/21,7.32%,B3GALT5;ST3GAL2;ST3GAL6;ST6GALNAC6;ST3GAL3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4402462004660418,0.9625742555724008,0.5470967741935484,0.9371889901495928,1.0,5/16,14.19%,DHX36;ZFP36L2;CPEB3;KHSRP;TARDBP
prerank,myelination (GO:0042552),0.38067022722624716,0.9624420354218862,0.5645514223194749,0.937005063098366,1.0,13/46,18.07%,MPZ;ACSBG1;AMIGO1;PARD3;EIF2B4;LGI4;CXCR4;NFASC;SCN8A;DEGS1;MARVELD1;SOX10;MBP
prerank,regulation of vasculature development (GO:1901342),0.40744010541161746,0.9623368488971359,0.5492788461538461,0.936763277048566,1.0,4/26,10.71%,SP100;HTATIP2;ETS1;CTNNB1
prerank,dopaminergic neuron differentiation (GO:0071542),0.4325851373969301,0.9623015544580135,0.529335071707953,0.9363221814744332,1.0,4/19,20.91%,NR4A2;CTNNB1;MANF;LMX1B
prerank,positive regulation of lipid localization (GO:1905954),0.47383274180311713,0.9616328802134035,0.5367847411444142,0.9374962538931856,1.0,1/11,2.74%,C3
prerank,negative regulation of developmental growth (GO:0048640),-0.27984539300918054,-0.9615999346772007,0.49635036496350365,0.8791526008696886,1.0,5/30,6.83%,DIP2B;MAG;ULK1;BBS2;WWC2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3947737020406861,0.9615139806709263,0.5400696864111498,0.9372822235714195,1.0,11/32,23.78%,F2R;CEMIP;CXCL10;AKAP6;CALM1;TRPC1;SNCA;CX3CL1;CALM3;HTT;THY1
prerank,regulation of G0 to G1 transition (GO:0070316),0.3949315408775362,0.9614416119390464,0.547806524184477,0.9369590569899683,1.0,9/38,19.58%,UXT;RBBP7;TFDP2;CDC7;APAF1;E2F6;RYBP;BMI1;RBBP8
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.34481453726368916,0.9613805861197238,0.609,0.936614055593166,1.0,52/260,15.82%,PPP1R9B;ABLIM1;CFAP44;FXYD5;PLK4;FLNA;CENPJ;RAB8A;MKS1;S1PR2;CCDC65;TMEM237;ITGB1;RFX2;CDH13;KIF24;KIT;DYNLL1;CEP89;MKKS;IQCB1;PARVA;DNM3;GSN;WDR90;ARL3;CFAP410;RAPGEF6;RAB11A;SPAG16;RILPL2;TMEM216;SCLT1;CEP19;WDR35;BBIP1;HYLS1;ACTR3;ARL6;TNIK;KIF3B;FNBP1L;SDCBP;EZR;CEP41;VCL;RAP2A;PCNT;PTPDC1;CCDC28B;B9D2;RFX3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3818906329508871,0.9608338858814597,0.5565509518477044,0.9374874093021065,1.0,10/43,16.39%,PRKCQ;SORBS1;ZBTB7B;NCK1;SORL1;IRS1;GRB14;SIRT1;RPS6KB1;GSK3A
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3422279795954207,0.9604760507510279,0.705,0.9378571021967198,1.0,201/834,22.55%,SKAP1;BCL11B;LEF1;RPS27A;EOMES;SOX3;IRF6;TCF15;NR4A3;CSRP3;CSRNP1;GATA3;ZNF395;RFX5;PLAC8;EHF;PBX1;HOXA7;MYBL2;NHLH2;RARG;NCK2;DCN;TXK;ATRX;WAS;HOXB4;PSMC3;AUTS2;SPIB;RTRAF;HMGB1;UBA52;LHX4;HTATIP2;TLR9;CDK8;AHR;IER2;HELZ2;PPP1R12A;HOXC4;CHCHD2;SMAD2;MYB;ELF4;POU2AF1;ATM;SREBF1;PRKD2;RARA;HDAC1;SMARCD3;UHRF1;HMGB2;CREBRF;NR4A2;PTPRN;CSRNP3;CDH13;NR1H2;NFATC2IP;TGFB2;LEO1;NR1D2;RNF111;CXCL10;ETS1;BMP4;NFYB;TNIP3;PIN1;RPS6KA5;RLF;TFDP2;GREM1;TCF12;NR4A1;HOXB2;BMP6;HEY2;SLC30A9;MED30;STAT5B;GLI3;DHX36;NCK1;MLLT10;DLGAP5;MEIS2;ZNF462;CTNNB1;ELF1;MOSPD1;SERPINE1;NFKBIA;SUB1;SMAD1;MED13;ASXL1;PCGF5;UBB;MMP12;FOXO1;DR1;ATF4;HSF2;TGFB3;NPM1;ATMIN;ACTR3;ARNT2;EPAS1;HLF;PRDM10;PAXBP1;WWTR1;JMJD6;AKNA;SIRT1;NCOA7;RIPK1;ATAD2B;TAF6;NCOA2;PTOV1;MAP2K5;IRF4;RUNX2;RFX3;WBP2;TCEA1;MYDGF;PPARGC1B;NRIP1;CDK13;ZNF507;CEBPB;NKRF;JAG1;KLF2;PPP3CB;SOX11;AGO2;IL33;KAT2B;PBX2;CALCOCO1;LILRB1;JUP;CRTC2;HDAC2;TNIP1;EAF2;DPF2;HES1;PER1;MYSM1;HINFP;EGR2;RORA;RGMA;HDAC4;CDC73;YY1;MLXIPL;MLX;RNASEL;MLLT6;MED24;RFXANK;SOX9;PLXND1;GLIS2;PCBP1;LMO7;CCNT1;NLRC5;SENP1;ASXL2;HNRNPU;LMX1B;HOXB3;NPAT;TNIP2;PRPF6;KLF6;RPRD1B;TEAD1;PPRC1;BRD4;EGR1;TBL1XR1;MET;DDX17;SSBP3;MTF2;DCAF6;CX3CL1;KDM1B;NFIB
prerank,regulation of bone mineralization (GO:0030500),-0.24590448303769233,-0.9603017886772096,0.5294117647058824,0.8803451482673915,1.0,8/55,5.44%,SLC8A1;BMP2K;MEF2C;BMPR2;NBR1;ANO6;TMEM119;TRPM4
prerank,lytic vacuole organization (GO:0080171),-0.27972929271773567,-0.9600638821913913,0.5,0.8786269346145197,1.0,10/32,11.89%,MYO7A;TPP1;LRRK2;MTOR;ACP2;CLVS1;HPS1;AKTIP;SNAPIN;VPS18
prerank,positive regulation of RNA splicing (GO:0033120),-0.2893896253246,-0.9596973282400818,0.5231788079470199,0.8773398011197572,1.0,7/29,7.87%,TRA2A;PIK3R1;THRAP3;U2AF2;RBMX;TRA2B;CIRBP
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4055506128536875,0.9595179737747361,0.5675029868578255,0.9397418104508645,1.0,9/27,24.85%,PDE6B;PER2;RBM4B;ID2;FBXL17;PER1;PPP1CA;CRY2;CRTC1
prerank,positive regulation of protein kinase activity (GO:0045860),0.34980356573923244,0.9585267049242602,0.6090452261306533,0.9416968261604506,1.0,41/148,23.39%,LTF;CD4;CCL5;DDR2;DAXX;IQGAP1;CLU;TAB2;TGFB2;PAK4;SRCIN1;HSP90AA1;TAOK3;SLC27A1;PRNP;SYAP1;ETAA1;AGAP2;STK4;RALB;TNIK;PPP2CA;CDKN1A;PAK1;MAPRE3;NEDD9;CALM1;DLG3;CCDC88A;CAMKK1;NAB2;PTPRC;SNCA;STK11;HSP90AB1;EFNA1;EGR1;CALM3;PRKAG1;IL34;INSR
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2935531465693815,-0.9584250806097669,0.5535714285714286,0.8786227283788508,1.0,8/25,17.58%,NCKAP1L;ACVR1B;FOXO3;PRKDC;TAL1;ABCB10;MED1;STAT3
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.45428443268564983,0.958261552809113,0.5251017639077341,0.9418218599547684,1.0,4/12,15.81%,NEDD4;BMP4;NUP214;AAAS
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4295698100276554,0.9581944864397632,0.5714285714285714,0.9414780400868475,1.0,11/21,25.48%,ACTG1;GPM6B;DAPK3;PTPRA;ROCK1;VCL;EPHA3;DUSP3;SLK;RHOA;PEAK1
prerank,bone morphogenesis (GO:0060349),0.4505583112238722,0.9579752004211969,0.5475862068965517,0.9414920056616473,1.0,1/14,0.23%,LTF
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4532685654799252,0.9579158698559742,0.5316455696202531,0.9411331123252257,1.0,4/13,14.97%,KDR;COL4A1;CTNNB1;SEMA3E
prerank,regulation of TOR signaling (GO:0032006),-0.23219776779946713,-0.9569749620674456,0.5813953488372093,0.8802022196831933,1.0,16/67,15.49%,TBCK;FLCN;PIK3CA;DEPTOR;FNIP1;GNA12;PRKAA2;WDR59;GOLPH3;MINAR1;RFFL;TSC2;SEC13;PIH1D1;AKT1S1;DGKQ
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3936445492412185,0.9568571109099039,0.5451428571428572,0.9431046960624407,1.0,5/33,9.67%,SCIN;MTURN;HMGB2;ETS1;STAT5B
prerank,positive regulation of TOR signaling (GO:0032008),-0.26191152224440317,-0.956756387935731,0.5,0.8784889147938981,1.0,9/40,12.57%,NCKAP1L;FLCN;PIK3CA;FNIP1;WDR59;GOLPH3;CLEC16A;SEC13;PIH1D1
prerank,phagosome-lysosome fusion (GO:0090385),0.4864536807029516,0.9566421477649855,0.5576368876080692,0.943105379464345,1.0,3/10,9.45%,ARL8B;CLN3;SYT7
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.39393205729982983,0.9562655245305824,0.5485380116959064,0.9435148789835116,1.0,15/31,24.89%,PARD3;MSN;LIN7C;CDC42;PDZD11;EZR;RAP2A;MTCL1;ANK1;DLG3;PDCD6IP;DLG1;RHOA;ERBIN;DLG2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.4570152824552589,0.9558511929811221,0.5396825396825397,0.9440352241417802,1.0,3/13,9.92%,RUNX3;ZBTB7B;GLI3
prerank,covalent chromatin modification (GO:0016569),0.45338065626182406,0.9555796416303535,0.5481682496607869,0.9441939173859302,1.0,6/14,22.75%,HLCS;HDAC1;SETD5;SIRT1;HELLS;MBD2
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4220318505646551,0.9554393244142957,0.5712515489467163,0.9439942300871413,1.0,8/21,27.92%,KDR;CDK1;ZFP36L2;CTSH;SOX9;KARS1;IGF1;MYC
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.42785857619216006,0.955345918197565,0.541507024265645,0.9437120981465448,1.0,2/17,9.32%,ANK3;AKAP6
prerank,respiratory electron transport chain (GO:0022904),0.45388490659752617,0.9550872491586353,0.547683923705722,0.9438406667821476,1.0,6/14,20.16%,SDHB;NDUFA5;ETFB;UQCRFS1;SLC25A22;GPD2
prerank,L-serine metabolic process (GO:0006563),0.48781308404992807,0.9550173436107096,0.5592011412268189,0.9434988702975303,1.0,4/10,19.19%,SHMT1;SRR;PHGDH;SERINC5
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4543606678556201,0.9545340508152539,0.5520110957004161,0.9441456180316885,1.0,3/13,11.77%,NFU1;CIAO1;CISD3
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.3642818871272462,-0.9543014312970194,0.4852941176470588,0.8829780912303993,1.0,2/13,2.01%,SLC8A1;CALM2
prerank,negative regulation of anoikis (GO:2000811),0.45538679846352476,0.9542863950061202,0.556,0.9442576773247984,1.0,5/14,19.53%,BCL2;ITGB1;CAV1;MCL1;SNAI2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4587235472937409,0.954038153998297,0.543978349120433,0.9443615862810618,1.0,2/13,5.24%,APOE;DKK3
prerank,response to progesterone (GO:0032570),0.42839077652451085,0.9537982853277945,0.5510996119016818,0.9444407723852327,1.0,6/18,17.97%,TGFB2;CAV1;ABHD2;TGFB3;WBP2;ACOD1
prerank,regulation of neuron projection development (GO:0010975),0.34913440158589665,0.9536780525330292,0.6221105527638191,0.9442214917383084,1.0,36/163,18.34%,S100A9;P3H1;LPAR1;NDNF;PAQR3;PLPPR5;EFNB2;PPFIA2;APOE;PTEN;ITM2C;TOX;FUT9;MDK;PTPN9;MFSD2A;CHN1;CFL1;SRCIN1;ADCY6;ZDHHC15;NTNG1;NTNG2;NPTN;DCC;GAK;PAK1;ABL2;STMN2;GSK3A;TWF2;ATP1B2;HDAC2;NTRK3;EPHA3;CCDC88A
prerank,cardiac ventricle morphogenesis (GO:0003208),0.38136489114307637,0.9535002976534093,0.5560588901472253,0.9441419374096678,1.0,9/41,17.28%,GATA3;TGFB2;BMP4;HEY2;FKBP1A;TGFBR3;GSK3A;JAG1;SOX11
prerank,negative regulation of platelet activation (GO:0010544),0.4387429183167712,0.9532657616339916,0.5443864229765013,0.9441901326507187,1.0,2/16,5.19%,CEACAM1;APOE
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3688406897113247,0.9532365937168371,0.5627009646302251,0.9437449780003427,1.0,22/52,26.87%,DNAJB9;LMNA;ACADVL;HSPA5;EXTL2;EDEM1;GOSR2;DDX11;SHC1;MYDGF;GSK3A;PREB;ARFGAP1;CXXC1;PPP2R5B;ERN1;PARP16;ADD1;HDGF;WFS1;SSR1;DNAJC3
prerank,autonomic nervous system development (GO:0048483),0.43435802280411945,0.9532166034889942,0.5666666666666667,0.9432816257348906,1.0,1/17,1.12%,GATA3
prerank,regulation of protein metabolic process (GO:0051246),-0.2602295094701081,-0.952946453982527,0.5340909090909091,0.8843806816431606,1.0,15/44,16.94%,ROCK2;GSAP;CHEK2;MDM2;PARL;CHRNA7;SPOP;HGS;APP;CENATAC;NEDD8;TMEM9;VPS35;MAPK8;MAPK7
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4334004363172701,0.9523671247886557,0.551948051948052,0.9448250437400797,1.0,5/17,11.50%,GJD3;GJC1;ATP1A3;ATP1A1;ATP1A2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.36312122956776816,0.9523547527559746,0.5860271115745568,0.9443477508884431,1.0,16/75,16.29%,ITGA4;HMGB1;SEMA5A;KDR;PRKD2;MDK;HMGB2;CDH13;BMP4;NR4A1;EGR3;PDCL3;TNFSF12;SIRT1;PPP1R16B;MYDGF
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.46234295985055945,0.9514690248102734,0.5594594594594594,0.9459635252192415,1.0,2/13,5.60%,PLA2R1;ATM
prerank,photoperiodism (GO:0009648),0.4019313015992324,0.951162899173478,0.5710843373493976,0.9461815039949514,1.0,9/28,24.85%,PDE6B;PER2;RBM4B;ID2;FBXL17;PER1;PPP1CA;CRY2;CRTC1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.35917745401573664,-0.9511356277200658,0.4857142857142857,0.8870355532559904,1.0,9/13,46.93%,KCND3;KCNK5;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNA5;KCNE2
prerank,positive regulation of receptor internalization (GO:0002092),0.415519849156601,0.9510513069340174,0.5686274509803921,0.9459357400884377,1.0,3/22,8.50%,ANGPT1;CD63;GREM1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.4086446490486679,0.9508989682127846,0.5563463819691578,0.9458019324820521,1.0,5/27,14.95%,DACH1;ATM;PRKD2;HMBOX1;CDKN1A
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.35934211276780503,0.9506724807227291,0.5920915712799167,0.9458452869501194,1.0,19/70,15.52%,CD247;CD3G;ACTG1;ACTB;WAS;CYFIP2;MYO1G;ARPC2;ARPC1A;CDC42;ARPC5;NCK1;HSP90AA1;NCKAP1;ACTR3;ABI1;MYO10;FYN;PAK1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.46095327118227547,0.9504868512519162,0.5493562231759657,0.9457860533325643,1.0,4/11,16.03%,GHR;IRS1;EIF2AK3;IGF1R
prerank,protein dephosphorylation (GO:0006470),0.349915565871663,0.9500510154660275,0.5987841945288754,0.9463279982570982,1.0,42/135,23.21%,PTPN22;PPP1R15A;PDP2;PTPN13;PPP2R2C;PPP2R2A;PPP1R12A;PTEN;CTDNEP1;DUSP5;PPM1L;PPP2R1A;PTPN12;PTPN9;DUSP6;PTPRA;NCK1;PPP1R15B;DUSP2;MTM1;DUSP16;PPM1M;PTPN4;PPP2CA;DUSP4;PPP2R1B;PPP2R3A;PPP3CB;PTPRC;PPP2R2B;STK11;TAB1;RPRD1B;PPP1CA;BTRC;DUSP3;PTPRD;PPP2R5B;PPP2R5E;DUSP10;TNS2;SBF1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.47219837507453233,0.9498779250633864,0.5652777777777778,0.9462415025799277,1.0,4/11,17.97%,CYBA;TIRAP;TREM2;ACOD1
prerank,limb morphogenesis (GO:0035108),-0.3088767137621663,-0.9498693057564274,0.5225225225225225,0.8880781733408633,1.0,3/20,4.36%,SKI;PCSK5;FBXW4
prerank,cellular response to ATP (GO:0071318),-0.3435370636144879,-0.9497884736202926,0.4795539033457249,0.8859720768979702,1.0,2/14,3.46%,P2RY12;P2RX4
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3958202998315136,0.9496826627030065,0.5497076023391813,0.946162525567554,1.0,14/29,28.66%,SMAD2;METTL3;TARBP2;SMAD1;DROSHA;ZC3H7B;AGO2;DGCR8;LIN28B;HNRNPA2B1;ADAR;PUM1;ZC3H7A;DICER1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.27166691520846753,-0.9495379705787135,0.5565217391304348,0.8844060446797464,1.0,8/33,12.18%,OPHN1;FCHO2;SYT2;ITSN1;CDK5;SNAP91;AMPH;PICALM
prerank,negative regulation of neuron projection development (GO:0010977),0.37141331855793824,0.9494027257074638,0.5720430107526882,0.9463232700501547,1.0,20/56,25.69%,LPAR1;PAQR3;EFNB2;APOE;PTEN;ITM2C;PTPN9;ADCY6;DCC;GAK;STMN2;HDAC2;LRP4;EFNA1;SPOCK1;THY1;RHOA;LINGO1;RAB29;CBFA2T2
prerank,chondroitin sulfate metabolic process (GO:0030204),0.39841975512792555,0.9493930014011038,0.5560747663551402,0.9458389690946776,1.0,5/30,6.84%,DCN;NDNF;BGN;UGDH;CHST9
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3916506643338106,0.9493099193438517,0.5629453681710214,0.945560141698551,1.0,8/30,17.66%,DKK3;SMAD2;FSTL1;TRIM33;FKBP1A;TGFBR3;SOX11;SMURF2
prerank,somite development (GO:0061053),0.4733685902250908,0.9490604568681933,0.5636623748211731,0.9456606072235881,1.0,5/11,26.74%,MTHFD1;PPP2R3A;SOX11;PTCH1;SMO
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.31700732008979554,-0.9489030743786491,0.5317073170731708,0.8839302404952967,1.0,9/19,17.98%,EXTL3;XYLT1;HS3ST5;HS6ST1;XYLT2;NDST4;NDST2;HS2ST1;GLCE
prerank,axoneme assembly (GO:0035082),0.3999908009891528,0.9488245458390814,0.571764705882353,0.9457070034999687,1.0,6/31,13.22%,CCDC65;CFAP46;DCX;SPAG16;DNAI4;CFAP206
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3817859980396741,0.9487650290495139,0.5881696428571429,0.9453414456897301,1.0,18/41,28.51%,GCK;NUP50;NUP214;NUP210;NUP88;RANBP2;AAAS;NUP62;PRKAG1;NUP93;NUP205;NDC1;NUP153;ZBTB7A;OGT;NUP98;TPR;HIF1A
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3436055411019648,0.9485495573740198,0.671,0.9453382852119937,1.0,72/327,19.53%,TCF7;TBX21;SOX3;PRKCQ;ZNF395;SOX7;RUNX3;DAXX;MYBL2;FADS1;ATRX;TCF7L1;ING2;PRRX2;AHR;RNF14;DAPK3;MYB;PFDN5;PRMT5;NR1D2;CREBL2;PPP2R1A;MSL3;NFYB;MLF1;RPS6KA5;NLK;UBE2L3;PSPC1;MED23;CCAR2;ACTR8;HP1BP3;GTF2IRD1;LIMD1;VHL;ERC1;CTR9;ATXN1;ATF4;MAGED1;NIF3L1;PTP4A3;ARNT2;WWTR1;PPP2CA;APBB3;NCOA2;BAZ2A;RBAK;RFX3;DMTF1;PPARGC1B;EDF1;CEBPB;NFIL3;SOX11;RYBP;GPBP1L1;HINFP;ATXN1L;NSD3;RORA;LYL1;NAB2;ZFP37;MLXIPL;MLX;MLLT6;BNC2;SNAI2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.45964861723240125,0.948460965923429,0.5415512465373962,0.9450483160519062,1.0,2/13,5.53%,HEXIM1;NELFCD
prerank,fatty acid beta-oxidation (GO:0006635),0.37297816618925844,0.9483099989125452,0.5760517799352751,0.9448927461673345,1.0,17/51,22.62%,PEX2;ACAT1;ACADVL;EHHADH;ACOXL;ABCD3;ETFB;HADHA;HADH;CPT2;ACADS;ACOT8;GCDH;ACAT2;HSD17B4;HADHB;DECR1
prerank,mitotic cytokinetic process (GO:1902410),0.4242940043863583,0.9482378295961319,0.5758754863813229,0.9445669142765951,1.0,4/20,12.30%,CHMP6;KIF20A;CHMP7;CHMP5
prerank,centromere complex assembly (GO:0034508),0.3903660997192931,0.9481772378456947,0.5853379152348225,0.9442118960292939,1.0,12/36,25.32%,RBBP7;CENPH;KNL1;NASP;DLGAP5;NPM1;RUVBL1;HELLS;MIS12;CENPF;CENPX;CENPO
prerank,triglyceride metabolic process (GO:0006641),0.3756132744579968,0.9481331204537057,0.5681570338058888,0.9438082359386639,1.0,9/48,16.57%,APOC1;FABP7;APOE;PLAAT3;FABP5;CAV1;SIRT1;FABP4;MOGAT3
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4534110354094792,0.9480115591695754,0.5524861878453039,0.9436004462570273,1.0,2/13,8.58%,KLRC2;SPHK2
prerank,dendritic cell differentiation (GO:0097028),0.40988239997410947,0.947717717560985,0.5460277427490542,0.9438014565003203,1.0,7/22,17.78%,CAMK4;FLT3;BLK;TREM2;BATF3;BATF;LILRB1
prerank,RNA splicing (GO:0008380),0.35536656851612897,0.9474877820539613,0.6071794871794872,0.9438343828378296,1.0,28/95,21.45%,PPP1R9B;DBR1;SRPK1;PRPF4;PPP2R1A;SNRPG;WBP4;SYNCRIP;CCAR2;PRPF8;MPHOSPH10;SF3B2;SF3B1;SF3A3;ZCRB1;SRSF7;PPP2CA;KHSRP;TARDBP;RBM8A;SNRPB;SLU7;LSM6;ZRSR2;MBNL1;LSM4;SRSF4;PRPF6
prerank,cartilage development (GO:0051216),0.37746490740678107,0.9472899151714815,0.570801317233809,0.9438393982826468,1.0,8/49,10.58%,RUNX3;ATP7A;SOX5;BMP4;CD44;GPLD1;ZBTB16;SNX19
prerank,positive regulation of actin nucleation (GO:0051127),0.4650809479047585,0.947127889308814,0.5546099290780142,0.9437003707144466,1.0,5/11,19.82%,SCIN;GSN;NCKAP1;WASF3;CYFIP1
prerank,negative regulation of metabolic process (GO:0009892),0.37081690686941055,0.9468783453530506,0.597860962566845,0.9438010758027151,1.0,14/54,24.43%,IL18R1;APOC1;NR1H2;LAMA4;LGR4;ATF4;LNPEP;RHEB;STK11;ARRDC3;TLE3;DDIT3;IP6K1;ZDHHC7
prerank,nucleocytoplasmic transport (GO:0006913),0.3776570222662245,0.9468252407803461,0.5620022753128555,0.9434395603853412,1.0,11/40,20.41%,XPO1;HTATIP2;MALT1;SNRPG;NXT2;ATXN1;NPM1;SNRPB;AAAS;GEMIN8;ANP32A
prerank,rRNA pseudouridine synthesis (GO:0031118),0.477727659981997,0.9468194403713854,0.5507246376811594,0.9429535118427077,1.0,4/10,26.33%,RPUSD4;NAF1;GAR1;TSR3
prerank,histone H3-K4 methylation (GO:0051568),0.40202009504681613,0.9465534526887841,0.5631768953068592,0.9430806803962702,1.0,11/26,27.47%,DYDC1;SETD1A;CTR9;WDR5;WDR5B;CXXC1;PRDM9;KMT2A;TET2;KMT2D;OGT
prerank,miRNA metabolic process (GO:0010586),0.4185755038301431,0.9456644925251739,0.5717948717948718,0.9446762756525595,1.0,11/20,32.24%,TARBP2;KHSRP;DROSHA;AGO2;DGCR8;DDX17;LIN28B;DICER1;TENT4B;PARN;TUT7
prerank,regulation of keratinocyte differentiation (GO:0045616),0.409375083932104,0.9456497351261804,0.559322033898305,0.9442128767990396,1.0,2/24,2.50%,TRIM16;HOXA7
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.4560843900285817,0.9454592967959801,0.5564738292011019,0.9441391097428582,1.0,4/12,20.45%,GREM1;NBL1;MIA3;CCN3
prerank,positive regulation of ossification (GO:0045778),-0.2609674404790051,-0.9451330570399611,0.5299145299145299,0.8917902833552953,1.0,7/39,7.70%,SLC8A1;MEF2C;BMPR2;ANO6;TMEM119;PTPN11;TGFB1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.43013530992033117,0.9450450846595153,0.5687583444592791,0.9446045949828814,1.0,2/16,8.58%,TMSB4X;SPHK2
prerank,folic acid metabolic process (GO:0046655),0.4333834085320864,0.9450078418154502,0.5549872122762148,0.9442063185210028,1.0,8/18,25.34%,MTHFD2;SHMT1;MTHFD1;ALDH1L2;SLC19A1;MTHFD1L;MTHFS;SHMT2
prerank,protein targeting to membrane (GO:0006612),0.3548621779693993,0.9449926838787709,0.5845360824742268,0.9437383898292179,1.0,22/83,17.51%,NCF1;PXMP2;PEX2;PARD3;ABCD3;AQP11;RTP4;PEX16;ZDHHC23;ZDHHC15;PEX13;ZDHHC12;ZDHHC2;MICALL1;ARL6;SDCBP;SIL1;ATG3;ZDHHC14;ZDHHC18;ARL6IP1;SGTB
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.47655291766630387,0.9449761479693661,0.5579399141630901,0.9432897683898167,1.0,2/10,9.79%,RACGAP1;CDC42
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4107498252261771,0.944232256034423,0.5558312655086849,0.9445617834590377,1.0,5/21,11.36%,SRGN;ASPN;GREM1;HEY2;ROCK1
prerank,negative regulation of chemokine production (GO:0032682),0.4460605755971086,0.9440739718130459,0.5630810092961488,0.944424892017202,1.0,4/14,16.32%,SIGIRR;MUL1;MAP2K5;APOD
prerank,protein modification by small protein conjugation (GO:0032446),0.33946056534567315,0.9439643310709802,0.682,0.9441989127715842,1.0,109/361,25.03%,RPS27A;RNF7;NEDD4;SDE2;TSPAN17;PEX2;UBA52;TRIM21;RNF14;RACK1;UFM1;BRAP;PAF1;UHRF1;UBE2H;BSPRY;BARD1;NUP50;LEO1;RNF103;ASB5;RNF111;MKRN1;CUL9;UBE2G2;RNF157;TRIM24;ASB1;UBE2L3;DCUN1D5;BIRC6;TRIM33;DTX2;AMFR;NUP214;NUP210;KLHL21;PEX13;SUMO2;NUP88;ZNRF3;MUL1;RANBP2;VHL;UBB;KLHL25;CTR9;VPS11;UBE2Z;TRIM68;VCPIP1;EPAS1;SIRT1;FBXL5;UBE2B;CUL3;DCUN1D2;PCNA;AAAS;ATG3;HUWE1;CHFR;FBXL17;KEAP1;SHPRH;AREL1;PIAS1;DERL1;SMURF2;RNF152;UCHL3;FBXO11;OS9;RNF135;CDC34;EGR2;FBXO10;UBE2F;CDC73;SELENOS;MSL2;DDB1;LMO7;PEX10;UBA3;UBE2D1;URM1;MKRN2;RNF220;TRIM28;BTRC;TMEM129;KCTD10;NUP62;UBE2W;NUP93;NUP205;IFIH1;NDC1;FBXO4;RNF20;KLHL7;FBXL7;RAD18;DCUN1D3;RTF1;FBXW7;TRAIP;USP9X
prerank,glial cell differentiation (GO:0010001),-0.2808447441038259,-0.9438757820020068,0.5094339622641509,0.8928284548255858,1.0,9/28,17.58%,CDK5;FGF10;EIF2B5;PAX2;PICK1;SOX4;SOX8;ERBB3;STAT3
prerank,synaptic vesicle exocytosis (GO:0016079),-0.25421369974981356,-0.9437740457695271,0.5106382978723404,0.890826629231249,1.0,12/40,19.89%,SYT2;SNAP29;SNAP25;STX2;CPLX1;CDK5;SYT10;SNAPIN;STX1B;RAB3A;SYT8;BLOC1S6
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.32479861375666796,-0.9434308124106618,0.5463414634146342,0.8894073275692762,1.0,8/18,21.76%,RNF185;PIK3R1;BAG6;USP13;TMEM259;XBP1;FCGR2B;BAK1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.4734746018518995,0.943351709760015,0.5670391061452514,0.9451106668088702,1.0,3/10,9.67%,GHR;JAK2;STAT5B
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.3524273507972648,-0.9433057483674886,0.5320754716981132,0.887521282651948,1.0,7/14,13.01%,ZNHIT6;NOL9;URB1;RPF2;RPL7L1;PES1;NIFK
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.4726821557753808,0.9429111353049666,0.5766016713091922,0.9456753383631056,1.0,4/10,20.32%,PTGIR;PTPN12;APOD;SNCA
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3886636970175974,0.9428372822001041,0.5638418079096045,0.945346942807603,1.0,13/33,27.23%,RTEL1;CDK2;HSP90AA1;ANKRD28;PTGES3;STN1;GAR1;HSP90AB1;CTC1;DCLRE1B;PPP6C;TERF1;TERF2IP
prerank,microtubule anchoring at centrosome (GO:0034454),0.4785683216588631,0.9426881614361223,0.5654008438818565,0.945200625503816,1.0,3/10,19.18%,CCDC120;CEP19;NINL
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.39599013610516987,0.9425694058857624,0.5656324582338902,0.9449841998870289,1.0,3/27,3.26%,DLC1;ARHGEF18;WAS
prerank,serine family amino acid biosynthetic process (GO:0009070),0.46153458224040655,0.9423919778128206,0.5834464043419267,0.9449063695576618,1.0,5/12,19.19%,MTHFD1;SRR;SEPHS2;PHGDH;SERINC5
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.44548442900539204,0.9421993651903134,0.5660881174899867,0.9448650144338567,1.0,7/14,26.00%,CST7;GRN;TREM2;PTPRC;LDLR;CX3CL1;IGF1
prerank,chromosome condensation (GO:0030261),0.388060053861805,0.9420315149229437,0.5717619603267211,0.9447317263452758,1.0,7/36,13.61%,H1-0;SMC4;NCAPG;CDK1;NCAPH;NCAPD3;TENT4A
prerank,secondary alcohol biosynthetic process (GO:1902653),0.39849200940098445,0.941765844918175,0.5868055555555556,0.9448457967291763,1.0,8/30,21.71%,LBR;HSD17B7;PMVK;ARV1;PLPP6;HMGCS1;ACAT2;MSMO1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3552684571667895,0.9416290077142653,0.6026970954356846,0.9446711301324395,1.0,19/71,15.52%,CD247;CD3G;ACTG1;ACTB;WAS;CYFIP2;MYO1G;ARPC2;ARPC1A;CDC42;ARPC5;NCK1;HSP90AA1;NCKAP1;ACTR3;ABI1;MYO10;FYN;PAK1
prerank,stabilization of membrane potential (GO:0030322),0.4413335633649764,0.9409773662242745,0.5773584905660377,0.9456691924388632,1.0,1/16,1.58%,KCNN4
prerank,regulation of neuroblast proliferation (GO:1902692),-0.333380801918753,-0.940913478824069,0.5196850393700787,0.8920336447095769,1.0,4/15,9.87%,CX3CR1;TAFA1;LRRK2;VEGFA
prerank,protein oxidation (GO:0018158),0.46392847883672855,0.9406419280723064,0.5667613636363636,0.9459786091751798,1.0,3/11,17.72%,LOX;TMX3;SUMF1
prerank,vesicle coating (GO:0006901),0.36363795649180747,0.9404808419628946,0.6071428571428571,0.9448738117668157,1.0,20/61,22.50%,F5;F8;GRIA1;CTSZ;SEC22B;LMAN1;NSF;GOSR2;ANKRD28;SAR1B;CUL3;SEC24D;TRAPPC4;CTSC;PREB;TRAPPC5;PPP6R1;TBC1D20;SEC24C;TMED2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.36363795649180747,0.9404808419628946,0.6071428571428571,0.9448738117668157,1.0,20/61,22.50%,F5;F8;GRIA1;CTSZ;SEC22B;LMAN1;NSF;GOSR2;ANKRD28;SAR1B;CUL3;SEC24D;TRAPPC4;CTSC;PREB;TRAPPC5;PPP6R1;TBC1D20;SEC24C;TMED2
prerank,COPII vesicle coating (GO:0048208),0.36363795649180747,0.9404808419628946,0.6071428571428571,0.9448738117668157,1.0,20/61,22.50%,F5;F8;GRIA1;CTSZ;SEC22B;LMAN1;NSF;GOSR2;ANKRD28;SAR1B;CUL3;SEC24D;TRAPPC4;CTSC;PREB;TRAPPC5;PPP6R1;TBC1D20;SEC24C;TMED2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3631709543689764,0.9402326124735767,0.5836909871244635,0.9449589313680267,1.0,10/54,10.49%,B3GALT6;SLC35D2;HSPG2;SDC2;UGDH;CHST9;HS3ST3B1;EXT2;GCNT2;GPC6
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.39537035102281787,0.9402165117996754,0.5803782505910166,0.9444926205050169,1.0,8/29,20.15%,RPS27A;UBA52;XPC;GTF2H5;UBB;ERCC5;DDB2;DDB1
prerank,cAMP metabolic process (GO:0046058),0.45135062025740935,0.9395743291782138,0.5609418282548476,0.945458194058233,1.0,6/13,27.31%,ADCY10;ADCY6;ADCY1;ADCY3;ADCY8;PDE4D
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.3221821672069814,-0.9390606948042454,0.5442477876106194,0.8947306862202056,1.0,3/16,2.52%,KLK2;BMPR2;PRCP
prerank,neuron apoptotic process (GO:0051402),0.41783547399935667,0.9390541284321754,0.5622641509433962,0.9461592628905634,1.0,5/19,14.28%,BCL2;BID;TRPC5;CIT;GAPDH
prerank,response to nutrient levels (GO:0031667),-0.31892776013108665,-0.9390510258533352,0.5405405405405406,0.8924998516524787,1.0,3/17,6.57%,MTOR;ULK1;PRKAA2
prerank,cellular response to increased oxygen levels (GO:0036295),0.4701524156681687,0.9390184417391436,0.5506607929515418,0.9457452116212052,1.0,5/11,19.74%,CAV1;ATP6AP1;FOXO1;ATP6V0A2;ATP6V1G1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.2887529382673594,-0.938818277414714,0.5333333333333333,0.8909179401259651,1.0,5/25,10.21%,MEF2C;LRRK2;ARRB2;GRIN2A;INSYN2A
prerank,neural tube development (GO:0021915),-0.3337650063271443,-0.9386074675133558,0.5413223140495868,0.8891862501645869,1.0,7/15,28.71%,PKD1;TGFB1;SOX4;ALDH1A2;PKD2;DACT1;STIL
prerank,protein modification by small protein removal (GO:0070646),0.3382945269329886,0.9384683966063164,0.683,0.9465398556038007,1.0,70/252,21.08%,RPS27A;GATA3;TFPT;ACTB;USP3;PSMC3;UBA52;USPL1;PSMD8;USP42;SMAD2;PTEN;PSME1;PSMD6;PSMB5;BARD1;POLB;CDK1;TNIP3;COPS6;USP1;PSMC6;PSMB4;USP46;ACTR8;NFKBIA;SMAD1;PSMA7;ASXL1;UBB;PSMB9;PSMA6;USP18;USP34;VCPIP1;COPS3;DESI1;DESI2;PSMC1;USP45;RIPK1;OTUD1;USP15;RUVBL1;USP32;USP49;PSMD7;PSMD2;KEAP1;USP28;MBD5;IL33;KAT2B;SMURF2;WDR48;UCHL3;TNIP1;PSMD5;DDB2;MYSM1;USP50;YY1;COPS8;PSMB6;SENP1;ASXL2;BIRC3;UBE2D1;TAB1;TRAF3
prerank,regulation of chromatin binding (GO:0035561),0.4695893378095684,0.9380013053565439,0.5632022471910112,0.9471268132639107,1.0,4/10,22.06%,WAPL;HMBOX1;DDX11;BTAF1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4013587738989071,0.9379423873582176,0.5597104945717732,0.94677477602927,1.0,8/25,24.16%,RANGRF;CAV1;CTNNA3;CALM1;JUP;DLG1;CALM3;CXADR
prerank,cellular response to sterol (GO:0036315),0.4424353570622064,0.9379042242318071,0.5724043715846995,0.9463715708465829,1.0,7/13,26.74%,GRAMD1B;GPLD1;MLC1;RORA;GRAMD1C;PTCH1;SMO
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.434046070781264,0.9376714000538073,0.575,0.9464076166713672,1.0,2/14,8.52%,AK7;CMPK1
prerank,regulation of neuron migration (GO:2001222),0.4047333721525656,0.93757606390081,0.5783847980997625,0.9461440140752154,1.0,6/26,13.31%,MDK;NIPBL;IGSF10;COL3A1;NTNG1;NTNG2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.3663157638152119,-0.9375470764941872,0.5537974683544303,0.8897148995765658,1.0,3/11,12.10%,RNF185;BAG6;POMT2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2627744338827756,-0.93749971060428,0.5447761194029851,0.8876089598459007,1.0,11/36,17.68%,RASSF2;MOB1B;CALM2;PDGFA;TOM1L1;VEGFA;MRE11;PPP2R5A;ERRFI1;TNKS1BP1;NEK10
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.46435341660699664,0.9372636073894725,0.575880758807588,0.9463658854186779,1.0,2/12,3.07%,NR4A3;DOCK5
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.39058771704412915,0.9371924357391535,0.5844471445929527,0.9460331516399119,1.0,5/28,12.39%,RPS27A;UBA52;TAB2;NOD1;UBB
prerank,regulation of DNA damage checkpoint (GO:2000001),0.47291505201058825,0.9371912423601902,0.5720108695652174,0.9455460488116854,1.0,4/10,19.18%,WDR76;CCAR2;ETAA1;THOC1
prerank,hexose metabolic process (GO:0019318),0.3757557030505347,0.9370412405537039,0.5728813559322034,0.945404163288884,1.0,8/39,12.24%,ALDOA;SORD;HK1;PMM2;ALDOC;DCXR;GALK1;GALT
prerank,dicarboxylic acid transport (GO:0006835),0.3978139744450886,0.9365707895525281,0.5784543325526932,0.9459787096184796,1.0,8/28,20.05%,SLC13A3;SLC1A6;PDPN;SLC26A6;SLC25A10;ARL6IP5;SLC19A1;SLC25A22
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.47428630050221876,0.9364242309766297,0.5695652173913044,0.9458182719911807,1.0,2/10,11.50%,NEDD4;ATP1A2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.47088111949551453,0.9358182218326977,0.56,0.9467187521098651,1.0,1/10,2.86%,NEDD4
prerank,regulation of extracellular matrix organization (GO:1903053),0.43923434325871413,0.9357821369050587,0.5731225296442688,0.9463197059563665,1.0,4/15,17.28%,DDR2;AEBP1;EFEMP2;FAP
prerank,histone monoubiquitination (GO:0010390),0.4105265106839681,0.9355779726239938,0.5767386091127098,0.946278731594175,1.0,8/24,20.15%,PAF1;UHRF1;LEO1;CTR9;RYBP;DDB2;CDC73;DDB1
prerank,positive regulation of secretion by cell (GO:1903532),-0.2290814208214488,-0.9350308459238447,0.5957446808510638,0.8918909188261794,1.0,19/70,15.68%,DTNBP1;RAB2B;MYH10;P2RX4;FRMD4A;RAB9A;TGFB1;MYOM1;PPID;MYO18A;GOLPH3;ADAM8;ADAM9;APBB1;GRK2;RAB5A;KCNB1;STX1B;RAB3A
prerank,protein tetramerization (GO:0051262),0.35623453675986033,0.9348246584519996,0.6101694915254238,0.947590882482196,1.0,12/67,16.35%,THG1L;UPB1;B2M;SHMT1;ALDOA;APIP;AQP4;NUDT21;ACACA;SOD2;MS4A1;SAMHD1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3365736666053567,0.9347978753987309,0.6996996996996997,0.9471658978191714,1.0,32/268,12.06%,SLC6A19;SLC6A14;SCN4A;SLC36A3;KCNN4;ATP1B3;KCNJ10;SLC6A8;KCNQ5;SLC24A4;ATP2B4;KCNA4;ATP2A3;ABCB7;NALCN;SCN1A;SCN7A;MCOLN2;SLC11A2;TRPC5;ATP1A3;ATP1A4;ATP1A1;KCNC4;SLC39A6;ATP5MF;CACNA1H;KCNA1;ATP1A2;HCN3;FKBP1A;SCN8A
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3375331022743146,0.934250335823675,0.7107107107107107,0.9479155100067773,1.0,70/291,22.82%,NR4A3;MMP9;PRDX5;WNT6;STAP1;BRINP2;ACTB;NCF1;P2RY1;PDCD4;HMGB1;AHR;SHMT1;ATM;RPS3;LBP;ATP2B4;PAF1;HMGB2;MAPK9;CXCL10;TNIP3;TSHR;SLC26A6;BRINP3;LAMTOR4;GPLD1;VIM;AKAP6;DHX36;CDK2;PDE3A;ADCY6;SERPINE1;CPEB3;HCN3;MAPT;CHMP5;IRS1;CARD16;CTR9;FOXO1;DEFA6;WNT3;TIRAP;EZR;TICAM1;ABL2;NRIP1;TWF2;LILRB1;ACOD1;EPHA3;RORA;CDC73;SELENOS;IP6K2;CD14;SOX9;PLAA;ABCB4;ZNF35;TNIP2;RAPGEF3;MTR;EGR1;SH3BP4;RAP1B;P2RX7;WNT9A
prerank,cardiac cell development (GO:0055006),-0.37558781728081975,-0.933932494099529,0.5166666666666667,0.8925266537864494,1.0,3/11,11.09%,SLC8A1;VEGFA;NOTCH1
prerank,mitotic chromosome condensation (GO:0007076),0.39860556851618933,0.9337156371516934,0.5940828402366863,0.9486484990417533,1.0,6/26,13.61%,SMC4;NCAPG;CDK1;NCAPH;NCAPD3;TENT4A
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.34918031428117213,0.9334071554123531,0.6189495365602472,0.9488527781714141,1.0,22/80,20.84%,RIPOR2;AUTS2;PLPPR5;TENM2;ARPC2;CLRN1;RAC2;CDC42;FAM98A;GPM6A;NCKAP1;TGFB3;ACTR3;FNBP1L;CARMIL2;TWF2;CDC42EP3;CCDC88A;RALA;EPS8L1;CYFIP1;PALM
prerank,positive regulation of leukocyte migration (GO:0002687),-0.28494541412483787,-0.9330687670599687,0.5214723926380368,0.8927225647168106,1.0,2/27,0.45%,NCKAP1L;IL6R
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.33732007502889316,0.9327310610042883,0.729,0.9498353485788749,1.0,80/366,19.53%,TCF7;TBX21;SOX3;PRKCQ;ZNF395;SOX7;RUNX3;DAXX;MYBL2;FADS1;ATRX;TCF7L1;SMC3;ING2;PRRX2;EIF2A;AHR;RNF14;DAPK3;FBXO5;MYB;PFDN5;PRMT5;NR1D2;CREBL2;PPP2R1A;MSL3;NFYB;MLF1;RPS6KA5;NLK;UBE2L3;EIF2B4;RBM4B;PSPC1;OBI1;MED23;CCAR2;ACTR8;HP1BP3;GTF2IRD1;LIMD1;VHL;ERC1;CTR9;ATXN1;ATF4;MAGED1;PTP4A3;ARNT2;WWTR1;PPP2CA;APBB3;NCOA2;BAZ2A;RBAK;RFX3;DMTF1;PPARGC1B;EDF1;CEBPB;NFIL3;SOX11;RYBP;GPBP1L1;CCDC88A;HINFP;ATXN1L;NSD3;RPL10;RORA;ESCO1;LYL1;NAB2;ZFP37;MLXIPL;MLX;MLLT6;BNC2;SNAI2
prerank,negative regulation of cell growth (GO:0030308),0.3433153033198766,0.9326048539128678,0.649390243902439,0.9496221870792595,1.0,28/121,20.45%,PPP1R9B;HRG;RBBP7;RACK1;SIPA1;TGFB2;PPP2R1A;SPHK2;CCAR2;DACT3;MUL1;DNAJB2;BCL6;JADE1;HSPA1A;PPP2CA;SIRT1;SERTAD2;DCC;CDKN1A;GSK3A;ING1;NME6;MAP2;SLIT3;IP6K2;STK11;CCN3
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.2957343152165253,-0.9317826297031421,0.5767195767195767,0.8939440673465138,1.0,8/23,16.76%,CAB39;CALM2;IRGM;PRKAG2;TGFB1;APP;TNKS1BP1;WNK3
prerank,nuclear envelope organization (GO:0006998),0.41765357068688613,0.9317380171408841,0.5795601552393272,0.951071811970733,1.0,3/20,6.95%,CTDNEP1;SPAG4;LEMD2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.37640371158872754,0.9317364495345783,0.5759911894273128,0.950584852673121,1.0,7/42,9.55%,NDNF;ARL2;ECM2;RAC2;PDPN;JAK2;GCNT2
prerank,cellular response to BMP stimulus (GO:0071773),0.35637982662671414,0.9316542790002216,0.6135163674762407,0.950280893962264,1.0,16/66,19.83%,PDCD4;SMAD2;AMH;TGFB2;BMP4;BMP6;SLC33A1;SMAD1;TGFBR3;TGFB3;GDF3;USP15;RUNX2;RGMA;RGMB;SOX9
prerank,brain development (GO:0007420),0.34448883919053125,0.9314905517054108,0.6428571428571429,0.950130102373997,1.0,35/136,20.43%,EOMES;PBX1;AMIGO1;PTEN;UGP2;UFM1;HSPG2;NIPBL;COL4A1;SETD1A;MKKS;CNTNAP2;POU6F1;MFSD2A;TBC1D23;ZFHX2;CXCR4;MEIS2;ATXN1;EPHA7;ROBO2;ADGRL2;ARNT2;VPS51;CIC;AFF2;APOD;PAFAH1B1;PHGDH;SLC6A17;PBX2;EGR2;PBX3;PAFAH1B2;ABCB6
prerank,replication fork processing (GO:0031297),0.379841651554046,0.9313873159392526,0.5886363636363636,0.9498643731108583,1.0,18/38,29.18%,RTEL1;ATRX;ETAA1;BLM;DDX11;PCNA;SAMHD1;THOC1;ATR;ZGRF1;WRN;CENPX;TRAIP;EXD2;BRCA2;MMS22L;BOD1L1;RFWD3
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.42770895912255213,0.9313338735282357,0.5772787318361955,0.9494818467418057,1.0,6/17,21.97%,SEC61B;DERL1;OS9;SELENOS;FAF2;TMEM129
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.39833824511282645,0.9304802703740755,0.6062424969987995,0.9508731661685724,1.0,6/26,10.38%,TLR9;FLOT2;SMPDL3B;CD36;LGR4;APPL1
prerank,regulation of neurotransmitter transport (GO:0051588),0.4267042176875798,0.9304092334619521,0.5719844357976653,0.9505586509001113,1.0,2/16,3.53%,MCTP2;KCNMB4
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.34774491146836595,-0.9299524681616914,0.5740740740740741,0.8966129953084623,1.0,4/14,14.13%,LPIN2;SELENOI;LPIN1;CHKA
prerank,cellular response to glucagon stimulus (GO:0071377),0.4244786233107901,0.929867945586981,0.5968586387434555,0.9512903657146625,1.0,4/17,16.49%,PRKAR1B;ADCY6;PRKAR1A;ADCY1
prerank,regulation of phospholipase C activity (GO:1900274),0.4379701058031008,0.9296717802942341,0.5792922673656619,0.9512436516545462,1.0,4/15,17.97%,RASGRP1;KIT;ABL2;NTRK3
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.30566856418104105,-0.9293895968084159,0.5320197044334976,0.8958696749208708,1.0,5/20,13.35%,ADCY9;ADRA1A;ADRA1B;ADRB1;ADRB2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.41744262391827014,0.929384728226712,0.5717852684144819,0.9513980332692369,1.0,4/18,15.99%,ATP7A;PDP2;POR;ABL2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.374914913393799,-0.92931248153089,0.5800711743772242,0.8938632171982213,1.0,5/11,27.65%,BIN1;CACNB2;CAMK2D;CACNB1;NOS1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.38246026476219047,0.9292664615463097,0.5693348365276212,0.9511919765012793,1.0,14/35,23.62%,PPP1R15A;PPP1R12A;PTPA;PPP1R15B;FKBP1A;MASTL;CALM1;GSK3B;PPP6R1;HSP90AB1;ITGA1;CALM3;CRY2;HTT
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3489191835141191,0.9291260488889944,0.6356192425793245,0.9509957663926705,1.0,21/94,17.04%,CD24;BCL2;PPP1R15A;ATM;GSKIP;ATP2A3;SFN;ITPR1;CRIP1;CASP4;APAF1;ATF4;STK24;BCL2L11;LGALS12;MSH6;CDKN1A;CUL3;ARL6IP5;CEBPB;PPP1R13B
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.2995353521740348,-0.9288778138724257,0.5175879396984925,0.8927721099516475,1.0,4/22,3.46%,ROCK2;MEF2A;PARP1;P2RX4
prerank,regulation of neuron differentiation (GO:0045664),-0.22911070802890365,-0.9288423210517367,0.5348837209302325,0.8907000040339209,1.0,15/76,13.51%,ZFHX3;MEF2C;ZEB1;BIN1;TCF4;LRRK2;SIN3A;NREP;VWC2;EIF2AK4;CDK5RAP2;CDK5RAP3;CDK5RAP1;BDNF;NEPRO
prerank,interstrand cross-link repair (GO:0036297),0.36192122079208633,0.9286211166209584,0.6071817192600653,0.9516376954450705,1.0,9/53,14.55%,RPS27A;UBA52;ERCC4;USP1;FANCL;FANCD2;UBB;ERCC1;MSH6
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.41695046325443086,0.9285049487677461,0.5785536159600998,0.951416125080676,1.0,4/20,11.99%,PPIA;PPIH;PIN1;FKBP1A
prerank,membrane depolarization during action potential (GO:0086010),0.4019713634017315,0.9283557991603848,0.5959232613908872,0.9512530168884245,1.0,9/26,19.95%,SCN4A;SCN1A;SCN7A;CACNA1H;ATP1A2;SCN8A;CACNA1I;SCN3B;SCN1B
prerank,photoreceptor cell development (GO:0042461),0.44349653332822647,0.9279885879549321,0.5994694960212201,0.9515881223170942,1.0,3/14,8.60%,DCX;MFSD2A;ARL3
prerank,regulation of cellular pH (GO:0030641),0.3912799429925336,0.9279391112320222,0.5919335705812574,0.9512141371967424,1.0,5/29,9.59%,CHP1;SLC26A6;CLN3;ATP6AP1;ATP1A4
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.4211351495016894,0.9275778414959023,0.5693333333333334,0.9515656073223081,1.0,4/16,18.49%,MCM7;MCM2;BLM;MCM6
prerank,activation of protein kinase A activity (GO:0034199),0.4290165793683396,0.9273856133219579,0.5854304635761589,0.9514871522656771,1.0,4/16,16.49%,PRKAR1B;ADCY6;PRKAR1A;ADCY1
prerank,membrane assembly (GO:0071709),0.3803078208274957,0.927169698003144,0.5842044134727061,0.9514734319292258,1.0,9/34,17.26%,UGCG;PTEN;FLOT2;CHMP7;ANK3;UBXN2A;S100A10;GAK;CEL
prerank,cellular response to fluid shear stress (GO:0071498),-0.3523487855794696,-0.9271042883605272,0.5568181818181818,0.8931434947157146,1.0,7/12,26.95%,MEF2C;NFE2L2;MAPK7;KLF4;SREBF2;MTSS1;PKD2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.36821221446422425,0.9266334035099898,0.6100217864923747,0.9522377156676318,1.0,13/51,21.30%,PRKCQ;CCT8;CCT2;ATM;MAP3K4;CTNNB1;HMBOX1;NAF1;EXOSC10;STN1;ATR;HNRNPU;CTC1
prerank,pore complex assembly (GO:0046931),0.40922418447830367,0.9262144304833816,0.5876152832674572,0.9526792859428116,1.0,12/19,28.43%,PDZD11;AHCTF1;AFDN;P2RX7;NUP93;NUP205;NDC1;NUP153;TMEM170A;NUP98;TPR;RTN4
prerank,regulation of anoikis (GO:2000209),0.41412365860138184,0.9261506596916964,0.58125,0.9523432074492088,1.0,3/19,8.62%,BCL2;ITGB1;CAV1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.38496230782047336,0.925550289878868,0.6067285382830626,0.9531850299482019,1.0,3/29,6.47%,GATA3;PTEN;SPRY1
prerank,CENP-A containing chromatin organization (GO:0061641),0.3898445769928428,0.9254086210469592,0.6016260162601627,0.9525325181790943,1.0,6/29,15.65%,RBBP7;CENPH;KNL1;NASP;NPM1;RUVBL1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.3898445769928428,0.9254086210469592,0.6016260162601627,0.9525325181790943,1.0,6/29,15.65%,RBBP7;CENPH;KNL1;NASP;NPM1;RUVBL1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3487361149093466,0.9251279929019235,0.6157840083073728,0.9526587453542791,1.0,20/69,21.97%,DNAJB9;SEC61B;HSPA5;RNF103;UBE2G2;PSMC6;AMFR;UBQLN1;DNAJB2;EDEM1;ECPAS;UBE4A;DERL1;SGTB;OS9;TMEM67;SELENOS;FAF2;DNAJB14;TMEM129
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3405362127110368,0.9250799864169199,0.6561866125760649,0.9522747296634057,1.0,33/129,18.13%,PSMC3;SEMA5A;PSMD8;DAPK3;PSME1;PSMD6;GSKIP;PSMB5;PIN1;CAV1;PSMC6;CSNK1G1;SCEL;CCAR2;PSMB4;LGR4;ILK;COL1A1;PSMA7;PSMB9;PSMA6;USP34;UBR5;PSMC1;UBE2B;GPC3;RUVBL1;PSMD7;PSMD2;SMURF2;JUP;CSNK1G3;PSMD5
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3717566354048943,0.9239128648530776,0.6215909090909091,0.954323734169286,1.0,17/40,29.18%,RTEL1;ATRX;POLE;ETAA1;BLM;DDX11;PCNA;THOC1;ATR;TIMELESS;WRN;CENPX;TRAIP;EXD2;MMS22L;BOD1L1;RFWD3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3672863718243853,0.9238087920355368,0.6002277904328018,0.9540513366562212,1.0,9/37,18.39%,CD6;PDCD4;IL17D;APPL1;PLD3;TICAM1;TREM2;APOD;PER1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.3605236500558511,-0.9237557220068906,0.5447761194029851,0.8997441125544656,1.0,3/11,3.71%,LYN;CD300A;TNFRSF21
prerank,positive regulation of calcium ion import (GO:0090280),0.4441510444229266,0.9236779916790436,0.56884561891516,0.9538615931860452,1.0,2/12,12.84%,SPHK2;LGALS3
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.39109252058098937,0.9236088050697286,0.5970873786407767,0.9535359842570822,1.0,10/25,20.32%,CCL5;DSCAM;MIF;BTBD10;ILK;SDCBP;GLMN;PTGES3;PTH1R;SNCA
prerank,positive regulation of GTPase activity (GO:0043547),0.33655871093221973,0.9227063882779252,0.691,0.9550151853235894,1.0,27/188,11.22%,TBC1D10C;RASGRP1;CCL5;CCL7;RABGAP1L;F2R;PKP4;RASGRP2;FERMT2;RGS1;RGS8;RGP1;RACK1;ADPRH;PLXNB1;ITGB1;ARHGEF19;RALGAPB;TBC1D22B;SIPA1;MMUT;PIN1;MAPRE2;RAPGEF6;RABGAP1;RGS6;TBC1D2B
prerank,cellular response to pH (GO:0071467),0.4146201594893869,0.9223043682160343,0.5847568988173456,0.9553799561386174,1.0,3/17,13.19%,CHP1;GPLD1;GPR68
prerank,mRNA splice site selection (GO:0006376),-0.26925220996789045,-0.9221595410772548,0.5988023952095808,0.9016442311580602,1.0,13/30,23.91%,LUC7L;SFSWAP;LUC7L3;CELF2;SRSF9;CELF4;SF3A1;CELF5;KHDC4;ISY1;SRSF12;SETX;PUF60
prerank,sphingolipid biosynthetic process (GO:0030148),0.3520999463893202,0.9221423354182833,0.6452947259565667,0.9552626133600509,1.0,20/71,21.91%,SMPD1;SPTSSA;SPTLC3;PRKD2;PPM1L;SPHK2;ELOVL7;CERS4;ST8SIA5;ELOVL1;FA2H;ELOVL6;HACD1;DEGS1;SGMS1;HACD2;SPTLC2;ACER2;PRKD3;HACD4
prerank,positive regulation of cell adhesion (GO:0045785),0.34977634658952017,0.9213832005599901,0.6381647549530761,0.9564295635658381,1.0,11/74,9.03%,CCL5;NDNF;ARL2;ECM2;ATM;PRKD2;MDK;CHRD;CD47;TGFB2;JAK2
prerank,response to insulin (GO:0032868),0.34500753723216254,0.9212973277311185,0.6520833333333333,0.9561355317572102,1.0,19/80,19.25%,GCK;SORBS1;CEACAM1;HDAC9;RAB8A;ZBTB7B;GPLD1;SLC27A1;SYAP1;IRS1;FOXO1;SIRT1;EPM2AIP1;RPS6KB1;GSK3A;KAT2B;SLC25A33;SELENOS;C2CD5
prerank,circulatory system development (GO:0072359),0.3408998510358889,0.9208960398167468,0.6727456940222898,0.9565530619782082,1.0,18/118,12.85%,PDLIM1;HEG1;PDLIM2;HDAC9;TAB2;PTEN;HSPG2;TGFB2;MKKS;POU6F1;SMYD4;HEY2;MTHFD1;ID2;CRIP1;COL3A1;CDH5;AKAP13
prerank,regulation of mononuclear cell migration (GO:0071675),0.4033508455267693,0.920422245593474,0.5880923450789793,0.957092241989045,1.0,5/23,12.84%,CCL5;MDK;MSN;RARRES2;LGALS3
prerank,aorta development (GO:0035904),0.4385928047413951,0.920102148419517,0.599195710455764,0.9572948557469515,1.0,4/14,16.79%,ROBO1;ROBO2;EFEMP2;JAG1
prerank,chromatin disassembly (GO:0031498),0.4318305524664672,0.9200142700975574,0.5871559633027523,0.9565265691278348,1.0,3/14,6.55%,SMARCC1;SMARCD3;NFE2
prerank,nucleosome disassembly (GO:0006337),0.4318305524664672,0.9200142700975574,0.5871559633027523,0.9565265691278348,1.0,3/14,6.55%,SMARCC1;SMARCD3;NFE2
prerank,negative regulation of heart contraction (GO:0045822),0.4602002485033962,0.9198221992327746,0.5979827089337176,0.9564420745560814,1.0,3/11,11.50%,SPTBN4;SRI;ATP1A2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.4422617524025153,0.9195047069918837,0.5886332882273342,0.9566456059110393,1.0,3/13,7.67%,FUT9;MDK;ETS1
prerank,neuropeptide signaling pathway (GO:0007218),0.35004967838566436,0.9195007844286432,0.635483870967742,0.9561750799365669,1.0,13/58,26.07%,LTB4R;SORCS2;GPR84;SORL1;SORCS3;GLRB;NXPH2;GRP;AGRP;GPR149;NMU;CYSLTR1;NMUR2
prerank,protein deneddylation (GO:0000338),0.4649095425430696,0.9192665381192564,0.5817923186344239,0.9562080435050316,1.0,5/10,29.39%,COPS6;COPS3;COPS8;COPS4;COPS7B
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3406184124689424,0.9190405440189887,0.6505154639175258,0.9562095823284964,1.0,16/101,12.48%,CD6;PTPN22;CCL5;STAP1;PDCD4;HMGB1;LBP;PAF1;HMGB2;CXCL10;TNIP3;VIM;SERPINE1;CHMP5;CARD16;CTR9
prerank,RNA catabolic process (GO:0006401),0.36348804028636,0.9189544257151453,0.6078212290502794,0.9559108067398684,1.0,11/46,17.39%,ISG20;RNASE3;RNASE6;XRN2;METTL3;NUDT16L1;ZFP36L2;ZPR1;HSPA1A;NUDT16;LSM6
prerank,negative regulation of response to stimulus (GO:0048585),0.3549787446956794,0.9189443277232427,0.6315217391304347,0.9554510490387343,1.0,9/60,7.85%,SPINK5;CLU;CDK6;HHIP;FBXO5;BRAP;PDCD1;NR1H2;AQP11
prerank,response to cAMP (GO:0051591),0.3753062007816333,0.9187825528715333,0.5943181818181819,0.9553166404504222,1.0,7/37,22.34%,AHR;SLC26A6;AKAP6;HCN3;EZR;RAPGEF3;RAP1B
prerank,positive regulation of type 2 immune response (GO:0002830),0.4311676463855755,0.9187271606385182,0.5978112175102599,0.9549496374852837,1.0,3/14,14.16%,CD74;RARA;RSAD2
prerank,Golgi ribbon formation (GO:0090161),-0.34947315081752806,-0.9186415816408139,0.5477031802120141,0.908576037353918,1.0,4/13,10.44%,STX16;TRIP11;MYO18A;GOLPH3
prerank,transepithelial transport (GO:0070633),0.42442978505087336,0.9184054735502167,0.5897097625329816,0.9551834200824637,1.0,3/15,12.30%,SLC26A6;GPLD1;ABCC1
prerank,response to leucine (GO:0043201),-0.3670066804758158,-0.9180064371000769,0.5306122448979592,0.9058166542390549,1.0,6/10,30.07%,SESN1;MTOR;SESN2;LARS1;KLHL22;UBR2
prerank,cellular response to leucine (GO:0071233),-0.3670066804758158,-0.9180064371000769,0.5306122448979592,0.9058166542390549,1.0,6/10,30.07%,SESN1;MTOR;SESN2;LARS1;KLHL22;UBR2
prerank,endomembrane system organization (GO:0010256),0.33475895199095623,0.917589832888242,0.6861167002012073,0.9564651892417084,1.0,47/178,23.74%,ATP8B4;PLEKHF1;SRGN;SYNGR2;CTDNEP1;ALS2CL;HOOK1;TMED4;SPAG4;LEMD2;CSNK1A1;SYNE1;COG7;LAPTM4B;ANK3;LMAN2;LMAN1;CDC42;ARHGAP21;BNIP1;LNPK;VPS11;UBXN2A;VPS51;RAB2A;GAK;EIF2AK3;SYP;SNX33;HUWE1;STX17;ATL1;MIA3;SEC31B;USP50;ARL1;DNM1L;ZW10;PLEKHJ1;TANGO2;TBC1D20;TMED2;CLASP2;NUP93;TMED5;HTT;LEMD3
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3689640383422521,-0.9174568847944563,0.5573248407643312,0.9050418659369078,1.0,3/10,15.49%,SIRT7;ZNF692;DGKQ
prerank,lipid transport (GO:0006869),0.34237103372219324,0.9174112278865426,0.6443298969072165,0.9563603349600399,1.0,20/97,16.09%,ABCA4;ABCA13;CEACAM1;ABCG4;UGCG;APOE;LBP;ABCD3;SLCO3A1;MFSD2A;FABP5;SLCO1C1;CLN3;CD36;SLC27A1;ABCA7;NCOA2;ACSL1;ABCA2;PRELID1
prerank,protein import (GO:0017038),0.34282199549047737,0.917350296521216,0.6503642039542143,0.956022328701929,1.0,16/84,12.44%,PXMP2;PEX2;CLU;TOMM22;APOE;NUP50;ABCD3;PEX16;HSP90AA1;APPL1;NUP214;NXT2;HSPA4;PEX13;NUP88;MMP12
prerank,cilium assembly (GO:0060271),0.32975637707986016,0.9167987946903713,0.7367367367367368,0.9567060126108913,1.0,74/297,21.79%,ABLIM1;CFAP44;PLK4;FLNA;CENPJ;RAB8A;MKS1;BBS10;CCDC65;TMEM237;CFAP46;GORAB;DCX;RFX2;KIF24;CDK1;DYNLL1;PPP2R1A;CEP89;MKKS;IQCB1;PARVA;GSN;WDR90;ARL3;CFAP410;C2CD3;RAB11A;SPAG16;HSP90AA1;RILPL2;TMEM216;SCLT1;CEP19;WDR35;BBIP1;HYLS1;HAUS5;CFAP206;ACTR3;ARL6;IFT57;KIF3B;FNBP1L;DYNLRB1;CEP41;PCNT;PTPDC1;CCDC28B;B9D2;RFX3;PAFAH1B1;HAUS4;HAUS2;IFT22;CEP43;TMEM80;OCRL;LZTFL1;DNAAF3;TMEM67;NINL;SPATA6;CCDC13;CEP70;CNGB1;SSX2IP;HAUS3;CFAP70;PIBF1;IFT140;YWHAG;CDC14A;TUBB4B
prerank,protein palmitoylation (GO:0018345),0.38713338324417884,0.916677713554666,0.6174801362088536,0.956505010733088,1.0,12/30,25.43%,ZDHHC17;ZDHHC23;ZDHHC15;ZDHHC12;ZDHHC2;ZDHHC14;ZDHHC18;CLIP3;GOLGA7B;ZDHHC21;ZDHHC7;ZDHHC5
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4156421045814267,0.9165235854580693,0.5930087390761548,0.9563255178451368,1.0,6/18,18.52%,DDR2;PDPN;EFEMP2;CARMIL2;EMILIN1;COLGALT1
prerank,regulation of organelle assembly (GO:1902115),0.3505370574181535,0.9164696267915383,0.6424870466321243,0.9559673999192243,1.0,21/73,22.04%,TBC1D10C;CENPJ;NPRL2;ADPRH;TBC1D22B;MSN;GSN;ATG5;RABGAP1;TBC1D2B;TBC1D19;VPS11;NPM1;EZR;ATG3;RABEP2;TBC1D13;RDX;PDCD6IP;IFT140;TBC1D20
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.40063681055571365,0.9164468965790932,0.5997375328083989,0.9555477568080721,1.0,6/17,18.34%,PPIA;UBQLN1;SIRT1;SOD2;TREM2;P4HB
prerank,positive regulation of interleukin-1 production (GO:0032732),0.3532565342943077,0.9163941268267604,0.6443024494142705,0.9551804863623182,1.0,12/51,22.79%,TRIM16;HMGB1;MALT1;JAK2;CD36;PANX1;AGER;S100A13;USP50;TYROBP;EGR1;P2RX7
prerank,glutathione derivative metabolic process (GO:1901685),-0.2947725395814458,-0.9161332144111772,0.5686274509803921,0.9040524328837711,1.0,7/20,24.28%,HPGDS;AKR1A1;GSTZ1;GSTO1;GSTM1;GSTA4;MGST3
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.2947725395814458,-0.9161332144111772,0.5686274509803921,0.9040524328837711,1.0,7/20,24.28%,HPGDS;AKR1A1;GSTZ1;GSTO1;GSTM1;GSTA4;MGST3
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.35533821566471374,0.9159908447625885,0.6285714285714286,0.9555999356062534,1.0,11/57,15.87%,SOX7;F2R;HMGB1;GRAMD4;CYFIP2;MALT1;TNFSF10;NOD1;SIRT1;FYN;ARL6IP5
prerank,mononuclear cell differentiation (GO:1903131),0.395570565856548,0.9158470445397594,0.583232077764277,0.9554267765396122,1.0,8/24,17.78%,IL31RA;MT1G;BMP4;FLT3;BLK;TREM2;BATF3;LILRB1
prerank,COPII-coated vesicle budding (GO:0090114),0.3519928965430021,0.9155700146005735,0.646875,0.9555116945602278,1.0,22/68,22.50%,F5;F8;GRIA1;CTSZ;SEC22B;LMAN1;NSF;GOSR2;ANKRD28;SAR1B;CUL3;SEC24D;MIA3;TRAPPC4;CTSC;SEC31B;PREB;TRAPPC5;PPP6R1;TBC1D20;SEC24C;TMED2
prerank,regulation of cellular senescence (GO:2000772),0.3852609970997428,0.9153497324492492,0.5964071856287425,0.9555012199155157,1.0,5/28,5.26%,CDK6;NEK4;ING2;B2M;FBXO5
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.36139056881198395,-0.915173880651942,0.5480427046263345,0.9043803701819799,1.0,6/12,23.42%,CHEK2;RAD17;HUS1;STK33;ORC1;SETMAR
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3293760746563314,0.9147911687638197,0.7637637637637638,0.9562222414846677,1.0,102/336,23.78%,NUDT1;BCL2;RTEL1;RAD54L;USP3;PPP1R15A;NEK4;ERCC4;RAD1;RFC4;MCM7;TICRR;BID;FBXO31;XPC;ATM;RPS3;GADD45A;METTL3;NIPBL;BARD1;POLB;FOXP1;CDK1;CHCHD6;LIG1;WDR76;PARP3;SUSD6;DCUN1D5;SFN;PDS5B;APTX;CRIP1;NOP53;TAOK3;NABP1;BTG2;WDHD1;FANCL;RFC5;ETAA1;FOXO1;MASTL;BLM;BCL6;MAPKAPK2;NPM1;VCPIP1;ERCC1;POLK;RMI2;UBR5;CTLA4;USP45;SIRT1;MACROD2;DDX11;BCL2L11;MSH6;UBE2B;CDKN1A;SETD7;BLK;PAK1;PWWP3A;HELB;SAMHD1;USP28;SHPRH;BATF;HPF1;WDR48;CGAS;DDB2;OARD1;HINFP;MCL1;YY1;CCDC13;RBBP8;SMC6;DDB1;STK11;ATR;MSH2;ACER2;UBE2E2;TRIM28;TRIP12;DYRK2;VAV3;ERCC8;SPRTN;DDIT3;TIMELESS;XPA;FANCA;NCOA6;WRN;SMC5;NSMCE4A
prerank,neuron projection organization (GO:0106027),-0.32045236516670017,-0.9147262848276416,0.5732217573221757,0.9033149986611485,1.0,5/15,12.25%,LGMN;ABCD2;CHRNA7;APP;PICK1
prerank,response to chemokine (GO:1990868),0.4293874293134659,0.9141643813448244,0.5891891891891892,0.9570811745956685,1.0,1/13,0.37%,RIPOR2
prerank,fat cell differentiation (GO:0045444),0.35691511176023605,0.9140368541334963,0.6317460317460317,0.95687713863799,1.0,9/57,14.04%,NR4A3;ADIG;STEAP4;NR4A2;MKKS;PER2;NR4A1;FOXO1;SIRT1
prerank,regulation of actin filament-based process (GO:0032970),0.35023504158369706,0.9139375924132533,0.656670113753878,0.9566008566287133,1.0,18/70,18.67%,HRG;DLC1;IQGAP1;GPM6B;ARHGEF19;CELSR1;IQGAP2;RAC2;RHOC;ABRACL;ROCK1;EPHA5;EZR;PAK1;TWF2;EPHA3;CCDC88A;CORO1A
prerank,vasculature development (GO:0001944),-0.32734054138706153,-0.9137165548564276,0.5142857142857142,0.9037017962257136,1.0,2/16,2.70%,BMPR2;PIK3CA
prerank,glutathione metabolic process (GO:0006749),0.3626012667878951,0.9136450292192135,0.614190687361419,0.9567736086904778,1.0,4/38,8.83%,CNDP2;GPX1;GSR;CHAC2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.42180049758307103,0.9131082195830945,0.5933333333333334,0.9574419939625537,1.0,6/15,26.00%,CLU;GPX1;PRELID1;GHITM;PSMD10;IGF1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3663346812447993,0.9130898181951586,0.6148723640399556,0.9570083661328325,1.0,11/39,27.17%,GCK;AIMP1;DRD2;BLK;GRP;MCU;RBP4;SELENOT;AACS;MYRIP;TRH
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.389738733258681,0.9130350160197396,0.6207317073170732,0.9566494398842581,1.0,5/26,11.01%,CHP1;ATP2B4;AKAP6;CHERP;PRNP
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4653785233177142,0.9129404018584952,0.6071942446043166,0.9563690374022689,1.0,1/10,2.81%,NCF1
prerank,acylglycerol metabolic process (GO:0006639),0.3711614743455007,0.9129148415254169,0.6066134549600912,0.9559562383706441,1.0,6/37,9.29%,DGKA;APOC1;APOE;PLAAT3;CAV1;ABHD2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3765797597611027,0.912772336611282,0.6152954808806489,0.9557830331697029,1.0,6/33,10.38%,PTEN;PSME1;ATP2B4;PAF1;ID2;APPL1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.43114364272278627,0.9127155974966809,0.5943517329910141,0.9549822969595596,1.0,3/15,13.14%,BLOC1S3;AP3M1;AP3S2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.43114364272278627,0.9127155974966809,0.5943517329910141,0.9549822969595596,1.0,3/15,13.14%,BLOC1S3;AP3M1;AP3S2
prerank,ERAD pathway (GO:0036503),0.34057846178623696,0.912638950835871,0.643595041322314,0.9546690795900319,1.0,23/83,21.97%,DNAJB9;SEC61B;RCN3;HSPA5;RNF103;UBE2G2;PSMC6;AMFR;UBQLN1;DNAJB2;EDEM1;ECPAS;UBE4A;UGGT1;DERL1;SGTB;UBXN6;OS9;TMEM67;SELENOS;FAF2;DNAJB14;TMEM129
prerank,telomere maintenance via telomerase (GO:0007004),0.3874753252844787,0.9123600778734837,0.6063084112149533,0.9547571324734963,1.0,10/28,27.23%,RTEL1;CDK2;HSP90AA1;ANKRD28;PTGES3;GAR1;HSP90AB1;PPP6C;TERF1;TERF2IP
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4139620558194185,0.9122208783072466,0.6012738853503184,0.9545815155616947,1.0,8/17,23.10%,MDK;ID2;CXCR4;CLCF1;HES1;EGR2;TENM4;IL34
prerank,catecholamine metabolic process (GO:0006584),0.4387123870593801,0.91184659723613,0.6139154160982264,0.9548707873704552,1.0,2/14,15.34%,ATP7A;DRD2
prerank,prostanoid biosynthetic process (GO:0046457),0.4244736178328023,0.9115141760238853,0.6074270557029178,0.9550917409429255,1.0,4/15,11.34%,CD74;PTGDS;MIF;PTGES
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.33696252308207675,0.9113241777551866,0.6792260692464358,0.9550316717040653,1.0,24/113,17.28%,NR4A3;SEMA5A;KDR;PRKD2;MDK;HMGB2;PTPRN;CDH13;BMP4;NME1;NR4A1;BMP6;EGR3;JAML;PDCL3;MMP12;GRN;TNFSF12;SIRT1;FGF7;PPP1R16B;MYDGF;LAMB1;SOX11
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.42910528477313375,0.9113209666130243,0.577027027027027,0.9545677745933158,1.0,5/13,26.89%,CD74;AGPAT2;IFIH1;AXL;MAVS
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.4603500838482041,0.9110655360920493,0.600828729281768,0.9546316699227158,1.0,4/10,22.89%,NR1H2;MID1IP1;MLXIPL;SLC45A3
prerank,metallo-sulfur cluster assembly (GO:0031163),0.40051606590378847,0.9105594482625973,0.617906683480454,0.9552142753457383,1.0,6/22,14.80%,NFU1;ABCB7;CIAO1;HSCB;NFS1;CIAO3
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4220852050203444,0.9104978079171266,0.6026666666666667,0.9548779162546066,1.0,4/16,11.36%,NR4A3;AKAP6;IL6ST;ROCK1
prerank,glycerolipid catabolic process (GO:0046503),0.40891572150582073,0.910412050369221,0.6151930261519303,0.9546072803643377,1.0,5/19,17.87%,PRDX6;ABHD2;GDPD1;GDPD3;GPCPD1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3493139609401275,-0.9103263914944432,0.5862068965517241,0.9102516591676361,1.0,5/13,10.80%,TNRC6C;TNRC6B;CNOT7;POLR2G;TOB1
prerank,positive regulation of histone modification (GO:0031058),0.3790969289704853,0.9102923419777679,0.6441441441441441,0.9544120262812361,1.0,5/33,8.18%,ING2;ZBTB7B;PAF1;NIPBL;RPS6KA5
prerank,regulation of actin filament-based movement (GO:1903115),0.46358284408002637,0.9100446767743628,0.5956834532374101,0.9544660907437479,1.0,2/10,9.72%,PDPN;SRI
prerank,positive regulation of signal transduction (GO:0009967),0.3251671057144197,0.9099600164645578,0.7354709418837675,0.9541712029611232,1.0,32/238,12.33%,CD226;TEDC1;GATA3;LIMS2;TRIM16;CD74;SCIMP;SORBS1;FLNA;C3;CLEC6A;IL7R;CD63;VTN;PTEN;RPS3;PRKD2;ZBTB7B;TPD52L1;LMO3;ING5;TGFB2;TMEM108;BMP6;JAK2;TUBD1;ROBO1;ILK;IL6ST;ASXL1;SORL1;IRS1
prerank,amide transport (GO:0042886),0.39196614738908536,0.9099174527888413,0.6164705882352941,0.9537826033589503,1.0,6/26,19.20%,ABCA13;AQP11;PDPN;SLC27A1;SLC19A1;TAP1
prerank,regulation of microtubule-based movement (GO:0060632),0.44103473591599196,0.9097933498378369,0.5968882602545968,0.9535633081885567,1.0,3/11,18.27%,CCDC65;NEFH;MAP2
prerank,mRNA stabilization (GO:0048255),0.36461036895578974,0.9097652804315588,0.6410256410256411,0.9531603027663342,1.0,10/40,15.88%,ELAVL4;BOLL;PABPC1;SYNCRIP;YBX3;MAPKAPK2;TARDBP;TIRAP;TENT5A;ANGEL2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.40638482783169827,0.9097051916159199,0.608058608058608,0.9523637380003226,1.0,10/22,24.43%,ZDHHC23;ZDHHC15;ZDHHC12;ZDHHC2;ZDHHC14;ZDHHC18;CLIP3;GOLGA7B;ZDHHC21;ZDHHC7
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.40638482783169827,0.9097051916159199,0.608058608058608,0.9523637380003226,1.0,10/22,24.43%,ZDHHC23;ZDHHC15;ZDHHC12;ZDHHC2;ZDHHC14;ZDHHC18;CLIP3;GOLGA7B;ZDHHC21;ZDHHC7
prerank,protein localization to plasma membrane (GO:0072659),0.3321307592655598,0.9094120175917724,0.6846388606307223,0.9525114179542236,1.0,41/129,23.39%,ATP1B3;PLEKHF1;FLNA;TSPAN17;P2RY1;RAB8A;RAB3D;PRAM1;CDH1;FLOT2;SPTBN4;TTC7B;RAMP1;ANK3;RAPGEF6;RAB11A;BSG;ZDHHC23;ROCK1;TSPAN32;ZDHHC2;TNIK;KCNIP4;S100A10;EZR;GAK;RAP2A;ANK1;JUP;CCDC88A;AFDN;C2CD5;SCN3B;TTC7A;RDX;DLG1;DPP10;TMED2;EHD1;CLASP2;ACTN2
prerank,bile acid and bile salt transport (GO:0015721),-0.2962214006006677,-0.9093960205973207,0.5823529411764706,0.9103988369652929,1.0,2/24,1.64%,SLCO2B1;NCOA1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3380175563039969,0.9093703691154224,0.6765913757700205,0.9521403081602674,1.0,22/95,17.67%,RPS27A;FAM89B;UBA52;ASPN;ING2;DKK3;SMAD2;SPRY1;RNF111;PIN1;CAV1;TRIM33;FKBP1A;TGFBR3;UBB;HSPA1A;SIRT1;SDCBP;SNX25;SOX11;SMURF2;EMILIN1
prerank,positive regulation of vasculature development (GO:1904018),0.34255379231821925,0.9093211579636993,0.6718106995884774,0.9517787831116118,1.0,20/94,17.78%,ANGPT4;SEMA5A;KDR;ITGB1;PRKD2;STIM1;ETS1;HIPK1;PAK4;PDCL3;SERPINE1;CDH5;GRN;TNFSF12;SIRT1;ITGAX;CTSH;MYDGF;AGO2;JUP
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.45404221219579505,0.9091917431524813,0.6028368794326241,0.9515893537163599,1.0,3/11,19.03%,EXOSC4;FBL;EXOSC10
prerank,regulation of response to interferon-gamma (GO:0060330),0.4354891031356858,0.9090136222105901,0.597544338335607,0.9515140635491466,1.0,6/14,25.16%,IFNGR1;JAK2;PIAS1;HSP90AB1;JAK1;CDC37
prerank,positive regulation of lipid storage (GO:0010884),0.40305009860938423,0.9088456543583708,0.6276202219482121,0.9514136436482834,1.0,3/21,13.47%,C3;PLIN2;APOC4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3736464812670256,0.9086465598050332,0.6318181818181818,0.9513704855185594,1.0,9/35,20.73%,RFC4;POLB;LIG1;POLE;RFC5;POLG;PCNA;POLD4;MPG
prerank,tRNA metabolic process (GO:0006399),0.4118623164143044,0.9080762949603439,0.6135770234986945,0.9520822432034018,1.0,1/17,1.14%,THG1L
prerank,chondrocyte differentiation (GO:0002062),0.3784065287816379,0.9079064985941367,0.62877030162413,0.9519705620851145,1.0,11/32,23.49%,RUNX3;SOX5;BMP4;GPLD1;SNX19;EIF2AK3;RUNX2;SOX9;CCN3;NFIB;FGFR3
prerank,positive regulation of transporter activity (GO:0032411),-0.3494016721876442,-0.9071362648427922,0.5977859778597786,0.9139942914770073,1.0,8/13,40.99%,WNK3;NR1H3;SGK2;KCTD7;STK39;TRPC6;PDZK1;SYNGR3
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3858525460812729,0.9068429829759284,0.6300236406619385,0.9536773404465321,1.0,5/26,11.36%,ACTG1;WAS;CDC42;SYNPO2;ROCK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3762486944207597,-0.9067663906327081,0.5667752442996743,0.910580155165406,1.0,4/10,21.99%,WNK1;MAPK7;KLF4;MYADM
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3762486944207597,-0.9067663906327081,0.5667752442996743,0.910580155165406,1.0,4/10,21.99%,WNK1;MAPK7;KLF4;MYADM
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3865089195133741,0.9067517551291489,0.6366950182260024,0.9534189759553445,1.0,9/29,21.23%,YTHDF3;TTLL12;METTL3;MUL1;USP18;SAMHD1;RNASEL;NLRC5;HSP90AB1
prerank,negative regulation of histone methylation (GO:0031061),0.46176188175435,0.9059981024890619,0.6119828815977175,0.9544593883536726,1.0,3/10,14.11%,DNMT1;JARID2;WDR5
prerank,positive regulation of glucose import (GO:0046326),0.39295367204701903,0.9057941191063738,0.6254728877679697,0.9543989361903286,1.0,4/21,12.33%,SORBS1;CREBL2;APPL1;IRS1
prerank,protein autophosphorylation (GO:0046777),0.3302122825326792,0.9057760887972298,0.7069486404833837,0.9539735513580545,1.0,43/157,23.49%,ITK;CAMK4;DDR2;TXK;LMTK2;MELK;HTATIP2;KDR;DAPK3;PIM1;ATM;PRKD2;MEX3B;KIT;STK17B;JAK2;RIOK2;TAOK3;MAPKAPK3;FLT3;STK24;MAPKAPK2;STK4;TNIK;RIPK1;EIF2AK3;PAK1;IGF1R;STK26;AAK1;MARK3;STK11;ATR;GSK3B;ERBB4;DDR1;GRK5;FGFR1;STK10;SLK;INSR;ERN1;FGFR3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.4665432574186391,0.905766787674517,0.6053748231966054,0.953524934155393,1.0,2/10,4.89%,CCT8;CCT2
prerank,negative regulation of cell communication (GO:0010648),0.39288848034405716,0.9055147168616594,0.6199494949494949,0.9535793342532339,1.0,2/21,5.69%,HHIP;BRAP
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3430479819516568,0.9053280357649356,0.6757322175732218,0.9534731454741545,1.0,29/76,26.54%,ANGPT1;LAPTM5;MALT1;UBE2L3;DCUN1D5;CAV1;UBQLN1;FKBP1A;MUL1;UBB;CUL3;DCUN1D2;HUWE1;GSK3A;PIAS1;DERL1;WDR48;TNIP1;HDAC4;BIRC3;UBE2D1;SPRTN;FBXO4;CENPX;DCUN1D3;FBXW7;PSMD10;TANK;WFS1
prerank,cellular response to nitrogen compound (GO:1901699),0.4038804874959511,0.905260907200721,0.6221945137157108,0.9531545608170301,1.0,6/20,17.92%,DAXX;ATRX;ATP2B4;BLM;DDX11;RIOK3
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.3503173320028857,-0.9049139080668931,0.5923344947735192,0.9132099887520133,1.0,7/12,29.87%,CTSS;LMO2;KLF9;MED1;CTSL;BRD8;GAS2L1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3578583877609758,0.9046891746388358,0.6343042071197411,0.9538857420063753,1.0,12/46,24.12%,IL18R1;NR1H2;LAMA4;LGR4;ATF4;LNPEP;RHEB;STK11;ARRDC3;TLE3;DDIT3;IP6K1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.42523087507319707,0.9045447121161438,0.6083333333333333,0.9537280503794003,1.0,3/14,13.73%,AK7;CMPK1;ME1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.27181852170342685,-0.9043559521053963,0.6376811594202898,0.912384346761683,1.0,8/28,14.49%,SHLD1;SIRT7;SHLD2;KMT5B;PRKDC;PNKP;WRAP53;MRNIP
prerank,negative regulation of cellular senescence (GO:2000773),0.43474903474258775,0.904267764890407,0.607192254495159,0.9538452520812466,1.0,3/13,14.04%,CDK6;FBXO5;SIRT1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.31445240163236376,-0.9038768315490614,0.5771144278606966,0.9114282180303834,1.0,7/17,16.53%,ABL1;NRP1;BAIAP2;CDK5;BAIAP2L1;HCK;FES
prerank,intracellular lipid transport (GO:0032365),-0.2922768319286656,-0.9033405972545904,0.6363636363636364,0.9107110774972496,1.0,7/21,11.77%,PLEKHA8;ABCD2;CPT1A;PRKAA2;PRKAG2;NPC2;CERT1
prerank,lung epithelium development (GO:0060428),0.45126663432671144,0.9029037972724193,0.6146131805157593,0.9561616070591609,1.0,2/10,7.67%,RCN3;BMP4
prerank,outflow tract septum morphogenesis (GO:0003148),0.3848259008657492,0.9026693077041731,0.6066176470588235,0.9561828223774496,1.0,5/24,12.94%,TGFB2;BMP4;PARVA;ROBO1;ROBO2
prerank,regulation of protein modification process (GO:0031399),0.35385773007658183,0.902119400917139,0.6520787746170679,0.9568487936793272,1.0,15/50,20.80%,CCDC88C;CADM4;PIN1;CCAR2;NOP53;CDH5;PPP2CA;PPP1R16B;ABCA2;HPF1;KAT2B;CCDC88A;FKTN;ATG14;PPIB
prerank,protein deubiquitination (GO:0016579),0.3249590010468725,0.9020724466126865,0.755,0.9564830735678703,1.0,65/242,21.08%,RPS27A;GATA3;TFPT;ACTB;USP3;PSMC3;UBA52;PSMD8;USP42;SMAD2;PTEN;PSME1;PSMD6;PSMB5;BARD1;POLB;CDK1;TNIP3;USP1;PSMC6;PSMB4;USP46;ACTR8;NFKBIA;SMAD1;PSMA7;ASXL1;UBB;PSMB9;PSMA6;USP18;USP34;VCPIP1;DESI2;PSMC1;USP45;RIPK1;OTUD1;USP15;RUVBL1;USP32;USP49;PSMD7;PSMD2;ENY2;KEAP1;USP28;MBD5;IL33;KAT2B;SMURF2;WDR48;UCHL3;TNIP1;PSMD5;DDB2;MYSM1;USP50;YY1;PSMB6;ASXL2;BIRC3;UBE2D1;TAB1;TRAF3
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4315178078262667,0.9014004508947541,0.5951417004048583,0.9573844144852758,1.0,4/14,20.29%,EHHADH;ACOXL;ACOT8;HSD17B4
prerank,regulation of smoothened signaling pathway (GO:0008589),0.34484093985593595,0.9012732208885418,0.6311745334796927,0.9571972609913233,1.0,11/50,21.72%,TEDC1;HHIP;RACK1;TUBD1;GLI3;GPC3;GAS1;FBXL17;RORA;GLIS2;BTRC
prerank,histone lysine demethylation (GO:0070076),-0.28961037481491114,-0.9003274673135422,0.6379310344827587,0.9159737368343611,1.0,8/25,14.65%,PHF8;KDM7A;KDM2A;KDM4A;KDM2B;KDM3A;PHF2;JMJD1C
prerank,iron-sulfur cluster assembly (GO:0016226),0.38813002342460623,0.9002655671264791,0.6427688504326329,0.9588296336149454,1.0,6/24,14.80%,NFU1;ABCB7;CIAO1;HSCB;NFS1;CIAO3
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3410135249429075,0.9002631252543997,0.6772867420349434,0.9583721172557411,1.0,15/86,15.01%,RASGRP1;DLC1;ARHGDIB;ARHGEF18;RAF1;CADM4;SPRY1;TGFB2;JAK2;SPRY3;EPHB2;AKAP13;SHC1;DENND3;CRKL
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3691885281182406,0.9000374808261288,0.6354401805869074,0.9583658468425298,1.0,9/33,20.19%,CLP1;LSM11;CSTF2;SNRPG;NUDT21;CSTF3;SNRPB;SLBP;CSTF2T
prerank,cellular response to organic cyclic compound (GO:0071407),0.3303008507332721,0.9000351698446009,0.7082494969818913,0.9579099523332367,1.0,36/141,22.79%,NR4A3;CCL5;ACTB;DIAPH1;P2RY1;AHR;CDH1;GABRB1;MSN;UBE2L3;SLC26A6;AKAP6;ATP1A3;ATP1A1;PDE3A;ADCY6;CTNNB1;TFPI;ATP1A2;HCN3;BLM;EZR;ARL6IP5;ADCY1;NRIP1;JUP;RIOK3;GNAI1;RORA;CASP7;ABCB4;RAPGEF3;SPP1;EGR1;RAP1B;P2RX7
prerank,P-body assembly (GO:0033962),0.44717872609207354,0.8999047391910281,0.619550858652576,0.9577206033059713,1.0,5/12,23.81%,LSM3;LIMD1;LSM4;DDX6;RC3H1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4403517243152396,0.8998921186937351,0.5980528511821975,0.9572826797154489,1.0,1/11,0.35%,ANXA1
prerank,activation of protein kinase B activity (GO:0032148),0.37703450497076274,0.8995801286297409,0.6318874560375146,0.9574136958205011,1.0,2/29,4.57%,NRG1;PPIA
prerank,negative regulation of cellular protein localization (GO:1903828),0.36049439980336306,0.8995374192651657,0.6076833527357393,0.9570437273693438,1.0,10/34,23.39%,RIPOR2;GPM6B;MAPT;LEPROTL1;SNX33;ANKRD13A;LZTFL1;GSK3B;DNAJA1;ACTN2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.33089167198498787,0.8995255876927034,0.7089627391742196,0.956608671115947,1.0,40/146,21.84%,PLK4;CENPJ;PSMC3;PSMD8;FBXO5;PSME1;PSMD6;PSMB5;CDK1;DYNLL1;PPP2R1A;PSMC6;RAB11A;CDK2;PSMB4;CDC7;HSP90AA1;PSMA7;PSMB9;PSMA6;HAUS5;PSMC1;CEP41;PCNT;PSMD7;PSMD2;PAFAH1B1;HAUS4;GPR132;HAUS2;PSMD5;CEP43;NINL;CEP70;HAUS3;PSMB6;MECP2;YWHAG;TUBB4B;BRD4
prerank,histone mRNA metabolic process (GO:0008334),0.37898107065674097,0.8993210158783237,0.6330166270783848,0.9565407216001632,1.0,8/27,19.03%,EXOSC4;ATM;LSM11;SNRPG;ERI1;SNRPB;SLBP;EXOSC10
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4531384567360258,0.8989882248313826,0.6026011560693642,0.956751062520612,1.0,2/10,5.04%,F2R;PARD3
prerank,cellular response to lipid (GO:0071396),0.32581989117891175,0.8988839867979888,0.749748743718593,0.9565295155090029,1.0,47/191,20.75%,WNT6;STAP1;BRINP2;PDCD4;HMGB1;AHR;ATM;LBP;PAF1;HMGB2;MSN;CXCL10;TNIP3;UBE2L3;SPHK2;BRINP3;GPLD1;VIM;ATP1A3;ATP1A1;ADCY6;TFPI;SERPINE1;ATP1A2;CHMP5;IRS1;CARD16;CTR9;DEFA6;WNT3;TICAM1;ABL2;ADCY1;NRIP1;TWF2;LILRB1;ACOD1;EPHA3;GNAI1;RORA;CDC73;SELENOS;CD14;SOX9;PLAA;ABCB4;ZNF35
prerank,sphingolipid metabolic process (GO:0006665),0.33412316348093896,0.8987584851339596,0.6971544715447154,0.9563172396881906,1.0,31/108,21.13%,SMPD1;SPTSSA;SPTLC3;UGCG;PRKD2;PPM1L;ST6GALNAC3;PPP2R1A;ESYT2;SPHK2;ELOVL7;CERS4;B4GALNT1;CERKL;ARV1;ELOVL1;FA2H;ELOVL6;TEX2;PPP2CA;HACD1;DEGS1;ABCA2;SGMS1;ESYT1;SUMF1;HACD2;GLB1;SPTLC2;ACER2;PRKD3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.34853139886607754,-0.8987500784956965,0.6258992805755396,0.9178436062662692,1.0,4/11,17.58%,FXR1;WTIP;PUM2;STAT3
prerank,regulation of steroid metabolic process (GO:0019218),0.3931517202638853,0.8987069811874393,0.6306748466257669,0.9559731647463464,1.0,7/23,21.17%,APOE;ACADVL;ARV1;ABCA2;RORA;TTC39B;FMO5
prerank,regulation of filopodium assembly (GO:0051489),0.36782649560894776,0.8984323952960592,0.6252796420581656,0.9560714403263463,1.0,9/38,15.14%,RIPOR2;PLPPR5;TENM2;CDC42;GPM6A;TGFB3;FNBP1L;PPP1R16B;MYO10
prerank,receptor metabolic process (GO:0043112),0.34812678857034934,0.8984183890386112,0.6594124047878128,0.9556430691234483,1.0,16/53,21.03%,CXCR2;NEDD4;LMTK2;ITGB1;RAMP1;DNM3;CAV1;CD36;SNX25;ITGB2;LILRB1;MVB12A;SNCA;FCER1G;PLEKHJ1;NSG1
prerank,protein localization to chromosome (GO:0034502),0.36903079199459976,0.898290859051163,0.6508670520231213,0.9554359068420477,1.0,5/34,8.17%,ATRX;WAPL;LEMD2;CHMP7;PARP3
prerank,RNA processing (GO:0006396),0.32910066506828983,0.8980654959386128,0.7299196787148594,0.9554268056309653,1.0,47/176,21.45%,PPP1R9B;DEDD2;M1AP;SRPK1;CLP1;PRPF4;XRN2;METTL3;LSM3;ELAVL4;PPP2R1A;SNRPG;WBP4;RNGTT;SYNCRIP;CCAR2;NUDT21;PRPF8;MPHOSPH10;CSTF3;ATXN1;SF3B2;SF3B1;SF3A3;ZCRB1;SF3A2;TENT4A;SRSF7;HNRNPF;PPP2CA;KHSRP;TARDBP;RBM8A;SNRPB;SLU7;DROSHA;RBMS2;LSM6;ZRSR2;RBM5;THOC1;RNASEL;MBNL1;HNRNPU;LSM4;SRSF4;PRPF6
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3712510485541066,0.8972678067638004,0.6273364485981309,0.9565396673533764,1.0,2/33,2.81%,MMP9;NCF1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.33240115484396754,0.8972189959395211,0.6646090534979424,0.9561869693774669,1.0,23/101,16.39%,CD28;YTHDF3;CYFIP2;METTL3;UHRF1;NR1H2;MSN;RPS4X;EEF2;VIM;EIF4A3;HSP90AA1;CPEB3;NFKBIA;VPS11;NPM1;METTL14;SAMD4A;POLDIP3;EIF3E;EZR;RPS6KB1;NIBAN1
prerank,mitotic spindle assembly (GO:0090307),0.36032516682105,0.8971261719564373,0.6500553709856035,0.9559158248870046,1.0,20/42,31.04%,FLNA;SMC3;RACGAP1;RAB11A;KIF3B;AAAS;KIF11;KIFC1;PIBF1;WRAP73;CLASP2;TOGARAM2;RHOA;MZT1;ABRAXAS1;KIF2A;ARHGEF10;BCCIP;LSM14A;STAG2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3502755085337945,0.8969414334591714,0.6800422386483632,0.9558248594769003,1.0,8/61,10.01%,RTEL1;ATRX;HMGB1;TOX;RPS3;PRKD2;PARP3;DHX36
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3490185978148755,0.8969369441465775,0.6457446808510638,0.9553757359434687,1.0,7/50,8.62%,GTPBP4;CHP1;ADGRB1;FBXO5;RPS3;PER2;CAV1
prerank,positive regulation of axon extension (GO:0045773),-0.2963094535642441,-0.8969061081645141,0.6096256684491979,0.9203132727603209,1.0,6/22,9.87%,MACF1;SHTN1;ZFYVE27;NRP1;GOLGA4;VEGFA
prerank,positive regulation of response to stimulus (GO:0048584),0.36036916162514965,0.8967795102604234,0.636568848758465,0.9552163458209125,1.0,7/40,14.16%,GATA3;B2M;TGFB2;NSMCE1;ILK;SIRT1;RSAD2
prerank,glycerolipid metabolic process (GO:0046486),-0.3671760940252579,-0.8967043172544998,0.5822368421052632,0.9187072896927704,1.0,3/11,5.00%,DGKZ;PLA2G15;PIP5K1A
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.33027063881925056,-0.8960373197583027,0.5670498084291188,0.9183034030337194,1.0,5/15,15.43%,VEGFA;PAX8;PAX2;SOX8;AGT
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.44384278331239224,0.8957116185144206,0.6257142857142857,0.956887391957764,1.0,2/11,15.53%,AKAP6;TREM2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.40312403425594373,0.8955157619400773,0.6408977556109726,0.9568378328847762,1.0,7/19,21.94%,AEN;HIPK1;SIRT1;TMEM109;USP28;MSH2;DYRK2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.3831214479277152,0.8955091822708885,0.6225961538461539,0.956394765743091,1.0,5/27,17.78%,RANGRF;CAV1;SRI;CTNNA3;JUP
prerank,peripheral nervous system development (GO:0007422),0.3908791707269802,0.8955037455346226,0.6294536817102138,0.955948807001904,1.0,5/23,18.62%,ADGRB1;NFASC;SCN8A;SOX10;EGR2
prerank,regulation of cell morphogenesis (GO:0022604),0.3739581337563074,0.8954858880814163,0.6359499431171786,0.9555255104355004,1.0,8/30,14.84%,FERMT2;MFSD2A;CD44;PDPN;CFL1;NTNG1;NTNG2;PDZD8
prerank,histone deubiquitination (GO:0016578),0.40456802048347906,0.8954447960500931,0.6,0.9551465978586999,1.0,4/18,16.23%,USP3;USP15;USP49;ENY2
prerank,regulation of transposition (GO:0010528),-0.32711132497240186,-0.8954089867021459,0.5446808510638298,0.9178116760922006,1.0,6/13,30.07%,SIRT7;MYBL1;TEX15;DDX4;PIWIL2;UBR2
prerank,heterochromatin assembly (GO:0031507),0.4044975373596434,0.8952630976631566,0.6184895833333334,0.9550559148286513,1.0,11/20,30.88%,HDAC1;SIRT1;BAZ2A;HELLS;MBD2;EZH1;POLE3;H3-3A;NRDE2;ZNFX1;SMCHD1
prerank,response to purine-containing compound (GO:0014074),-0.3055605107900534,-0.895219742581398,0.6096491228070176,0.9162295073780473,1.0,4/17,15.49%,P2RY6;P2RX4;TRPM2;DGKQ
prerank,ureteric bud morphogenesis (GO:0060675),0.4171692104549141,0.8951202910868329,0.610079575596817,0.9548883058863744,1.0,2/16,7.67%,GATA3;BMP4
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.43535528743293106,0.894709229785837,0.6276150627615062,0.9552271001525016,1.0,3/13,12.13%,CBLB;RGPD1;RANBP2
prerank,organelle transport along microtubule (GO:0072384),0.3715925210501513,0.8946612146284829,0.6409666283084005,0.954866041610478,1.0,7/31,12.39%,UXT;CLN3;BICDL1;CDC42;MAPT;ARHGAP21;UBB
prerank,negative regulation of hormone secretion (GO:0046888),0.44688924556838,0.8946246262289098,0.615727002967359,0.9544826796678297,1.0,1/10,3.36%,RAB11FIP1
prerank,ceramide metabolic process (GO:0006672),0.3477874604409944,0.8942317650891439,0.65625,0.9547919468346895,1.0,11/49,15.68%,SMPD1;SPTSSA;SPTLC3;ST6GALNAC3;PPP2R1A;CERS4;FA2H;PPP2CA;DEGS1;ABCA2;SGMS1
prerank,cholesterol biosynthetic process (GO:0006695),0.37728969595038303,0.8941842177363795,0.648960739030023,0.9544448059322554,1.0,8/31,21.71%,LBR;HSD17B7;PMVK;ARV1;PLPP6;HMGCS1;ACAT2;MSMO1
prerank,post-translational protein modification (GO:0043687),0.3242725276621087,0.8941758032636826,0.8138138138138138,0.9540080094959191,1.0,105/332,27.28%,IGFBP7;F5;LGALS1;RNF7;C3;PRKCSH;PSMC3;RAB8A;KBTBD8;RBBP7;PSMD8;APOE;FBXO31;SDC2;PSME1;PSMD6;PSMB5;ASB5;CUL9;BMP4;ASB1;COPS6;FEM1C;PSMC6;FSTL1;ATG5;TIMP1;RAB11A;ZBTB16;PSMB4;BTBD1;KLHL21;PSMA7;ANO8;VHL;COP1;KLHL25;PSMB9;PSMA6;COPS3;EPAS1;FBXO41;RAB2A;PSMC1;WDR5;FBXL5;GPC3;CUL3;PSMD7;PSMD2;MIA3;SPARCL1;KEAP1;LAMB1;MFGE8;SOCS6;SCG3;SUMF1;UCHL3;PSMD5;DDB2;FBXO11;P4HB;FBXO10;ESCO1;UBE2F;COPS8;CKAP4;MXRA8;PTP4A2;SHISA5;DDB1;LMO7;PSMB6;UBA3;BTRC;SPP1;ERCC8;DCAF6;PSMA3;IGFBP4;FBXW9;MBTPS1;FBXO4;FBXL7;CHML;UBXN7;DCUN1D3;PSMB2;FBXW7;COPS4;PSMD1;KLHL20;PSMD10;SERPINC1;DDA1;VWA1;WFS1;FN1;FBXO44;DNAJC3;FBXW8;LTBP1;STT3B;PSMB3
prerank,mitochondrial fusion (GO:0008053),0.4031117810552225,0.894140771252806,0.6388888888888888,0.9536206005162258,1.0,1/18,1.14%,THG1L
prerank,digestive tract development (GO:0048565),0.36595000204654815,0.8937991229401,0.6505073280721533,0.95382802383393,1.0,5/33,9.92%,NIPBL;KIT;TGFB2;RARRES2;GLI3
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.3208433087632758,-0.8935327658240401,0.625,0.9182305989700503,1.0,3/15,5.61%,CAMK1;BAG3;XPO4
prerank,protein localization to cilium (GO:0061512),0.3666226623695596,0.8935133752772905,0.6337543053960965,0.9539148144563966,1.0,4/32,13.80%,TTC21A;ARL3;WDR35;ARL6
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4503171309324248,0.8932927489424349,0.6200564971751412,0.9539070063351506,1.0,4/10,19.16%,ACADVL;ETFB;ACADS;GCDH
prerank,cellular response to heat (GO:0034605),0.36465883301432733,0.8931726427847725,0.6384439359267735,0.9536811211082972,1.0,18/35,31.10%,DAXX;RBBP7;DHX36;HSP90AA1;MAPT;HSPA1A;SLU7;HSP90AB1;POLR2D;ZFAND1;IL1A;PDCD6;FGF1;TPR;TCIM;ATXN3;HSF1;CLPB
prerank,regulation of cellular protein localization (GO:1903827),0.34961900922276384,0.8931441927012927,0.6455266138165345,0.9532806884137696,1.0,11/45,15.06%,LCP1;PIN1;HSP90AA1;GPC6;CTNNB1;TRIM67;MAPT;VCPIP1;RALB;GPC3;ABCA2
prerank,cellular response to retinoic acid (GO:0071300),0.35938215769629944,0.8928707046480185,0.6618942731277533,0.9533699214194401,1.0,10/42,20.75%,WNT6;BRINP2;ATM;BRINP3;WNT3;ABL2;TWF2;EPHA3;SOX9;ZNF35
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.2974056721041053,-0.8928312842074434,0.6186046511627907,0.9178877393038666,1.0,5/18,14.18%,DTNBP1;LRRK2;SNAPIN;VPS18;RAB5A
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.35303396288896327,0.8927646022754105,0.6582694414019715,0.9531141023684759,1.0,9/50,16.92%,MMP9;RAF1;GPX1;CD44;SFN;CARD16;BEX3;MAP2K5;ARL6IP1
prerank,endoplasmic reticulum organization (GO:0007029),0.3381413840945124,0.892416372282814,0.6793650793650794,0.953335153174995,1.0,17/72,18.19%,TRAM1L1;GET1;SEC61B;LMAN2;LMAN1;PRNP;BNIP1;LNPK;VCPIP1;REEP1;GAK;EIF2AK3;WDR83OS;ATL1;MIA3;SEC31B;CYB5A
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3300533804387487,0.8923448590362235,0.7277327935222672,0.9530275438339404,1.0,21/138,14.43%,NR4A3;NCOR2;RARG;HDAC9;HDAC7;RARA;HDAC1;NR4A2;NR1H2;NR1D2;CCN2;NR4A1;NR6A1;GTF2H5;MED23;MED7;DR1;POLR2F;WWTR1;NCOR1;TAF6
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.33735232971998136,-0.8922937060702915,0.5851851851851851,0.9170529336172654,1.0,6/13,14.21%,PNPT1;CNOT8;CNOT7;GTPBP1;MOV10;ZC3H12A
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.3897179423438081,0.8921994763792874,0.6282853566958698,0.9528608285793703,1.0,2/21,6.96%,SLC18A2;ABCB7
prerank,cellular protein modification process (GO:0006464),0.31951378300375144,0.8919500700605714,0.926,0.952908824777362,1.0,220/983,20.61%,LCK;CD247;ANXA1;CD3G;B3GNT3;MAP4K2;PTPN22;P3H1;IGFBP7;RUNX3;F5;CAMK4;PLK4;LGALS1;RNF7;EVPL;C3;UST;PRKCSH;PIGH;HLCS;TXK;SRPK1;CDK6;PSMC3;LMTK2;MELK;RAB8A;NEK4;UBA52;KBTBD8;PDP2;PTPN13;RBBP7;RSKR;CDK8;BIRC5;ILF3;UGCG;CDK17;PPP2R2A;PPP1R12A;PSMD8;DAPK3;APOE;PIM1;FBXO31;PTEN;ADPRH;PRKAR1B;ATM;SDC2;CTDNEP1;PRKD2;PSME1;FUT9;DUSP5;RARA;PSMD6;PPM1L;MEX3B;MAN2A1;PSMB5;MAPK9;CSNK1A1;CDK1;TGFB2;PTAR1;ASB5;CUL9;PPP2R1A;PTPN12;PTPN9;DUSP6;BMP4;HIPK1;PTPRA;ASB1;COG7;STK17B;COPS6;FEM1C;UBL5;PARP3;RPS6KA5;NLK;UBE2L3;BIRC6;GRK6;PAK4;PSMC6;JAK2;FSTL1;PMM2;ATG5;GCNT2;TIMP1;ST3GAL1;RAB11A;FAM20A;ZBTB16;ST8SIA5;CDK2;PSMB4;DUSP2;PARP8;TAOK3;BTBD1;CDC42BPG;LOX;DDOST;GPAA1;ZAP70;ILK;MTM1;ROCK1;SIK3;KLHL21;HCST;SLC35A1;LCMT1;PSMA7;DUSP16;DCLK1;ANO8;VHL;COP1;KLHL25;NIM1K;ABCA7;PSMB9;STK24;COL3A1;PSMA6;MATK;MAPKAPK2;STK4;TESK2;PPM1M;COQ8A;COPS3;EPAS1;PTPN4;FBXO41;RAB2A;TNIK;PSMC1;PPP2CA;SIRT1;PADI4;MACROD2;WDR5;FBXL5;GPC3;EIF2AK3;CUL3;DUSP4;FYN;HIPK3;PKN1;PAK1;ZC3HAV1;ABL2;PSMD7;ATG3;MAP4K5;PSMD2;GSK3A;MIA3;PPP2R1B;CDK13;SPARCL1;KEAP1;STK26;LAMB1;PPP2R3A;PIGT;MFGE8;PPP3CB;CEL;SOCS6;MMP15;ALG1;BRAF;SCG3;SUMF1;CSNK1G3;UCHL3;PSMD5;DDB2;B3GNT2;METAP2;PARP10;FBXO11;P4HB;OARD1;CDC34;FNTB;FBXO10;UBE2F;AAK1;PTPRC;COPS8;MARK3;RNASEL;OGA;B3GALNT2;CKAP4;MXRA8;PTP4A2;SHISA5;DDB1;LMO7;CCNT1;ATG4B;STK11;PSMB6;UBA3;GSK3B;YWHAZ
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3975783038585573,0.8918211505192201,0.6380368098159509,0.9527198470486352,1.0,3/23,6.36%,H1-0;HMGB1;HMGB2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.32178324473782616,-0.8914739106712615,0.5702479338842975,0.9170386669566862,1.0,10/15,35.14%,DCTN2;CEP192;NEDD1;CCDC14;CEP83;SNX10;STIL;CEP131;SPAG5;HOOK3
prerank,endothelial cell migration (GO:0043542),0.36644463238076946,0.8911042530419483,0.6477146042363434,0.9537287056047523,1.0,12/37,20.45%,DPP4;CDH13;NR4A1;FSTL1;EGR3;CDH5;PTP4A3;TNFSF12;LGALS12;FAP;PLXND1;CCN3
prerank,protein ubiquitination (GO:0016567),0.320191873243237,0.8908146837366375,0.868,0.9538562190655532,1.0,102/471,19.11%,RNF125;RPS27A;RNF7;BCL2;NEDD4;SDE2;TSPAN17;PEX2;PSMC3;UBA52;KBTBD8;TRIM21;RNF14;PSMD8;FBXO31;RACK1;BRAP;PSME1;PSMD6;PAF1;UHRF1;UBE2H;PSMB5;BSPRY;BARD1;LEO1;RNF103;ASB5;RNF111;MKRN1;CUL9;UBE2G2;RNF157;TRIM24;ASB1;UBE2L3;BIRC6;PELI1;PSMC6;TRIM33;OBI1;DTX2;HERC6;NHLRC3;AMFR;PSMB4;CTNNB1;FANCL;KLHL21;PEX13;PSMA7;ZNRF3;MUL1;VHL;UBB;KLHL25;CTR9;PSMB9;VPS11;HECTD2;PSMA6;UBE2Z;TRIM68;VCPIP1;EPAS1;FBXO41;UBR5;PSMC1;SIRT1;LNPEP;FBXL5;UBE2B;CUL3;LONRF1;PCNA;PSMD7;ATG3;HUWE1;PSMD2;CHFR;FBXL17;KEAP1;UBE4A;SHPRH;RNFT1;AREL1;ZNRF2;DERL1;SMURF2;RNF152;UCHL3;PSMD5;DDB2;FBXO11;OS9;RNF135;CDC34;UBE3D;FBXO10;CDC73;SELENOS;MSL2
prerank,cytosolic calcium ion transport (GO:0060401),0.37468810156911314,0.8906832452186548,0.6264775413711584,0.9536651920692102,1.0,12/28,23.89%,ITPR3;SMDT1;ATP2A3;JPH4;CACNA2D1;SLC35G1;ATP2B3;JPH1;SLC25A23;MCU;JPH3;MCUB
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3232326336723302,0.8903483756306239,0.778,0.9538907606704623,1.0,42/224,20.66%,GABRP;MPZ;CAMK4;NPTX2;SLC18A2;HTR7;KCNMB4;GABRA4;KIF5A;PRKAR1B;GABRB1;GRIA1;HTR4;SLC12A7;PCDHB11;SLC1A6;DTNA;CACNB4;GABRG1;KCNC4;KCNA1;GPR176;SLC12A5;SLC12A4;GRIA2;PCDHB16;PRKAR1A;SDCBP;GLRB;GRM1;PAFAH1B1;PDE7B;CALM1;CEL;MBP;HTR1F;CAMKK1;GRIA3;GRIK2;SNCA;NPTX1;CACNA1B
prerank,chromatin remodeling at centromere (GO:0031055),0.37288770109869407,0.8903462667431954,0.6400462962962963,0.9534476422561845,1.0,7/31,18.83%,RBBP7;CENPH;KNL1;NASP;NPM1;RUVBL1;HELLS
prerank,excitatory postsynaptic potential (GO:0060079),-0.2959046722679871,-0.8902996253308326,0.589622641509434,0.9177182984227706,1.0,4/19,9.52%,MEF2C;LRRK2;ARRB2;GRIN2A
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3371302187167841,0.8898887865982137,0.7012320328542094,0.953872008616778,1.0,22/87,18.67%,HRG;DLC1;ARHGDIB;IQGAP1;GPM6B;DAPK3;ARHGEF19;MDK;CELSR1;IQGAP2;RAC2;RHOC;ROCK1;EPHA5;EZR;SEMA3E;PAK1;ABL2;TWF2;EPHA3;CCDC88A;CORO1A
prerank,axonal transport (GO:0098930),-0.2570658056116693,-0.8897218289931538,0.7565217391304347,0.9170776951631714,1.0,11/36,13.97%,SPAST;OPA1;DTNBP1;NEFL;DST;KIF3A;SYBU;DYNC1H1;SNAPIN;BLOC1S5;AP3B2
prerank,regulation of axonogenesis (GO:0050770),0.35500791769767076,0.8892556536301817,0.6772428884026258,0.954614265739206,1.0,18/51,25.00%,CHODL;AMIGO1;PTEN;PLXNB1;CHN1;PLXNA2;ROBO1;ROBO2;PAK1;TIAM1;PLXND1;LRP4;GSK3B;SLITRK1;LRRC4C;THY1;RHOA;LINGO1
prerank,regulation of endocytosis (GO:0030100),0.33981377146123704,0.8890139133762028,0.6737513283740701,0.9546355799670526,1.0,23/61,20.32%,SMPD1;APOE;CDH13;CALY;RAB5B;RUFY2;RAB5C;ROCK1;HIP1;STON2;ABCA7;LGALS3;GPC3;ABL2;SNX33;CLIP3;AP2S1;LILRB1;EPHA3;ARFGAP1;STON1;SNX12;SNCA
prerank,regulation of amyloid-beta formation (GO:1902003),0.3611911359113396,0.8889377627325586,0.656,0.9543407486029506,1.0,11/34,16.39%,CLU;APOE;IFNGR1;PIN1;PRNP;ROCK1;SORL1;ABCA7;ABCA2;SLC2A13;GSK3A
prerank,polyamine metabolic process (GO:0006595),-0.3327947664325822,-0.888861735171686,0.5807692307692308,0.9170565156914932,1.0,5/13,23.59%,SAT1;AMD1;HDAC6;HDAC10;SAT2
prerank,B cell mediated immunity (GO:0019724),0.4472346278808223,0.8888433828980844,0.6161616161616161,0.9540872055011218,1.0,1/10,1.89%,CD74
prerank,immunoglobulin mediated immune response (GO:0016064),0.4441317846780601,0.8882289542898931,0.637155297532656,0.9548316970838712,1.0,1/10,1.89%,CD74
prerank,cellular response to unfolded protein (GO:0034620),0.3777163734531149,0.8879821907751579,0.6448152562574494,0.9548775466963813,1.0,3/26,6.17%,DAXX;HSPA8;HSPA5
prerank,mRNA 3'-end processing (GO:0031124),0.33496832317580766,0.8874784068804182,0.6965020576131687,0.9553938614485766,1.0,28/78,25.48%,CLP1;PAF1;LSM11;LEO1;CSTF2;PABPC1;EIF4A3;NUDT21;PAPOLG;CSTF3;CDC40;SRSF7;POLDIP3;RBM8A;SLU7;SLBP;CDC73;THOC1;CSTF2T;GRSF1;SRSF4;POLR2D;RPRD1B;TUT1;PAPOLA;CPSF2;RPRD2;SRSF6
prerank,response to prostaglandin E (GO:0034695),0.44585153877249706,0.8874008395141553,0.6297335203366059,0.9550965740491748,1.0,2/10,12.07%,ADCY6;TGFBR3
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4493979591755456,0.8873570371247586,0.6068965517241379,0.9547307516387102,1.0,2/11,4.89%,CCT8;CCT2
prerank,N-glycan processing (GO:0006491),0.40172249288462525,0.8872802161533815,0.6305732484076433,0.9544275459121149,1.0,9/18,21.21%,PRKCSH;MAN2A1;ST8SIA5;GANC;GANAB;GNPTAB;MAN1A2;FUT8;ST8SIA6
prerank,positive regulation of protein depolymerization (GO:1901881),0.4373185550888523,0.8870161518951524,0.625169147496617,0.9544860192655582,1.0,3/11,16.08%,SEMA5A;KATNB1;STMN2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3517385689586621,0.8864584463993622,0.6492204899777283,0.9550830282517896,1.0,12/46,21.25%,TOMM22;DNAJC15;TOMM7;HK1;TIMM9;TIMM17B;TIMM10;TIMM17A;TSPO;RALA;TIMM22;MFF
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3385742472237421,0.8857050212349552,0.6810982048574445,0.956105974090061,1.0,14/65,19.30%,ANGPT4;NDNF;LMNA;NOP53;HP1BP3;UBQLN1;CARD16;SUV39H2;EPAS1;SIRT1;NDRG1;P4HB;RORA;BNIP3
prerank,modified amino acid transport (GO:0072337),0.42203837117475096,0.8855579472552431,0.6567741935483871,0.9559274732420794,1.0,2/15,8.65%,SLC6A8;PDPN
prerank,RNA polyadenylation (GO:0043631),0.3742927842977692,0.8854523479282846,0.6377491207502931,0.9552289549977521,1.0,11/26,24.77%,CLP1;PAF1;LEO1;PABPC1;PAPOLG;CSTF3;CDC73;GRSF1;TUT1;PAPOLA;CPSF2
prerank,mRNA polyadenylation (GO:0006378),0.3742927842977692,0.8854523479282846,0.6377491207502931,0.9552289549977521,1.0,11/26,24.77%,CLP1;PAF1;LEO1;PABPC1;PAPOLG;CSTF3;CDC73;GRSF1;TUT1;PAPOLA;CPSF2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3282506463225993,0.8853363433245972,0.6923076923076923,0.9550089593266335,1.0,15/88,14.89%,NRG1;CLU;BID;RACK1;RPS3;MPP7;RHOC;SYNPO2;SNF8;CDH5;LGALS3;ERCC1;BCL2L11;SDCBP;TIRAP
prerank,regulation of presynapse assembly (GO:1905606),0.4026499867810237,0.8850862502391215,0.631917631917632,0.9545950358845198,1.0,7/18,27.60%,SLITRK2;GPC6;SNCA;SLITRK1;PTPRD;EIF4G1;IL1RAPL1
prerank,regulation of presynapse organization (GO:0099174),0.4026499867810237,0.8850862502391215,0.631917631917632,0.9545950358845198,1.0,7/18,27.60%,SLITRK2;GPC6;SNCA;SLITRK1;PTPRD;EIF4G1;IL1RAPL1
prerank,embryonic axis specification (GO:0000578),0.4087524282935626,0.8847101964433842,0.631578947368421,0.9548941872094902,1.0,4/15,27.13%,SMAD2;SMAD6;PTCH1;TASOR
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.37961786376869383,0.8846706024926457,0.6346153846153846,0.9545226406399105,1.0,6/25,17.01%,ATP1B3;ANK3;DMD;NDUFA4;TCAF1;ATP1B2
prerank,protein depolymerization (GO:0051261),0.37852542052877153,0.8844411914547265,0.6516587677725119,0.9545091385292421,1.0,7/27,16.94%,KIF24;GSN;CFL1;DSTN;KATNB1;STMN2;TWF2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.33567628441490655,-0.8841880141700079,0.5905172413793104,0.9262765976621479,1.0,5/14,16.01%,PIK3CA;NRP1;PIK3CD;VEGFA;VEGFB
prerank,response to ATP (GO:0033198),-0.2963400211799646,-0.8839428310680791,0.6079295154185022,0.924774291624318,1.0,2/18,3.46%,P2RY12;P2RX4
prerank,steroid biosynthetic process (GO:0006694),-0.22166463308358442,-0.8838352204058121,0.7647058823529411,0.922960995855266,1.0,22/56,28.19%,OSBPL9;OSBP;SCP2;PRKAG2;PRLR;CYP27A1;CH25H;OSBPL7;CYP51A1;SC5D;LSS;OSBPL3;INSIG2;FDXR;DHCR7;DHRS11;TM7SF2;SLC27A2;AMACR;SRD5A1;INSIG1;STAR
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.35957302687711307,0.8836576854323992,0.670045045045045,0.9555372980808279,1.0,8/40,12.33%,NEK4;ING2;FBXO5;NSMCE1;WDR76;USP1;MAPT;ETAA1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.38969893878491635,0.8835148642965652,0.6507177033492823,0.95536820129825,1.0,5/21,11.62%,PTPN22;STAP1;FOXP1;ELF1;PAX5
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.33567049057526327,0.8834223243614884,0.6916578669482577,0.9550945010795422,1.0,12/70,16.39%,DEDD2;BCL2;DAXX;BID;TGFB2;HIPK1;JAK2;APPL1;TNFSF12;RIPK1;DCC;GSK3A
prerank,cellular response to hydroxyurea (GO:0072711),0.444341386140879,0.8833821368449521,0.6454413892908828,0.9547324880402481,1.0,3/10,14.10%,ATRX;BLM;DDX11
prerank,regulation of cellular response to stress (GO:0080135),0.3251943738986886,0.8832934975421175,0.717896865520728,0.954461180862146,1.0,38/115,24.01%,CHORDC1;DNAJB1;NEK4;HSPA8;ING2;CHCHD2;ATM;NUP50;HSPH1;CLN3;AMFR;CCAR2;HSP90AA1;NUP214;NUP210;MAPT;NUP88;RANBP2;ATF4;MAPKAPK2;MANF;NPM1;HSPA1A;SIRT1;AAAS;CEBPB;CRYAB;PTGES3;MCL1;BAG1;ATR;GSK3B;HSP90AB1;NUP62;NUP93;NUP205;NDC1;DNAJC7
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3375721010084695,0.8829525288681237,0.6854166666666667,0.9546505222730095,1.0,21/72,21.07%,CLU;HSPA8;APOE;PFDN5;IAPP;MID1IP1;PFDN1;CDH5;TREM2;KATNB1;STMN2;PFDN4;CRYAB;TWF2;CLIP3;EMILIN1;MAP2;CORO1A;LDLR;SNCA;VBP1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.35019909072292454,-0.8829191036088782,0.5821917808219178,0.9229774097139347,1.0,6/11,17.32%,MTOR;SIRT7;NOL11;PIH1D1;IPPK;SMARCB1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.39152367239457997,0.882902065123811,0.6271604938271605,0.9542984311184117,1.0,6/20,20.56%,BCL2;APPL1;DCC;GSK3A;MCL1;GSK3B
prerank,nucleotide metabolic process (GO:0009117),0.37763006851216796,0.8828598199106152,0.6253041362530414,0.9539429826773893,1.0,4/23,13.73%,AK7;CMPK1;REXO2;ME1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3620575058131358,0.882728530004145,0.6417050691244239,0.9537710300423664,1.0,6/33,11.17%,HRG;DPP4;PLAU;TGFB2;JAM3;SERPINE1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.33884883877097155,0.8826468842679224,0.6968085106382979,0.9534989554936204,1.0,15/65,17.67%,RPS27A;FAM89B;UBA52;ASPN;SMAD2;SPRY1;PIN1;CAV1;FKBP1A;UBB;HSPA1A;SIRT1;SNX25;SMURF2;EMILIN1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.27311449055779524,-0.8824929224712247,0.6153846153846154,0.9219073415574864,1.0,8/29,24.79%,SMAD7;TGFB1;TPM1;NOTCH1;PKP2;S1PR1;ENG;ZFPM1
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.25771568791736765,-0.8819264162411935,0.6666666666666666,0.9211393273730559,1.0,9/32,13.74%,FOXO3;PUM3;GEMIN5;EIF4E;NOLC1;APP;PICALM;ATXN2;PRKCD
prerank,mitochondrial fission (GO:0000266),0.4050195018075321,0.8814742626804914,0.6370757180156658,0.9553067721803084,1.0,7/16,23.73%,MTFR2;DNM3;MUL1;MTFR1;DNM1L;MFF;GDAP1
prerank,carbohydrate homeostasis (GO:0033500),0.33726085773458603,0.8812410869475671,0.689873417721519,0.9553187189090703,1.0,20/67,26.93%,GCK;RPS6;PYGL;IRS1;IGF1R;BACE2;MBD5;CRTC2;MLXIPL;STK11;ADIPOR2;MCU;RBP4;SELENOT;CRY2;INSR;ADCY8;WFS1;PPARG;CYB5R4
prerank,maturation of 5.8S rRNA (GO:0000460),0.40869399271633594,0.8811871890439401,0.6456996148908858,0.9549819949472137,1.0,6/17,19.03%,EXOSC4;NSA2;FTSJ3;RRP15;WDR12;EXOSC10
prerank,visual perception (GO:0007601),0.3335324578167963,0.8808146401234217,0.710929519918284,0.9552659003815548,1.0,3/84,1.47%,ABLIM1;COL18A1;SFRP5
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3931364698329457,0.8807169864124454,0.6434010152284264,0.9550066141409133,1.0,11/19,32.43%,CHMP5;CCSAP;HSPA1A;HNRNPU;PDCD6IP;TPR;VPS4B;CHMP1A;CHMP2A;CEP97;EML3
prerank,epithelial tube morphogenesis (GO:0060562),0.3608994362257056,0.8806806693134092,0.6628440366972477,0.9546282970983474,1.0,5/32,10.71%,GATA3;PRKD2;COL4A1;BMP4;CTNNB1
prerank,programmed necrotic cell death (GO:0097300),-0.2945116858830049,-0.8805919996844679,0.6509433962264151,0.9223119993214546,1.0,9/18,18.30%,TLR4;LY96;TLR3;CYLD;PGAM5;TRPM7;TICAM2;IPMK;ITPK1
prerank,clathrin coat assembly (GO:0048268),0.40963154220764264,0.8805587130995071,0.6442953020134228,0.9544126449901966,1.0,6/15,21.03%,FCHO1;CALY;HIP1;NSG2;AP2S1;NSG1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.34661279924823274,0.8803705561197879,0.6922234392113911,0.9543296427980811,1.0,11/54,18.27%,TRAF1;LAPTM5;RACK1;HIPK1;CASP4;CARD16;SHARPIN;HSPA1A;RIPK1;CLIP3;CPNE1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.4385648087384535,0.8802370315299367,0.6327433628318584,0.9541514329323172,1.0,3/10,19.29%,SIGIRR;MAP2K5;PTPRC
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.40398874470842316,0.8801138060097885,0.6606217616580311,0.9539353827032846,1.0,3/18,6.04%,ITGA4;HMGB1;MDK
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3849459611090284,0.8798163905952926,0.6607565011820331,0.9540925366765539,1.0,13/25,27.33%,SHMT1;GART;MTHFD1;GMPR2;AMPD3;HPRT1;GMPS;APRT;SHMT2;PRPS2;PRPS1L1;PRPS1;DCK
prerank,zinc ion transport (GO:0006829),-0.29477056535743756,-0.8797718414224865,0.6359223300970874,0.9222090339142083,1.0,8/21,19.39%,SLC30A4;SLC30A5;SLC39A13;TRPM2;SLC39A8;SLC39A3;SLC30A1;SLC39A11
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3240132876877083,0.8794557629442958,0.7153061224489796,0.9543414963815384,1.0,24/107,19.04%,DNAJB9;BCL2;ERP44;PPP1R15A;RCN3;EIF2S1;UFM1;HSPA5;ATP2A3;ITPR1;CASP4;NCK1;PPP1R15B;UBQLN1;ATF4;BCL2L11;EIF2AK3;NIBAN1;CEBPB;DERL1;UBXN6;P4HB;OS9;SELENOS
prerank,regulation of cilium movement (GO:0003352),0.44612453360377413,0.8791695815035178,0.6407624633431085,0.9544535080701019,1.0,3/10,17.88%,CCDC65;CFAP206;DNAH11
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3807166551886805,0.8790564084160369,0.6415094339622641,0.9542262901924329,1.0,6/23,17.66%,DKK3;SMAD2;TRIM33;TGFBR3;SOX11;SMURF2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.32984155322335573,0.8788555911083492,0.7131147540983607,0.9541664823446501,1.0,28/80,27.04%,ANGPT1;LAPTM5;RPS2;MALT1;PIN1;UBE2L3;DCUN1D5;CAV1;UBQLN1;FKBP1A;UBB;CUL3;DCUN1D2;HUWE1;GSK3A;DERL1;BMI1;BIRC3;UBE2D1;ARRDC3;SPRTN;FBXO4;CENPX;DCUN1D3;FBXW7;PSMD10;WFS1;PDCD6
prerank,regulation of cell size (GO:0008361),0.375639470146099,0.8782806772163175,0.6579572446555819,0.9548026244282191,1.0,12/23,28.05%,RARG;PTEN;MSN;LAMTOR4;EZR;RDX;VAV3;RHOA;PLEK;RAP1GAP2;RPTOR;MTPN
prerank,negative regulation of cell junction assembly (GO:1901889),0.3703931653444672,0.8782607861102201,0.6378698224852071,0.9543984704613963,1.0,7/25,19.05%,DLC1;PTEN;ROCK1;ROBO2;APOD;ARHGAP6;SLIT1
prerank,negative regulation of signaling (GO:0023057),0.36782009283693023,0.8782498011409235,0.6365824308062575,0.9539823699160721,1.0,2/25,5.69%,HHIP;BRAP
prerank,lysosome organization (GO:0007040),-0.2498571488318363,-0.8780528754520783,0.6666666666666666,0.9242510678216117,1.0,14/36,20.46%,MYO7A;TPP1;LRRK2;MTOR;ACP2;CLVS1;HPS1;AKTIP;SNAPIN;VPS18;CLN6;ABCA1;TFEB;ATP10B
prerank,positive regulation of JUN kinase activity (GO:0043507),0.38725931803747016,0.8779091096865559,0.6698113207547169,0.9541717573087458,1.0,5/23,15.52%,TLR9;RPS3;MAP3K4;TAOK3;PAK1
prerank,histone H3-K9 demethylation (GO:0033169),0.4337852365888255,0.8777171923040717,0.6267806267806267,0.9541098326429025,1.0,3/11,10.71%,HR;KDM4C;KDM3B
prerank,organelle disassembly (GO:1903008),-0.24800163448823023,-0.8776630805439898,0.6737588652482269,0.923083441441616,1.0,11/33,18.52%,RETREG1;STX5;KIF5B;ULK1;PLK3;GFM2;MTIF3;MCTS1;ULK2;ATG2B;UFL1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.42435722534862524,0.877126696071723,0.6349862258953168,0.9547973899936277,1.0,3/12,17.99%,STARD3NL;CACNA1H;TSPO
prerank,positive regulation of tissue remodeling (GO:0034105),0.4448985644147206,0.8768825826796568,0.6260744985673352,0.9548285861071982,1.0,1/10,0.59%,HRG
prerank,organic hydroxy compound transport (GO:0015850),-0.25358289393591205,-0.8768522619911001,0.6917293233082706,0.922995291893894,1.0,5/36,9.28%,SLCO2B1;NCOA1;OSBP;NPC2;ABCC4
prerank,mismatch repair (GO:0006298),0.3717380900217425,0.8768421747989794,0.657074340527578,0.9544610330827733,1.0,8/27,20.68%,XPC;LIG1;ERCC1;MLH3;MSH6;PCNA;POLD4;MSH2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.37084381962646706,0.8766681195979641,0.6489988221436984,0.954329026756364,1.0,8/28,18.27%,ARL2;MAPRE2;MAPT;PRUNE1;MAP1B;STMN2;MAPRE3;MAP2
prerank,necroptotic process (GO:0070266),-0.3079384172066746,-0.876585909090014,0.6561085972850679,0.9216527383460623,1.0,9/16,18.30%,TLR4;LY96;TLR3;CYLD;PGAM5;TRPM7;TICAM2;IPMK;ITPK1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.26606871300654905,-0.8765595584644352,0.6848484848484848,0.9196832822138963,1.0,13/26,25.07%,DLG4;LRRK2;CHRNA7;SHANK1;APP;STX1B;SHANK3;MTMR2;PTK2B;CUX2;CBLN1;SLC8A2;NLGN2
prerank,intracellular cholesterol transport (GO:0032367),-0.3140485131897165,-0.8759275320230101,0.6192468619246861,0.9192031746569077,1.0,5/15,17.24%,RELCH;OSBP;NPC2;LRP6;ABCA1
prerank,response to growth factor (GO:0070848),-0.24491384977359182,-0.8755416387887521,0.75,0.9181467057287491,1.0,5/41,5.57%,TGFBR1;BMPR2;HTRA2;ACVR1B;TGFBR2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.34610269317451714,0.875428244108243,0.6821120689655172,0.9562462178300926,1.0,11/48,16.47%,LIMS2;FLNA;DOCK5;FERMT2;MDK;CDC42;ILK;S100A10;CRKL;CSPG5;NEDD9
prerank,negative regulation of protein kinase activity (GO:0006469),0.3280572711107833,0.8752394087496087,0.7194244604316546,0.9561444244069096,1.0,24/88,21.94%,DBNDD1;CHP1;CEACAM1;RTRAF;SMCR8;PPIA;GADD45A;GSKIP;TARBP2;CAV1;SFN;SRCIN1;SORL1;NPM1;WWTR1;CDKN1A;GNAQ;CEP43;PTPRC;MVP;SNCA;TAB1;YWHAG;DUSP3
prerank,regulation of plasminogen activation (GO:0010755),0.42941647961847595,0.8750649006099372,0.6526019690576652,0.9560322744783375,1.0,3/12,11.17%,CLEC3B;CTSZ;SERPINE1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3344291387990904,0.874150750529442,0.691817215727949,0.957236723257239,1.0,17/62,21.40%,AFF4;NELFCD;PAF1;LEO1;GTF2H5;ELOF1;CTR9;POLR2F;PCID2;TCEA1;CDK13;EAF2;CDC73;MLLT3;CCNT1;MLLT1;POLR2D
prerank,sensory perception of pain (GO:0019233),0.3842196091441884,0.8736046646202675,0.6452410383189122,0.9577891601910309,1.0,1/21,0.51%,CCR2
prerank,autophagosome maturation (GO:0097352),0.36703900992992405,0.8735720351387429,0.6632064590542099,0.9574100875570781,1.0,13/32,22.95%,MAP1LC3A;CLN3;UBQLN1;LIX1;STX17;TECPR1;CALM1;LAMP2;VIPAS39;ATG14;VPS16;GABARAP;MAP1LC3B
prerank,protein localization to nucleus (GO:0034504),0.32322269506735285,0.8731536749038826,0.736734693877551,0.9577243077205596,1.0,18/102,12.55%,RPL11;LMNA;ARL2;CTDNEP1;GBP2;PAF1;NUP50;BMP4;ARL2BP;APPL1;NOP53;NUP214;NXT2;COL1A1;NUP88;NOL8;MMP12;ABCA7
prerank,negative regulation of defense response (GO:0031348),0.3286564989156238,0.872884644541631,0.6978193146417445,0.9577966364126129,1.0,16/77,21.47%,FPR2;GATA3;TRIM21;APOE;SMPDL3B;MUL1;CDH5;SHARPIN;TNFAIP6;MAPKBP1;ACOD1;RORA;SELENOS;AOAH;CCN3;NLRC3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3778013020127576,0.8726258006143548,0.6546762589928058,0.9578213251520923,1.0,2/25,2.23%,HRG;STAP1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3355690011253491,0.8725586324905882,0.6934619506966774,0.9575085961822114,1.0,17/65,18.13%,PSMC3;PSMD8;PSME1;PSMD6;PSMB5;PSMC6;PSMB4;NABP1;PSMA7;PSMB9;PSMA6;PSMC1;PSMD7;PSMD2;CHFR;GPR132;PSMD5
prerank,phagolysosome assembly (GO:0001845),0.423572173299572,0.872478069459366,0.665283540802213,0.9572192383651211,1.0,7/12,27.87%,ARL8B;CLN3;SYT7;CORO1A;PIKFYVE;RAB7A;RAB7B
prerank,embryonic hemopoiesis (GO:0035162),0.4205386850943954,0.8722458308180353,0.649025069637883,0.9572364642616176,1.0,4/12,14.64%,KDR;KIT;ATF4;KITLG
prerank,positive regulation of lyase activity (GO:0051349),-0.31040874171388266,-0.8721703406777601,0.623015873015873,0.9239786735036202,1.0,1/14,0.19%,CACNA1D
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.2930169771602932,-0.8721489391178541,0.6684210526315789,0.9220056341336861,1.0,8/19,23.62%,CUX1;CAPRIN1;SS18L1;CAMK2B;LRP8;CDKL5;CUL7;CUX2
prerank,amide biosynthetic process (GO:0043604),0.34447777805262947,0.872126852684555,0.7041484716157205,0.9570139759647923,1.0,12/47,21.50%,SMPD1;SPTSSA;SPTLC3;CERS4;DMD;PM20D1;FA2H;DEGS1;SGMS1;ASS1;SPTLC2;SLC25A2
prerank,protein polyubiquitination (GO:0000209),0.31461605420150196,0.8718281040637179,0.851,0.9571112933949272,1.0,93/297,26.18%,RNF125;RPS27A;TRAF1;BCL2;NEDD4;PSMC3;UBA52;TRIM21;RNF14;PSMD8;FBXO31;FZR1;PSME1;PSMD6;UBE2H;PSMB5;BARD1;MKRN1;UBE2G2;UBE2L3;PELI1;PSMC6;HERC6;NHLRC3;AMFR;PSMB4;CTNNB1;PSMA7;MUL1;UBB;PSMB9;HECTD2;PSMA6;SHARPIN;TRIM68;FBXO41;UBR5;PSMC1;LNPEP;FBXL5;UBE2B;RNF216;CUL3;LONRF1;TTC3;PSMD7;HUWE1;PSMD2;CHFR;FBXL17;UBE4A;SHPRH;AREL1;ZNRF2;SMURF2;RNF152;PSMD5;DDB2;FBXO11;RNF135;CDC34;UBE3D;FBXO10;LMO7;PSMB6;UBE2D1;TRAF3;UBE2E2;BTRC;TRIP12;TMEM129;ERCC8;NHLRC1;PSMA3;FBXW9;UBE2W;FBXO28;RC3H1;RNF166;FBXO4;RNF20;FBXL7;PSMB2;TRIM3;FBXW7;PSMD1;CDC26;RBCK1;KLHL20;PSMD10;BLMH;ANAPC7;DDA1
prerank,positive regulation of calcium ion transport (GO:0051928),0.35779922564191646,0.871715112586418,0.662870159453303,0.9568908716568794,1.0,6/36,12.84%,CCL5;F2R;SPHK2;CAV1;P2RX5;LGALS3
prerank,cellular response to calcium ion (GO:0071277),0.3334858491797834,0.8716437062799424,0.7077244258872651,0.9565889024811955,1.0,8/67,9.45%,SLC25A24;SMPD1;IQGAP1;RASGRP2;ALOX5AP;SYT4;GPLD1;SYT7
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3167957198676278,-0.8714322789703258,0.6264591439688716,0.9216961747587555,1.0,7/14,31.00%,RFFL;GPS2;PYDC1;PTPN2;PELI3;GAS6;CCDC3
prerank,protein phosphorylation (GO:0006468),0.3126726751404602,0.8711405171203948,0.898,0.9570623297280697,1.0,93/479,17.23%,LCK;MAPK13;MAP4K2;PRKCQ;RUNX3;CAMK4;PLK4;SBK1;DDR2;TXK;SRPK1;CDK6;LMTK2;MELK;NEK4;HTATIP2;TLR9;RSKR;CDK8;BIRC5;ILF3;KDR;CDK17;DAPK3;PIM1;SMAD2;PRKAR1B;ATM;PRKD2;RARA;MEX3B;MAPK9;KIT;CSNK1A1;CDK1;TGFB2;BMP4;HIPK1;STK17B;RPS6KA5;NLK;BIRC6;GRK6;PAK4;JAK2;GTF2H5;CSNK1G1;FAM20A;CDK2;CDC7;RIOK2;TAOK3;CDC42BPG;ZAP70;ILK;ROCK1;SIK3;HCST;EPHB2;MAPKAPK3;DCLK1;TGFBR3;FLT3;ERC1;CIT;NIM1K;STK24;MASTL;MATK;MAPKAPK2;STK4;TESK2;COQ8A;TNIK;RIPK1;EIF2AK3;ABI1;FYN;RPS6KB1;HIPK3;BLK;PKN1;PAK1;USP15;PKDCC;ABL2;IGF1R;MAP4K5;GSK3A;CDK13;STK26;TOP1;PPP3CB
prerank,androgen receptor signaling pathway (GO:0030521),0.43159801571444534,0.8710258836783534,0.6429567642956764,0.9568404254421468,1.0,2/11,4.68%,DAXX;RNF14
prerank,regulation of endocytic recycling (GO:2001135),0.43341214706250614,0.8706567785419906,0.641726618705036,0.9570693016465209,1.0,7/11,33.07%,SORL1;EHD1;ACTN2;PLA2G3;EIPR1;RAB11B;ARHGAP1
prerank,positive regulation of cell cycle process (GO:0090068),0.32424028010932704,0.8704435344077229,0.7333333333333333,0.9570035811323351,1.0,14/91,15.44%,CD28;PLK4;PKP4;ATRX;RACGAP1;GPSM2;CDC42;CDC7;CIT;DDX11;PCID2;CUL3;DRD2;NUDT16
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.4237861410894031,0.8699306372529763,0.6364883401920439,0.9575169684990864,1.0,3/12,21.39%,TLR9;SOX9;RBP4
prerank,fatty acid metabolic process (GO:0006631),0.32005586331864744,0.8698215665821099,0.7467071935157041,0.9572952603972925,1.0,20/115,15.21%,ACSBG1;PEX2;ALOX5AP;ACSF3;NAAA;GPX1;ABCD3;PER2;ACADSB;CD36;FASN;FA2H;FAAH;THEM4;GNPAT;ACACA;CPT1C;CPT2;ACSL1;GPX4
prerank,regulation of transferase activity (GO:0051338),-0.3061970469927305,-0.8694654860460825,0.6394230769230769,0.9241219698328123,1.0,9/17,22.19%,LDB1;LDB2;NABP2;FEM1A;SLAMF8;SMG6;BAG5;JMJD8;PPP1R3F
prerank,early endosome to late endosome transport (GO:0045022),-0.2913066757249961,-0.8694191414206386,0.6261682242990654,0.9222545304492424,1.0,8/20,14.18%,BECN1;WDR81;ANKRD27;AKTIP;SNX16;STX8;PIK3C3;RAB5A
prerank,hepaticobiliary system development (GO:0061008),0.3880034757834216,0.8690057062179706,0.6654040404040404,0.9582906790510942,1.0,3/20,12.07%,PRKCSH;NIPBL;TGFBR3
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.2947295086801267,-0.8688122929647211,0.6176470588235294,0.9216057091779769,1.0,3/17,6.65%,PPARD;PRKAA2;PRKAG2
prerank,inner mitochondrial membrane organization (GO:0007007),0.34240615998609225,0.868583180242154,0.6904761904761905,0.958647083330455,1.0,14/47,21.55%,ATP5PD;TIMM9;IMMT;CHCHD6;ATP5MG;ATP5PF;ATP5MF;ATP5F1D;ATP5MC1;MTX3;TIMM10;DMAC2L;TIMM22;GHITM
prerank,regulation of ERAD pathway (GO:1904292),-0.33976031604343127,-0.8685773313009647,0.6421052631578947,0.9201491941146773,1.0,7/11,26.70%,RNF185;BAG6;USP13;TMEM259;UBXN1;USP25;HERPUD1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.37662456602129807,0.8685055063103828,0.6486810551558753,0.9583464488388582,1.0,5/24,18.69%,C3;IL6ST;ATF4;EIF2AK3;RORA
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.2521032345005238,-0.8682625966863535,0.680672268907563,0.9169447852314211,1.0,15/31,27.62%,GTF2H2;MNAT1;CMTR1;POLR2G;ERCC2;CCNH;NCBP2;POLR2K;RAMAC;POLR2C;POLR2H;GTF2H4;GTF2F2;POLR2J;POLR2L
prerank,7-methylguanosine RNA capping (GO:0009452),-0.2521032345005238,-0.8682625966863535,0.680672268907563,0.9169447852314211,1.0,15/31,27.62%,GTF2H2;MNAT1;CMTR1;POLR2G;ERCC2;CCNH;NCBP2;POLR2K;RAMAC;POLR2C;POLR2H;GTF2H4;GTF2F2;POLR2J;POLR2L
prerank,renal filtration (GO:0097205),0.4384018781860023,0.8682377339784265,0.6591549295774648,0.958379241521255,1.0,4/10,20.35%,JCHAIN;TBC1D8B;MCAM;XPNPEP3
prerank,regulation of membrane depolarization (GO:0003254),0.3919609782177618,0.8681596533504611,0.6645244215938303,0.9580987734903916,1.0,1/18,1.49%,RANGRF
prerank,DNA methylation (GO:0006306),0.37763575730572657,0.8680819949476506,0.6505441354292624,0.9578005910978301,1.0,7/23,18.83%,ATRX;DNMT1;ATF7IP;GATAD2A;BAZ2A;DMAP1;HELLS
prerank,smooth muscle cell differentiation (GO:0051145),-0.3339667522251872,-0.8675786798982696,0.6420664206642066,0.9164686116338824,1.0,2/12,2.76%,MEF2C;MRTFB
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.31731669296214743,-0.86711495084054,0.6475409836065574,0.9156309918179077,1.0,7/15,22.88%,LACTB2;ZC3H12A;ZC3H12B;RPP30;POP1;ZC3H12C;RPP40
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.34738102687394823,0.8669443355314718,0.6807095343680709,0.9594679203489769,1.0,17/42,27.27%,ACTB;SMARCC1;HDAC1;NASP;VPS72;ACTR8;GATAD2B;HDAC2;DMAP1;PBRM1;CECR2;MBD2;HNRNPC;ACTR6;ARID1A;INO80B;SMARCA1
prerank,regulation of GTPase activity (GO:0043087),0.3162045071809442,0.8669152675605108,0.7740963855421686,0.9590868116597225,1.0,23/177,9.65%,RASGRP1;CCL5;KLRK1;CCL7;F2R;PKP4;RASGRP2;FERMT2;RGS1;RGS8;RGP1;ARL2;RACK1;ARHGAP15;PLXNB1;ITGB1;MMUT;PIN1;MAPRE2;CHN1;PLXNA2;RAPGEF6;RABGAP1
prerank,lamellipodium assembly (GO:0030032),0.3682824744500648,0.8661147095161111,0.6602870813397129,0.9601051921356,1.0,4/26,6.94%,ABLIM1;ITGB1;CDH13;KIT
prerank,exit from mitosis (GO:0010458),-0.3282463617874749,-0.8659784563756251,0.6291390728476821,0.9162564716929951,1.0,2/12,4.90%,SPAST;SIRT7
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3473934405134442,0.8659745958143877,0.7003293084522503,0.9599353293342265,1.0,10/43,16.35%,TICRR;FZR1;ATM;CDK1;NOP53;TAOK3;NABP1;BLM;CDKN1A;CHFR
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.33675387664876066,-0.8655809478709148,0.6423357664233577,0.9151677536642813,1.0,4/12,21.76%,PIK3R1;PTPN1;XBP1;BAK1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.43724855742858326,0.8654555575121365,0.6587887740029542,0.9604262418202,1.0,2/10,5.80%,VTN;PRKD2
prerank,Rac protein signal transduction (GO:0016601),-0.29468642327424677,-0.8650532025646079,0.695852534562212,0.9143621294398877,1.0,3/18,4.82%,ELMO1;FARP2;WASF1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.44687945490676906,0.865045141641696,0.6548797736916548,0.960704368716178,1.0,2/10,2.74%,STAP1;C3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.36512024735066734,0.8650027590476242,0.6436363636363637,0.96035804044165,1.0,3/26,5.48%,ATP1B3;NEDD4;ITGB1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3748887195544968,0.8644699389994935,0.6650426309378806,0.9608655550435496,1.0,8/23,29.48%,ITGB1;GPSM2;PAFAH1B1;ZW10;HTT;SPDL1;GJA1;NDEL1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.35070363082491157,-0.8640235485711758,0.6225165562913907,0.914699740230478,1.0,2/10,6.71%,WWP2;CORO2B
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3426491390684302,0.8638916635272831,0.694206008583691,0.9614620881257813,1.0,11/47,11.33%,ADIG;PIM1;ZBTB7B;LMO3;CREBL2;RARRES2;ID2;TMEM64;ZBTB16;NAPEPLD;SYAP1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.39969791651383924,0.863888962323349,0.6543535620052771,0.9610327117897991,1.0,2/16,9.05%,NIPBL;PDS5B
prerank,mesenchyme morphogenesis (GO:0072132),0.39129487094546855,0.8634436449987664,0.6479057591623036,0.9613886081538309,1.0,2/17,7.11%,SMAD2;TGFB2
prerank,diol biosynthetic process (GO:0034312),0.40032784404827615,0.8632829931070225,0.6404639175257731,0.9612437985804544,1.0,6/15,22.72%,SPTLC3;SPHK2;ABCA2;SPTLC2;ACER2;QDPR
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.2865615021149323,-0.8628540594801772,0.649746192893401,0.9154237410492544,1.0,5/22,7.77%,ROCK2;LYN;GSAP;CHRNA7;CASP3
prerank,negative regulation of cilium assembly (GO:1902018),-0.3478308457024979,-0.8625801727723568,0.6507352941176471,0.91417728586109,1.0,6/12,27.95%,CCP110;TBC1D30;TCHP;TBC1D7;ODF2L;TESK1
prerank,positive regulation of angiogenesis (GO:0045766),0.32328115750371594,0.8625667639203616,0.7612704918032787,0.9621137319136178,1.0,24/108,19.28%,ANGPT4;SEMA5A;KDR;ITGB1;PRKD2;MDK;STIM1;ETS1;HIPK1;PAK4;PDCL3;SERPINE1;SMAD1;CDH5;GRN;TNFSF12;SIRT1;ITGAX;CTSH;MYDGF;AGO2;JUP;S100A1;ADAM12
prerank,protein insertion into ER membrane (GO:0045048),0.34509730225123997,0.8623748815638689,0.6666666666666666,0.9620151494724762,1.0,5/37,11.01%,TRAM1L1;GET1;SEC61B;EMC3;PRNP
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.31075310928339006,-0.8622728649695381,0.600896860986547,0.9129662613528846,1.0,3/16,3.21%,SIRPA;APPL2;ABCD2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.37762415242619707,0.8622661832032719,0.6687192118226601,0.9617845887135523,1.0,6/23,16.24%,TOMM22;TIMM9;HSP90AA1;HSPA4;BCL2L11;TIMM10
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4051569928922042,0.8622437907932767,0.6666666666666666,0.9613999286910532,1.0,2/15,6.82%,KDR;CDH13
prerank,establishment of apical/basal cell polarity (GO:0035089),0.412297988639571,0.8618711690933117,0.6559139784946236,0.9616499465107918,1.0,5/14,15.41%,PATJ;MSN;CDC42;EZR;RAP2A
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.32838676905860525,0.861472300901655,0.7114164904862579,0.961913998494206,1.0,17/64,21.40%,AFF4;NELFCD;PAF1;LEO1;GTF2H5;ELOF1;CTR9;POLR2F;PCID2;TCEA1;CDK13;EAF2;CDC73;MLLT3;CCNT1;MLLT1;POLR2D
prerank,regulation of lipid catabolic process (GO:0050994),0.39066505390822626,0.8607793046025228,0.6666666666666666,0.9627100334967632,1.0,2/19,8.27%,APOC1;RARRES2
prerank,RNA interference (GO:0016246),0.39841930762705235,0.8602876769368972,0.6732804232804233,0.9631478819111444,1.0,5/17,19.49%,CLP1;TARBP2;DROSHA;AGO2;TSNAX
prerank,regulation of protein ubiquitination (GO:0031396),0.32027016314872964,0.860275995903533,0.7640449438202247,0.9627354392421714,1.0,21/108,16.39%,GTPBP4;CHP1;ADGRB1;DAXX;ANGPT1;LAPTM5;RPS3;MALT1;PER2;UBE2L3;CAV1;HSP90AA1;UBQLN1;FKBP1A;DNAJB2;UBB;VPS28;HSPA1A;CUL3;HUWE1;GSK3A
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.43153104372048356,0.8600305620564315,0.6561604584527221,0.9627467907412711,1.0,2/10,14.48%,CTNNB1;WNT3
prerank,negative regulation of centrosome duplication (GO:0010826),0.4358988351993849,0.8600081347452248,0.672752808988764,0.9623517902252869,1.0,4/11,18.91%,NPM1;MDM1;KAT2B;TMEM67
prerank,regulation of protein localization to Cajal body (GO:1904869),0.4325477264077877,0.8599833035593488,0.6815642458100558,0.9615401950956901,1.0,2/11,4.89%,CCT8;CCT2
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.4325477264077877,0.8599833035593488,0.6815642458100558,0.9615401950956901,1.0,2/11,4.89%,CCT8;CCT2
prerank,positive regulation of insulin secretion (GO:0032024),0.34811117964998006,0.8597903496930679,0.6602491506228766,0.9614708118665682,1.0,11/36,27.17%,GCK;BAIAP3;GPLD1;BLK;PPP3CB;MCU;RBP4;AACS;MYRIP;ADCY8;TRH
prerank,nervous system development (GO:0007399),0.30955587636005666,0.8597753402280376,0.911,0.9610686544944015,1.0,89/429,20.24%,SCIN;NRG1;SOX3;SCD5;MPZ;ADGRB1;KALRN;SMPD1;ADORA2A;NHLH2;HAPLN2;LPAR1;BPNT1;SPINK5;SDCBP2;GPM6B;SEMA5A;MARCKSL1;FABP7;PTEN;CDH1;DCX;DSCAM;MDK;RNF103;GDA;CELSR1;PCDHB11;NRSN1;DNM3;JARID2;GSN;SHANK2;TRPC5;TMOD2;LGI1;KIRREL3;CHERP;ZBTB16;CXCR4;NFASC;BTBD1;APAF1;UTP11;ROBO1;NBL1;GPM6A;EPHB2;DCLK1;SCN8A;ADAM23;P2RX5;ATXN1;NCKAP1;ROBO2;PCDHA6;SLC2A1;ARNT2;PCDHB16;WWTR1;CAPG;RBFOX1;GLRB;ARHGAP26;MYT1L;DRD2;CSPG5;PRX;FBXL17;JAG1;RBFOX2;MBD5;DPYSL5;SOX10;MBP;DPF2;HES1;FKTN;FAT4;EGR2;HDAC4;NAB2;GDF11;SZT2;MBNL1;PLXND1;MARCKS;GLIS2;VLDLR
prerank,endosome organization (GO:0007032),0.34599489188047083,0.8594276895135423,0.6968325791855203,0.9612390786534154,1.0,9/41,21.39%,PLEKHF1;ALS2CL;HOOK1;LAPTM4B;VPS11;SNX33;USP50;PLEKHJ1;RAB27A
prerank,protein kinase A signaling (GO:0010737),0.41679743678551695,0.8593725659821907,0.6406926406926406,0.9609100986246064,1.0,3/12,20.94%,LCP1;EZR;RDX
prerank,membrane lipid metabolic process (GO:0006643),0.38061372386397485,0.859126422591538,0.6896120150187734,0.9609084846062239,1.0,5/22,12.77%,SPHK2;SMPDL3B;CERKL;ARV1;TEX2
prerank,regulation of acrosome reaction (GO:0060046),0.42800984283828,0.8590430013316922,0.6656671664167916,0.9606238011593634,1.0,1/10,10.26%,CACNA1H
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.2663042359081511,-0.8587920520275125,0.703125,0.9188628773473364,1.0,6/24,12.62%,PARP1;GNL3L;DCP2;TEN1;SLX4;NAT10
prerank,heart contraction (GO:0060047),0.3453007687795152,0.8579576595119291,0.6794150731158605,0.9621477382629553,1.0,8/41,19.95%,CSRP3;GPX1;DMD;ATP1A2;TNNI1;SGCG;SCN3B;SCN1B
prerank,positive regulation of cellular senescence (GO:2000774),0.430100790420636,0.8574140047144748,0.6446043165467625,0.9626563310638727,1.0,4/10,19.78%,B2M;SIRT1;CGAS;EEF1E1
prerank,protein O-linked mannosylation (GO:0035269),-0.29622411990854625,-0.857000006256035,0.6497695852534562,0.9208612125551628,1.0,8/18,23.29%,LARGE1;TMTC2;POMT2;DPM2;DPM1;FKRP;POMT1;TMTC4
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.37733902277599307,0.8568381421708416,0.6521181001283697,0.9632427757945905,1.0,2/18,5.48%,CHP1;UFM1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.32690634905785804,0.8567045571311146,0.7200832466181062,0.9630473275552426,1.0,14/72,16.98%,TFAP4;ATRX;SP100;ATM;GADD45A;CDK1;TFDP2;SFN;PCBP4;BTG2;NDRG1;CDKN1A;PCNA;BATF
prerank,organelle assembly (GO:0070925),0.3074833932828247,0.8567007485172674,0.882,0.9626261882932793,1.0,99/385,23.84%,ABLIM1;CFAP44;PLK4;FLNA;RPS23;CENPJ;CHMP6;YTHDF3;RAB8A;MKS1;MRPL22;EIF2A;EIF2S1;CCDC65;TMEM237;RPS3;RFX2;RCC1;KIF24;LSM3;DYNLL1;MAP1LC3A;CHMP7;CEP89;MKKS;IQCB1;PARVA;GSN;MAPRE2;WDR90;ARL3;CFAP410;ATG5;TMOD2;RAB11A;SPAG16;DLGAP5;RILPL2;TMEM216;SCLT1;UBQLN1;MAPT;CEP19;LIMD1;WDR35;BBIP1;SNF8;CHMP5;HYLS1;HAUS5;UBXN2A;VPS28;NPM1;ACTR3;ARL6;NCOR1;KIF3B;SAC3D1;FNBP1L;CEP41;PCNT;PTPDC1;CCDC28B;B9D2;RFX3;ATG3;MAPRE3;HAUS4;HAUS2;OCRL;CORO1A;LZTFL1;TMEM67;MIS12;ATG14;CNGB1;SSX2IP;MVB12A;HAUS3;CFAP70;ABCB6;PIBF1;LSM4;PDCD6IP;IFT140;CDC14A;DDX6;NUP62;GABARAP;TCTN3;ATG16L1;MAP1LC3B;ACTR2;EHD1;CEP20;CENPF;DZIP1;RC3H1;IST1
prerank,regulation of gluconeogenesis (GO:0006111),0.3575763802626707,0.8565842670273598,0.6596491228070176,0.9624099809880556,1.0,1/27,0.90%,GCK
prerank,regulation of intracellular signal transduction (GO:1902531),0.308805115091236,0.8562761693129773,0.913,0.9625287083008637,1.0,108/420,22.38%,TMSB4X;CD24;PTPN22;DLC1;TRAF1;ARHGEF3;ARHGDIB;RPL11;DAXX;KALRN;ENTPD5;ARHGEF18;CEACAM1;CLEC6A;RAD1;PTPN13;RBBP7;RCN3;ING2;RFC4;RACGAP1;PTEN;ARHGAP15;PRKAR1B;ATM;LBH;PRKD2;ARHGEF19;HDAC1;BARD1;DEPDC7;PRMT5;CDK1;PLEKHG2;ING5;RHOJ;HIPK1;PIN1;RAC2;CHN1;SPHK2;PAK4;L3MBTL1;AKAP6;CDC42;CDK2;NOP53;TAOK3;SOS2;ARHGAP32;RHOC;NFKBIA;RFC5;MAPT;ARHGEF12;ARHGAP21;AKAP13;BLM;STK4;ZFAND6;RMI2;ARHGAP33;BRIP1;RHOU;TNIK;PRKAR1A;GNA13;TAF6;EZR;PPP1R16B;ARHGAP26;PAK1;TREM2;SGMS1;ARHGAP11A;AGER;TIAM1;PPP1R13B;ARHGAP6;HDAC2;NTRK3;PHLPP1;CPNE1;TBP;GNAI1;OCRL;ARHGAP30;ARHGEF26;MEAF6;RBBP8;STK11;ATR;BIRC3;ARHGEF6;PIP5K1B;TRAF3;PIP4P1;PRKAB2;PAK1IP1;ATP6AP2;PTPMT1;MCF2L;DYRK2;VAV3;DLG1;SRGAP1;TRIO;BOP1
prerank,regulation of neuron apoptotic process (GO:0043523),0.31923945998926945,0.8557367623110854,0.7520408163265306,0.963074180144141,1.0,18/96,15.53%,BCL2;F2R;NDNF;APOE;MDK;TGFB2;GRID2;CLN3;CTNNB1;PRNP;CLCF1;ATF4;EPHA7;AGAP2;TGFB3;GRN;SOD2;TREM2
prerank,hyaluronan metabolic process (GO:0030212),0.3715630644918137,0.8553876805265634,0.6794081381011098,0.9632419239851421,1.0,3/23,7.70%,CHP1;CEMIP;CD44
prerank,histone exchange (GO:0043486),0.3466602907795566,0.8552176447450357,0.699666295884316,0.9630915399241253,1.0,8/37,18.09%,RBBP7;CENPH;KNL1;NASP;VPS72;NPM1;RUVBL1;DMAP1
prerank,protein acylation (GO:0043543),0.3518154177526518,0.8552025801223396,0.6877113866967306,0.9626913389300183,1.0,10/38,17.60%,ING5;ZDHHC17;ZDHHC23;ZDHHC15;ZDHHC12;FOXO1;ZDHHC2;ZDHHC14;ZDHHC18;KAT2B
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.36128482970100817,-0.8550202065352661,0.6456953642384106,0.9234558228183546,1.0,3/10,17.27%,HNMT;COMT;SARDH
prerank,regulation of ion transport (GO:0043269),0.32238231254316535,0.8550016218733875,0.7394002068252327,0.9626144774975267,1.0,9/76,9.60%,KCNJ10;NEDD4;KCNJ15;SYT4;B2M;SPTBN4;ANK3;SYT7;ATP1A1
prerank,protein localization to synapse (GO:0035418),0.413169001015802,0.8548877459037022,0.6606145251396648,0.9623879349687186,1.0,3/12,11.71%,MPP4;ZDHHC15;ZDHHC12
prerank,microtubule-based transport (GO:0099111),0.4052456808738431,0.8548302622408618,0.664804469273743,0.9620541736144924,1.0,1/13,3.49%,ADCY10
prerank,ncRNA transcription (GO:0098781),0.40825855474826134,0.8547056723950989,0.667578659370725,0.9618302799308603,1.0,2/13,6.46%,USPL1;POLR1G
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.2539211886109753,-0.8546249475620947,0.7254901960784313,0.922449531047225,1.0,5/27,9.35%,FXR1;DDX5;TGFB1;TNRC6B;WTIP
prerank,negative regulation of cell activation (GO:0050866),0.4056871555429649,0.8544442298463786,0.6662216288384513,0.9618493838944276,1.0,4/14,19.70%,APOE;TREM2;EMILIN1;LDLR
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.32704994976592355,0.8538787263072058,0.7463002114164905,0.9624092523254669,1.0,9/65,11.90%,MMP9;CEACAM1;RHBDF1;SPRY1;CDH13;PTPN12;CDC42;EPS15L1;HIP1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.4118015888715467,0.8536774311493427,0.6757493188010899,0.962345463969285,1.0,3/13,11.34%,SMCR8;SEC22B;MTM1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.32691672024019786,0.8536436185315229,0.7267876200640342,0.9619786349403604,1.0,14/59,15.93%,RPS27A;UBA52;TAB2;TLR9;NFKBIA;ROCK1;TBKBP1;UBB;ERC1;SHARPIN;RIPK1;NKIRAS2;TICAM1;AZI2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.25861818330846553,-0.853618865872635,0.6878612716763006,0.9227818401425965,1.0,10/25,22.64%,DLG4;ITGB3;ANKRD13D;APP;PICALM;ATXN2;ANKRD13B;PSEN1;MTMR2;ARF6
prerank,negative regulation of cartilage development (GO:0061037),-0.31404113912202014,-0.8533558922596275,0.6666666666666666,0.921438074335506,1.0,3/13,13.56%,TGFBR1;PTPN11;EFEMP1
prerank,transport along microtubule (GO:0010970),-0.3208121949969434,-0.8528936000086041,0.6475095785440613,0.9205102290667371,1.0,5/13,12.41%,BAG3;SPG11;COPG2;APP;APBA1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3240120183452711,-0.852510413463981,0.631578947368421,0.9195437724854858,1.0,6/14,26.03%,ADRA1A;VEGFA;DGKD;ADGRV1;MYADM;WNT5A
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3116643905409871,0.8523764632319503,0.8227593152064451,0.9637065275387362,1.0,39/190,18.71%,TMSB4X;MMP9;SFRP5;BCL2;HDAC7;NPRL2;RACK1;PTEN;ATP2B4;RNF157;TNIP3;CAV1;ITPR1;SHANK2;SPRY3;PIK3IP1;PDE3A;NOP53;THEM4;LIMD1;MUL1;CIT;ABCA7;DAG1;SIRT1;RIPK1;UBE2B;DRD2;TREM2;GSK3A;MAPKBP1;RIOK3;TNIP1;PHLPP1;CPNE1;PER1;CDC34;RORA;MCL1
prerank,cellular response to gamma radiation (GO:0071480),0.3918011373073254,0.8523073139420134,0.6679946879150066,0.9634083261729913,1.0,9/17,30.94%,ATM;TMEM109;CRYAB;ATR;WRN;YAP1;RPL26;HRAS;HSF1
prerank,protein localization to lysosome (GO:0061462),0.3603275096235458,0.8522682239168877,0.6809015421115066,0.963042829816737,1.0,13/28,29.15%,NEDD4;LAPTM5;AP3M1;LAMTOR4;SORL1;SZT2;M6PR;SH3BP4;ATP13A2;RAB7A;KPTN;RTN4;SCARB2
prerank,acylglycerol catabolic process (GO:0046464),0.3575618396243495,0.8522027263332537,0.6933797909407665,0.962733783399571,1.0,5/30,14.90%,FABP7;FABP5;ABHD2;FAAH;FABP4
prerank,ncRNA catabolic process (GO:0034661),0.3544568012782735,0.8519718687988024,0.6795774647887324,0.9626862379032547,1.0,2/28,2.84%,DEDD2;EXOSC4
prerank,lipoprotein biosynthetic process (GO:0042158),0.42440340521997566,0.8515767442663922,0.6826265389876881,0.9629550493769348,1.0,2/11,5.19%,UGCG;APOE
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.28731886892327796,-0.8513410702305999,0.6649214659685864,0.9202477718336907,1.0,4/18,9.13%,SKI;CD300A;MED25;B4GALT7
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3861244115565759,0.851227352391506,0.6713917525773195,0.9631351648786441,1.0,4/17,15.16%,SYT4;RAB3D;CACNA1H;CACNA1I
prerank,positive regulation of cellular protein localization (GO:1903829),0.3259117234528579,0.8510821785770013,0.7369519832985386,0.9629583769642613,1.0,18/69,23.14%,RANGRF;FERMT2;CDK1;MAPT;ABCA7;RIC3;VPS28;WWTR1;EIF2AK3;FYN;SNX33;CCDC88A;TYROBP;GSK3B;HSP90AB1;NUP62;TFRC;LIMK2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3492969475647216,0.850875641016464,0.6731428571428572,0.9629055659498424,1.0,7/33,19.10%,GATA3;PTEN;PIK3C2B;IRS1;PIK3R5;IGF1R;NYAP2
prerank,protein deacylation (GO:0035601),-0.27250755688070094,-0.8506608122285794,0.7258064516129032,0.9198098868465479,1.0,13/23,24.14%,ABHD17B;PPT1;SIN3A;SIRT7;SIRT3;ABHD17C;LYPLA1;HDAC6;SIRT5;ABHD10;SIRT2;HDAC10;SIRT6
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3782803992648997,0.8504830920656691,0.6831072749691739,0.9631567516769413,1.0,4/20,9.66%,ENTPD5;C3;PSTPIP1;C3AR1
prerank,negative regulation of axon extension (GO:0030517),-0.24255374413480416,-0.8496370299239349,0.7323943661971831,0.9200992338593014,1.0,3/30,4.80%,DIP2B;SEMA4C;MAG
prerank,regulation of DNA repair (GO:0006282),-0.21665329077245218,-0.8493123254949906,0.75,0.9189352806600211,1.0,11/44,15.51%,BABAM2;CDK9;SIRT7;TMEM161A;POLH;FGF10;NPAS2;RAD52;WRAP53;BABAM1;EYA4
prerank,protein mannosylation (GO:0035268),-0.2739336790171452,-0.8489691211529143,0.7005988023952096,0.9177487754021469,1.0,9/22,23.29%,LARGE1;TMTC2;POMT2;DPM2;DPM1;DPY19L1;FKRP;POMT1;TMTC4
prerank,protein targeting to mitochondrion (GO:0006626),0.3329687586927079,0.8488930290651459,0.7215601300108342,0.9654408834680935,1.0,13/52,21.36%,TOMM22;DNAJC15;TOMM7;TIMM9;HSP90AA1;HSPA4;TIMM17B;TIMM10;TIMM17A;TSPO;TIMM22;MFF;PMPCA
prerank,response to hydroxyurea (GO:0072710),0.4231148177469656,0.8485385626791184,0.6848920863309352,0.9656570884854845,1.0,3/11,14.10%,ATRX;BLM;DDX11
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.31329628805170706,0.8484726088623405,0.7663265306122449,0.9653468052263581,1.0,21/100,18.15%,XPO1;RPL11;CLU;RNF14;RACK1;CSNK1A1;CCAR2;NOP53;EIF3H;SUMO2;DNAJB2;COP1;DESI1;HSPA1A;SDCBP;GSK3A;ZER1;KEAP1;GLMN;PIAS1;RYBP
prerank,ERBB signaling pathway (GO:0038127),0.3212542759264273,0.8479822463946055,0.728051391862955,0.9657309412039036,1.0,9/64,14.64%,NRG1;IQGAP1;NCK2;PTPN12;RPS6KA5;BCAR1;HSP90AA1;MATK;SHC1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.3165853598160477,-0.8478821456208901,0.6382978723404256,0.9183465602217732,1.0,6/13,18.02%,UBAC2;SVIP;EDEM2;UBE2J1;BRSK2;YOD1
prerank,axon guidance (GO:0007411),0.30794792636889023,0.8474777413348246,0.8466933867735471,0.9661684144926574,1.0,47/201,20.24%,LRTM1;PRKCQ;EMB;LAMA5;SEMA5A;EFNB2;KIF5A;PLXNB1;DSCAM;SPTBN4;UNC5D;PTPRA;RPS6KA5;RAC2;CHN1;PLXNA2;LGI1;BSG;CXCR4;ROBO1;ALCAM;EPHB2;UNC5C;DOK2;DAG1;EPHA7;ROBO2;EPHA5;NPTN;SHC1;DCC;KIF5C;EZR;SEMA3E;FYN;DOK4;RANBP9;EPHA3;DAB1;SLIT3;SLIT1;SEMA5B;SEMA3D;CYFIP1;SCN1B;PLXND1;VLDLR
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3860361995424048,0.8470652285278539,0.6842105263157895,0.9664366994463666,1.0,4/18,12.78%,RIPOR2;RACK1;ROCK1;CDH5
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.3817572875293468,0.8470083097454726,0.6899618805590851,0.9652607148679375,1.0,7/20,28.30%,BUB1B;ATM;ZW10;MAD1L1;CENPF;TEX14;TPR
prerank,spindle assembly checkpoint signaling (GO:0071173),0.3817572875293468,0.8470083097454726,0.6899618805590851,0.9652607148679375,1.0,7/20,28.30%,BUB1B;ATM;ZW10;MAD1L1;CENPF;TEX14;TPR
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.3817572875293468,0.8470083097454726,0.6899618805590851,0.9652607148679375,1.0,7/20,28.30%,BUB1B;ATM;ZW10;MAD1L1;CENPF;TEX14;TPR
prerank,protein methylation (GO:0006479),0.3436022714740774,0.8468032725431788,0.7018140589569161,0.9651871203852661,1.0,16/40,26.13%,PRMT5;FAM98A;METTL22;LCMT1;METTL21A;GSPT1;ETF1;SNRPB;TRMT112;NSD3;PRMT7;ETFBKMT;EEF2KMT;VCPKMT;EZH2;BHMT
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.3797729767514181,0.8466653476727851,0.6871165644171779,0.9649995594961975,1.0,4/20,13.89%,PRKD2;SPRY1;SPRY3;NPTN
prerank,positive regulation of neuron differentiation (GO:0045666),-0.23401576512813294,-0.8461383763013082,0.7864077669902912,0.920136266964824,1.0,5/40,7.30%,MEF2C;ZEB1;TCF4;SIN3A;VWC2
prerank,cellular response to virus (GO:0098586),0.35509131096088786,0.8458076708108409,0.6872093023255814,0.9659832952403203,1.0,4/30,10.37%,CCL5;POU2AF1;CXCL10;HSP90AA1
prerank,cellular response to insulin stimulus (GO:0032869),0.30777679347491554,0.8457612528370111,0.7993890020366599,0.9656294369016657,1.0,29/124,19.74%,GCK;SORBS1;CEACAM1;ATP6V1G2;HDAC9;RAB8A;RARRES2;BCAR1;GPLD1;ATP6AP1;APPL1;ATP6V0B;SLC27A1;SYAP1;IRS1;FOXO1;GRB14;SHC1;ATP6V0A2;RPS6KB1;IGF1R;GSK3A;ATP6V0E1;KAT2B;ATP6V1F;SLC25A33;SELENOS;C2CD5;ATP6V1G1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.32026126166885177,0.8449539528201786,0.7449947312961012,0.9665737867474089,1.0,21/78,22.18%,RANGRF;SORBS1;ACTB;ITGB1;ATP2B4;PLS1;PTPN9;CNPY4;CLN3;APPL1;EPHB2;ZDHHC2;LGALS3;TREM2;CLIP3;EPHA3;TMBIM1;TMEM59;STAC2;DLG1;DPP10
prerank,skeletal muscle tissue development (GO:0007519),0.348978830900633,0.8446506101834506,0.7176196032672112,0.9666779124527449,1.0,3/32,8.62%,CSRP3;LEMD2;CAV1
prerank,protein N-linked glycosylation (GO:0006487),0.3234148485844611,0.8445901655461483,0.7340425531914894,0.9663520084467263,1.0,17/66,21.27%,ENTPD5;DOLPP1;MPDU1;MAGT1;PMM2;LMAN1;DPM3;ST3GAL1;DDOST;TUSC3;MGAT3;UGGT1;DPAGT1;ALG1;FUT8;GFPT2;TMEM165
prerank,sensory perception of taste (GO:0050909),0.4114042607777192,0.8443564470673958,0.6587078651685393,0.9663311215903543,1.0,1/10,9.75%,CD36
prerank,histone mRNA catabolic process (GO:0071044),0.3927424179959925,0.8436658711943762,0.6862483311081442,0.967047887095384,1.0,3/15,12.11%,EXOSC4;ATM;ERI1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3080101065251111,0.8428903364949476,0.8133874239350912,0.9679084536183041,1.0,43/132,24.53%,PLEKHF1;ENTPD5;DCN;HMGB1;NPRL2;LAPTM5;TRIM21;APOE;MSN;PRXL2C;GPLD1;HSP90AA1;ROCK1;IRS1;FOXO1;VPS11;TRIM68;KHSRP;EZR;TICAM1;ZC3H18;ZC3HAV1;SNX33;GSK3A;RNF152;BNIP3;MLXIPL;GAPDHS;PRR5L;SNCA;STK11;GSK3B;GRSF1;RDX;TMEM59;SH3BP4;P2RX7;SH3D19;INSR;RC3H1;LIN28B;MTDH;TRIM8
prerank,regulation of cell cycle process (GO:0010564),0.31306176259885476,0.8426702549553432,0.7908629441624365,0.9678591697736185,1.0,24/104,19.83%,PLK4;DAPK3;RACGAP1;FBXO5;RCC1;PRMT5;KIF20A;CUL9;PIN1;BIRC6;L3MBTL1;CDC42;RAB11A;CTNNB1;KLHL21;RMI2;NUDT16;KIF11;CDK13;CALM1;RAB11FIP4;AHCTF1;TXLNG;SOX9
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.42124436864537995,0.8424874017626486,0.6909090909090909,0.9677362619485771,1.0,3/10,12.49%,ATP1A2;FKBP1A;CBARP
prerank,response to gamma radiation (GO:0010332),0.36519557031095934,0.8421409667200261,0.6931540342298288,0.9678932736592344,1.0,12/24,30.94%,ATM;FANCD2;TMEM109;CRYAB;ATR;WRN;DCUN1D3;YAP1;MYC;RPL26;HRAS;HSF1
prerank,insulin receptor signaling pathway (GO:0008286),0.31658730497514015,0.8419410169152433,0.7537154989384289,0.9677921059190752,1.0,20/69,20.56%,SORBS1;ATP6V1G2;RARRES2;BCAR1;GPLD1;ATP6AP1;APPL1;ATP6V0B;IRS1;FOXO1;GRB14;SHC1;ATP6V0A2;IGF1R;GSK3A;ATP6V0E1;ATP6V1F;C2CD5;ATP6V1G1;GSK3B
prerank,glucose metabolic process (GO:0006006),0.3240029459984317,0.8418750137541944,0.7393617021276596,0.9674794022099632,1.0,21/58,25.53%,ALDOA;SORD;PER2;GPI;ALDOC;DCXR;MDH2;SLC25A10;ATF4;GAPDH;SLC25A1;APOD;CRTC2;OMA1;GAPDHS;RBP4;PGK1;GOT2;ADPGK;ENO1;GDPGP1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.41422916743129307,0.841849167678629,0.6807639836289222,0.9671141958076365,1.0,1/13,2.97%,BPNT1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.25830499166624776,-0.841365757443734,0.7368421052631579,0.9283208975283729,1.0,15/28,33.07%,FCHSD2;PAK3;SH3BP1;COTL1;GBA2;ARHGAP35;WDR1;NAA80;BRK1;RASA1;FCHSD1;ARHGAP28;ARHGAP18;ESAM;DBN1
prerank,sensory perception of light stimulus (GO:0050953),0.3178108142295282,0.8413635529501398,0.7807377049180327,0.9675453417908151,1.0,10/87,17.50%,ABLIM1;COL18A1;SFRP5;CLRN1;COL1A1;RDH12;KIFC3;SLC4A10;OAT;IMPG2
prerank,DNA repair (GO:0006281),0.30306153545337,0.8389566099693391,0.895,0.9711130534804705,1.0,53/284,16.40%,RPS27A;NUDT1;RAD54L;USP3;MDC1;UBA52;ERCC4;RAD1;RFC4;TICRR;XPC;ATM;GADD45A;BARD1;POLB;CDK1;TEX264;NSMCE1;LIG1;PARP3;USP1;POLE;PDS5B;SLC30A9;GTF2H5;APTX;NOP53;NABP1;ACTR8;BTG2;WDHD1;FANCL;FANCD2;RFC5;UBB;BLM;NPM1;DDX1;VCPIP1;ERCC1;TENT4A;POLK;RMI2;BRIP1;MLH3;USP45;SIRT1;MSH6;UBE2B;PWWP3A;PCNA;HUWE1;ERCC5
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.43726348261683634,0.8378404012118962,0.6905444126074498,0.9721594567417322,1.0,2/10,8.58%,RACK1;SPHK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.43726348261683634,0.8378404012118962,0.6905444126074498,0.9721594567417322,1.0,2/10,8.58%,RACK1;SPHK2
prerank,DNA replication initiation (GO:0006270),0.3441285970850516,0.8378041295074359,0.7284090909090909,0.9717925794349406,1.0,9/37,18.52%,MCM7;MCM2;NOC3L;POLE;CDK2;CDC7;ORC6;MCM6;CDC34
prerank,ganglioside metabolic process (GO:0001573),-0.28175536678081636,-0.8377245792092706,0.689119170984456,0.9341225239439634,1.0,6/20,14.94%,HEXB;ST6GALNAC6;GM2A;NEU1;ST8SIA3;CLN6
prerank,regulation of cellular protein metabolic process (GO:0032268),0.33142340481143523,0.8374635456063144,0.7280701754385965,0.9719446285389758,1.0,7/47,11.35%,EIF2A;APOE;UHRF1;NR1H2;EIF2B4;RBM4B;NFKBIA
prerank,establishment of mitotic spindle localization (GO:0040001),0.3521259102502728,0.8371809102553167,0.7141162514827996,0.9719939041643625,1.0,9/28,26.95%,ITGB1;GPSM2;ESPL1;PAFAH1B1;ZW10;CLASP2;HTT;SPDL1;GJA1
prerank,heart morphogenesis (GO:0003007),0.32866536148756054,0.8371181474387218,0.7372972972972973,0.971674994739346,1.0,6/50,12.07%,DLC1;NIPBL;TGFB2;HEY2;FKBP1A;TGFBR3
prerank,neuromuscular process controlling balance (GO:0050885),-0.3271695941740936,-0.8370840775686456,0.6597222222222222,0.9336221059279225,1.0,4/12,10.53%,MYO7A;TPP1;TIFAB;SHANK1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.415965456370867,0.8369009275011092,0.682962962962963,0.9715933530097036,1.0,3/11,23.10%,ID2;RIPK1;IL34
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.21817914586834536,-0.8366946782686523,0.8108108108108109,0.9324929615897855,1.0,20/55,25.69%,PID1;GRB2;TGFBR2;BCO2;PARL;XDH;RNF41;PAX2;AATF;THBS1;ZC3H12A;AGT;DHRS4;SIRT5;COQ7;CBR1;SIRT2;PRKN;ROMO1;RAC1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.39599698515386306,0.8361675678758305,0.67828418230563,0.9723611351256066,1.0,3/13,15.16%,SYT4;CACNA1H;CACNA1I
prerank,dendrite morphogenesis (GO:0048813),-0.23650998271930704,-0.8357401608191339,0.6942148760330579,0.932529991006366,1.0,8/35,12.97%,MEF2A;FARP1;DLG4;PAK3;CHRNA7;BTBD3;SHANK1;KLF7
prerank,cellular response to amino acid starvation (GO:0034198),0.3200470578287066,0.8357214300036245,0.751578947368421,0.9726615686293023,1.0,18/71,19.77%,DAPL1;ATP6V1G2;NPRL2;EIF2S1;DAP;LAMTOR4;ATP6V0B;SESN3;ATF4;CDKN1A;EIF2AK3;RHEB;CEBPB;ATP6V0E1;RNF152;ATP6V1F;ATP6V1G1;SZT2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.41863863886896563,0.8353586789971615,0.6960227272727273,0.9728339329579453,1.0,5/11,27.52%,HSPA5;ATF4;CEBPB;DDIT3;ATF6B
prerank,dopamine metabolic process (GO:0042417),0.3851344941588441,0.8351941657972571,0.7060333761232349,0.9726809567421005,1.0,5/18,24.54%,ATP7A;TGFB2;DRD2;SNCA;MAOB
prerank,cellular response to drug (GO:0035690),-0.26196350872721236,-0.8351713706521111,0.7365269461077845,0.9318560013369865,1.0,3/25,6.20%,MEF2C;PPM1E;AIM2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.3171216442880085,-0.8349032176386364,0.6798561151079137,0.9305391998597028,1.0,4/13,13.13%,SEC16A;EDEM2;CD81;TM9SF4
prerank,synapse assembly (GO:0007416),0.32054592518960195,0.8346142117039473,0.7379958246346555,0.9732276598493215,1.0,12/67,15.34%,PTEN;PLXNB1;CDH1;DSCAM;PCDHB11;DNM3;GRID2;SHANK2;KIRREL3;GPM6A;PCDHB16;DRD2
prerank,regulation of neuron projection arborization (GO:0150011),0.3886153728141074,0.8342473463501345,0.6798975672215108,0.9734077216075284,1.0,5/15,14.52%,MFSD2A;SPRY3;NTNG1;NTNG2;GRIP1
prerank,mitochondrial transcription (GO:0006390),-0.330849003425428,-0.8340649599133246,0.6816816816816816,0.9304378976013121,1.0,7/10,23.71%,FOXO3;TFAM;POLRMT;TWNK;TEFM;TFB2M;MTERF2
prerank,glycerophospholipid metabolic process (GO:0006650),0.3145292648670598,0.8339338770144826,0.7631027253668763,0.9734922588341052,1.0,15/75,19.19%,PRDX6;PIGC;PIGH;PIGA;PLCB3;CLN3;GPLD1;PIGG;GDPD1;PIGZ;PAFAH1B1;GDPD3;GPCPD1;CPNE1;SERINC5
prerank,regulation of viral transcription (GO:0046782),0.33768540593801577,0.8338914979298606,0.7098976109215017,0.9731481777470605,1.0,5/39,8.15%,HEXIM1;TRIM21;NELFCD;IFITM3;TARBP2
prerank,microtubule bundle formation (GO:0001578),0.3372440926527546,0.8338479600165495,0.713302752293578,0.972798384732425,1.0,8/42,15.89%,CHP1;CFAP46;DCX;KIF20A;SPAG16;CFAP206;AAAS;MTCL1
prerank,peptidyl-lysine modification (GO:0018205),0.30864451322013736,0.8338196664298247,0.7812177502579979,0.9724265839154496,1.0,30/99,24.30%,ATP7A;HDAC9;USPL1;NUP50;LIPT2;NUP214;NUP210;LOX;SUMO2;NUP88;RANBP2;METTL21A;SIRT1;AAAS;PIAS1;KAT2B;EGR2;VIPAS39;HDAC4;ESCO1;SENP1;TRIM28;ETFBKMT;NUP62;NUP93;VCPKMT;NUP205;IFIH1;NDC1;SIRT4
prerank,regulation of autophagy (GO:0010506),0.3018265310282088,0.8330560182007285,0.8776328986960883,0.9732327214469096,1.0,61/216,25.06%,PTPN22;DAPL1;PLEKHF1;BCL2;NEDD4;DCN;ATP6V1G2;RAB8A;HMGB1;NPRL2;TAB2;SMCR8;TRIM21;DAPK3;ATM;SREBF1;DAP;LAMTOR4;EEF1A1;ITPR1;ATP6V0B;ROCK1;UBQLN1;MAPT;FOXO1;TRIM68;GAPDH;RMC1;CAPNS1;ATP6V0A2;TICAM1;TREM2;RHEB;ABL2;GSK3A;KEAP1;ATP6V0E1;RNF152;MCL1;BNIP3;ATP6V1G1;STK11;DNM1L;GSK3B;ACER2;TMEM59;PRKAB2;MET;SH3BP4;GFAP;PRKAG1;DDIT3;ATP6V1B2;ERN1;RRAGB;MTDH;TRIM8;FBXW7;CTSA;FOXK1;ATP13A2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.37034129669409505,0.8324716231510458,0.708128078817734,0.9738281186585377,1.0,6/22,12.84%,PPP1R15A;PTPA;ROCK1;FKBP1A;MASTL;LGALS3
prerank,spindle assembly (GO:0051225),0.3225069911927672,0.8323460344325103,0.7597471022128557,0.9736054653370266,1.0,23/67,25.19%,FLNA;SMC3;RPS3;RCC1;MAPRE2;RAB11A;HAUS5;NCOR1;KIF3B;SAC3D1;AAAS;KIF11;KIFC1;MAPRE3;HAUS4;HAUS2;HAUS3;PIBF1;WRAP73;CLASP2;TOGARAM2;RHOA;MZT1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.37040550571770287,0.8323223485522244,0.7052767052767053,0.9732292463156462,1.0,4/19,16.92%,GATA3;SLCO1C1;MAP2K5;KLF2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.34147554282268033,0.8323121598690415,0.7040094339622641,0.9728323739718626,1.0,6/31,11.93%,CDK6;HDAC7;CHRD;GREM1;TMEM64;LIMD1
prerank,negative regulation of B cell activation (GO:0050869),0.37070887891411575,0.8318555726992648,0.715158924205379,0.9731855684360846,1.0,8/21,20.18%,LAPTM5;ATM;PARP3;ID2;CTLA4;BLK;TYROBP;TNFRSF13B
prerank,ventricular septum development (GO:0003281),0.3367016876037365,0.8315037718327368,0.7056128293241696,0.9733387038233192,1.0,9/37,19.05%,GATA3;TGFB2;HEY2;ROBO1;TGFBR3;ROBO2;SOX11;HES1;SLIT3
prerank,positive regulation of glycolytic process (GO:0045821),0.3687605455222636,0.8313581583319347,0.6855345911949685,0.9727300005642181,1.0,10/20,28.51%,ENTPD5;PRXL2C;MLXIPL;GAPDHS;P2RX7;INSR;IGF1;ARNT;PFKFB1;HIF1A
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3687605455222636,0.8313581583319347,0.6855345911949685,0.9727300005642181,1.0,10/20,28.51%,ENTPD5;PRXL2C;MLXIPL;GAPDHS;P2RX7;INSR;IGF1;ARNT;PFKFB1;HIF1A
prerank,regulation of response to cytokine stimulus (GO:0060759),0.36654750566604866,0.8310709680592899,0.7153558052434457,0.9727669387000171,1.0,1/19,0.30%,CD24
prerank,secretion (GO:0046903),-0.3025077902013543,-0.8309301902447254,0.6814159292035398,0.9348539865120522,1.0,2/14,3.43%,PRKCI;TPD52
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2313864673834511,-0.8308341583097204,0.75,0.9331721291269742,1.0,14/36,20.50%,CHEK2;DNA2;DOT1L;MAP3K20;PRPF19;ATRIP;RAD17;RHNO1;DONSON;HUS1;TIPIN;CEP63;E2F1;RAD9A
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.3275559624078931,0.8308150880633326,0.7339149400218102,0.9727632795118426,1.0,18/48,28.51%,GCK;NUP50;NUP214;NUP210;NUP88;RANBP2;AAAS;NUP62;PRKAG1;NUP93;NUP205;NDC1;NUP153;ZBTB7A;OGT;NUP98;TPR;HIF1A
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.315672788000426,-0.8305446253700853,0.7083333333333334,0.9318897799225109,1.0,5/14,17.61%,SCAP;SEC24A;SEC23A;SEC13;SEC24B
prerank,regulation of mitochondrial fission (GO:0090140),0.3585494855013313,0.8303803630971437,0.720098643649815,0.9730579726515632,1.0,9/24,21.25%,DCN;KDR;MAPT;MUL1;RALA;BNIP3;DNM1L;MCU;MFF
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.37500886219178436,0.8299980275880954,0.7068965517241379,0.9732581254657503,1.0,6/18,25.39%,MSN;VPS11;EZR;SNX12;RDX;PTPN23
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.3157960302073982,-0.8299021794413813,0.7251908396946565,0.9313761835157086,1.0,6/12,29.40%,TK2;DHODH;UCKL1;UCK1;TK1;CAD
prerank,cardiac muscle contraction (GO:0060048),0.3403409855967132,0.8298541721701763,0.7208237986270023,0.9730657664261695,1.0,7/34,19.95%,CSRP3;GSN;DMD;ATP1A2;TNNI1;SCN3B;SCN1B
prerank,brain morphogenesis (GO:0048854),0.3980226259164775,0.8297873752497734,0.684931506849315,0.9727482478677646,1.0,4/12,16.52%,PTEN;MKKS;VPS51;PAFAH1B1
prerank,regulation of epithelial cell migration (GO:0010632),0.32519456858235485,0.8297727829886681,0.7204301075268817,0.9723508963861562,1.0,7/51,9.79%,GLIPR2;CEACAM1;DOCK5;TGFB2;RHOJ;INSL3;RAB11A
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.3872465891642165,0.8297102997456868,0.6913907284768211,0.9720429002728539,1.0,3/15,11.36%,NR4A3;IL6ST;ROCK1
prerank,tryptophan catabolic process (GO:0006569),-0.3249317859886199,-0.8295664356933559,0.6747404844290658,0.930255307198599,1.0,4/11,28.24%,KMO;IL4I1;KYNU;AFMID
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.31792876963152217,0.8294221085287986,0.7518716577540107,0.9720885206375415,1.0,17/59,21.69%,LEF1;CDK8;PTEN;CDK1;MED30;MED23;CTNNB1;MED7;MED13;CDKN1A;RUNX2;CEBPB;MED24;SOX9;MED26;MECP2;TRIM28
prerank,glycoprotein biosynthetic process (GO:0009101),0.31218796205611793,0.829311958178377,0.7882231404958677,0.9718596261524665,1.0,10/79,11.04%,B3GNT3;ATP7A;B3GALT6;FUT9;CHST9;COG7;PMM2;GCNT2;ST8SIA5;DDOST
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3372771769154702,0.8292610252353166,0.7308120133481646,0.97152331102638,1.0,9/38,20.56%,SP100;GPX1;TNFSF10;SERPINE1;LGALS3;RIPK1;TMC8;TMBIM1;GSK3B
prerank,ceramide transport (GO:0035627),0.4089832786204125,0.8288307383224984,0.6917900403768507,0.9718246281729828,1.0,1/12,1.54%,ABCA13
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.33859566272495,0.8286136631782451,0.7293318233295584,0.9717623143320974,1.0,17/38,29.94%,TNIP3;SIRT1;RIPK1;TREM2;MAPKBP1;RIOK3;TNIP1;PER1;RORA;NLRC3;PPM1A;OTUD7A;TANK;RHOH;USP10;OTUD7B;TLE1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.35925893599991243,0.8284695442009039,0.6982968369829684,0.9715734584526886,1.0,4/24,18.17%,PTPN22;HSP90AA1;LILRB1;CGAS
prerank,regulation of interleukin-17 production (GO:0032660),0.3479063559557503,0.8280463767192809,0.7373271889400922,0.9718081249837353,1.0,5/31,15.22%,PRKCQ;ZBTB7B;PRNP;SLC7A5;SLAMF6
prerank,carbohydrate derivative transport (GO:1901264),0.3795650488921364,0.8272433818582297,0.7148488830486203,0.972692005210158,1.0,3/18,8.98%,LBP;MFSD2A;CLN3
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3070720095205416,0.8270384092513127,0.8118609406952966,0.9726162751055033,1.0,16/104,14.95%,LTF;GTPBP4;CCND2;ACTB;GADD45A;SLC27A1;SYAP1;CNPPD1;KSR1;SNF8;ETAA1;BLM;RALB;PPP2CA;SIRT1;CDKN1A
prerank,regulation of stress fiber assembly (GO:0051492),0.31487039040638976,0.8267843564283616,0.7800829875518672,0.9726071919815749,1.0,14/74,15.52%,DLC1;ACTG1;ARHGEF18;LPAR1;WAS;FERMT2;CD47;CCN2;CDC42;RHOC;ROCK1;TGFB3;S100A10;PAK1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.34458735710566324,0.826585749468247,0.7136150234741784,0.9725179974925441,1.0,9/31,24.55%,CDK6;PTEN;JADE1;CDKN1A;CDC73;WEE1;DLG1;RBL2;DCUN1D3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4038115756506751,0.8264674402877533,0.6957123098201936,0.9723123533069185,1.0,4/12,19.61%,SEC61B;HSPA5;SGTB;SEC63
prerank,ERBB2 signaling pathway (GO:0038128),0.3375498704763203,0.8262122468865606,0.7208480565371025,0.97230171708939,1.0,5/31,14.64%,NRG1;PTPN12;HSP90AA1;MATK;SHC1
prerank,ovarian follicle development (GO:0001541),0.39971363141229554,0.8261770260731708,0.7098930481283422,0.9719426572269693,1.0,3/13,16.76%,KIT;EIF2B4;CEBPB
prerank,maturation of LSU-rRNA (GO:0000470),0.3516852663086894,0.8257262760857984,0.7388149939540508,0.9722533877397755,1.0,10/26,22.38%,RPL10A;NSA2;FTSJ3;RPL35;RPL7;RRP15;WDR12;RPL7A;ZNHIT3;BOP1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.36043810293339584,0.8253380820584781,0.7320799059929495,0.9724487954326554,1.0,6/26,16.08%,ARL2;RPS3;MAPT;PAK1;KATNB1;STMN2
prerank,cellular response to interferon-beta (GO:0035458),0.3875356095328977,0.8246127431547661,0.6983914209115282,0.9731818751004059,1.0,4/14,18.52%,IFITM2;UBE2G2;ACOD1;CDC34
prerank,regulation of transport (GO:0051049),0.3380129378003512,0.8243124542132723,0.723404255319149,0.9732393609382429,1.0,9/36,23.18%,ACTG1;ACTB;RAB11A;MUL1;ARL6IP5;EPB41;SNCA;MBTPS1;DNAJA1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.3846932659914585,0.8241010818360843,0.7103896103896103,0.9731417516501069,1.0,2/16,9.00%,NR4A3;BCAR1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.3007440567832693,-0.823142082595381,0.6830188679245283,0.9414454574263258,1.0,6/14,22.54%,ABCD2;AKT2;LONP2;IRS2;TYSND1;MTLN
prerank,positive regulation of catalytic activity (GO:0043085),0.3282219080653567,0.8231217891322283,0.7358708189158016,0.9743060275618611,1.0,7/37,15.99%,ATP7A;YWHAB;CAV1;MID1IP1;MSH6;AZIN2;ABL2
prerank,presynapse assembly (GO:0099054),0.37953229799971716,0.8227506770624623,0.7015706806282722,0.9744803095689557,1.0,8/16,30.16%,PTEN;CEL;LRP4;PTPRD;PCLO;NLGN3;IL1RAPL1;DVL1
prerank,regulation of cation channel activity (GO:2001257),0.30749663769111224,0.8226499620529224,0.8,0.9742181665241639,1.0,25/89,24.89%,MMP9;AHNAK;CACNG7;ITGB1;GRIA1;ANK3;CACNB4;JPH4;DMD;GSG1L;SHISA9;FKBP1A;GRIA2;CALM1;DLG3;GRIA3;JPH1;DLG1;JPH3;ACTN2;PRRT1;FGF14;RELN;GRIN1;DLG2
prerank,positive regulation of protein transport (GO:0051222),0.31468876655319217,0.8225893591634759,0.7492163009404389,0.9738959353206751,1.0,13/67,15.56%,CHP1;PPIA;RACK1;TGFB2;CNST;CLN3;BMP6;TGFB3;VPS28;APBB3;EZR;TREM2;PCNT
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.31860064983222885,0.8225400839992774,0.7555321390937829,0.9735592223513759,1.0,10/63,11.02%,SDE2;FBXO31;ATM;GADD45A;CDK1;TFDP2;SFN;PCBP4;CDK2;BTG2
prerank,hippo signaling (GO:0035329),0.35306793583937957,0.8225376967934357,0.7180124223602484,0.9731486293585659,1.0,9/26,26.40%,AMOTL1;SAV1;YWHAB;STK4;WWTR1;FAT4;TEAD1;TJP2;YAP1
prerank,energy reserve metabolic process (GO:0006112),0.36979721998791043,0.8223009400646774,0.707196029776675,0.973121269940503,1.0,5/19,20.58%,UGP2;PYGM;PYGL;GSK3B;GFPT2
prerank,purine nucleotide biosynthetic process (GO:0006164),0.4044517053050492,0.8221371761489802,0.6997282608695652,0.9729638329900053,1.0,7/12,29.78%,GART;MTHFD1;HPRT1;PRPS2;PRPS1L1;PRPS1;ADSL
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.3947704277120376,0.8218710523826784,0.7087912087912088,0.9729841321144773,1.0,4/13,13.07%,BMP4;BMP6;JAK2;TGFB3
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3698247468291067,0.821107769376745,0.682741116751269,0.9737372412886468,1.0,3/17,16.42%,CCND2;CCNY;MAPRE3
prerank,regulation of endothelial cell proliferation (GO:0001936),0.30820270450611986,0.8209286110280539,0.796277145811789,0.9735986662291458,1.0,17/88,16.29%,ANGPT1;SEMA5A;KDR;APOE;PRKD2;HMGB2;CDH13;BMP4;AIMP1;CAV1;NR4A1;EGR3;PDCL3;TNFSF12;SIRT1;PPP1R16B;MYDGF
prerank,atrial septum development (GO:0003283),-0.3135455844311337,-0.8208392184740965,0.6826568265682657,0.9442652233898802,1.0,3/13,8.09%,BMPR2;ANK2;NPHP3
prerank,response to glucagon (GO:0033762),0.3682354701438624,0.819594295145839,0.717391304347826,0.9752676091987744,1.0,4/19,16.49%,PRKAR1B;ADCY6;PRKAR1A;ADCY1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.373741715515852,0.819587586759849,0.7121401752190237,0.9748646514392547,1.0,9/18,29.68%,GRID2;GRIA2;GRIK5;GRIK2;CDH8;GRIK1;SLC17A6;SLC1A4;UNC13B
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.24841631889621887,-0.8195765101871139,0.8044692737430168,0.9449974379599899,1.0,7/25,14.90%,DDX39B;SCAF8;LDB1;ZNF326;TSFM;THOC5;CCNT2
prerank,transcription by RNA polymerase II (GO:0006366),0.29707883468335144,0.8195727418370422,0.928,0.9744729533956387,1.0,70/305,22.00%,DEAF1;NR4A3;NCOR2;RARG;HDAC9;HDAC7;CLP1;AFF4;NELFCD;RARA;ZBTB7B;PAF1;HDAC1;NR4A2;SOX5;LSM11;NR1H2;LEO1;NR1D2;CCN2;CSTF2;TRIM24;SNRPG;INTS7;MNT;NR4A1;RNGTT;NR6A1;GTF2H5;MED23;KLF13;NUDT21;NABP1;ELOF1;MED7;PAX5;CSTF3;CTR9;ATF4;POLR2F;WWTR1;NCOR1;PCID2;TAF6;SNRPB;TBPL1;NRBF2;TCEA1;BTF3;CDK13;DEK;TSC22D1;PRRX1;KAT2B;SLBP;EAF2;TBP;RORA;CDC73;MLLT3;INTS14;MED26;CSTF2T;CCNT1;MLLT1;POLR2D;RPRD1B;TEAD1;TBL1XR1;RNMT
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3046888935350028,-0.819327439581534,0.7175572519083969,0.9436099248289529,1.0,2/13,2.02%,MEF2C;FGF2
prerank,nucleic acid metabolic process (GO:0090304),-0.20030486401948708,-0.8191039228312543,0.926829268292683,0.94222987078638,1.0,32/69,32.26%,HNRNPH1;MMS19;PCBP2;RBMX;DNASE1L1;DNA2;HNRNPL;POLR2G;ATXN2;PTBP1;NCBP2;HNRNPD;POLR2K;DNASE2;KPNA2;POLR2C;POLR2H;PDE12;SETMAR;GTF2F2;RAD50;POLR2J;DXO;POLR2L;DNASE1L2;LSM1;WDR74;HNRNPA3;FEN1;POLR2E;POLR2I;ENPP1
prerank,iron ion transmembrane transport (GO:0034755),-0.3383737494008077,-0.8188396020286026,0.6993670886075949,0.9409075798324649,1.0,4/10,12.17%,SLC40A1;ABCC5;SLC39A8;SLC25A28
prerank,lipid biosynthetic process (GO:0008610),0.3099198377720253,0.8187556672243396,0.7799586776859504,0.9753413857802598,1.0,10/77,14.68%,SCD5;FADS1;DOLPP1;ACSF3;SREBF1;ABCD3;GNPAT;ACACA;SCD;ACSL1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.34153952956202693,0.8181776891088851,0.7349112426035503,0.9758477955675883,1.0,11/30,27.93%,DACH1;ERCC4;CDKN1A;EXOSC10;STN1;HNRNPU;CTC1;HNRNPC;XRN1;TERF1;CERS1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3426127423956087,0.8180862008842523,0.721120186697783,0.9755685881712102,1.0,4/31,12.07%,NRG1;TGFB2;FKBP1A;TGFBR3
prerank,phospholipid biosynthetic process (GO:0008654),0.3373464144952015,0.8178178753333062,0.7318181818181818,0.9755575247817211,1.0,9/36,18.27%,FADS1;DOLPP1;SPHK2;CLN3;GNPAT;DHDDS;SGMS1;DPAGT1;CPNE1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.33564889758404715,-0.8176058386931951,0.7272727272727273,0.9415140032452279,1.0,3/11,13.85%,F11R;RAP2B;TJP1
prerank,striated muscle cell differentiation (GO:0051146),0.3741932580965233,0.8175336067111553,0.7069182389937106,0.9755665868176026,1.0,3/16,13.31%,NRG1;AKAP13;PLD3
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.232993213944427,-0.8174490543017551,0.816793893129771,0.9400317598829678,1.0,14/33,23.45%,FGF2;PKM;ITGA5;EPN2;PIK3CB;VEGFA;THBS1;TJP1;BMPER;KLF4;PDPK1;JMJD8;E2F2;CEMIP2
prerank,postsynaptic membrane organization (GO:0001941),0.37244508340030624,0.8173629535488561,0.7195902688860435,0.9754286042447985,1.0,7/17,25.96%,GPHN;APOE;CEL;LRP4;LRRC4;LHFPL4;NLGN3
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.36646483779628564,0.8172092870757894,0.7144607843137255,0.975239233844807,1.0,7/18,27.46%,BID;MUL1;HSPA1A;GSK3A;GSK3B;MPV17L;FZD9
prerank,positive regulation of dendritic spine development (GO:0060999),-0.26997431545387024,-0.8170211090836055,0.743455497382199,0.9390818513757245,1.0,10/20,23.62%,CAMK1;CAPRIN1;LLPH;SHANK1;CAMK2B;LRP8;DLG5;PSEN1;SHANK3;CUX2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.30428613375655833,0.816957752331207,0.7904066736183525,0.9752371174395692,1.0,15/76,17.44%,CLU;LAPTM5;RNF14;RACK1;PTEN;CSNK1A1;NOP53;SUMO2;DNAJB2;COP1;HSPA1A;GSK3A;ZER1;KEAP1;PIAS1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3495078438847011,0.8169001819260493,0.7201447527141134,0.9749157790098867,1.0,4/24,7.85%,CLU;RACK1;NR1H2;AQP11
prerank,response to amino acid starvation (GO:1990928),0.31238663723351023,0.8167490447218019,0.7728706624605678,0.9747314636000183,1.0,18/72,19.77%,DAPL1;ATP6V1G2;NPRL2;EIF2S1;DAP;LAMTOR4;ATP6V0B;SESN3;ATF4;CDKN1A;EIF2AK3;RHEB;CEBPB;ATP6V0E1;RNF152;ATP6V1F;ATP6V1G1;SZT2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3977965615500145,0.8166283215457181,0.7154362416107383,0.9744879432385705,1.0,3/12,17.23%,BAIAP3;GPLD1;PPP3CB
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.2772501734875826,-0.8166141526228612,0.7637130801687764,0.9380936681715265,1.0,9/18,23.42%,SETD3;EHMT1;SETD4;SMYD2;EHMT2;ASH1L;SUV39H1;KMT2B;SETMAR
prerank,mesenchymal cell differentiation (GO:0048762),0.3187518814201883,0.816519262781577,0.7647058823529411,0.974240866932003,1.0,15/51,23.13%,LEF1;HNRNPAB;TGFB2;HEY2;CTNNB1;ROCK1;TGFBR3;AKNA;FBXL17;SNAI2;SOX9;GSK3B;TRIM28;DDX17;FGFR1
prerank,multivesicular body assembly (GO:0036258),0.33886344934614976,0.8163232593207719,0.7313609467455622,0.974131831552007,1.0,6/30,13.08%,CHMP6;CHMP7;RAB11A;SNF8;CHMP5;VPS28
prerank,peptidyl-lysine trimethylation (GO:0018023),0.34297449772627625,0.8161600603158508,0.7218225419664268,0.9739719526081025,1.0,14/26,28.99%,SETD1A;SETD5;CTR9;SUV39H2;SMYD5;ETFBKMT;EEF2KMT;VCPKMT;PRDM9;KMT2A;TET2;KMT2D;OGT;KMT5C
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.34917903953783425,0.8159998553167361,0.7291666666666666,0.9738117905774749,1.0,7/26,23.13%,BCL2;HSPA1A;MAP2K5;PPP2R1B;MCL1;SNAI2;FGFR1
prerank,cardiolipin metabolic process (GO:0032048),0.3939207314803794,0.8157908507319629,0.7338820301783264,0.973734775985412,1.0,5/13,22.19%,SLC27A1;HADHA;TAMM41;PTPMT1;HADHB
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3465249942735903,0.8157829043158221,0.7281323877068558,0.9733417582971264,1.0,4/28,9.03%,CCL5;C3;CD47;JAK2
prerank,cellular response to estradiol stimulus (GO:0071392),-0.2794080650352834,-0.8152964179794074,0.7192982456140351,0.9387247767088337,1.0,13/18,50.24%,CCDC62;LCOR;RUVBL2;NCOA3;FAM210B;CRHBP;SSTR2;SFRP1;RAMP3;ESR1;GPER1;POU4F2;POU4F1
prerank,secondary alcohol metabolic process (GO:1902652),-0.22449204384324428,-0.8152921870188404,0.8495575221238938,0.9369130425521612,1.0,13/42,24.23%,PPARD;SCAP;CYP27A1;CH25H;ABCA5;CLN8;CLN6;GBA2;ABCA1;STARD3;FDX1;OSBPL5;ANGPTL3
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.400740611372157,0.815256390715024,0.71875,0.9737664170081488,1.0,5/12,19.29%,PTPN22;ELF1;PAX5;BLK;PTPRC
prerank,organophosphate catabolic process (GO:0046434),0.4039489765280417,0.8144254726535044,0.70042194092827,0.9746348434457465,1.0,2/11,13.81%,NUDT15;PLBD1
prerank,regulation of double-strand break repair (GO:2000779),0.32854212498521806,0.8143050490571554,0.7564825253664036,0.9744110220680522,1.0,3/39,3.26%,FIGNL1;RTEL1;WAS
prerank,positive regulation of DNA repair (GO:0045739),-0.21537050676833153,-0.8139156095554334,0.8961038961038961,0.9377267696670092,1.0,11/46,15.51%,PARP1;BABAM2;SLF2;TMEM161A;ZCWPW1;FGF10;FAM168A;NPAS2;WRAP53;BABAM1;EYA4
prerank,renal absorption (GO:0070293),0.41591720077880157,0.8136580750396676,0.7316017316017316,0.974966659462789,1.0,1/10,8.38%,GSN
prerank,lipoprotein transport (GO:0042953),0.411491415901574,0.8134258841887559,0.7097222222222223,0.9749159854853211,1.0,3/10,16.44%,ZDHHC17;CD36;MIA3
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.31833903688689746,0.8131749698865053,0.7801268498942917,0.9748844866497904,1.0,7/58,6.81%,HMGB1;MDC1;ERCC4;ATM;HMGB2;BARD1;POLB
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.30856328443838565,0.8129537063182839,0.7958115183246073,0.9748259900800936,1.0,12/69,15.40%,BCL2;F2R;NDNF;APOE;MDK;CLN3;ZPR1;CLCF1;AGAP2;TGFB3;GRN;SOD2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.31575555375027575,-0.8126098643333031,0.7338403041825095,0.9383549371116239,1.0,5/12,17.95%,TMEM119;NOTCH1;BDNF;BHLHE41;XBP1
prerank,ganglioside biosynthetic process (GO:0001574),0.3807889626800438,0.8123765175713663,0.7182175622542595,0.975296161830399,1.0,3/15,9.78%,ST6GALNAC3;B4GALNT1;ST3GAL1
prerank,regulation of RNA splicing (GO:0043484),0.31073754914222734,0.8116332399700854,0.7941483803552769,0.9760234933564058,1.0,24/69,23.41%,MBNL3;AHNAK;SRPK1;RPS26;PTBP3;ZPR1;CWC22;PTBP2;HSPA1A;MBNL2;JMJD6;HNRNPF;KHDRBS2;AFF2;PRX;KHDRBS3;RBM20;YTHDC1;MBNL1;GRSF1;FASTK;TIA1;RBM38;ERN1
prerank,establishment of epithelial cell polarity (GO:0090162),0.3677060761157589,0.811373545694114,0.7291139240506329,0.976005702492135,1.0,7/19,19.48%,PARD3;MSN;CDC42;EZR;RAP2A;SIPA1L3;CYTH1
prerank,motor neuron axon guidance (GO:0008045),0.3820519906226926,0.8110203471320478,0.7139141742522757,0.9761647423580337,1.0,5/15,27.91%,RAC2;CHN1;SLIT1;RHOG;RHOH
prerank,early endosome to Golgi transport (GO:0034498),-0.3124036587947993,-0.8109474536935589,0.6583629893238434,0.9396179443952484,1.0,2/11,4.99%,STX5;SNX2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.24669110938915073,-0.8109416085733306,0.8352941176470589,0.9378243313431902,1.0,8/27,16.60%,LPIN2;PLA2G15;SELENOI;PNPLA8;ABHD4;LPIN1;CHKA;PLA2G4E
prerank,tRNA methylation (GO:0030488),-0.23638578506528374,-0.8104877463992878,0.8529411764705882,0.9368932096110381,1.0,16/34,23.55%,DALRD3;TRMT1;FTSJ1;TRMT1L;ALKBH8;TRMT10A;PRORP;TRMT12;LCMT2;GTPBP3;TRMT5;BCDIN3D;TRMT10C;TRDMT1;MTO1;TYW3
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3013387682470294,0.8104659027947161,0.8406091370558376,0.9765808797226894,1.0,36/117,27.34%,HLCS;SLC6A8;SLC16A1;ACSF3;NAAA;ME2;PER2;ACADSB;CD36;FASN;BSG;FA2H;THEM4;GNPAT;CPT1C;SCPEP1;PDZD11;ME1;MCCC1;ACOT6;AOAH;CYP26B1;PCCB;MTHFD1L;MSMO1;MTHFS;ME3;LDHAL6B;PCCA;GOT2;BTD;IGF1;GAMT;PPARG;ALDH4A1;ACOT11
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.30221070931685656,0.8103992034284598,0.8072916666666666,0.9762825316425543,1.0,16/78,17.44%,CLU;RNF14;RACK1;FZR1;CSNK1A1;CAV1;NOP53;UBQLN1;SUMO2;DNAJB2;COP1;HSPA1A;GSK3A;ZER1;KEAP1;PIAS1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.40210499953388085,0.8103529337569835,0.7251700680272108,0.9759537563238599,1.0,3/12,18.37%,HSPA5;GPAA1;OS9
prerank,multivesicular body organization (GO:0036257),0.3340846970251648,0.8098826692006219,0.7344300822561692,0.9762646259715193,1.0,9/31,21.39%,CHMP6;CHMP7;RAB11A;SNF8;CHMP5;VPS28;MVB12A;PDCD6IP;RAB27A
prerank,striated muscle cell development (GO:0055002),-0.2913561919707113,-0.8095476647646325,0.7546468401486989,0.9368353734566833,1.0,1/14,1.15%,CAPN3
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.35618584639195305,0.8095091024460057,0.7200488997555012,0.9764236408156072,1.0,3/22,9.53%,NCF1;GADD45A;MAP3K4
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.40137758576195903,0.8093697006249594,0.7048022598870056,0.9762144562965733,1.0,1/10,2.69%,RTEL1
prerank,proteoglycan biosynthetic process (GO:0030166),0.3335946487054308,0.8092537517007541,0.7415599534342259,0.9759864087999217,1.0,6/31,10.95%,B3GALT6;UGDH;CHST9;HS3ST3B1;EXT2;NDST3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.257622694450676,-0.8091993618356259,0.7513227513227513,0.9356897307505581,1.0,4/21,6.28%,OPA1;LRRK2;TXNDC12;TMBIM6
prerank,ketone body metabolic process (GO:1902224),0.4030904447145536,0.8091777821835244,0.7142857142857143,0.9756977403032724,1.0,2/10,7.87%,ACAT1;BDH1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.3623635191435598,0.8090070379983204,0.7215836526181354,0.9755503177985979,1.0,3/19,10.01%,PRDX5;MAF1;DHX36
prerank,regulation of dendrite development (GO:0050773),0.32859063653280257,0.8090070142427095,0.75,0.975144683570823,1.0,9/37,20.56%,NEDD4;SDC2;MFSD2A;ZDHHC15;TNIK;DCC;RAP2A;VLDLR;GSK3B
prerank,positive regulation of glucose metabolic process (GO:0010907),0.3836867582069128,0.8080475391162196,0.7161981258366801,0.9761503385774251,1.0,5/14,22.89%,GPLD1;IRS1;SIRT1;DDB1;SLC45A3
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.356474286483179,0.807716930243703,0.7334167709637046,0.9762160153780651,1.0,7/19,24.89%,PATJ;PARD3;MTCL1;DLG3;DLG1;ERBIN;DLG2
prerank,defense response to protozoan (GO:0042832),0.39488197204865005,0.8071376923691759,0.7108603667136812,0.976666385832133,1.0,4/12,23.79%,GBP2;IRF4;BATF;LYST
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.28851782600337544,-0.8061492767341863,0.7607655502392344,0.9394019257765245,1.0,8/15,22.55%,CHEK2;RAD17;MRE11;HUS1;TIPIN;RAD9A;EME2;NEK11
prerank,dephosphorylation (GO:0016311),0.29411447265528456,0.8060492081437688,0.8368580060422961,0.9778636889830412,1.0,39/147,23.21%,PTPN22;PDP2;PTPN13;PLPPR5;PPP2R2A;PPP1R12A;PTEN;CTDNEP1;DUSP5;PPM1L;PPP2R1A;PTPN12;PTPN9;DUSP6;PTPRA;ACP3;DUSP2;MTM1;DUSP16;PLPP6;PPM1M;PTPN4;PPP2CA;DUSP4;PPP2R1B;PLPPR2;PPP2R3A;PPP3CB;PTPRC;STK11;TAB1;PPP1CA;BTRC;DUSP3;PTPRD;PPP2R5B;PPP2R5E;DUSP10;SBF1
prerank,TOR signaling (GO:0031929),0.34184821562584067,0.8057230924610306,0.7328519855595668,0.9779236233661056,1.0,2/26,2.92%,GATA3;RPS6
prerank,sulfur amino acid metabolic process (GO:0000096),0.3571309733935679,0.8054847573098443,0.7289156626506024,0.9778672376582566,1.0,3/24,9.23%,ADI1;MMUT;MTHFD1
prerank,fatty acid oxidation (GO:0019395),0.31527079923857176,0.805303451598213,0.7790821771611526,0.9777243502813734,1.0,16/57,22.62%,PEX2;ACAT1;ACADVL;EHHADH;ABCD3;PEX13;HADHA;HADH;CPT2;ADH5;ACADS;ACAT2;HSD17B4;ADIPOR2;HADHB;DECR1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.40538584582054205,0.8050820229298954,0.7242857142857143,0.9776643862106307,1.0,3/10,17.67%,DPP4;FAP;EMILIN1
prerank,regulation of BMP signaling pathway (GO:0030510),0.3030339411607192,0.804637230489798,0.7943336831059811,0.9778824326992634,1.0,15/73,17.66%,SMAD2;CHRD;LEMD2;BMP4;GREM1;FSTL1;TRIM33;NBL1;SMAD1;SORL1;CDH5;SPART;GDF3;SOX11;SMURF2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.3124851975601105,0.8045095255895429,0.7760869565217391,0.9776701521790785,1.0,11/51,14.25%,CHRD;LEMD2;GREM2;GREM1;FSTL1;TRIM33;NBL1;SMAD1;SORL1;SPART;GDF3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.31797678174744076,0.8043178512825265,0.7717391304347826,0.9775567961092418,1.0,14/48,21.94%,BCL2;AEN;ATM;HIPK1;SFN;CRIP1;SIRT1;BCL2L11;MSH6;TMEM109;USP28;MCL1;MSH2;DYRK2
prerank,regulation of microtubule polymerization (GO:0031113),0.3296145351567588,0.8042379718570462,0.7740863787375415,0.9772740853358832,1.0,12/40,21.99%,ARL2;RPS3;MAPT;PRUNE1;CDH5;PAK1;STMN2;MAPRE3;CLIP3;MAP2;SNCA;MET
prerank,atrial septum morphogenesis (GO:0060413),0.40926832825557014,0.8037932092644738,0.7339312406576981,0.97753715492865,1.0,2/10,9.08%,TGFB2;HEY2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.254099868902533,-0.8029154713850425,0.7731958762886598,0.9437182538975382,1.0,11/23,23.42%,INTS3;PLK3;ZFYVE19;NABP2;CDK5RAP3;ZWILCH;ZWINT;BUB1;PLK2;PABIR1;SETMAR
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.4024809464657811,0.8028299170509331,0.723342939481268,0.978571346521804,1.0,1/10,2.96%,CEACAM1
prerank,aminoglycan metabolic process (GO:0006022),0.40246474170100466,0.8027401243664765,0.7165467625899281,0.978314034901579,1.0,2/10,6.84%,B3GALT6;CHST9
prerank,peroxisomal membrane transport (GO:0015919),0.3390149654103871,0.8025864730259555,0.7377245508982035,0.9781267383998445,1.0,5/27,11.66%,PXMP2;PEX2;ABCD3;PEX16;PEX13
prerank,protein export from nucleus (GO:0006611),0.34030720848527646,0.8024218518416198,0.7398568019093079,0.9779629912826545,1.0,7/27,18.62%,XPO1;CHP1;NUP214;DUSP16;DESI1;RANBP17;EGR2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2901673075504229,0.8022309381011086,0.9379379379379379,0.9778440981376674,1.0,90/314,26.06%,TBX21;RPS27A;DNAJB9;NEDD4;PSMC3;SEC61B;UBA52;BUB1B;PSMD8;FBXO5;FBXO31;FZR1;PSME1;PSMD6;HSPA5;PSMB5;CDK1;RNF103;UBE2G2;FEM1C;PELI1;PSMC6;NHLRC3;AMFR;CDK2;PSMB4;CTNNB1;UBQLN1;PSMA7;DNAJB2;COP1;UBB;PSMB9;EDEM1;PSMA6;UBXN2A;SHARPIN;PSMC1;SIRT1;FBXL5;UBE2B;RNF216;CUL3;PSMD7;HUWE1;PSMD2;GSK3A;ECPAS;FBXL17;UBE4A;AREL1;DERL1;SGTB;SMURF2;PSMD5;OS9;CDC34;UBE3D;TMEM67;SELENOS;FAF2;DDB1;PSMB6;PLAA;UBE2D1;BTRC;DNAJB14;TBL1XR1;TMEM129;KCTD10;ERCC8;NHLRC1;PSMA3;DDIT3;UBE2W;UBXN8;FBXO4;FBXL7;PSMB2;TRIM3;SPOPL;FBXW7;PSMD1;CDC26;GID8;RBCK1;KLHL20;ERLIN1;PSMD10;ANAPC7
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3076367650140646,0.8021736956164599,0.7927083333333333,0.9775177949812373,1.0,17/68,20.99%,CLP1;POLR1G;LSM11;PRMT5;CSTF2;SNRPG;GTF2H5;NUDT21;TAF1B;CSTF3;POLR2F;SNRPB;SLBP;TBP;CAVIN1;CSTF2T;POLR1F
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.34428205484881447,0.8018957485811454,0.7410501193317423,0.9775324094168295,1.0,6/26,15.07%,FBXO5;RIOK2;DLGAP5;ESPL1;LCMT1;CUL3
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.30678926673408535,-0.8018015349351277,0.7455197132616488,0.9439291046035061,1.0,9/13,47.38%,GLS;NOS1;GLS2;GLUD1;DAO;DDAH1;GLUL;ARG1;NOS2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.39663165328829353,0.8016781359421401,0.7016348773841962,0.9774474408552002,1.0,2/12,4.89%,CCT8;CCT2
prerank,isotype switching (GO:0045190),0.4034016586146684,0.8013380136360242,0.7249647390691114,0.9775456282201729,1.0,5/10,30.23%,MSH6;BATF;MSH2;HSPD1;RNF168
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.31707051315501894,0.8010508232453838,0.7615384615384615,0.977565945007466,1.0,4/42,5.51%,FIGNL1;RTEL1;WAS;PARPBP
prerank,regulation of stem cell population maintenance (GO:2000036),-0.2731377942952272,-0.8006257160489119,0.7575757575757576,0.9442911840769842,1.0,4/18,21.65%,TAF5L;TAF6L;CNOT3;REST
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.2226185781231212,-0.8004738119482919,0.7967479674796748,0.9427784885298461,1.0,7/34,10.97%,MEF2C;LRRK2;ARRB2;GRIN2A;INSYN2A;GABRA1;GABRG2
prerank,mitotic sister chromatid segregation (GO:0000070),0.2985430834542577,0.80022278098688,0.8381443298969072,0.9783920601097439,1.0,18/98,16.23%,CHMP6;SMC4;NCAPG;NIPBL;CDK1;CHMP7;CDCA8;NCAPH;PDS5B;KIF22;RAB11A;DLGAP5;ESPL1;CHMP5;NCAPD3;TENT4A;CUL3;KIFC1
prerank,synaptonemal complex assembly (GO:0007130),0.36991638910793523,0.8002222936541036,0.7250324254215305,0.9775875393159319,1.0,2/15,9.71%,SYCP2;STAG3
prerank,synaptonemal complex organization (GO:0070193),0.36991638910793523,0.8002222936541036,0.7250324254215305,0.9775875393159319,1.0,2/15,9.71%,SYCP2;STAG3
prerank,metal ion homeostasis (GO:0055065),0.3232397249878408,0.7998379420439564,0.7629796839729119,0.9777447353905171,1.0,7/40,12.04%,SLC12A7;CAV1;ANK3;FAM20A;KCNA1;SLC12A5;SLC12A4
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3027133029743068,0.7997206189010776,0.8066875653082549,0.9775026214634512,1.0,14/79,14.25%,NEDD4;CADM4;ATP2B4;SPRY1;CHRD;LEMD2;GREM1;TRIM33;SPRY3;NBL1;SMAD1;SORL1;SPART;GDF3
prerank,protein targeting to peroxisome (GO:0006625),0.33428188640262757,0.7996446639094091,0.7676056338028169,0.9772076131517218,1.0,6/29,13.60%,PXMP2;PEX2;ABCD3;PEX16;PEX13;ZFAND6
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3689522714389487,0.7995984991703914,0.7316129032258064,0.9768797795049453,1.0,8/16,24.95%,CLN3;GSPT1;ETF1;IGF1R;BNIP3;TBC1D25;INSR;MTRF1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.34484306736083825,0.7995694996823302,0.7517647058823529,0.9765216093978263,1.0,10/24,24.82%,TGFB2;CTNNB1;PRNP;ATF4;EPHA7;GRN;MCL1;TYROBP;DDIT3;FBXW7
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2997265275348829,0.7994703083284973,0.8227320125130344,0.9762640784675602,1.0,8/76,11.35%,TMSB4X;CHP1;MTURN;TLR9;TRIM21;DAP;G3BP2;NFKBIA
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.2674440565823435,-0.7994139019157633,0.7788944723618091,0.942863707420158,1.0,11/22,24.82%,ERI3;EXOSC7;NOL9;URB1;EXOSC8;PES1;EXOSC3;RPP40;ERI2;RRS1;EXOSC2
prerank,response to cholesterol (GO:0070723),0.36184032045197073,0.7991149081846329,0.7404980340760158,0.9763769868489492,1.0,6/17,17.19%,SMAD2;GRAMD1B;PMVK;GPLD1;ABCA2;MLC1
prerank,C4-dicarboxylate transport (GO:0015740),0.3757715838491646,0.7988765530540808,0.7148488830486203,0.9763320719069466,1.0,5/14,20.05%,SLC1A6;SLC25A10;SLC25A14;SLC25A30;SLC25A22
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.40084603513536055,0.7988346579115426,0.7280453257790368,0.9759922318891368,1.0,3/11,17.93%,JAK2;SIRT1;HDAC2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.3846175014504202,0.7987720587921598,0.7325268817204301,0.9756876928708399,1.0,6/13,24.20%,CLN3;SHISA9;SYP;SLC4A10;GRIK2;PPFIA3
prerank,negative regulation of RNA splicing (GO:0033119),0.35774509777933894,0.7987022995190537,0.743073047858942,0.9753850315592942,1.0,5/19,13.93%,RPS26;PTBP3;PCBP4;PTBP2;SRSF7
prerank,regulation of establishment of protein localization (GO:0070201),0.3781527225299691,0.7985714224425565,0.7308192457737321,0.9751766132274708,1.0,3/14,15.53%,CENPJ;PTP4A3;TREM2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3781011151294211,0.7980279301278836,0.7446236559139785,0.9755894561202422,1.0,3/14,9.67%,GHR;JAK2;STAT5B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3744263159663079,0.7979691022539628,0.7299077733860343,0.9748636881560651,1.0,5/15,17.35%,PABPC1;DHX36;ZFP36L2;CPEB3;AGO2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3744263159663079,0.7979691022539628,0.7299077733860343,0.9748636881560651,1.0,5/15,17.35%,PABPC1;DHX36;ZFP36L2;CPEB3;AGO2
prerank,base-excision repair (GO:0006284),0.3146665853980948,0.7979215475705445,0.7792494481236203,0.9745359826277936,1.0,13/48,23.53%,RFC4;POLB;LIG1;POLE;RFC5;POLG;PCNA;HUWE1;ERCC5;POLD4;MPG;XPA;WRN
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.34175062707949355,0.7978065755554452,0.7481481481481481,0.9742982873051065,1.0,5/24,16.92%,CHD6;HSPA5;ATF4;CEBPB;KLF2
prerank,positive regulation of organelle organization (GO:0010638),0.33234346111575397,0.7976445148353537,0.7748502994011977,0.9741139601413549,1.0,8/32,20.56%,ANXA1;SMCR8;LMAN1;LNPK;TREM2;KATNBL1;C2CD5;GSK3B
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4062709027306214,0.7976159681640566,0.7209985315712188,0.9737642402860219,1.0,2/10,10.38%,ATP7A;APPL1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.2932478794991835,0.7974656288255915,0.8834170854271357,0.9735819037314898,1.0,24/166,15.58%,NR4A3;NCOR2;RARG;HDAC9;HDAC7;RARA;HDAC1;POLR1G;NR4A2;NR1H2;NR1D2;CCN2;NR4A1;NR6A1;GTF2H5;MED23;TAF1B;MED7;POLR2F;WWTR1;NCOR1;TAF6;TBPL1;NRBF2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3293604694390753,0.7973974462341994,0.7553551296505073,0.9732914708717456,1.0,6/35,9.79%,STAP1;ARHGDIB;DAPK3;MDK;IQGAP2;CDC42
prerank,megakaryocyte differentiation (GO:0030219),-0.3153684741616034,-0.7972463789265434,0.7328990228013029,0.9449331768364727,1.0,3/11,17.16%,SH2B3;TAL1;MED1
prerank,lamellipodium organization (GO:0097581),0.3325739665320436,0.797063416439932,0.7497034400948992,0.9733659969528796,1.0,4/29,6.94%,ABLIM1;ITGB1;CDH13;KIT
prerank,ether lipid metabolic process (GO:0046485),0.379349495006804,0.7966979949573645,0.7447916666666666,0.9734931229150094,1.0,7/14,26.47%,PLAAT3;GNPAT;DHRS7B;PAFAH1B1;PEDS1;NCEH1;FAR1
prerank,regulation of rRNA processing (GO:2000232),-0.2765771431896762,-0.7964480732724394,0.7345132743362832,0.944557503215943,1.0,5/16,11.15%,SIRT7;UTP15;WDR75;BUD23;RIOK1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.30469308418036967,-0.7963527306258688,0.7418300653594772,0.9429494670985382,1.0,1/13,0.27%,P2RY12
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.30192433721235634,0.796211616926601,0.8166491043203372,0.9737804923195944,1.0,18/73,24.48%,RAF1;PRKD2;ATP2B4;MIF;CREBL2;CD44;CAV1;HSP90AA1;STK4;PAK1;BRAF;NTRK3;SNCA;HSP90AB1;RAPGEF3;TFRC;TXN;CAPRIN2
prerank,sterol transport (GO:0015918),0.35522550529023705,0.7960459084932529,0.7355163727959698,0.9736062106386482,1.0,3/19,11.19%,CAV1;CD36;ARV1
prerank,regulation of viral life cycle (GO:1903900),0.34973769086996886,0.7955969997579505,0.7540574282147315,0.9738435358863666,1.0,3/21,13.15%,PPIA;TRIM21;TRIM68
prerank,Golgi organization (GO:0007030),0.29412507309202185,0.7955258146993572,0.8511722731906218,0.9735468303525545,1.0,21/112,16.27%,ATP8B4;TMED4;CSNK1A1;PRMT5;CDK1;SYNE1;COG7;SEC22B;LMAN2;LMAN1;CDC42;ARHGAP21;UBXN2A;GOSR2;VCPIP1;STX6;VPS51;RAB2A;GAK;HUWE1;STX17
prerank,organophosphate biosynthetic process (GO:0090407),0.3238641266242009,0.7953374345607841,0.7725274725274726,0.97341449489554,1.0,7/37,13.55%,TKT;FADS1;GPHN;MOCOS;GNPAT;NFS1;PPIP5K1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.4043567848350573,0.7953043680851472,0.7348066298342542,0.9726634115903782,1.0,2/10,28.12%,CNGB1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.4043567848350573,0.7953043680851472,0.7348066298342542,0.9726634115903782,1.0,2/10,28.12%,CNGB1;CEP250
prerank,regulation of Golgi organization (GO:1903358),-0.2715771169894428,-0.7952008243392391,0.780952380952381,0.943162847859874,1.0,2/17,4.08%,MYO5A;STX5
prerank,negative regulation of mRNA processing (GO:0050686),-0.2917574802796697,-0.7951700437254487,0.7407407407407407,0.9414518629836379,1.0,5/15,12.68%,U2AF2;SFSWAP;RBMX;SRSF9;PTBP1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.36171299647635163,0.7948949864980926,0.7474358974358974,0.9728513784207061,1.0,5/17,15.29%,S1PR2;PPP1R12A;ROCK1;CDH5;VCL
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.363899288153101,0.7940217267958822,0.7441253263707572,0.9736885874112085,1.0,4/16,14.01%,PPP2R1A;CAV1;VHL;PPP2CA
prerank,protein localization to Golgi apparatus (GO:0034067),0.3341677244089689,0.7937632293744215,0.7612826603325415,0.9736706358263997,1.0,8/27,20.79%,PAQR3;VPS13A;COG7;ZDHHC15;SORL1;GAK;ARL1;SYS1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3003692438191483,-0.7933661718712115,0.7473309608540926,0.94267523066894,1.0,8/12,31.98%,ADSS1;LHPP;PAICS;ATIC;IMPDH2;ADSS2;PPAT;IMPDH1
prerank,negative regulation of ion transport (GO:0043271),0.3441297698110442,0.7931391219725418,0.75375,0.9741737288422914,1.0,2/24,3.93%,NEDD4;GPM6B
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3005462515844712,0.7930891644311376,0.7991675338189386,0.9738540684398769,1.0,20/72,21.72%,PSMC3;PSMD8;PSME1;PSMD6;MALT1;PSMB5;PSMC6;PSMB4;PSMA7;PSMB9;PSMA6;PSMC1;TIRAP;PSMD7;PSMD2;PSMD5;COPS8;PSMB6;BIRC3;BTRC
prerank,positive regulation of nervous system development (GO:0051962),-0.2190074958446896,-0.7928609907541685,0.8636363636363636,0.9418070782834665,1.0,9/42,15.41%,NUMB;CX3CR1;IL1RAP;SYNDIG1;FAIM;BDNF;TGM2;NUMBL;DLG5
prerank,regulation of chromatin organization (GO:1902275),0.3795369507839982,0.7926834178946254,0.7493188010899182,0.9740202184258385,1.0,6/14,20.71%,SETD1A;SETD5;HPF1;ALKBH4;MLLT3;HNRNPU
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.32796524684657613,0.7924024345526336,0.7833523375142531,0.9740355926204919,1.0,3/33,7.67%,GATA3;TGFB2;ETS1
prerank,positive regulation of cytokinesis (GO:0032467),0.32913106065901027,0.7923617312078819,0.7657342657342657,0.9736910114721444,1.0,10/32,24.99%,PKP4;RACGAP1;CDC42;CIT;CUL3;DRD2;SVIL;CDC14A;RHOA;PKN2
prerank,RNA metabolic process (GO:0016070),0.29407730059449944,0.7923426242100913,0.8662613981762918,0.9733277938260476,1.0,33/127,22.98%,DEDD2;M1AP;ISG20;CLP1;RNASE3;RNASE6;PRPF4;XRN2;METTL3;ELAVL4;RNGTT;SYNCRIP;DHX36;PAPOLG;MPHOSPH10;ATXN1;POLR2F;METTL14;HNRNPF;DROSHA;RBMS2;RBFOX2;AGO2;RBM5;THOC1;RNASEL;PCBP1;PCBP3;HNRNPU;POLR2D;DDX17;SNRNP40;RNASEH1
prerank,organelle fission (GO:0048285),0.34349943355462226,0.7923166185824473,0.7481108312342569,0.9729705022915522,1.0,9/24,25.80%,MTFR2;DNM3;MUL1;MTFR1;ACOT8;DNM1L;MFF;GDAP1;TMCC1
prerank,positive regulation of B cell activation (GO:0050871),0.30990331471860016,0.7918125754197656,0.7971491228070176,0.9732609324511112,1.0,15/50,22.64%,CD74;BCL2;TLR9;MIF;SASH3;EPHB2;CLCF1;TNFRSF13C;TIRAP;CD320;PTPRC;GPR183;TNIP2;VAV3;TFRC
prerank,positive regulation of embryonic development (GO:0040019),0.3544210293424019,0.7916065964441712,0.7503201024327785,0.9731555897859939,1.0,2/19,9.90%,RACK1;CFL1
prerank,negative regulation of endocytosis (GO:0045806),0.3446291201548399,0.7916019303478601,0.764775413711584,0.9727662547475295,1.0,8/24,18.07%,APOC1;NR1H2;CAV1;ABCA7;LGALS3;SNX33;LILRB1;EPHA3
prerank,transcription by RNA polymerase I (GO:0006360),-0.2171353871336169,-0.7914286105055857,0.875,0.9424705137782516,1.0,12/34,23.76%,GTF2H2;TAF1D;MNAT1;UBTF;ERCC2;CCNH;POLR2K;RRN3;POLR1C;MAPK3;POLR2H;GTF2H4
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3867825292202091,0.7913134645962075,0.7417582417582418,0.9727748625082396,1.0,6/12,26.91%,IDH3A;IREB2;ASS1;IDH1;SIRT4;IDH3G
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.379863162530926,0.7910812861024801,0.7470967741935484,0.972702363867921,1.0,4/15,17.96%,CCT8;CCT2;RUVBL1;NAF1
prerank,base conversion or substitution editing (GO:0016553),-0.302352535901009,-0.791002179567589,0.7395833333333334,0.9414837678027387,1.0,2/11,5.22%,APOBEC1;ADARB1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3054410943931354,0.7908592905971418,0.7848518111964874,0.9726202920770898,1.0,19/52,26.47%,MBNL3;RBM11;RBM15;MBNL2;RBFOX1;KHDRBS2;RBM8A;RBFOX2;KHDRBS3;YTHDC1;RBM5;MBNL1;HNRNPU;DDX17;KHDRBS1;CELF1;CELF6;SRSF6;ZBTB7A
prerank,mitotic nuclear division (GO:0140014),0.3031683824735147,0.7907049643540641,0.8185610010427529,0.9724416073573312,1.0,20/71,25.19%,FLNA;SMC3;SMC4;CHMP7;CDCA8;RAB11A;ESPL1;KIF3B;AAAS;KIF11;KIFC1;MIS12;ZW10;PIBF1;NUP62;WRAP73;CLASP2;TOGARAM2;RHOA;MZT1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.28904691682707306,0.7902017966777382,0.8987975951903807,0.9727466686429058,1.0,44/173,23.69%,RANGRF;F5;CD55;F8;SPTBN4;GRIA1;TMED4;COG6;DCTN4;DYNLL1;COG7;CTSZ;SEC22B;ANK3;LMAN2;LMAN1;NSF;COPB2;GOSR2;USE1;RAB2A;SAR1B;F10;CUL3;SEC24D;STX17;ARFGAP2;ANK1;MIA3;ACTR10;TRAPPC4;CTSC;PREB;ARFGAP1;ARFGAP3;TRAPPC5;ZW10;MPPE1;TBC1D20;SEC24C;TMED2;COG5;TMED5;PGAP1
prerank,regulation of mitochondrial fusion (GO:0010635),0.3883763397023279,0.789940000137529,0.7237569060773481,0.972707567598077,1.0,6/11,22.64%,MUL1;VAT1;HUWE1;OMA1;BNIP3;TFRC
prerank,tRNA export from nucleus (GO:0006409),0.32322120915493385,0.78965900676709,0.7548460661345496,0.9723162597487855,1.0,14/32,29.69%,NUP50;NUP214;NUP210;NUP88;RANBP2;AAAS;NUP62;NUP93;NUP205;NDC1;NUP153;NUP98;TPR;NUP35
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.32322120915493385,0.78965900676709,0.7548460661345496,0.9723162597487855,1.0,14/32,29.69%,NUP50;NUP214;NUP210;NUP88;RANBP2;AAAS;NUP62;NUP93;NUP205;NDC1;NUP153;NUP98;TPR;NUP35
prerank,regulation of protein localization to nucleus (GO:1900180),0.31243923051162975,0.7892496746259368,0.7795454545454545,0.9725011752567432,1.0,7/43,14.99%,FERMT2;CDK1;BMP4;NVL;PIN1;WWTR1;EIF2AK3
prerank,regulation of chromosome segregation (GO:0051983),0.36586379419924225,0.7891551012845743,0.7548387096774194,0.9722349284288475,1.0,8/16,27.66%,RMI2;SMC6;SMC5;RAD18;MKI67;CSNK2A2;CSNK2A1;PUM1
prerank,neuromuscular process (GO:0050905),-0.2886181430624898,-0.7887793134604514,0.7564102564102564,0.9434793748488124,1.0,4/16,10.53%,TPP1;TIFAB;GCH1;SHANK1
prerank,negative regulation of receptor internalization (GO:0002091),-0.3085993733164659,-0.7885577633964475,0.6985294117647058,0.9421957611112137,1.0,4/12,14.69%,DLG4;ANKRD13D;ATXN2;ANKRD13B
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.37580006157538504,0.7885471968386611,0.7286501377410468,0.9726561445982316,1.0,3/13,25.74%,NAXE;PARP10;PARP16
prerank,signal release from synapse (GO:0099643),0.3143993438025434,0.7884622948178587,0.8017429193899782,0.9723804528118541,1.0,12/43,25.51%,HSPA8;NAAA;LIN7C;DNAJC5;PDZD11;SYN3;CPLX2;SNCA;RIMS1;SNPH;PPFIA3;PCLO
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.33426463554714375,0.7881591880957438,0.7560679611650486,0.9724171536329512,1.0,4/27,6.84%,DCN;BGN;UGDH;CHST9
prerank,limb development (GO:0060173),0.33140365419191886,0.7880790142330271,0.7523584905660378,0.9721313913250758,1.0,8/28,20.09%,SMOC1;GREM1;GLI3;ZNRF3;LNPK;KAT2B;RSPO2;LRP4
prerank,positive regulation of bone mineralization (GO:0030501),0.32299326285859076,0.7879205746507653,0.7891077636152954,0.9719580859575699,1.0,4/35,8.99%,LTF;GPM6B;BMP4;BMP6
prerank,modification-dependent protein catabolic process (GO:0019941),0.28417705036049595,0.7877250071335516,0.908908908908909,0.9718527880556708,1.0,34/193,18.73%,RNF125;RPS27A;RNF7;NEDD4;UBA52;BUB1B;RNF14;LONP1;FZR1;UHRF1;UBE2H;RNF111;UBE2G2;FEM1C;UBE2L3;BIRC6;AMFR;UBQLN1;ZNRF3;UBB;KLHL25;COPS3;UBE2B;CUL3;TTC3;CHFR;KEAP1;UBE4A;AREL1;SMURF2;FBXO11;OS9;CDC34;FBXO10
prerank,peptide metabolic process (GO:0006518),0.29175599704499683,0.7873652581302968,0.8234064785788924,0.971979431355907,1.0,11/75,18.14%,CPXM2;AEBP1;GPX1;GSR;CPM;DNPEP;DMD;LNPEP;MGAT3;BACE2;SPPL3
prerank,modulation by symbiont of entry into host (GO:0052372),0.36696757328578156,0.7872957135812269,0.7483530961791831,0.9716915110537583,1.0,3/16,13.15%,TRIM21;CAV1;TRIM68
prerank,chondroitin sulfate catabolic process (GO:0030207),0.37772556259072343,0.7870936343405996,0.75,0.9715852505594893,1.0,2/13,5.41%,DCN;BGN
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.28551566887014906,0.7866154845521856,0.939,0.9718401930965027,1.0,81/241,27.22%,SYF2;DBR1;HSPA8;CLP1;CD2BP2;PRPF4;PPIH;METTL3;LSM3;RBM15;CSTF2;SNRPG;UBL5;WBP4;PABPC1;RBM4B;EIF4A3;PSPC1;SYNCRIP;CHERP;PHF5A;SNRPA;NUDT21;PRPF8;CWC22;CSTF3;CDC40;SF3B2;SF3B1;RBM10;SF3A3;POLR2F;ZCRB1;METTL14;SF3A2;WBP11;SRSF7;HNRNPF;XAB2;RBM8A;SNRPB;SLU7;USP49;RAVER2;DDX46;LSM6;YTHDC1;ZRSR2;PRCC;RBM5;CSTF2T;PCBP1;PRPF31;PLRG1;HNRNPU;LSM4;SRSF4;POLR2D;PRPF6;DDX41;SF3B6;YBX1;SNRNP40;PAPOLA;CWF19L1;HNRNPUL1;CDC5L;HNRNPC;SNRPC;CPSF2;SRSF6;RALY;GCFC2;AQR;U2SURP;DHX35;HNRNPA2B1;SF3B3;PABPN1;RBM19;HNRNPR
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.25931778921348153,-0.7864282779669778,0.7544642857142857,0.9441010454854286,1.0,4/19,12.62%,GNL3L;DCP2;TEN1;NAT10
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.22095825073721903,-0.7863178008867108,0.8095238095238095,0.9425537875642997,1.0,12/32,23.76%,GTF2H2;TAF1D;MNAT1;UBTF;ERCC2;CCNH;POLR2K;RRN3;POLR1C;MAPK3;POLR2H;GTF2H4
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2909341865182652,0.7858841811542079,0.8746208291203236,0.972453115377291,1.0,30/129,21.79%,PLK4;CENPJ;MELK;PPP2R2A;PPP1R12A;TPD52L1;CDK1;DYNLL1;PPP2R1A;CDK2;HSP90AA1;LCMT1;MASTL;HAUS5;CCNY;CDKN1A;CEP41;PCNT;PAFAH1B1;FBXL17;HAUS4;HAUS2;CEP43;NINL;CEP70;WEE1;HAUS3;YWHAG;BTRC;TUBB4B
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.39124380213351484,0.7858223502041075,0.7247579529737206,0.9721415707840513,1.0,2/11,8.50%,EFNB2;GREM1
prerank,transferrin transport (GO:0033572),0.32506198278558496,0.7857413496077486,0.7603305785123967,0.9718641147284566,1.0,10/33,23.14%,ATP6V1G2;LMTK2;ATP6AP1;ATP6V0B;ATP6V0A2;ATP6V0E1;ATP6V1F;ATP6V1G1;TFRC;ATP6V1B2
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.31088473668341104,0.7855668957514469,0.796440489432703,0.9717221826397804,1.0,14/42,23.57%,LARS2;MARS2;AIMP1;TARS2;TARS3;GARS1;PPA2;DARS1;RARS1;EEF1E1;KARS1;SARS1;SARS2;EPRS1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.36142145104679324,0.7854440688586161,0.7739130434782608,0.9715047845552267,1.0,8/18,26.49%,PRKD2;RPS6KA5;EPHA5;ADCY1;CRTC2;RELN;CRTC1;ADCY8
prerank,positive regulation of lamellipodium organization (GO:1902745),0.31958203438541116,0.7848803483737551,0.7668997668997669,0.9718883765766787,1.0,9/32,16.94%,AUTS2;ARPC2;CLRN1;RAC2;CDC42;NCKAP1;ACTR3;CARMIL2;TWF2
prerank,regulation of cytoplasmic translation (GO:2000765),0.3686691054731507,0.7844802880686952,0.7555847568988173,0.972070144964171,1.0,3/14,12.16%,DHX36;CPEB3;YBX3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3269209769315715,0.7841187496178769,0.7788018433179723,0.972195349985376,1.0,8/30,20.69%,CADM4;PPP2R1A;CAV1;SRCIN1;PPP2CA;PTPRC;MVP;PIBF1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.26716036449467895,-0.7837538039466185,0.7647058823529411,0.9452118902553142,1.0,5/20,13.40%,MCUR1;PARL;SLC8B1;LETM1;MAIP1
prerank,response to glucose (GO:0009749),0.31339566138830754,0.7833634912454861,0.7958287596048299,0.9728474751399019,1.0,4/46,9.18%,GCK;RACK1;GPLD1;EIF2B4
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.31288850911825455,-0.7831109092068977,0.724025974025974,0.944504777093177,1.0,1/10,0.75%,LYN
prerank,neurotransmitter secretion (GO:0007269),0.31177819241931426,0.7829569916004275,0.8133187772925764,0.9730397585310782,1.0,12/44,25.51%,HSPA8;NAAA;LIN7C;DNAJC5;PDZD11;SYN3;CPLX2;SNCA;RIMS1;SNPH;PPFIA3;PCLO
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.3830254116762848,0.7818534598808071,0.7517337031900139,0.9741823070683293,1.0,3/12,19.18%,CCDC120;CEP19;NINL
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.28345603297709704,0.7817856689185169,0.953,0.9738863893433324,1.0,82/264,25.64%,SYF2;DBR1;SRPK1;HSPA8;CLP1;CD2BP2;PRPF4;PPIH;METTL3;PRMT5;LSM3;RBM15;CSTF2;SNRPG;UBL5;WBP4;SRPK3;PABPC1;RBM4B;EIF4A3;PSPC1;SYNCRIP;CHERP;PHF5A;SNRPA;NUDT21;PRPF8;CWC22;CSTF3;CDC40;SF3B2;SF3B1;RBM10;SF3A3;POLR2F;DDX1;ZCRB1;METTL14;SF3A2;WBP11;SRSF7;HNRNPF;XAB2;RBM8A;SNRPB;SLU7;USP49;CDK13;RAVER2;DDX46;LSM6;YTHDC1;ZRSR2;PRCC;RBM5;GEMIN8;CSTF2T;PCBP1;PRPF31;PLRG1;HNRNPU;LSM4;PRMT7;SRSF4;POLR2D;PRPF6;DDX17;DDX41;SF3B6;YBX1;SNRNP40;PAPOLA;CWF19L1;HNRNPUL1;CDC5L;HNRNPC;SNRPC;CPSF2;SRSF6;RALY;GCFC2;AQR
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.2507156726336691,-0.7814504509438226,0.8095238095238095,0.945455121441377,1.0,3/23,4.25%,CX3CR1;NLRP3;TNFAIP3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.30527574086300446,0.7813811671453711,0.798918918918919,0.9740546336752087,1.0,10/45,22.79%,TRIM16;MALT1;JAK2;CD36;PANX1;AGER;USP50;TYROBP;EGR1;P2RX7
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2911994098421427,0.7813465567651373,0.8331595411887383,0.9737122323753584,1.0,24/84,22.20%,MBNL3;PRDX6;RBM11;SRPK1;RBM15;PCBP4;NCL;CWC22;RBMXL1;MBNL2;JMJD6;SRSF7;RBFOX1;KHDRBS2;RBM8A;RBFOX2;KHDRBS3;YTHDC1;RBM5;MBNL1;HNRNPU;SRSF4;DDX17;TIA1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.32516029588235795,0.7812634974716642,0.7735632183908046,0.9734441937614738,1.0,9/32,20.82%,MCTP2;KCNMB4;BAIAP3;RIMS3;CPLX2;RIMS4;PNKD;GSK3B;RIMS1
prerank,pinocytosis (GO:0006907),0.39368158560777905,0.781241888071103,0.743849493487699,0.9730935955263001,1.0,4/10,22.77%,MAPKAPK3;MAPKAPK2;SNX33;DOCK2
prerank,phosphorylation (GO:0016310),0.2817244931787612,0.7809634208856839,0.979,0.9730837387464132,1.0,72/385,17.23%,LCK;MAP4K2;RUNX3;CAMK4;PLK4;TXK;DGKA;SRPK1;CDK6;LMTK2;MELK;NEK4;RSKR;CDK8;BIRC5;ILF3;CDK17;DAPK3;PIM1;PRKAR1B;ATM;PRKD2;RARA;MEX3B;HK1;MAPK9;CSNK1A1;CDK1;TGFB2;HIPK1;STK17B;RPS6KA5;NLK;BIRC6;SPHK2;GRK6;PAK4;JAK2;CERKL;FAM20A;CDK2;TAOK3;CDC42BPG;ZAP70;ILK;ROCK1;SIK3;HCST;EPHB2;LIMD1;DCLK1;NIM1K;STK24;EPHA7;MATK;MAPKAPK2;STK4;TESK2;COQ8A;TNIK;EIF2AK3;FYN;HIPK3;PKN1;PAK1;MAP4K5;GSK3A;GNPTAB;CDK13;STK26;TOP1;PPP3CB
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3364885161134905,0.7806963497234537,0.7709637046307884,0.9730560820233521,1.0,3/23,12.04%,SLC12A7;SLC12A5;SLC12A4
prerank,regulation of spindle assembly (GO:0090169),0.3371039849433139,0.7806823371994128,0.7576875768757687,0.972688256066583,1.0,12/25,32.43%,GPSM2;CHMP5;CCSAP;HSPA1A;HNRNPU;PDCD6IP;TPR;VPS4B;CHMP1A;CHMP2A;CEP97;EML3
prerank,regulation of protein processing (GO:0070613),0.34218824136004583,0.7805314044547722,0.753731343283582,0.9725073580772826,1.0,5/21,21.30%,CLN3;PRNP;GAS1;SNX12;TMEM59
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.32160374514973467,0.780086139247391,0.7893544733861835,0.9727107934023096,1.0,9/35,21.99%,FLNA;SEMA5A;PLXNB1;PLXNA2;SEMA3E;SEMA5B;SEMA3D;PLXND1;MET
prerank,cellular response to starvation (GO:0009267),0.2865804953496269,0.7797186858234878,0.8763819095477386,0.9728089705343014,1.0,34/147,19.77%,DAPL1;FADS1;ATP6V1G2;HSPA8;NPRL2;EIF2S1;SREBF1;HSPA5;MAP1LC3A;MFSD2A;DAP;LAMTOR4;ATG5;ATP6V0B;SESN3;NIM1K;FOXO1;ATF4;STK24;RALB;XPR1;SIRT1;CDKN1A;EIF2AK3;RHEB;CEBPB;STK26;ATP6V0E1;RNF152;LAMP2;ATP6V1F;ATG14;ATP6V1G1;SZT2
prerank,negative regulation of histone modification (GO:0031057),0.3753064838412592,0.779699154884682,0.7444005270092227,0.9724477514397707,1.0,2/14,8.58%,JARID2;SPHK2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.2957204273640697,0.779209243819774,0.84472049689441,0.9727547967061405,1.0,16/86,16.94%,NCK2;CLU;SEMA5A;ARL2;APOE;RPS3;GPX1;NCK1;SYNPO2;MAPT;NCKAP1;EFEMP2;PAK1;KATNB1;STMN2;CDC42EP3
prerank,regulation of tube diameter (GO:0035296),0.3760069034240463,0.7790218668702397,0.7538247566063978,0.9722336535397681,1.0,3/13,12.88%,ADCY6;ROCK1;SCPEP1
prerank,vascular process in circulatory system (GO:0003018),0.3760069034240463,0.7790218668702397,0.7538247566063978,0.9722336535397681,1.0,3/13,12.88%,ADCY6;ROCK1;SCPEP1
prerank,ncRNA export from nucleus (GO:0097064),0.3143927491041088,0.778968163984658,0.7827547592385219,0.9719189764392965,1.0,14/36,28.30%,NUP50;NUP214;NUP210;NUP88;RANBP2;NPM1;AAAS;NUP62;NUP93;NUP205;NDC1;NUP153;NUP98;TPR
prerank,protein sumoylation (GO:0016925),0.30563778913592066,0.7789082784676346,0.8169934640522876,0.9716136145548593,1.0,19/49,28.30%,NUP50;NUP214;NUP210;SUMO2;NUP88;RANBP2;AAAS;PIAS1;EGR2;TRIM28;NUP62;NUP93;NUP205;IFIH1;NDC1;NUP153;NUP98;PIAS3;TPR
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3217505624505801,0.7787456655107652,0.780630105017503,0.9714530939639251,1.0,3/31,6.17%,DAXX;HSPA8;HSPA5
prerank,double-strand break repair via homologous recombination (GO:0000724),0.29223666726093894,0.7786710833847406,0.8602261048304214,0.9711591863501671,1.0,19/95,19.92%,RAD54L;ERCC4;MCM7;MCM2;GINS2;NIPBL;MORF4L1;NSMCE1;CDC7;NABP1;BLM;PALB2;REV3L;SAMHD1;ERCC5;MCM6;YY1;RBBP8;SMC6
prerank,organelle fusion (GO:0048284),0.3465504744609495,0.7785824442549379,0.7707558859975217,0.9708962194537567,1.0,1/22,1.14%,THG1L
prerank,negative regulation of transferase activity (GO:0051348),0.3312443288751117,0.7785039512870068,0.753810082063306,0.9706204740967487,1.0,7/28,20.71%,NPRL2;ERCC4;FBXO5;MAPT;GSK3A;GSK3B;HNRNPU
prerank,positive regulation of synapse assembly (GO:0051965),0.33127043870358547,0.7784748070342865,0.7693222354340071,0.9702729584967946,1.0,3/27,11.78%,SLITRK2;GRID2;EPHB2
prerank,embryonic eye morphogenesis (GO:0048048),0.383860665172794,0.7782801326373963,0.7390710382513661,0.9701695167567904,1.0,1/11,2.58%,RARG
prerank,tRNA transport (GO:0051031),0.31651316159146614,0.7782792010400227,0.7887640449438202,0.9697870781227971,1.0,14/35,28.30%,NUP50;NUP214;NUP210;NUP88;RANBP2;AAAS;NUP62;YBX1;NUP93;NUP205;NDC1;NUP153;NUP98;TPR
prerank,nucleotide biosynthetic process (GO:0009165),0.3559926929906866,0.7780622294059389,0.7455919395465995,0.9696949117728341,1.0,10/18,30.70%,GART;MTHFD1;ME1;RRM2B;HPRT1;PRPS2;PRPS1L1;PRPS1;ADSL;NMNAT3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.34999650258586334,0.7774264311367127,0.7585335018963337,0.970177815944328,1.0,3/19,11.18%,GATA3;MDK;ZAP70
prerank,hemidesmosome assembly (GO:0031581),0.3862205237675478,0.7772656424727199,0.7393103448275862,0.970023536822565,1.0,1/11,2.49%,PLEC
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3146179476559107,0.7769880363972048,0.8047404063205418,0.9699898610131719,1.0,12/39,24.79%,FBLN1;HOXA7;GCNT2;SEMA3E;JAG1;ACER2;CX3CL1;SPOCK1;ITGB1BP1;ACTN4;RHOA;FZD7
prerank,protein hydroxylation (GO:0018126),0.3582057205684315,0.7769614071176933,0.7316421895861148,0.9696396313317885,1.0,1/15,1.30%,P3H1
prerank,regulation of mitotic spindle organization (GO:0060236),0.3196492122988538,0.7763997182204675,0.7848101265822784,0.9699982717825985,1.0,9/35,22.31%,GPSM2;PARP3;CHMP5;CCSAP;HSPA1A;GNAI1;HNRNPU;PDCD6IP;NUP62
prerank,RNA modification (GO:0009451),0.30500487989029507,0.7755614783045424,0.8286637931034483,0.970761940457907,1.0,18/54,26.81%,THG1L;PUS7;METTL3;RBM15;FTSJ3;MRM2;TRMT6;JMJD6;NSUN2;ANKRD16;TRMT9B;URM1;CTU2;NOP2;TSR3;CTU1;ADAR;ALKBH1
prerank,regulation of pH (GO:0006885),0.37904169927649584,0.7755296430345502,0.752112676056338,0.9704192653482174,1.0,2/11,9.59%,ATP6AP1;ATP1A4
prerank,protein K63-linked ubiquitination (GO:0070534),0.30958169325078344,0.7755277543148746,0.7911111111111111,0.9700388678253508,1.0,9/41,21.38%,TRAF1;NEDD4;TRIM21;PELI1;UBE2B;RNF152;RNF135;TRAF3;UBE2E2
prerank,nuclear membrane disassembly (GO:0051081),-0.2930337088985274,-0.7752553908409954,0.7791666666666667,0.9540403492646983,1.0,4/14,13.68%,NEK6;AKAP8L;PRKCB;LPIN1
prerank,O-glycan processing (GO:0016266),0.3024667708011431,0.7752462458309644,0.8076923076923077,0.970017794213143,1.0,6/54,15.11%,B3GNT3;ST3GAL1;GALNT15;GALNT13;GALNT6;GXYLT2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.33477524929809854,0.7751039344741144,0.7788819875776397,0.9698288410414116,1.0,1/25,0.95%,MMP9
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.32228581530524164,-0.7744600377612872,0.7138364779874213,0.9536740487761701,1.0,3/10,9.41%,ABCA3;MTMR4;MTMR3
prerank,peroxisome organization (GO:0007031),0.32779019467095866,0.7737270625626862,0.767639902676399,0.9712498752209403,1.0,8/25,21.25%,PEX2;ABCD3;PLAAT3;PEX16;ACOT8;PEX10;DNM1L;MFF
prerank,activation of protein kinase activity (GO:0032147),0.28711178315838226,0.7733728352660286,0.861336032388664,0.9713288520895763,1.0,22/106,20.69%,NRG1;GHR;ANGPT1;PPIA;PRKAR1B;MALT1;TGFB2;PAK4;JAK2;ADCY6;TAOK3;STK4;TNIK;PRKAR1A;TIRAP;PAK1;ADCY1;NTRK3;CCDC88A;COPS8;STK11;PIBF1
prerank,histone H2A monoubiquitination (GO:0035518),-0.27108710805337155,-0.77311446334197,0.780373831775701,0.9539914062549344,1.0,7/17,22.40%,PCGF3;KDM2B;BCOR;CUL4B;PCGF6;RING1;RNF2
prerank,sterol biosynthetic process (GO:0016126),0.3246152641769967,0.7731001767842273,0.7835051546391752,0.9713217678274657,1.0,8/33,21.71%,LBR;HSD17B7;PMVK;ARV1;PLPP6;HMGCS1;ACAT2;MSMO1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.30323078066019127,-0.7730517984988765,0.7142857142857143,0.952354173989813,1.0,3/11,11.02%,SH2B3;NF2;HGS
prerank,signal transduction in response to DNA damage (GO:0042770),0.30620695341140447,0.7729155470190614,0.8244274809160306,0.9711790985488595,1.0,13/49,20.96%,ATRX;RAD1;BID;ATM;GADD45A;INTS7;BRIP1;NDRG1;USP28;BATF;HINFP;ATR;ACER2
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3060448675337837,-0.7725188656390736,0.7798507462686567,0.9514718366706371,1.0,5/12,17.87%,PPT1;LRRK2;CLN6;TMEM9;CCDC115
prerank,DNA replication checkpoint signaling (GO:0000076),-0.277322810695259,-0.7723869816877144,0.7982832618025751,0.9499644178127756,1.0,6/16,21.08%,DNA2;RAD17;HUS1;TIPIN;RAD9A;ORC1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.2913706118961783,-0.7723128799202988,0.8048780487804879,0.9483638200551366,1.0,6/13,28.13%,SEC16A;CD81;TM9SF4;BRSK2;GCC2;INSIG1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.3586554617924963,0.7721716771822807,0.7604871447902571,0.9717782859094889,1.0,3/15,16.00%,APOE;GPLD1;SNX33
prerank,male meiosis I (GO:0007141),0.3524816251445144,0.7715254812599697,0.7450980392156863,0.9722262911910734,1.0,2/16,11.49%,ING2;SYCP3
prerank,neuron migration (GO:0001764),0.3068413809916692,0.7711831234949666,0.810989010989011,0.9723035587893124,1.0,10/48,16.52%,AUTS2;NDNF;DCX;NR4A2;CELSR1;PEX13;GPM6A;CEP85L;MAP1B;PAFAH1B1
prerank,neuromuscular synaptic transmission (GO:0007274),0.347467753536447,0.770640879109334,0.7812895069532237,0.9726164088146146,1.0,3/18,12.40%,ERC2;DTNA;ERC1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.2917238549521533,0.7704800269357888,0.8515463917525773,0.972441922744303,1.0,20/83,21.79%,PLK4;CENPJ;CDK1;DYNLL1;PPP2R1A;CDK2;HSP90AA1;HAUS5;NPM1;CEP41;PCNT;PAFAH1B1;HAUS4;HAUS2;CEP43;NINL;CEP70;HAUS3;YWHAG;TUBB4B
prerank,establishment of vesicle localization (GO:0051650),0.35290481926024064,0.770414310075848,0.7659846547314578,0.9721428274285557,1.0,7/18,23.14%,KIF5A;RAB11A;KIF5C;TMEM230;CCDC186;RAB27A;LIMK2
prerank,integrated stress response signaling (GO:0140467),0.3665214196515311,0.7699766075633392,0.7456258411843876,0.9723244404902683,1.0,6/14,23.08%,EIF2S1;HSPA5;ATF4;EIF2AK3;OMA1;DDIT3
prerank,ventricular septum morphogenesis (GO:0060412),0.32570879340978626,0.7696069521667088,0.7837514934289128,0.9724303431695949,1.0,9/27,19.05%,TGFB2;BMP4;HEY2;ROBO1;TGFBR3;ROBO2;SOX11;HES1;SLIT3
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.29538161322539913,0.7695817775523508,0.8301486199575372,0.9720837109163754,1.0,12/66,18.09%,FLNA;CCT8;FERMT2;CCT2;CDH1;CDK1;ZPR1;WWTR1;UBR5;EIF2AK3;JUP;DMAP1
prerank,cellular macromolecule catabolic process (GO:0044265),0.3027059456069944,0.7694104826935849,0.7993456924754635,0.9719008229304851,1.0,5/49,7.43%,ISG20;RNASE3;RNASE6;XRN2;UBE2G2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3410227573149438,0.7691447325319147,0.7879161528976573,0.9718639788582587,1.0,5/22,12.77%,PSMB5;PSMB4;PSMA7;PSMB9;PSMA6
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.33364754749497344,0.7690628675005885,0.7660098522167488,0.9715918691594004,1.0,10/23,28.51%,ENTPD5;PRXL2C;MLXIPL;GAPDHS;P2RX7;INSR;IGF1;ARNT;PFKFB1;HIF1A
prerank,cell cycle G2/M phase transition (GO:0044839),0.2849678177219038,0.7688047650467212,0.8977732793522267,0.971535736514155,1.0,30/130,21.79%,PLK4;CENPJ;MELK;PPP2R2A;PPP1R12A;TPD52L1;CDK1;DYNLL1;PPP2R1A;CDK2;HSP90AA1;LCMT1;MASTL;HAUS5;CCNY;CDKN1A;CEP41;PCNT;PAFAH1B1;FBXL17;HAUS4;HAUS2;CEP43;NINL;CEP70;WEE1;HAUS3;YWHAG;BTRC;TUBB4B
prerank,ubiquinone biosynthetic process (GO:0006744),0.35998954509876013,0.7685552580435637,0.7585301837270341,0.9714664349359796,1.0,4/15,13.63%,NDUFA9;COQ10B;COQ8A;COQ3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3224807019140237,0.7683675691945634,0.7824561403508772,0.9713276530883117,1.0,4/27,11.35%,MAPK9;NR1H2;CD36;NFKBIA
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3320063960757742,0.7682430674813279,0.7884841363102233,0.9711140360704996,1.0,7/28,21.99%,ARL2;RPS3;MAPT;HSPA1A;PAK1;MECP2;MET
prerank,positive regulation of phosphatase activity (GO:0010922),0.3408284611728667,0.7682198648096089,0.7590799031476998,0.9707596848301755,1.0,8/21,22.74%,PPP1R15A;PTPA;GPLD1;PPP1R15B;CALM1;HSP90AB1;ITGA1;CALM3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3267646591724246,0.7679785750684688,0.8028169014084507,0.9706841982637621,1.0,7/27,20.05%,SLC3A2;SLC1A6;SLC7A1;SLC7A5;ARL6IP5;SLC38A1;SLC25A22
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.30658986883923706,0.7679575017660376,0.7822120866590649,0.9703330062249693,1.0,15/38,26.61%,NCK2;CAV1;SRCIN1;PRNP;SHC1;NEDD9;DLG3;PTPRC;MVP;EFNA1;IL34;THY1;RELN;LILRA5;DOK7
prerank,rRNA methylation (GO:0031167),-0.25186936909915586,-0.7679216660634551,0.8131313131313131,0.9534470626002489,1.0,9/22,22.45%,METTL16;METTL5;NSUN4;BUD23;NSUN5;NSUN3;MRM1;MRM3;TFB2M
prerank,protein glycosylation (GO:0006486),0.2822580119908435,0.7676582870380697,0.8929292929292929,0.9703387748763412,1.0,28/125,21.27%,B3GNT3;ENTPD5;DOLPP1;FUT9;MAGT1;AQP11;COG7;PMM2;GCNT2;DPM3;ST3GAL1;ST8SIA5;DDOST;GALNT6;TUSC3;GALNT18;MGAT3;DPAGT1;ALG1;B3GNT2;FKTN;POGLUT1;FUT8;OGA;B3GALNT2;GFPT2;ST8SIA6;TMEM165
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.2899131127844258,-0.7676319322424391,0.7928286852589641,0.9521630345090257,1.0,4/13,9.85%,NR3C2;PGR;PLPP1;NR3C1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3246395605677259,0.7674673070428217,0.8028335301062574,0.9702065705756842,1.0,9/29,22.21%,EXOSC4;DCP1A;LSM3;HBS1L;EXOSC1;LSM6;LSM4;EXOSC9;DDX6
prerank,myeloid cell differentiation (GO:0030099),0.30402093897351296,0.7674448286462641,0.8304157549234136,0.9698660476856947,1.0,6/47,14.89%,RPS14;KIT;JAK2;ZBTB16;RPS19;TIRAP
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.30641496181955813,0.7669570077950119,0.8124306326304107,0.970110924684535,1.0,3/41,5.91%,PTPN22;LBP;RARA
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3209295957885908,0.7669256158863127,0.7792056074766355,0.9697703171454836,1.0,7/30,21.23%,RPL11;CCAR2;NOP53;EIF3H;SDCBP;RYBP;HSP90AB1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.23813266146028086,-0.766117502110912,0.7777777777777778,0.9528474462575325,1.0,6/22,14.90%,DDX39B;SCAF8;TCERG1;THOC5;EAPP;CCNT2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2958585870476826,0.7659828577727742,0.8320610687022901,0.970590433052182,1.0,10/56,12.42%,RTKN;RACGAP1;BIN3;KIF20A;ARL3;ANK3;RHOC;ESPL1;ROCK1;CIT
prerank,purine ribonucleotide catabolic process (GO:0009154),0.33941809856242905,0.7659770686589978,0.7572327044025158,0.9702193469684506,1.0,5/21,18.74%,ACAT1;NUDT4;NUDT16;AMPD3;HPRT1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.30606621440318277,0.7654437864266755,0.814317673378076,0.9705232492663757,1.0,15/41,26.61%,STAP1;NCF1;SRCIN1;PRNP;FYN;DOCK3;NEDD9;DLG3;EFNA1;IL34;RELN;FBXW7;LILRA5;NTRK2;DOK7
prerank,synaptic vesicle localization (GO:0097479),-0.2935079222476099,-0.7652215232458646,0.7554744525547445,0.9524781205522656,1.0,5/13,11.60%,KIF5B;SYNDIG1;CDK5;SPG11;SNAPIN
prerank,positive regulation of cell development (GO:0010720),-0.22536148246523932,-0.7650607274730935,0.8636363636363636,0.951053345523947,1.0,2/31,0.84%,NUMB;CX3CR1
prerank,actin filament-based transport (GO:0099515),-0.24815206020615227,-0.7649266704196405,0.7604166666666666,0.9495968484436875,1.0,6/21,18.65%,MYO7A;MYO5A;MYO1F;MYO19;MYO1B;MYO5B
prerank,regulation of TORC1 signaling (GO:1903432),0.3081322795712397,0.7648883106330262,0.7883040935672515,0.9708180258157653,1.0,13/33,28.08%,SMCR8;ATM;SESN3;SIK3;RNF152;SZT2;STK11;PIP4P1;RRAGB;ITFG2;CASTOR2;DEPDC5;KPTN
prerank,regulation of protein export from nucleus (GO:0046825),0.33134618684693373,0.7646743380725562,0.7904993909866017,0.9707138632783286,1.0,3/23,6.63%,SP100;ANP32B;BARD1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.24574798879958368,-0.7645568331819205,0.8333333333333334,0.9484322334624901,1.0,9/23,25.28%,TNFAIP3;MINDY2;OTUD4;USP37;YOD1;USP5;BAP1;MINDY1;USP25
prerank,positive regulation of axonogenesis (GO:0050772),0.3058278533900673,0.7645489498750776,0.8044444444444444,0.9704846539247394,1.0,10/43,16.94%,CHODL;AMIGO1;PLXNB1;PLXNA2;ROBO1;MAPT;ISLR2;ROBO2;TIAM1;TWF2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3235785738904818,0.7642775061155527,0.813953488372093,0.9704555948306781,1.0,5/29,8.39%,FBXO5;RPS2;PIN1;UBE2L3;DCUN1D5
prerank,calcium ion transport into cytosol (GO:0060402),0.34041193389752106,0.7639902908072117,0.7589175891758918,0.9704566582576821,1.0,8/21,24.22%,ITPR3;ATP2B4;JPH4;CACNA2D1;MS4A1;JPH1;JPH3;GRIN1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.24922757231732856,-0.7637333584972928,0.8085106382978723,0.9480385573960449,1.0,7/23,15.43%,FGF2;PIK3CD;VEGFA;PAX8;PAX2;SOX8;AGT
prerank,positive regulation of histone acetylation (GO:0035066),-0.23675524244100177,-0.7635598258952266,0.8587570621468926,0.946589706139282,1.0,7/23,20.38%,PAXIP1;BRD7;PPARGC1A;ARRB1;PIH1D1;SMARCB1;MAPK3
prerank,signal transduction by p53 class mediator (GO:0072331),0.3182691841812564,0.7626451088114614,0.7983777520278099,0.9718128506749563,1.0,8/30,23.93%,ATRX;GREM1;NDRG1;BATF;PPP1R13B;STK11;ACER2;MDM4
prerank,peptidyl-lysine acetylation (GO:0018394),0.3831919650631291,0.7622169713737121,0.749648382559775,0.9719622274517773,1.0,3/10,18.77%,SIRT1;KAT2B;ESCO1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.33534437781679144,0.7618494903884506,0.7884856070087609,0.9720320860941163,1.0,2/20,7.99%,BCL2;THADA
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3188940585080015,0.7604854330087683,0.8050239234449761,0.9734230795808914,1.0,2/27,4.05%,PTPN22;TLR9
prerank,phagosome acidification (GO:0090383),-0.2380673552712151,-0.7603840450150048,0.8618421052631579,0.9499040308167653,1.0,11/26,22.85%,ATP6V0A1;TCIRG1;RAB39A;ATP6V1D;ATP6V1A;RAB20;RAB38;SLAMF8;ATP6V1C1;ATP6V0E2;ATP6V0D2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.28868262002640194,0.7603745061090506,0.8805815160955348,0.9731711035331321,1.0,19/83,19.51%,CDK6;CDK17;FBXO5;RCC1;TFDP2;POLE;NASP;CDK2;CDC7;GSPT1;CDKN1A;CUL3;TYMS;RPS6KB1;PCNA;GPR132;HINFP;CDC34;KLF11
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3277822019505853,0.75974587680865,0.7672301690507152,0.9732019101128917,1.0,5/20,17.61%,ACAD8;ACAT1;ACADSB;SLC25A44;MCCC1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3277822019505853,0.75974587680865,0.7672301690507152,0.9732019101128917,1.0,5/20,17.61%,ACAD8;ACAT1;ACADSB;SLC25A44;MCCC1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.27805479950375156,0.75967609484752,0.9081735620585267,0.9729164584060422,1.0,35/152,19.03%,PSMC3;SEMA5A;PSMD8;DAPK3;PSME1;PSMD6;GSKIP;PSMB5;PIN1;CAV1;PSMC6;CSNK1G1;SCEL;CCAR2;PSMB4;LGR4;ILK;COL1A1;PSMA7;PSMB9;PSMA6;USP34;UBR5;PSMC1;UBE2B;GPC3;RUVBL1;PSMD7;PSMD2;SMURF2;JUP;CSNK1G3;PSMD5;RSPO2;CDC73
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.23744081050680105,-0.7590367478808149,0.8715083798882681,0.9501375226170224,1.0,9/24,25.54%,PARP1;TTLL7;TTLL3;TTLL4;TTLL1;AGTPBP1;NAA10;AGBL4;NAA80
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.36752579775427535,0.7587566646857592,0.7835325365205843,0.9736775972724577,1.0,3/13,10.36%,PIM1;ZBTB7B;NAPEPLD
prerank,cell differentiation in hindbrain (GO:0021533),0.38112709803047806,0.7582629808454372,0.7643758765778401,0.9739065158266624,1.0,2/11,7.89%,ATP7A;GRID2
prerank,membrane fusion (GO:0061025),0.30830112304804685,0.7582382621651355,0.8072976054732041,0.9735619473429212,1.0,8/33,20.82%,CHP1;DNM3;NSF;UBXN2A;GCA;HUWE1;DNM1L;RIMS1
prerank,actin filament bundle assembly (GO:0051017),0.31663842627741606,0.7581684959058558,0.8140068886337543,0.9732714202045115,1.0,9/33,26.14%,PAWR;PLS1;LCP1;EZR;NEDD9;CALD1;RHOD;ESPN;ADD1
prerank,regulation of NMDA receptor activity (GO:2000310),0.31053722969107733,0.7579825112794432,0.8137931034482758,0.9731089759236882,1.0,11/32,24.89%,CCR2;GRIA1;EPHB2;GRIA2;DLG3;GRIA3;DLG1;ACTN2;RELN;GRIN1;DLG2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3730910907099607,0.7577564523707367,0.7695473251028807,0.9730061477858184,1.0,2/12,12.89%,TICRR;BLM
prerank,modulation of chemical synaptic transmission (GO:0050804),0.2812990401777402,0.7574641483284614,0.8793103448275862,0.9729801315926715,1.0,26/107,20.85%,MCTP2;NPTX2;KCNMB4;TPRG1L;PTEN;ITGB1;GRID2;BAIAP3;TMEM108;CLN3;LGI1;USP46;ATP1A2;RIMS3;SYN3;GRM1;CPLX2;DRD2;GRIK5;AGER;CEL;GRIK2;NPTX1;CACNA1B;RIMS1;NRG3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3660956868631665,0.7572185715615898,0.7723035952063915,0.9729219202272777,1.0,2/13,10.02%,BMS1;RPS21
prerank,mitotic cytokinesis (GO:0000281),0.29859169542549824,0.7571794637369799,0.822742474916388,0.9725984638417052,1.0,9/47,12.42%,RTKN;RACGAP1;KIF20A;ARL3;ANK3;RHOC;ESPL1;ROCK1;CIT
prerank,positive regulation of protein processing (GO:0010954),0.3356772107428492,0.7571330497028469,0.7793190416141236,0.9722859869803124,1.0,2/19,8.38%,CLEC3B;GSN
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.23391654043856908,-0.7569471889764999,0.834319526627219,0.9515923685019193,1.0,8/26,20.65%,ROCK2;LYN;AIM2;PICALM;STAT3;PSME3;APH1A;PYCARD
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.26414614183137053,-0.7568963636556388,0.8106995884773662,0.9499911112953815,1.0,6/16,25.93%,FLCN;CLEC16A;PIH1D1;LARS1;RRAGA;KLHL22
prerank,response to fatty acid (GO:0070542),0.35058548098531084,0.7568762257471067,0.7782051282051282,0.9722101060453504,1.0,8/17,28.92%,CD36;IRS1;FOXO1;SCD;SOX9;PDK3;PPP5C;LPL
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.37223823167500303,0.7564536310768094,0.7708333333333334,0.9719942130425459,1.0,4/11,22.74%,SRI;FKBP1A;CALM1;CALM3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.37223823167500303,0.7564536310768094,0.7708333333333334,0.9719942130425459,1.0,4/11,22.74%,SRI;FKBP1A;CALM1;CALM3
prerank,peptide catabolic process (GO:0043171),-0.23770492037845742,-0.7563506858696812,0.8527918781725888,0.9491124299476996,1.0,3/23,8.16%,NPEPPS;TPP1;GGT5
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.2941619585687382,-0.756321994037686,0.8080808080808081,0.9474704463415827,1.0,11/11,70.61%,AGT;LIPC;PLA2G10;APOA2;AGTR1;PLA2G5;PLA2G7;APOB;MPO;ABCG1;PLA2G3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3241505953569397,0.7562635510288153,0.782608695652174,0.9718638160724047,1.0,8/25,18.87%,LONP1;CLPP;CUL3;ZER1;FBXL17;UGGT1;DERL1;OMA1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3246202428477727,0.7559576177743014,0.7789855072463768,0.97188039249647,1.0,5/24,19.79%,SEMA5A;DSCAM;SEMA3E;SEMA5B;SEMA3D
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.31517519213535805,0.7557668483313706,0.7790834312573442,0.971745169256511,1.0,7/30,19.57%,MAGT1;LMAN1;DPM3;DDOST;TUSC3;UGGT1;FUT8
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.35496778000152157,0.7556969076910076,0.7822685788787483,0.9714602323776355,1.0,6/14,22.82%,RFLNA;GREM1;RFLNB;SNAI2;SOX9;WNT9A
prerank,peptidyl-serine phosphorylation (GO:0018105),0.27725941325749937,0.7556617177654317,0.9245472837022133,0.9711338720526972,1.0,26/153,15.51%,MAPK13;PRKCQ;CAMK4;SBK1;LMTK2;ATM;PRKD2;MAPK9;CSNK1A1;CDK1;HIPK1;RPS6KA5;NLK;CSNK1G1;CDK2;CDC7;ROCK1;MAPKAPK3;MASTL;MAPKAPK2;STK4;RIPK1;EIF2AK3;RPS6KB1;HIPK3;PKN1
prerank,mRNA destabilization (GO:0061157),0.30532310416994446,0.7554593972472757,0.8214285714285714,0.97100443797011,1.0,9/38,14.19%,YTHDF3;METTL3;DHX36;ZFP36L2;CPEB3;ROCK1;METTL14;KHSRP;TARDBP
prerank,vesicle transport along actin filament (GO:0030050),-0.2561574589410232,-0.7551245659740906,0.8199052132701422,0.9475668990270267,1.0,6/19,18.65%,MYO7A;MYO5A;MYO1F;MYO19;MYO1B;MYO5B
prerank,negative regulation of hippo signaling (GO:0035331),0.36656096246506564,0.7549345626864385,0.7641379310344828,0.9712782286481106,1.0,4/12,19.38%,SHANK2;LIMD1;CIT;MARK3
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.36875653305914824,0.7546531033531512,0.7859116022099447,0.9712198162997253,1.0,6/12,27.13%,DNMT1;ATF7IP;TRIM28;SETDB1;RESF1;TASOR
prerank,positive regulation of developmental growth (GO:0048639),0.29896852271127644,0.754559803822585,0.8369565217391305,0.970955081888593,1.0,12/49,23.39%,GHR;SYT4;RASAL1;RNF157;MAPT;ISLR2;TWF2;PLAA;PPIB;RIMS1;SYT17;INSR
prerank,regulation of Wnt signaling pathway (GO:0030111),0.27533511329788407,0.7534142802254669,0.8851626016260162,0.9719702208725468,1.0,22/108,21.74%,SFRP5;SOX7;TCF7L1;TMEM237;RACK1;GSKIP;PPP2R1A;NLK;CTNNB1;DACT3;CCNY;PPP2CA;GPC3;TIAM1;GNAQ;RSPO2;CDC73;TRABD2B;PPP1CA;ATP6AP2;BTRC;CTNND2
prerank,histone H4-K8 acetylation (GO:0043982),-0.2750844027052813,-0.7530024600404269,0.7660550458715596,0.9472847880321237,1.0,6/15,20.33%,JADE2;ING4;HCFC1;KANSL2;MCRS1;KAT8
prerank,histone H4-K5 acetylation (GO:0043981),-0.2750844027052813,-0.7530024600404269,0.7660550458715596,0.9472847880321237,1.0,6/15,20.33%,JADE2;ING4;HCFC1;KANSL2;MCRS1;KAT8
prerank,positive regulation of reproductive process (GO:2000243),0.3088069972536519,0.7528625866643133,0.7913247362250879,0.9722824809953419,1.0,6/31,17.66%,TAC4;CACNA1H;PDE3A;TACR1;AGO2;SMURF2
prerank,homeostasis of number of cells (GO:0048872),0.3647095869917128,0.7527089062156975,0.7671601615074024,0.972078225212832,1.0,2/12,10.36%,F2R;NAPEPLD
prerank,peptidyl-proline modification (GO:0018208),0.32395291702567414,0.7526624445856593,0.7845238095238095,0.9717682441134596,1.0,4/25,11.99%,PPIA;PPIH;PIN1;FKBP1A
prerank,nucleoside salvage (GO:0043174),-0.3023863440270982,-0.7522634462618524,0.7915194346289752,0.9466775951548283,1.0,4/10,24.97%,TK2;UCKL1;UCK1;TK1
prerank,carboxylic acid metabolic process (GO:0019752),0.315257677982525,0.7522314559759644,0.8194444444444444,0.971895952375871,1.0,8/33,20.95%,GSTO2;MIF;LIPT2;ST3GAL1;SLC2A1;DDO;CYB5A;CSGALNACT1
prerank,protein localization to mitochondrion (GO:0070585),-0.29483070297511776,-0.751946427177519,0.797153024911032,0.9454834331352169,1.0,2/11,3.87%,HK2;LRRK2
prerank,sensory perception (GO:0007600),0.29759449176382874,0.7516365590441875,0.8370288248337029,0.972213471413269,1.0,4/45,11.34%,CCR2;ADORA2A;CLRN1;PTGES
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.34857855320170794,0.7514005320815932,0.7904642409033877,0.972133956187189,1.0,5/18,19.03%,CCT8;CCT2;RUVBL1;NAF1;EXOSC10
prerank,erythrocyte differentiation (GO:0030218),0.30120664104316,0.7513899245093872,0.8220994475138121,0.9717753710724225,1.0,6/44,12.65%,RPS14;KIT;JAK2;ID2;TGFBR3;RPS19
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2857587756822263,0.7508542048273499,0.8545837723919916,0.9720522769377997,1.0,8/66,12.36%,TRIM16;F2R;MALT1;FOXP1;JAK2;CD36;PANX1;CARD16
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.2640345427434458,-0.7507501503384114,0.8116591928251121,0.9454695563641116,1.0,3/16,10.36%,DDX5;TADA3;EGLN2
prerank,negative regulation of organelle assembly (GO:1902116),-0.21318707620791022,-0.7506883276285461,0.888,0.9439147492099633,1.0,9/35,14.66%,CCP110;LRRK2;TBC1D30;PHF23;CDK5RAP2;TCHP;CHMP4B;CHMP4A;FEZ1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.2858240877583961,-0.7505851351257505,0.7948717948717948,0.9424100068746916,1.0,3/12,8.96%,PARP12;PARP1;PARP2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.3529193554668434,0.7503440234191612,0.7642276422764228,0.9723141512436325,1.0,1/14,3.00%,ATRX
prerank,regulation of cellular respiration (GO:0043457),-0.2638478628944125,-0.7501548586170746,0.825,0.941363502206202,1.0,6/17,27.56%,IL10RB;PNPT1;NOA1;IDE;CBFA2T3;PRDM16
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3043845978975036,0.7500457051866523,0.810126582278481,0.9723038519920462,1.0,6/36,18.90%,APOE;ATP2B4;CAV1;HSP90AA1;CALM1;S100A1
prerank,negative regulation of ossification (GO:0030279),0.3252721594158516,0.7499967902906998,0.8063337393422655,0.971989036349159,1.0,3/23,8.50%,SRGN;MDK;GREM1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.28587576009645,0.7499812022037595,0.8491561181434599,0.9716361254464677,1.0,9/64,15.21%,ACSBG1;FADS1;GPX1;ELOVL1;FAAH;ELOVL6;CPT2;ACSL1;GPX4
prerank,protein import into nucleus (GO:0006606),0.2855538174216566,0.7497968944934339,0.8622502628811777,0.9714860921959835,1.0,10/66,12.44%,CBLB;RPL23;RGPD1;NUP50;APPL1;NUP214;NXT2;NUP88;RANBP2;MMP12
prerank,regulation of protein acetylation (GO:1901983),-0.2873260619227429,-0.7497237366543087,0.784452296819788,0.940288570288499,1.0,1/12,0.83%,CAMK1
prerank,positive regulation of nuclear division (GO:0051785),0.31954411112232806,0.7493866175142897,0.8043217286914766,0.9716145586730766,1.0,1/25,1.52%,CD28
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.37075738828919985,0.7493250451064589,0.8022922636103151,0.9713220964139625,1.0,2/11,14.15%,BMP4;RIPK1
prerank,homologous chromosome segregation (GO:0045143),-0.24235712421583538,-0.7493003746377769,0.8457943925233645,0.9392688957466477,1.0,5/20,22.25%,SIRT7;ZCWPW1;PTTG1;FMN2;IHO1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.27645073178933904,0.7491948483889034,0.9141414141414141,0.9711026217466592,1.0,25/125,21.42%,XPO1;BUB1B;CENPH;BIRC5;RPS27;RCC1;DYNLL1;PTPA;CDCA8;GPSM2;KNL1;DLGAP5;ESPL1;RANBP2;KIF3B;PCNT;B9D2;KIF11;PAFAH1B1;AHCTF1;MIS12;MAP4;ZW10;MECP2;NEK9
prerank,positive regulation of macrophage migration (GO:1905523),0.3356408766849118,0.7491028323505514,0.775483870967742,0.9708401268494048,1.0,3/19,8.27%,CCL5;MDK;RARRES2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3004018071707411,0.7488857431527965,0.8407079646017699,0.9707383979963017,1.0,5/43,10.61%,CBLB;CHMP6;SPRY1;CDC42;EPS15L1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.3416768642513283,0.7484267687703606,0.79296875,0.9709074093710727,1.0,2/17,9.05%,ZDHHC17;FSTL1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.29457058263450503,0.7483306288253397,0.8414766558089034,0.9706452885495959,1.0,11/51,15.52%,ATP7A;PLXNB1;CNTNAP2;TAOK3;NBL1;GPM6A;DCLK1;UBB;NCKAP1;TNIK;PAK1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.2998020528234283,0.7480976939752824,0.823463687150838,0.9705524499725569,1.0,8/40,16.76%,WNT6;GPM6B;FBXO5;BMP4;BMP6;TGFB3;PKDCC;CEBPB
prerank,cellular response to fatty acid (GO:0071398),-0.2789686244179519,-0.7478486005364229,0.7976653696498055,0.9397413965118221,1.0,1/12,1.29%,PID1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.29222903895860247,0.7472118334949619,0.8247311827956989,0.9712597782938881,1.0,18/52,25.34%,MTHFD2;SHMT1;ME2;MTHFD1;MDH2;ME1;ALDH1L2;SLC19A1;ACOT8;ASS1;MTHFD1L;L2HGDH;MTHFS;IDH1;ME3;D2HGDH;GOT2;SHMT2
prerank,negative regulation of transport (GO:0051051),0.29149803228728055,0.747093088182961,0.8362255965292842,0.9710443132368333,1.0,13/51,20.32%,NRG1;RACK1;PTEN;NR1H2;ABCA7;LGALS3;ARL6IP5;SNX33;CRYAB;LILRB1;EPHA3;SNX12;SNCA
prerank,nitric oxide metabolic process (GO:0046209),0.353244218992508,0.7468855826960635,0.765399737876802,0.9709355600005843,1.0,4/14,27.44%,NQO1;CYB5B;CYB5R3;SPR
prerank,cation transmembrane transport (GO:0098655),0.29252170798922394,0.7466388622582951,0.828039430449069,0.970860881174707,1.0,6/44,14.93%,SLC3A2;SLC7A1;CACNA1H;ATP1A2;SLC7A5;SFXN3
prerank,cellular protein localization (GO:0034613),0.2698356574248704,0.7451794049917568,0.969,0.972235646277128,1.0,46/285,15.78%,TBC1D10C;CSRP3;CD74;RABGAP1L;FLNA;ANGPT1;FERMT2;LAPTM5;CD63;ADPRH;FBLN5;NIPBL;TMED4;TBC1D22B;CELSR1;CNTNAP2;GRID2;COG7;RTP4;HEY2;JAM3;DMD;RABGAP1;NSF;RAB5B;ARL4C;CTNNB1;ZDHHC15;RAB5C;TBC1D2B;COPB2;ABHD17A;TBC1D8B;RIC3;SCG5;NPM1;REEP1;STX6;ARL6;SAR1B;FGF7;VCL;SIL1;RAP2A;SLU7;EIF2D
prerank,negative regulation of defense response to virus (GO:0050687),0.3731289473279865,0.7450011325984033,0.7784256559766763,0.9720741060751921,1.0,2/10,12.12%,TARBP2;MUL1
prerank,glucose homeostasis (GO:0042593),0.278270967166509,0.744889111923694,0.8743509865005192,0.9718353509342013,1.0,24/83,26.93%,GCK;RPS6;HK1;PYGL;IRS1;FOXO1;SIRT1;IGF1R;BACE2;MBD5;CRTC2;MLXIPL;STK11;ADIPOR2;MCU;RBP4;SELENOT;CRY2;INSR;FOXK1;ADCY8;WFS1;PPARG;CYB5R4
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.24010214469307756,-0.7443894443060282,0.8333333333333334,0.9429949386005975,1.0,5/20,15.53%,RGS10;CHRNA7;GRK2;CDK5R1;PLCB1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.2695527347788014,-0.7442355609392035,0.8543307086614174,0.9415886280040396,1.0,5/15,27.45%,KMO;GSTZ1;FAH;IL4I1;KYNU
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.30011149569981366,-0.7442110004100086,0.7534246575342466,0.94000709188094,1.0,3/10,10.06%,UBAC2;SVIP;UBE2J1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.36033219284724516,0.7440822340209415,0.7934782608695652,0.9724019136792994,1.0,5/12,20.32%,CDH5;STMN2;CLIP3;MAP2;SNCA
prerank,regulation of glucose metabolic process (GO:0010906),-0.20969415054611865,-0.7438850332495469,0.9035087719298246,0.9388415582156538,1.0,8/34,17.43%,PDK1;AKT2;SIRT7;RUBCNL;ZNF692;BCKDK;DGKQ;IRS2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.3351903408177386,0.7438714386682812,0.7952443857331571,0.9722785681948137,1.0,6/19,24.11%,ASPA;DDO;PHYKPL;GCDH;SLC25A21;GOT2
prerank,microtubule depolymerization (GO:0007019),0.34740798293611425,0.7434473779578735,0.7881578947368421,0.9724010076354693,1.0,4/17,16.08%,KIF24;CCSAP;KATNB1;STMN2
prerank,alpha-amino acid metabolic process (GO:1901605),0.29474186553535014,0.7431852815032638,0.8430493273542601,0.972343299080688,1.0,10/45,20.49%,ATP7A;MMUT;MTHFD1;SRR;PYCR2;ASPA;GPT;OAT;KYAT1;ASS1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2755662138367253,0.7431582575724378,0.8855359001040582,0.9720103821581101,1.0,17/85,17.44%,CLU;PSMC3;RNF14;RACK1;CSNK1A1;PSMC6;NOP53;SUMO2;DNAJB2;COP1;HSPA1A;TREM2;GSK3A;ZER1;KEAP1;RNFT1;PIAS1
prerank,mitotic cell cycle phase transition (GO:0044772),0.27171129872884775,0.7428608260023939,0.944,0.9720074431071718,1.0,40/204,20.23%,CCND2;PLK4;CENPJ;CDK6;MELK;PPP2R2A;PPP1R12A;RCC1;TPD52L1;CDK1;DYNLL1;CHMP7;PPP2R1A;POLE;NASP;CDK2;CDC7;HSP90AA1;LCMT1;MASTL;HAUS5;GSPT1;CCNY;CDKN1A;CUL3;CEP41;RPS6KB1;PCNT;PAFAH1B1;FBXL17;HAUS4;GPR132;HAUS2;CEP43;HINFP;CDC34;NINL;CEP70;WEE1;HAUS3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.33786616547969606,0.7427202398668059,0.8010335917312662,0.9718088527457109,1.0,8/17,29.89%,APOE;SREBF1;ABCA2;SEC14L2;MBTPS1;ERLIN1;FGF1;ABCG1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3303636624439801,0.7419356627086195,0.8091697645600991,0.9723314240404533,1.0,4/20,15.76%,CHD6;SMAD1;ATF4;RUNX2
prerank,cell differentiation in spinal cord (GO:0021515),-0.3033820797726726,-0.7418495571754908,0.7750865051903114,0.9400548758683354,1.0,5/10,38.47%,SOX4;MDGA2;MDGA1;LHX1;ISL1
prerank,leukotriene metabolic process (GO:0006691),0.33468125067302446,0.7418255487235759,0.7873417721518987,0.9721091751164552,1.0,3/19,13.03%,ALOX5AP;ABCC1;MAPKAPK2
prerank,mitotic spindle organization (GO:0007052),0.2727378506749103,0.7408324424001778,0.9366197183098591,0.9729131102606942,1.0,41/153,26.33%,XPO1;FLNA;BUB1B;SMC3;CENPH;BIRC5;RPS27;RCC1;DYNLL1;PTPA;CDCA8;GPSM2;KNL1;RAB11A;DLGAP5;RANBP2;KIF3B;PCNT;B9D2;AAAS;KIF11;KIFC1;PAFAH1B1;AHCTF1;MIS12;MAP4;ZW10;PIBF1;MECP2;NEK9;WRAP73;CLASP2;MAD1L1;CENPF;TOGARAM2;RHOA;MZT1;CENPO;SPDL1;EML4;ABRAXAS1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3242786360783406,0.7402462407239433,0.7839506172839507,0.973236684161204,1.0,4/20,21.23%,CCND2;CCNY;MAPRE3;HSP90AB1
prerank,regulation of exosomal secretion (GO:1903541),0.33197963966617916,0.7398154848057438,0.8177150192554558,0.9733767470932576,1.0,8/19,29.89%,CHMP6;SNF8;SDCBP;PDCD6IP;ATP13A2;RAB7A;VPS4B;CHMP2A
prerank,T cell differentiation in thymus (GO:0033077),0.3496880161277319,0.7396971096707023,0.7804551539491299,0.9731424261971459,1.0,3/14,19.29%,GLI3;ZFP36L2;PTPRC
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.2489912255232236,-0.7391050141346206,0.8227272727272728,0.9420806661866715,1.0,2/18,5.48%,MANBA;NAGA
prerank,response to laminar fluid shear stress (GO:0034616),-0.2981416720737163,-0.7381552899765601,0.802675585284281,0.9416696652731812,1.0,5/10,19.63%,SMAD7;NFE2L2;MAPK7;ABCA1;KLF4
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3063935221027494,0.7380252364527188,0.8373424971363116,0.9747418149732094,1.0,9/32,21.94%,AEN;HIPK1;SIRT1;TMEM109;USP28;PPP1R13B;STK11;MSH2;DYRK2
prerank,establishment of spindle orientation (GO:0051294),0.31194877254453807,0.7378986729047543,0.8259833134684148,0.9745075309240316,1.0,8/28,26.95%,ITGB1;GPSM2;PAFAH1B1;MAP4;ZW10;HTT;SPDL1;GJA1
prerank,atrioventricular valve development (GO:0003171),-0.2724966495421234,-0.7373305419980373,0.8262548262548263,0.9411322988077225,1.0,3/14,11.09%,BMPR2;TGFBR2;NOTCH1
prerank,fatty acid catabolic process (GO:0009062),0.28461553395141903,0.7365211110279046,0.8723628691983122,0.9757500926121014,1.0,23/67,25.24%,PEX2;ACAT1;ACADVL;EHHADH;ABCD3;MMUT;ABHD2;FAAH;PEX13;HADHA;HADH;CPT2;ACADS;CEL;ACOT8;ACAT2;HSD17B4;PCCB;HADHB;DECR1;PCCA;ACADM;ACAD10
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.3278154196806369,0.7357166811169664,0.7961290322580645,0.9763230061747998,1.0,3/19,15.82%,ADCY10;AQP4;RFX3
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3418030891169429,0.7354578170202882,0.8352788586251622,0.9762506347419848,1.0,3/16,10.12%,ST6GALNAC3;B4GALNT1;ST8SIA5
prerank,histone lysine methylation (GO:0034968),0.30059809593904546,0.7352550338122075,0.8249427917620137,0.9761079014010744,1.0,12/33,25.21%,DYDC1;SUV39H2;WDR5;WDR5B;PRDM5;TRMT112;SMYD1;CXXC1;SETDB1;PRDM9;EZH2;KMT2A
prerank,negative regulation of nervous system development (GO:0051961),0.34228848838571413,0.7349925202296748,0.8172458172458172,0.9760300492867912,1.0,4/17,19.05%,B2M;SORL1;ROBO2;SLIT1
prerank,lipoprotein localization (GO:0044872),0.3674671288656167,0.734863690972897,0.7997237569060773,0.9758148974151619,1.0,3/11,16.44%,ZDHHC17;CD36;MIA3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2629413568166258,-0.7346780617680205,0.8304347826086956,0.9430166479560533,1.0,6/15,26.18%,ZFAND2A;SEC61A1;ZFAND2B;RAB10;SPCS3;RAB3GAP1
prerank,muscle cell migration (GO:0014812),0.37167810279526836,0.7344515728944686,0.7779390420899854,0.9759384975466605,1.0,4/10,24.14%,ROCK1;CCN3;DDR1;ITGB1BP1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.367056814401197,0.7341579981472879,0.7914201183431953,0.9759153998521376,1.0,2/10,9.37%,GABRA4;GABRG1
prerank,protein localization to vacuole (GO:0072665),-0.282048567471748,-0.7335462435164275,0.8068181818181818,0.9428294147618123,1.0,6/13,22.34%,SH3GLB1;GLMP;MFSD1;CD81;LMBRD1;RNF128
prerank,nitric oxide biosynthetic process (GO:0006809),0.3532614450625954,0.7333374580397021,0.7981157469717362,0.9764919769290504,1.0,4/13,27.44%,NQO1;CYB5B;CYB5R3;SPR
prerank,neural crest cell migration (GO:0001755),0.2980936793351179,0.7328002055653995,0.8245219347581553,0.9767448607336997,1.0,13/36,31.32%,ANXA6;SEMA5A;SEMA3E;SOX10;SEMA5B;SEMA3D;ERBB4;SEMA4A;FN1;PHACTR4;RADIL;SEMA4B;GDNF
prerank,dendritic spine morphogenesis (GO:0060997),0.34060269793735526,0.7325294908203319,0.7903645833333334,0.9766908532879446,1.0,6/15,25.61%,PTEN;CDC42;EPHB2;DIP2A;CTNND2;DOCK10
prerank,reticulophagy (GO:0061709),0.3589133938421376,0.7324847082952788,0.8137254901960784,0.9763784729101225,1.0,2/12,7.26%,UFM1;TEX264
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.37551363180859887,0.7323310106313708,0.7827338129496403,0.9761827935255628,1.0,4/10,15.41%,MSN;CDC42;EZR;RAP2A
prerank,intracellular protein transmembrane transport (GO:0065002),0.29668435545518335,0.7322781684124678,0.8312710911136107,0.975871957829387,1.0,10/42,20.31%,PEX2;SEC61B;DNAJC15;HSPA5;PEX16;TIMM17B;TIMM17A;C2CD5;SEC63;PEX10
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.20710513421757049,-0.731909316553508,0.8503401360544217,0.9432714248211943,1.0,9/33,22.27%,DGLUCY;GLS;ALDH18A1;SLC39A8;NIT2;RIMKLB;ALDH5A1;FPGS;GOT1
prerank,negative regulation of neuron death (GO:1901215),0.27418031265720166,0.7317707007173657,0.9040247678018576,0.9760708864571039,1.0,17/93,16.43%,BCL2;F2R;NDNF;APOE;MDK;CLN3;BTBD10;PM20D1;SORL1;CLCF1;ATF4;AGAP2;TGFB3;GRN;NENF;SOD2;INPP5A
prerank,glycerophospholipid catabolic process (GO:0046475),0.30778124154512465,0.7308405145276088,0.8327526132404182,0.9767689383001396,1.0,4/27,17.87%,PRDX6;GDPD1;GDPD3;GPCPD1
prerank,activation of GTPase activity (GO:0090630),0.2742285614449561,0.7306681607552028,0.8920570264765784,0.9765898061043681,1.0,8/89,6.78%,TBC1D10C;RASGRP1;RABGAP1L;ADPRH;ARHGEF19;RALGAPB;TBC1D22B;SIPA1
prerank,female gonad development (GO:0008585),0.3293911269646989,0.7304873255436648,0.806930693069307,0.9764238488450956,1.0,3/19,16.76%,KIT;EIF2B4;CEBPB
prerank,positive regulation of developmental process (GO:0051094),0.2656089720568854,0.7290707647029749,0.9407035175879397,0.9776640166927828,1.0,41/164,24.02%,BMP1;DCN;LMNA;TMEM79;KDR;APOE;FBXO5;MDK;SOX5;CCN2;BMP4;CFL1;ZBTB16;ZDHHC15;CPEB3;MUL1;SORL1;VHL;DAG1;SIRT1;GRIP1;CEBPB;AGO2;SMURF2;RALA;BNIP3;SLC6A6;SOX9;PHLDB1;VLDLR;DNM1L;MCU;HSP90AB1;MFF;RAPGEF3;TFRC;FGFR1;CLASP2;INSR;ENPP2;RELN
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.27018396403106826,0.7286764507406351,0.8917525773195877,0.9777449959470059,1.0,22/95,20.36%,STAP1;PDCD4;HMGB1;LBP;PAF1;HMGB2;CXCL10;TNIP3;VIM;SERPINE1;CHMP5;CARD16;CTR9;DEFA6;TIRAP;TICAM1;LILRB1;ACOD1;CDC73;SELENOS;CD14;PLAA
prerank,diol metabolic process (GO:0034311),0.3271836558604444,0.7283621065017005,0.8023560209424084,0.9777250560496578,1.0,4/19,16.77%,NAAA;SPHK2;HSP90AA1;CALM1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.3320661805857538,0.7283473127318427,0.8286445012787724,0.9773766265046309,1.0,4/18,14.99%,FLNA;MAF1;ATF4;EIF2AK3
prerank,protein acetylation (GO:0006473),0.30605378032353503,0.7281918897479912,0.834326579261025,0.9771887436219421,1.0,7/30,18.77%,ING5;NAA16;MAPT;FOXO1;SIRT1;KAT2B;ESCO1
prerank,positive regulation of intracellular transport (GO:0032388),0.29686892337273296,0.7280893079246067,0.8510158013544018,0.9769433793795215,1.0,14/38,28.30%,NEDD4;SORL1;PCNT;MLC1;PRR5L;STK11;TBC1D20;EHD1;ACTN2;PGAP1;ZFAND1;RAB29;KIF20B;TPR
prerank,protein complex oligomerization (GO:0051259),0.2720195300705633,0.7280793800650216,0.882414151925078,0.9765878288945291,1.0,18/85,21.19%,LRRC8C;PRF1;UPB1;UGDH;AQP11;NUDT21;G3BP2;BLM;JMJD6;MS4A1;IKZF4;MAT2A;ATL1;RNF135;SNCA;DNM1L;PDCD6IP;MCU
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3162793606854125,0.7276892415934938,0.8103864734299517,0.9766541696935104,1.0,3/22,9.28%,TOX;MDK;ID2
prerank,negative regulation of axonogenesis (GO:0050771),-0.2204173839863453,-0.727588276405188,0.8823529411764706,0.9471834456279986,1.0,3/27,6.35%,DIP2B;MAG;ULK1
prerank,regulation of protein polymerization (GO:0032271),0.29379414072639093,0.7275035154258913,0.8331428571428572,0.9765017431469506,1.0,7/35,18.27%,ARL2;PLEKHG2;HSP90AA1;MAPT;PRUNE1;MAPRE3;MAP2
prerank,alcohol catabolic process (GO:0046164),0.36314889717027254,0.7270668181599546,0.793400286944046,0.9766152087976452,1.0,2/10,17.26%,APOE;CEL
prerank,ear morphogenesis (GO:0042471),0.3195523079600177,0.7260781828811455,0.8067331670822943,0.977356052656923,1.0,3/20,11.78%,NIPBL;TMIE;EPHB2
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.2692184008751531,-0.7259889498239185,0.8281786941580757,0.9476148871210408,1.0,3/12,12.62%,CTPS1;DPYD;ALDH6A1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.28363832552579715,-0.7259402011540763,0.7883211678832117,0.946090608629318,1.0,6/13,20.85%,RNF185;BAG6;NFE2L2;USP13;TMEM259;SGTA
prerank,Notch signaling involved in heart development (GO:0061314),0.3557729969063772,0.7256614947289346,0.8079658605974396,0.9774735659213261,1.0,3/11,19.53%,HEY2;JAG1;SNAI2
prerank,lipid catabolic process (GO:0016042),0.33118071594813553,0.7254965764145097,0.8297604035308953,0.9772847243820891,1.0,2/18,8.00%,HSD11B1;PLAAT3
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.3596270922084908,0.7249460712934711,0.7968299711815562,0.9775285666283937,1.0,3/10,15.34%,SMARCD3;CTNNB1;DRD2
prerank,regulation of autophagosome assembly (GO:2000785),0.30393979292101414,0.7248066929874001,0.8431372549019608,0.9773287301463677,1.0,6/33,13.46%,NPRL2;SMCR8;ADPRH;SEC22B;MTM1;RALB
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.29203805359806656,0.7240013031538606,0.8647450110864745,0.9778594102906546,1.0,4/43,7.67%,GATA3;TGFB2;ETS1;BMP4
prerank,extracellular transport (GO:0006858),0.341711749175924,0.7237515385396368,0.813443072702332,0.9777843673189324,1.0,1/13,3.49%,ADCY10
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.28972636806405916,0.7231037040967243,0.8695175438596491,0.9781179631694549,1.0,7/46,15.34%,CCR2;CACNG7;TPRG1L;CLN3;ATP1A2;GRM1;DRD2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.2970864978206052,0.72305094707289,0.835990888382688,0.9778186867897634,1.0,8/35,17.75%,DAXX;NEDD4;RNF14;UBR5;WBP2;PPARGC1B;RBFOX2;CALCOCO1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.32741264654619884,0.7228628651564353,0.8136020151133502,0.9776568355195766,1.0,4/17,15.87%,SCIMP;TGFB2;TAOK3;ARL6IP5
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.3191841036965184,0.7218351725326193,0.8104089219330854,0.9784274384736288,1.0,4/20,19.79%,SEMA5A;SEMA3E;SEMA5B;SEMA3D
prerank,regulation of neurogenesis (GO:0050767),0.2832351080409931,0.721798546236957,0.8767567567567568,0.9781050996086945,1.0,13/55,22.43%,B2M;HMGB2;PER2;HEY2;CTNNB1;PRUNE1;SORL1;WNT3;SOX11;HES1;HES6;MME;CX3CL1
prerank,regulation of fibroblast migration (GO:0010762),0.3264939058462966,0.7216864864697357,0.832282471626734,0.9778727658720096,1.0,4/20,10.38%,DDR2;ITGB1;CLN3;APPL1
prerank,kidney development (GO:0001822),0.2767088319093286,0.7214209528819562,0.8789808917197452,0.977799020878225,1.0,9/65,14.46%,GATA3;NIPBL;TGFB2;BMP4;PYGO1;ARL3;ZBTB16;ROBO2;CTSH
prerank,protein import into peroxisome matrix (GO:0016558),0.3543869328667701,0.7211708398560471,0.8072625698324022,0.9777068740897366,1.0,3/12,11.66%,PEX2;PEX16;PEX13
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.3468847922789759,0.7206328375445415,0.7939560439560439,0.9779646022426111,1.0,2/12,11.35%,NR1H2;NFKBIA
prerank,histone methylation (GO:0016571),0.30602699027462865,0.7205278916533703,0.8417945690672963,0.9777127471802629,1.0,7/26,21.01%,PRMT5;FBL;SUV39H2;TRMT112;SMYD1;NSD3;PRMT7
prerank,cardiac muscle cell contraction (GO:0086003),0.32303716158171314,0.7199710666234163,0.8302583025830258,0.9779887179865977,1.0,6/19,19.95%,SCN1A;GSN;ATP1A1;CACNA2D1;SCN3B;SCN1B
prerank,tRNA aminoacylation (GO:0043039),0.29061138571258854,0.7199651495387945,0.8568207440811725,0.9776305200361207,1.0,12/37,23.57%,LARS2;MARS2;AIMP1;GARS1;PPA2;DARS1;RARS1;EEF1E1;KARS1;SARS1;SARS2;EPRS1
prerank,regulation of synapse organization (GO:0050807),0.30384451922451094,0.719031864471443,0.8534583821805393,0.9783012921105569,1.0,5/26,12.60%,SLITRK2;NEDD4;CLN3;SETD5;ABHD17A
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.27147569576726277,0.7168834189539761,0.8915537017726799,0.9802717037509412,1.0,10/77,14.15%,MMP9;BCL2;CLU;NR4A2;GPX1;BMP4;BIRC6;LGALS3;HSPA1A;RIPK1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.27135347951151506,0.7164644349365987,0.9027921406411582,0.9803651762212211,1.0,25/88,25.14%,PSMC3;PSMD8;FBXO31;PSME1;PSMD6;PSMB5;PSMC6;PSMB4;PSMA7;PSMB9;PSMA6;PSMC1;FBXL5;PSMD7;PSMD2;FBXL17;PSMD5;PSMB6;BTRC;PSMA3;FBXO4;FBXL7;PSMB2;FBXW7;PSMD1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.2996647368703078,0.7147561095295072,0.8428053204353083,0.9818240002172149,1.0,10/27,27.65%,PTEN;NTNG1;NTNG2;TREM2;GSK3A;CCDC88A;GSK3B;MBOAT1;IL1RAPL1;NCS1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.28988587938976834,0.7146197718914766,0.8566629339305711,0.9815971224012905,1.0,9/36,22.77%,RPL11;AQP11;CCAR2;NOP53;EIF3H;SDCBP;RYBP;HSP90AB1;PRKCG
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.32752131235286674,0.7138400210230318,0.8263707571801566,0.9820721092535466,1.0,3/16,11.44%,PRDX6;NCL;RBMXL1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2759419054090022,0.7137622374222817,0.8853838065194533,0.9817908983082377,1.0,14/67,16.94%,TBC1D10C;WAS;TBC1D22B;CAV1;ATG5;RABGAP1;CDC42;TBC1D2B;TBC1D19;PPP1R16B;MYO10;ATG3;RABEP2;TWF2
prerank,positive regulation of protein secretion (GO:0050714),0.27141802843320156,0.7137205786319627,0.8837209302325582,0.9814735134058505,1.0,22/69,27.17%,GCK;PPIA;TGFB2;BMP6;TGFB3;APBB3;EZR;BLK;TREM2;DNM1L;MCU;RBP4;AACS;CD2AP;CD33;ATP13A2;PTPN23;IER3IP1;MYRIP;IGF1;IL1A;TRH
prerank,neuron remodeling (GO:0016322),0.35860748118998625,0.7136762296837856,0.8383838383838383,0.9811633428821005,1.0,1/10,2.74%,C3
prerank,peptidyl-asparagine modification (GO:0018196),0.2966368748063163,0.7136055095239985,0.8321596244131455,0.9808783726289444,1.0,7/31,19.57%,MAGT1;LMAN1;DPM3;DDOST;TUSC3;UGGT1;FUT8
prerank,positive regulation of cellular respiration (GO:1901857),-0.2819092196547362,-0.7133368608170857,0.8526315789473684,0.9596033614184747,1.0,1/11,3.16%,IL10RB
prerank,cell junction maintenance (GO:0034331),0.33883158517075596,0.7132451362680935,0.8317503392130258,0.9809107756476165,1.0,1/14,2.59%,F2R
prerank,cellular glucose homeostasis (GO:0001678),0.28317548410837334,0.7128618850362913,0.8490566037735849,0.9809604014443251,1.0,6/41,16.03%,GCK;RACK1;HK1;FOXO1;SIRT1;IGF1R
prerank,regulation of biomineral tissue development (GO:0070167),0.3059616561886902,0.7128398731713604,0.8382352941176471,0.9806281355055864,1.0,7/26,19.83%,DDR2;FBXO5;HEY2;ROCK1;CEBPB;TXLNG;SOX9
prerank,purine ribonucleotide metabolic process (GO:0009150),0.27431135846969956,0.7126600131098104,0.8929695697796433,0.9804581874112982,1.0,10/68,19.16%,GIMAP7;BPNT1;ACAT1;THEM4;GMPR2;AMPD3;DBI;ACOT6;HPRT1;ACOT8
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.2679182761900999,-0.7124249570130934,0.84251968503937,0.9590672915294297,1.0,5/14,16.39%,MMS19;PARP1;WRAP53;MRNIP;ARID2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.35525878023114044,0.7119988962533297,0.8017241379310345,0.9807711046176397,1.0,1/10,4.47%,RGP1
prerank,SNARE complex assembly (GO:0035493),-0.2962123653571688,-0.7114879974863098,0.8571428571428571,0.9585175033155722,1.0,4/10,27.02%,UVRAG;VAMP3;VAMP8;VAMP2
prerank,mRNA processing (GO:0006397),0.2574362548312656,0.7109663028077531,0.987,0.9815146893615756,1.0,84/287,25.64%,SYF2;DBR1;HSPA8;CLP1;CD2BP2;PRPF4;PPIH;METTL3;LSM3;RBM15;CSTF2;SNRPG;UBL5;WBP4;RNGTT;PABPC1;RBM4B;GTF2H5;EIF4A3;CMTR2;PSPC1;SYNCRIP;CHERP;PHF5A;SNRPA;NUDT21;PRPF8;CWC22;CSTF3;CDC40;SF3B2;SF3B1;RBM10;SF3A3;POLR2F;ZCRB1;METTL14;SF3A2;WBP11;SRSF7;HNRNPF;POLDIP3;XAB2;RBM8A;SNRPB;SLU7;USP49;RAVER2;DDX46;LSM6;YTHDC1;ZRSR2;PRCC;RBM5;THOC1;CSTF2T;PCBP1;PRPF31;PLRG1;HNRNPU;LSM4;SRSF4;POLR2D;PRPF6;RPRD1B;RNMT;DDX41;SF3B6;YBX1;SNRNP40;ERN1;PAPOLA;CWF19L1;HNRNPUL1;CDC5L;HNRNPC;SNRPC;CPSF2;RPRD2;CELF1;SRSF6;RALY;GCFC2;AQR
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.34536785420135296,0.7103124639237209,0.830393487109905,0.981102161832346,1.0,3/12,15.07%,DLGAP5;ESPL1;CUL3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.34536785420135296,0.7103124639237209,0.830393487109905,0.981102161832346,1.0,3/12,15.07%,DLGAP5;ESPL1;CUL3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.34536785420135296,0.7103124639237209,0.830393487109905,0.981102161832346,1.0,3/12,15.07%,DLGAP5;ESPL1;CUL3
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.33616858459684296,0.7096460646244921,0.8110236220472441,0.9814413405969402,1.0,2/15,8.58%,RACK1;SPHK2
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.3459888750736233,0.7091919324394053,0.8169398907103825,0.9815677771627691,1.0,2/12,7.04%,CTDNEP1;CDK1
prerank,lipid homeostasis (GO:0055088),0.2729499262213616,0.7086582331899629,0.8806451612903226,0.9817804026789544,1.0,8/57,15.53%,RCN3;APOE;ACOXL;NR1D2;THADA;SIRT1;ABCA2;TREM2
prerank,inhibitory synapse assembly (GO:1904862),-0.2833565711360374,-0.7082170721938174,0.797945205479452,0.9605285586521922,1.0,3/11,10.97%,GABRB2;GABRA1;GABRG2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3213418597573094,0.7081859149076487,0.8226857887874837,0.9819482848688684,1.0,4/17,19.53%,BMP4;HEY2;JAG1;SNAI2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.26269339720173895,0.7080650704553262,0.9414141414141414,0.9817192922750041,1.0,20/118,15.52%,NEDD4;CEACAM1;SP100;FERMT2;HTATIP2;PPFIA2;SDC2;ETS1;CHN1;CFL1;SRCIN1;CTNNB1;ZDHHC15;MAPT;DAG1;BCL6;TNIK;PDZD8;RAP2A;PAK1
prerank,angiogenesis involved in wound healing (GO:0060055),0.35774701658424624,0.7079333627643483,0.8280346820809249,0.9815043454793629,1.0,2/11,4.54%,NDNF;KDR
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.238482825469749,-0.7079070635519935,0.8849557522123894,0.959263459963878,1.0,11/18,32.36%,DLG4;CHRNA7;SHANK1;STX1B;SHANK3;PTK2B;CUX2;NLGN2;NLGN1;WNT7A;NRXN1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.2871094296038149,-0.7066950276037285,0.7877813504823151,0.9590522693028612,1.0,4/10,15.97%,GALNT3;POGLUT3;POGLUT2;GALNT2
prerank,regulation of type I interferon production (GO:0032479),0.26337695009867723,0.7066695336034287,0.9214876033057852,0.9824639688531931,1.0,17/84,22.05%,RNF125;PTPN22;TRIM21;PIN1;DHX36;CTNNB1;POLR2F;GAPDH;TIRAP;RNF216;ACOD1;CGAS;RNF135;CD14;NLRC5;TRAF3;DDX41
prerank,chordate embryonic development (GO:0043009),0.27714236205941734,0.7063357661565858,0.8855291576673866,0.9824543623245869,1.0,2/55,1.12%,DEAF1;GATA3
prerank,renal system development (GO:0072001),0.2753532399799568,0.706077885953534,0.8694232861806311,0.9823645076166435,1.0,5/52,8.60%,GATA3;TGFB2;BMP4;PYGO1;ARL3
prerank,mitochondrion organization (GO:0007005),0.2573372459821982,0.7060176663437795,0.9535822401614531,0.982075977672952,1.0,35/165,22.08%,COX7A1;THG1L;IFIT2;ATP7A;TOMM22;MTFR2;BID;LONP1;CHCHD2;ATPAF1;TOMM7;POLG2;TIMM9;DNM3;ATP5F1D;MTM1;MUL1;TIMM17B;MTX3;TIMM10;MTFR1;TIMM17A;TSPO;SLC25A4;SLC25A33;OMA1;BNIP3;CLUH;HIGD2A;TIMM22;DNM1L;RAB5IF;MFF;PPRC1;AFG1L
prerank,negative regulation of cell death (GO:0060548),0.26411165496091144,0.7056513363238326,0.9318885448916409,0.9821226614494399,1.0,30/88,27.70%,CLU;FERMT2;CCN2;BMP4;ATG5;BTBD10;PM20D1;NCK1;SORL1;HSPA1A;TMEM109;NENF;FYN;INPP5A;SOX11;BNIP3;MECOM;SNCA;CCN3;GSK3B;NUP62;RAD18;ATP13A2;SRSF6;PARP16;WFS1;CHGA;EIF4G1;BNIP3L;SPEF1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.27477166255539426,0.7050606833910673,0.8871851040525739,0.9823759231528661,1.0,9/48,20.01%,ADCY10;NPR2;ACAT1;SLC25A16;ADCY6;ADCY1;AMPD3;PAPSS2;GMPS
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.24440263123518594,-0.7046109332178054,0.8853211009174312,0.9597458903831745,1.0,9/16,31.98%,ADSS1;LHPP;PAICS;ATIC;IMPDH2;AMPD2;ADSS2;PPAT;IMPDH1
prerank,phospholipid metabolic process (GO:0006644),0.2670171106991731,0.7042985662739977,0.9088050314465409,0.9828220580045962,1.0,11/71,16.70%,LGALS13;SMPD1;FADS1;PLPPR5;PLAAT3;GNPAT;PLBD1;ABCA2;GPX4;AGPAT2;PLPPR2
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.21153089954677692,-0.703063695642163,0.9265536723163842,0.9598679491865191,1.0,12/28,36.26%,WWP2;MMP14;ARRB1;HIF1AN;EGF;DLK2;RITA1;NOTCH3;EGFL7;HEY1;DLK1;YTHDF2
prerank,regulation of cellular metabolic process (GO:0031323),0.2763988344519008,0.7029989639027877,0.8725055432372506,0.9838621235248628,1.0,5/45,15.06%,NCOR2;MBOAT7;FASN;ACACA;ABCA2
prerank,intracellular sterol transport (GO:0032366),0.3406267296599955,0.7027479259211009,0.8102288021534321,0.9837657628371262,1.0,2/13,11.19%,STARD4;ARV1
prerank,peptidyl-serine modification (GO:0018209),0.2566798797547986,0.702162522403337,0.9689067201604814,0.9839885794982156,1.0,26/166,15.51%,MAPK13;PRKCQ;CAMK4;SBK1;LMTK2;NDNF;ATM;PRKD2;MAPK9;CSNK1A1;CDK1;HIPK1;RPS6KA5;CSNK1G1;CDK2;GALNT13;CDC7;ROCK1;MAPKAPK3;MASTL;MAPKAPK2;STK4;EIF2AK3;RPS6KB1;HIPK3;PKN1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.2457750157391485,-0.7018729097355209,0.896,0.9596260870883183,1.0,7/16,25.45%,SFSWAP;DCPS;NCBP2;SART1;SRSF12;DDX23;CACTIN
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.2769665583756726,0.7015184596365128,0.8922413793103449,0.984277795449944,1.0,10/51,15.52%,LPAR1;FERMT2;CD47;CCN2;CDC42;RHOC;SYNPO2;TGFB3;S100A10;PAK1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.27334896692892346,0.7015123254384865,0.8827433628318584,0.9839232355602174,1.0,11/46,21.69%,FLNA;NEDD4;CDH1;ANP32B;ZPR1;UBR5;JUP;DMAP1;GSK3B;RAPGEF3;TRIM28
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.2958567523456871,0.6998716030738079,0.8478002378121284,0.9852597633894502,1.0,6/27,16.39%,PRKCQ;NCK1;IRS1;GRB14;RPS6KB1;GSK3A
prerank,positive regulation of synaptic transmission (GO:0050806),0.26803536924615645,0.6988734899079153,0.9159663865546218,0.9859227906771056,1.0,12/72,16.49%,CCR2;CACNG7;BAIAP3;SHANK2;LGI1;ZDHHC12;EPHB2;RIMS3;ZDHHC2;NPTN;AGER;ADCY1
prerank,rRNA 3'-end processing (GO:0031125),-0.2969487166936587,-0.6983603629246403,0.8118466898954704,0.9618095654276362,1.0,6/10,24.82%,ERI3;EXOSC7;EXOSC8;EXOSC3;ERI2;EXOSC2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3001194638144622,0.697767947209646,0.8423586040914561,0.9866492561623589,1.0,9/24,28.57%,RBBP7;DNMT1;JARID2;SMYD5;BMI1;MTF2;EZH2;TASOR;H3-3A
prerank,tRNA modification (GO:0006400),0.2680433901560874,0.6977551560914735,0.9026737967914439,0.9863016094165684,1.0,18/62,26.81%,THG1L;PUS7;THADA;TRMT44;TARBP1;TRMT6;NSUN2;TRMT112;OSGEP;ANKRD16;TRMT9B;URM1;CTU2;TRMO;TRMT13;THUMPD3;CTU1;ALKBH1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2761728258108096,0.697500287053541,0.8744541484716157,0.9862126240299582,1.0,7/44,16.94%,SCIN;NCK2;GSN;NCK1;NCKAP1;CARMIL2;CDC42EP3
prerank,proteasomal protein catabolic process (GO:0010498),0.2527896477734621,0.6974895233364051,0.970912738214644,0.9858639391979538,1.0,58/201,25.94%,TBX21;NEDD4;PSMC3;RCN3;PSMD8;PSME1;PSMD6;PSMB5;FEM1C;PELI1;PSMC6;NHLRC3;PSMB4;CTNNB1;PSMA7;COP1;PSMB9;PSMA6;UBXN2A;SHARPIN;PSMC1;SIRT1;UBE2B;RNF216;CUL3;PSMD7;HUWE1;PSMD2;GSK3A;FBXL17;AREL1;SOCS6;DERL1;SMURF2;UBXN6;PSMD5;CDC34;UBE3D;DDB1;PSMB6;PLAA;BTRC;TBL1XR1;KCTD10;ERCC8;NHLRC1;PSMA3;DDIT3;UBE2W;PSMB2;TRIM3;SPOPL;FBXW7;PSMD1;GID8;RBCK1;KLHL20;PSMD10
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.27777790485187115,0.697484321119755,0.8741721854304636,0.985507530111841,1.0,12/44,17.35%,YTHDF3;METTL3;PABPC1;DHX36;ZFP36L2;BTG2;CPEB3;ROCK1;METTL14;KHSRP;ZC3HAV1;AGO2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.2884017134786409,0.6967060547183042,0.8711864406779661,0.9859264804228864,1.0,5/31,15.16%,SYT4;SYT7;CACNA1H;CBARP;CACNA1I
prerank,epithelial cell migration (GO:0010631),0.2851989947793933,0.6963862667297634,0.8795045045045045,0.9858841490974286,1.0,9/37,17.28%,DPP4;CDH13;KIT;FSTL1;ROCK1;PTP4A3;TNFSF12;PKN1;FAP
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.2898811048697801,-0.6963383430052275,0.8256578947368421,0.9624311058334611,1.0,2/10,13.32%,WHRN;ADGRV1
prerank,tRNA processing (GO:0008033),0.26692620794330474,0.696265142063447,0.8949579831932774,0.9856349921264024,1.0,14/61,22.48%,THG1L;RTRAF;CLP1;CSTF2;DDX1;TRMT6;NSUN2;ANKRD16;TRMT9B;URM1;POP5;CTU2;KARS1;SARS1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.34790958007344464,0.6958273301080268,0.8333333333333334,0.9857347561642412,1.0,3/11,18.29%,PARP3;PARP8;PARP10
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.2830237373998075,0.6957552672982072,0.8652073732718893,0.985440946232372,1.0,6/33,15.51%,RNF14;UFM1;KDM4C;TRIM68;NCOA2;PKN1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.24921260837303785,0.695511478942347,0.991,0.9853127270617797,1.0,94/341,26.30%,RNF125;TBX21;RNF7;NEDD4;PSMC3;BUB1B;RNF14;PSMD8;FZR1;PSME1;PSMD6;UHRF1;UBE2H;PSMB5;RNF111;UBE2G2;FEM1C;UBE2L3;BIRC6;PELI1;PSMC6;NHLRC3;AMFR;PSMB4;CTNNB1;UBQLN1;PSMA7;ZNRF3;COP1;KLHL25;PSMB9;PSMA6;UBXN2A;SHARPIN;VPS28;COPS3;PSMC1;SIRT1;UBE2B;RNF216;CUL3;TTC3;PSMD7;HUWE1;PSMD2;CHFR;GSK3A;FBXL17;KEAP1;UBE4A;AREL1;SMURF2;PSMD5;FBXO11;OS9;CDC34;UBE3D;FBXO10;MVB12A;DDB1;PSMB6;PLAA;UBE2D1;BTRC;TRIP12;TBL1XR1;KCTD10;ERCC8;NHLRC1;PSMA3;DDIT3;UBE2W;RC3H1;RNF166;RNF20;FBXL7;PSMB2;TRIM3;SPOPL;FBXW7;USP9X;PSMD1;CDC26;RNF13;PTPN23;ZRANB1;OTUD7A;GID8;RBCK1;KLHL20;PSMD10;ANAPC7;VPS37C;TRPC4AP
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.34404117570614745,0.6954631647149307,0.8200836820083682,0.9850087939878266,1.0,3/11,15.53%,CDH13;P2RX5;TREM2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.28788574286494106,0.6948027219629189,0.8551724137931035,0.9853205450875117,1.0,6/29,18.00%,NR1H2;PLAAT3;MBOAT7;PLBD1;PLA2G12A;DBI
prerank,endocardial cushion morphogenesis (GO:0003203),0.31321214346538384,0.6946975786873416,0.838501291989664,0.9850656300355803,1.0,2/18,7.67%,TGFB2;BMP4
prerank,serine family amino acid catabolic process (GO:0009071),0.3470153868819348,0.6944677008748997,0.834733893557423,0.9849471287947972,1.0,1/10,4.64%,SHMT1
prerank,regulation of axon regeneration (GO:0048679),-0.2690941012150268,-0.6932594336649345,0.875,0.9641119695945662,1.0,1/12,0.82%,RTN4RL1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.31504579895406765,0.6929946713690063,0.8598247809762203,0.9860564918361856,1.0,2/19,8.99%,ADAM19;BMP6
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3280098338282736,0.6928270486006136,0.8396624472573839,0.9858709158061244,1.0,3/13,17.54%,MPDU1;DPAGT1;ALG1
prerank,regulation of RNA metabolic process (GO:0051252),0.2682284801521869,0.692594848918686,0.9010638297872341,0.9857562217523562,1.0,18/59,23.81%,MBNL3;AHNAK;PTBP3;OASL;PCBP4;PTBP2;MBNL2;HNRNPF;AFF2;PRX;RBM20;MBNL1;PCBP1;PCBP3;GRSF1;FASTK;RBM38;RC3H1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2538133633686442,0.6922568398865655,0.9627391742195368,0.9857458891329878,1.0,22/151,14.42%,GSTO2;SPTSSA;SPTLC3;STARD10;GPHN;APOE;PRKD2;PPM1L;PCYT1A;MFSD2A;SPHK2;ELOVL7;CERS4;DMD;SLC27A1;ELOVL1;FA2H;MOCOS;NFS1;ELOVL6;HACD1;DEGS1
prerank,aminoglycan catabolic process (GO:0006026),0.28729476573675755,0.692197659918741,0.8640093786635404,0.9854470094509324,1.0,5/28,15.53%,HSPG2;SDC2;GPC6;GPC3;SGSH
prerank,histone H4-K16 acetylation (GO:0043984),0.3108437634693526,0.692036709314332,0.8442211055276382,0.9852648082305214,1.0,10/19,28.24%,MSL3;JADE1;WDR5;JADE3;MSL2;MEAF6;KMT2A;OGT;KAT7;PHF20
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.28960287737919943,-0.6918088026779833,0.875,0.9639528704097474,1.0,3/10,17.32%,CAMK1;PIH1D1;SMARCB1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.34015906299973325,0.6917363434403969,0.8382749326145552,0.9851872643112587,1.0,3/12,20.82%,SYT7;RIMS3;RIMS1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.17793279121477698,-0.6917262151337722,0.9473684210526315,0.9624402039793808,1.0,10/44,16.12%,OSBPL9;OSBP;SCP2;PRKAG2;CYP27A1;CH25H;OSBPL7;SC5D;OSBPL3;INSIG2
prerank,regulation of nervous system process (GO:0031644),0.30982085279069316,0.6914855693846192,0.8480392156862745,0.9850831143295145,1.0,2/18,8.72%,NPTX2;TMEM108
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2761533150882569,-0.691250115190234,0.8491228070175438,0.9613549637337518,1.0,7/11,25.02%,AGK;TIMM10B;NDUFA13;TIMM13;TIMM8B;ROMO1;TIMM29
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.2695164112781324,-0.6910168727743063,0.8674242424242424,0.9600252832895465,1.0,7/13,21.22%,PRPF3;PRPF19;AAR2;SART3;USP4;SRSF12;LSM2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.3150767180615208,0.6906457439098549,0.8490322580645161,0.9855888084031994,1.0,3/16,16.67%,MDK;ETS1;ITGB2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.2837123596507536,-0.6906282471909395,0.8456375838926175,0.9588229094038888,1.0,4/10,25.45%,SIRPA;PPM1B;PYCARD;CACTIN
prerank,lipoprotein catabolic process (GO:0042159),-0.2802525075655721,-0.690329940918088,0.858085808580858,0.9575706552313434,1.0,4/11,14.74%,ABHD17B;PPT1;ABHD17C;LYPLA1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.27870835160530316,0.690251852541761,0.8866442199775533,0.9856034016335152,1.0,4/37,5.76%,CEMIP;S1PR2;PARD3;CADM4
prerank,regulation of ossification (GO:0030278),0.28064885923785304,0.6898768650333041,0.8646188850967008,0.9856046676395107,1.0,9/36,20.09%,DDR2;MDK;TGFB2;BMP4;ZBTB16;SOX11;TXLNG;SOX9;LRP4
prerank,cellular response to oxygen levels (GO:0071453),0.35063348878877876,0.6897262754809765,0.8236151603498543,0.9853929433285262,1.0,3/10,19.74%,ATP6AP1;ATP6V0A2;ATP6V1G1
prerank,positive regulation of heart contraction (GO:0045823),0.3057629492349231,0.689350291306676,0.8445006321112516,0.9853993196502843,1.0,4/19,19.30%,TGFB2;ATP1A2;GSK3A;SCN3B
prerank,phosphate ion homeostasis (GO:0055062),0.34471404802658034,0.6893043163138259,0.8424068767908309,0.985085719312269,1.0,1/10,13.88%,XPR1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.3405399903618841,0.6890904842627236,0.8358620689655173,0.9849394616950566,1.0,2/11,12.89%,FBXO5;BLM
prerank,striated muscle tissue development (GO:0014706),0.28843313279338556,0.6890581244927813,0.8675263774912075,0.9846176319994452,1.0,2/29,8.62%,CSRP3;CAV1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.34623539280739124,0.6880863731143109,0.8286908077994429,0.9851895490415881,1.0,3/10,23.81%,PRNP;PRKAR1A;RC3H1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.29022460241378256,0.6878973594824986,0.8683274021352313,0.9850254623958444,1.0,1/29,0.89%,PKP1
prerank,positive regulation of sodium ion transport (GO:0010765),0.337120584815611,0.6878850108988271,0.8326359832635983,0.984681700252475,1.0,5/12,26.41%,ANK3;SCN3B;SCN1B;PRSS8;GPD1L
prerank,dendritic spine organization (GO:0097061),0.29158090888404004,0.6878137878095837,0.8802395209580839,0.9843995308818864,1.0,10/26,23.39%,PTEN;CDC42;PRNP;EPHB2;FYN;TREM2;IGF1R;DIP2A;CTNND2;INSR
prerank,anterior/posterior pattern specification (GO:0009952),0.2695997206105541,0.6869837521328795,0.8943436499466382,0.9848509251601304,1.0,8/53,13.10%,HOXA7;HOXB4;HOXC4;SMAD2;HEY2;HOXC9;HOXC5;HOXB9
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.28298704826766286,0.6868159754741016,0.8765714285714286,0.9846499151975328,1.0,9/33,24.55%,CDK6;PTEN;JADE1;CDKN1A;CDC73;WEE1;DLG1;RBL2;DCUN1D3
prerank,pteridine-containing compound metabolic process (GO:0042558),0.32411060803604463,0.686556967136813,0.8523035230352304,0.9845397133989364,1.0,5/13,27.44%,HSP90AA1;CALM1;MTHFD1L;QDPR;SPR
prerank,cholesterol metabolic process (GO:0008203),0.2627085649177635,0.6864635253894324,0.9011566771819137,0.9842665992915678,1.0,14/68,21.71%,LBR;APOE;SOAT1;HSD17B7;PMVK;ARV1;PLPP6;CEL;HMGCS1;SOAT2;ACAT2;OSBPL1A;PIP4P1;MSMO1
prerank,determination of bilateral symmetry (GO:0009855),0.29232113535896814,0.6861905482942395,0.8654761904761905,0.9841766682658112,1.0,4/25,17.88%,MKKS;ARL6;KIF3B;DNAH11
prerank,protein catabolic process (GO:0030163),0.2652106819189789,0.685808024564011,0.8983957219251337,0.9842049306554952,1.0,14/59,20.15%,CEACAM1;HSPA8;APOE;UBE2G2;TRIM24;HSP90AA1;USE1;RIPK1;DENND3;SOCS6;UCHL3;LAMP2;OGA;DDB1
prerank,mitotic recombination (GO:0006312),0.32038657884638144,0.6854818543828386,0.851145038167939,0.9841533751049639,1.0,4/15,23.68%,DMC1;ERCC1;SMC6;SMC5
prerank,spliceosomal complex assembly (GO:0000245),0.27030305023839835,0.6852843988018861,0.9036144578313253,0.9839931134337055,1.0,16/46,25.63%,SRPK1;SNRPG;SRPK3;LUC7L2;SF3B1;SF3A3;DDX1;SF3A2;YTHDC1;ZRSR2;RBM5;PRPF6;CELF1;CELF6;SRSF6;GCFC2
prerank,neuron maturation (GO:0042551),0.3100876470962838,0.6849859079971927,0.8541935483870968,0.9839498954907139,1.0,2/18,10.00%,C3;LGI4
prerank,ion homeostasis (GO:0050801),0.28530316140797396,0.6847650265014434,0.8622273249138921,0.9838091245810275,1.0,1/30,1.49%,RANGRF
prerank,respiratory chain complex IV assembly (GO:0008535),-0.21938562654943722,-0.6845497094357332,0.9356435643564357,0.9616191236436914,1.0,9/21,27.32%,OXA1L;COX19;COX10;BCS1L;SURF1;COX14;COA3;COA6;COA8
prerank,phosphate-containing compound metabolic process (GO:0006796),0.24797401123470697,0.6842468232703038,0.9729458917835672,0.9839586005287724,1.0,52/198,23.14%,GCK;LGALS13;ACYP1;PLPPR5;ALDOA;PTEN;DUSP5;HK1;PLCB3;PLAAT3;GPI;ACP3;SPHK2;SLC20A1;NUDT4;ALDOC;CERKL;ACYP2;EPHB2;DUSP16;LIMD1;EPHA7;COQ8A;PPIP5K1;PLBD1;GPX4;DUSP4;PAK1;PPA2;AGPAT2;INPP5A;PFKP;PLPPR2;CALM1;TOP1;PPP3CB;PLCH1;OCRL;PTPRC;IP6K2;PLCD4;GPD2;PLAA;GFPT2;PIP4P1;PGK1;PPP1CA;DUSP3;PTPRD;PRKCG;DUSP10;LIMK2
prerank,phosphatidylserine metabolic process (GO:0006658),0.2792692540115586,0.6842168841896175,0.8755813953488372,0.9836357587965577,1.0,8/32,25.40%,PTDSS2;PLAAT3;SLC27A1;PLA2G12A;SERINC5;OSBPL8;MBOAT1;SERINC1
prerank,protein K48-linked ubiquitination (GO:0070936),0.26514451460112054,0.6840830793960081,0.886021505376344,0.9834170550629256,1.0,13/54,21.38%,UBE2H;UBE2G2;PELI1;AMFR;UBR5;UBE2B;RNF216;CUL3;TTC3;RNF152;CDC34;UBE2D1;UBE2E2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.22941081170786135,-0.6840219236354347,0.9113300492610837,0.9606127771189118,1.0,5/19,13.44%,BMPR2;TGFBR2;OLFM1;NOTCH1;SOX4
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.266395910810427,0.6836929153559297,0.9131832797427653,0.9834194525945565,1.0,16/57,24.89%,NPTX2;CACNG7;LYNX1;GRIA1;GSG1L;SHISA9;GRIA2;DLG3;GRIA3;NPTX1;DLG1;ACTN2;PRRT1;RELN;GRIN1;DLG2
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.22008979056632832,-0.683683714204478,0.918918918918919,0.9593737612356837,1.0,7/22,22.00%,EPB41L4B;STXBP4;FGF10;KLF9;MED1;PRKD1;NOTCH2
prerank,embryonic digit morphogenesis (GO:0042733),0.3144160296638086,0.6835319564938914,0.8586118251928021,0.9832124013980634,1.0,4/18,18.36%,HDAC1;GLI3;HDAC2;ECE1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.28446262032457764,0.6830170320610588,0.8856476079346558,0.983362179970102,1.0,9/31,22.21%,EXOSC4;DCP1A;LSM3;HBS1L;EXOSC1;LSM6;LSM4;EXOSC9;DDX6
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.2881999001094425,0.6829741886877243,0.8682352941176471,0.9830533236167728,1.0,9/29,19.45%,APOE;CLN3;SHISA9;EPHB2;ZDHHC2;SYP;DRD2;SLC4A10;GRIK2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.31062239519809753,0.6827866918131735,0.8482490272373541,0.9828815561018475,1.0,2/17,8.88%,GET1;EMC3
prerank,vasculogenesis (GO:0001570),0.2857535471445509,0.6827394815853216,0.8766006984866124,0.9825745186081688,1.0,4/32,12.07%,KDR;CAV1;HEY2;TGFBR3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.30631896057391983,0.6826165936489399,0.8567741935483871,0.9823471270435928,1.0,6/18,24.79%,HDAC1;GSK3A;HDAC4;CCN3;FRS2;FZD7
prerank,positive regulation of stress fiber assembly (GO:0051496),0.2736963454899474,0.6817086466490357,0.9123767798466593,0.9828935785657479,1.0,9/44,15.52%,LPAR1;FERMT2;CD47;CCN2;CDC42;RHOC;TGFB3;S100A10;PAK1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.3174615867848388,0.6812641318313898,0.8659658344283837,0.9829363750442128,1.0,2/15,9.75%,MAPK9;CD36
prerank,muscle cell development (GO:0055001),0.2812611489924037,0.6812122075552925,0.8714622641509434,0.9826365174609922,1.0,4/30,9.63%,MYH11;NEBL;HEY2;DMD
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.32751430924840164,0.6808300568985259,0.830028328611898,0.9826438092603507,1.0,5/13,30.08%,GJC1;SCN3B;KCNN2;GJA1;CACNA1C
prerank,regulation of hemopoiesis (GO:1903706),0.34509379599159373,0.6807786095162528,0.8360881542699724,0.9823428486725164,1.0,4/10,24.07%,IL17D;LGALS3;MYSM1;PURB
prerank,blood vessel morphogenesis (GO:0048514),0.26614440812892665,0.6807105920110825,0.9149623250807319,0.9820584519611394,1.0,7/54,12.07%,EFNB2;KDR;COL4A1;CAV1;HEY2;LOX;TGFBR3
prerank,cytosolic transport (GO:0016482),0.24964415806533863,0.6798869754310957,0.9408163265306122,0.9824865928018517,1.0,16/108,14.96%,TBC1D10C;LMTK2;LAPTM5;RGP1;VPS13A;HOOK1;BAIAP3;TBC1D23;CLN3;HEATR5B;SNF8;ERC1;GOSR2;STX6;VPS51;GAK
prerank,indolalkylamine catabolic process (GO:0046218),-0.2758333695906505,-0.6797375191865239,0.8311258278145696,0.9616103398842415,1.0,3/10,27.45%,KMO;IL4I1;KYNU
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.30802404700241826,0.6795305055282511,0.8710888610763454,0.9824648052798582,1.0,1/19,2.97%,BPNT1
prerank,regulation of astrocyte differentiation (GO:0048710),0.33217494580709545,0.6792371622657114,0.8634538152610441,0.982388714470108,1.0,3/12,18.22%,ID2;CLCF1;HES1
prerank,organelle organization (GO:0006996),0.24443096348629487,0.6791549599233647,0.997,0.9821213877454449,1.0,65/388,18.05%,ATP8B4;CCL7;PLEKHF1;ATP7A;DIAPH1;CHMP6;PEX2;YTHDF3;PPIA;MTFR2;APOE;LONP1;CHCHD2;MDK;TMED4;SIPA1;POLG2;CSNK1A1;ABCD3;CHMP7;SYNE1;COG7;PLAAT3;WDR73;CDCA8;CAV1;PAK4;LMAN2;CFAP410;LMAN1;PEX16;CDC42;CFL1;LIMD1;ARHGAP21;BNIP1;CHMP5;LNPK;VPS11;UBXN2A;VPS51;RHOU;RAB2A;TNIK;SAR1B;FNBP1L;KIF5C;PDZD8;GAK;EIF2AK3;TTC17;CSPG5;MTX3;HUWE1;STX17;ATL1;ANK1;MIA3;NEDD9;MTFR1;SNX11;WASF3;SIPA1L3;RANBP9;SEC31B
prerank,leukotriene biosynthetic process (GO:0019370),0.3196951672609456,0.6782572828281336,0.844804318488529,0.9826145277069338,1.0,1/14,4.15%,ALOX5AP
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.28321293193138153,0.6780610016225145,0.882420091324201,0.9824412921391654,1.0,6/31,10.97%,PPFIA2;PTEN;CFL1;SRCIN1;DHX36;ZDHHC15
prerank,cardiac atrium morphogenesis (GO:0003209),0.318692590172929,0.6780477275542597,0.8676671214188267,0.9821022653783456,1.0,2/16,9.08%,TGFB2;HEY2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.3399216397659188,0.6776103897029846,0.8526170798898072,0.9821543750787254,1.0,5/10,22.89%,GPLD1;IRS1;PTH1R;SNCA;SLC45A3
prerank,positive regulation of autophagy (GO:0010508),0.2541946614579725,0.6774959084210498,0.9346473029045643,0.9819099269756418,1.0,24/81,24.53%,PLEKHF1;DCN;HMGB1;NPRL2;KDR;TRIM21;SESN3;ROCK1;FOXO1;TRIM68;SIRT1;TICAM1;GSK3A;RNF152;BNIP3;PAFAH1B2;STK11;GSK3B;TMEM59;SH3BP4;EPM2A;HTT;MTDH;TRIM8
prerank,positive regulation of cell division (GO:0051781),0.27563280211012076,0.6773371782485393,0.8977272727272727,0.981703546003194,1.0,10/38,24.99%,PKP4;RACGAP1;CDC42;CIT;CUL3;DRD2;SVIL;CDC14A;RHOA;PKN2
prerank,positive regulation of proteolysis (GO:0045862),0.26346448386952975,0.6772642415760327,0.9171210468920392,0.9814201370396917,1.0,10/55,17.95%,RCN3;APOE;CYFIP2;GPLD1;CTSH;SNX33;CTSC;WDR48;HDAC2;TNIP1
prerank,RNA methylation (GO:0001510),0.2610318257900949,0.6770124925468068,0.920995670995671,0.9813000720780197,1.0,12/60,17.00%,METTL3;RBM15;THADA;TRMT44;FTSJ3;MRM2;TARBP1;METTL14;FBL;TRMT6;NSUN2;TRMT112
prerank,regulation of cell division (GO:0051302),0.2582857835317535,0.6769339012731679,0.9236401673640168,0.9810208997931437,1.0,15/72,19.38%,PLK4;RACK1;KIF20A;PIN1;BIRC6;SFN;RAB11A;KLHL21;BLM;SMYD5;CALM1;RAB11FIP4;AHCTF1;ORC6;MLLT3
prerank,regulation of receptor internalization (GO:0002090),0.27914858654956376,0.6766044251883786,0.886150234741784,0.9809756794542958,1.0,7/35,18.82%,ANGPT1;CD63;GREM1;SDCBP;ANKRD13A;RIN3;MKLN1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.26562720633976006,0.6762084038592351,0.9093851132686084,0.9809980117111152,1.0,11/56,19.09%,TGFB2;BMP4;PIN1;GREM1;BMP6;TGFB3;GDF3;SDCBP;SNX25;EMILIN1;GDF11
prerank,manganese ion transport (GO:0006828),0.31891773154633585,0.6757837208188241,0.8560105680317041,0.9810588469952717,1.0,5/14,21.27%,SLC11A2;TRPC5;TRPC4;TRPC1;TMEM165
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3009029146933634,0.6751866793390257,0.8688725490196079,0.9812496383063058,1.0,2/19,11.01%,KDR;PRNP
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.2755094403033269,-0.6749116963787665,0.8512110726643599,0.9645735550623249,1.0,4/10,22.81%,EMC7;EMC4;EMC1;EMC10
prerank,meiosis I (GO:0007127),0.2909200112140963,0.6748250022626855,0.8784933171324423,0.9812217045022734,1.0,3/23,14.13%,ING2;SYCP3;BCL2L11
prerank,DNA modification (GO:0006304),0.2969695518271469,0.6747979314146824,0.879950495049505,0.980891968717476,1.0,2/22,8.17%,EXOSC4;PARP3
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2869467615873076,0.6745951177473355,0.8848837209302326,0.9803873542120486,1.0,5/29,19.16%,ACAT1;THEM4;DBI;ACOT6;ACOT8
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2869467615873076,0.6745951177473355,0.8848837209302326,0.9803873542120486,1.0,5/29,19.16%,ACAT1;THEM4;DBI;ACOT6;ACOT8
prerank,response to amino acid (GO:0043200),-0.19967268801511676,-0.6741994773615305,0.9444444444444444,0.9636938333252055,1.0,9/31,21.72%,MTOR;IPO5;TMBIM6;CPEB1;SESN2;GLRA3;XBP1;LARS1;RRAGA
prerank,protein transport (GO:0015031),0.24335023027212282,0.6739613781077334,0.994,0.9806087243334645,1.0,78/332,23.79%,TBC1D10C;CD3G;CD74;MON1A;RABGAP1L;ATP6V1G2;CLU;LMTK2;RAB8A;LTBP2;LAPTM5;RCN3;RAB3D;APOE;ADPRH;TMED4;AFM;TBC1D22B;RAMP1;TMEM167A;COG7;ZDHHC17;ANK3;ATP6AP1;RABGAP1;CD36;NSF;RAB5B;ARL4C;ATP6V0B;RAB5C;TBC1D2B;COPB2;TBC1D8B;SCG5;NPM1;STX6;ARL6;SAR1B;KIF3B;ATP6V0A2;SIL1;SLU7;EIF2D;ARL6IP5;SNX33;STX17;MIA3;ATP6V0E1;GGA1;IFT22;SEC31B;LAMP2;ATP6V1F;VIPAS39;PREB;TANGO6;ARFGAP3;CANX;ATP6V1G1;TBC1D13;VLDLR;ARL1;RAB24;SYS1;TXNIP;TANGO2;TMED2;ARRDC3;TFRC;IFT27;ATP6V1B2;TBC1D25;EHD1;TMED5;CENPF;NDC1;SCAMP3
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2593756871071243,0.6738517641435492,0.9095688748685594,0.9803632178475755,1.0,11/59,16.39%,SBK1;LMTK2;PRKD2;CDK1;HIPK1;NLK;CDC42BPG;ROCK1;CIT;HIPK3;GSK3A
prerank,negative regulation of type I interferon production (GO:0032480),0.2680793007138936,0.6738406803443561,0.9043381535038932,0.9800280279320633,1.0,9/40,21.47%,RNF125;PIN1;RNF216;LILRB1;ACOD1;RNF135;YY1;NLRC5;NLRC3
prerank,calcium import into the mitochondrion (GO:0036444),0.33525449890873965,0.6737668066950118,0.8453757225433526,0.9797445051559404,1.0,4/10,23.89%,SMDT1;SLC25A23;MCU;MCUB
prerank,microtubule polymerization (GO:0046785),0.28840814557943517,0.6737525017677088,0.889018691588785,0.9794125889408258,1.0,3/29,11.67%,CENPJ;PIN1;MAPT
prerank,positive regulation of neurogenesis (GO:0050769),0.25579182455112315,0.6731005407502126,0.9258098223615465,0.9796722811568159,1.0,24/68,27.60%,CHODL;AMIGO1;PLXNB1;SMARCD3;PLXNA2;CTNNB1;ROBO1;ROBO2;NPTN;DRD2;TIAM1;SOX11;PLXND1;MME;SLITRK1;PTPRD;CX3CL1;CAPRIN2;RHOA;NTRK2;SERPINF1;FBXW8;FZD3;IL1RAPL1
prerank,regulation of synapse assembly (GO:0051963),0.2664497813577471,0.6730486009876302,0.9164835164835164,0.979374054410858,1.0,11/46,23.25%,SLITRK2;GRID2;GPC6;EPHB2;SETD5;ROBO2;SLIT1;SNCA;SLITRK1;PTPRD;LHFPL4
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.31531361838387634,0.6726247434794292,0.872870249017038,0.9794186518276644,1.0,14/14,68.50%,ECE1;CORIN;NOS3;EDN1;AGTR1;AVPR1A;EDN2;EDN3;OXTR;ACE2;ACE;AVPR2;RASL10B;ENPEP
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.29463085853348503,0.6723195489983299,0.8596938775510204,0.9793535077591028,1.0,3/18,15.40%,PPIA;SIRT1;SOD2
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.2689960331829883,-0.6717467349219636,0.8593155893536122,0.9642417460498758,1.0,8/11,40.20%,ASAH1;DGKQ;WNT4;BMP5;STAR;BMP2;NR1H4;FGFR4
prerank,positive regulation of protein import into nucleus (GO:0042307),0.2819501358122271,0.670857742310974,0.8841463414634146,0.9803250129416251,1.0,6/28,18.09%,FLNA;CDH1;ZPR1;UBR5;JUP;DMAP1
prerank,RNA destabilization (GO:0050779),0.3075052905467348,0.6707507127834142,0.8711340206185567,0.9800638726480397,1.0,5/18,15.73%,YTHDF3;METTL3;ROCK1;METTL14;ZC3H18
prerank,metanephros development (GO:0001656),0.28731253408438656,0.6701263033309843,0.8727050183598531,0.9802578007394478,1.0,4/26,14.46%,NIPBL;BMP4;ROBO2;CTSH
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.22589370392885183,-0.669334983207189,0.9147982062780269,0.9647712927842312,1.0,3/18,9.06%,PLCG2;NMI;IFI35
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.28416004022366875,0.6689709788895475,0.8831325301204819,0.9809235207225635,1.0,8/24,22.38%,B2M;SAR1B;SEC24D;TAP1;CANX;TAPBP;FCER1G;SEC24C
prerank,bicarbonate transport (GO:0015701),-0.21139443175078867,-0.6686324521388988,0.9194630872483222,0.9638938453122243,1.0,16/25,42.78%,SLC4A7;CA2;SLC39A8;CYB5RL;SLC4A2;SLC4A3;CYB5R1;SLC4A9;SLC26A7;CFTR;CYB5R2;CA4;SLC4A1;SLC4A5;SLC4A4;AQP1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.25370762299279137,0.6684217584072459,0.9454732510288066,0.981052772825661,1.0,9/76,12.66%,PLK4;STAP1;NCK2;SEMA5A;GPSM2;CDC42;NCK1;SYNPO2;NCKAP1
prerank,cellular response to nutrient levels (GO:0031669),0.2592047253472183,0.6678012933773522,0.9271168274383709,0.9812647436456469,1.0,12/62,19.57%,FADS1;HSPA8;SREBF1;MAP1LC3A;MFSD2A;FOXO1;STK24;RALB;SIRT1;STK26;LAMP2;ATG14
prerank,NAD biosynthetic process (GO:0009435),0.2929401409801242,0.6677536687001611,0.8758002560819462,0.9809605882863861,1.0,3/20,18.29%,NAXE;NADSYN1;PARP10
prerank,response to alcohol (GO:0097305),0.28443966395716974,0.6677466377960859,0.896551724137931,0.9806219339271008,1.0,8/27,24.22%,SMAD2;GRIN3A;PMVK;TGFBR3;ABCA2;SLIT3;GOT2;GRIN1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.33791739477384053,0.6677395696749523,0.8619246861924686,0.9799355303735657,1.0,2/10,16.94%,CDC42;CDC42EP3
prerank,regulation of pseudopodium assembly (GO:0031272),0.33791739477384053,0.6677395696749523,0.8619246861924686,0.9799355303735657,1.0,2/10,16.94%,CDC42;CDC42EP3
prerank,negative regulation of TOR signaling (GO:0032007),0.27048157705418113,0.6673500592343611,0.8925339366515838,0.979917393052074,1.0,15/36,28.08%,NPRL2;ATM;SESN3;SIRT1;GSK3A;RNF152;SZT2;STK11;SH3BP4;EPM2A;ITFG2;CASTOR2;DEPDC5;PDCD6;KPTN
prerank,lysosome localization (GO:0032418),0.2710516388959073,0.6672094089150018,0.9037372593431483,0.9796951321641865,1.0,4/37,10.58%,NR4A3;KIT;ARL8B;FAM98A
prerank,DNA double-strand break processing (GO:0000729),0.30624019452239654,0.6671882829162288,0.8726591760299626,0.9793673203052071,1.0,3/18,12.89%,ATM;BARD1;BLM
prerank,peptidyl-threonine modification (GO:0018210),0.25506697302796233,0.666987583156129,0.9421661409043113,0.9792108411037015,1.0,10/66,12.42%,SBK1;LMTK2;PRKD2;CDK1;HIPK1;NLK;GALNT13;CDC42BPG;ROCK1;CIT
prerank,ganglion development (GO:0061548),0.329209272158807,0.6666621930414536,0.8601997146932953,0.9791657015804083,1.0,2/11,12.28%,CTNNB1;UNC5C
prerank,carnitine shuttle (GO:0006853),0.3351751309591331,0.6657725764740715,0.8491083676268861,0.9796160555936667,1.0,3/11,12.91%,MID1IP1;ACACA;CPT2
prerank,cell cycle G1/S phase transition (GO:0044843),0.25818387916338376,0.6650279054747317,0.9295478443743428,0.9799217359750543,1.0,13/61,18.52%,CDK6;RCC1;POLE;NASP;CDK2;CDC7;GSPT1;CDKN1A;CUL3;RPS6KB1;GPR132;HINFP;CDC34
prerank,microtubule anchoring (GO:0034453),0.32321283114820876,0.6644788783142936,0.8577348066298343,0.9800696177134355,1.0,2/12,12.83%,SAXO2;DAG1
prerank,mitochondrial membrane organization (GO:0007006),0.27977187719106006,0.6644444753597182,0.897887323943662,0.9797524946910751,1.0,7/32,21.55%,BCL2;IMMT;CHCHD6;MTX3;SLC25A4;BNIP3;GHITM
prerank,protein modification process (GO:0036211),0.2540880866179191,0.6635644837369111,0.9302564102564103,0.9802072473161263,1.0,19/76,22.09%,PIGH;UBA52;ADPRH;UBL5;UBE2L3;ST3GAL1;LOX;SLC35A1;LCMT1;PADI4;ABL2;ATG3;MMP15;CSNK1G3;FBXO11;CDC34;UBA3;GGCX;STK38
prerank,endocytic recycling (GO:0032456),0.2587665389378395,0.6635120978036327,0.9190101237345332,0.9799119392464053,1.0,14/50,25.90%,MICALL2;LMTK2;ARL4C;SNF8;MICALL1;STX6;VPS51;RAB11FIP4;SNX12;VPS39;EHD1;ANKRD50;PTPN23;EHD3
prerank,cellular response to acid chemical (GO:0071229),-0.19801604675374326,-0.6634166436154848,0.9444444444444444,0.9667319527672555,1.0,8/27,21.72%,MTOR;IPO5;VEGFA;CPEB1;SESN2;XBP1;LARS1;RRAGA
prerank,ethanol metabolic process (GO:0006067),-0.253232644268818,-0.6633151133435691,0.8970588235294118,0.965266112811671,1.0,3/12,21.68%,ACSS1;ALDH2;SULT1A1
prerank,proteasome assembly (GO:0043248),0.3298215776849843,0.6633029546634996,0.873015873015873,0.9797525680057659,1.0,3/11,18.13%,POMP;PSMG1;PSMD5
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.3154009714969771,0.6632494351926647,0.8673740053050398,0.9794530923498826,1.0,5/15,17.35%,PABPC1;BTG2;CPEB3;TENT4A;AGO2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.24996001385249103,0.6631810389731944,0.9333333333333333,0.9791705631455995,1.0,14/74,20.56%,BCL2;GPX1;BMP4;TNFSF10;BIRC6;SERPINE1;LGALS3;HSPA1A;RIPK1;MAP2K5;MCL1;SNAI2;TMBIM1;GSK3B
prerank,positive regulation of cell cycle (GO:0045787),0.25541866168443406,0.6618151587958567,0.9376344086021505,0.9800189349366792,1.0,10/62,16.42%,CCND2;TRIM21;RARA;TGFB2;MEIS2;CCNY;RPS15A;NUDT16;RPS6KB1;MAPRE3
prerank,cilium movement (GO:0003341),0.2597916769757409,0.6618094411910302,0.9069003285870756,0.9796806566759013,1.0,11/48,27.70%,ADCY10;CFAP251;DNAI4;CFAP206;ODAD1;DNAH11;CFAP70;DNAH17;DNAAF5;CCDC39;SPEF1
prerank,intracellular protein transport (GO:0006886),0.2395168590524147,0.6614937177554318,0.995,0.9796195201720308,1.0,57/304,19.35%,TBC1D10C;RANGRF;XPO1;CHP1;CD74;RPL11;RABGAP1L;LTBP2;LAPTM5;ADPRH;TMED4;TBC1D22B;NUP50;COG7;AP1S3;LMAN1;AKAP6;RABGAP1;NSF;APPL1;TECPR2;RAB5B;ARL4C;NUP214;NXT2;RAB5C;TBC1D2B;COPB2;NUP88;SORL1;SNF8;MMP12;TBC1D8B;SCG5;VPS28;NPM1;DESI1;STX6;ARL6;AP4S1;SAR1B;SIL1;KATNB1;SLU7;EIF2D;STX17;CLIP3;GGA1;IFT22;SEC31B;RANBP17;LAMP2;EGR2;VIPAS39;PREB;C2CD5;ARFGAP3
prerank,protein polyglutamylation (GO:0018095),0.3243174692721126,0.6611162800228821,0.8650568181818182,0.9795977714913724,1.0,2/11,15.22%,TTLL11;CEP41
prerank,RNA 3'-end processing (GO:0031123),0.2524581320152119,0.6605350225298104,0.9357894736842105,0.9797559870706848,1.0,21/69,25.48%,CLP1;CSTF2;EIF4A3;NUDT21;CSTF3;CDC40;TENT4A;SRSF7;POLDIP3;RBM8A;SLU7;THOC1;CSTF2T;SRSF4;RPRD1B;TUT1;PAPOLA;LIN28B;CPSF2;RPRD2;SRSF6
prerank,regulation of lipid storage (GO:0010883),0.28893058087440965,0.6599412287450604,0.8905109489051095,0.9799248780973822,1.0,3/22,14.04%,C3;NFKBIA;SIRT1
prerank,protein K11-linked ubiquitination (GO:0070979),0.2804558187752433,0.6593056399533179,0.8960573476702509,0.9801399110378164,1.0,8/27,26.06%,FZR1;UBE2H;UBE2L3;UBE2B;UBE2E2;UBE2W;CDC26;ANAPC7
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.30638543102248517,0.6589135312681588,0.8794233289646134,0.9801399157824797,1.0,3/15,17.78%,TGFB2;TGFB3;LILRB1
prerank,regulation of catecholamine secretion (GO:0050433),-0.19071777245377144,-0.6580198453821683,0.9705882352941176,0.9681621915639501,1.0,11/29,25.97%,DTNBP1;SYT2;SYT10;GRK2;KCNB1;KCNA2;SYT8;SYT9;PRKN;SYT3;CHRNA4
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.2762412171514441,0.6573456925024296,0.8925233644859814,0.9811409425280262,1.0,9/28,21.03%,APOE;CALB1;EPHB2;ZDHHC2;AGER;ADCY1;TYROBP;GSK3B;NSG1
prerank,spinal cord development (GO:0021510),-0.25191183433241615,-0.6571281793353095,0.9238754325259516,0.9673293918202343,1.0,3/12,13.44%,PKD1;LOXL3;SOX4
prerank,muscle cell differentiation (GO:0042692),0.2700294138099893,0.6561288362299637,0.9038901601830663,0.9818667795780569,1.0,4/32,9.63%,NEBL;SYNE1;HEY2;DMD
prerank,eye morphogenesis (GO:0048592),0.2909575565047847,0.6555438570077835,0.8784810126582279,0.9819992099357059,1.0,2/19,6.30%,RARG;NIPBL
prerank,mRNA methylation (GO:0080009),0.305756319008863,0.6554830546984662,0.8680738786279684,0.9817041287320349,1.0,4/15,16.13%,METTL3;METTL14;TRMT6;NSUN2
prerank,cellular response to hexose stimulus (GO:0071331),-0.20330557362568452,-0.6554703250184203,0.9529411764705882,0.9671140877811506,1.0,7/23,17.95%,PRKAA2;TRA2B;PAX2;SLC2A5;SOX4;KCNB1;XBP1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.27690641599901744,0.6554607124784089,0.90625,0.981382180442586,1.0,5/26,15.40%,PPIA;ATF4;SIRT1;FYN;SOD2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2663444635567233,0.654569479211184,0.9172259507829977,0.9818095661933213,1.0,4/32,10.81%,STARD10;PCYT1A;MFSD2A;SLC27A1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.2938628030105756,0.6544856271493836,0.8815286624203822,0.9815335899067223,1.0,5/18,16.39%,CLU;IFNGR1;ABCA2;SLC2A13;GSK3A
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.24645916990404867,-0.6541308707654965,0.8856088560885609,0.9666680441241764,1.0,3/13,10.31%,ZMIZ1;SMARCD1;SPI1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.3126436381196043,0.6537447555220685,0.8771466314398944,0.9818181193124784,1.0,2/14,19.69%,ATP6AP1;TYROBP
prerank,protein autoubiquitination (GO:0051865),0.2524189055672713,0.653618785584659,0.9439153439153439,0.9815839254020841,1.0,16/61,25.26%,TRIM21;UHRF1;RNF157;OBI1;AMFR;TRIM68;UBE2B;CUL3;RNFT1;DDB2;UBE3D;RNF220;ERCC8;RNF141;RAD18;RNF13
prerank,lipid phosphorylation (GO:0046834),0.3308076383710091,0.6535767993331612,0.863768115942029,0.9812799044280421,1.0,1/10,3.05%,DGKA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.3240452406679927,0.6529114210874909,0.8805309734513275,0.9811458152657779,1.0,4/10,30.11%,NCOR1;HDAC4;PFKFB1;NUPR1
prerank,negative regulation of glycolytic process (GO:0045820),0.3240452406679927,0.6529114210874909,0.8805309734513275,0.9811458152657779,1.0,4/10,30.11%,NCOR1;HDAC4;PFKFB1;NUPR1
prerank,lipid oxidation (GO:0034440),-0.24968245124355867,-0.6515522357422812,0.8904109589041096,0.9672689169266525,1.0,3/12,32.53%,PPARGC1A;ADIPOR1;ALOX5
prerank,regulation of mRNA processing (GO:0050684),0.2731927130893659,0.6508517061081851,0.9134948096885813,0.9825306612447857,1.0,8/32,17.60%,SRPK1;SLTM;SRPK3;CWC22;JMJD6;KHDRBS2;KHDRBS3;YTHDC1
prerank,lipid modification (GO:0030258),0.26154498898627804,0.6506618929337228,0.9184597961494904,0.9823433374840809,1.0,4/37,11.94%,DGKA;PLPPR5;MBOAT7;PLPP6
prerank,positive regulation of protein import (GO:1904591),0.27018768971677554,0.6493035385512425,0.908433734939759,0.9831253108992497,1.0,6/30,18.09%,FLNA;CDH1;ZPR1;UBR5;JUP;DMAP1
prerank,anterograde axonal transport (GO:0008089),0.26360411733817435,0.6489847989075433,0.9037372593431483,0.9830412939441644,1.0,6/37,14.77%,BLOC1S3;AP3M1;KIF5A;AP3S2;KIF3B;KIF5C
prerank,regulation of intracellular transport (GO:0032386),0.26142739747973726,0.6485735525788039,0.9203640500568828,0.9830361421140308,1.0,8/38,18.27%,LCP1;NEFH;NUP214;AAAS;GAS1;CRYAB;MLC1;MAP2
prerank,regulation of cytokinesis (GO:0032465),0.24627814569102924,0.6478101792672382,0.9386056191467221,0.9833215789396592,1.0,15/78,17.94%,PLK4;PKP4;RACGAP1;KIF20A;PIN1;BIRC6;CDC42;RAB11A;KLHL21;CIT;CUL3;DRD2;CALM1;RAB11FIP4;AHCTF1
prerank,polarized epithelial cell differentiation (GO:0030859),0.31506366007664127,0.6476468745215467,0.8656716417910447,0.9831187626599468,1.0,4/13,15.41%,MSN;CDC42;EZR;RAP2A
prerank,RNA transport (GO:0050658),0.24734843476065296,0.6472750041857449,0.9472573839662447,0.9830711194508228,1.0,16/71,22.78%,SIDT1;RTRAF;EIF4A3;NUP214;CDC40;SRSF7;RBFOX1;POLDIP3;KIF5C;RBM8A;SLU7;SLBP;THOC1;SRSF4;NUP62;YBX1
prerank,amyloid-beta metabolic process (GO:0050435),0.2953056193479126,0.6471861930409037,0.8872077028885832,0.9828081273937179,1.0,4/16,22.12%,ABCA7;MGAT3;BACE2;MME
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.27117192765468767,0.6470082190101664,0.9148446490218642,0.9826101860936645,1.0,4/31,12.34%,GPHN;MOCOS;PYCR2;NFS1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.3044730478621718,0.6466707200703397,0.8786279683377308,0.9825424184393309,1.0,3/14,15.59%,TLR9;OASL;USP15
prerank,glycine metabolic process (GO:0006544),0.3128274361550891,0.6459617794844925,0.8882758620689655,0.9827829527374038,1.0,1/12,4.64%,SHMT1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.25366251963656206,0.6459118780565899,0.9433760683760684,0.9824828547352673,1.0,11/53,22.16%,PLA2R1;ATM;RPS3;NSMCE1;CCAR2;SIRT1;PCNA;EEF1E1;ATR;TRIM28;ERCC8
prerank,regulation of regulated secretory pathway (GO:1903305),0.26648104876173695,0.6453734855588354,0.9164759725400458,0.9825998886068346,1.0,9/34,22.10%,SYT4;RAB3D;SYT7;RIMS3;RIMS4;GSK3B;RIMS1;RAB27A;SYT17
prerank,steroid metabolic process (GO:0008202),0.24833204142967746,0.6447736819163478,0.9483122362869199,0.982746808154942,1.0,11/72,23.09%,CYP2A6;DHRS9;HSD11B1;HSD17B7;ARV1;CYP7B1;TSPO;CYP26B1;HSD17B4;MSMO1;LIPA
prerank,histone H2A ubiquitination (GO:0033522),-0.21749713398008352,-0.6444027117623737,0.9282296650717703,0.9708783088814644,1.0,6/17,22.40%,KDM2B;BCOR;CUL4B;DTX3L;RING1;RNF2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.2625283802329056,0.6437446387968245,0.9244186046511628,0.9832331318031304,1.0,9/32,27.60%,NEDD4;SDC2;TNIK;RAP2A;GSK3B;PTPRD;CAPRIN2;FBXW8;IL1RAPL1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.23780475537948448,0.6432139450944638,0.9605809128630706,0.9833411791302914,1.0,21/91,20.06%,RAB8A;RAB3D;CDH13;SYT7;RAB11A;NSF;RAB5B;RUFY2;RAB5C;HIP1;STON2;CPLX2;STXBP5L;ABL2;GAS1;AP2S1;RALA;PTPRC;ARFGAP1;STON1;SNX12
prerank,regulation of protein localization (GO:0032880),0.24575498974694351,0.6432083854321772,0.9458023379383634,0.9830052780354083,1.0,19/58,28.30%,RABGAP1L;TRIM21;RACK1;HSP90AA1;TRIM67;FKBP1A;TRIM68;STX6;MAP2;AAK1;AFDN;HSP90AB1;DLG1;ZDHHC7;FBXW7;WDPCP;TRIM25;MMD2;TPR
prerank,endocardial cushion development (GO:0003197),0.2829197713685121,0.6431977036708058,0.8969849246231156,0.9826740809952662,1.0,2/21,7.67%,TGFB2;BMP4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3036819142810231,0.6427188580021431,0.8804780876494024,0.9827333828721162,1.0,4/15,16.92%,LNPK;REEP1;ATL1;ARL6IP1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.26782724117778345,0.6422207760304977,0.9085648148148148,0.9827768321054569,1.0,8/32,23.27%,MID1IP1;CDH5;KATNB1;STMN2;CLIP3;MAP2;SNCA;CLASP2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.24150045198657843,0.6421709774754899,0.9575569358178054,0.9821364645512247,1.0,18/78,20.71%,CD74;RACGAP1;KIF5A;CTSE;DCTN4;DYNLL1;AP1S3;KIF22;SAR1B;KIF3B;SEC24D;KIF11;ACTR10;AP2S1;KLC1;CANX;OSBPL1A;FCER1G
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.24150045198657843,0.6421709774754899,0.9575569358178054,0.9821364645512247,1.0,18/78,20.71%,CD74;RACGAP1;KIF5A;CTSE;DCTN4;DYNLL1;AP1S3;KIF22;SAR1B;KIF3B;SEC24D;KIF11;ACTR10;AP2S1;KLC1;CANX;OSBPL1A;FCER1G
prerank,ncRNA metabolic process (GO:0034660),0.2601429166643187,0.641713671135372,0.9273356401384083,0.9821412735801983,1.0,7/37,22.04%,TARBP2;MAPT;KHSRP;DROSHA;AGO2;DGCR8;DDX17
prerank,negative regulation of leukocyte migration (GO:0002686),0.3273954124949649,0.6415403596904256,0.8798283261802575,0.981944244539417,1.0,1/10,2.50%,HOXA7
prerank,negative regulation of myoblast differentiation (GO:0045662),0.30828940143185246,0.6409233917591753,0.8972972972972973,0.9820771070321356,1.0,3/13,19.83%,BMP4;SRA1;SOX9
prerank,connective tissue development (GO:0061448),0.2639571444641629,0.6397930956935276,0.9115566037735849,0.9826084664718676,1.0,4/35,10.11%,ATP7A;SOX5;CD44;ZBTB16
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2411509813591286,0.6396122581052903,0.9435146443514645,0.9824080511563726,1.0,10/80,13.75%,TBC1D10C;RGP1;BAIAP3;TBC1D23;LMAN1;HEATR5B;ERC1;GOSR2;STX6;VPS51
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2856768750666846,0.6394706331439987,0.9,0.9821813797736426,1.0,5/22,23.37%,MDK;BCL6;CTLA4;DUSP10;FANCA
prerank,regulation of intracellular protein transport (GO:0033157),-0.18883122273847652,-0.638724050678121,0.9523809523809523,0.9734111964599353,1.0,15/32,30.54%,SIRT7;PLK3;TGFB1;PTPN1;TENM1;RIPOR1;PTPN14;RUFY3;GCC2;ICE1;VAMP2;UHMK1;CEP290;CEP131;B3GAT3
prerank,mRNA export from nucleus (GO:0006406),0.23626784778608423,0.6375714245490325,0.9704081632653061,0.9833292930058294,1.0,36/102,29.71%,AGFG1;NUP50;EIF4A3;NUP214;NUP210;NUP88;CDC40;RANBP2;SRSF7;POLDIP3;PCID2;RBM8A;SLU7;AAAS;ENY2;YTHDC1;SLBP;THOC1;SRSF4;POLR2D;SMG7;NUP62;NUP93;NUP205;NDC1;CPSF2;NUP153;SRSF6;HNRNPA2B1;PABPN1;NUP98;TPR;DDX19B;THOC3;NUP35;SARNP
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.2929934199414481,0.6369827352526054,0.9015544041450777,0.9834652173228612,1.0,3/16,12.07%,PIM1;AKAP6;TGFBR3
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.29687540318014255,0.6361482258724295,0.8904458598726115,0.9837698653358562,1.0,4/15,19.03%,PAF1;NPM1;CUL3;CDC73
prerank,phosphatidylcholine metabolic process (GO:0046470),0.24025962285640556,0.635971946421575,0.9558359621451105,0.9835820606556319,1.0,10/70,15.47%,STARD10;NR1H2;PCYT1A;MFSD2A;PLAAT3;MBOAT7;GPLD1;SLC27A1;PLBD1;PLA2G12A
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.2652308618967103,-0.6355621160086494,0.9124579124579124,0.9740784409947906,1.0,3/10,13.10%,ARHGAP12;NOTCH1;LRP6
prerank,response to hexose (GO:0009746),-0.19999841067329543,-0.6342887754935105,0.9882352941176471,0.9734343912129517,1.0,8/25,23.02%,PFKL;EIF2B5;SLC2A5;THBS1;IRS2;TCF7L2;ZBED3;KHK
prerank,steroid hormone biosynthetic process (GO:0120178),0.2684072988815711,0.6341617688851646,0.9145907473309609,0.9846177249987526,1.0,2/29,7.33%,STARD3NL;HSD17B7
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.29063389480746804,0.6341349985340635,0.9052774018944519,0.9842980588669225,1.0,3/15,16.08%,ZNRF3;GPC3;TIAM1
prerank,regulation of spindle organization (GO:0090224),0.28881943292169165,0.63339334104927,0.9060150375939849,0.9845339516492209,1.0,4/18,22.31%,GPSM2;PARP3;GNAI1;NUP62
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.3186814124587717,0.6326936436609034,0.8945945945945946,0.9847276358852839,1.0,3/11,15.87%,GSKIP;STK24;ARL6IP5
prerank,regulation of calcium-mediated signaling (GO:0050848),0.27034149734076585,0.6326718634513084,0.9037304452466908,0.9844007437435994,1.0,5/25,15.53%,CDH13;ITPR1;MAPT;P2RX5;TREM2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.25203991498252193,0.6324161280184368,0.933982683982684,0.9842482948047194,1.0,11/45,19.82%,EIF2A;EIF2B4;RBM4B;GCNT2;NUDT21;ZC3H7B;YTHDC1;PER1;RPL10;ATG14;CYFIP1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.2879690278721402,0.6315253059235318,0.9017038007863696,0.9845753992245599,1.0,7/18,29.71%,POLDIP3;PCID2;ENY2;NUP93;PABPN1;DDX19B;SARNP
prerank,response to sterol (GO:0036314),0.31113316932322466,0.631100719413652,0.8954802259887006,0.9845639809667965,1.0,4/11,18.69%,SMAD2;PMVK;ABCA2;RORA
prerank,Golgi inheritance (GO:0048313),0.3068557803933886,0.630894332468274,0.8753541076487252,0.9843839914862517,1.0,3/11,20.61%,CDK1;VCPIP1;YWHAZ
prerank,positive regulation of exocytosis (GO:0045921),0.2589311015786538,0.6307378149577499,0.9301260022909508,0.9841669417100817,1.0,11/35,25.06%,RAB3D;ATP6AP1;SNF8;CADPS;SDCBP;SNCA;PDCD6IP;RAB27A;STXBP5;CLASP2;ATP13A2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.2884146055823421,0.6298698504239978,0.8843710292249047,0.9844748691350602,1.0,4/17,19.96%,PBX1;DLGAP5;KAT2B;PLXND1
prerank,synaptic vesicle transport (GO:0048489),0.317876529643907,0.6296000287264907,0.8720112517580872,0.9843285037922379,1.0,4/11,21.39%,KIF5A;KIF5C;TMEM230;RAB27A
prerank,regulation of intracellular pH (GO:0051453),0.25822276144649225,0.6292633752363084,0.9339407744874715,0.9842381275774709,1.0,3/34,8.98%,CHP1;SLC26A6;CLN3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2457586229543704,0.6283357716883533,0.9505376344086022,0.9845845502267754,1.0,9/54,15.76%,ATM;GADD45A;CDK1;TFDP2;SFN;PCBP4;BTG2;CDKN1A;PCNA
prerank,negative regulation of double-strand break repair (GO:2000780),0.26094924427468696,0.6272086671179237,0.9119047619047619,0.9850890920675036,1.0,6/30,18.17%,PARPBP;NUDT16L1;RMI2;UBR5;HELB;CGAS
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2344715630881705,0.6251986559485931,0.9680412371134021,0.9861979010512895,1.0,18/79,20.71%,CD74;RACGAP1;KIF5A;CTSE;DCTN4;DYNLL1;AP1S3;KIF22;SAR1B;KIF3B;SEC24D;KIF11;ACTR10;AP2S1;KLC1;CANX;OSBPL1A;FCER1G
prerank,acylglycerol homeostasis (GO:0055090),0.2769647663094766,0.6250418875693665,0.9054726368159204,0.9859776875656726,1.0,4/20,19.40%,APOE;APOC4;RORA;MLXIPL
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2762706098300761,0.6241040122013936,0.9085290482076638,0.9859842451302523,1.0,7/21,23.32%,ERCC4;GTF2H5;ERCC1;ERCC5;DDB2;DDB1;XPA
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2762706098300761,0.6241040122013936,0.9085290482076638,0.9859842451302523,1.0,7/21,23.32%,ERCC4;GTF2H5;ERCC1;ERCC5;DDB2;DDB1;XPA
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.2562853373316303,0.6240099519126172,0.9402985074626866,0.9857228543874371,1.0,4/34,15.07%,CD28;DLGAP5;ESPL1;CUL3
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.27208499799346664,0.6237455029923036,0.9291139240506329,0.9855816105351347,1.0,4/21,11.70%,MED30;DHX36;SUB1;MED13
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.30925739909901895,0.6231871626840015,0.9125528913963329,0.98565925385493,1.0,2/11,15.52%,BCAR1;PAK1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.2615646431006514,0.6221017880221198,0.9266589057043073,0.9861189176679536,1.0,6/30,20.56%,GPX1;TNFSF10;SERPINE1;RIPK1;TMBIM1;GSK3B
prerank,response to organonitrogen compound (GO:0010243),0.251437704590102,0.6219756651551435,0.9320712694877505,0.9858574985166585,1.0,6/38,18.10%,HLCS;RCN3;GLRB;DRD2;DERL1;UBXN6
prerank,positive regulation of bone resorption (GO:0045780),-0.2498253449216934,-0.6217765816023273,0.9359430604982206,0.9802871501501801,1.0,3/11,15.66%,TNFRSF11A;ADAM8;SYK
prerank,regulation of centrosome duplication (GO:0010824),0.25941912977370307,0.6216729154162359,0.9145907473309609,0.9857384618720526,1.0,6/30,20.98%,CENPJ;CHMP5;NPM1;SIRT1;TMEM67;PDCD6IP
prerank,regulation of urine volume (GO:0035809),0.31127274248185965,0.62049725347889,0.8876404494382022,0.9862285018668616,1.0,1/10,10.41%,ADCY6
prerank,pre-miRNA processing (GO:0031054),0.2975196874740163,0.6188790970186298,0.9009370816599732,0.987014631081814,1.0,6/14,28.66%,TARBP2;DROSHA;AGO2;LIN28B;ADAR;DICER1
prerank,UV protection (GO:0009650),0.3163097434348784,0.6185307625659743,0.8920454545454546,0.9869051537894528,1.0,3/10,23.32%,GPX1;ERCC5;XPA
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.2557447853182131,-0.618470967563009,0.9003215434083601,0.980769956014648,1.0,6/11,40.19%,RSPO3;NKD1;DAB2;SFRP1;CSNK1E;WNT5B
prerank,negative regulation of synaptic transmission (GO:0050805),0.2675150061055378,0.6183948905696682,0.9197604790419162,0.986657130344831,1.0,6/23,23.42%,PTEN;SHANK2;DRD2;PNKD;SLC24A2;PRRT1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.27823360935371544,0.6179095702400117,0.9221105527638191,0.9866430553208014,1.0,5/20,19.49%,TARBP2;DROSHA;ZC3H7B;AGO2;TSNAX
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.2561803545721228,0.6175479701533296,0.9315230224321134,0.9865531221592753,1.0,6/29,24.08%,SYCP2;STAG3;FANCD2;MEI4;TEX11;PRDM9
prerank,establishment of protein localization to organelle (GO:0072594),0.23282361887395533,0.6175373039569914,0.9657676348547718,0.9862235357207971,1.0,10/72,12.44%,TSPAN17;HK1;NUP50;RAB11A;APPL1;NUP214;NXT2;ZDHHC15;NUP88;MMP12
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.267119240707483,0.6170117882055776,0.924433249370277,0.9862268843989415,1.0,6/22,26.50%,TMEM108;MAPT;STMN2;NTRK3;EHD1;NTRK2
prerank,regulation of neutrophil migration (GO:1902622),0.30730745573234064,0.6164401783940101,0.8909090909090909,0.9862853817455784,1.0,2/10,9.35%,RAC2;JAM3
prerank,regulation of gene silencing by RNA (GO:0060966),0.23964156499947314,0.616248123893577,0.9449152542372882,0.9857466439181459,1.0,19/50,28.57%,NUP50;NUP214;NUP210;NUP88;RANBP2;POLR2F;AAAS;AGO2;POLR2D;NUP62;NUP93;NUP205;NDC1;NUP153;EIF4G1;PUM1;NUP98;TPR;H3-3A
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.23964156499947314,0.616248123893577,0.9449152542372882,0.9857466439181459,1.0,19/50,28.57%,NUP50;NUP214;NUP210;NUP88;RANBP2;POLR2F;AAAS;AGO2;POLR2D;NUP62;NUP93;NUP205;NDC1;NUP153;EIF4G1;PUM1;NUP98;TPR;H3-3A
prerank,cellular response to ketone (GO:1901655),0.2480870997525871,0.6154104922487317,0.9305239179954442,0.9859965552838985,1.0,7/35,18.51%,AHR;MSN;SPHK2;ADCY6;ADCY1;ACOD1;GNAI1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.25652801105671874,0.6152914152061343,0.9441860465116279,0.9857445310753644,1.0,4/30,11.30%,GJC1;SCN1A;ATP1A1;CACNA2D1
prerank,DNA damage checkpoint signaling (GO:0000077),0.2651388832382148,0.6152088364615196,0.9339735894357744,0.9854676828213634,1.0,7/28,20.46%,RAD1;ATM;INTS7;BRIP1;USP28;HINFP;ATR
prerank,regulation of cellular catabolic process (GO:0031329),0.2359438676156014,0.6148942091424855,0.9723404255319149,0.9853375669984887,1.0,10/62,16.66%,RAB8A;SMCR8;DAPK3;ATM;ITPR1;ROCK1;MAPT;RMC1;ABL2;KEAP1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.23615021621043736,-0.6143236807926424,0.92,0.9817779504870042,1.0,1/13,0.93%,PPARD
prerank,negative regulation of calcium ion transport (GO:0051926),0.2847792380701595,0.614143319192103,0.9155495978552279,0.9855072796314205,1.0,7/15,31.80%,ATP1A2;CBARP;LILRB1;CD33;EPO;ADRA2A;TRIM27
prerank,divalent inorganic cation homeostasis (GO:0072507),0.26482318684057543,0.6138662218935974,0.9284862932061978,0.985358342589583,1.0,9/25,26.54%,CAV1;ANK3;FAM20A;KCNA1;TMC8;SNCA;GRIN1;ATP13A2;WFS1
prerank,protein prenylation (GO:0018342),-0.25266197554947606,-0.6134145653218886,0.9411764705882353,0.9807941355706473,1.0,1/10,0.87%,PGGT1B
prerank,negative regulation of neurogenesis (GO:0050768),0.2544603800006587,0.6128232857261277,0.9315068493150684,0.9857009761408753,1.0,10/34,29.45%,B2M;PTEN;SORL1;LRP4;THY1;RHOA;LINGO1;OMG;RTN4;NF1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.2705792777438285,0.6128042635163706,0.9315403422982885,0.9853770667813763,1.0,3/23,12.07%,ID2;FKBP1A;TGFBR3
prerank,basement membrane organization (GO:0071711),0.2948796173395935,0.6126693646399676,0.9173553719008265,0.9851302330014533,1.0,4/14,16.87%,COL4A1;NTNG1;NTNG2;LAMB1
prerank,oligodendrocyte differentiation (GO:0048709),0.27949991556031545,0.612486175977832,0.9237611181702668,0.9849152420320509,1.0,7/19,26.92%,EIF2B4;SOX10;SOX9;SOX13;EIF2B2;PTPRZ1;MYRF
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.24059531145788196,0.6123014957297418,0.9519015659955258,0.9847067970879708,1.0,4/45,9.00%,IQGAP1;NCK2;RPS6KA5;BCAR1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.23173189992408855,0.6103826709528696,0.9709241952232607,0.9856555482817825,1.0,18/80,20.68%,RACGAP1;KIF5A;COG7;SEC22B;LMAN2;KIF22;NSF;COPB2;BNIP1;USE1;KIF3B;KIF11;ARFGAP2;KLC1;ARFGAP1;ARFGAP3;TAPBP;ZW10
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.29577491970912423,0.610055169359762,0.8915159944367177,0.9855486562883679,1.0,4/12,23.39%,SMCR8;IGF1R;BNIP3;INSR
prerank,myelination in peripheral nervous system (GO:0022011),0.29344161696589466,0.6100070508717013,0.9005376344086021,0.9852486760547735,1.0,3/13,16.50%,PARD3;LGI4;PRX
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.2696386011783772,0.6094244742777151,0.9326683291770573,0.9852997670404211,1.0,6/21,23.89%,ANXA6;SMDT1;PDZD8;SLC25A23;MCU;MCUB
prerank,microtubule nucleation (GO:0007020),0.2737519975476814,0.6086906665684849,0.9194139194139194,0.9854318691219728,1.0,1/20,2.95%,CENPJ
prerank,oligodendrocyte development (GO:0014003),-0.22003206802881786,-0.6072258976359218,0.9617021276595744,0.9829346627843972,1.0,4/15,18.04%,PLP1;EIF2B5;NSUN5;CNTNAP1
prerank,"transcription, DNA-templated (GO:0006351)",0.22234249660963065,0.6070161030817192,0.993993993993994,0.9861740400859337,1.0,37/207,19.38%,DEAF1;MRPL12;AFF4;NELFCD;ZBTB7B;PAF1;NR4A2;SOX5;PRMT5;LEO1;CREBL2;MLF1;TRIM24;MNT;RNGTT;GTF2H5;KLF13;TAF1B;GTF3C3;PAX5;CTR9;ATF4;POLR2F;TAF6;BAZ2A;XAB2;TBPL1;HIPK3;TCEA1;BTF3;DEK;TSC22D1;EAF2;TBP;SLC25A33;CDC73;MLLT3
prerank,Notch signaling pathway (GO:0007219),0.23368333294809768,0.6066313900507684,0.96051227321238,0.9860836205133527,1.0,11/59,19.96%,PBX1;MDK;HEY2;DTX2;DLGAP5;JAG1;KAT2B;HES1;SNAI2;NLE1;PLXND1
prerank,regulation of chromosome organization (GO:0033044),0.26727366305983774,0.6059005149765829,0.9302030456852792,0.9862472388281658,1.0,3/22,13.63%,WAPL;MAPT;RMI2
prerank,negative regulation of viral release from host cell (GO:1902187),0.2886303090667228,0.6047634048224846,0.9163292847503374,0.9866481816633712,1.0,5/13,28.77%,TRIM21;TRIM28;TRIM8;TRIM11;TRIM26
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.27101528616187187,0.6040373354744137,0.9215189873417722,0.9867668478777814,1.0,3/18,15.90%,PET100;FASTKD3;SMIM20
prerank,regulation of RNA export from nucleus (GO:0046831),-0.24761343325279467,-0.6032137716759931,0.9063545150501672,0.9836377282294347,1.0,1/11,1.66%,AKAP8L
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.2474293255696206,-0.6019297235663297,0.9484536082474226,0.982797345623265,1.0,5/10,27.84%,ZNHIT6;PIH1D1;RUVBL2;SHQ1;TAF9
prerank,acyl-CoA metabolic process (GO:0006637),0.24875964818131174,0.6018571456179266,0.9467723669309174,0.9878476216828647,1.0,7/35,19.44%,THEM4;ACACA;SUCLG2;DBI;ACOT6;ACOT8;HMGCS1
prerank,retrograde axonal transport (GO:0008090),0.2733016774424744,0.6010903582947491,0.9232804232804233,0.9879973394838517,1.0,4/16,16.80%,KIF5A;TMEM108;PAFAH1B1;ACTR10
prerank,regulation of hippo signaling (GO:0035330),0.27454031657126676,0.600724013370997,0.9310793237971391,0.9879034693660194,1.0,5/17,19.38%,SHANK2;LIMD1;CIT;SOX11;MARK3
prerank,vesicle transport along microtubule (GO:0047496),0.2609542106964606,0.5994409290404474,0.9344660194174758,0.988381965528029,1.0,5/23,16.52%,KIF5A;CLN3;BICDL1;KIF3B;PAFAH1B1
prerank,mRNA transport (GO:0051028),0.22243499351354237,0.5992280363871441,0.9816700610997964,0.9881750817110488,1.0,34/101,29.71%,AGFG1;NUP50;EIF4A3;NUP214;NUP210;NUP88;CDC40;RANBP2;SRSF7;POLDIP3;KIF5C;RBM8A;SLU7;AAAS;YTHDC1;SLBP;THOC1;SRSF4;SMG7;NUP62;NUP93;NUP205;NDC1;CPSF2;NUP153;SRSF6;HNRNPA2B1;ZFP36;NUP98;TPR;DDX19B;THOC3;NUP35;SARNP
prerank,response to light stimulus (GO:0009416),0.23276870927446555,0.5991899497615234,0.9527896995708155,0.9878671545802693,1.0,12/55,23.25%,ERCC4;USP1;CCAR2;COPS3;MSH6;UBE2B;DRD2;ERCC5;DDB2;ERCC8;SPRTN;CRY2
prerank,Rap protein signal transduction (GO:0032486),0.2996491807548254,0.5986121456506965,0.9218106995884774,0.9878936944898675,1.0,3/10,22.34%,RAP2A;RAPGEF3;RAP1B
prerank,mRNA catabolic process (GO:0006402),0.23633904976630488,0.5980377485514676,0.9657836644591612,0.9878907526613319,1.0,16/44,27.67%,EXOSC4;XRN2;METTL3;NUDT16L1;ZFP36L2;HSPA1A;NUDT16;LSM6;EXOSC10;EXOSC9;ERN1;RC3H1;ZC3H12D;XRN1;ZFP36;NBDY
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.25544493005418983,0.5960701159236717,0.9494451294697904,0.9887741086335945,1.0,4/25,17.28%,SMAD2;BMP4;CDH5;SOX11
prerank,triglyceride homeostasis (GO:0070328),0.25450864058485717,0.5958948638305451,0.9305389221556887,0.9885487038910266,1.0,5/26,19.40%,APOE;APOC4;SIRT1;RORA;MLXIPL
prerank,ureteric bud development (GO:0001657),0.27526315243764105,0.5956545006524151,0.9490861618798956,0.9883575676533916,1.0,3/17,14.90%,BMP4;ROBO2;GPC3
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.25780510506206805,0.5952104969689356,0.941031941031941,0.9883013095418463,1.0,3/23,15.47%,PLAAT3;PLBD1;PLA2G12A
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.23987431525389832,0.5951645276979658,0.9542410714285714,0.9880007498190474,1.0,6/45,14.59%,TGFB2;BMP4;BMP6;TGFB3;GDF3;SDCBP
prerank,amino sugar metabolic process (GO:0006040),0.3037996044811705,0.5950618394354592,0.9110473457675753,0.9877318014384068,1.0,4/10,20.95%,ST3GAL1;EXTL2;GFPT2;CSGALNACT1
prerank,positive regulation of DNA replication (GO:0045740),0.27262418901346136,0.5948681934486155,0.9184993531694696,0.9875164784511675,1.0,6/16,30.18%,PCNA;STN1;CTC1;BRPF3;KAT7;GLI2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2226256005380742,0.5941997371763498,0.972193614830072,0.9875654283499936,1.0,11/86,14.59%,ING2;SMAD2;TGFB2;RNF111;BMP4;BMP6;JAK2;CDH5;TGFB3;GDF3;SDCBP
prerank,regulation of actin filament depolymerization (GO:0030834),0.28925665926739363,0.5941380604892414,0.9053497942386831,0.9872691912917919,1.0,1/12,4.35%,SEMA5A
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2869110512887798,0.5940080602038621,0.918010752688172,0.9870148647008375,1.0,5/13,27.49%,VDAC2;BCL2L11;BNIP3;RHOT2;BNIP3L
prerank,alpha-amino acid catabolic process (GO:1901606),0.24596447734109197,0.5938775613260686,0.9468599033816425,0.9867650453478679,1.0,7/29,27.10%,ACAT1;ACADSB;DDO;KYAT1;GOT2;BLMH;ALDH4A1
prerank,transcription preinitiation complex assembly (GO:0070897),0.2894563746296784,0.5934090038456199,0.9300411522633745,0.9867128071262331,1.0,3/12,18.30%,TAF1B;DR1;TBP
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.2705821063970304,0.5919151507138398,0.9300254452926209,0.9872589796881797,1.0,2/17,5.76%,PARD3;CADM4
prerank,aorta morphogenesis (GO:0035909),0.2675101607551097,0.5917409375541011,0.9421593830334191,0.9870313239267612,1.0,3/17,16.79%,HEY2;EFEMP2;JAG1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.2874125131805404,0.5897625037191497,0.9333333333333333,0.9875129276719754,1.0,3/12,18.14%,AKAP6;CHERP;SPPL3
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.2874125131805404,0.5897625037191497,0.9333333333333333,0.9875129276719754,1.0,3/12,18.14%,AKAP6;CHERP;SPPL3
prerank,regulation of DNA metabolic process (GO:0051052),0.23100167968301769,0.5895745351465954,0.9608269858541894,0.9872910750643287,1.0,5/44,11.41%,IL7R;TICRR;USP1;WDR70;SUB1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.23569325963189292,0.5893986437548311,0.9550056242969629,0.9870693710021173,1.0,5/39,9.40%,SYT4;PPFIA2;MYO1G;CLN3;BICDL1
prerank,regulation of macroautophagy (GO:0016241),0.21773530204625857,0.5878502205485863,0.9858299595141701,0.9876279676904748,1.0,26/105,23.64%,NEDD4;DCN;ATP6V1G2;SMCR8;KDR;LAMTOR4;CLN3;ATP6V0B;SESN3;UBQLN1;SIRT1;GAPDH;CAPNS1;ATP6V0A2;RHEB;ATP6V0E1;BNIP3;ATP6V1G1;PAFAH1B2;PRKAB2;EPM2A;PRKAG1;ATP6V1B2;TBC1D25;ERN1;RRAGB
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.30122249469891854,0.5876160397038404,0.9289772727272727,0.9874425500772134,1.0,3/10,20.58%,HK1;PFKP;GFPT2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.2466161189698547,0.5873397709707459,0.9418604651162791,0.9872605811394877,1.0,4/30,15.01%,RASGRP1;JAK2;SHC1;CRKL
prerank,cytoskeleton organization (GO:0007010),0.21705323731965181,0.586673731622951,0.9847560975609756,0.9872940991952688,1.0,34/114,26.54%,CCL7;DIAPH1;APOE;MDK;SIPA1;RAC2;PAK4;CFAP410;CFL1;RHOC;LIMD1;RHOU;TNIK;PDZD8;CSPG5;ANK1;NEDD9;WASF3;SIPA1L3;RANBP9;CECR2;MAST4;NCKIPSD;FMNL3;SH3D19;THY1;RHOA;RHOD;ZRANB1;PCLO;RHOG;KLHL20;WDPCP;PALLD
prerank,nuclear export (GO:0051168),0.22241262953376986,0.5860437382874185,0.9833333333333333,0.9872940383229667,1.0,15/80,19.18%,XPO1;CHP1;MALT1;EIF4A3;NUP214;CDC40;ATXN1;DESI1;SRSF7;POLDIP3;RBM8A;SLU7;RANBP17;EGR2;THOC1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.2819042963045117,0.5858110536394637,0.9247311827956989,0.9870990161276625,1.0,4/12,23.03%,SREBF1;ABCA2;SEC14L2;MBTPS1
prerank,positive regulation of viral transcription (GO:0050434),-0.17841816996232776,-0.5857137288084275,0.9715909090909091,0.989304853662292,1.0,14/25,35.63%,CDK9;POLR2G;POLR2K;MDFIC;POLR2C;POLR2H;NELFE;GTF2F2;POLR2J;POLR2L;POLR2E;POLR2I;POLR2B;NELFA
prerank,determination of left/right symmetry (GO:0007368),0.23693625095910523,0.584562003564228,0.9617547806524185,0.9874668995697452,1.0,5/37,17.88%,MKKS;ARL6;KIF3B;RFX3;DNAH11
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2170217258532349,0.5835490660939978,0.9836233367451381,0.9877050924451296,1.0,25/96,25.48%,AGFG1;NUP50;EIF4A3;NUP214;NUP210;NUP88;CDC40;RANBP2;SRSF7;POLDIP3;RBM8A;SLU7;AAAS;YTHDC1;SLBP;THOC1;SRSF4;SMG7;NUP62;NUP93;NUP205;NDC1;CPSF2;NUP153;SRSF6
prerank,protein ADP-ribosylation (GO:0006471),0.2503730501377091,0.5833803199312818,0.9426900584795321,0.9874663308344092,1.0,9/28,25.74%,PARP3;PARP8;SIRT1;ZC3HAV1;HPF1;PARP10;ART4;SIRT4;PARP16
prerank,snRNA 3'-end processing (GO:0034472),0.2615018052929583,0.5832797278681552,0.9399477806788512,0.9871958864605325,1.0,6/19,23.84%,EXOSC4;INTS7;INTS14;EXOSC9;INTS2;TUT1
prerank,long-term synaptic potentiation (GO:0060291),0.25727671628825716,0.5830228636318618,0.9396863691194209,0.9870048696147701,1.0,9/21,33.19%,SHANK2;NPTN;SLC24A2;MPP2;PRKCZ;GRIN2B;STX4;SLC8A3;RGS14
prerank,quinone biosynthetic process (GO:1901663),0.27619136173566694,0.5820030832826926,0.937748344370861,0.9872448876589537,1.0,5/14,25.25%,COQ10B;COQ8A;COQ3;COQ2;PDSS1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.29244937573246654,0.5809427348499879,0.9306930693069307,0.9868503717775354,1.0,4/10,27.16%,BLM;ERCC1;WRN;TERF1
prerank,t-circle formation (GO:0090656),0.29244937573246654,0.5809427348499879,0.9306930693069307,0.9868503717775354,1.0,4/10,27.16%,BLM;ERCC1;WRN;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.29244937573246654,0.5809427348499879,0.9306930693069307,0.9868503717775354,1.0,4/10,27.16%,BLM;ERCC1;WRN;TERF1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.2338695140411276,0.580546664293349,0.9675615212527964,0.9867478408931243,1.0,14/37,28.86%,DYNLL1;WDR35;IFT57;KIF3B;DYNLRB1;IFT22;SSX2IP;IFT140;IFT27;IFT172;DYNC2H1;IFT80;DYNC2I1;KIF17
prerank,regulation of mRNA polyadenylation (GO:1900363),0.26601263111195905,0.5804170113508647,0.939820742637644,0.9864819059652017,1.0,6/17,26.52%,NUDT21;CPEB3;CTR9;CCNT1;RNF20;RNF40
prerank,rRNA transcription (GO:0009303),0.26850265899289627,0.5795807853807942,0.9302325581395349,0.9865879733899285,1.0,3/17,11.52%,POLR1G;TAF1B;GTF3C3
prerank,cellular response to glucose stimulus (GO:0071333),0.2399337732648527,0.5794106460249201,0.945852534562212,0.986358975773615,1.0,9/30,26.49%,RACK1;PTPRN;AGER;IGF1R;MLXIPL;SELENOT;ERN1;PDK3;ADCY8
prerank,positive regulation of protein sumoylation (GO:0033235),0.2897334716336923,0.5793871355433354,0.9164222873900293,0.9860418641505652,1.0,3/10,18.76%,MUL1;PIAS1;HDAC4
prerank,termination of RNA polymerase I transcription (GO:0006363),0.24154769226356887,0.5784817298954534,0.9500580720092915,0.986215389093208,1.0,7/30,20.99%,POLR1G;GTF2H5;TAF1B;POLR2F;TBP;CAVIN1;POLR1F
prerank,phospholipid dephosphorylation (GO:0046839),0.23387622793023116,0.5769751018007118,0.9598623853211009,0.9866871189470363,1.0,12/37,26.79%,PLPPR5;PTEN;MTM1;PLPP6;PLPPR2;OCRL;PIP4P1;MTMR1;MTMR10;SGPP1;SGPP2;SYNJ2
prerank,regulation of cilium assembly (GO:1902017),0.22274959743485861,0.5763293193324281,0.9810326659641728,0.9866994795641237,1.0,14/62,23.62%,TBC1D10C;TBC1D22B;ATG5;RABGAP1;TBC1D2B;TBC1D19;ATG3;RABEP2;CCDC88A;TBC1D13;IFT140;TBC1D20;LIMK2;HTT
prerank,regulation of epidermal cell differentiation (GO:0045604),0.260436602887006,0.5743127008583748,0.9459119496855346,0.9874289097007487,1.0,4/21,14.25%,BMP4;SFN;ROCK1;GDF3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.2729222350309859,0.5738538368103615,0.9307589880159787,0.9873271531792066,1.0,2/13,8.71%,PLXNB1;PLXNA2
prerank,RNA export from nucleus (GO:0006405),0.21255670053321019,0.5738024079258587,0.9887983706720977,0.987024208649339,1.0,25/100,25.48%,AGFG1;NUP50;EIF4A3;NUP214;NUP210;NUP88;CDC40;RANBP2;SRSF7;POLDIP3;RBM8A;SLU7;AAAS;YTHDC1;SLBP;THOC1;SRSF4;SMG7;NUP62;NUP93;NUP205;NDC1;CPSF2;NUP153;SRSF6
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.2782766433486668,0.5734207619798339,0.9240162822252375,0.9868959386927044,1.0,4/12,26.55%,POU2AF1;GPR183;DOCK10;LFNG
prerank,cytoplasmic translational initiation (GO:0002183),0.26126838645273426,0.5712121777858716,0.9407313997477932,0.9877130274610836,1.0,6/17,27.60%,EIF3I;EIF2D;EIF4B;DHX29;EIF4G1;DENR
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.214314917760603,0.5706988774139766,0.983419689119171,0.9876528411605632,1.0,17/87,24.14%,CCL5;NDNF;CD44;NR4A1;EGR3;ZFP36L2;POLR2F;HNRNPF;FGF7;RBFOX2;POLR2D;TIA1;TIAL1;FRS2;FGFR1;FGFR3;ITGB1BP1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.27638298105390985,0.5706558655735066,0.9350282485875706,0.987347224922368,1.0,4/11,27.44%,HSP90AA1;CALM1;QDPR;SPR
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.28962163715294537,0.5690044311291926,0.9461756373937678,0.9878583455658912,1.0,3/10,20.69%,PPP2R1A;PPP2CA;PIBF1
prerank,regulation of viral release from host cell (GO:1902186),0.2458573547424026,0.5667918734078229,0.947239263803681,0.9886322154834307,1.0,8/21,29.89%,TRIM21;DDB1;TRIM28;TRIM8;TRIM25;TRIM11;TRIM26;CHMP2A
prerank,establishment of spindle localization (GO:0051293),0.2707523122303823,0.5666463292944339,0.9539295392953929,0.9883812195005889,1.0,4/14,23.27%,CFL1;ESPL1;MAP4;CLASP2
prerank,estrogen metabolic process (GO:0008210),0.26747987508876814,0.5657844385828116,0.9357798165137615,0.9884745795904867,1.0,1/15,7.33%,HSD17B7
prerank,rRNA modification (GO:0000154),0.2514622867391606,0.5657688955899628,0.9416149068322981,0.9881537366914784,1.0,5/21,20.00%,FTSJ3;MRM2;FBL;TRMT112;GAR1
prerank,pancreas development (GO:0031016),-0.2200389227195681,-0.5644196569593224,0.9649805447470817,0.9966381422789863,1.0,12/12,78.02%,NPHP3;TCF7L2;CCDC40;ISL1;DNAAF1;NKX6-1;FOXF1;ZIC3;PROX1;CCDC39;SELENOT;MET
prerank,regulation of microtubule depolymerization (GO:0031114),0.24218687650606652,0.5634391883899489,0.963572267920094,0.9889583819858181,1.0,4/25,16.08%,MID1IP1;MAP1B;KATNB1;STMN2
prerank,N-terminal protein amino acid modification (GO:0031365),-0.21662441775632413,-0.5630532495338976,0.9566929133858267,0.9956147276056714,1.0,9/14,38.32%,NAA40;NAA35;NAA10;NAA60;NAA15;AANAT;METAP1D;NAA50;METAP1
prerank,lipid droplet organization (GO:0034389),0.2461648620087566,0.5624201360697684,0.9603365384615384,0.9891204912669762,1.0,1/22,4.57%,PPIA
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.27136960064722965,0.5610802055393982,0.9355742296918768,0.9890695587871887,1.0,5/11,27.31%,PTEN;INPP5A;OCRL;SYNJ2;IMPA2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.27136960064722965,0.5610802055393982,0.9355742296918768,0.9890695587871887,1.0,5/11,27.31%,PTEN;INPP5A;OCRL;SYNJ2;IMPA2
prerank,sterol metabolic process (GO:0016125),0.21907063907426963,0.5610671592551912,0.9797225186766275,0.9887493777004569,1.0,12/60,23.09%,LBR;APOE;SOAT1;PMVK;ARV1;CYP7B1;SOAT2;OSBPL1A;CYP26B1;PIP4P1;MSMO1;LIPA
prerank,protein O-linked glycosylation (GO:0006493),0.21062234895527346,0.5610320515447007,0.9938208032955715,0.9884363022418249,1.0,16/96,19.60%,B3GNT3;DPM3;ST3GAL1;GALNT15;GALNT13;SDF2L1;GALNT6;GXYLT2;GALNT18;B3GNT2;FKTN;GALNTL6;CRPPA;POGLUT1;OGA;B3GALNT2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.22597979998380605,0.5605698441028926,0.9715909090909091,0.9883347842373925,1.0,6/37,17.77%,APOE;NCOR1;SDCBP;ABCA2;ANKRD13A;RIN3
prerank,autophagy of peroxisome (GO:0030242),0.2762598496194327,0.5601280232535135,0.946793997271487,0.9882103679173275,1.0,1/12,5.60%,ATM
prerank,inner dynein arm assembly (GO:0036159),0.2755806654111739,0.5599727065022314,0.9415855354659249,0.9879548465651405,1.0,11/11,72.46%,DNAAF5;CCDC39;CCDC103;ZMYND10;CFAP73;DNAAF4;CFAP100;DNAH1;DNAAF1;DNAI3;CCDC40
prerank,myelin assembly (GO:0032288),0.27844545452445724,0.5584398044476878,0.9365079365079365,0.9883361972053314,1.0,5/10,28.66%,ABCA2;TENM4;PMP22;NCMAP;DICER1
prerank,cognition (GO:0050890),0.22316191756061893,0.5583895353734908,0.9730337078651685,0.9880309846243661,1.0,9/42,22.01%,NIPBL;MFSD2A;MAGT1;SETD5;TUSC3;MGAT3;CYFIP1;LINS1;SOBP
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.24905721633588732,0.5575476684021149,0.9514321295143213,0.9880903128408524,1.0,9/20,29.78%,GART;GMPR2;AMPD3;HPRT1;GMPS;AK4;AK3;PFAS;ADSL
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.2501335071419423,0.5574378059562672,0.9528535980148883,0.987814533070658,1.0,7/19,25.72%,SREBF1;GSK3A;DNM1L;HTT;FBXW7;ATP13A2;CSNK2A2
prerank,positive regulation of ion transport (GO:0043270),0.21863079197525156,0.5562993332245636,0.9846994535519126,0.9879986434483218,1.0,15/48,26.54%,CCL5;F2R;ANK3;DRD2;SCN3B;SCN1B;PRSS8;DLG1;STIM2;P2RX7;ACTN2;LILRA5;ATP2B1;GPD1L;WFS1
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.19283537730859135,-0.5550571647201493,0.9863013698630136,0.9969712094772949,1.0,8/17,34.87%,NEIL2;NEIL1;NEIL3;ACD;SMUG1;UNG;NTHL1;MUTYH
prerank,synaptic vesicle cycle (GO:0099504),0.23150062463422436,0.5536617111696382,0.9686046511627907,0.9888389089318691,1.0,6/30,20.82%,SLC18A2;SYT7;DNAJC5;CPLX2;SNCA;RIMS1
prerank,negative regulation of cell division (GO:0051782),0.27893163448974617,0.5534631653578507,0.9386331938633193,0.9885926041731443,1.0,4/11,27.92%,BLM;ORC6;TXNIP;MYC
prerank,nucleic acid-templated transcription (GO:0097659),0.22096713971281018,0.5534319984273184,0.9733629300776915,0.9882810406177814,1.0,7/42,14.79%,NR4A2;CREBL2;MLF1;TAF1B;POLR2F;BAZ2A;XAB2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.23485359707467102,0.5531536225532913,0.9744483159117305,0.988075302025083,1.0,6/31,20.31%,PEX2;DNAJC15;PEX16;TIMM17B;TIMM17A;PEX10
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.23612207264092902,0.5525500581850241,0.9703791469194313,0.98802497117552,1.0,12/29,28.14%,COG6;NSF;COPB2;GOSR2;COG5;COPZ1;NAPG;COG2;RAB33B;TRAPPC10;COPZ2;COG8
prerank,positive regulation of organelle assembly (GO:1902117),0.22257708712124746,0.5519659678221704,0.9757442116868799,0.987943629138502,1.0,12/44,23.62%,PLK4;LCP1;GPSM2;G3BP2;RALB;CAPG;SDCBP;CCDC88A;PDCD6IP;NUP62;CNOT6L;HTT
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.23930145360866661,0.5491656629053752,0.9614906832298137,0.9887822559172869,1.0,9/22,29.22%,NEDD4;SNF8;VPS28;MVB12A;PLAA;PTPN23;VPS37C;RNF115;VPS4B
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.21670926300449572,0.546894671199624,0.9782844733984799,0.9894381072126173,1.0,13/52,23.81%,EXOSC4;DCP1A;LSM3;HBS1L;EXOSC1;SAMD4A;LSM6;LSM4;POLR2D;EXOSC9;DDX6;CNOT6L;RC3H1
prerank,double-strand break repair (GO:0006302),0.19943760844499048,0.5468615298973294,0.9909819639278558,0.9891245946868291,1.0,23/158,17.25%,HMGB1;MDC1;ERCC4;ATM;HMGB2;BARD1;POLB;MORF4L1;NSMCE1;PARP3;APTX;NABP1;ACTR8;BLM;DDX1;ERCC1;TENT4A;BRIP1;PALB2;REV3L;SAMHD1;ERCC5;HPF1
prerank,protein import into mitochondrial matrix (GO:0030150),0.2521221697328168,0.545539267706809,0.9663760896637609,0.9893504227484049,1.0,3/18,17.48%,DNAJC15;TIMM17B;TIMM17A
prerank,chemical homeostasis (GO:0048878),0.20954306317509355,0.5454836359490767,0.981151832460733,0.989045953416579,1.0,5/61,9.91%,ACOXL;NR1D2;AQP11;THADA;AQP4
prerank,lysine metabolic process (GO:0006553),-0.21578796597686983,-0.5439166361350137,0.9765100671140939,0.9974665494558025,1.0,2/12,10.74%,DLD;OGDH
prerank,lysine catabolic process (GO:0006554),-0.21578796597686983,-0.5439166361350137,0.9765100671140939,0.9974665494558025,1.0,2/12,10.74%,DLD;OGDH
prerank,regulation of AMPA receptor activity (GO:2000311),0.2346047682236187,0.5436213627852481,0.966547192353644,0.9894735388933246,1.0,3/25,10.80%,CACNG7;GSG1L;SHISA9
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.26330720711565997,0.5422883269684008,0.9561643835616438,0.9896706655581704,1.0,4/12,22.13%,CAV1;CTNNA3;JUP;DLG1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2059367840732909,0.5386257350161671,0.9948024948024948,0.9907848151830687,1.0,24/62,29.70%,NUP50;NUP214;NUP210;NUP88;LIMD1;RANBP2;POLR2F;AAAS;AGO2;POLR2D;NUP62;NUP93;NUP205;NDC1;NUP153;PPARG;ZFP36;EIF4G1;PUM1;NUP98;TPR;H3-3A;NUP35;ELAVL1
prerank,L-glutamate transmembrane transport (GO:0015813),0.27869038298328896,0.5362126831518038,0.9548762736535662,0.9913453214536172,1.0,3/10,20.05%,SLC1A6;ARL6IP5;SLC25A22
prerank,positive regulation of exosomal secretion (GO:1903543),0.249054394835514,0.5354720707774987,0.9603174603174603,0.9912941005712617,1.0,7/15,29.89%,SNF8;SDCBP;PDCD6IP;ATP13A2;RAB7A;VPS4B;CHMP2A
prerank,B cell activation involved in immune response (GO:0002312),0.25568057481532713,0.534038332415214,0.9590723055934516,0.9915017688010764,1.0,4/13,21.23%,MSH6;BATF;MSH2;GPR183
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.22287361505049944,0.5338770084237993,0.970344009489917,0.9912301681843729,1.0,4/29,15.91%,UFM1;VPS11;PAK1;WBP2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.24837284110376895,0.5329182425465572,0.9672131147540983,0.991226867817207,1.0,1/16,3.94%,ERCC4
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.22046344847349142,0.5328801965058023,0.9804372842347526,0.9909151995842949,1.0,9/37,23.27%,MAPRE2;ROCK1;MAPT;STMN2;MAPRE3;EPHA3;PHLDB1;GSK3B;CLASP2
prerank,homocysteine metabolic process (GO:0050667),0.27281175587947976,0.5326414136734565,0.9515235457063712,0.9906782011166362,1.0,1/11,7.25%,MMUT
prerank,regulation of receptor recycling (GO:0001919),-0.1879844233638499,-0.5319058878477104,0.9726027397260274,0.9992392090313073,1.0,6/16,26.25%,ANXA2;TBC1D16;KIF16B;VAMP3;AP1AR;SCRIB
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.19653093940290922,-0.5313696896231646,0.9838709677419355,0.9978379425519885,1.0,3/14,19.97%,TLR8;THBS1;CMKLR1
prerank,inositol phosphate catabolic process (GO:0071545),0.25318593208951357,0.5301408964045246,0.9519230769230769,0.9912420102180048,1.0,3/12,18.64%,PTEN;INPP5A;OCRL
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.25926221787128934,0.5298969548963001,0.9554937413073713,0.9909992104812961,1.0,3/11,20.38%,PCBP4;PCBP1;PCBP3
prerank,ubiquinone metabolic process (GO:0006743),0.24943374151195402,0.5298815461753903,0.9642384105960264,0.9906834760208653,1.0,5/15,25.25%,COQ10B;COQ8A;COQ3;COQ2;PDSS1
prerank,dorsal/ventral pattern formation (GO:0009953),0.22968934646102052,0.5279198070561945,0.9741267787839586,0.9910440846417334,1.0,2/20,11.27%,GREM1;NBL1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.21857777013891141,-0.5273675724949719,0.9779411764705882,0.9972573002767005,1.0,2/10,11.77%,NOC2L;TAF7
prerank,AMP metabolic process (GO:0046033),0.25228150144429645,0.5269730286767698,0.9737569060773481,0.9910314378156192,1.0,6/13,29.78%,AK9;AMPD3;AK4;AK3;NUDT2;ADSL
prerank,negative regulation of lipid storage (GO:0010888),0.2372977299848803,0.5269714150155242,0.974293059125964,0.9907091867036486,1.0,4/19,18.72%,NR1H2;NFKBIA;TREM2;TTC39B
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.24595037278838952,0.5244573206226516,0.9699042407660738,0.9912108877478547,1.0,4/16,18.17%,PARPBP;RMI2;HELB;CGAS
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.24735483373983247,0.5239995530314165,0.968421052631579,0.9910337637318162,1.0,4/15,21.47%,CD36;TREM2;USP50;NLRC3
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.22693261395123399,0.5209909637769459,0.9839704069050554,0.9913705580537315,1.0,5/23,21.23%,ING2;RNF111;SDCBP;STK11;HSP90AB1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.22693261395123399,0.5209909637769459,0.9839704069050554,0.9913705580537315,1.0,5/23,21.23%,ING2;RNF111;SDCBP;STK11;HSP90AB1
prerank,Golgi localization (GO:0051645),0.25732865595742027,0.5191677894074581,0.9709141274238227,0.9916105593268021,1.0,3/11,20.61%,CDC42;ARHGAP21;YWHAZ
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.22901199179504808,0.5182161925314525,0.9734620024125452,0.9915750832796786,1.0,3/21,16.08%,MID1IP1;KATNB1;STMN2
prerank,aspartate family amino acid metabolic process (GO:0009066),0.23465693776457225,0.5180270756807294,0.9659090909090909,0.9913074647017661,1.0,6/18,25.28%,ADI1;MTHFD1;ASPA;ASS1;GOT2;SMS
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.22034772506686276,0.5171941844164609,0.982989064398542,0.9912316484523978,1.0,9/27,26.39%,RNASE6;CSTF3;NYNRIN;NUDT16;RNASEH1;ERN1;ZC3H12D;XRN1;KHNYN
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.22493481355592504,0.5170365627547341,0.9642416769420469,0.9909594620408412,1.0,4/21,24.45%,PLAAT3;PLA2G12A;OSBPL8;MBOAT1
prerank,glycoprotein catabolic process (GO:0006516),0.23165446262230327,0.5159119358384612,0.9710327455919395,0.9909850592929123,1.0,7/17,30.00%,MMP12;EDEM1;OGA;FBXO44;STT3B;NGLY1;ADAMTS9
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.2556800601013298,0.5148615396959215,0.9684361549497847,0.9909702173770207,1.0,2/11,14.21%,ELOF1;SERTAD2
prerank,response to ethanol (GO:0045471),0.2426384722569561,0.5130365038721308,0.9827127659574468,0.9911551690317505,1.0,6/14,33.34%,GRIN3A;GOT2;GRIN1;GRIN2B;SOD1;GLRA2
prerank,regulation of synapse maturation (GO:0090128),-0.2062017450254221,-0.5120405390115125,0.99,0.999223470013968,1.0,10/10,79.40%,CAMK2B;ANAPC2;NRXN1;ARHGEF15;CDC20;ADGRL1;NEUROD2;DAB2IP;RELN;YWHAZ
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.26010384729869,0.5115463225783905,0.9539106145251397,0.9912495128734726,1.0,1/10,8.99%,BMP6
prerank,body fluid secretion (GO:0007589),0.24273485539406023,0.5099327427286551,0.9730077120822622,0.9913848246258399,1.0,1/15,6.08%,ZBTB7B
prerank,positive regulation of hormone secretion (GO:0046887),-0.17294649585531272,-0.5087164391736986,0.9956140350877193,0.9982941689834205,1.0,17/17,82.73%,VAMP7;HFE;VAMP8;C1QTNF3;TFR2;HCAR2;RASL10B;NMB;EDN3;CYP19A1;EDN1;SNX4;FGG;PLA2G3;SPP1;GRP;SOX11
prerank,regulation of dopamine secretion (GO:0014059),0.21879881707208093,0.5065481368403371,0.9847417840375586,0.992006103052205,1.0,6/25,24.35%,SYT4;SYT7;DRD2;SNCA;SYT17;SYT13
prerank,purine-containing compound salvage (GO:0043101),0.24977011273119648,0.5056330243701207,0.9686221009549796,0.9919347768574387,1.0,5/12,27.33%,GMPR2;AMPD3;HPRT1;APRT;DCK
prerank,positive regulation of dendrite development (GO:1900006),0.25544444815415596,0.5045028707100514,0.9656652360515021,0.9919119095009078,1.0,2/10,20.24%,ZDHHC15;VLDLR
prerank,phasic smooth muscle contraction (GO:0014821),-0.20368285057596602,-0.5026588348879774,0.9894366197183099,0.9978435474725185,1.0,1/10,4.76%,TIFAB
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.192412713969847,0.5001667604894091,0.9914438502673797,0.992701155448122,1.0,9/59,20.29%,ACSF3;ABCD3;PER2;SRR;ACACA;CYP7B1;ACOT8;OSBPL1A;HSD17B4
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.23997825519533686,0.4981612622145627,0.9699042407660738,0.9928667405824049,1.0,2/13,14.38%,LCMT1;PCID2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.173529240611977,-0.4974041275593523,0.9870689655172413,0.997212793637606,1.0,1/16,2.13%,PDK1
prerank,cellular amino acid catabolic process (GO:0009063),0.1822765778414939,0.4964115035380717,0.9989648033126294,0.9929741798024745,1.0,22/87,29.25%,SHMT1;ACAD8;ACAT1;ACADSB;ASPA;DDO;PHYKPL;SLC25A44;MCCC1;KYAT1;GCDH;DBT;QDPR;SLC25A21;GOT2;SHMT2;BLMH;HIBCH;ALDH4A1;HIBADH;CARNMT1;GAD1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.23670575916311282,0.4944261149417055,0.9683195592286501,0.9930999222449574,1.0,5/13,29.59%,HEY2;GSK3A;RYR2;CPE;SMAD4
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.22460015109991824,0.4942308749848781,0.9849246231155779,0.9928176437180993,1.0,6/19,27.33%,GMPR2;TYMS;AMPD3;HPRT1;APRT;DCK
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.17920567598590442,-0.49100617689974824,0.9957264957264957,0.9967526005302735,1.0,9/14,43.99%,NOTCH1;THBS1;KLF4;STARD13;MEOX2;PDCD10;CARD10;DLL4;TBXA2R
prerank,regulation of centrosome cycle (GO:0046605),0.2150011657676272,0.490338841766531,0.9887780548628429,0.993381442181388,1.0,8/21,30.71%,CHMP5;NPM1;SIRT1;PDCD6IP;VPS4B;CHMP1A;CHMP2A;ATF5
prerank,ncRNA 3'-end processing (GO:0043628),0.23113760935779182,0.48582130081197655,0.981994459833795,0.9940434129688102,1.0,4/14,23.64%,INTS7;ERI1;INTS14;INTS2
prerank,motile cilium assembly (GO:0044458),-0.18883796848515289,-0.48389050401600553,1.0,0.9962025482068081,1.0,12/12,81.14%,E2F4;BBOF1;CCDC40;RSPH9;DNAAF1;RSPH6A;ZMYND10;MCIDAS;BBS5;CCDC39;SPATA6;DNAAF3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.22429461716920904,0.4830365051649059,0.9839786381842457,0.9943067473884557,1.0,1/16,5.19%,APOE
prerank,regulation of microtubule-based process (GO:0032886),0.19561035207452054,0.4751859021148925,0.9977272727272727,0.9954638989256152,1.0,8/36,23.27%,DIAPH1;ROCK1;MAPT;EPHA3;PHLDB1;GSK3B;MEMO1;CLASP2
prerank,regulation of cholesterol storage (GO:0010885),0.2181263182506086,0.466550049188542,0.9867899603698811,0.9966460379494819,1.0,7/15,29.89%,NR1H2;TREM2;TTC39B;EHD1;PPARG;LPL;ABCG1
prerank,retinoic acid metabolic process (GO:0042573),0.21650572400132223,0.46543478932642346,0.9871134020618557,0.9965056296168481,1.0,2/14,19.97%,SCPEP1;CYP26B1
prerank,embryonic heart tube development (GO:0035050),0.22081999120989498,0.46510602033032783,0.9810040705563093,0.9962328551089596,1.0,14/14,77.94%,HES1;RYR2;SOX18;FGF8;APELA;TBX20;MEGF8;SOX17;PITX2;CITED2;TBX2;ACVR1;IFT122;NDRG4
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.20026117366390064,0.4641015086509927,0.9987714987714987,0.9960827079516145,1.0,9/23,29.87%,PTEN;MTM1;OCRL;PIP4P1;MTMR1;MTMR10;SYNJ2;PIP4P2;MTMR12
prerank,mitochondrial protein processing (GO:0034982),0.22852978549594338,0.4636982165787206,0.9887323943661972,0.995822134179923,1.0,3/11,24.87%,OMA1;PMPCA;STOML2
prerank,cellular senescence (GO:0090398),0.1953044988216557,0.4603832665598166,0.9854191980558931,0.995998541660752,1.0,6/27,25.84%,ID2;SIRT1;CDKN1A;SMC6;SMC5;CALR
prerank,glycerol metabolic process (GO:0006071),0.23155941443669237,0.45905269491051415,0.9855699855699855,0.9958710914308279,1.0,5/10,32.46%,COQ3;COQ2;TKFC;GK;TPI1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.2286919625616771,0.45676782129402776,0.9901129943502824,0.9958695470845854,1.0,1/11,9.60%,ATP1A1
prerank,peptidyl-methionine modification (GO:0018206),0.22208794201922938,0.4548819974302682,0.9915730337078652,0.995801261754641,1.0,2/12,18.28%,NAA16;METAP2
prerank,regulation of response to stress (GO:0080134),-0.18871869654952927,-0.44965735090262837,0.9966887417218543,0.998015626743004,1.0,5/10,34.40%,CORO2B;OPRM1;STOX1;DYRK3;CRHBP
prerank,membrane repolarization during action potential (GO:0086011),0.21596642270456828,0.44811303583281326,0.9959128065395095,0.9963771293964198,1.0,1/13,9.60%,ATP1A1
prerank,inorganic ion transmembrane transport (GO:0098660),0.2117680185862111,0.44165241449560777,0.9865771812080537,0.9968124936422635,1.0,1/12,10.26%,CACNA1H
prerank,recombinational repair (GO:0000725),0.16162159732053707,0.42767526529342376,1.0,0.9978813330818775,1.0,15/77,23.68%,ERCC4;MORF4L1;NSMCE1;NABP1;BLM;PALB2;REV3L;SAMHD1;ERCC5;YY1;RBBP8;SMC6;SEM1;WRN;SMC5
prerank,negative regulation of protein depolymerization (GO:1901880),0.18490235360385163,0.4244194632080616,0.9976359338061466,0.9978464561414714,1.0,7/24,28.59%,MID1IP1;KATNB1;STMN2;CLASP2;SPEF1;LIMA1;PLEKHH2
prerank,regulation of lipase activity (GO:0060191),0.20268939067027344,0.4193680292561273,0.9972972972972973,0.9979205233554747,1.0,4/13,28.92%,RHOC;SNCA;RHOA;LPL
prerank,cellular response to amino acid stimulus (GO:0071230),0.1703066428980625,0.4176237972026852,0.9988751406074241,0.9977293719878472,1.0,9/33,27.98%,LAMTOR4;SESN3;CPEB3;FYN;SH3BP4;RRAGB;CASTOR2;RPTOR;SLC38A9
prerank,regulation of protein localization to centrosome (GO:1904779),0.20745715899818,0.4046467428892133,0.9943422913719944,0.9982436375386203,1.0,10/10,79.27%,GSK3B;NUP62;CEP250;NSFL1C;APC;UBXN2B;BICD1;PARD6A;CEP72;MARK4
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.17391225409237107,0.3684029948967604,0.9986666666666667,0.9993538221945274,1.0,1/15,9.60%,ATP1A1
